data_2mmg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mmg _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 115.065 1.506 . . . . 100.0 115.065 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -122.81 134.75 54.4 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.001 1.721 . . . . 100.0 106.694 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.53 132.4 53.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.647 -0.871 . . . . 100.0 108.647 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.47 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 87.8 tttt -89.04 116.94 27.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.23 129.22 56.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-N 114.251 -1.34 . . . . 100.0 107.874 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.12 124.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.155 -1.424 . . . . 100.0 107.155 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.5 tp -105.27 117.72 34.74 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.771 -1.566 . . . . 100.0 106.771 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.97 162.72 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.259 -1.337 . . . . 100.0 112.567 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.91 172.49 20.68 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 109.629 -1.388 . . . . 100.0 109.629 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.1 159.62 34.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.831 0.824 . . . . 100.0 112.778 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 139.44 39.69 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 110.173 -1.171 . . . . 100.0 110.173 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.65 2.8 89.88 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 118.592 -1.116 . . . . 100.0 114.774 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 p -64.06 -39.72 94.69 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 118.767 1.283 . . . . 100.0 113.887 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.18 19.32 5.17 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-O 118.941 -0.922 . . . . 100.0 111.477 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.66 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 10.3 mtmp? -60.08 -47.64 85.04 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 118.889 1.344 . . . . 100.0 111.143 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.3 m -64.55 -42.99 95.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.096 1.358 . . . . 100.0 110.671 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.2 m -63.12 -40.77 98.59 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.665 1.186 . . . . 100.0 109.177 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.524 ' CG ' ' HE2' ' A' ' 89' ' ' MET . 68.1 t80 -60.67 -48.12 83.19 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.335 1.454 . . . . 100.0 110.369 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.28 -43.25 97.18 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 O-C-N 123.55 0.531 . . . . 100.0 111.025 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.71 -39.83 92.91 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.79 0.663 . . . . 100.0 112.79 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.733 HH21 ' HA ' ' A' ' 151' ' ' ALA . 13.1 ttm180 -60.48 -45.86 92.2 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.262 1.025 . . . . 100.0 109.086 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -64.35 -42.38 96.26 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.296 0.85 . . . . 100.0 113.296 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.61 -44.6 66.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.3 p -119.36 -23.3 6.73 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 117.826 2.528 . . . . 100.0 117.826 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.92 -7.73 73.45 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 110.992 -0.843 . . . . 100.0 110.992 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.0 156.58 30.06 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.765 1.226 . . . . 100.0 109.142 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -114.65 118.26 33.15 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 102.612 -3.107 . . . . 100.0 102.612 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -87.81 110.21 20.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.905 0.86 . . . . 100.0 111.085 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.06 -40.12 68.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.107 1.363 . . . . 100.0 113.85 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HE3' HG22 ' A' ' 206' ' ' THR . 96.3 mttt -80.06 131.17 35.72 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.389 1.076 . . . . 100.0 112.218 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -99.41 110.45 22.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.142 -1.023 . . . . 100.0 108.266 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.7 122.46 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 102.418 -3.178 . . . . 100.0 102.418 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.27 142.33 57.79 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.282 0.845 . . . . 100.0 113.282 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.5 m -92.95 127.22 38.38 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 104.431 -2.433 . . . . 100.0 104.431 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -105.34 127.14 52.81 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 107.916 -1.142 . . . . 100.0 107.916 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.32 -121.19 12.83 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.007 -1.637 . . . . 100.0 109.007 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.23 142.92 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.162 0.506 . . . . 100.0 110.197 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -121.13 123.59 42.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 105.007 -2.22 . . . . 100.0 105.007 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.6 t -100.31 122.02 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.675 -1.231 . . . . 100.0 107.675 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -126.65 124.45 24.19 Favored Pre-proline 0 N--CA 1.434 -1.238 0 CA-C-N 115.924 -0.58 . . . . 100.0 112.016 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.74 127.58 8.01 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 124.612 3.541 . . . . 100.0 112.81 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.0 tp -133.17 126.83 32.5 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.987 -1.116 . . . . 100.0 107.987 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.6 t -114.99 135.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 O-C-N 121.604 -0.685 . . . . 100.0 110.268 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -124.3 143.86 50.32 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.051 0.941 . . . . 100.0 109.102 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -102.35 127.38 49.37 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.022 -1.473 . . . . 100.0 107.022 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.7 p -122.0 179.24 4.58 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.982 0.896 . . . . 100.0 109.249 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -58.16 -36.62 73.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.875 2.07 . . . . 100.0 109.617 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -91.54 8.07 38.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 113.864 1.061 . . . . 100.0 113.864 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.74 176.19 20.07 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 121.907 -0.496 . . . . 100.0 112.074 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.61 138.21 29.0 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 123.271 2.647 . . . . 100.0 113.554 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -131.09 142.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 124.11 0.881 . . . . 100.0 109.003 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -106.76 132.65 52.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.473 -0.785 . . . . 100.0 112.112 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.62 117.8 34.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.527 -2.768 . . . . 100.0 103.527 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.522 HD21 ' HE1' ' A' ' 64' ' ' TRP . 55.5 t30 -94.8 100.76 12.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 100.508 -3.886 . . . . 100.0 100.508 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.74 126.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 CA-C-N 115.387 -0.824 . . . . 100.0 110.171 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.522 ' HE1' HD21 ' A' ' 62' ' ' ASN . 21.1 m95 -104.64 99.53 9.2 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.162 -2.162 . . . . 100.0 105.162 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.23 116.79 24.63 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.32 164.06 11.97 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.321 0.86 . . . . 100.0 113.321 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.04 131.62 35.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.212 1.005 . . . . 100.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.23 -10.5 80.15 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 114.492 0.557 . . . . 100.0 114.492 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -70.24 -38.76 75.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.15 2.18 . . . . 100.0 112.314 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HB2' HH11 ' A' ' 76' ' ' ARG . 96.6 mt-10 -62.29 137.03 58.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 124.973 1.309 . . . . 100.0 113.536 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.494 -1.23 . . . . 100.0 109.525 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -67.38 131.74 46.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.752 -1.944 . . . . 100.0 105.752 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.29 -176.1 40.27 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 118.788 -1.672 . . . . 100.0 114.474 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.72 64.38 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 127.188 2.327 . . . . 100.0 113.835 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.65 -37.72 85.09 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.21 1.804 . . . . 100.0 109.573 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.408 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.6 mtp85 -89.36 10.34 22.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 126.413 1.885 . . . . 100.0 115.762 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.8 -39.09 90.49 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 115.844 1.794 . . . . 100.0 115.844 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.79 86.16 Favored Glycine 0 C--N 1.355 1.631 0 C-N-CA 124.171 0.891 . . . . 100.0 113.26 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -62.47 -43.0 99.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.721 1.208 . . . . 100.0 109.819 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.589 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.4 t80 -88.81 -18.99 26.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 114.905 1.446 . . . . 100.0 114.905 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.25 131.65 21.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 CA-C-N 119.316 0.962 . . . . 100.0 109.667 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.279 91.6 mt-30 60.23 27.32 16.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 127.249 2.22 . . . . 100.0 115.377 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.3 46.75 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 107.029 -1.471 . . . . 100.0 107.029 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -106.35 -24.75 12.17 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 116.342 -0.39 . . . . 100.0 110.908 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.4 p -158.11 165.0 36.08 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.767 0.827 . . . . 100.0 109.233 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.78 155.79 41.45 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 119.627 -0.829 . . . . 100.0 112.863 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.39 126.81 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.714 -2.328 . . . . 100.0 104.714 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.52 124.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 103.789 -2.671 . . . . 100.0 103.789 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.552 ' HB3' HD22 ' A' ' 122' ' ' ASN . 55.7 mtt -112.64 135.4 53.41 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 116.549 2.055 . . . . 100.0 116.549 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -132.49 161.27 34.16 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 113.035 -1.893 . . . . 100.0 109.696 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.74 123.67 48.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.002 -1.851 . . . . 100.0 106.002 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -63.72 -20.38 26.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 114.063 1.134 . . . . 100.0 114.063 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -90.18 -2.46 58.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 118.896 -0.573 . . . . 100.0 111.479 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.5 t -125.79 113.43 17.27 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 122.578 1.18 . . . . 100.0 111.678 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -65.22 -38.67 91.15 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 114.896 -1.047 . . . . 100.0 111.934 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.25 -41.89 91.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 124.836 1.254 . . . . 100.0 108.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.6 m -62.62 -41.54 99.07 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 122.769 0.428 . . . . 100.0 110.532 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.381 0.672 . . . . 100.0 110.841 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.45 -35.34 73.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 124.679 1.192 . . . . 100.0 111.578 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -76.03 -9.78 58.89 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 115.848 1.795 . . . . 100.0 115.848 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.6 t -59.24 -44.99 99.21 Favored Pre-proline 0 C--N 1.363 1.174 0 CA-C-O 116.03 -1.938 . . . . 100.0 112.115 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -59.08 -31.64 95.93 Favored 'Trans proline' 0 C--N 1.376 2.022 0 CA-C-N 122.747 2.017 . . . . 100.0 113.058 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.65 -42.95 81.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.783 0.72 . . . . 100.0 109.818 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -63.91 -45.79 87.75 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 109.565 -0.532 . . . . 100.0 109.565 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -90.72 70.17 6.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.543 -1.28 . . . . 100.0 107.543 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -168.02 -55.2 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 100.329 -3.952 . . . . 100.0 100.329 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.61 -43.82 98.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.691 -1.596 . . . . 100.0 106.691 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.589 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.6 mp -63.02 -50.14 71.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 113.366 0.876 . . . . 100.0 113.366 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.267 33.3 m -67.25 -22.81 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.267 90.9 mtt180 -61.24 -39.89 92.0 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.705 -0.85 . . . . 100.0 108.705 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.01 -47.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 113.735 1.013 . . . . 100.0 113.735 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.295 63.5 m -105.04 -2.28 24.62 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 119.405 3.113 . . . . 100.0 119.405 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.285 41.3 mt-10 54.96 -119.31 1.43 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.94 1.089 . . . . 100.0 113.94 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.49 110.73 22.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 120.151 1.341 . . . . 100.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.8 152.05 51.2 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 104.754 -2.313 . . . . 100.0 104.754 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.43 126.67 18.95 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.337 2.025 . . . . 100.0 112.251 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.403 ' HB ' HD21 ' A' ' 144' ' ' LEU . 64.5 mt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.747 -1.205 . . . . 100.0 107.747 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.46 132.15 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.416 -1.265 . . . . 100.0 108.417 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.36 124.75 44.74 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.387 -2.079 . . . . 100.0 105.387 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.452 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -116.74 124.73 50.36 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 122.259 1.028 . . . . 100.0 111.577 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.09 102.73 2.84 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 104.911 -3.276 . . . . 100.0 104.911 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.552 HD22 ' HB3' ' A' ' 89' ' ' MET . 72.7 m-80 -81.17 163.15 23.28 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 124.954 1.302 . . . . 100.0 111.865 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.71 38.51 24.94 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 128.386 2.674 . . . . 100.0 114.826 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.57 -14.7 18.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 113.787 1.032 . . . . 100.0 113.787 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.465 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 23.4 t70 -64.38 -37.1 86.31 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.755 1.222 . . . . 100.0 109.597 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.27 131.32 29.94 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-O 122.127 0.965 . . . . 100.0 109.82 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.68 -45.5 92.51 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -85.36 77.08 10.03 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.599 0.714 . . . . 100.0 110.29 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.94 138.79 38.24 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.615 -1.254 . . . . 100.0 107.615 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.67 -43.62 6.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.489 -0.56 . . . . 100.0 109.489 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.13 107.8 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.225 -2.139 . . . . 100.0 105.225 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -77.78 148.54 34.74 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.088 -1.415 . . . . 100.0 109.158 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.77 88.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.169 0.988 . . . . 100.0 110.161 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.11 -41.1 97.89 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.111 1.364 . . . . 100.0 111.066 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.9 m -62.43 -37.8 87.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.717 1.607 . . . . 100.0 113.465 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.568 HG23 ' HD1' ' A' ' 139' ' ' HIS . 88.9 mt -65.19 120.09 11.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-O 122.382 1.087 . . . . 100.0 110.099 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.44 -7.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 125.626 1.571 . . . . 100.0 112.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -58.85 -41.36 86.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.124 1.37 . . . . 100.0 111.161 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.568 ' HD1' HG23 ' A' ' 136' ' ' ILE . 44.7 p-80 -61.28 -38.66 87.56 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 123.795 0.838 . . . . 100.0 111.716 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.92 -46.1 89.4 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.528 0.731 . . . . 100.0 111.367 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.57 -40.97 89.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.039 0.936 . . . . 100.0 112.838 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -92.83 2.23 56.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 116.808 2.151 . . . . 100.0 116.808 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 54.96 47.83 21.28 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-O 123.13 1.443 . . . . 100.0 113.672 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.403 HD21 ' HB ' ' A' ' 117' ' ' ILE . 44.9 mt -110.55 159.85 17.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.91 -1.495 . . . . 100.0 107.481 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.435 ' HG3' ' CD1' ' A' ' 163' ' ' TRP . 92.3 mm-40 -97.14 141.9 29.71 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.421 -1.326 . . . . 100.0 107.421 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -118.0 132.78 56.35 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 120.977 0.417 . . . . 100.0 111.701 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.23 135.13 42.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.594 -0.73 . . . . 100.0 112.448 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -86.66 123.42 31.82 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.517 -3.512 . . . . 100.0 101.517 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.5 pt -135.07 157.14 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 122.384 1.088 . . . . 100.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.465 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 40.3 t -141.19 114.01 8.39 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.853 -1.906 . . . . 100.0 105.853 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.733 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -64.0 -39.36 93.94 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.809 0.844 . . . . 100.0 108.776 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.97 -46.8 85.99 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.682 1.993 . . . . 100.0 114.261 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.8 p -103.86 -0.46 29.11 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 114.962 1.467 . . . . 100.0 114.962 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 65.72 21.33 11.57 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.145 1.778 . . . . 100.0 114.048 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -70.58 120.29 16.0 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.142 -1.429 . . . . 100.0 107.142 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 54.02 33.64 18.0 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.175 2.19 . . . . 100.0 111.867 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -60.29 -38.68 84.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.678 1.362 . . . . 100.0 114.678 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -88.49 -10.74 47.97 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 115.786 1.773 . . . . 100.0 115.786 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.267 95.5 mttt -59.87 -45.57 98.26 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 118.768 2.877 . . . . 100.0 118.768 -176.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -58.98 -41.99 56.29 Favored 'Trans proline' 0 C--N 1.372 1.79 0 CA-C-N 122.626 1.973 . . . . 100.0 113.696 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.9 -43.04 94.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 124.083 0.865 . . . . 100.0 112.013 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.85 -43.1 94.13 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 112.96 0.726 . . . . 100.0 112.96 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.511 ' HE1' ' HE3' ' A' ' 167' ' ' LYS . 60.6 t-105 -63.21 -44.67 94.65 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 123.597 0.561 . . . . 100.0 110.408 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.16 -41.38 96.66 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 123.483 0.49 . . . . 100.0 110.806 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.85 99.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 123.705 0.802 . . . . 100.0 110.611 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -61.7 -47.07 86.95 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 118.654 -0.689 . . . . 100.0 111.402 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.511 ' HE3' ' HE1' ' A' ' 163' ' ' TRP 0.26 92.9 mttt -66.95 -42.79 84.66 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 114.911 1.449 . . . . 100.0 114.911 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.43 -46.88 78.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.247 0.832 . . . . 100.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.5 -38.28 73.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.018 0.927 . . . . 100.0 109.963 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.52 10.23 55.81 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-O 118.436 -1.202 . . . . 100.0 113.861 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.47 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 52.2 t0 -111.58 112.51 53.95 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 106.018 -1.845 . . . . 100.0 106.018 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.07 -15.73 43.65 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.648 2.898 . . . . 100.0 112.67 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -92.78 2.77 56.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.941 1.296 . . . . 100.0 113.816 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 69.5 mt -59.19 133.21 55.89 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 119.576 1.08 . . . . 100.0 113.339 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.432 -1.37 0 CA-C-N 114.156 -1.384 . . . . 100.0 109.009 -178.351 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 104.162 -2.532 . . . . 100.0 104.162 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -63.63 132.0 95.05 Favored Pre-proline 0 N--CA 1.439 -0.997 0 C-N-CA 122.754 0.422 . . . . 100.0 111.887 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 183' ' ' ALA . 45.5 Cg_exo -65.64 147.16 85.91 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.819 3.013 . . . . 100.0 112.78 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.93 147.6 91.93 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 123.505 2.803 . . . . 100.0 111.012 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -63.26 -43.55 97.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 123.816 0.846 . . . . 100.0 112.584 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.8 t 68.99 99.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 127.112 2.165 . . . . 100.0 111.81 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.48 -71.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 103.08 -2.933 . . . . 100.0 103.08 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.256 77.1 mtp 9.34 -128.72 0.0 OUTLIER 'General case' 0 C--N 1.367 1.348 0 C-N-CA 131.396 3.879 . . . . 100.0 119.374 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.326 85.6 m-20 . . . . . 0 C--N 1.377 1.799 0 C-N-CA 131.383 3.873 . . . . 100.0 115.71 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.439 -1.012 0 CA-C-O 118.813 -0.613 . . . . 100.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -65.9 -42.41 90.23 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.833 0.853 . . . . 100.0 112.255 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.0 mt -60.88 -41.63 96.38 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.751 0.82 . . . . 100.0 111.553 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.97 -43.39 98.93 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.348 1.059 . . . . 100.0 111.347 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.14 -45.51 98.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 108.193 -1.04 . . . . 100.0 108.193 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.69 95.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 113.928 1.084 . . . . 100.0 113.928 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -61.76 -44.36 97.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.738 1.215 . . . . 100.0 111.96 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.401 HG22 ' HE3' ' A' ' 38' ' ' LYS . 97.4 m -64.72 -43.64 92.75 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.459 1.504 . . . . 100.0 110.427 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 124.316 2.008 . . . . 100.0 115.079 -177.951 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 118.533 2.79 . . . . 100.0 118.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -126.01 134.61 51.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.698 -2.046 . . . . 100.0 107.639 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.29 130.62 53.33 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.476 -0.935 . . . . 100.0 108.476 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.18 114.04 26.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.203 -1.777 . . . . 100.0 106.203 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.5 tp -113.21 129.2 56.59 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 114.374 -1.284 . . . . 100.0 109.612 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -112.25 125.73 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 118.563 -1.255 . . . . 100.0 109.363 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.81 121.33 41.89 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 108.074 -1.084 . . . . 100.0 108.074 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.76 160.38 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 113.613 -1.631 . . . . 100.0 110.814 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.08 172.35 20.65 Favored Glycine 0 CA--C 1.493 -1.311 0 N-CA-C 109.893 -1.283 . . . . 100.0 109.893 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' HB2' HG21 ' A' ' 97' ' ' THR . 85.3 m-20 -71.58 159.86 33.71 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.115 0.96 . . . . 100.0 113.189 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.07 139.8 40.92 Favored Glycine 0 C--N 1.353 1.495 0 N-CA-C 109.94 -1.264 . . . . 100.0 109.94 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.09 2.16 89.48 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 118.864 -0.964 . . . . 100.0 114.892 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.1 p -63.32 -39.32 94.25 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 114.31 1.226 . . . . 100.0 114.31 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.03 16.51 6.73 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 118.666 -1.074 . . . . 100.0 112.003 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.611 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 10.2 mtmp? -60.0 -46.47 89.38 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 119.045 1.422 . . . . 100.0 111.664 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.0 m -64.13 -44.59 91.74 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.83 1.252 . . . . 100.0 110.967 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -63.47 -40.62 97.6 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.037 0.935 . . . . 100.0 109.954 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.36 -48.04 83.1 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.277 1.031 . . . . 100.0 111.227 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.54 -42.02 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 123.123 0.265 . . . . 100.0 111.026 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.69 -40.35 94.68 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.547 0.739 . . . . 100.0 111.188 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.615 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.8 tmm_? -61.62 -43.46 98.82 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 123.606 0.762 . . . . 100.0 110.192 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -63.04 -42.17 99.69 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.352 0.501 . . . . 100.0 112.352 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -70.1 -43.96 70.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.912 1.819 . . . . 100.0 115.912 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.1 p -120.14 -24.88 5.87 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.891 2.552 . . . . 100.0 117.891 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.93 68.19 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.816 -0.914 . . . . 100.0 110.816 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.9 152.36 35.41 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.137 0.975 . . . . 100.0 109.198 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.31 117.67 31.75 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 102.074 -3.306 . . . . 100.0 102.074 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -92.61 117.92 30.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.4 -0.963 . . . . 100.0 108.4 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.08 -11.97 29.5 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.633 -1.167 . . . . 100.0 112.976 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.31 123.74 47.36 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.591 -0.892 . . . . 100.0 108.591 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.79 115.45 27.44 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.261 1.029 . . . . 100.0 111.117 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -121.25 123.96 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 101.216 -3.624 . . . . 100.0 101.216 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.2 139.29 58.49 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 113.942 1.09 . . . . 100.0 113.942 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.0 m -84.76 130.01 34.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.25 127.32 51.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 106.857 -1.534 . . . . 100.0 106.857 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.57 -120.61 15.26 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.808 -1.317 . . . . 100.0 109.808 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.99 144.82 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 120.931 0.396 . . . . 100.0 110.415 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -119.91 124.0 44.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 103.172 -2.899 . . . . 100.0 103.172 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.1 t -101.31 120.82 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.26 -1.385 . . . . 100.0 107.26 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -127.11 123.02 23.31 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.85 -0.614 . . . . 100.0 111.772 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.596 ' HB3' ' HZ1' ' A' ' 60' ' ' LYS . 17.9 Cg_exo -80.81 129.81 7.31 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 124.165 3.243 . . . . 100.0 111.204 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -132.23 128.84 38.75 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.169 -1.048 . . . . 100.0 108.169 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.82 134.85 54.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 108.462 -0.94 . . . . 100.0 108.462 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -124.8 140.86 52.54 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.675 1.59 . . . . 100.0 109.073 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -105.33 124.01 48.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.326 1.06 . . . . 100.0 108.884 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.5 p -119.58 -179.99 4.05 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.354 -1.294 . . . . 100.0 111.432 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.08 -36.36 74.96 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 127.281 2.233 . . . . 100.0 109.512 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.01 7.38 40.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.384 0.883 . . . . 100.0 113.384 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.03 179.6 20.78 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 118.853 0.751 . . . . 100.0 111.948 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.19 140.0 36.51 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.14 2.56 . . . . 100.0 113.225 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 pt -130.27 140.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.811 -1.552 . . . . 100.0 106.811 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.596 ' HZ1' ' HB3' ' A' ' 49' ' ' PRO . 33.4 ttpt -113.72 132.77 55.69 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.994 -1.082 . . . . 100.0 110.884 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.51 118.88 37.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.288 -2.116 . . . . 100.0 105.288 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.72 97.7 10.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 100.74 -3.8 . . . . 100.0 100.74 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.65 126.82 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 121.297 0.57 . . . . 100.0 110.968 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -108.1 99.38 8.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.188 -1.782 . . . . 100.0 106.188 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -89.13 117.52 28.18 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.004 -2.221 . . . . 100.0 105.004 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -97.67 164.87 12.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.805 1.039 . . . . 100.0 113.805 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.1 131.85 34.75 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.154 0.982 . . . . 100.0 109.304 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.09 -10.45 84.87 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.352 0.501 . . . . 100.0 114.352 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.97 -39.77 75.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.393 1.877 . . . . 100.0 112.485 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -62.92 134.82 56.8 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.035 0.934 . . . . 100.0 113.365 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.49 154.65 40.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.975 -1.012 . . . . 100.0 110.263 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -66.76 132.26 47.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.707 1.603 . . . . 100.0 106.949 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.41 -176.8 38.74 Favored Glycine 0 C--N 1.356 1.642 0 C-N-CA 119.212 -1.47 . . . . 100.0 114.621 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.52 -23.64 65.08 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 127.057 2.265 . . . . 100.0 113.744 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -62.43 -31.86 72.62 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.488 1.115 . . . . 100.0 111.527 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.4 mtp-105 -92.33 10.21 30.75 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.631 1.572 . . . . 100.0 114.409 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.69 -38.02 86.28 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 116.082 1.882 . . . . 100.0 116.082 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.68 -38.68 92.24 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.77 0.7 . . . . 100.0 113.457 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -63.26 -42.72 99.17 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.157 0.983 . . . . 100.0 110.217 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.492 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 3.0 t80 -91.35 -18.59 24.04 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 114.726 1.38 . . . . 100.0 114.726 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.6 pt -61.18 136.42 24.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 CA-C-N 119.787 1.176 . . . . 100.0 111.19 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 63.66 21.93 12.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.719 2.008 . . . . 100.0 113.824 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.87 145.56 46.81 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 107.368 -1.345 . . . . 100.0 107.368 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -103.76 -24.02 13.37 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.883 -0.599 . . . . 100.0 110.71 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.6 p -159.38 165.51 33.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 123.536 0.735 . . . . 100.0 110.391 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.71 156.31 42.2 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 113.309 0.855 . . . . 100.0 113.309 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.5 126.45 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 104.752 -2.314 . . . . 100.0 104.752 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 65.2 mt -108.21 124.22 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 102.343 -3.206 . . . . 100.0 102.343 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.576 ' HB3' HD22 ' A' ' 122' ' ' ASN . 94.8 mtp -114.41 132.31 56.28 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.805 -1.089 . . . . 100.0 113.22 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -132.84 161.44 34.15 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.87 -1.513 . . . . 100.0 109.374 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -104.26 125.47 50.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.847 -1.538 . . . . 100.0 106.847 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.9 -19.42 24.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.952 1.093 . . . . 100.0 113.952 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -89.25 -4.87 58.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 119.262 -0.399 . . . . 100.0 111.474 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -125.56 115.23 19.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.737 1.256 . . . . 100.0 112.035 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.15 -39.49 93.07 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 114.491 -1.231 . . . . 100.0 110.984 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.08 -41.6 89.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 C-N-CA 125.073 1.349 . . . . 100.0 109.22 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 18' ' ' ASP . 94.5 m -62.87 -41.78 99.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.161 0.584 . . . . 100.0 109.807 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.48 ' HH ' HG21 ' A' ' 136' ' ' ILE . 79.7 t80 -65.27 -39.79 93.06 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.246 0.618 . . . . 100.0 111.038 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -59.34 -36.72 76.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.738 1.215 . . . . 100.0 111.057 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.41 -10.88 60.01 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.552 1.686 . . . . 100.0 115.552 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -59.43 -44.02 97.22 Favored Pre-proline 0 C--N 1.361 1.072 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.777 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 85.9 Cg_exo -57.4 -35.29 98.87 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.759 2.306 . . . . 100.0 112.466 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.73 -43.08 85.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.884 0.874 . . . . 100.0 110.356 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -63.79 -45.39 89.9 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 51.0 t-80 -90.68 69.62 6.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.639 -1.245 . . . . 100.0 107.639 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -169.4 -53.09 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 100.592 -3.855 . . . . 100.0 100.592 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.81 -43.89 97.59 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.579 -1.638 . . . . 100.0 106.579 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.492 ' HG ' ' CZ ' ' A' ' 80' ' ' TYR . 6.6 mp -62.81 -48.64 78.25 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.303 1.041 . . . . 100.0 113.139 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.22 -34.26 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 C-N-CA 127.358 2.263 . . . . 100.0 110.696 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.25 -40.17 81.07 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 118.657 -0.687 . . . . 100.0 111.253 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.262 11.8 m -97.33 -34.95 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 116.009 1.855 . . . . 100.0 116.009 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.294 70.6 m -105.13 -3.19 23.34 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 118.23 2.678 . . . . 100.0 118.23 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 54.38 -121.8 1.86 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.309 1.444 . . . . 100.0 113.462 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -94.48 109.2 21.1 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.335 1.064 . . . . 100.0 113.617 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.28 149.92 50.03 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 104.434 -2.432 . . . . 100.0 104.434 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.64 128.6 25.06 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.15 1.9 . . . . 100.0 113.138 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.42 135.4 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.439 -1.319 . . . . 100.0 107.439 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.45 132.07 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.168 -1.378 . . . . 100.0 108.738 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.0 mt -98.15 125.64 43.26 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.686 -1.968 . . . . 100.0 105.686 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -118.05 125.22 49.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.017 0.913 . . . . 100.0 112.53 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.97 102.24 2.72 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 105.277 -3.129 . . . . 100.0 105.277 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.576 HD22 ' HB3' ' A' ' 89' ' ' MET . 70.1 m-80 -81.5 162.92 23.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.517 1.527 . . . . 100.0 112.865 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 57.86 42.3 23.41 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.65 2.38 . . . . 100.0 115.122 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' A' ' 148' ' ' ASP . 34.1 m -65.02 -16.24 19.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 CA-C-N 115.902 -0.59 . . . . 100.0 112.348 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.52 ' CG ' ' HG ' ' A' ' 150' ' ' SER . 90.1 m-20 -62.29 -37.91 87.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 124.216 1.006 . . . . 100.0 112.41 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.24 132.38 27.93 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 CA-C-O 121.844 0.83 . . . . 100.0 109.82 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.93 -45.5 92.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 116.76 2.133 . . . . 100.0 116.76 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -86.07 77.47 9.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.305 0.574 . . . . 100.0 110.706 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -81.43 132.75 35.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.849 -0.797 . . . . 100.0 108.849 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -99.06 -41.95 7.31 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 115.976 -0.556 . . . . 100.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.21 106.23 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.42 155.52 25.85 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.129 -0.942 . . . . 100.0 109.253 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.02 83.19 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.527 1.131 . . . . 100.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.56 -40.91 96.41 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.216 1.006 . . . . 100.0 111.755 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.6 m -61.51 -38.54 87.72 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 125.615 1.566 . . . . 100.0 113.22 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.568 HG23 ' HD1' ' A' ' 139' ' ' HIS . 86.3 mt -65.56 121.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 122.074 0.94 . . . . 100.0 110.319 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.34 -9.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.093 -1.412 . . . . 100.0 112.009 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -58.57 -39.51 80.5 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.305 1.442 . . . . 100.0 111.746 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.568 ' HD1' HG23 ' A' ' 136' ' ' ILE . 49.0 p-80 -60.89 -39.87 90.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 123.931 0.892 . . . . 100.0 111.695 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.19 -44.29 92.46 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.304 0.642 . . . . 100.0 112.147 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.08 -42.28 94.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.464 1.106 . . . . 100.0 111.53 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -94.62 3.1 55.51 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 118.109 2.633 . . . . 100.0 118.109 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 55.08 47.18 22.53 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 123.137 1.446 . . . . 100.0 113.59 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.3 mt -110.63 160.02 17.05 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 113.9 -1.5 . . . . 100.0 107.369 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -101.98 140.76 35.84 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.25 -1.389 . . . . 100.0 107.25 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -115.2 134.81 54.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.204 0.526 . . . . 100.0 112.184 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.99 136.18 41.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.624 -0.716 . . . . 100.0 112.529 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.449 ' HB3' HG12 ' A' ' 124' ' ' VAL . 22.4 m-20 -87.55 123.77 32.79 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 101.724 -3.436 . . . . 100.0 101.724 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.4 pt -134.43 157.53 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.309 1.052 . . . . 100.0 111.914 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.52 ' HG ' ' CG ' ' A' ' 125' ' ' ASP . 35.4 t -141.9 115.87 9.3 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 105.942 -1.873 . . . . 100.0 105.942 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.615 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.06 -38.94 93.17 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.964 0.905 . . . . 100.0 108.908 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.41 -43.84 93.13 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.832 1.653 . . . . 100.0 115.126 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -102.52 -4.16 25.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.604 1.335 . . . . 100.0 114.604 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 68.94 17.02 8.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.851 1.66 . . . . 100.0 113.25 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -66.97 119.64 12.29 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 107.59 -1.263 . . . . 100.0 107.59 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 54.48 30.85 13.64 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 127.048 2.139 . . . . 100.0 112.083 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -60.64 -38.23 84.11 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.372 1.249 . . . . 100.0 114.372 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -86.42 -13.86 45.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.598 1.703 . . . . 100.0 115.598 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.27 62.8 mttp -59.93 -45.68 98.16 Favored Pre-proline 0 C--N 1.358 0.952 0 N-CA-C 118.759 2.874 . . . . 100.0 118.759 -175.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.35 -41.28 60.05 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 122.455 1.912 . . . . 100.0 113.573 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.83 -44.15 94.06 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.962 0.905 . . . . 100.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.06 -42.5 94.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.856 0.687 . . . . 100.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -62.07 -45.53 93.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 123.374 0.422 . . . . 100.0 110.41 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.23 -41.7 97.33 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 123.803 0.689 . . . . 100.0 110.854 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 123.56 0.744 . . . . 100.0 110.556 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.05 -45.87 91.64 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 118.568 -0.729 . . . . 100.0 112.233 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -68.99 -42.69 76.18 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 119.981 -0.688 . . . . 100.0 112.582 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.48 -46.33 80.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 113.666 0.987 . . . . 100.0 113.666 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.02 -38.23 74.64 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.536 1.135 . . . . 100.0 109.56 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.39 9.93 54.59 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 118.371 -1.239 . . . . 100.0 114.6 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.447 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 57.8 t0 -113.61 112.48 48.4 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 106.969 -1.493 . . . . 100.0 106.969 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.31 -15.36 45.62 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.831 3.02 . . . . 100.0 113.025 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -93.04 1.43 57.26 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 114.411 1.263 . . . . 100.0 114.411 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 92.9 mt -60.97 133.88 56.54 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 119.452 1.024 . . . . 100.0 113.647 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 . . . . . 0 N--CA 1.432 -1.372 0 CA-C-N 114.683 -1.144 . . . . 100.0 109.802 179.676 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 CA--C 1.5 -0.946 0 CA-C-O 122.36 1.076 . . . . 100.0 112.354 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.09 146.95 33.54 Favored Pre-proline 0 N--CA 1.425 -1.687 0 CA-C-N 114.014 -1.448 . . . . 100.0 112.59 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.8 157.88 56.63 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 124.382 3.388 . . . . 100.0 110.045 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -60.55 148.36 91.37 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 123.188 2.592 . . . . 100.0 113.561 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.62 138.24 58.29 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.723 1.264 . . . . 100.0 110.683 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.0 135.87 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 106.607 -1.627 . . . . 100.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.38 -76.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 107.973 -1.121 . . . . 100.0 107.973 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.7 ptm -80.8 -176.01 5.62 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 116.91 -1.519 . . . . 100.0 111.463 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--N 1.361 1.103 0 O-C-N 118.342 -2.723 . . . . 100.0 118.146 -179.124 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 N--CA 1.439 -1.016 0 CA-C-O 119.16 -0.448 . . . . 100.0 110.515 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -64.06 -43.35 95.73 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.642 1.177 . . . . 100.0 111.484 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.53 -43.55 98.66 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 123.432 0.693 . . . . 100.0 111.678 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.5 -44.94 92.89 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 123.79 0.836 . . . . 100.0 112.334 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.25 35.7 m -62.89 -39.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.196 0 CA-C-O 118.657 -0.687 . . . . 100.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.2 -44.25 88.99 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.089 0.955 . . . . 100.0 112.928 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -62.89 -41.6 99.48 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.709 1.204 . . . . 100.0 111.863 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 86.7 m -66.31 -42.27 88.5 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.795 1.638 . . . . 100.0 111.934 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 96.1 m . . . . . 0 C--N 1.359 0.998 0 CA-C-O 121.97 0.891 . . . . 100.0 111.184 -178.318 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.435 -1.194 0 N-CA-C 115.568 1.692 . . . . 100.0 115.568 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -125.43 133.93 52.29 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -121.95 130.72 53.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.88 116.07 28.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.96 -1.496 . . . . 100.0 106.96 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.2 tp -110.31 127.07 54.84 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 113.964 -1.471 . . . . 100.0 107.999 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.83 124.86 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 N-CA-C 107.024 -1.472 . . . . 100.0 107.024 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.9 tp -105.73 116.9 32.73 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 106.734 -1.58 . . . . 100.0 106.734 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.58 162.09 36.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 114.481 -1.236 . . . . 100.0 112.414 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.46 170.87 18.16 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 109.605 -1.398 . . . . 100.0 109.605 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.404 ' OD2' ' HA ' ' A' ' 97' ' ' THR . 84.0 m-20 -70.52 160.7 31.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.479 0.918 . . . . 100.0 113.479 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.63 140.19 40.34 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 110.865 -0.894 . . . . 100.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 2.76 90.44 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.646 -1.085 . . . . 100.0 114.303 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.0 p -63.55 -39.17 93.7 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 118.522 1.161 . . . . 100.0 114.131 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 16.8 6.28 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.711 -0.757 . . . . 100.0 111.926 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.91 -47.9 83.9 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 118.58 1.19 . . . . 100.0 111.461 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.4 m -64.67 -43.35 93.87 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.986 1.314 . . . . 100.0 111.034 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.9 m -63.47 -40.62 97.59 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.163 0.985 . . . . 100.0 109.5 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.43 ' CG ' ' HE2' ' A' ' 89' ' ' MET . 85.4 t80 -61.14 -48.29 82.31 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 124.677 1.191 . . . . 100.0 110.319 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.76 -41.89 93.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.919 0 O-C-N 123.277 0.36 . . . . 100.0 111.699 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.02 -42.34 98.28 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.624 0.769 . . . . 100.0 110.718 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.569 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.2 tmm_? -62.28 -42.91 99.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.305 0.642 . . . . 100.0 110.706 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -63.96 -41.83 97.46 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 113.191 0.811 . . . . 100.0 113.191 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.28 -44.45 68.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 115.232 1.567 . . . . 100.0 115.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -120.02 -23.67 6.28 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 118.317 2.71 . . . . 100.0 118.317 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.65 -7.67 71.05 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.311 -0.716 . . . . 100.0 111.311 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.04 154.38 37.99 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.85 1.26 . . . . 100.0 109.456 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HZ ' HD22 ' A' ' 154' ' ' ASN . 91.3 m-85 -115.61 120.52 39.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.322 -2.844 . . . . 100.0 103.322 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -94.73 115.95 28.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.51 0.724 . . . . 100.0 109.16 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -91.39 -31.81 15.89 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.989 -0.284 . . . . 100.0 111.603 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.13 129.83 34.88 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.375 0.607 . . . . 100.0 111.379 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.97 116.51 29.32 Favored 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.116 0.96 . . . . 100.0 112.265 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.61 121.95 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 101.048 -3.686 . . . . 100.0 101.048 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.09 142.25 57.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.708 0.803 . . . . 100.0 113.077 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.6 m -92.61 127.83 38.25 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.99 126.26 50.98 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.387 -1.338 . . . . 100.0 107.387 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.48 -121.69 15.83 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.949 -1.261 . . . . 100.0 109.949 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.3 142.6 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.138 0.495 . . . . 100.0 110.602 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.91 122.89 43.33 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.721 -3.066 . . . . 100.0 102.721 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.39 116.68 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.168 -1.419 . . . . 100.0 107.168 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -124.4 121.69 25.97 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 112.403 0.52 . . . . 100.0 112.403 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HB3' ' HZ2' ' A' ' 60' ' ' LYS . 90.1 Cg_endo -80.05 129.4 7.87 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 124.067 3.178 . . . . 100.0 112.602 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 tp -132.75 126.59 32.79 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.126 -1.435 . . . . 100.0 107.126 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.18 135.36 49.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.351 -0.611 . . . . 100.0 109.351 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.13 137.51 54.12 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 125.138 1.375 . . . . 100.0 107.407 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -103.52 125.24 49.96 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.708 -2.33 . . . . 100.0 104.708 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.2 p -124.71 176.97 6.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.751 0.786 . . . . 100.0 110.421 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -60.41 -27.0 67.12 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.295 1.438 . . . . 100.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -94.4 7.11 46.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 126.785 2.034 . . . . 100.0 112.974 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.0 175.85 25.58 Favored Glycine 0 C--N 1.357 1.7 0 N-CA-C 111.133 -0.787 . . . . 100.0 111.133 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.36 138.88 33.76 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.423 2.748 . . . . 100.0 113.444 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -132.04 142.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 106.974 -1.491 . . . . 100.0 106.974 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.484 ' HZ2' ' HB3' ' A' ' 49' ' ' PRO . 33.9 ttpt -116.97 131.32 56.98 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 118.074 -1.45 . . . . 100.0 111.403 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.87 119.17 38.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 105.325 -2.102 . . . . 100.0 105.325 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.483 ' ND2' ' HE1' ' A' ' 64' ' ' TRP . 46.5 t30 -94.37 100.8 12.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 100.344 -3.947 . . . . 100.0 100.344 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.4 t -87.9 125.77 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-N 115.309 -0.86 . . . . 100.0 109.251 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.483 ' HE1' ' ND2' ' A' ' 62' ' ' ASN . 19.7 m0 -107.34 103.88 13.35 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.05 116.88 23.69 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.584 -2.376 . . . . 100.0 104.584 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 p -103.5 163.05 12.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 113.393 0.886 . . . . 100.0 113.393 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.28 36.14 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 123.78 0.832 . . . . 100.0 110.778 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.52 -8.07 77.98 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 113.834 0.294 . . . . 100.0 113.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -70.41 -39.56 74.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.73 2.012 . . . . 100.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HB2' HH11 ' A' ' 76' ' ' ARG . 95.1 mt-10 -62.96 137.75 58.36 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 125.035 1.334 . . . . 100.0 112.459 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.41 151.65 44.94 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.468 -1.242 . . . . 100.0 111.011 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -65.55 131.17 45.71 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.607 1.963 . . . . 100.0 107.547 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.12 -173.81 36.01 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 118.895 -1.622 . . . . 100.0 115.632 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -20.15 62.64 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 127.699 2.571 . . . . 100.0 113.383 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.16 -38.14 82.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.039 2.135 . . . . 100.0 109.104 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.448 HH11 ' HB2' ' A' ' 70' ' ' GLU . 78.2 mtp85 -92.18 12.85 20.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.653 1.981 . . . . 100.0 115.599 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.11 -39.18 91.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.417 1.636 . . . . 100.0 115.417 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.5 90.83 Favored Glycine 0 C--N 1.357 1.695 0 C-N-CA 123.956 0.788 . . . . 100.0 113.731 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -62.13 -43.3 99.14 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.514 1.126 . . . . 100.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.608 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.5 t80 -87.02 -22.69 25.34 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.204 1.557 . . . . 100.0 115.204 -174.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.5 mt -57.21 133.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 0 CA-C-N 119.342 0.973 . . . . 100.0 109.732 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 63.45 23.18 13.58 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.141 2.176 . . . . 100.0 114.858 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 147.53 45.35 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.139 -1.06 . . . . 100.0 108.139 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -108.2 -22.13 12.49 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 116.419 -0.355 . . . . 100.0 111.261 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.4 p -156.63 164.41 38.21 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.752 -0.462 . . . . 100.0 109.752 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB3' ' HH ' ' A' ' 80' ' ' TYR . . . -148.53 155.65 41.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.308 0.855 . . . . 100.0 113.308 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.5 mt -127.74 126.88 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 104.319 -2.474 . . . . 100.0 104.319 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 68.1 mt -109.96 122.44 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 103.243 -2.873 . . . . 100.0 103.243 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.43 ' HE2' ' CG ' ' A' ' 26' ' ' PHE . 46.8 mtt -112.05 134.75 53.41 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 115.977 1.843 . . . . 100.0 115.977 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -131.49 159.83 36.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.556 -1.656 . . . . 100.0 109.181 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -103.98 124.66 49.41 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.847 -1.909 . . . . 100.0 105.847 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.46 -20.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 N-CA-C 113.79 1.033 . . . . 100.0 113.79 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.3 p -91.35 -2.93 57.22 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 119.146 -0.454 . . . . 100.0 112.014 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -122.67 115.04 21.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 122.92 1.343 . . . . 100.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -64.27 -41.96 96.67 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.095 -1.411 . . . . 100.0 110.689 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.15 -42.31 92.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 125.244 1.417 . . . . 100.0 109.35 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.404 ' HA ' ' OD2' ' A' ' 18' ' ' ASP . 98.2 m -62.96 -41.43 99.52 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.475 0.31 . . . . 100.0 110.981 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.432 ' HH ' HG21 ' A' ' 136' ' ' ILE . 75.5 t80 -65.15 -41.06 95.1 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.636 0.775 . . . . 100.0 111.037 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 95.1 mttt -60.47 -35.18 75.26 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.106 1.362 . . . . 100.0 111.304 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -76.88 -9.28 58.58 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 115.827 1.788 . . . . 100.0 115.827 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.58 -43.26 95.36 Favored Pre-proline 0 C--N 1.361 1.103 0 CA-C-O 116.365 -1.779 . . . . 100.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 71.8 Cg_exo -57.37 -35.17 98.87 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.7 2.267 . . . . 100.0 112.685 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.7 -43.13 85.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 118.683 0.674 . . . . 100.0 110.826 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -63.61 -46.38 86.0 Favored 'General case' 0 C--N 1.366 1.296 0 N-CA-C 109.556 -0.535 . . . . 100.0 109.556 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -90.8 70.14 6.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.843 1.306 . . . . 100.0 107.768 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -165.07 -59.12 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 99.536 -4.246 . . . . 100.0 99.536 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -63.05 -39.72 95.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 123.877 0.736 . . . . 100.0 109.224 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.608 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -61.91 -50.31 72.68 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.757 0.661 . . . . 100.0 112.123 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.264 34.2 m -66.35 -27.86 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 113.046 0.758 . . . . 100.0 113.046 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -60.94 -39.14 88.36 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 118.247 0.476 . . . . 100.0 109.951 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.3 t -86.89 -47.98 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 113.909 1.077 . . . . 100.0 113.909 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.304 62.1 m -106.46 1.76 25.8 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 120.074 3.361 . . . . 100.0 120.074 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 55.56 -121.39 1.69 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.377 1.071 . . . . 100.0 113.241 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -97.43 112.58 24.36 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.911 1.232 . . . . 100.0 111.6 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 41.4 pt -144.62 149.5 43.85 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 104.49 -2.411 . . . . 100.0 104.49 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.27 129.26 27.73 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.28 1.987 . . . . 100.0 112.608 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.414 ' HB ' HD21 ' A' ' 144' ' ' LEU . 66.9 mt -133.12 135.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.275 -1.379 . . . . 100.0 107.275 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.08 131.67 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 114.303 -1.317 . . . . 100.0 108.389 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . 0.261 86.0 mt -98.82 127.31 44.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.461 -2.051 . . . . 100.0 105.461 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.423 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.74 125.34 49.43 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.871 0.843 . . . . 100.0 111.686 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.68 101.1 2.57 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 104.026 -3.629 . . . . 100.0 104.026 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.83 162.02 24.19 Favored 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 124.966 1.306 . . . . 100.0 112.532 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 58.1 40.81 24.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 127.76 2.424 . . . . 100.0 115.324 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.39 -15.0 18.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 112.634 0.605 . . . . 100.0 112.634 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.442 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 38.4 t70 -62.43 -38.87 91.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.051 1.74 . . . . 100.0 110.35 178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.45 131.58 29.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 124.024 0.93 . . . . 100.0 109.8 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.56 -42.88 91.35 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 116.593 2.072 . . . . 100.0 116.593 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.45 74.56 10.36 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-O 121.697 0.761 . . . . 100.0 110.121 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -83.73 137.42 33.76 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 115.669 -0.696 . . . . 100.0 110.557 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.66 -44.91 4.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.009 -0.541 . . . . 100.0 110.724 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.4 t -95.55 107.16 19.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 105.765 -1.939 . . . . 100.0 105.765 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -81.35 150.14 28.57 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.756 -1.111 . . . . 100.0 109.755 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.46 87.73 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.658 1.183 . . . . 100.0 111.988 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -62.4 -40.82 97.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.021 0.928 . . . . 100.0 111.267 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.3 m -62.15 -35.55 79.13 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.897 1.679 . . . . 100.0 113.511 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.516 HG23 ' HD1' ' A' ' 139' ' ' HIS . 94.2 mt -64.37 121.36 13.24 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 CA-C-O 122.66 1.219 . . . . 100.0 109.774 -177.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.571 HG13 HH21 ' A' ' 140' ' ' ARG . 29.2 m -128.49 -9.59 3.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-N 113.331 -1.759 . . . . 100.0 112.812 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.19 -41.85 84.82 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 125.233 1.413 . . . . 100.0 111.789 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.516 ' HD1' HG23 ' A' ' 136' ' ' ILE . 45.2 p-80 -61.47 -40.29 94.0 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.65 -0.691 . . . . 100.0 112.687 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.571 HH21 HG13 ' A' ' 137' ' ' VAL . 91.8 mtm-85 -64.41 -43.16 95.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.687 0.676 . . . . 100.0 112.301 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.47 -41.3 93.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.31 1.044 . . . . 100.0 111.638 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.2 7.2 47.08 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 117.488 2.403 . . . . 100.0 117.488 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.44 49.38 16.94 Favored 'General case' 0 C--N 1.362 1.144 0 CA-C-O 122.756 1.265 . . . . 100.0 112.813 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.414 HD21 ' HB ' ' A' ' 117' ' ' ILE . 43.7 mt -116.96 160.98 20.08 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.048 -1.093 . . . . 100.0 108.048 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.405 ' HG3' ' NE1' ' A' ' 163' ' ' TRP . 97.5 mm-40 -98.87 140.54 32.89 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -117.05 134.83 54.26 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.557 0.694 . . . . 100.0 112.41 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -134.15 136.87 44.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.328 -0.851 . . . . 100.0 111.999 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -88.29 125.45 34.67 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 101.165 -3.643 . . . . 100.0 101.165 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.93 157.29 38.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 CA-C-O 122.138 0.971 . . . . 100.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.442 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 42.3 t -141.86 116.43 9.67 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 105.285 -2.117 . . . . 100.0 105.285 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.569 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.43 -40.8 98.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.651 0.78 . . . . 100.0 109.651 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.32 -42.29 75.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.151 1.537 . . . . 100.0 115.151 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 m -93.16 -7.74 44.48 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 114.291 1.219 . . . . 100.0 114.291 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.455 HD22 ' HZ ' ' A' ' 35' ' ' PHE . 87.4 m-20 66.56 18.63 10.81 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.147 1.779 . . . . 100.0 112.81 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -69.66 118.92 13.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.45 -1.315 . . . . 100.0 107.45 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.52 33.16 15.57 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 127.383 2.273 . . . . 100.0 111.701 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.47 -39.31 90.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.324 1.601 . . . . 100.0 115.324 -175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -89.47 -8.12 53.58 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 115.616 1.71 . . . . 100.0 115.616 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 95.8 mttt -61.03 -44.27 93.85 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 118.189 2.663 . . . . 100.0 118.189 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.11 -41.3 61.94 Favored 'Trans proline' 0 C--N 1.374 1.894 0 CA-C-N 122.459 1.914 . . . . 100.0 112.994 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -64.5 -43.97 92.44 Favored 'General case' 0 CA--C 1.495 -1.141 0 O-C-N 124.055 0.847 . . . . 100.0 112.062 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.0 -42.86 94.11 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 113.098 0.777 . . . . 100.0 113.098 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.405 ' NE1' ' HG3' ' A' ' 145' ' ' GLN . 62.9 t-105 -62.82 -45.89 90.5 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 123.453 0.471 . . . . 100.0 110.224 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.65 -42.83 97.78 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 123.653 0.595 . . . . 100.0 110.819 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.32 99.08 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 123.668 0.787 . . . . 100.0 111.107 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.05 -45.12 94.95 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.609 0.764 . . . . 100.0 112.024 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.64 -43.4 76.36 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 112.469 0.544 . . . . 100.0 112.469 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.17 -46.64 80.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.195 0.813 . . . . 100.0 113.195 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.85 -38.62 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 125.127 1.371 . . . . 100.0 110.455 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.96 11.82 57.25 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 118.678 -1.068 . . . . 100.0 112.818 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -109.62 109.25 59.85 Favored Pre-proline 0 C--N 1.361 1.075 0 N-CA-C 106.719 -1.586 . . . . 100.0 106.719 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.35 -22.23 66.32 Favored 'Trans proline' 0 C--N 1.365 1.396 0 C-N-CA 124.087 3.191 . . . . 100.0 113.462 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -100.17 12.0 38.02 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 114.079 1.14 . . . . 100.0 114.079 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.16 131.65 51.17 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.516 0.726 . . . . 100.0 109.946 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--N 1.357 0.906 0 CA-C-N 115.883 -0.599 . . . . 100.0 111.158 -178.203 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 108.273 -1.01 . . . . 100.0 108.273 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.12 118.26 71.13 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.677 -2.342 . . . . 100.0 104.677 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.43 143.09 62.05 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 123.687 2.925 . . . . 100.0 116.211 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.26 160.58 48.46 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 123.626 2.884 . . . . 100.0 108.889 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.95 -48.15 83.17 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 112.927 0.714 . . . . 100.0 112.927 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.254 39.0 t 60.47 96.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.871 2.068 . . . . 100.0 112.603 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.18 -91.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 102.191 -3.263 . . . . 100.0 102.191 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.8 mtm 50.19 -130.35 2.06 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 127.951 2.501 . . . . 100.0 115.145 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.338 63.2 m-20 . . . . . 0 C--N 1.365 1.277 1 N-CA-C 124.788 5.107 . . . . 100.0 124.788 -179.557 . . . . . . . . 2 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 110.006 -0.368 . . . . 100.0 110.006 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -64.69 -41.12 96.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.255 1.422 . . . . 100.0 111.431 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.4 -42.82 99.34 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.882 0.873 . . . . 100.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -63.0 -45.55 91.87 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 123.995 0.918 . . . . 100.0 111.801 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.259 34.5 m -62.9 -39.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.363 1.193 0 CA-C-O 119.025 -0.512 . . . . 100.0 110.377 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.69 92.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.916 1.286 . . . . 100.0 112.238 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -62.74 -39.69 94.88 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.523 1.129 . . . . 100.0 111.43 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 84.8 m -65.52 -42.54 91.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.697 1.599 . . . . 100.0 111.488 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--N 1.358 0.949 0 C-N-CA 124.259 1.024 . . . . 100.0 112.329 -177.882 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 118.574 2.805 . . . . 100.0 118.574 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.267 19.1 tt0 -131.39 136.72 48.27 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.835 1.654 . . . . 100.0 108.237 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -128.33 131.93 48.61 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.877 -0.786 . . . . 100.0 108.877 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.468 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.2 tttt -90.44 115.35 27.54 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 105.294 -2.113 . . . . 100.0 105.294 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.478 ' HG ' ' SG ' ' A' ' 85' ' ' CYS . 2.8 tt -116.51 130.24 56.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.362 -1.348 . . . . 100.0 107.362 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -111.25 125.39 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 118.577 -1.249 . . . . 100.0 109.713 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 mp -102.08 120.45 40.45 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -128.87 161.19 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.057 -1.429 . . . . 100.0 111.235 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.14 172.59 20.92 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.555 -1.418 . . . . 100.0 109.555 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -71.0 160.12 33.5 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.777 0.799 . . . . 100.0 112.827 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.52 140.09 40.41 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 110.316 -1.114 . . . . 100.0 110.316 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.68 89.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 118.608 -1.107 . . . . 100.0 114.536 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 p -64.05 -39.4 93.99 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 118.802 1.301 . . . . 100.0 114.084 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.54 17.83 5.94 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 118.992 -0.893 . . . . 100.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.56 -47.75 84.35 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 118.923 1.361 . . . . 100.0 110.611 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 m -64.83 -43.23 93.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.209 1.403 . . . . 100.0 111.158 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.4 m -63.08 -41.59 99.45 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.369 1.068 . . . . 100.0 109.483 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.451 ' CG ' ' HE2' ' A' ' 89' ' ' MET . 89.6 t80 -61.3 -48.14 82.73 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.748 1.219 . . . . 100.0 110.429 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -43.08 96.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 122.739 0.415 . . . . 100.0 111.112 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.56 -41.96 98.14 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.885 0.874 . . . . 100.0 111.056 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HG2' HH11 ' A' ' 29' ' ' ARG . 28.5 ttp85 -61.64 -43.21 99.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.041 0.937 . . . . 100.0 110.35 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -63.82 -41.32 97.89 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 112.829 0.677 . . . . 100.0 112.829 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -69.3 -44.44 71.76 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.355 1.613 . . . . 100.0 115.355 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.8 p -118.94 -23.1 7.03 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 117.708 2.484 . . . . 100.0 117.708 -176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.22 -7.74 72.46 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.582 -1.007 . . . . 100.0 110.582 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.12 153.93 31.71 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.857 1.663 . . . . 100.0 109.662 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -117.32 119.07 34.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.993 -2.966 . . . . 100.0 102.993 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.25 119.06 37.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.608 -0.837 . . . . 100.0 108.854 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.7 -13.85 33.35 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.87 1.063 . . . . 100.0 113.87 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 199' ' ' HIS . 98.2 mttt -94.74 124.99 39.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.384 -1.339 . . . . 100.0 107.384 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -96.61 112.48 24.21 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.815 0.817 . . . . 100.0 109.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.33 124.33 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 102.453 -3.166 . . . . 100.0 102.453 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.97 142.43 57.46 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.172 1.175 . . . . 100.0 114.172 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.8 m -92.37 130.08 38.14 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.3 -2.111 . . . . 100.0 105.3 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -102.92 126.67 50.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.404 -0.961 . . . . 100.0 108.404 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.83 -121.89 18.03 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 109.543 -1.423 . . . . 100.0 109.543 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.08 141.73 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.216 -0.661 . . . . 100.0 109.216 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -124.26 125.1 43.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.084 -2.562 . . . . 100.0 104.084 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.85 121.52 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.561 -1.2 . . . . 100.0 108.169 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.86 122.14 25.57 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 115.583 -0.735 . . . . 100.0 111.269 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.12 128.35 7.28 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.561 2.841 . . . . 100.0 110.969 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -131.64 123.6 28.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.067 -1.086 . . . . 100.0 108.067 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.9 t -110.32 135.9 47.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 N-CA-C 108.863 -0.792 . . . . 100.0 108.863 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -124.35 138.52 54.37 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.495 -1.298 . . . . 100.0 107.495 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -98.59 126.28 44.12 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 107.208 -1.404 . . . . 100.0 107.208 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 p -124.11 -179.78 4.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.956 -1.02 . . . . 100.0 109.868 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.91 -35.6 73.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.052 2.141 . . . . 100.0 109.484 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.23 10.94 29.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 124.182 0.993 . . . . 100.0 113.554 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.53 176.1 25.03 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.758 -0.537 . . . . 100.0 111.758 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.71 136.8 40.13 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.365 2.71 . . . . 100.0 114.486 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.78 142.35 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.486 -1.672 . . . . 100.0 106.486 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -113.64 131.94 55.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.707 -0.797 . . . . 100.0 110.404 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -106.91 119.03 38.25 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.142 -2.54 . . . . 100.0 104.142 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -92.55 99.14 11.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 100.163 -4.014 . . . . 100.0 100.163 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 83.7 t -85.74 125.96 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-N 115.805 -0.634 . . . . 100.0 110.674 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.468 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 36.5 m95 -107.31 98.02 7.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.132 -2.173 . . . . 100.0 105.132 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -86.31 116.11 24.27 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 104.3 -2.481 . . . . 100.0 104.3 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.0 163.93 12.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 113.482 0.919 . . . . 100.0 113.482 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 133.02 35.13 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.28 1.032 . . . . 100.0 109.61 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.16 83.54 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 116.667 -0.242 . . . . 100.0 113.516 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -70.37 -40.69 73.85 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 127.243 2.217 . . . . 100.0 111.856 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.536 ' HB2' HH11 ' A' ' 76' ' ' ARG . 47.0 mt-10 -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.494 1.294 . . . . 100.0 114.494 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.32 151.65 45.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.313 -1.312 . . . . 100.0 109.765 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -68.24 131.59 45.64 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.242 -2.133 . . . . 100.0 105.242 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.44 -174.98 40.53 Favored Glycine 0 C--N 1.355 1.597 0 C-N-CA 118.728 -1.701 . . . . 100.0 114.818 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -22.26 65.03 Favored Glycine 0 C--N 1.353 1.498 0 C-N-CA 126.992 2.234 . . . . 100.0 113.552 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.67 -37.47 84.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.189 1.796 . . . . 100.0 110.03 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.536 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.4 mtp85 -88.64 7.72 32.08 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.431 1.892 . . . . 100.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.95 -38.57 89.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 116.615 2.08 . . . . 100.0 116.615 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -38.07 90.2 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.676 0.655 . . . . 100.0 112.839 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.251 22.0 m-30 -62.35 -43.28 99.18 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.985 1.314 . . . . 100.0 109.856 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 3.4 t80 -90.95 -19.99 22.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.934 1.457 . . . . 100.0 114.934 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.38 135.8 24.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-N 119.631 1.105 . . . . 100.0 108.843 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 66.72 18.22 10.68 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.51 1.924 . . . . 100.0 114.245 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.28 146.69 48.77 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.98 -1.118 . . . . 100.0 107.98 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -106.79 -21.74 12.94 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.698 -0.683 . . . . 100.0 111.2 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.478 ' SG ' ' HG ' ' A' ' 13' ' ' LEU . 7.5 p -160.38 164.96 31.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.718 0.807 . . . . 100.0 109.808 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.1 156.91 42.49 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 113.721 1.008 . . . . 100.0 113.721 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.19 127.17 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.316 -2.105 . . . . 100.0 105.316 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.2 mt -110.67 123.63 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 N-CA-C 103.113 -2.921 . . . . 100.0 103.113 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.562 ' HB3' HD22 ' A' ' 122' ' ' ASN . 57.2 mtt -113.75 135.03 54.39 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 116.542 2.053 . . . . 100.0 116.542 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -132.99 162.02 32.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.445 -1.707 . . . . 100.0 109.975 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -106.11 125.09 50.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.186 -1.783 . . . . 100.0 106.186 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -63.86 -19.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 N-CA-C 113.934 1.087 . . . . 100.0 113.934 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.3 p -90.1 -3.26 58.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 111.987 0.366 . . . . 100.0 111.987 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -124.69 115.08 20.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 122.527 1.156 . . . . 100.0 111.347 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -65.51 -39.55 91.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.742 -1.117 . . . . 100.0 111.078 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -61.64 -41.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 124.982 1.313 . . . . 100.0 109.19 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 96.6 m -62.49 -41.72 99.0 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.959 0.504 . . . . 100.0 110.147 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -65.31 -40.29 93.59 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.238 0.615 . . . . 100.0 110.962 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.475 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -59.79 -35.87 75.54 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.259 1.024 . . . . 100.0 111.237 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -74.01 -11.67 60.4 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 115.415 1.635 . . . . 100.0 115.415 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.39 -43.73 96.84 Favored Pre-proline 0 C--N 1.362 1.12 0 CA-C-O 116.141 -1.885 . . . . 100.0 111.792 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 86.5 Cg_exo -57.37 -35.11 98.87 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.529 2.153 . . . . 100.0 111.939 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.32 -41.9 84.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 123.453 0.701 . . . . 100.0 111.291 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -63.66 -45.73 88.81 Favored 'General case' 0 C--N 1.365 1.278 0 N-CA-C 109.197 -0.668 . . . . 100.0 109.197 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -90.79 69.81 6.55 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.838 -1.542 . . . . 100.0 106.838 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -167.75 -55.5 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 100.937 -3.727 . . . . 100.0 100.937 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.68 -43.27 99.24 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.674 -1.602 . . . . 100.0 106.674 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.439 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -63.31 -50.15 71.17 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.83 -23.59 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 113.287 0.847 . . . . 100.0 113.287 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -60.31 -41.24 93.04 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.674 0.79 . . . . 100.0 109.759 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.257 15.1 m -98.36 -34.43 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 115.958 1.836 . . . . 100.0 115.958 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.292 68.9 m -107.05 -4.62 18.75 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 117.823 2.527 . . . . 100.0 117.823 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.339 66.3 mt-10 53.59 -119.31 1.47 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.636 1.347 . . . . 100.0 114.636 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -95.94 112.11 23.93 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 118.386 -1.326 . . . . 100.0 111.872 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 pt -145.12 153.83 53.53 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -61.21 126.18 18.78 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.622 2.214 . . . . 100.0 111.78 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.407 ' HB ' HD21 ' A' ' 144' ' ' LEU . 61.1 mt -133.35 134.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.685 -1.228 . . . . 100.0 107.685 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -116.0 131.59 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.928 -1.487 . . . . 100.0 108.687 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.5 mt -100.03 126.4 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 104.957 -2.238 . . . . 100.0 104.957 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.476 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 70.9 m -118.18 125.0 49.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 122.026 0.917 . . . . 100.0 111.871 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.92 101.21 2.57 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 104.492 -3.443 . . . . 100.0 104.492 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.562 HD22 ' HB3' ' A' ' 89' ' ' MET . 70.6 m-80 -81.31 163.17 23.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.611 1.164 . . . . 100.0 112.17 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 57.78 42.02 24.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.877 2.471 . . . . 100.0 115.442 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.0 m -67.5 -13.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 112.051 0.389 . . . . 100.0 112.051 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.529 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 32.8 t70 -63.38 -38.86 92.8 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.641 1.976 . . . . 100.0 110.399 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.06 133.89 28.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 124.19 0.996 . . . . 100.0 110.583 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.59 -46.94 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.081 1.882 . . . . 100.0 116.081 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -85.26 77.11 10.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.587 0.63 . . . . 100.0 110.723 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -85.57 134.05 34.03 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.05 -40.87 6.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.681 -0.691 . . . . 100.0 112.355 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.07 106.7 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 106.028 -1.841 . . . . 100.0 106.028 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.69 146.86 37.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.951 -1.022 . . . . 100.0 109.375 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.0 88.57 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.412 1.085 . . . . 100.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.58 -40.09 95.8 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.71 1.204 . . . . 100.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.1 m -61.9 -38.24 87.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.358 1.463 . . . . 100.0 113.233 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.537 HG23 ' HD1' ' A' ' 139' ' ' HIS . 95.3 mt -63.73 122.37 14.48 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 122.389 1.09 . . . . 100.0 110.07 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.61 -6.55 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.848 0 CA-C-N 113.785 -1.552 . . . . 100.0 112.21 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -58.89 -39.66 82.12 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.86 1.264 . . . . 100.0 111.323 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.537 ' HD1' HG23 ' A' ' 136' ' ' ILE . 49.2 p-80 -61.07 -39.95 91.85 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 123.497 0.719 . . . . 100.0 111.616 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.08 -43.64 94.79 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 118.662 0.664 . . . . 100.0 112.101 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.369 1.067 . . . . 100.0 111.337 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.22 6.94 47.57 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 118.325 2.713 . . . . 100.0 118.325 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 54.63 46.41 24.81 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.058 1.343 . . . . 100.0 113.943 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.407 HD21 ' HB ' ' A' ' 117' ' ' ILE . 38.0 mt -109.57 159.47 17.07 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.618 -1.173 . . . . 100.0 108.464 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -96.47 141.67 29.49 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.414 -1.699 . . . . 100.0 106.414 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -118.32 133.52 55.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.159 0.504 . . . . 100.0 111.268 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.74 134.85 43.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.663 -0.698 . . . . 100.0 111.991 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -88.59 123.37 33.01 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 101.683 -3.451 . . . . 100.0 101.683 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.73 158.3 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 122.64 1.21 . . . . 100.0 112.302 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.529 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 28.7 t -143.12 111.32 6.13 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 105.751 -1.944 . . . . 100.0 105.751 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.89 92.14 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.549 -0.908 . . . . 100.0 108.549 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.17 -43.5 91.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 114.875 1.435 . . . . 100.0 114.875 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 87.5 p -100.89 -2.28 32.43 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 114.916 1.45 . . . . 100.0 114.916 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 70.79 9.53 6.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 125.774 1.629 . . . . 100.0 112.953 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -63.49 121.73 14.54 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.403 1.001 . . . . 100.0 108.945 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 53.34 34.58 18.23 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 127.271 2.228 . . . . 100.0 111.459 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 158' ' ' GLU . 10.8 p90 -59.67 -41.46 90.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.799 1.777 . . . . 100.0 115.799 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 157' ' ' PHE . 94.3 mt-10 -93.04 -3.48 54.25 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 115.503 1.668 . . . . 100.0 115.503 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 96.8 mttt -60.36 -44.31 95.56 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 116.969 2.211 . . . . 100.0 116.969 -177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.4 -43.11 42.78 Favored 'Trans proline' 0 C--N 1.375 1.956 0 CA-C-N 122.5 1.929 . . . . 100.0 113.095 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -64.65 -43.68 92.89 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.247 0.967 . . . . 100.0 111.863 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.28 -43.25 95.39 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 118.827 -0.606 . . . . 100.0 112.565 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -62.11 -46.62 88.24 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 123.487 0.492 . . . . 100.0 110.793 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.49 -42.77 97.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 124.131 0.895 . . . . 100.0 110.686 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.9 97.93 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.521 0.729 . . . . 100.0 111.154 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -63.48 -44.63 93.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 118.557 -0.735 . . . . 100.0 112.488 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -69.01 -43.14 75.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.406 0.441 . . . . 100.0 112.051 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.2 -46.91 75.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 113.239 0.829 . . . . 100.0 113.239 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.16 -38.42 77.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 125.29 1.436 . . . . 100.0 110.368 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.71 10.23 56.8 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 118.238 -1.312 . . . . 100.0 113.815 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -108.88 110.65 61.01 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.071 -1.455 . . . . 100.0 107.071 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.34 -22.22 66.36 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.912 3.074 . . . . 100.0 113.51 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -102.01 11.26 38.74 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 114.206 1.187 . . . . 100.0 114.206 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.45 133.16 54.62 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 CA--C 1.484 -1.564 0 CA-C-O 121.337 0.589 . . . . 100.0 111.687 -179.328 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 107.753 -1.203 . . . . 100.0 107.753 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -75.13 127.48 86.52 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-O 119.367 -0.349 . . . . 100.0 110.4 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 94.2 Cg_endo -71.39 143.31 42.9 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.573 2.848 . . . . 100.0 110.023 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 28.0 Cg_exo -69.95 125.82 12.48 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.016 1.811 . . . . 100.0 110.254 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.57 -42.04 71.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 123.712 0.633 . . . . 100.0 110.864 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.566 33.9 m 52.55 63.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.113 0 N-CA-C 119.469 3.137 . . . . 100.0 119.469 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.03 -41.71 10.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.177 0 C-N-CA 124.818 1.247 . . . . 100.0 112.138 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 86.3 mtp -70.73 167.43 18.76 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.078 1.351 . . . . 100.0 113.476 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.363 1.191 0 N-CA-C 118.75 2.87 . . . . 100.0 118.75 -179.078 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . 0.426 ' CE1' ' HD2' ' A' ' 38' ' ' LYS . 39.3 t60 . . . . . 0 N--CA 1.442 -0.868 0 CA-C-O 119.756 -0.164 . . . . 100.0 110.724 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.75 -43.95 82.76 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.966 1.306 . . . . 100.0 112.073 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.27 -44.63 96.92 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-O 118.567 -0.73 . . . . 100.0 112.81 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.79 -47.52 84.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 123.829 0.706 . . . . 100.0 112.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.08 -41.0 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 O-C-N 123.828 0.705 . . . . 100.0 111.996 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.56 -45.37 72.28 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.68 1.363 . . . . 100.0 114.68 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -63.83 -40.44 96.6 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.861 1.265 . . . . 100.0 113.497 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.7 m -66.45 -40.97 89.75 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.626 1.17 . . . . 100.0 111.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 122.628 1.204 . . . . 100.0 111.865 -176.499 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 118.167 2.655 . . . . 100.0 118.167 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.288 45.9 tt0 -131.29 135.33 47.21 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.19 -2.152 . . . . 100.0 105.19 175.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . 0.278 80.9 m-85 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 106.439 -1.689 . . . . 100.0 106.439 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -92.38 118.28 30.77 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.341 -2.096 . . . . 100.0 105.341 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 85' ' ' CYS 0.362 4.3 mt -114.9 132.51 56.51 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 105.797 -1.927 . . . . 100.0 105.797 -178.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -110.24 127.75 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 116.47 -2.092 . . . . 100.0 106.823 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 tp -103.17 118.01 35.83 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.344 -1.354 . . . . 100.0 107.344 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.83 162.0 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 125.479 1.512 . . . . 100.0 112.93 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.57 171.07 17.75 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.05 -1.62 . . . . 100.0 109.05 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -70.42 159.27 34.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.97 0.89 . . . . 100.0 113.187 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.68 139.03 40.67 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.54 -1.024 . . . . 100.0 110.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 3.51 90.13 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-O 118.354 -1.248 . . . . 100.0 115.276 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 p -64.43 -38.75 92.13 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.095 1.448 . . . . 100.0 113.553 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 19.89 4.77 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 111.132 -0.787 . . . . 100.0 111.132 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.6 -48.72 80.55 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 124.334 1.054 . . . . 100.0 110.87 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.3 m -65.75 -43.42 88.96 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.228 1.411 . . . . 100.0 110.95 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.3 m -62.82 -41.66 99.4 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.393 1.077 . . . . 100.0 109.505 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.478 ' CD2' ' HE2' ' A' ' 89' ' ' MET . 87.3 t80 -61.72 -47.51 84.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 124.103 0.961 . . . . 100.0 110.696 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.56 -41.31 91.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 O-C-N 122.893 0.121 . . . . 100.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.0 -39.92 93.88 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.56 0.744 . . . . 100.0 111.097 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.84 -44.09 97.43 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.069 0.548 . . . . 100.0 110.313 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -62.21 -43.92 97.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.812 0.671 . . . . 100.0 112.812 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.69 -44.74 66.36 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.547 2.055 . . . . 100.0 116.547 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.5 p -117.4 -24.93 7.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 117.521 2.415 . . . . 100.0 117.521 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.01 -8.08 70.05 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.695 -0.962 . . . . 100.0 110.695 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.88 156.36 30.41 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.469 1.107 . . . . 100.0 109.671 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -115.8 116.56 28.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 101.087 -3.671 . . . . 100.0 101.087 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -96.88 118.96 34.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.154 -1.424 . . . . 100.0 107.154 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.64 -11.18 34.84 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.828 -1.078 . . . . 100.0 113.235 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -101.22 126.18 47.92 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.174 -1.047 . . . . 100.0 108.174 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -95.04 116.42 28.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.927 0.87 . . . . 100.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.05 121.08 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.784 -3.413 . . . . 100.0 101.784 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.95 141.9 58.55 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.371 0.668 . . . . 100.0 112.591 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.7 m -94.51 129.06 41.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 105.281 -2.118 . . . . 100.0 105.281 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.37 129.15 48.75 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.053 -1.091 . . . . 100.0 108.053 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.69 14.32 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 109.614 -1.395 . . . . 100.0 109.614 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.48 143.25 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 109.157 -0.682 . . . . 100.0 109.157 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -127.32 125.55 41.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.608 -2.738 . . . . 100.0 103.608 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -99.04 125.46 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.509 -0.922 . . . . 100.0 108.509 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -121.45 123.71 27.51 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-N 114.803 -1.09 . . . . 100.0 111.176 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' CB ' ' HE3' ' A' ' 60' ' ' LYS . 75.8 Cg_endo -80.08 126.64 6.46 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.702 3.602 . . . . 100.0 111.91 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 tp -133.45 130.12 38.19 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.927 -1.138 . . . . 100.0 107.927 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -118.25 134.61 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.775 -0.824 . . . . 100.0 108.775 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -124.98 142.61 51.37 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.374 -0.973 . . . . 100.0 108.374 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -98.43 124.0 42.89 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.851 -0.796 . . . . 100.0 108.851 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.1 p -121.36 -177.67 3.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.336 -0.847 . . . . 100.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.22 -35.61 73.95 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.388 2.275 . . . . 100.0 109.333 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -88.21 3.25 50.06 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.13 1.372 . . . . 100.0 113.266 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.59 -179.5 22.73 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.117 -1.193 . . . . 100.0 110.117 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.66 137.29 45.4 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.348 2.698 . . . . 100.0 113.919 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -130.84 137.47 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.488 -1.301 . . . . 100.0 107.488 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.429 ' HE3' ' CB ' ' A' ' 49' ' ' PRO . 85.4 tttt -105.1 133.51 49.76 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.967 0.889 . . . . 100.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.94 116.85 31.92 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 103.098 -2.927 . . . . 100.0 103.098 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.06 99.25 11.89 Favored 'General case' 0 N--CA 1.434 -1.238 1 N-CA-C 99.979 -4.082 . . . . 100.0 99.979 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.53 125.69 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.768 -0.827 . . . . 100.0 108.768 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -102.74 97.75 7.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 105.089 -2.189 . . . . 100.0 105.089 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -85.84 116.32 24.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 104.938 -2.245 . . . . 100.0 104.938 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -99.53 166.06 11.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 114.576 1.324 . . . . 100.0 114.576 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.21 131.75 34.16 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.625 0.77 . . . . 100.0 109.301 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.71 -8.47 82.77 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.45 0.54 . . . . 100.0 114.45 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -70.6 -39.67 73.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.462 1.505 . . . . 100.0 112.731 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' HB2' HH11 ' A' ' 76' ' ' ARG . 49.0 mt-10 -62.33 134.56 56.66 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.472 1.509 . . . . 100.0 113.689 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.24 154.51 40.18 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.04 -0.982 . . . . 100.0 109.984 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -67.21 132.73 48.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 125.95 1.7 . . . . 100.0 107.673 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.72 -175.51 40.68 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.001 -1.571 . . . . 100.0 114.14 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.78 -23.28 65.23 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 126.747 2.118 . . . . 100.0 113.6 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.95 -28.34 69.75 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.416 1.087 . . . . 100.0 110.86 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.5 HH11 ' HB2' ' A' ' 70' ' ' GLU . 75.5 mtp85 -92.29 9.31 34.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.68 1.592 . . . . 100.0 114.562 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.59 -38.51 84.87 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 115.687 1.736 . . . . 100.0 115.687 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.95 89.89 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 124.271 0.939 . . . . 100.0 113.433 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -61.54 -48.32 81.52 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.129 0.972 . . . . 100.0 109.086 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.463 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU 0.423 25.7 m-85 -70.64 -37.43 73.76 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 120.223 3.416 . . . . 100.0 120.223 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -54.03 131.97 16.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.78 0.8 . . . . 100.0 109.963 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 68.55 14.37 9.06 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.19 145.73 54.05 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-N 118.882 0.764 . . . . 100.0 109.864 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -102.87 -30.72 10.66 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.369 -0.832 . . . . 100.0 110.51 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.476 ' SG ' HD21 ' A' ' 13' ' ' LEU . 31.9 p -160.81 170.08 21.42 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.315 0.646 . . . . 100.0 109.472 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.48 157.46 43.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 113.333 0.864 . . . . 100.0 113.333 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.23 126.62 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.482 -2.414 . . . . 100.0 104.482 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.2 mt -109.59 123.97 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 103.286 -2.857 . . . . 100.0 103.286 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.478 ' HE2' ' CD2' ' A' ' 26' ' ' PHE . 40.4 mtt -114.09 135.28 54.2 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 115.322 1.601 . . . . 100.0 115.322 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -132.75 159.62 39.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.926 -1.943 . . . . 100.0 110.003 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -103.72 125.07 49.95 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.105 -1.813 . . . . 100.0 106.105 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.51 -19.79 24.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 114.117 1.154 . . . . 100.0 114.117 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.4 p -88.45 -6.55 57.57 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 119.072 -0.49 . . . . 100.0 111.51 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -123.18 114.29 20.09 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.804 1.287 . . . . 100.0 112.238 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -65.43 -38.49 90.04 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.398 -1.274 . . . . 100.0 111.327 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.996 1.318 . . . . 100.0 109.154 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.8 m -62.76 -41.32 99.16 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.94 0.496 . . . . 100.0 110.16 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.23 -39.84 93.28 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.541 0.736 . . . . 100.0 110.973 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.478 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -59.33 -36.71 76.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.687 1.195 . . . . 100.0 111.101 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.28 -10.67 59.82 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 115.782 1.771 . . . . 100.0 115.782 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.43 -43.82 96.86 Favored Pre-proline 0 C--N 1.36 1.034 0 CA-C-O 116.128 -1.891 . . . . 100.0 111.621 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.8 Cg_exo -58.35 -33.6 97.91 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.576 2.184 . . . . 100.0 112.503 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -67.23 -42.99 83.12 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.782 0.833 . . . . 100.0 109.862 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -63.26 -46.98 84.32 Favored 'General case' 0 C--N 1.368 1.375 0 N-CA-C 108.649 -0.871 . . . . 100.0 108.649 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -89.53 70.75 7.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.892 1.33 . . . . 100.0 107.776 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -168.4 -55.54 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 100.315 -3.957 . . . . 100.0 100.315 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.267 -1.383 . . . . 100.0 107.267 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.463 ' HG ' ' CZ ' ' A' ' 80' ' ' TYR . 7.1 mp -61.88 -50.35 72.57 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.396 1.078 . . . . 100.0 112.806 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.259 32.8 m -70.15 -19.66 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 113.799 1.037 . . . . 100.0 113.799 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -60.55 -39.61 88.55 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.787 0.435 . . . . 100.0 110.511 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.89 -47.13 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-O 120.757 0.313 . . . . 100.0 110.792 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.404 ' SG ' ' HD1' ' A' ' 80' ' ' TYR . 95.9 m -70.87 -36.9 73.0 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 119.478 3.14 . . . . 100.0 119.478 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 61.72 -122.22 0.77 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 126.053 1.741 . . . . 100.0 109.31 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -93.41 113.02 25.08 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.294 1.861 . . . . 100.0 112.273 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 36.3 pt -144.4 149.16 43.4 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.133 -2.173 . . . . 100.0 105.133 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.431 ' HG2' ' HB3' ' A' ' 85' ' ' CYS . 41.5 Cg_endo -64.31 128.99 22.78 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.018 1.812 . . . . 100.0 110.437 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.428 ' HB ' HD21 ' A' ' 144' ' ' LEU . 76.6 mt -131.91 135.09 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.316 -1.364 . . . . 100.0 107.316 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.33 131.69 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 114.402 -1.272 . . . . 100.0 107.799 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.9 126.55 43.34 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.388 -2.079 . . . . 100.0 105.388 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.95 125.93 50.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 122.055 0.931 . . . . 100.0 111.71 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.47 2.57 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 104.711 -3.356 . . . . 100.0 104.711 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.47 161.91 24.65 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.765 1.226 . . . . 100.0 112.489 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.4 mttt 57.81 43.28 22.03 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 127.858 2.463 . . . . 100.0 115.023 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.7 m -68.9 -11.7 15.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 CA-C-N 115.983 -0.553 . . . . 100.0 111.603 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.542 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 35.1 t70 -63.51 -39.04 93.39 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.936 2.095 . . . . 100.0 109.74 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.06 132.02 29.82 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 C-N-CA 124.095 0.958 . . . . 100.0 110.132 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.83 -45.0 91.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 116.435 2.013 . . . . 100.0 116.435 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -84.93 77.51 10.09 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.648 0.737 . . . . 100.0 109.731 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -82.8 137.66 34.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.503 -0.925 . . . . 100.0 108.503 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.07 -42.69 5.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 119.4 -0.333 . . . . 100.0 111.496 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.1 107.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.59 -2.004 . . . . 100.0 105.59 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.62 148.86 36.68 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.104 -0.953 . . . . 100.0 109.349 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.22 90.32 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.165 0.986 . . . . 100.0 110.91 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -62.4 -40.8 97.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.661 1.184 . . . . 100.0 110.907 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 65.4 m -61.49 -37.64 84.39 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.686 1.594 . . . . 100.0 113.556 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.554 HG23 ' HD1' ' A' ' 139' ' ' HIS . 93.1 mt -62.42 123.52 15.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 CA-C-O 122.523 1.154 . . . . 100.0 110.035 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.587 HG13 HH21 ' A' ' 140' ' ' ARG . 27.4 m -127.52 -10.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 CA-C-N 113.531 -1.668 . . . . 100.0 112.592 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -58.49 -40.34 82.49 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.1 1.36 . . . . 100.0 111.864 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.554 ' HD1' HG23 ' A' ' 136' ' ' ILE . 46.1 p-80 -61.17 -40.01 92.28 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 118.679 -0.677 . . . . 100.0 111.601 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.587 HH21 HG13 ' A' ' 137' ' ' VAL . 87.0 mtm-85 -64.04 -43.6 95.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 112.806 0.669 . . . . 100.0 112.806 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.65 -42.21 95.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 123.566 0.746 . . . . 100.0 111.853 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -97.28 6.81 47.74 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 117.902 2.556 . . . . 100.0 117.902 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.26 71.2 m-20 53.23 50.75 16.97 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-O 123.062 1.41 . . . . 100.0 114.279 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.428 HD21 ' HB ' ' A' ' 117' ' ' ILE . 35.3 mt -114.38 158.29 21.71 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.981 -1.463 . . . . 100.0 107.092 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -98.78 143.77 28.76 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.259 -1.015 . . . . 100.0 108.259 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -117.34 136.06 53.41 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.25 0.548 . . . . 100.0 112.344 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.05 137.74 44.87 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.356 -0.838 . . . . 100.0 112.838 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -89.42 123.88 33.97 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 101.583 -3.488 . . . . 100.0 101.583 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.3 pt -133.85 157.44 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.623 1.201 . . . . 100.0 112.084 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.542 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 32.4 t -143.91 111.36 5.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.066 0.946 . . . . 100.0 108.553 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.34 -46.79 84.95 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 126.637 1.975 . . . . 100.0 113.365 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.2 p -100.75 -2.84 31.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 115.44 1.645 . . . . 100.0 115.44 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 70.47 11.47 7.36 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.337 1.855 . . . . 100.0 113.353 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.2 118.33 10.45 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.686 -1.227 . . . . 100.0 107.686 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 54.31 29.31 10.58 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 128.756 2.822 . . . . 100.0 111.952 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . 0.413 3.7 p90 -62.53 -35.92 80.95 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 114.216 1.191 . . . . 100.0 114.216 -175.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.272 40.6 mt-10 -85.93 -8.33 58.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.304 1.964 . . . . 100.0 116.304 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.303 95.3 mttt -60.6 -44.11 94.45 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 117.149 2.278 . . . . 100.0 117.149 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -59.45 -40.48 66.53 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-N 122.333 1.869 . . . . 100.0 112.962 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.31 -44.36 95.18 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 124.608 1.163 . . . . 100.0 111.194 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.89 -43.71 92.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 112.661 0.615 . . . . 100.0 112.661 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -61.92 -45.86 91.86 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 123.28 0.362 . . . . 100.0 110.577 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 89.6 mt -61.04 -42.8 99.17 Favored 'General case' 0 CA--C 1.495 -1.167 0 O-C-N 123.959 0.787 . . . . 100.0 110.442 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.3 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.554 0.741 . . . . 100.0 110.955 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -62.52 -45.33 93.49 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 123.147 0.579 . . . . 100.0 112.401 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.33 -43.55 77.29 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 112.119 0.415 . . . . 100.0 112.119 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.69 -47.2 76.25 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.776 1.028 . . . . 100.0 113.776 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.26 -38.7 75.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 124.162 0.985 . . . . 100.0 109.852 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.22 9.63 55.38 Favored Glycine 0 C--N 1.353 1.472 0 CA-C-O 118.306 -1.274 . . . . 100.0 114.051 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . 0.463 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 59.9 t0 -109.74 113.02 58.03 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 106.665 -1.606 . . . . 100.0 106.665 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.99 -16.91 50.81 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 123.87 3.047 . . . . 100.0 113.092 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -97.39 8.38 44.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 57.1 mt -60.89 134.13 56.78 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 119.233 0.924 . . . . 100.0 112.568 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.43 -1.427 0 CA-C-N 114.839 -1.073 . . . . 100.0 109.857 -179.174 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.1 mt . . . . . 0 N--CA 1.436 -1.156 0 N-CA-C 105.914 -1.884 . . . . 100.0 105.914 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -132.78 144.76 54.26 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -64.53 148.15 90.49 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.778 2.319 . . . . 100.0 110.626 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.33 154.4 68.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 123.701 2.934 . . . . 100.0 114.144 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -61.6 -49.13 77.83 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.17 0.918 . . . . 100.0 111.19 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.301 5.9 m 52.35 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 128.214 2.605 . . . . 100.0 117.848 177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.84 -67.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.387 0 N-CA-C 107.819 -1.178 . . . . 100.0 107.819 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.1 ptp -70.57 156.33 39.56 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 114.657 1.355 . . . . 100.0 114.657 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.6 t70 . . . . . 0 C--N 1.36 1.034 0 N-CA-C 116.475 2.028 . . . . 100.0 116.475 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.438 -1.036 0 CA-C-O 118.794 -0.622 . . . . 100.0 111.156 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -64.73 -43.16 94.28 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.042 0.937 . . . . 100.0 111.529 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.49 -41.8 97.83 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 124.312 1.045 . . . . 100.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.37 -42.54 98.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.424 1.09 . . . . 100.0 110.963 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.12 -43.65 96.72 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 108.325 -0.991 . . . . 100.0 108.325 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.0 90.1 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.269 1.027 . . . . 100.0 113.333 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -63.3 -40.39 97.22 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 125.11 1.364 . . . . 100.0 112.713 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 66.4 m -65.89 -41.79 91.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.879 1.672 . . . . 100.0 110.265 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m . . . . . 0 C--N 1.361 1.102 0 CA-C-O 122.991 1.377 . . . . 100.0 107.87 -178.281 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 115.259 1.577 . . . . 100.0 115.259 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.262 23.5 tt0 -125.87 131.71 52.32 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.448 -2.427 . . . . 100.0 104.448 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.402 ' CD1' HD11 ' A' ' 168' ' ' LEU . 90.7 m-85 -125.71 134.12 51.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.268 -0.641 . . . . 100.0 109.268 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.0 tttt -90.69 116.3 28.46 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.016 -1.105 . . . . 100.0 108.016 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 85' ' ' CYS . 41.5 mt -113.6 131.56 56.07 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.059 -1.459 . . . . 100.0 107.059 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 t -109.3 123.36 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.521 -1.659 . . . . 100.0 106.521 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.462 HD12 ' SD ' ' A' ' 89' ' ' MET . 64.6 tp -103.25 115.65 30.97 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.667 -1.605 . . . . 100.0 106.667 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.68 162.59 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 113.777 -1.556 . . . . 100.0 110.625 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.05 168.07 14.87 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 108.098 -2.001 . . . . 100.0 108.098 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -72.1 159.94 33.3 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 140.24 40.89 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.756 -1.338 . . . . 100.0 109.756 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.84 1.77 89.81 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-O 118.913 -0.937 . . . . 100.0 114.344 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.2 m -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.59 1.195 . . . . 100.0 112.303 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.08 15.49 7.79 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.956 -0.858 . . . . 100.0 110.956 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -60.94 -44.12 97.7 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.289 1.435 . . . . 100.0 111.436 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -65.17 -42.33 93.79 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.224 1.41 . . . . 100.0 109.738 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.16 -41.59 99.29 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.13 1.372 . . . . 100.0 109.369 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.15 -48.11 83.12 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.137 1.775 . . . . 100.0 109.769 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.87 -43.52 96.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 122.568 0.347 . . . . 100.0 111.491 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -40.13 95.22 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.211 0.604 . . . . 100.0 112.099 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.477 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 35.1 ttp180 -62.15 -44.13 97.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.543 1.137 . . . . 100.0 109.482 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.84 -42.9 97.49 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.331 0.514 . . . . 100.0 112.081 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.4 -48.41 75.53 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.508 1.67 . . . . 100.0 115.508 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.1 p -121.55 -21.62 6.16 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.06 -7.56 69.74 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 110.586 -1.006 . . . . 100.0 110.586 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 149.95 39.59 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.351 1.06 . . . . 100.0 109.666 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.412 ' HZ ' HD22 ' A' ' 154' ' ' ASN . 98.3 m-85 -111.91 125.69 54.32 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.546 -2.761 . . . . 100.0 103.546 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.06 114.17 28.07 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 118.925 -1.11 . . . . 100.0 110.575 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.66 -43.29 63.36 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.659 -1.155 . . . . 100.0 113.047 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.02 135.45 44.91 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.514 1.525 . . . . 100.0 111.397 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -103.1 119.12 38.27 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.007 -1.479 . . . . 100.0 107.007 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.3 123.69 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 102.92 -2.993 . . . . 100.0 102.92 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 139.0 58.72 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.596 0.712 . . . . 100.0 112.198 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.0 m -97.07 125.06 41.26 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.326 -2.472 . . . . 100.0 104.326 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -106.09 130.11 54.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.464 -1.68 . . . . 100.0 106.464 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.8 -127.1 33.16 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 109.547 -1.421 . . . . 100.0 109.547 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -128.09 139.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 121.22 0.533 . . . . 100.0 109.89 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -115.53 123.16 47.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 103.58 -2.748 . . . . 100.0 103.58 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.65 120.4 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 106.894 -1.521 . . . . 100.0 106.894 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -124.6 121.72 25.79 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.273 -0.876 . . . . 100.0 111.007 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -78.71 130.43 9.7 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 123.598 2.866 . . . . 100.0 111.03 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.58 128.52 48.05 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.873 -1.529 . . . . 100.0 106.873 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.04 128.56 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.583 -1.636 . . . . 100.0 106.583 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.14 131.45 56.41 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -99.33 122.54 42.61 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.228 -1.767 . . . . 100.0 106.228 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.8 p -122.42 -179.99 4.38 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.633 -0.712 . . . . 100.0 111.459 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -59.07 -37.36 76.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.913 1.685 . . . . 100.0 109.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -87.67 2.93 49.72 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.065 0.765 . . . . 100.0 113.065 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.27 -179.9 19.14 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 121.557 -0.715 . . . . 100.0 111.399 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.3 140.87 54.57 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.263 2.642 . . . . 100.0 113.794 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.9 mt -130.35 138.58 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 103.565 -2.754 . . . . 100.0 103.565 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -116.27 128.66 55.77 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 118.972 -1.091 . . . . 100.0 108.692 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.64 118.06 35.81 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.077 -2.194 . . . . 100.0 105.077 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -91.94 106.46 18.48 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 101.889 -3.374 . . . . 100.0 101.889 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.84 124.95 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 107.966 -1.124 . . . . 100.0 107.966 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.435 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 19.2 m0 -103.56 106.8 17.41 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.304 -1.739 . . . . 100.0 106.304 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -86.04 116.29 24.17 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 104.136 -2.542 . . . . 100.0 104.136 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.6 ' HG1' HH22 ' A' ' 76' ' ' ARG . 56.3 p -98.44 163.11 12.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.46 0.911 . . . . 100.0 113.46 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.66 130.95 34.98 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.312 -0.995 . . . . 100.0 108.312 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.5 -11.0 80.94 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 116.624 -0.262 . . . . 100.0 112.56 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -67.6 -39.74 84.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.796 2.039 . . . . 100.0 111.809 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -61.32 141.73 57.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.275 1.43 . . . . 100.0 114.616 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.01 150.73 46.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.213 1.405 . . . . 100.0 110.982 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -72.95 132.22 43.17 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.236 -1.394 . . . . 100.0 107.236 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.3 -167.25 33.91 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 119.077 -1.535 . . . . 100.0 115.007 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.69 -22.0 63.57 Favored Glycine 0 C--N 1.355 1.585 0 C-N-CA 127.541 2.496 . . . . 100.0 114.49 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.78 -38.41 87.96 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.236 1.814 . . . . 100.0 109.293 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.6 HH22 ' HG1' ' A' ' 66' ' ' THR . 20.9 mmm180 -82.77 -2.21 53.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.301 2.64 . . . . 100.0 113.959 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.29 -42.93 96.51 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -37.87 91.55 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 123.907 0.765 . . . . 100.0 113.489 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -62.18 -43.52 98.65 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.236 1.814 . . . . 100.0 108.983 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.61 ' HH ' ' HB3' ' A' ' 86' ' ' ALA . 8.2 t80 -90.89 -13.94 32.68 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 114.296 1.221 . . . . 100.0 114.296 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.8 mt -60.69 134.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 CA-C-N 119.333 0.969 . . . . 100.0 109.876 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.29 24.55 14.32 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.498 1.919 . . . . 100.0 114.196 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.24 138.94 45.86 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 108.218 -1.03 . . . . 100.0 108.218 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.02 -34.61 13.64 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.138 -0.937 . . . . 100.0 108.676 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.5 ' HB2' ' CD2' ' A' ' 13' ' ' LEU . 64.7 m -153.94 164.04 39.07 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 123.026 0.53 . . . . 100.0 110.978 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.61 ' HB3' ' HH ' ' A' ' 80' ' ' TYR . . . -139.98 153.32 46.84 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 113.838 1.051 . . . . 100.0 113.838 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.25 123.92 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 103.293 -2.854 . . . . 100.0 103.293 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.2 mt -110.21 122.38 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 102.579 -3.119 . . . . 100.0 102.579 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.477 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 58.5 mtp -112.23 132.99 54.62 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 113.574 0.953 . . . . 100.0 113.574 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.38 159.22 37.66 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 113.631 -1.622 . . . . 100.0 108.742 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -101.72 124.97 48.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.15 -2.167 . . . . 100.0 105.15 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.75 -21.87 29.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 113.683 0.994 . . . . 100.0 113.683 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.1 p -89.98 -4.58 57.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 118.888 -0.577 . . . . 100.0 111.591 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.16 115.78 24.33 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 122.464 1.126 . . . . 100.0 111.569 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.85 -38.44 86.38 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 114.362 -1.29 . . . . 100.0 110.554 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.76 -43.04 96.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 C-N-CA 125.394 1.478 . . . . 100.0 109.892 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 92.2 m -63.16 -42.38 99.41 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.086 -0.709 . . . . 100.0 109.086 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.568 ' HH ' HG21 ' A' ' 136' ' ' ILE . 81.4 t80 -63.45 -40.23 96.58 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.29 0.636 . . . . 100.0 110.207 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.492 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -60.69 -37.41 81.55 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.314 1.046 . . . . 100.0 111.762 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.32 -12.03 60.7 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 114.502 1.297 . . . . 100.0 114.502 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.07 -43.4 94.01 Favored Pre-proline 0 C--N 1.364 1.203 0 CA-C-O 116.252 -1.832 . . . . 100.0 111.509 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 87.1 Cg_exo -58.65 -34.63 99.03 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.347 2.031 . . . . 100.0 112.645 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.38 -43.63 85.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.951 0.782 . . . . 100.0 110.106 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -62.98 -46.6 86.95 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -91.01 63.86 5.25 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.947 1.356 . . . . 100.0 109.524 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.0 ttm105 -157.93 -57.81 0.08 Allowed 'General case' 0 CA--C 1.485 -1.533 1 N-CA-C 100.155 -4.017 . . . . 100.0 100.155 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.66 -41.17 98.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.395 -0.965 . . . . 100.0 108.395 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.532 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 6.5 mp -62.04 -46.24 90.04 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.936 0.895 . . . . 100.0 111.492 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.55 -38.95 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 126.267 1.827 . . . . 100.0 109.543 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -59.7 -46.2 89.8 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.817 -0.438 . . . . 100.0 109.817 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.91 -49.25 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 115.494 1.665 . . . . 100.0 115.494 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.8 m -113.45 9.13 18.05 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 120.788 3.625 . . . . 100.0 120.788 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 55.45 -124.79 2.09 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.473 1.109 . . . . 100.0 112.561 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -102.74 115.74 31.19 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 120.276 1.398 . . . . 100.0 109.667 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 41.7 pt -141.68 152.6 63.37 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 103.76 -2.681 . . . . 100.0 103.76 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.06 127.6 22.73 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.155 1.904 . . . . 100.0 112.412 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' HB ' HD21 ' A' ' 144' ' ' LEU . 67.2 mt -131.26 135.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 107.209 -1.404 . . . . 100.0 107.209 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.13 131.57 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.672 -1.233 . . . . 100.0 107.672 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 86.5 mt -98.87 125.6 44.31 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.491 -2.411 . . . . 100.0 104.491 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.477 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.5 m -115.84 123.36 47.97 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.334 -0.848 . . . . 100.0 109.468 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.61 101.49 2.63 Favored Glycine 0 CA--C 1.485 -1.806 1 N-CA-C 102.8 -4.12 . . . . 100.0 102.8 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -86.73 165.72 15.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.985 0.898 . . . . 100.0 110.61 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 60.48 41.72 15.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 128.515 2.726 . . . . 100.0 113.521 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.5 m -67.52 -15.54 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 CA-C-N 115.866 -0.606 . . . . 100.0 111.937 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 38.1 t70 -61.74 -39.42 91.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.034 2.134 . . . . 100.0 110.355 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.01 130.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 124.12 0.968 . . . . 100.0 108.498 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.46 -39.24 88.72 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 117.022 2.23 . . . . 100.0 117.022 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -83.04 76.78 9.82 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.892 0.853 . . . . 100.0 109.049 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -88.5 129.27 35.49 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.533 -1.284 . . . . 100.0 107.533 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.51 -41.25 7.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 115.407 -0.815 . . . . 100.0 111.216 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.69 108.26 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 103.803 -2.666 . . . . 100.0 103.803 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.47 151.31 23.62 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.777 -1.101 . . . . 100.0 110.665 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.45 96.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.165 0.986 . . . . 100.0 112.245 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.94 -41.16 99.41 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.331 1.053 . . . . 100.0 110.801 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.4 m -63.03 -38.13 89.96 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.999 1.72 . . . . 100.0 114.072 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.585 HG23 ' HD1' ' A' ' 139' ' ' HIS . 91.1 mt -63.46 123.54 16.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 122.128 0.966 . . . . 100.0 109.204 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.25 -9.0 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.567 1.547 . . . . 100.0 111.464 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -59.17 -45.05 92.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.061 1.344 . . . . 100.0 111.935 -176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.585 ' HD1' HG23 ' A' ' 136' ' ' ILE . 52.5 p-80 -62.51 -41.02 98.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.799 0.666 . . . . 100.0 112.799 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.64 -45.86 90.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.168 1.387 . . . . 100.0 110.377 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.98 -42.62 89.6 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.498 0.719 . . . . 100.0 112.759 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -90.84 1.92 56.56 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 115.715 1.746 . . . . 100.0 115.715 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 55.92 47.17 20.6 Favored 'General case' 0 C--N 1.361 1.092 0 CA-C-O 122.922 1.344 . . . . 100.0 113.025 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 117' ' ' ILE . 40.6 mt -112.59 160.07 18.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.323 -1.362 . . . . 100.0 107.323 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -96.6 140.6 30.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.14 -1.059 . . . . 100.0 108.14 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -117.24 131.41 56.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.176 0.513 . . . . 100.0 111.469 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . 0.255 81.4 m-85 -128.75 138.3 52.03 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 114.979 -1.01 . . . . 100.0 111.616 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.39 121.34 31.54 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 101.973 -3.343 . . . . 100.0 101.973 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.17 152.97 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 CA-C-O 122.537 1.161 . . . . 100.0 111.535 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.421 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 37.1 t -134.8 117.09 15.57 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.116 -2.55 . . . . 100.0 104.116 175.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -63.43 -45.94 88.63 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.703 0.627 . . . . 100.0 109.617 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.64 -41.16 79.8 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 115.426 1.639 . . . . 100.0 115.426 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -90.92 -4.63 56.37 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 115.275 1.584 . . . . 100.0 115.275 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.477 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 65.7 m-80 63.7 22.74 13.23 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.018 1.327 . . . . 100.0 112.484 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -76.0 123.6 26.01 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.239 -1.763 . . . . 100.0 106.239 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 53.27 40.54 31.44 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.141 2.176 . . . . 100.0 111.76 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.59 -49.31 76.81 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 126.227 1.811 . . . . 100.0 114.487 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -94.68 -6.82 42.42 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 115.424 1.639 . . . . 100.0 115.424 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.284 96.1 mttt -59.72 -45.3 98.48 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 118.857 2.91 . . . . 100.0 118.857 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -60.16 -41.67 49.54 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 122.782 2.029 . . . . 100.0 112.756 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -63.82 -45.04 91.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 124.235 0.959 . . . . 100.0 111.229 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.91 -42.9 97.3 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 118.699 -0.667 . . . . 100.0 112.793 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.19 -44.4 95.47 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 123.736 0.648 . . . . 100.0 109.955 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.402 HD21 ' SG ' ' A' ' 85' ' ' CYS . 87.7 mt -61.4 -44.14 97.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.498 0.719 . . . . 100.0 110.693 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.36 99.01 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 124.061 0.944 . . . . 100.0 111.369 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -61.9 -45.3 94.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.216 1.007 . . . . 100.0 110.998 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.1 -44.66 83.72 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 113.598 0.962 . . . . 100.0 113.598 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.402 HD11 ' CD1' ' A' ' 11' ' ' PHE . 74.0 mt -63.48 -47.31 82.28 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 123.412 0.685 . . . . 100.0 112.061 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 91.8 mt -70.09 -39.15 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 124.191 0.996 . . . . 100.0 111.217 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.97 10.96 58.21 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-O 118.562 -1.132 . . . . 100.0 111.874 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -108.47 109.46 61.52 Favored Pre-proline 0 C--N 1.362 1.111 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.14 -22.89 53.61 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.718 2.946 . . . . 100.0 113.933 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -92.03 3.91 54.23 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.118 1.367 . . . . 100.0 113.521 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.39 130.75 47.63 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-N 118.411 0.55 . . . . 100.0 110.175 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 . . . . . 0 N--CA 1.438 -1.032 0 CA-C-O 121.323 0.582 . . . . 100.0 111.169 -178.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 108.403 -0.962 . . . . 100.0 108.403 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -80.12 125.96 80.46 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.429 -1.322 . . . . 100.0 107.429 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.85 145.06 90.07 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 123.558 2.838 . . . . 100.0 113.261 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.96 166.27 30.08 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.532 2.821 . . . . 100.0 111.849 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -60.93 -43.86 98.05 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.446 1.098 . . . . 100.0 112.182 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.8 t 57.46 70.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.27 0 C-N-CA 126.484 1.913 . . . . 100.0 110.102 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.9 m -82.99 164.4 2.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 115.003 1.482 . . . . 100.0 115.003 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.305 61.5 mtm 51.42 -124.49 2.25 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 127.873 2.469 . . . . 100.0 116.816 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 . . . . . 0 C--N 1.369 1.421 0 N-CA-C 118.371 2.73 . . . . 100.0 118.371 -179.217 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 110.203 -0.295 . . . . 100.0 110.203 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -62.88 -40.93 99.03 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.97 1.308 . . . . 100.0 109.929 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.2 mt -62.9 -40.51 97.78 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.846 0.858 . . . . 100.0 110.316 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.37 -42.17 99.2 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.016 0.927 . . . . 100.0 110.871 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.71 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 C-N-CA 124.204 1.001 . . . . 100.0 108.418 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.13 98.82 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 124.419 1.088 . . . . 100.0 110.958 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.89 -42.7 99.39 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.943 1.297 . . . . 100.0 110.433 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.6 m -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.682 1.193 . . . . 100.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.4 m . . . . . 0 C--N 1.357 0.923 0 C-N-CA 124.205 1.002 . . . . 100.0 112.551 -178.541 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 121.871 0.843 . . . . 100.0 110.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 50.2 tt0 -124.46 132.42 53.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.968 -2.234 . . . . 100.0 104.968 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -118.05 135.27 54.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.995 -1.113 . . . . 100.0 107.995 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -91.31 112.59 24.56 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.302 -1.74 . . . . 100.0 106.302 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.4 tp -108.01 124.43 50.15 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.11 -1.859 . . . . 100.0 107.829 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 t -108.94 123.68 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.225 -1.769 . . . . 100.0 106.225 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.98 117.97 35.41 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.696 -1.594 . . . . 100.0 106.696 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -127.21 162.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 C-N-CA 125.11 1.364 . . . . 100.0 110.896 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.46 171.77 19.71 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 108.404 -1.878 . . . . 100.0 108.404 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -73.46 162.65 29.05 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.762 0.653 . . . . 100.0 112.762 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 140.52 36.18 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 110.079 -1.208 . . . . 100.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.12 1.63 90.54 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.667 0.651 . . . . 100.0 113.728 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.578 HG23 HD22 ' A' ' 122' ' ' ASN . 56.2 m -63.92 -41.57 97.63 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 117.817 0.809 . . . . 100.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.6 17.75 5.94 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.211 -0.995 . . . . 100.0 112.06 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.29 -46.62 89.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.122 1.369 . . . . 100.0 110.125 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.0 m -63.92 -43.39 96.07 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.395 1.478 . . . . 100.0 109.5 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -63.61 -41.07 98.34 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.265 1.026 . . . . 100.0 110.044 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.13 -48.34 82.12 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.306 1.442 . . . . 100.0 109.727 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.74 -43.76 96.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 C-N-CA 123.08 0.552 . . . . 100.0 111.217 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.09 -39.25 94.14 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 112.477 0.547 . . . . 100.0 112.477 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.439 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 39.9 ttp180 -61.49 -44.61 96.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 124.321 1.048 . . . . 100.0 108.99 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -63.56 -44.34 94.41 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 112.405 0.52 . . . . 100.0 112.405 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.96 -48.6 73.48 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 116.371 1.989 . . . . 100.0 116.371 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -119.23 -24.0 6.57 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.07 2.248 . . . . 100.0 117.07 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.92 73.4 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 110.434 -1.066 . . . . 100.0 110.434 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.43 151.71 38.07 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-N 118.017 0.908 . . . . 100.0 109.766 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' HZ ' HD22 ' A' ' 154' ' ' ASN . 99.0 m-85 -110.61 127.2 55.14 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.111 -2.552 . . . . 100.0 104.111 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -104.55 116.92 32.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.798 -0.816 . . . . 100.0 108.798 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.0 -34.33 13.08 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 116.181 -0.463 . . . . 100.0 110.785 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -86.04 126.29 34.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.105 -1.072 . . . . 100.0 108.105 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -98.38 124.25 42.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.312 -1.355 . . . . 100.0 109.377 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.42 130.0 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 101.829 -3.397 . . . . 100.0 101.829 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.35 139.66 58.14 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.692 0.758 . . . . 100.0 112.861 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.2 m -93.58 123.46 36.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.075 -2.935 . . . . 100.0 103.075 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.17 125.98 50.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 105.959 -1.867 . . . . 100.0 105.959 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.26 -125.45 34.09 Favored Glycine 0 C--N 1.355 1.605 0 N-CA-C 109.147 -1.581 . . . . 100.0 109.147 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.82 139.1 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.559 0.695 . . . . 100.0 110.601 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -110.5 123.93 50.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.215 -2.883 . . . . 100.0 103.215 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.86 116.66 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 106.217 -1.772 . . . . 100.0 106.217 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.47 118.91 21.59 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 120.435 -0.506 . . . . 100.0 111.279 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -78.7 127.97 8.29 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.887 2.392 . . . . 100.0 109.658 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.24 126.84 45.81 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 106.248 -1.76 . . . . 100.0 106.248 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 128.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 100.0 105.875 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -118.66 131.74 56.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.649 -1.982 . . . . 100.0 105.649 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -97.28 123.98 41.25 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.0 p -124.19 179.71 4.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.815 -0.629 . . . . 100.0 110.85 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -58.79 -37.62 76.74 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.933 1.693 . . . . 100.0 110.208 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.45 -0.46 54.98 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 113.029 0.752 . . . . 100.0 113.029 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.53 -179.57 18.12 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 110.842 -0.903 . . . . 100.0 110.842 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.01 138.23 43.39 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.415 2.744 . . . . 100.0 113.437 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.98 140.41 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 103.258 -2.868 . . . . 100.0 103.258 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 37.8 ttmt -115.5 127.97 55.67 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 118.649 -1.22 . . . . 100.0 109.35 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -104.77 118.65 37.09 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.56 -2.755 . . . . 100.0 103.56 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -92.48 109.42 20.82 Favored 'General case' 0 N--CA 1.427 -1.58 1 N-CA-C 98.798 -4.519 . . . . 100.0 98.798 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.9 t -95.04 126.52 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.947 -1.501 . . . . 100.0 106.947 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -107.76 102.04 11.29 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.23 117.98 26.34 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 103.441 -2.8 . . . . 100.0 103.441 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.9 p -100.06 160.38 14.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 112.943 0.719 . . . . 100.0 112.943 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.0 36.97 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.085 -0.709 . . . . 100.0 109.085 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.36 -12.39 75.97 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 112.109 -0.396 . . . . 100.0 112.109 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.68 -39.46 84.47 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.625 1.57 . . . . 100.0 111.699 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.43 139.71 58.57 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.544 1.138 . . . . 100.0 113.385 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -67.15 147.91 52.5 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.48 1.912 . . . . 100.0 111.151 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -70.38 132.26 45.36 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.236 -1.764 . . . . 100.0 106.236 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.57 -166.87 33.96 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 119.118 -1.515 . . . . 100.0 115.534 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.36 -22.7 63.66 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 127.599 2.523 . . . . 100.0 114.337 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.0 -38.43 88.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.704 2.002 . . . . 100.0 110.021 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -82.99 -1.0 51.42 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 127.509 2.323 . . . . 100.0 113.895 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -42.85 93.61 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.476 2.399 . . . . 100.0 117.476 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -38.53 93.01 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 118.672 0.669 . . . . 100.0 113.345 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -62.36 -43.43 98.84 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 125.9 1.68 . . . . 100.0 109.592 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.566 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 6.3 t80 -89.84 -14.26 34.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 114.173 1.175 . . . . 100.0 114.173 -175.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -61.24 134.92 26.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 119.369 0.986 . . . . 100.0 109.358 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 66.1 20.25 11.18 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 127.363 2.265 . . . . 100.0 113.296 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.09 139.1 52.5 Favored 'General case' 0 C--N 1.365 1.278 0 O-C-N 121.199 -0.938 . . . . 100.0 108.669 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -99.54 -31.7 11.48 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.514 -0.767 . . . . 100.0 109.008 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.2 p -148.75 160.35 43.28 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 120.733 0.301 . . . . 100.0 111.431 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.36 150.81 39.66 Favored 'General case' 0 CA--C 1.487 -1.479 0 C-N-CA 119.371 -0.931 . . . . 100.0 113.021 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.0 mt -125.74 126.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 103.592 -2.744 . . . . 100.0 103.592 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.81 122.28 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.423 -3.177 . . . . 100.0 102.423 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.483 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 38.5 mtt -111.89 134.29 53.54 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 114.459 1.281 . . . . 100.0 114.459 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -130.14 157.17 43.16 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 112.546 -2.115 . . . . 100.0 109.229 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -102.18 125.53 48.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.08 -21.66 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.7 p -88.89 -5.84 57.73 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.996 -0.526 . . . . 100.0 111.62 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.1 t -119.79 116.79 26.61 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 122.859 1.314 . . . . 100.0 111.841 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.11 -39.71 86.73 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.887 -1.506 . . . . 100.0 110.804 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.79 -43.33 97.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 C-N-CA 125.24 1.416 . . . . 100.0 109.456 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.176 0.59 . . . . 100.0 109.914 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.44 -40.42 95.7 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.911 0.485 . . . . 100.0 110.723 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.2 mttt -60.77 -37.23 81.16 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.118 0.967 . . . . 100.0 111.445 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -73.43 -11.49 60.48 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 114.995 1.48 . . . . 100.0 114.995 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.35 -43.11 92.32 Favored Pre-proline 0 C--N 1.363 1.16 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.48 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 90.9 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.726 2.284 . . . . 100.0 112.702 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.55 -43.03 86.21 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.488 1.115 . . . . 100.0 109.901 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -63.16 -46.21 88.25 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -90.74 65.0 5.77 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 123.054 1.407 . . . . 100.0 107.883 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -159.69 -57.0 0.06 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 100.567 -3.864 . . . . 100.0 100.567 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.02 -43.72 98.24 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.107 1.363 . . . . 100.0 108.254 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -62.5 -46.34 88.88 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.267 1.027 . . . . 100.0 112.145 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.53 -39.84 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 126.498 1.919 . . . . 100.0 109.309 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -59.68 -45.19 92.83 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.113 0.565 . . . . 100.0 110.75 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.99 -50.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 72.3 m -115.03 9.4 15.99 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.989 3.329 . . . . 100.0 119.989 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.257 80.9 mm-40 53.82 -123.16 2.1 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.45 1.5 . . . . 100.0 113.943 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -98.13 112.97 24.74 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.631 1.105 . . . . 100.0 112.416 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.3 pt -143.35 151.75 55.56 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 104.161 -2.533 . . . . 100.0 104.161 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.52 127.97 22.27 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 121.982 1.788 . . . . 100.0 112.503 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.405 ' HB ' HD21 ' A' ' 144' ' ' LEU . 59.7 mt -130.56 136.0 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 107.271 -1.381 . . . . 100.0 107.271 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.84 131.39 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.175 -1.375 . . . . 100.0 107.922 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.43 125.12 45.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 104.329 -2.471 . . . . 100.0 104.329 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.483 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.8 m -116.49 122.19 44.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.986 0.898 . . . . 100.0 110.328 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.53 101.84 2.69 Favored Glycine 0 CA--C 1.476 -2.394 1 N-CA-C 102.862 -4.095 . . . . 100.0 102.862 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.578 HD22 HG23 ' A' ' 21' ' ' THR 0.412 56.7 p30 -92.69 170.31 9.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 118.899 -1.12 . . . . 100.0 113.943 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 93.1 mttt 60.81 40.39 15.99 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 128.105 2.562 . . . . 100.0 112.155 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.77 -18.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.474 0.71 . . . . 100.0 112.893 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.419 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 37.5 t70 -61.28 -39.14 89.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.054 1.742 . . . . 100.0 110.58 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.18 130.77 28.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 123.766 0.826 . . . . 100.0 109.109 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.35 -41.53 96.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.345 1.609 . . . . 100.0 115.345 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -84.26 81.39 8.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.482 0.658 . . . . 100.0 109.325 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -89.85 130.71 36.05 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.433 -1.321 . . . . 100.0 107.433 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.37 -44.36 7.26 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.598 -0.728 . . . . 100.0 109.821 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.95 112.16 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 105.026 -2.213 . . . . 100.0 105.026 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -86.38 150.87 24.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.787 -1.551 . . . . 100.0 110.106 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.25 94.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.171 0.989 . . . . 100.0 110.669 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.096 1.358 . . . . 100.0 110.839 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 m -62.66 -38.51 90.62 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 125.757 1.623 . . . . 100.0 112.695 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.588 HG23 ' HD1' ' A' ' 139' ' ' HIS . 76.4 mt -65.67 121.7 15.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.646 1.213 . . . . 100.0 110.358 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.58 -4.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 CA-C-N 113.627 -1.624 . . . . 100.0 111.07 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.77 -42.92 94.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.351 1.46 . . . . 100.0 111.339 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.588 ' HD1' HG23 ' A' ' 136' ' ' ILE . 48.1 p-80 -61.33 -42.19 98.28 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.534 0.733 . . . . 100.0 112.518 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -63.5 -45.07 92.37 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 123.937 0.895 . . . . 100.0 111.252 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.06 -41.19 95.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.512 0.725 . . . . 100.0 112.042 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.64 1.97 56.97 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 116.222 1.934 . . . . 100.0 116.222 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 55.58 49.23 16.97 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.227 1.411 . . . . 100.0 113.572 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.405 HD21 ' HB ' ' A' ' 117' ' ' ILE . 44.5 mt -118.7 159.11 24.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.676 -1.602 . . . . 100.0 106.676 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.308 78.9 mt-30 -101.63 140.23 36.2 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 118.609 -1.236 . . . . 100.0 110.578 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -109.38 131.15 55.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.987 0.736 . . . . 100.0 112.987 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.31 134.22 48.86 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.634 -1.166 . . . . 100.0 111.403 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -87.53 120.86 29.27 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 102.802 -3.036 . . . . 100.0 102.802 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 45.1 pt -130.93 154.4 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.355 1.074 . . . . 100.0 111.244 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.419 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 41.3 t -136.07 118.42 15.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.369 -2.456 . . . . 100.0 104.369 176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.439 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.81 -44.99 88.08 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 123.273 0.629 . . . . 100.0 109.435 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.11 -43.56 86.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 114.276 1.213 . . . . 100.0 114.276 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.1 m -92.25 -5.22 52.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.276 1.584 . . . . 100.0 115.276 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.444 HD22 ' HZ ' ' A' ' 35' ' ' PHE . 63.9 m-80 64.26 21.78 12.62 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 124.861 1.264 . . . . 100.0 112.167 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -75.72 125.1 28.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.189 -1.782 . . . . 100.0 106.189 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 53.31 40.39 31.24 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.064 2.146 . . . . 100.0 111.979 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -57.71 -48.6 79.1 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 126.706 2.003 . . . . 100.0 111.297 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.587 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 92.7 mt-10 -80.59 -24.75 38.93 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 118.396 2.739 . . . . 100.0 118.396 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.302 95.0 mttt -59.16 -45.31 99.34 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 121.456 3.872 . . . . 100.0 121.456 -173.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -60.04 -45.81 22.11 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 123.098 2.142 . . . . 100.0 112.74 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.587 ' CE2' ' HA ' ' A' ' 158' ' ' GLU 0.343 28.2 p90 -66.44 -40.72 89.63 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.346 1.029 . . . . 100.0 113.113 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.71 -43.23 97.18 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-O 118.403 -0.808 . . . . 100.0 112.877 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -63.89 -43.2 96.72 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 118.807 -0.616 . . . . 100.0 110.415 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.2 mt -60.78 -44.5 96.71 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.601 0.563 . . . . 100.0 110.806 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.0 99.91 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.891 0.876 . . . . 100.0 111.417 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -62.96 -45.27 93.25 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.364 0.666 . . . . 100.0 111.473 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -64.32 -47.02 81.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.798 0.839 . . . . 100.0 112.347 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.93 -46.48 81.44 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.234 0.827 . . . . 100.0 113.234 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.08 -39.17 76.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 123.694 0.798 . . . . 100.0 110.527 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.62 8.53 59.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-O 118.669 -1.073 . . . . 100.0 111.82 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -102.46 108.36 57.18 Favored Pre-proline 0 C--N 1.361 1.096 0 N-CA-C 106.655 -1.609 . . . . 100.0 106.655 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.12 -23.22 53.4 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.969 3.113 . . . . 100.0 113.569 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.6 6.72 47.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.161 1.384 . . . . 100.0 113.676 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.05 128.75 37.31 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.648 0.658 . . . . 100.0 110.127 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 . . . . . 0 CA--C 1.499 -1.012 0 CA-C-O 121.59 0.71 . . . . 100.0 110.509 -179.125 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 CA--C 1.484 -1.567 0 CA-C-O 121.317 0.579 . . . . 100.0 110.4 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.58 127.55 67.55 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 103.429 -2.804 . . . . 100.0 103.429 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.66 141.18 90.08 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.175 2.583 . . . . 100.0 114.208 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.83 167.39 27.39 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.839 3.026 . . . . 100.0 112.514 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.72 -42.21 96.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.68 1.592 . . . . 100.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.2 t 68.08 101.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.022 0 C-N-CA 127.374 2.27 . . . . 100.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.1 m -129.25 166.99 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 113.956 -1.474 . . . . 100.0 108.809 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 82.7 mtp 53.21 -131.89 2.03 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 126.917 2.087 . . . . 100.0 115.4 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 . . . . . 0 C--N 1.373 1.607 0 C-N-CA 128.736 2.814 . . . . 100.0 118.521 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 118.839 -0.6 . . . . 100.0 110.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -62.32 -43.87 97.82 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 123.911 0.884 . . . . 100.0 110.578 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.15 -43.83 97.97 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.384 0.674 . . . . 100.0 110.681 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.49 -44.58 96.02 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.552 1.141 . . . . 100.0 111.993 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.1 -42.55 97.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 C-N-CA 123.774 0.83 . . . . 100.0 109.295 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.89 97.88 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.642 0.777 . . . . 100.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -63.76 -40.76 97.49 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.357 1.063 . . . . 100.0 112.143 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -63.82 -42.96 97.55 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.732 1.213 . . . . 100.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.3 m . . . . . 0 C--N 1.358 0.975 0 C-N-CA 124.645 1.178 . . . . 100.0 111.688 -178.765 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.444 -0.746 0 CA-C-O 121.458 0.647 . . . . 100.0 110.924 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 33.1 tt0 -128.36 136.22 50.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.827 -1.916 . . . . 100.0 105.827 176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -119.95 132.61 55.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.732 -1.581 . . . . 100.0 106.732 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.39 117.22 28.93 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -110.18 129.01 55.79 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.838 -1.528 . . . . 100.0 106.93 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -110.53 124.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 105.253 -2.129 . . . . 100.0 105.253 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.01 116.71 32.4 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.948 -1.871 . . . . 100.0 105.948 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.405 ' HA ' ' HZ1' ' A' ' 23' ' ' LYS . 32.9 m -125.31 162.16 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 113.696 -1.593 . . . . 100.0 110.496 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.91 168.2 15.39 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 107.476 -2.25 . . . . 100.0 107.476 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -71.82 162.45 29.43 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 113.215 0.82 . . . . 100.0 113.215 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.78 141.43 38.28 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.293 -1.123 . . . . 100.0 110.293 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.18 1.44 90.36 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.715 0.674 . . . . 100.0 113.982 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.8 m -65.02 -41.23 95.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.758 0.823 . . . . 100.0 111.648 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.43 15.77 6.86 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 120.57 -0.824 . . . . 100.0 112.087 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HZ1' ' HA ' ' A' ' 16' ' ' VAL . 20.1 ptmt -61.5 -44.32 97.29 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.77 1.228 . . . . 100.0 111.713 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.5 m -64.96 -42.31 94.7 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.906 1.282 . . . . 100.0 109.659 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.7 m -63.47 -41.01 98.61 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.272 1.029 . . . . 100.0 109.353 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -60.25 -47.5 85.73 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.072 1.349 . . . . 100.0 110.013 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.08 -43.6 97.53 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 C-N-CA 123.591 0.756 . . . . 100.0 111.831 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.605 1.162 . . . . 100.0 109.734 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.461 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 36.8 ttp180 -61.72 -45.15 95.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 125.43 1.492 . . . . 100.0 110.462 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -63.9 -43.72 95.14 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.59 0.589 . . . . 100.0 112.59 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -65.05 -47.58 76.83 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 115.23 1.567 . . . . 100.0 115.23 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.0 p -120.01 -23.57 6.32 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 119.104 3.002 . . . . 100.0 119.104 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.91 -4.33 71.57 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 110.733 -0.947 . . . . 100.0 110.733 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -76.94 147.15 37.11 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 126.422 1.889 . . . . 100.0 108.563 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.447 ' HZ ' HD22 ' A' ' 154' ' ' ASN . 93.0 m-85 -114.29 126.32 54.9 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 105.391 -2.077 . . . . 100.0 105.391 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -105.49 113.93 27.79 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 120.071 -0.651 . . . . 100.0 111.907 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -72.96 -42.26 63.55 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.0 1.32 . . . . 100.0 112.511 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -84.75 130.91 34.62 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 125.904 1.682 . . . . 100.0 111.419 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -99.73 120.67 40.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 122.407 1.099 . . . . 100.0 110.77 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 1 N-CA-C 99.994 -4.076 . . . . 100.0 99.994 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.21 58.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 113.871 1.063 . . . . 100.0 113.871 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 m -91.45 126.18 36.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 103.708 -2.701 . . . . 100.0 103.708 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.74 128.79 53.91 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.77 -125.38 30.56 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.378 -1.489 . . . . 100.0 109.378 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.8 t -126.79 139.51 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 123.56 0.744 . . . . 100.0 109.987 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -113.87 124.57 52.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.276 -2.861 . . . . 100.0 103.276 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.56 113.35 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.899 -1.148 . . . . 100.0 107.899 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -125.97 120.77 24.09 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 113.018 0.747 . . . . 100.0 113.018 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.88 135.0 12.28 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 122.475 2.117 . . . . 100.0 111.148 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.58 132.67 53.94 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 105.414 -2.069 . . . . 100.0 105.414 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.457 HG21 ' HE3' ' A' ' 60' ' ' LYS . 19.6 t -109.44 126.58 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.554 -2.017 . . . . 100.0 105.554 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.31 129.45 54.01 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.269 -1.752 . . . . 100.0 106.269 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -98.83 122.9 42.66 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 105.749 -1.945 . . . . 100.0 105.749 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.9 p -122.67 -178.3 3.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.426 -0.806 . . . . 100.0 110.787 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -59.41 -37.34 77.79 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.7 1.6 . . . . 100.0 108.6 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.33 -3.41 52.56 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.206 1.802 . . . . 100.0 112.458 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.81 -177.02 19.7 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 110.829 -0.908 . . . . 100.0 110.829 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.33 137.16 50.22 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.972 3.115 . . . . 100.0 113.418 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.46 142.97 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.317 -2.105 . . . . 100.0 105.317 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HE3' HG21 ' A' ' 51' ' ' VAL 0.284 44.8 mttp -115.1 132.34 56.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 118.046 -1.462 . . . . 100.0 110.588 175.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.48 116.83 33.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.087 -2.931 . . . . 100.0 103.087 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -92.5 100.46 13.0 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 101.089 -3.671 . . . . 100.0 101.089 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.45 124.74 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.704 -0.68 . . . . 100.0 109.276 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -106.72 106.36 16.85 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 104.954 -2.239 . . . . 100.0 104.954 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.51 117.11 24.22 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 102.934 -2.987 . . . . 100.0 102.934 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.6 p -100.14 162.64 12.84 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 113.14 0.792 . . . . 100.0 113.14 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.97 128.74 34.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.682 -0.859 . . . . 100.0 108.682 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.14 -12.19 82.7 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 116.02 -0.536 . . . . 100.0 113.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -67.77 -39.16 84.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.399 1.48 . . . . 100.0 112.069 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.34 137.66 58.3 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.778 1.231 . . . . 100.0 112.45 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.76 153.9 41.68 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.869 -1.06 . . . . 100.0 112.427 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -68.08 131.99 46.43 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.818 1.647 . . . . 100.0 108.115 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.61 -171.4 34.78 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 119.237 -1.459 . . . . 100.0 115.446 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -21.04 62.85 Favored Glycine 0 C--N 1.356 1.692 0 C-N-CA 127.959 2.695 . . . . 100.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.23 -37.93 84.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.362 2.265 . . . . 100.0 109.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -87.86 6.82 33.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 126.269 1.828 . . . . 100.0 115.19 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 -42.24 90.35 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 115.487 1.662 . . . . 100.0 115.487 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.02 94.33 Favored Glycine 0 C--N 1.353 1.497 0 C-N-CA 123.804 0.716 . . . . 100.0 113.165 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -60.87 -45.56 94.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.448 1.499 . . . . 100.0 108.694 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.602 ' HH ' ' HB3' ' A' ' 86' ' ' ALA . 6.1 t80 -89.29 -11.05 44.57 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 115.076 1.51 . . . . 100.0 115.076 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.5 131.66 25.44 Favored 'Isoleucine or valine' 0 C--N 1.366 1.326 0 CA-C-N 119.924 1.238 . . . . 100.0 110.838 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.309 63.9 mt-30 57.21 36.9 28.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 128.197 2.599 . . . . 100.0 113.863 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.88 142.87 42.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 105.611 -1.996 . . . . 100.0 105.611 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -100.15 -31.31 11.47 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.076 -1.083 . . . . 100.0 108.076 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.4 p -153.89 160.86 42.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 122.783 0.433 . . . . 100.0 110.377 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.602 ' HB3' ' HH ' ' A' ' 80' ' ' TYR . . . -141.82 153.46 44.52 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 113.578 0.955 . . . . 100.0 113.578 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.5 mt -126.26 125.81 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 103.935 -2.617 . . . . 100.0 103.935 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 69.7 mt -109.95 124.48 66.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 101.23 -3.618 . . . . 100.0 101.23 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -119.05 133.26 55.92 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 118.358 -1.337 . . . . 100.0 111.322 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -128.57 158.9 37.17 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.741 -1.572 . . . . 100.0 110.017 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.65 123.98 44.43 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.883 -1.895 . . . . 100.0 105.883 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -65.03 -21.08 28.79 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 113.348 0.87 . . . . 100.0 113.348 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -90.57 -5.8 55.48 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 118.712 -0.661 . . . . 100.0 111.765 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.7 t -119.65 116.7 26.53 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.83 1.3 . . . . 100.0 111.167 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -66.27 -39.6 89.55 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.566 -1.652 . . . . 100.0 111.336 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -43.17 96.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 125.132 1.373 . . . . 100.0 109.326 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 96.9 m -62.66 -43.17 99.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 122.89 0.476 . . . . 100.0 109.905 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.57 ' HH ' HG21 ' A' ' 136' ' ' ILE . 76.5 t80 -63.89 -39.54 94.41 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 122.811 0.445 . . . . 100.0 110.524 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 92.5 mttt -60.53 -38.33 84.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.271 1.429 . . . . 100.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.38 -12.07 60.7 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 114.569 1.322 . . . . 100.0 114.569 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.82 -43.09 94.17 Favored Pre-proline 0 C--N 1.364 1.236 0 CA-C-O 115.952 -1.975 . . . . 100.0 111.34 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 97.4 Cg_exo -57.41 -36.39 98.82 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.483 2.122 . . . . 100.0 112.517 177.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -66.35 -41.96 88.79 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.005 0.815 . . . . 100.0 111.164 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -62.6 -46.35 88.72 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 108.928 -0.768 . . . . 100.0 108.928 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.4 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 48.0 t-80 -91.62 65.9 5.21 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-O 123.0 1.381 . . . . 100.0 108.425 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -162.06 -56.6 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 101.103 -3.665 . . . . 100.0 101.103 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.23 -41.7 99.15 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.189 -1.041 . . . . 100.0 108.189 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.565 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -62.66 -46.04 90.04 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.86 0.864 . . . . 100.0 111.534 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.87 -39.23 82.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 126.378 1.871 . . . . 100.0 109.438 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -58.8 -45.6 89.52 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.34 1.056 . . . . 100.0 109.971 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.66 -50.38 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 115.512 1.671 . . . . 100.0 115.512 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.81 8.83 20.67 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 120.981 3.697 . . . . 100.0 120.981 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 53.98 -125.02 2.29 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 125.213 1.405 . . . . 100.0 113.241 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -97.88 113.98 25.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 120.289 1.404 . . . . 100.0 112.326 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.1 pt -142.73 152.74 60.18 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.03 127.15 20.47 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 122.231 1.954 . . . . 100.0 113.066 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.411 ' HB ' HD21 ' A' ' 144' ' ' LEU . 67.4 mt -131.28 134.8 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.693 1.235 . . . . 100.0 107.756 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.66 133.04 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 113.598 -1.637 . . . . 100.0 108.332 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . 0.272 88.3 mt -100.6 126.74 47.1 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 104.614 -2.365 . . . . 100.0 104.614 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -116.58 123.02 46.34 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.839 0.828 . . . . 100.0 109.696 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.09 102.57 2.68 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.33 -3.908 . . . . 100.0 103.33 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.412 54.0 p30 -94.45 173.36 7.66 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 114.584 1.328 . . . . 100.0 114.584 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 60.56 40.4 16.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 127.704 2.402 . . . . 100.0 111.323 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.45 -12.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 CA-C-N 115.717 -0.674 . . . . 100.0 112.417 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.82 -39.57 92.23 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.64 1.576 . . . . 100.0 109.588 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.22 130.28 29.03 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 124.232 1.013 . . . . 100.0 109.822 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.42 -40.01 89.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 115.4 1.629 . . . . 100.0 115.4 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -82.96 81.18 8.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.344 -0.984 . . . . 100.0 108.344 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -90.86 134.1 34.71 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.243 -1.762 . . . . 100.0 106.243 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -101.35 -40.85 6.91 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 110.011 -0.366 . . . . 100.0 110.011 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.15 109.89 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.948 -2.241 . . . . 100.0 104.948 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.27 145.44 29.11 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.648 -1.16 . . . . 100.0 110.833 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.21 98.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.08 0.952 . . . . 100.0 112.257 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.15 -39.87 95.92 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.07 0.548 . . . . 100.0 111.599 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.7 m -62.18 -36.57 82.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.524 1.93 . . . . 100.0 113.471 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.57 HG21 ' HH ' ' A' ' 98' ' ' TYR . 93.8 mt -63.66 123.64 16.83 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-O 122.336 1.065 . . . . 100.0 109.778 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 -4.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 125.583 1.553 . . . . 100.0 112.001 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -59.41 -43.43 93.03 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 125.098 1.359 . . . . 100.0 111.456 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.555 ' HD1' HG23 ' A' ' 136' ' ' ILE . 51.7 p-80 -62.18 -40.53 96.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 112.766 0.654 . . . . 100.0 112.766 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -62.97 -45.72 91.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.295 1.038 . . . . 100.0 110.547 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.56 -41.41 96.32 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.793 0.837 . . . . 100.0 111.686 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.84 4.46 53.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 117.284 2.328 . . . . 100.0 117.284 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 57.05 46.08 19.86 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 122.176 0.989 . . . . 100.0 112.403 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.411 HD21 ' HB ' ' A' ' 117' ' ' ILE . 45.2 mt -115.24 162.28 17.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 108.251 -1.018 . . . . 100.0 108.251 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -101.34 139.18 37.36 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.783 -1.192 . . . . 100.0 107.783 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -114.29 130.34 56.65 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.384 0.611 . . . . 100.0 111.542 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -128.12 134.68 49.15 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.263 -0.881 . . . . 100.0 110.629 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -89.06 121.23 31.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 102.711 -3.07 . . . . 100.0 102.711 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 48.3 pt -132.63 157.19 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 122.194 0.997 . . . . 100.0 112.144 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.7 t -139.9 119.12 12.8 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.225 -2.509 . . . . 100.0 104.225 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.426 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.87 -44.17 93.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.359 -0.837 . . . . 100.0 109.614 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -63.18 -46.31 87.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.605 1.962 . . . . 100.0 114.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -97.16 -1.06 45.87 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 115.93 1.826 . . . . 100.0 115.93 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.461 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 63.1 m-80 64.65 21.77 12.48 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 125.075 1.35 . . . . 100.0 113.296 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -72.42 123.2 22.6 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.289 -1.745 . . . . 100.0 106.289 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.1 40.58 31.44 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.507 2.323 . . . . 100.0 112.389 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.405 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 18.4 t80 -55.83 -49.92 71.97 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 126.968 2.107 . . . . 100.0 115.589 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -96.34 -2.85 44.93 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.271 96.6 mttt -59.88 -44.86 97.91 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 118.277 2.695 . . . . 100.0 118.277 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.14 -42.65 41.49 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 122.523 1.937 . . . . 100.0 112.503 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -64.24 -43.95 93.31 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.534 1.146 . . . . 100.0 112.297 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.64 -44.96 92.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 123.923 0.764 . . . . 100.0 112.869 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -64.09 -42.58 96.88 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 123.501 0.5 . . . . 100.0 110.296 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.42 -43.66 98.48 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 118.892 -0.575 . . . . 100.0 111.106 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.5 98.68 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.209 0.604 . . . . 100.0 111.478 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.414 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 89.5 mtt180 -62.44 -45.39 93.31 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.278 0.631 . . . . 100.0 111.546 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -65.02 -45.24 86.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.986 0.915 . . . . 100.0 111.714 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.89 -45.56 85.44 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 123.614 0.766 . . . . 100.0 112.947 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.47 -39.21 78.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 C-N-CA 123.545 0.738 . . . . 100.0 109.975 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.81 9.75 57.11 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-O 118.602 -1.11 . . . . 100.0 111.206 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -104.83 109.28 62.87 Favored Pre-proline 0 C--N 1.364 1.231 0 N-CA-C 107.705 -1.22 . . . . 100.0 107.705 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.51 -24.31 56.56 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 124.086 3.191 . . . . 100.0 113.994 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.36 3.62 51.59 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.609 1.964 . . . . 100.0 113.708 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 21.9 tp -62.85 130.75 46.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.451 0.537 . . . . 100.0 112.451 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 . . . . . 0 CA--C 1.496 -1.118 0 CA-C-O 121.842 0.829 . . . . 100.0 110.595 178.797 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 121.414 0.625 . . . . 100.0 112.274 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.87 123.59 68.75 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 104.158 -2.534 . . . . 100.0 104.158 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -62.87 135.03 49.64 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 123.47 2.78 . . . . 100.0 113.175 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.81 157.32 43.66 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 123.28 2.654 . . . . 100.0 113.989 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.66 -38.73 92.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.868 1.667 . . . . 100.0 111.474 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.275 30.0 t 71.52 82.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 128.199 2.6 . . . . 100.0 109.836 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.24 163.57 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.945 2.098 . . . . 100.0 107.955 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 80.3 mtp 60.15 -114.02 0.63 Allowed 'General case' 0 C--N 1.355 0.847 0 N-CA-C 115.574 1.694 . . . . 100.0 115.574 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 . . . . . 0 C--N 1.371 1.512 1 N-CA-C 123.75 4.722 . . . . 100.0 123.75 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 118.443 -0.789 . . . . 100.0 111.874 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.01 -43.8 97.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 123.595 0.56 . . . . 100.0 111.882 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.7 -45.4 94.15 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 123.465 0.478 . . . . 100.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.4 -42.63 98.78 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 117.999 -1.0 . . . . 100.0 113.14 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.49 -45.0 99.54 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-N 118.613 0.642 . . . . 100.0 109.311 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.46 93.52 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 112.696 0.628 . . . . 100.0 112.696 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.28 -42.8 96.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.143 0.977 . . . . 100.0 112.877 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.7 m -63.95 -39.3 93.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.717 1.607 . . . . 100.0 111.913 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--N 1.366 1.305 0 CA-C-O 122.295 1.045 . . . . 100.0 110.599 -177.558 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.438 -1.039 0 N-CA-C 114.236 1.198 . . . . 100.0 114.236 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 60' ' ' LYS 0.272 30.9 tt0 -126.6 134.51 50.78 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 103.811 -2.663 . . . . 100.0 103.811 177.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -124.27 136.44 54.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.765 -1.198 . . . . 100.0 107.765 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.74 116.31 28.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.543 -2.021 . . . . 100.0 105.543 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.78 128.57 55.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.436 -1.711 . . . . 100.0 107.574 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.27 122.1 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 106.098 -1.815 . . . . 100.0 106.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -104.08 118.14 35.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.479 -1.674 . . . . 100.0 106.479 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.5 m -127.59 163.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 113.664 -1.607 . . . . 100.0 111.412 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.11 169.66 16.53 Favored Glycine 0 CA--C 1.493 -1.296 0 N-CA-C 108.053 -2.019 . . . . 100.0 108.053 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -71.28 160.65 32.42 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.892 0.853 . . . . 100.0 113.022 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.32 140.25 41.06 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.428 -1.069 . . . . 100.0 110.428 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.4 2.01 90.54 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.381 -0.677 . . . . 100.0 114.643 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.401 HG22 ' C ' ' A' ' 89' ' ' MET . 68.5 m -64.28 -42.27 96.51 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.225 1.012 . . . . 100.0 112.279 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.04 17.73 4.46 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.689 -0.767 . . . . 100.0 111.846 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -60.71 -47.54 85.83 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 125.927 1.691 . . . . 100.0 110.354 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.6 m -64.5 -42.88 95.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.402 1.481 . . . . 100.0 109.509 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.1 m -62.72 -41.96 99.42 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 125.012 1.325 . . . . 100.0 109.473 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.426 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 88.4 t80 -60.55 -48.49 81.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.956 1.302 . . . . 100.0 110.49 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.3 -42.03 90.04 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 123.333 0.396 . . . . 100.0 111.289 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.93 -40.09 94.29 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.274 0.63 . . . . 100.0 112.139 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.426 ' NH1' ' HA ' ' A' ' 26' ' ' PHE . 32.3 ttp-105 -62.14 -44.31 96.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 123.78 0.832 . . . . 100.0 109.058 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -62.8 -45.61 91.85 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 112.332 0.493 . . . . 100.0 112.332 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.83 -48.75 73.21 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 116.459 2.022 . . . . 100.0 116.459 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.4 p -118.9 -21.45 7.75 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 116.689 2.107 . . . . 100.0 116.689 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.72 71.8 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.524 -0.598 . . . . 100.0 112.128 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.04 146.88 45.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.924 1.29 . . . . 100.0 109.022 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.36 120.38 42.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.05 -3.315 . . . . 100.0 102.05 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.73 114.22 28.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 119.13 -1.028 . . . . 100.0 111.622 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.73 -43.72 62.59 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 114.595 -1.184 . . . . 100.0 113.512 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -76.44 145.58 39.17 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 123.161 0.584 . . . . 100.0 111.414 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -107.03 124.09 49.14 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 119.227 -0.989 . . . . 100.0 108.435 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -115.64 125.85 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 101.474 -3.528 . . . . 100.0 101.474 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.38 138.84 58.67 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 112.924 0.713 . . . . 100.0 112.924 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.6 m -96.23 125.36 40.69 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 103.665 -2.717 . . . . 100.0 103.665 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.07 129.05 54.24 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.658 -1.608 . . . . 100.0 106.658 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.51 -126.33 32.69 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 109.742 -1.343 . . . . 100.0 109.742 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.75 137.58 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 123.135 0.574 . . . . 100.0 109.907 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -114.36 126.11 54.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 103.827 -2.657 . . . . 100.0 103.827 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.02 121.36 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.854 -1.536 . . . . 100.0 106.854 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -127.37 122.78 22.99 Favored Pre-proline 0 N--CA 1.431 -1.405 0 CA-C-N 115.458 -0.792 . . . . 100.0 110.9 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.18 125.29 5.78 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.968 2.445 . . . . 100.0 110.225 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -122.41 126.7 48.51 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.717 -1.586 . . . . 100.0 106.717 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.19 130.56 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 N-CA-C 106.821 -1.548 . . . . 100.0 106.821 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -118.36 132.42 56.27 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.513 -2.032 . . . . 100.0 105.513 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.487 ' HD1' ' HG3' ' A' ' 58' ' ' PRO . 97.8 m-70 -102.8 123.49 46.55 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 106.541 -1.652 . . . . 100.0 106.541 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 p -123.64 -177.42 3.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.024 -0.535 . . . . 100.0 111.791 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -58.98 -38.26 78.74 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.263 1.825 . . . . 100.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -86.55 -0.23 55.7 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.861 0.864 . . . . 100.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.63 -178.8 19.51 Favored Glycine 0 N--CA 1.432 -1.63 0 O-C-N 122.034 -0.416 . . . . 100.0 112.194 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.487 ' HG3' ' HD1' ' A' ' 53' ' ' HIS . 33.6 Cg_exo -64.99 139.46 61.62 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.092 3.195 . . . . 100.0 113.782 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.7 mt -129.66 138.43 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.472 -2.788 . . . . 100.0 103.472 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 40.7 ttmt -118.68 128.94 54.99 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.4 -1.32 . . . . 100.0 108.889 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -108.63 117.58 34.56 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -92.25 106.53 18.52 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 102.519 -3.141 . . . . 100.0 102.519 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.37 124.4 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-N 112.447 -2.16 . . . . 100.0 109.198 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -104.77 105.9 16.17 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 104.715 -2.328 . . . . 100.0 104.715 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.76 118.7 27.45 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 104.339 -2.467 . . . . 100.0 104.339 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.1 p -96.54 162.27 13.54 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 114.041 1.126 . . . . 100.0 114.041 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.71 128.73 34.75 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.139 -1.43 . . . . 100.0 107.139 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.45 -13.39 80.44 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.948 -0.362 . . . . 100.0 112.386 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -65.81 -41.04 92.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.359 1.864 . . . . 100.0 112.13 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.71 137.73 58.2 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.828 0.851 . . . . 100.0 111.991 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -71.8 156.24 39.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.3 1.048 . . . . 100.0 113.019 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -66.85 132.71 48.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.413 1.885 . . . . 100.0 108.267 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.92 -171.77 34.43 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 119.608 -1.282 . . . . 100.0 114.548 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.04 -21.53 63.82 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 127.915 2.674 . . . . 100.0 113.824 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.65 -36.88 84.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.595 1.558 . . . . 100.0 110.649 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -87.45 1.21 54.08 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.742 1.617 . . . . 100.0 113.592 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.43 -39.78 92.06 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 116.044 1.868 . . . . 100.0 116.044 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.11 91.67 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 118.836 0.744 . . . . 100.0 113.436 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -62.91 -42.2 99.71 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.24 1.816 . . . . 100.0 108.912 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.578 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 8.8 t80 -89.32 -14.31 36.01 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 114.271 1.211 . . . . 100.0 114.271 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.6 mt -61.83 135.86 25.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 CA-C-N 119.108 0.867 . . . . 100.0 108.862 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 64.56 21.71 12.5 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 126.558 1.943 . . . . 100.0 114.441 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.51 141.29 50.16 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 108.158 -1.053 . . . . 100.0 108.158 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -100.0 -32.38 10.98 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.006 -1.109 . . . . 100.0 108.006 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.7 p -150.3 160.96 43.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.964 0.411 . . . . 100.0 111.391 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.479 ' HB3' ' HH ' ' A' ' 80' ' ' TYR . . . -143.52 152.43 41.46 Favored 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 119.616 -0.834 . . . . 100.0 113.114 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.0 mt -126.16 126.7 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.258 -2.497 . . . . 100.0 104.258 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 67.9 mt -109.27 124.26 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 N-CA-C 101.483 -3.525 . . . . 100.0 101.483 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.401 ' C ' HG22 ' A' ' 21' ' ' THR . 50.1 ttm -119.03 133.27 55.92 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.239 -1.384 . . . . 100.0 111.083 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -127.63 158.3 37.9 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.461 -1.7 . . . . 100.0 109.665 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -102.42 125.75 49.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 105.473 -2.047 . . . . 100.0 105.473 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.66 -22.96 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 114.167 1.173 . . . . 100.0 114.167 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -85.29 -10.83 55.97 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 118.736 -0.649 . . . . 100.0 111.072 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 t -116.17 116.71 28.31 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.272 1.511 . . . . 100.0 112.541 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -65.8 -41.45 91.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.938 -1.937 . . . . 100.0 109.223 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.08 -43.62 97.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 C-N-CA 125.431 1.492 . . . . 100.0 110.353 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -63.17 -43.23 98.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.101 0.561 . . . . 100.0 109.74 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.59 ' HH ' HG21 ' A' ' 136' ' ' ILE . 86.8 t80 -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.572 0.349 . . . . 100.0 110.289 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.4 mttt -60.25 -37.97 82.03 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 124.15 0.98 . . . . 100.0 111.335 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -73.27 -11.28 60.45 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.238 1.57 . . . . 100.0 115.238 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.97 -42.92 93.02 Favored Pre-proline 0 C--N 1.361 1.1 0 CA-C-O 116.58 -1.676 . . . . 100.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 92.9 Cg_exo -59.3 -34.27 97.87 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.488 2.125 . . . . 100.0 112.422 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.98 -43.38 88.02 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.07 0.948 . . . . 100.0 110.116 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -62.76 -47.11 84.95 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 109.111 -0.7 . . . . 100.0 109.111 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.549 ' HD1' ' NZ ' ' A' ' 142' ' ' LYS . 50.2 t-80 -91.46 64.52 5.06 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.78 1.276 . . . . 100.0 108.351 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -154.81 -60.59 0.12 Allowed 'General case' 0 CA--C 1.489 -1.387 1 N-CA-C 99.736 -4.172 . . . . 100.0 99.736 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.52 -39.99 95.32 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.192 0.597 . . . . 100.0 111.138 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.578 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -61.56 -45.85 92.39 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 122.998 0.519 . . . . 100.0 110.583 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.6 -39.08 83.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 126.395 1.878 . . . . 100.0 109.784 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.27 45.7 mtm105 -59.01 -44.52 91.71 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.048 0.539 . . . . 100.0 109.753 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.43 -51.84 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 115.563 1.69 . . . . 100.0 115.563 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -108.26 4.02 24.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 119.911 3.3 . . . . 100.0 119.911 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 54.11 -121.05 1.76 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.326 1.45 . . . . 100.0 111.28 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -95.19 112.88 24.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.884 1.22 . . . . 100.0 111.134 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.2 pt -144.79 153.09 53.81 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.942 -2.984 . . . . 100.0 102.942 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -62.31 126.0 17.57 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.311 2.007 . . . . 100.0 111.9 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.418 ' HB ' HD21 ' A' ' 144' ' ' LEU . 69.1 mt -130.69 133.81 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.461 -1.311 . . . . 100.0 107.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -115.38 133.12 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 114.044 -1.435 . . . . 100.0 108.077 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.89 124.8 47.11 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.69 -2.337 . . . . 100.0 104.69 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.8 m -116.94 122.34 44.0 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.75 0.786 . . . . 100.0 110.348 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.42 103.15 2.82 Favored Glycine 0 CA--C 1.478 -2.259 0 N-CA-C 103.626 -3.79 . . . . 100.0 103.626 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.41 54.0 p30 -93.09 170.62 9.5 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 114.817 1.414 . . . . 100.0 114.817 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.7 mttt 61.11 41.67 13.4 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.586 2.754 . . . . 100.0 112.201 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.8 m -64.76 -18.9 24.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.275 -0.875 . . . . 100.0 112.781 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.528 ' CG ' ' HG ' ' A' ' 150' ' ' SER . 93.1 m-20 -61.11 -38.25 85.67 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 123.624 0.77 . . . . 100.0 112.4 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.61 130.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.843 0.83 . . . . 100.0 108.981 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.61 -42.74 98.19 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.767 1.627 . . . . 100.0 114.84 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.32 77.03 10.06 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.51 1.147 . . . . 100.0 108.742 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.453 ' NH2' ' HH ' ' A' ' 146' ' ' TYR . 78.0 ttt180 -92.95 125.9 37.77 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.618 -1.623 . . . . 100.0 106.618 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -98.05 -39.17 9.06 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.32 -0.855 . . . . 100.0 112.302 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.96 107.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 103.908 -2.627 . . . . 100.0 103.908 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.9 144.34 31.04 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.422 -1.263 . . . . 100.0 109.962 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.84 -40.56 95.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.286 1.035 . . . . 100.0 111.348 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -40.76 98.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.909 1.284 . . . . 100.0 110.722 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.6 m -63.28 -38.09 89.8 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.124 1.77 . . . . 100.0 113.057 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.59 HG21 ' HH ' ' A' ' 98' ' ' TYR . 96.2 mt -62.01 123.76 15.34 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-O 122.553 1.168 . . . . 100.0 110.022 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.56 -5.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.434 -1.712 . . . . 100.0 110.701 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -59.61 -41.74 91.06 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.243 1.417 . . . . 100.0 111.4 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.586 ' HD1' HG23 ' A' ' 136' ' ' ILE . 45.0 p-80 -61.27 -42.71 99.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.403 0.681 . . . . 100.0 112.364 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -63.8 -44.23 93.95 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 124.195 0.998 . . . . 100.0 110.859 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.8 -42.31 97.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.937 0.895 . . . . 100.0 111.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.549 ' NZ ' ' HD1' ' A' ' 105' ' ' HIS . 33.8 mmtp -95.69 4.46 52.98 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.655 2.095 . . . . 100.0 116.655 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 55.54 46.89 22.05 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-O 122.898 1.333 . . . . 100.0 113.257 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 117' ' ' ILE . 40.7 mt -113.36 159.66 19.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.377 -1.342 . . . . 100.0 107.377 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.7 mm-40 -99.38 140.82 32.99 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 109.577 -0.527 . . . . 100.0 109.577 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.453 ' HH ' ' NH2' ' A' ' 129' ' ' ARG . 57.2 t80 -114.29 130.98 56.66 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.472 0.653 . . . . 100.0 112.067 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -129.06 135.1 48.47 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.027 -0.988 . . . . 100.0 111.401 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -90.04 120.83 31.57 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 101.872 -3.381 . . . . 100.0 101.872 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 48.8 pt -131.9 154.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.489 1.138 . . . . 100.0 112.07 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.528 ' HG ' ' CG ' ' A' ' 125' ' ' ASP . 33.1 t -138.95 118.2 12.71 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 104.497 -2.408 . . . . 100.0 104.497 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.239 -0.891 . . . . 100.0 109.142 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -44.26 87.62 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.061 1.504 . . . . 100.0 115.061 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -93.73 -2.17 54.15 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.022 1.49 . . . . 100.0 115.022 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 66.46 21.0 10.89 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 125.012 1.325 . . . . 100.0 111.133 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -73.9 118.09 16.45 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.778 -1.193 . . . . 100.0 107.778 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 52.29 36.8 20.53 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 127.955 2.502 . . . . 100.0 111.145 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -63.06 -40.71 98.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 115.613 1.709 . . . . 100.0 115.613 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.57 -10.24 49.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 113.75 1.018 . . . . 100.0 113.75 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.311 94.8 mttt -60.14 -43.98 95.25 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 118.605 2.817 . . . . 100.0 118.605 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -59.65 -41.32 56.99 Favored 'Trans proline' 0 C--N 1.372 1.787 0 CA-C-N 123.187 2.174 . . . . 100.0 112.344 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -63.38 -44.78 93.75 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 124.051 0.844 . . . . 100.0 111.278 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.28 -42.61 96.33 Favored 'General case' 0 CA--C 1.483 -1.609 0 CA-C-O 118.394 -0.812 . . . . 100.0 112.73 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.416 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.2 t90 -64.25 -42.61 96.43 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.711 0.632 . . . . 100.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.72 -43.78 97.42 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 123.406 0.441 . . . . 100.0 110.651 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.85 99.93 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.59 0.756 . . . . 100.0 111.548 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -61.77 -46.14 90.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 124.199 1.0 . . . . 100.0 111.11 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -65.8 -45.98 80.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 123.71 0.804 . . . . 100.0 112.685 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.96 -45.73 84.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.513 0.725 . . . . 100.0 112.397 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 98.3 mt -70.79 -38.16 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 124.207 1.003 . . . . 100.0 111.052 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.74 10.07 55.71 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 118.589 -1.117 . . . . 100.0 113.365 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 110.62 61.7 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 106.733 -1.58 . . . . 100.0 106.733 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -70.78 -18.08 32.48 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.272 2.648 . . . . 100.0 113.783 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -97.24 9.14 43.03 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.088 0.955 . . . . 100.0 112.595 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 26.9 tp -63.31 129.27 39.55 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 109.055 -0.72 . . . . 100.0 109.055 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 . . . . . 0 CA--C 1.493 -1.237 0 CA-C-O 121.42 0.629 . . . . 100.0 111.017 -178.503 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 CA--C 1.484 -1.562 0 N-CA-C 114.405 1.261 . . . . 100.0 114.405 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.52 120.7 68.92 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 101.094 -3.669 . . . . 100.0 101.094 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 66.9 Cg_endo -63.04 145.16 93.99 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.78 2.986 . . . . 100.0 116.224 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 24.7 Cg_exo -70.57 159.53 52.5 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.543 2.829 . . . . 100.0 111.57 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -61.14 -44.01 98.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.92 1.288 . . . . 100.0 112.581 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.27 24.9 t 62.97 84.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.08 0 C-N-CA 127.123 2.169 . . . . 100.0 110.515 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 m -110.54 177.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 125.123 1.369 . . . . 100.0 109.548 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.277 85.9 mmm 54.44 -118.5 1.32 Allowed 'General case' 0 C--N 1.359 1.0 0 N-CA-C 117.862 2.542 . . . . 100.0 117.862 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.28 86.7 m-20 . . . . . 0 C--N 1.367 1.337 0 N-CA-C 121.225 3.787 . . . . 100.0 121.225 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 N--CA 1.436 -1.169 0 CA-C-O 118.407 -0.806 . . . . 100.0 111.03 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.2 -46.22 88.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 118.302 0.501 . . . . 100.0 111.908 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.88 -45.13 93.97 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.451 0.469 . . . . 100.0 112.145 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -64.66 -42.97 95.03 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 118.1 -0.952 . . . . 100.0 112.516 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.18 -43.13 98.66 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 CA-C-O 118.626 -0.702 . . . . 100.0 109.581 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.19 95.18 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 118.034 0.379 . . . . 100.0 111.244 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.35 -42.37 96.27 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.898 0.879 . . . . 100.0 113.169 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.5 m -64.81 -39.45 93.6 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.935 1.694 . . . . 100.0 111.744 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.362 1.126 0 C-N-CA 123.624 0.77 . . . . 100.0 110.091 -178.741 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.442 -0.839 0 CA-C-O 122.091 0.948 . . . . 100.0 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 50.8 tt0 -125.26 131.77 53.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.387 -2.449 . . . . 100.0 104.387 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -119.49 135.43 54.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.102 -1.073 . . . . 100.0 108.102 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -92.85 120.58 33.34 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 123.176 1.465 . . . . 100.0 107.122 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 tt -110.47 128.72 55.74 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 112.638 -2.074 . . . . 100.0 106.526 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -109.82 123.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 105.926 -1.879 . . . . 100.0 105.926 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.0 tp -106.19 118.04 35.58 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.148 -1.427 . . . . 100.0 107.148 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.49 164.28 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 113.6 -1.636 . . . . 100.0 110.657 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 172.16 21.09 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.203 -1.959 . . . . 100.0 108.203 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -74.43 164.07 27.03 Favored 'General case' 0 CA--C 1.5 -0.98 0 O-C-N 122.207 -0.584 . . . . 100.0 112.153 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.18 142.01 36.83 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 109.392 -1.483 . . . . 100.0 109.392 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.28 90.48 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 123.781 0.705 . . . . 100.0 114.012 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.1 m -63.58 -42.69 98.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 117.922 0.861 . . . . 100.0 112.268 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.88 12.58 7.71 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.145 -1.026 . . . . 100.0 111.863 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -61.97 -41.83 98.45 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.043 0.937 . . . . 100.0 112.601 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.4 m -64.18 -43.17 95.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.71 1.204 . . . . 100.0 109.122 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.1 m -63.03 -41.78 99.61 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.4 1.48 . . . . 100.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.69 -48.54 81.28 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 126.017 1.727 . . . . 100.0 109.929 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.74 -42.91 93.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 119.253 -0.403 . . . . 100.0 111.608 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.16 -39.77 93.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 123.027 0.531 . . . . 100.0 111.656 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 28.1 ttp180 -61.81 -44.59 96.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.797 1.239 . . . . 100.0 109.586 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -62.77 -44.79 95.28 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.175 0.443 . . . . 100.0 111.914 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.06 -47.7 76.42 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 116.535 2.05 . . . . 100.0 116.535 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -118.47 -23.61 7.11 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 117.193 2.294 . . . . 100.0 117.193 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.46 71.76 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 110.751 -0.94 . . . . 100.0 110.751 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.71 151.19 36.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 118.08 0.94 . . . . 100.0 109.531 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.447 ' HZ ' HD22 ' A' ' 154' ' ' ASN . 92.0 m-85 -112.07 124.69 52.95 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 102.084 -3.302 . . . . 100.0 102.084 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -104.8 113.56 27.22 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.66 -0.816 . . . . 100.0 110.311 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.76 -43.39 62.92 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.057 1.343 . . . . 100.0 112.826 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -74.6 134.93 42.04 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 123.519 0.727 . . . . 100.0 111.344 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -102.88 119.71 39.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.264 -1.384 . . . . 100.0 107.264 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.33 127.14 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 103.301 -2.852 . . . . 100.0 103.301 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.14 58.74 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.563 0.697 . . . . 100.0 112.73 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.0 m -93.09 124.58 37.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 104.085 -2.561 . . . . 100.0 104.085 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD22 HE22 ' A' ' 69' ' ' GLN . 83.7 mt -104.59 127.51 52.35 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.09 -1.819 . . . . 100.0 106.09 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.71 -125.72 33.58 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.176 -1.17 . . . . 100.0 110.176 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.77 137.99 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.543 0.737 . . . . 100.0 110.038 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -114.43 124.87 53.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.084 -2.932 . . . . 100.0 103.084 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.18 117.4 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 124.855 1.262 . . . . 100.0 107.731 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -129.29 119.9 19.77 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 111.909 0.336 . . . . 100.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 22.2 Cg_exo -79.94 128.98 7.77 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.811 2.341 . . . . 100.0 112.232 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.8 mt -124.67 130.97 53.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.544 -1.28 . . . . 100.0 107.544 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.46 130.9 61.69 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.706 -1.22 . . . . 100.0 107.706 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.37 130.47 54.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.646 -1.983 . . . . 100.0 105.646 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -99.85 122.59 43.03 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.584 -2.006 . . . . 100.0 105.584 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.8 p -124.19 177.83 5.64 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.664 0.745 . . . . 100.0 110.891 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -59.54 -36.45 76.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.016 1.726 . . . . 100.0 109.7 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -85.4 0.9 50.78 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.329 1.051 . . . . 100.0 111.885 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.06 178.21 19.99 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 121.543 -0.723 . . . . 100.0 111.558 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -68.17 138.87 44.65 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 123.297 2.665 . . . . 100.0 112.769 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 mm -130.51 140.53 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.668 -2.345 . . . . 100.0 104.668 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.8 ttmt -116.27 128.95 56.01 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.13 -1.028 . . . . 100.0 109.586 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.11 118.51 36.83 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.64 -2.356 . . . . 100.0 104.64 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -93.37 107.8 19.57 Favored 'General case' 0 N--CA 1.429 -1.514 1 N-CA-C 100.028 -4.064 . . . . 100.0 100.028 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.9 t -95.13 123.01 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.025 -0.989 . . . . 100.0 109.092 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -103.15 106.51 17.04 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -87.3 117.79 26.3 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.595 -2.742 . . . . 100.0 103.595 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.3 p -100.19 163.0 12.6 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.755 -0.657 . . . . 100.0 112.401 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.88 131.0 35.33 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.58 -0.526 . . . . 100.0 109.58 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.9 -11.57 81.23 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 112.238 -0.345 . . . . 100.0 112.238 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.435 HE22 HD22 ' A' ' 43' ' ' LEU . 53.8 mt-30 -65.07 -41.88 94.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.832 2.453 . . . . 100.0 111.102 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.46 141.29 58.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.939 1.296 . . . . 100.0 113.632 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 149.22 50.71 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.784 2.034 . . . . 100.0 111.297 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -71.33 130.5 41.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.884 -1.525 . . . . 100.0 106.884 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.53 -169.24 34.41 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.184 -1.484 . . . . 100.0 115.501 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.55 -21.87 63.11 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 127.78 2.61 . . . . 100.0 114.325 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.99 -37.66 85.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.8 1.64 . . . . 100.0 109.886 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.5 mmm-85 -86.16 2.46 46.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.047 1.739 . . . . 100.0 113.955 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.22 -41.8 93.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 115.514 1.672 . . . . 100.0 115.514 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.95 -38.22 92.41 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.858 0.742 . . . . 100.0 113.473 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -62.44 -43.51 98.64 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 125.745 1.618 . . . . 100.0 109.097 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.547 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 7.5 t80 -88.35 -14.25 38.65 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.266 1.21 . . . . 100.0 114.266 -176.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.27 134.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.364 1.229 0 CA-C-N 119.56 1.073 . . . . 100.0 109.378 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 63.27 26.36 15.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.174 2.19 . . . . 100.0 113.396 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.25 139.68 42.71 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 107.456 -1.313 . . . . 100.0 107.456 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -97.97 -34.88 10.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.4 p -148.37 161.05 42.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 120.709 0.29 . . . . 100.0 111.476 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB3' ' HH ' ' A' ' 80' ' ' TYR . . . -142.06 152.6 43.48 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.07 -1.052 . . . . 100.0 113.737 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.69 125.73 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 104.232 -2.507 . . . . 100.0 104.232 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.98 123.65 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 100.96 -3.719 . . . . 100.0 100.96 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -118.59 133.78 55.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.37 -1.332 . . . . 100.0 111.14 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -129.08 158.87 37.71 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 100.0 109.911 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -100.9 125.35 47.44 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 105.848 -1.908 . . . . 100.0 105.848 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.93 -22.26 30.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.71 1.004 . . . . 100.0 113.71 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -88.2 -7.48 56.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 118.953 -0.546 . . . . 100.0 111.568 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.1 t -117.86 116.55 27.19 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 122.891 1.329 . . . . 100.0 112.165 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.75 -40.18 88.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.553 -1.658 . . . . 100.0 110.141 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.92 -43.43 97.47 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 125.258 1.423 . . . . 100.0 109.754 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 95.0 m -63.06 -42.96 99.8 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 122.851 0.46 . . . . 100.0 109.954 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.566 ' HH ' HG21 ' A' ' 136' ' ' ILE . 76.7 t80 -64.34 -39.74 94.49 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 122.818 0.447 . . . . 100.0 110.504 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 93.6 mttt -60.71 -37.56 82.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.814 1.245 . . . . 100.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.91 -11.14 60.27 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.072 1.508 . . . . 100.0 115.072 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -59.97 -43.08 93.62 Favored Pre-proline 0 C--N 1.364 1.226 0 CA-C-O 116.208 -1.853 . . . . 100.0 111.199 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 93.7 Cg_exo -58.03 -35.45 98.74 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.626 2.217 . . . . 100.0 112.516 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -65.56 -43.75 88.86 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.135 0.974 . . . . 100.0 109.979 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -62.6 -47.31 84.33 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 109.507 -0.553 . . . . 100.0 109.507 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -91.11 64.62 5.35 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 123.055 1.407 . . . . 100.0 108.397 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -156.28 -62.12 0.1 Allowed 'General case' 0 CA--C 1.485 -1.527 1 N-CA-C 100.04 -4.059 . . . . 100.0 100.04 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -63.97 -39.75 94.83 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.376 -0.829 . . . . 100.0 110.428 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.547 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -62.03 -46.05 90.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.123 0.569 . . . . 100.0 110.762 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.54 -39.57 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 126.19 1.796 . . . . 100.0 109.675 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.11 -44.51 94.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 119.082 -0.485 . . . . 100.0 110.507 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.4 t -72.51 -49.37 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 114.958 1.466 . . . . 100.0 114.958 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.9 m -113.47 11.03 18.32 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 120.16 3.393 . . . . 100.0 120.16 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 54.18 -126.52 2.33 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 125.166 1.386 . . . . 100.0 112.367 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -102.54 115.75 31.21 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 117.772 -1.571 . . . . 100.0 109.986 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.94 150.42 67.43 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 102.453 -3.165 . . . . 100.0 102.453 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -60.82 128.5 25.8 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.917 1.745 . . . . 100.0 112.89 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.404 ' HB ' HD21 ' A' ' 144' ' ' LEU . 61.8 mt -131.16 135.17 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.479 -1.304 . . . . 100.0 107.479 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.77 131.63 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-N 113.579 -1.646 . . . . 100.0 108.169 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.6 mt -98.55 124.6 43.39 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 104.328 -2.471 . . . . 100.0 104.328 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 92.6 m -114.81 121.76 44.27 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.201 -0.909 . . . . 100.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.49 102.33 2.69 Favored Glycine 0 CA--C 1.479 -2.165 0 N-CA-C 103.099 -4.0 . . . . 100.0 103.099 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.386 55.4 p30 -92.67 171.61 8.89 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 114.326 1.232 . . . . 100.0 114.326 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 61.05 40.9 14.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 128.339 2.656 . . . . 100.0 111.95 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.34 -19.89 25.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.075 0 CA-C-N 115.517 -0.765 . . . . 100.0 112.669 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.547 ' CG ' ' HG ' ' A' ' 150' ' ' SER . 94.5 m-20 -61.0 -38.09 84.82 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.143 0.977 . . . . 100.0 112.549 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.66 129.82 26.44 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 N-CA-C 108.693 -0.855 . . . . 100.0 108.693 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.01 -41.25 95.49 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 116.357 1.984 . . . . 100.0 116.357 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.24 83.98 7.82 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.402 -1.333 . . . . 100.0 107.402 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.478 ' NH2' ' HH ' ' A' ' 146' ' ' TYR . 78.3 ttt180 -94.97 127.0 40.7 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.814 -1.921 . . . . 100.0 105.814 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.66 -38.66 9.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.994 -0.548 . . . . 100.0 112.304 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.33 105.93 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 103.804 -2.665 . . . . 100.0 103.804 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.37 151.32 25.58 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.265 -0.88 . . . . 100.0 111.187 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.4 -42.03 98.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.35 1.06 . . . . 100.0 111.555 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.11 -39.94 96.18 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.854 0.861 . . . . 100.0 111.102 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -62.54 -38.07 88.56 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.787 1.635 . . . . 100.0 112.982 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.608 HG23 ' HD1' ' A' ' 139' ' ' HIS . 90.4 mt -64.06 122.56 15.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 CA-C-O 122.421 1.105 . . . . 100.0 109.878 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.9 -7.25 4.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 C-N-CA 125.734 1.614 . . . . 100.0 111.598 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.394 1.478 . . . . 100.0 111.261 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.608 ' HD1' HG23 ' A' ' 136' ' ' ILE . 44.2 p-80 -61.7 -42.23 98.66 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 118.82 -0.61 . . . . 100.0 112.077 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -63.18 -45.31 92.37 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.656 0.782 . . . . 100.0 111.491 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.29 -40.63 94.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 123.611 0.764 . . . . 100.0 112.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.84 3.28 55.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 116.283 1.957 . . . . 100.0 116.283 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 57.6 t30 55.51 50.36 14.76 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.501 1.52 . . . . 100.0 112.624 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.404 HD21 ' HB ' ' A' ' 117' ' ' ILE . 49.9 mt -118.11 159.33 23.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.726 1.21 . . . . 100.0 108.048 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.403 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.2 mm-40 -98.29 140.19 32.94 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.478 ' HH ' ' NH2' ' A' ' 129' ' ' ARG . 61.0 t80 -114.58 130.62 56.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.554 0.692 . . . . 100.0 111.273 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -128.14 134.77 49.14 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.919 -1.037 . . . . 100.0 111.375 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -88.42 120.95 30.28 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 102.348 -3.205 . . . . 100.0 102.348 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 49.4 pt -131.16 154.43 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.652 1.215 . . . . 100.0 111.281 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.547 ' HG ' ' CG ' ' A' ' 125' ' ' ASP . 33.2 t -136.69 119.59 16.35 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 105.091 -2.188 . . . . 100.0 105.091 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.433 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.2 -45.1 89.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 124.211 0.944 . . . . 100.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.7 -44.68 89.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 115.145 1.535 . . . . 100.0 115.145 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 94.1 p -95.77 -0.26 51.54 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 115.537 1.68 . . . . 100.0 115.537 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.468 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 70.6 m-80 63.7 24.27 13.82 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.869 0.868 . . . . 100.0 112.638 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.76 123.25 24.61 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 106.046 -1.835 . . . . 100.0 106.046 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.05 40.57 31.42 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.939 2.095 . . . . 100.0 112.011 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.428 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 30.4 t80 -57.25 -49.04 77.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.369 1.867 . . . . 100.0 114.315 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.16 -9.02 40.85 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 115.463 1.653 . . . . 100.0 115.463 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.304 95.0 mttt -59.66 -44.44 97.44 Favored Pre-proline 0 CA--C 1.498 -1.045 0 N-CA-C 119.282 3.067 . . . . 100.0 119.282 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.1 -42.28 44.88 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.391 1.89 . . . . 100.0 111.678 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.95 -44.13 93.75 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 124.414 1.071 . . . . 100.0 111.794 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.62 -43.99 95.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 112.968 0.729 . . . . 100.0 112.968 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.403 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.5 t90 -64.61 -43.14 94.71 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.834 0.709 . . . . 100.0 109.975 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 88.9 mt -61.55 -43.06 99.55 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.448 0.468 . . . . 100.0 111.136 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.27 99.22 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 123.78 0.832 . . . . 100.0 110.765 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -61.96 -45.39 93.87 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.514 0.726 . . . . 100.0 111.667 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -64.6 -46.84 80.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.289 0.636 . . . . 100.0 111.879 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.35 -46.13 81.44 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 113.675 0.991 . . . . 100.0 113.675 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.85 -38.86 79.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.404 1.082 . . . . 100.0 109.388 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.67 8.9 59.17 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 118.635 -1.092 . . . . 100.0 112.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -107.62 110.15 62.64 Favored Pre-proline 0 C--N 1.361 1.074 0 N-CA-C 106.047 -1.834 . . . . 100.0 106.047 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.5 -18.85 43.33 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 123.842 3.028 . . . . 100.0 113.834 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -97.78 11.02 38.61 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.39 1.076 . . . . 100.0 112.611 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.5 tp -63.19 130.47 44.71 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.742 0.817 . . . . 100.0 109.145 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 . . . . . 0 CA--C 1.496 -1.118 0 CA-C-O 121.367 0.603 . . . . 100.0 110.413 -178.827 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 CA--C 1.484 -1.583 0 CA-C-O 121.473 0.654 . . . . 100.0 110.961 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -84.32 124.35 73.93 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 102.697 -3.075 . . . . 100.0 102.697 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 60.8 Cg_endo -62.08 140.51 84.48 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 123.397 2.732 . . . . 100.0 113.905 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 31.2 Cg_exo -67.18 155.18 71.76 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.244 2.629 . . . . 100.0 112.188 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.41 -45.3 94.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.32 1.048 . . . . 100.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.0 t 68.56 102.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.243 0 C-N-CA 126.651 1.98 . . . . 100.0 106.747 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.7 m -92.51 157.01 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 115.331 1.604 . . . . 100.0 115.331 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.368 85.3 mmm 52.71 -118.44 1.33 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.989 2.515 . . . . 100.0 117.548 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 . . . . . 0 C--N 1.365 1.269 0 N-CA-C 117.705 2.483 . . . . 100.0 117.705 -178.384 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 N--CA 1.442 -0.855 0 N-CA-C 110.608 -0.145 . . . . 100.0 110.608 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -63.16 -41.94 99.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.803 1.241 . . . . 100.0 111.234 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.63 -42.6 99.68 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.519 0.728 . . . . 100.0 111.084 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.77 -44.37 96.37 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.472 0.709 . . . . 100.0 111.239 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.76 -42.99 98.34 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 C-N-CA 123.844 0.857 . . . . 100.0 109.077 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.83 99.59 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.274 1.029 . . . . 100.0 111.673 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -62.66 -42.7 99.75 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.921 0.888 . . . . 100.0 110.803 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.5 m -63.82 -42.69 97.61 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.734 1.214 . . . . 100.0 111.631 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.356 0.858 0 C-N-CA 124.454 1.102 . . . . 100.0 113.454 -177.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.492 -1.258 0 CA-C-O 120.492 0.187 . . . . 100.0 110.568 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.99 95.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.733 1.213 . . . . 100.0 111.204 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.43 98.88 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 123.869 0.867 . . . . 100.0 109.713 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -66.54 -37.26 84.61 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.335 1.054 . . . . 100.0 111.82 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.6 15.9 35.88 Favored Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 109.23 -1.548 . . . . 100.0 109.23 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 10' ' ' GLN . 24.1 pt-20 -90.06 114.95 62.73 Favored Pre-proline 0 N--CA 1.414 -2.236 0 N-CA-C 106.128 -1.804 . . . . 100.0 106.128 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.63 -50.34 5.64 Favored 'Trans proline' 0 C--N 1.377 2.069 0 N-CA-C 103.215 -3.417 . . . . 100.0 103.215 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -123.68 -71.25 0.73 Allowed 'General case' 0 N--CA 1.379 -3.993 1 N-CA-C 99.148 -4.39 . . . . 100.0 99.148 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.7 145.12 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 115.065 1.506 . . . . 100.0 115.065 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 38.4 tt0 -122.81 134.75 54.4 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.001 1.721 . . . . 100.0 106.694 176.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.53 132.4 53.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.647 -0.871 . . . . 100.0 108.647 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.47 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 87.8 tttt -89.04 116.94 27.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.23 129.22 56.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-N 114.251 -1.34 . . . . 100.0 107.874 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.12 124.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.155 -1.424 . . . . 100.0 107.155 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.5 tp -105.27 117.72 34.74 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.771 -1.566 . . . . 100.0 106.771 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.97 162.72 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.259 -1.337 . . . . 100.0 112.567 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.91 172.49 20.68 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 109.629 -1.388 . . . . 100.0 109.629 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -71.1 159.62 34.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.831 0.824 . . . . 100.0 112.778 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 139.44 39.69 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 110.173 -1.171 . . . . 100.0 110.173 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.65 2.8 89.88 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 118.592 -1.116 . . . . 100.0 114.774 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 p -64.06 -39.72 94.69 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 118.767 1.283 . . . . 100.0 113.887 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.18 19.32 5.17 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-O 118.941 -0.922 . . . . 100.0 111.477 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.66 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 10.3 mtmp? -60.08 -47.64 85.04 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 118.889 1.344 . . . . 100.0 111.143 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.3 m -64.55 -42.99 95.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.096 1.358 . . . . 100.0 110.671 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.2 m -63.12 -40.77 98.59 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.665 1.186 . . . . 100.0 109.177 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.524 ' CG ' ' HE2' ' A' ' 89' ' ' MET . 68.1 t80 -60.67 -48.12 83.19 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.335 1.454 . . . . 100.0 110.369 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.28 -43.25 97.18 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 O-C-N 123.55 0.531 . . . . 100.0 111.025 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.71 -39.83 92.91 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.79 0.663 . . . . 100.0 112.79 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.733 HH21 ' HA ' ' A' ' 151' ' ' ALA . 13.1 ttm180 -60.48 -45.86 92.2 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.262 1.025 . . . . 100.0 109.086 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -64.35 -42.38 96.26 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.296 0.85 . . . . 100.0 113.296 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.61 -44.6 66.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.3 p -119.36 -23.3 6.73 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 117.826 2.528 . . . . 100.0 117.826 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.92 -7.73 73.45 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 110.992 -0.843 . . . . 100.0 110.992 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.0 156.58 30.06 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.765 1.226 . . . . 100.0 109.142 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -114.65 118.26 33.15 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 102.612 -3.107 . . . . 100.0 102.612 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -87.81 110.21 20.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.905 0.86 . . . . 100.0 111.085 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.06 -40.12 68.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.107 1.363 . . . . 100.0 113.85 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HE3' HG22 ' A' ' 206' ' ' THR . 96.3 mttt -80.06 131.17 35.72 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.389 1.076 . . . . 100.0 112.218 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -99.41 110.45 22.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.142 -1.023 . . . . 100.0 108.266 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.7 122.46 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 102.418 -3.178 . . . . 100.0 102.418 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.27 142.33 57.79 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.282 0.845 . . . . 100.0 113.282 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.5 m -92.95 127.22 38.38 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 104.431 -2.433 . . . . 100.0 104.431 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -105.34 127.14 52.81 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 107.916 -1.142 . . . . 100.0 107.916 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.32 -121.19 12.83 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.007 -1.637 . . . . 100.0 109.007 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.23 142.92 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.162 0.506 . . . . 100.0 110.197 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -121.13 123.59 42.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 105.007 -2.22 . . . . 100.0 105.007 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.6 t -100.31 122.02 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.675 -1.231 . . . . 100.0 107.675 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -126.65 124.45 24.19 Favored Pre-proline 0 N--CA 1.434 -1.238 0 CA-C-N 115.924 -0.58 . . . . 100.0 112.016 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.74 127.58 8.01 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 124.612 3.541 . . . . 100.0 112.81 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.0 tp -133.17 126.83 32.5 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.987 -1.116 . . . . 100.0 107.987 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.6 t -114.99 135.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 O-C-N 121.604 -0.685 . . . . 100.0 110.268 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -124.3 143.86 50.32 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.051 0.941 . . . . 100.0 109.102 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.475 ' HD1' ' HB ' ' A' ' 177' ' ' VAL . 66.0 t-80 -102.35 127.38 49.37 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.022 -1.473 . . . . 100.0 107.022 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.7 p -122.0 179.24 4.58 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.982 0.896 . . . . 100.0 109.249 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -58.16 -36.62 73.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.875 2.07 . . . . 100.0 109.617 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -91.54 8.07 38.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 113.864 1.061 . . . . 100.0 113.864 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.74 176.19 20.07 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 121.907 -0.496 . . . . 100.0 112.074 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.61 138.21 29.0 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 123.271 2.647 . . . . 100.0 113.554 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -131.09 142.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 124.11 0.881 . . . . 100.0 109.003 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -106.76 132.65 52.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.473 -0.785 . . . . 100.0 112.112 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.62 117.8 34.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.527 -2.768 . . . . 100.0 103.527 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.522 HD21 ' HE1' ' A' ' 64' ' ' TRP . 55.5 t30 -94.8 100.76 12.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 100.508 -3.886 . . . . 100.0 100.508 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.74 126.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 CA-C-N 115.387 -0.824 . . . . 100.0 110.171 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.522 ' HE1' HD21 ' A' ' 62' ' ' ASN . 21.1 m95 -104.64 99.53 9.2 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.162 -2.162 . . . . 100.0 105.162 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.23 116.79 24.63 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.32 164.06 11.97 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.321 0.86 . . . . 100.0 113.321 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.04 131.62 35.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.212 1.005 . . . . 100.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.23 -10.5 80.15 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 114.492 0.557 . . . . 100.0 114.492 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -70.24 -38.76 75.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.15 2.18 . . . . 100.0 112.314 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HB2' HH11 ' A' ' 76' ' ' ARG . 96.6 mt-10 -62.29 137.03 58.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 124.973 1.309 . . . . 100.0 113.536 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.494 -1.23 . . . . 100.0 109.525 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -67.38 131.74 46.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.752 -1.944 . . . . 100.0 105.752 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.29 -176.1 40.27 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 118.788 -1.672 . . . . 100.0 114.474 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.72 64.38 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 127.188 2.327 . . . . 100.0 113.835 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.65 -37.72 85.09 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.21 1.804 . . . . 100.0 109.573 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.408 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.6 mtp85 -89.36 10.34 22.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 126.413 1.885 . . . . 100.0 115.762 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.8 -39.09 90.49 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 115.844 1.794 . . . . 100.0 115.844 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.79 86.16 Favored Glycine 0 C--N 1.355 1.631 0 C-N-CA 124.171 0.891 . . . . 100.0 113.26 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -62.47 -43.0 99.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.721 1.208 . . . . 100.0 109.819 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.589 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.4 t80 -88.81 -18.99 26.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 114.905 1.446 . . . . 100.0 114.905 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.25 131.65 21.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 CA-C-N 119.316 0.962 . . . . 100.0 109.667 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.279 91.6 mt-30 60.23 27.32 16.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 127.249 2.22 . . . . 100.0 115.377 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.3 46.75 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 107.029 -1.471 . . . . 100.0 107.029 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -106.35 -24.75 12.17 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 116.342 -0.39 . . . . 100.0 110.908 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.4 p -158.11 165.0 36.08 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.767 0.827 . . . . 100.0 109.233 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.78 155.79 41.45 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 119.627 -0.829 . . . . 100.0 112.863 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.39 126.81 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.714 -2.328 . . . . 100.0 104.714 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.52 124.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 103.789 -2.671 . . . . 100.0 103.789 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.552 ' HB3' HD22 ' A' ' 122' ' ' ASN . 55.7 mtt -112.64 135.4 53.41 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 116.549 2.055 . . . . 100.0 116.549 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -132.49 161.27 34.16 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 113.035 -1.893 . . . . 100.0 109.696 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.74 123.67 48.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.002 -1.851 . . . . 100.0 106.002 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -63.72 -20.38 26.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 114.063 1.134 . . . . 100.0 114.063 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -90.18 -2.46 58.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 118.896 -0.573 . . . . 100.0 111.479 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.5 t -125.79 113.43 17.27 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 122.578 1.18 . . . . 100.0 111.678 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -65.22 -38.67 91.15 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 114.896 -1.047 . . . . 100.0 111.934 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.25 -41.89 91.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 124.836 1.254 . . . . 100.0 108.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.6 m -62.62 -41.54 99.07 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 122.769 0.428 . . . . 100.0 110.532 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.381 0.672 . . . . 100.0 110.841 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.45 -35.34 73.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 124.679 1.192 . . . . 100.0 111.578 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -76.03 -9.78 58.89 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 115.848 1.795 . . . . 100.0 115.848 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.6 t -59.24 -44.99 99.21 Favored Pre-proline 0 C--N 1.363 1.174 0 CA-C-O 116.03 -1.938 . . . . 100.0 112.115 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -59.08 -31.64 95.93 Favored 'Trans proline' 0 C--N 1.376 2.022 0 CA-C-N 122.747 2.017 . . . . 100.0 113.058 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.65 -42.95 81.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.783 0.72 . . . . 100.0 109.818 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -63.91 -45.79 87.75 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 109.565 -0.532 . . . . 100.0 109.565 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -90.72 70.17 6.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.543 -1.28 . . . . 100.0 107.543 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -168.02 -55.2 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 100.329 -3.952 . . . . 100.0 100.329 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.61 -43.82 98.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.691 -1.596 . . . . 100.0 106.691 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.589 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.6 mp -63.02 -50.14 71.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 113.366 0.876 . . . . 100.0 113.366 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.267 33.3 m -67.25 -22.81 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.267 90.9 mtt180 -61.24 -39.89 92.0 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.705 -0.85 . . . . 100.0 108.705 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.01 -47.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 113.735 1.013 . . . . 100.0 113.735 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.295 63.5 m -105.04 -2.28 24.62 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 119.405 3.113 . . . . 100.0 119.405 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.285 41.3 mt-10 54.96 -119.31 1.43 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.94 1.089 . . . . 100.0 113.94 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.49 110.73 22.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 120.151 1.341 . . . . 100.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.8 152.05 51.2 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 104.754 -2.313 . . . . 100.0 104.754 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.43 126.67 18.95 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.337 2.025 . . . . 100.0 112.251 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.403 ' HB ' HD21 ' A' ' 144' ' ' LEU . 64.5 mt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.747 -1.205 . . . . 100.0 107.747 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.46 132.15 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.416 -1.265 . . . . 100.0 108.417 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.36 124.75 44.74 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.387 -2.079 . . . . 100.0 105.387 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.452 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -116.74 124.73 50.36 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 122.259 1.028 . . . . 100.0 111.577 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.09 102.73 2.84 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 104.911 -3.276 . . . . 100.0 104.911 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.552 HD22 ' HB3' ' A' ' 89' ' ' MET . 72.7 m-80 -81.17 163.15 23.28 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 124.954 1.302 . . . . 100.0 111.865 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.71 38.51 24.94 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 128.386 2.674 . . . . 100.0 114.826 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.57 -14.7 18.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 113.787 1.032 . . . . 100.0 113.787 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.465 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 23.4 t70 -64.38 -37.1 86.31 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.755 1.222 . . . . 100.0 109.597 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.27 131.32 29.94 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-O 122.127 0.965 . . . . 100.0 109.82 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.68 -45.5 92.51 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -85.36 77.08 10.03 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.599 0.714 . . . . 100.0 110.29 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.94 138.79 38.24 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.615 -1.254 . . . . 100.0 107.615 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.67 -43.62 6.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.489 -0.56 . . . . 100.0 109.489 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.13 107.8 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.225 -2.139 . . . . 100.0 105.225 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -77.78 148.54 34.74 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.088 -1.415 . . . . 100.0 109.158 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.77 88.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.169 0.988 . . . . 100.0 110.161 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.11 -41.1 97.89 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.111 1.364 . . . . 100.0 111.066 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.9 m -62.43 -37.8 87.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.717 1.607 . . . . 100.0 113.465 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.568 HG23 ' HD1' ' A' ' 139' ' ' HIS . 88.9 mt -65.19 120.09 11.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-O 122.382 1.087 . . . . 100.0 110.099 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.44 -7.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 125.626 1.571 . . . . 100.0 112.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -58.85 -41.36 86.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.124 1.37 . . . . 100.0 111.161 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.568 ' HD1' HG23 ' A' ' 136' ' ' ILE . 44.7 p-80 -61.28 -38.66 87.56 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 123.795 0.838 . . . . 100.0 111.716 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.92 -46.1 89.4 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.528 0.731 . . . . 100.0 111.367 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.57 -40.97 89.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.039 0.936 . . . . 100.0 112.838 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -92.83 2.23 56.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 116.808 2.151 . . . . 100.0 116.808 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 54.96 47.83 21.28 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-O 123.13 1.443 . . . . 100.0 113.672 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.403 HD21 ' HB ' ' A' ' 117' ' ' ILE . 44.9 mt -110.55 159.85 17.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.91 -1.495 . . . . 100.0 107.481 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.435 ' HG3' ' CD1' ' A' ' 163' ' ' TRP . 92.3 mm-40 -97.14 141.9 29.71 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.421 -1.326 . . . . 100.0 107.421 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -118.0 132.78 56.35 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 120.977 0.417 . . . . 100.0 111.701 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.23 135.13 42.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.594 -0.73 . . . . 100.0 112.448 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -86.66 123.42 31.82 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.517 -3.512 . . . . 100.0 101.517 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.5 pt -135.07 157.14 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 122.384 1.088 . . . . 100.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.465 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 40.3 t -141.19 114.01 8.39 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.853 -1.906 . . . . 100.0 105.853 176.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.733 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -64.0 -39.36 93.94 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.809 0.844 . . . . 100.0 108.776 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.97 -46.8 85.99 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.682 1.993 . . . . 100.0 114.261 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.8 p -103.86 -0.46 29.11 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 114.962 1.467 . . . . 100.0 114.962 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 65.72 21.33 11.57 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.145 1.778 . . . . 100.0 114.048 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -70.58 120.29 16.0 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.142 -1.429 . . . . 100.0 107.142 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 54.02 33.64 18.0 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.175 2.19 . . . . 100.0 111.867 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -60.29 -38.68 84.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.678 1.362 . . . . 100.0 114.678 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -88.49 -10.74 47.97 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 115.786 1.773 . . . . 100.0 115.786 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.267 95.5 mttt -59.87 -45.57 98.26 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 118.768 2.877 . . . . 100.0 118.768 -176.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -58.98 -41.99 56.29 Favored 'Trans proline' 0 C--N 1.372 1.79 0 CA-C-N 122.626 1.973 . . . . 100.0 113.696 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.9 -43.04 94.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 124.083 0.865 . . . . 100.0 112.013 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.85 -43.1 94.13 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 112.96 0.726 . . . . 100.0 112.96 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.511 ' HE1' ' HE3' ' A' ' 167' ' ' LYS . 60.6 t-105 -63.21 -44.67 94.65 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 123.597 0.561 . . . . 100.0 110.408 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.16 -41.38 96.66 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 123.483 0.49 . . . . 100.0 110.806 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.85 99.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 123.705 0.802 . . . . 100.0 110.611 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -61.7 -47.07 86.95 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 118.654 -0.689 . . . . 100.0 111.402 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.511 ' HE3' ' HE1' ' A' ' 163' ' ' TRP 0.26 92.9 mttt -66.95 -42.79 84.66 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 114.911 1.449 . . . . 100.0 114.911 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.43 -46.88 78.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.247 0.832 . . . . 100.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.5 -38.28 73.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.018 0.927 . . . . 100.0 109.963 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.52 10.23 55.81 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-O 118.436 -1.202 . . . . 100.0 113.861 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.47 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 52.2 t0 -111.58 112.51 53.95 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 106.018 -1.845 . . . . 100.0 106.018 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.07 -15.73 43.65 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.648 2.898 . . . . 100.0 112.67 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -92.78 2.77 56.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.941 1.296 . . . . 100.0 113.816 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 69.5 mt -59.19 133.21 55.89 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 119.576 1.08 . . . . 100.0 113.339 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -132.86 148.31 52.3 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.156 -1.384 . . . . 100.0 109.009 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -76.21 136.84 39.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.812 -1.551 . . . . 100.0 106.812 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.475 ' HB ' ' HD1' ' A' ' 53' ' ' HIS . 64.5 t -116.91 146.76 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 102.481 -3.155 . . . . 100.0 102.481 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.32 -46.2 83.47 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 115.387 1.625 . . . . 100.0 115.387 -175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 55.6 ttm 94.98 122.84 0.02 OUTLIER Pre-proline 0 C--N 1.359 1.014 0 C-N-CA 127.647 2.379 . . . . 100.0 108.895 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -58.17 135.62 69.56 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.736 2.291 . . . . 100.0 110.366 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.62 127.65 33.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.711 1.257 . . . . 100.0 111.911 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.14 137.23 37.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 104.162 -2.532 . . . . 100.0 104.162 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -63.63 132.0 95.05 Favored Pre-proline 0 N--CA 1.439 -0.997 0 C-N-CA 122.754 0.422 . . . . 100.0 111.887 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 183' ' ' ALA . 45.5 Cg_exo -65.64 147.16 85.91 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.819 3.013 . . . . 100.0 112.78 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.93 147.6 91.93 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 123.505 2.803 . . . . 100.0 111.012 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -63.26 -43.55 97.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 123.816 0.846 . . . . 100.0 112.584 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.8 t 68.99 99.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 127.112 2.165 . . . . 100.0 111.81 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.48 -71.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 103.08 -2.933 . . . . 100.0 103.08 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.256 77.1 mtp 9.34 -128.72 0.0 OUTLIER 'General case' 0 C--N 1.367 1.348 0 C-N-CA 131.396 3.879 . . . . 100.0 119.374 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.326 85.6 m-20 142.43 -39.71 0.0 OUTLIER Pre-proline 0 C--N 1.377 1.799 0 C-N-CA 131.383 3.873 . . . . 100.0 115.71 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.13 -75.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.966 0 CA-C-N 123.885 2.423 . . . . 100.0 117.164 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.71 94.39 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 123.953 0.901 . . . . 100.0 110.973 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.1 mt -62.33 -38.2 88.55 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 117.468 2.396 . . . . 100.0 117.468 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.26 169.39 13.84 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 115.41 1.633 . . . . 100.0 115.41 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 73.96 -47.55 0.65 Allowed 'General case' 0 C--N 1.359 1.014 0 C-N-CA 127.956 2.502 . . . . 100.0 116.44 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -60.17 -35.72 75.98 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 126.758 2.023 . . . . 100.0 112.17 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -59.97 -39.26 85.05 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.35 1.06 . . . . 100.0 112.218 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -59.44 -38.36 80.49 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 124.614 1.166 . . . . 100.0 111.151 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.49 -45.4 93.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 118.813 -0.613 . . . . 100.0 110.912 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -65.9 -42.41 90.23 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.833 0.853 . . . . 100.0 112.255 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.0 mt -60.88 -41.63 96.38 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.751 0.82 . . . . 100.0 111.553 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.97 -43.39 98.93 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.348 1.059 . . . . 100.0 111.347 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.14 -45.51 98.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 108.193 -1.04 . . . . 100.0 108.193 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.69 95.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 113.928 1.084 . . . . 100.0 113.928 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -61.76 -44.36 97.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.738 1.215 . . . . 100.0 111.96 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.401 HG22 ' HE3' ' A' ' 38' ' ' LYS . 97.4 m -64.72 -43.64 92.75 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.459 1.504 . . . . 100.0 110.427 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.7 m -65.25 127.06 30.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 124.316 2.008 . . . . 100.0 115.079 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -115.54 148.87 39.02 Favored 'General case' 0 N--CA 1.428 -1.55 1 N-CA-C 99.344 -4.317 . . . . 100.0 99.344 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 93.3 mt -64.08 130.08 94.33 Favored Pre-proline 0 C--N 1.355 0.837 0 N-CA-C 112.599 0.592 . . . . 100.0 112.599 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 209' ' ' LEU . 25.3 Cg_exo -76.1 85.07 1.71 Allowed 'Trans proline' 0 CA--C 1.492 -1.611 0 N-CA-C 117.963 2.255 . . . . 100.0 117.963 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -96.04 103.58 15.47 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 101.261 -3.607 . . . . 100.0 101.261 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -101.95 -74.82 0.61 Allowed 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 103.149 -2.908 . . . . 100.0 103.149 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -134.51 42.98 2.81 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 122.118 0.961 . . . . 100.0 108.727 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.91 -37.17 83.62 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 125.318 1.447 . . . . 100.0 110.04 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.02 -40.12 92.37 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.297 1.439 . . . . 100.0 111.964 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--O 1.256 1.447 0 CA-C-O 117.067 -1.444 . . . . 100.0 107.853 179.865 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttt . . . . . 0 CA--C 1.499 -1.013 0 CA-C-O 120.389 0.138 . . . . 100.0 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.01 95.41 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.096 1.358 . . . . 100.0 111.999 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.26 99.24 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.593 0.757 . . . . 100.0 109.785 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -66.94 -36.31 81.96 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 125.104 1.361 . . . . 100.0 111.627 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.558 ' HA3' ' HZ2' ' A' ' 60' ' ' LYS . . . 91.63 22.5 31.11 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 108.589 -1.804 . . . . 100.0 108.589 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 9' ' ' VAL 0.386 24.7 tt0 -92.04 98.95 2.22 Favored Pre-proline 0 N--CA 1.42 -1.952 1 N-CA-C 100.13 -4.026 . . . . 100.0 100.13 -178.703 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -60.57 -50.8 6.07 Favored 'Trans proline' 0 C--N 1.387 2.6 0 N-CA-C 105.321 -2.607 . . . . 100.0 105.321 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 99.8 mm-40 -122.82 -69.77 0.81 Allowed 'General case' 0 N--CA 1.38 -3.963 1 N-CA-C 96.151 -5.5 . . . . 100.0 96.151 173.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.474 ' HA ' ' HG2' ' A' ' 6' ' ' GLU . 21.6 m -118.8 152.07 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 118.533 2.79 . . . . 100.0 118.533 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.402 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 51.9 tt0 -126.01 134.61 51.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.698 -2.046 . . . . 100.0 107.639 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.29 130.62 53.33 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.476 -0.935 . . . . 100.0 108.476 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.18 114.04 26.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.203 -1.777 . . . . 100.0 106.203 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.5 tp -113.21 129.2 56.59 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 114.374 -1.284 . . . . 100.0 109.612 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -112.25 125.73 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 118.563 -1.255 . . . . 100.0 109.363 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.81 121.33 41.89 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 108.074 -1.084 . . . . 100.0 108.074 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.76 160.38 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 113.613 -1.631 . . . . 100.0 110.814 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.08 172.35 20.65 Favored Glycine 0 CA--C 1.493 -1.311 0 N-CA-C 109.893 -1.283 . . . . 100.0 109.893 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' HB2' HG21 ' A' ' 97' ' ' THR . 85.3 m-20 -71.58 159.86 33.71 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.115 0.96 . . . . 100.0 113.189 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.07 139.8 40.92 Favored Glycine 0 C--N 1.353 1.495 0 N-CA-C 109.94 -1.264 . . . . 100.0 109.94 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.09 2.16 89.48 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 118.864 -0.964 . . . . 100.0 114.892 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.1 p -63.32 -39.32 94.25 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 114.31 1.226 . . . . 100.0 114.31 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.03 16.51 6.73 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 118.666 -1.074 . . . . 100.0 112.003 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.611 ' HB2' ' HZ1' ' A' ' 23' ' ' LYS . 10.2 mtmp? -60.0 -46.47 89.38 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 119.045 1.422 . . . . 100.0 111.664 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.0 m -64.13 -44.59 91.74 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.83 1.252 . . . . 100.0 110.967 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -63.47 -40.62 97.6 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.037 0.935 . . . . 100.0 109.954 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.36 -48.04 83.1 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.277 1.031 . . . . 100.0 111.227 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.54 -42.02 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 123.123 0.265 . . . . 100.0 111.026 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.69 -40.35 94.68 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.547 0.739 . . . . 100.0 111.188 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.615 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.8 tmm_? -61.62 -43.46 98.82 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 123.606 0.762 . . . . 100.0 110.192 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -63.04 -42.17 99.69 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.352 0.501 . . . . 100.0 112.352 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -70.1 -43.96 70.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.912 1.819 . . . . 100.0 115.912 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.1 p -120.14 -24.88 5.87 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.891 2.552 . . . . 100.0 117.891 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.93 68.19 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.816 -0.914 . . . . 100.0 110.816 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.533 ' HA ' ' HD2' ' A' ' 210' ' ' PRO . 49.3 mt-10 -76.9 152.36 35.41 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.137 0.975 . . . . 100.0 109.198 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.31 117.67 31.75 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 102.074 -3.306 . . . . 100.0 102.074 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -92.61 117.92 30.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.4 -0.963 . . . . 100.0 108.4 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.08 -11.97 29.5 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.633 -1.167 . . . . 100.0 112.976 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.31 123.74 47.36 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.591 -0.892 . . . . 100.0 108.591 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.79 115.45 27.44 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.261 1.029 . . . . 100.0 111.117 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -121.25 123.96 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 101.216 -3.624 . . . . 100.0 101.216 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.2 139.29 58.49 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 113.942 1.09 . . . . 100.0 113.942 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.0 m -84.76 130.01 34.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.25 127.32 51.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 106.857 -1.534 . . . . 100.0 106.857 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.57 -120.61 15.26 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.808 -1.317 . . . . 100.0 109.808 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.99 144.82 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 120.931 0.396 . . . . 100.0 110.415 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -119.91 124.0 44.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 103.172 -2.899 . . . . 100.0 103.172 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.1 t -101.31 120.82 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.26 -1.385 . . . . 100.0 107.26 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -127.11 123.02 23.31 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.85 -0.614 . . . . 100.0 111.772 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.596 ' HB3' ' HZ1' ' A' ' 60' ' ' LYS . 17.9 Cg_exo -80.81 129.81 7.31 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 124.165 3.243 . . . . 100.0 111.204 178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -132.23 128.84 38.75 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.169 -1.048 . . . . 100.0 108.169 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.82 134.85 54.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 108.462 -0.94 . . . . 100.0 108.462 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -124.8 140.86 52.54 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.675 1.59 . . . . 100.0 109.073 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -105.33 124.01 48.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.326 1.06 . . . . 100.0 108.884 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.5 p -119.58 -179.99 4.05 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.354 -1.294 . . . . 100.0 111.432 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.08 -36.36 74.96 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 127.281 2.233 . . . . 100.0 109.512 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.01 7.38 40.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.384 0.883 . . . . 100.0 113.384 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.03 179.6 20.78 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 118.853 0.751 . . . . 100.0 111.948 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.19 140.0 36.51 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.14 2.56 . . . . 100.0 113.225 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 pt -130.27 140.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.811 -1.552 . . . . 100.0 106.811 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.596 ' HZ1' ' HB3' ' A' ' 49' ' ' PRO . 33.4 ttpt -113.72 132.77 55.69 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.994 -1.082 . . . . 100.0 110.884 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.51 118.88 37.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.288 -2.116 . . . . 100.0 105.288 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.72 97.7 10.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 100.74 -3.8 . . . . 100.0 100.74 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.65 126.82 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 121.297 0.57 . . . . 100.0 110.968 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -108.1 99.38 8.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.188 -1.782 . . . . 100.0 106.188 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -89.13 117.52 28.18 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.004 -2.221 . . . . 100.0 105.004 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -97.67 164.87 12.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.805 1.039 . . . . 100.0 113.805 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.1 131.85 34.75 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.154 0.982 . . . . 100.0 109.304 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.09 -10.45 84.87 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.352 0.501 . . . . 100.0 114.352 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.97 -39.77 75.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.393 1.877 . . . . 100.0 112.485 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -62.92 134.82 56.8 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.035 0.934 . . . . 100.0 113.365 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.49 154.65 40.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.975 -1.012 . . . . 100.0 110.263 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -66.76 132.26 47.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.707 1.603 . . . . 100.0 106.949 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.41 -176.8 38.74 Favored Glycine 0 C--N 1.356 1.642 0 C-N-CA 119.212 -1.47 . . . . 100.0 114.621 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.52 -23.64 65.08 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 127.057 2.265 . . . . 100.0 113.744 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -62.43 -31.86 72.62 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.488 1.115 . . . . 100.0 111.527 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.4 mtp-105 -92.33 10.21 30.75 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.631 1.572 . . . . 100.0 114.409 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.69 -38.02 86.28 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 116.082 1.882 . . . . 100.0 116.082 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.68 -38.68 92.24 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.77 0.7 . . . . 100.0 113.457 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -63.26 -42.72 99.17 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.157 0.983 . . . . 100.0 110.217 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.492 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 3.0 t80 -91.35 -18.59 24.04 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 114.726 1.38 . . . . 100.0 114.726 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.6 pt -61.18 136.42 24.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 CA-C-N 119.787 1.176 . . . . 100.0 111.19 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 63.66 21.93 12.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.719 2.008 . . . . 100.0 113.824 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.87 145.56 46.81 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 107.368 -1.345 . . . . 100.0 107.368 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -103.76 -24.02 13.37 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.883 -0.599 . . . . 100.0 110.71 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.6 p -159.38 165.51 33.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 123.536 0.735 . . . . 100.0 110.391 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.71 156.31 42.2 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 113.309 0.855 . . . . 100.0 113.309 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.5 126.45 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 104.752 -2.314 . . . . 100.0 104.752 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 65.2 mt -108.21 124.22 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 102.343 -3.206 . . . . 100.0 102.343 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.576 ' HB3' HD22 ' A' ' 122' ' ' ASN . 94.8 mtp -114.41 132.31 56.28 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.805 -1.089 . . . . 100.0 113.22 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -132.84 161.44 34.15 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.87 -1.513 . . . . 100.0 109.374 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -104.26 125.47 50.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.847 -1.538 . . . . 100.0 106.847 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.9 -19.42 24.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.952 1.093 . . . . 100.0 113.952 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -89.25 -4.87 58.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 119.262 -0.399 . . . . 100.0 111.474 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -125.56 115.23 19.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.737 1.256 . . . . 100.0 112.035 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.15 -39.49 93.07 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 114.491 -1.231 . . . . 100.0 110.984 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.08 -41.6 89.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 C-N-CA 125.073 1.349 . . . . 100.0 109.22 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 18' ' ' ASP . 94.5 m -62.87 -41.78 99.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.161 0.584 . . . . 100.0 109.807 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.48 ' HH ' HG21 ' A' ' 136' ' ' ILE . 79.7 t80 -65.27 -39.79 93.06 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.246 0.618 . . . . 100.0 111.038 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -59.34 -36.72 76.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.738 1.215 . . . . 100.0 111.057 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.41 -10.88 60.01 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.552 1.686 . . . . 100.0 115.552 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -59.43 -44.02 97.22 Favored Pre-proline 0 C--N 1.361 1.072 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.777 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 85.9 Cg_exo -57.4 -35.29 98.87 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.759 2.306 . . . . 100.0 112.466 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.73 -43.08 85.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.884 0.874 . . . . 100.0 110.356 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -63.79 -45.39 89.9 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 51.0 t-80 -90.68 69.62 6.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.639 -1.245 . . . . 100.0 107.639 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -169.4 -53.09 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 100.592 -3.855 . . . . 100.0 100.592 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.81 -43.89 97.59 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.579 -1.638 . . . . 100.0 106.579 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.492 ' HG ' ' CZ ' ' A' ' 80' ' ' TYR . 6.6 mp -62.81 -48.64 78.25 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.303 1.041 . . . . 100.0 113.139 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.22 -34.26 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 C-N-CA 127.358 2.263 . . . . 100.0 110.696 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.25 -40.17 81.07 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 118.657 -0.687 . . . . 100.0 111.253 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.262 11.8 m -97.33 -34.95 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 116.009 1.855 . . . . 100.0 116.009 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.294 70.6 m -105.13 -3.19 23.34 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 118.23 2.678 . . . . 100.0 118.23 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 54.38 -121.8 1.86 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.309 1.444 . . . . 100.0 113.462 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -94.48 109.2 21.1 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.335 1.064 . . . . 100.0 113.617 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.28 149.92 50.03 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 104.434 -2.432 . . . . 100.0 104.434 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.64 128.6 25.06 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.15 1.9 . . . . 100.0 113.138 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 70.7 mt -132.42 135.4 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.439 -1.319 . . . . 100.0 107.439 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.45 132.07 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.168 -1.378 . . . . 100.0 108.738 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.0 mt -98.15 125.64 43.26 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.686 -1.968 . . . . 100.0 105.686 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -118.05 125.22 49.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.017 0.913 . . . . 100.0 112.53 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.97 102.24 2.72 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 105.277 -3.129 . . . . 100.0 105.277 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.576 HD22 ' HB3' ' A' ' 89' ' ' MET . 70.1 m-80 -81.5 162.92 23.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.517 1.527 . . . . 100.0 112.865 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 57.86 42.3 23.41 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.65 2.38 . . . . 100.0 115.122 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' A' ' 148' ' ' ASP . 34.1 m -65.02 -16.24 19.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 CA-C-N 115.902 -0.59 . . . . 100.0 112.348 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.52 ' CG ' ' HG ' ' A' ' 150' ' ' SER . 90.1 m-20 -62.29 -37.91 87.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 124.216 1.006 . . . . 100.0 112.41 177.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.24 132.38 27.93 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 CA-C-O 121.844 0.83 . . . . 100.0 109.82 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.93 -45.5 92.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 116.76 2.133 . . . . 100.0 116.76 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -86.07 77.47 9.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.305 0.574 . . . . 100.0 110.706 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -81.43 132.75 35.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.849 -0.797 . . . . 100.0 108.849 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -99.06 -41.95 7.31 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 115.976 -0.556 . . . . 100.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.21 106.23 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.42 155.52 25.85 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.129 -0.942 . . . . 100.0 109.253 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.02 83.19 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.527 1.131 . . . . 100.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.56 -40.91 96.41 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.216 1.006 . . . . 100.0 111.755 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.6 m -61.51 -38.54 87.72 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 125.615 1.566 . . . . 100.0 113.22 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.568 HG23 ' HD1' ' A' ' 139' ' ' HIS . 86.3 mt -65.56 121.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 122.074 0.94 . . . . 100.0 110.319 -177.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.34 -9.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.093 -1.412 . . . . 100.0 112.009 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -58.57 -39.51 80.5 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.305 1.442 . . . . 100.0 111.746 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.568 ' HD1' HG23 ' A' ' 136' ' ' ILE . 49.0 p-80 -60.89 -39.87 90.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 123.931 0.892 . . . . 100.0 111.695 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.19 -44.29 92.46 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.304 0.642 . . . . 100.0 112.147 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.08 -42.28 94.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.464 1.106 . . . . 100.0 111.53 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -94.62 3.1 55.51 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 118.109 2.633 . . . . 100.0 118.109 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 55.08 47.18 22.53 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 123.137 1.446 . . . . 100.0 113.59 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.3 mt -110.63 160.02 17.05 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 113.9 -1.5 . . . . 100.0 107.369 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -101.98 140.76 35.84 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.25 -1.389 . . . . 100.0 107.25 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -115.2 134.81 54.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.204 0.526 . . . . 100.0 112.184 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.99 136.18 41.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.624 -0.716 . . . . 100.0 112.529 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.449 ' HB3' HG12 ' A' ' 124' ' ' VAL . 22.4 m-20 -87.55 123.77 32.79 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 101.724 -3.436 . . . . 100.0 101.724 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.4 pt -134.43 157.53 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.309 1.052 . . . . 100.0 111.914 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.52 ' HG ' ' CG ' ' A' ' 125' ' ' ASP . 35.4 t -141.9 115.87 9.3 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 105.942 -1.873 . . . . 100.0 105.942 176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.615 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.06 -38.94 93.17 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.964 0.905 . . . . 100.0 108.908 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.41 -43.84 93.13 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.832 1.653 . . . . 100.0 115.126 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -102.52 -4.16 25.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.604 1.335 . . . . 100.0 114.604 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 68.94 17.02 8.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.851 1.66 . . . . 100.0 113.25 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -66.97 119.64 12.29 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 107.59 -1.263 . . . . 100.0 107.59 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 54.48 30.85 13.64 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 127.048 2.139 . . . . 100.0 112.083 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -60.64 -38.23 84.11 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.372 1.249 . . . . 100.0 114.372 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -86.42 -13.86 45.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.598 1.703 . . . . 100.0 115.598 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.27 62.8 mttp -59.93 -45.68 98.16 Favored Pre-proline 0 C--N 1.358 0.952 0 N-CA-C 118.759 2.874 . . . . 100.0 118.759 -175.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.35 -41.28 60.05 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 122.455 1.912 . . . . 100.0 113.573 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.83 -44.15 94.06 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.962 0.905 . . . . 100.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.06 -42.5 94.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.856 0.687 . . . . 100.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -62.07 -45.53 93.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 123.374 0.422 . . . . 100.0 110.41 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.23 -41.7 97.33 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 123.803 0.689 . . . . 100.0 110.854 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 123.56 0.744 . . . . 100.0 110.556 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.05 -45.87 91.64 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 118.568 -0.729 . . . . 100.0 112.233 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -68.99 -42.69 76.18 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 119.981 -0.688 . . . . 100.0 112.582 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.48 -46.33 80.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 113.666 0.987 . . . . 100.0 113.666 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.02 -38.23 74.64 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.536 1.135 . . . . 100.0 109.56 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.39 9.93 54.59 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 118.371 -1.239 . . . . 100.0 114.6 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.447 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 57.8 t0 -113.61 112.48 48.4 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 106.969 -1.493 . . . . 100.0 106.969 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.31 -15.36 45.62 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.831 3.02 . . . . 100.0 113.025 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -93.04 1.43 57.26 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 114.411 1.263 . . . . 100.0 114.411 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 92.9 mt -60.97 133.88 56.54 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 119.452 1.024 . . . . 100.0 113.647 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -134.14 153.46 51.81 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.683 -1.144 . . . . 100.0 109.802 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -81.24 130.71 35.15 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 105.253 -2.129 . . . . 100.0 105.253 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.0 m -131.68 141.33 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 112.535 0.569 . . . . 100.0 112.535 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 49.03 -121.39 1.53 Allowed 'General case' 0 C--N 1.361 1.088 0 C-N-CA 126.121 1.768 . . . . 100.0 112.111 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . 0.29 58.9 tpp 117.35 107.44 0.0 OUTLIER Pre-proline 0 CA--C 1.491 -1.305 0 C-N-CA 130.135 3.374 . . . . 100.0 109.506 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.82 167.57 26.89 Favored 'Trans proline' 0 N--CA 1.437 -1.813 0 C-N-CA 123.081 2.52 . . . . 100.0 108.4 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.98 145.7 52.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.171 0.51 . . . . 100.0 110.972 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.8 132.0 51.0 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.677 1.191 . . . . 100.0 112.354 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -104.09 146.95 33.54 Favored Pre-proline 0 N--CA 1.425 -1.687 0 CA-C-N 114.014 -1.448 . . . . 100.0 112.59 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.8 157.88 56.63 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 124.382 3.388 . . . . 100.0 110.045 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -60.55 148.36 91.37 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 123.188 2.592 . . . . 100.0 113.561 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.62 138.24 58.29 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.723 1.264 . . . . 100.0 110.683 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.0 135.87 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 106.607 -1.627 . . . . 100.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.38 -76.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 107.973 -1.121 . . . . 100.0 107.973 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.7 ptm -80.8 -176.01 5.62 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 116.91 -1.519 . . . . 100.0 111.463 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -122.55 -46.96 0.04 OUTLIER Pre-proline 0 C--N 1.361 1.103 0 O-C-N 118.342 -2.723 . . . . 100.0 118.146 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.91 -62.66 0.26 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 121.339 3.553 . . . . 100.0 121.339 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.08 88.71 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 118.878 0.763 . . . . 100.0 111.441 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.22 -37.01 85.57 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 116.242 1.941 . . . . 100.0 116.242 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.2 167.29 8.43 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 115.125 1.528 . . . . 100.0 115.125 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 75.79 -49.74 0.61 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 128.44 2.696 . . . . 100.0 115.426 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -60.31 -35.3 75.28 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 126.023 1.729 . . . . 100.0 112.62 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -59.7 -38.58 82.01 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 113.925 1.083 . . . . 100.0 113.925 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.75 -40.35 92.12 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 123.632 0.773 . . . . 100.0 110.577 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -61.8 -42.62 99.24 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.389 0.676 . . . . 100.0 110.515 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -64.06 -43.35 95.73 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.642 1.177 . . . . 100.0 111.484 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.53 -43.55 98.66 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 123.432 0.693 . . . . 100.0 111.678 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.5 -44.94 92.89 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 123.79 0.836 . . . . 100.0 112.334 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.25 35.7 m -62.89 -39.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.196 0 CA-C-O 118.657 -0.687 . . . . 100.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.2 -44.25 88.99 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.089 0.955 . . . . 100.0 112.928 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -62.89 -41.6 99.48 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.709 1.204 . . . . 100.0 111.863 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 86.7 m -66.31 -42.27 88.5 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.795 1.638 . . . . 100.0 111.934 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 96.1 m -62.19 130.58 46.08 Favored 'General case' 0 C--N 1.359 0.998 0 CA-C-O 121.97 0.891 . . . . 100.0 111.184 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -84.05 134.15 34.63 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.496 -2.039 . . . . 100.0 105.496 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 69.4 mt -114.41 128.32 25.95 Favored Pre-proline 0 N--CA 1.433 -1.325 0 N-CA-C 107.834 -1.173 . . . . 100.0 107.834 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.533 ' HD2' ' HA ' ' A' ' 34' ' ' GLU . 38.9 Cg_exo -79.59 67.99 8.43 Favored 'Trans proline' 0 C--N 1.367 1.545 0 N-CA-C 106.23 -2.258 . . . . 100.0 106.23 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -80.13 121.12 25.16 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-O 121.833 0.825 . . . . 100.0 109.684 -176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -99.14 -58.41 1.94 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 104.999 -2.223 . . . . 100.0 104.999 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 57.7 p30 -149.94 11.43 0.74 Allowed 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 124.636 1.175 . . . . 100.0 111.193 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -59.88 -35.84 75.65 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.493 2.317 . . . . 100.0 115.923 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.09 -43.88 95.21 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.234 0.614 . . . . 100.0 111.569 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--O 1.259 1.577 0 CA-C-O 115.915 -1.993 . . . . 100.0 105.731 179.833 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 CA--C 1.492 -1.262 0 N-CA-C 110.042 -0.355 . . . . 100.0 110.042 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.17 95.45 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.075 1.35 . . . . 100.0 111.799 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.78 -42.53 99.12 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.615 0.766 . . . . 100.0 109.714 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.87 -38.04 85.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.609 1.564 . . . . 100.0 111.093 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.525 ' HA3' ' HZ3' ' A' ' 60' ' ' LYS . . . 91.29 23.01 30.41 Favored Glycine 0 C--N 1.359 1.843 0 N-CA-C 108.592 -1.803 . . . . 100.0 108.592 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 8' ' ' GLN 0.391 32.6 tt0 -91.32 103.52 7.7 Favored Pre-proline 0 N--CA 1.421 -1.883 0 N-CA-C 100.588 -3.856 . . . . 100.0 100.588 -179.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.78 -52.65 2.78 Favored 'Trans proline' 0 C--N 1.388 2.61 0 N-CA-C 103.517 -3.301 . . . . 100.0 103.517 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 10.8 tp-100 -125.1 -63.19 1.17 Allowed 'General case' 1 N--CA 1.375 -4.197 1 N-CA-C 97.435 -5.024 . . . . 100.0 97.435 174.672 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.2 t -117.77 144.61 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 115.568 1.692 . . . . 100.0 115.568 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -125.43 133.93 52.29 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -121.95 130.72 53.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.88 116.07 28.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.96 -1.496 . . . . 100.0 106.96 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.2 tp -110.31 127.07 54.84 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 113.964 -1.471 . . . . 100.0 107.999 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.83 124.86 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 N-CA-C 107.024 -1.472 . . . . 100.0 107.024 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.9 tp -105.73 116.9 32.73 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 106.734 -1.58 . . . . 100.0 106.734 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.58 162.09 36.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 114.481 -1.236 . . . . 100.0 112.414 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.46 170.87 18.16 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 109.605 -1.398 . . . . 100.0 109.605 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' OD2' ' HA ' ' A' ' 97' ' ' THR . 84.0 m-20 -70.52 160.7 31.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.479 0.918 . . . . 100.0 113.479 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.63 140.19 40.34 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 110.865 -0.894 . . . . 100.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 2.76 90.44 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.646 -1.085 . . . . 100.0 114.303 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.0 p -63.55 -39.17 93.7 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 118.522 1.161 . . . . 100.0 114.131 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 16.8 6.28 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.711 -0.757 . . . . 100.0 111.926 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.91 -47.9 83.9 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 118.58 1.19 . . . . 100.0 111.461 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.4 m -64.67 -43.35 93.87 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.986 1.314 . . . . 100.0 111.034 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.9 m -63.47 -40.62 97.59 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.163 0.985 . . . . 100.0 109.5 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.43 ' CG ' ' HE2' ' A' ' 89' ' ' MET . 85.4 t80 -61.14 -48.29 82.31 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 124.677 1.191 . . . . 100.0 110.319 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.76 -41.89 93.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.919 0 O-C-N 123.277 0.36 . . . . 100.0 111.699 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.02 -42.34 98.28 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.624 0.769 . . . . 100.0 110.718 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.569 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.2 tmm_? -62.28 -42.91 99.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.305 0.642 . . . . 100.0 110.706 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -63.96 -41.83 97.46 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 113.191 0.811 . . . . 100.0 113.191 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.28 -44.45 68.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 115.232 1.567 . . . . 100.0 115.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -120.02 -23.67 6.28 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 118.317 2.71 . . . . 100.0 118.317 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.65 -7.67 71.05 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.311 -0.716 . . . . 100.0 111.311 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.04 154.38 37.99 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.85 1.26 . . . . 100.0 109.456 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.455 ' HZ ' HD22 ' A' ' 154' ' ' ASN . 91.3 m-85 -115.61 120.52 39.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.322 -2.844 . . . . 100.0 103.322 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -94.73 115.95 28.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.51 0.724 . . . . 100.0 109.16 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -91.39 -31.81 15.89 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.989 -0.284 . . . . 100.0 111.603 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.13 129.83 34.88 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.375 0.607 . . . . 100.0 111.379 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.97 116.51 29.32 Favored 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.116 0.96 . . . . 100.0 112.265 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.61 121.95 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 101.048 -3.686 . . . . 100.0 101.048 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.09 142.25 57.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.708 0.803 . . . . 100.0 113.077 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.6 m -92.61 127.83 38.25 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.99 126.26 50.98 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.387 -1.338 . . . . 100.0 107.387 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.48 -121.69 15.83 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.949 -1.261 . . . . 100.0 109.949 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.3 142.6 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.138 0.495 . . . . 100.0 110.602 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.91 122.89 43.33 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.721 -3.066 . . . . 100.0 102.721 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.39 116.68 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.168 -1.419 . . . . 100.0 107.168 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -124.4 121.69 25.97 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 112.403 0.52 . . . . 100.0 112.403 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HB3' ' HZ2' ' A' ' 60' ' ' LYS . 90.1 Cg_endo -80.05 129.4 7.87 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 124.067 3.178 . . . . 100.0 112.602 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 tp -132.75 126.59 32.79 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.126 -1.435 . . . . 100.0 107.126 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.18 135.36 49.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.351 -0.611 . . . . 100.0 109.351 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.13 137.51 54.12 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 125.138 1.375 . . . . 100.0 107.407 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -103.52 125.24 49.96 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.708 -2.33 . . . . 100.0 104.708 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.2 p -124.71 176.97 6.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.751 0.786 . . . . 100.0 110.421 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -60.41 -27.0 67.12 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.295 1.438 . . . . 100.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -94.4 7.11 46.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 126.785 2.034 . . . . 100.0 112.974 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.0 175.85 25.58 Favored Glycine 0 C--N 1.357 1.7 0 N-CA-C 111.133 -0.787 . . . . 100.0 111.133 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.36 138.88 33.76 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.423 2.748 . . . . 100.0 113.444 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -132.04 142.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 106.974 -1.491 . . . . 100.0 106.974 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HZ3' ' HA3' ' A' ' 5' ' ' GLY . 33.9 ttpt -116.97 131.32 56.98 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 118.074 -1.45 . . . . 100.0 111.403 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.87 119.17 38.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 105.325 -2.102 . . . . 100.0 105.325 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.483 ' ND2' ' HE1' ' A' ' 64' ' ' TRP . 46.5 t30 -94.37 100.8 12.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 100.344 -3.947 . . . . 100.0 100.344 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.4 t -87.9 125.77 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-N 115.309 -0.86 . . . . 100.0 109.251 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.483 ' HE1' ' ND2' ' A' ' 62' ' ' ASN . 19.7 m0 -107.34 103.88 13.35 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.05 116.88 23.69 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.584 -2.376 . . . . 100.0 104.584 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 p -103.5 163.05 12.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 113.393 0.886 . . . . 100.0 113.393 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.28 36.14 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 123.78 0.832 . . . . 100.0 110.778 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.52 -8.07 77.98 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 113.834 0.294 . . . . 100.0 113.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -70.41 -39.56 74.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.73 2.012 . . . . 100.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HB2' HH11 ' A' ' 76' ' ' ARG . 95.1 mt-10 -62.96 137.75 58.36 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 125.035 1.334 . . . . 100.0 112.459 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.41 151.65 44.94 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.468 -1.242 . . . . 100.0 111.011 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -65.55 131.17 45.71 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.607 1.963 . . . . 100.0 107.547 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.12 -173.81 36.01 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 118.895 -1.622 . . . . 100.0 115.632 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -20.15 62.64 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 127.699 2.571 . . . . 100.0 113.383 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.16 -38.14 82.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.039 2.135 . . . . 100.0 109.104 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.448 HH11 ' HB2' ' A' ' 70' ' ' GLU . 78.2 mtp85 -92.18 12.85 20.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.653 1.981 . . . . 100.0 115.599 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.11 -39.18 91.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.417 1.636 . . . . 100.0 115.417 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.5 90.83 Favored Glycine 0 C--N 1.357 1.695 0 C-N-CA 123.956 0.788 . . . . 100.0 113.731 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -62.13 -43.3 99.14 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.514 1.126 . . . . 100.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.608 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.5 t80 -87.02 -22.69 25.34 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.204 1.557 . . . . 100.0 115.204 -174.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.5 mt -57.21 133.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 0 CA-C-N 119.342 0.973 . . . . 100.0 109.732 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 63.45 23.18 13.58 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.141 2.176 . . . . 100.0 114.858 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 147.53 45.35 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.139 -1.06 . . . . 100.0 108.139 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -108.2 -22.13 12.49 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 116.419 -0.355 . . . . 100.0 111.261 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.4 p -156.63 164.41 38.21 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.752 -0.462 . . . . 100.0 109.752 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB3' ' HH ' ' A' ' 80' ' ' TYR . . . -148.53 155.65 41.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.308 0.855 . . . . 100.0 113.308 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.5 mt -127.74 126.88 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 104.319 -2.474 . . . . 100.0 104.319 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 68.1 mt -109.96 122.44 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 103.243 -2.873 . . . . 100.0 103.243 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.43 ' HE2' ' CG ' ' A' ' 26' ' ' PHE . 46.8 mtt -112.05 134.75 53.41 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 115.977 1.843 . . . . 100.0 115.977 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -131.49 159.83 36.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.556 -1.656 . . . . 100.0 109.181 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -103.98 124.66 49.41 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.847 -1.909 . . . . 100.0 105.847 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.46 -20.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 N-CA-C 113.79 1.033 . . . . 100.0 113.79 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.3 p -91.35 -2.93 57.22 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 119.146 -0.454 . . . . 100.0 112.014 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -122.67 115.04 21.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 122.92 1.343 . . . . 100.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -64.27 -41.96 96.67 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.095 -1.411 . . . . 100.0 110.689 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.15 -42.31 92.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 125.244 1.417 . . . . 100.0 109.35 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.404 ' HA ' ' OD2' ' A' ' 18' ' ' ASP . 98.2 m -62.96 -41.43 99.52 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.475 0.31 . . . . 100.0 110.981 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.432 ' HH ' HG21 ' A' ' 136' ' ' ILE . 75.5 t80 -65.15 -41.06 95.1 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.636 0.775 . . . . 100.0 111.037 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 95.1 mttt -60.47 -35.18 75.26 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.106 1.362 . . . . 100.0 111.304 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -76.88 -9.28 58.58 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 115.827 1.788 . . . . 100.0 115.827 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.58 -43.26 95.36 Favored Pre-proline 0 C--N 1.361 1.103 0 CA-C-O 116.365 -1.779 . . . . 100.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 71.8 Cg_exo -57.37 -35.17 98.87 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.7 2.267 . . . . 100.0 112.685 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.7 -43.13 85.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 118.683 0.674 . . . . 100.0 110.826 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -63.61 -46.38 86.0 Favored 'General case' 0 C--N 1.366 1.296 0 N-CA-C 109.556 -0.535 . . . . 100.0 109.556 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -90.8 70.14 6.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.843 1.306 . . . . 100.0 107.768 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -165.07 -59.12 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 99.536 -4.246 . . . . 100.0 99.536 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -63.05 -39.72 95.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 123.877 0.736 . . . . 100.0 109.224 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.608 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -61.91 -50.31 72.68 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.757 0.661 . . . . 100.0 112.123 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.264 34.2 m -66.35 -27.86 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 113.046 0.758 . . . . 100.0 113.046 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -60.94 -39.14 88.36 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 118.247 0.476 . . . . 100.0 109.951 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.3 t -86.89 -47.98 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 113.909 1.077 . . . . 100.0 113.909 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.304 62.1 m -106.46 1.76 25.8 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 120.074 3.361 . . . . 100.0 120.074 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 55.56 -121.39 1.69 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.377 1.071 . . . . 100.0 113.241 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -97.43 112.58 24.36 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.911 1.232 . . . . 100.0 111.6 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 41.4 pt -144.62 149.5 43.85 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 104.49 -2.411 . . . . 100.0 104.49 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.27 129.26 27.73 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.28 1.987 . . . . 100.0 112.608 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.414 ' HB ' HD21 ' A' ' 144' ' ' LEU . 66.9 mt -133.12 135.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.275 -1.379 . . . . 100.0 107.275 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.08 131.67 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 114.303 -1.317 . . . . 100.0 108.389 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . 0.261 86.0 mt -98.82 127.31 44.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.461 -2.051 . . . . 100.0 105.461 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.423 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.74 125.34 49.43 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.871 0.843 . . . . 100.0 111.686 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.68 101.1 2.57 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 104.026 -3.629 . . . . 100.0 104.026 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.83 162.02 24.19 Favored 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 124.966 1.306 . . . . 100.0 112.532 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 58.1 40.81 24.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 127.76 2.424 . . . . 100.0 115.324 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.39 -15.0 18.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 112.634 0.605 . . . . 100.0 112.634 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.442 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 38.4 t70 -62.43 -38.87 91.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.051 1.74 . . . . 100.0 110.35 178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.45 131.58 29.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 124.024 0.93 . . . . 100.0 109.8 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.56 -42.88 91.35 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 116.593 2.072 . . . . 100.0 116.593 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.45 74.56 10.36 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-O 121.697 0.761 . . . . 100.0 110.121 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -83.73 137.42 33.76 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 115.669 -0.696 . . . . 100.0 110.557 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.66 -44.91 4.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.009 -0.541 . . . . 100.0 110.724 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.4 t -95.55 107.16 19.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 105.765 -1.939 . . . . 100.0 105.765 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -81.35 150.14 28.57 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.756 -1.111 . . . . 100.0 109.755 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.46 87.73 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.658 1.183 . . . . 100.0 111.988 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -62.4 -40.82 97.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.021 0.928 . . . . 100.0 111.267 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.3 m -62.15 -35.55 79.13 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.897 1.679 . . . . 100.0 113.511 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.516 HG23 ' HD1' ' A' ' 139' ' ' HIS . 94.2 mt -64.37 121.36 13.24 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 CA-C-O 122.66 1.219 . . . . 100.0 109.774 -177.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.571 HG13 HH21 ' A' ' 140' ' ' ARG . 29.2 m -128.49 -9.59 3.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-N 113.331 -1.759 . . . . 100.0 112.812 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.19 -41.85 84.82 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 125.233 1.413 . . . . 100.0 111.789 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.516 ' HD1' HG23 ' A' ' 136' ' ' ILE . 45.2 p-80 -61.47 -40.29 94.0 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.65 -0.691 . . . . 100.0 112.687 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.571 HH21 HG13 ' A' ' 137' ' ' VAL . 91.8 mtm-85 -64.41 -43.16 95.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.687 0.676 . . . . 100.0 112.301 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.47 -41.3 93.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.31 1.044 . . . . 100.0 111.638 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.2 7.2 47.08 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 117.488 2.403 . . . . 100.0 117.488 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.44 49.38 16.94 Favored 'General case' 0 C--N 1.362 1.144 0 CA-C-O 122.756 1.265 . . . . 100.0 112.813 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.414 HD21 ' HB ' ' A' ' 117' ' ' ILE . 43.7 mt -116.96 160.98 20.08 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.048 -1.093 . . . . 100.0 108.048 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.405 ' HG3' ' NE1' ' A' ' 163' ' ' TRP . 97.5 mm-40 -98.87 140.54 32.89 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -117.05 134.83 54.26 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.557 0.694 . . . . 100.0 112.41 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -134.15 136.87 44.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.328 -0.851 . . . . 100.0 111.999 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -88.29 125.45 34.67 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 101.165 -3.643 . . . . 100.0 101.165 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.93 157.29 38.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 CA-C-O 122.138 0.971 . . . . 100.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.442 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 42.3 t -141.86 116.43 9.67 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 105.285 -2.117 . . . . 100.0 105.285 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.569 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.43 -40.8 98.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.651 0.78 . . . . 100.0 109.651 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.32 -42.29 75.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.151 1.537 . . . . 100.0 115.151 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 m -93.16 -7.74 44.48 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 114.291 1.219 . . . . 100.0 114.291 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.455 HD22 ' HZ ' ' A' ' 35' ' ' PHE . 87.4 m-20 66.56 18.63 10.81 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.147 1.779 . . . . 100.0 112.81 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -69.66 118.92 13.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.45 -1.315 . . . . 100.0 107.45 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.52 33.16 15.57 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 127.383 2.273 . . . . 100.0 111.701 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.47 -39.31 90.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.324 1.601 . . . . 100.0 115.324 -175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -89.47 -8.12 53.58 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 115.616 1.71 . . . . 100.0 115.616 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 95.8 mttt -61.03 -44.27 93.85 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 118.189 2.663 . . . . 100.0 118.189 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.11 -41.3 61.94 Favored 'Trans proline' 0 C--N 1.374 1.894 0 CA-C-N 122.459 1.914 . . . . 100.0 112.994 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -64.5 -43.97 92.44 Favored 'General case' 0 CA--C 1.495 -1.141 0 O-C-N 124.055 0.847 . . . . 100.0 112.062 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.0 -42.86 94.11 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 113.098 0.777 . . . . 100.0 113.098 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.405 ' NE1' ' HG3' ' A' ' 145' ' ' GLN . 62.9 t-105 -62.82 -45.89 90.5 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 123.453 0.471 . . . . 100.0 110.224 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.65 -42.83 97.78 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 123.653 0.595 . . . . 100.0 110.819 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.32 99.08 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 123.668 0.787 . . . . 100.0 111.107 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.05 -45.12 94.95 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.609 0.764 . . . . 100.0 112.024 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.64 -43.4 76.36 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 112.469 0.544 . . . . 100.0 112.469 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.17 -46.64 80.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.195 0.813 . . . . 100.0 113.195 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.85 -38.62 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 125.127 1.371 . . . . 100.0 110.455 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.96 11.82 57.25 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 118.678 -1.068 . . . . 100.0 112.818 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -109.62 109.25 59.85 Favored Pre-proline 0 C--N 1.361 1.075 0 N-CA-C 106.719 -1.586 . . . . 100.0 106.719 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.35 -22.23 66.32 Favored 'Trans proline' 0 C--N 1.365 1.396 0 C-N-CA 124.087 3.191 . . . . 100.0 113.462 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -100.17 12.0 38.02 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 114.079 1.14 . . . . 100.0 114.079 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.16 131.65 51.17 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.516 0.726 . . . . 100.0 109.946 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -134.72 149.57 50.48 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 115.883 -0.599 . . . . 100.0 111.158 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -77.24 136.27 38.52 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.632 -1.248 . . . . 100.0 107.632 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.97 155.43 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.731 -1.211 . . . . 100.0 107.731 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -40.67 -96.33 0.0 OUTLIER 'General case' 0 C--N 1.355 0.827 0 N-CA-C 118.178 2.658 . . . . 100.0 118.178 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.492 ' SD ' ' HD2' ' A' ' 180' ' ' PRO . 46.0 tpp -160.57 142.03 9.08 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 106.499 -1.667 . . . . 100.0 106.499 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.492 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 40.5 Cg_endo -63.92 138.6 63.71 Favored 'Trans proline' 0 CA--C 1.49 -1.675 0 C-N-CA 122.997 2.465 . . . . 100.0 110.787 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -95.37 105.66 17.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.728 -2.323 . . . . 100.0 104.728 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.8 mt -101.12 157.19 16.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.882 -1.053 . . . . 100.0 108.273 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.12 118.26 71.13 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.677 -2.342 . . . . 100.0 104.677 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.43 143.09 62.05 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 123.687 2.925 . . . . 100.0 116.211 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.26 160.58 48.46 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 123.626 2.884 . . . . 100.0 108.889 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.95 -48.15 83.17 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 112.927 0.714 . . . . 100.0 112.927 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.254 39.0 t 60.47 96.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.871 2.068 . . . . 100.0 112.603 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.18 -91.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 102.191 -3.263 . . . . 100.0 102.191 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.8 mtm 50.19 -130.35 2.06 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 127.951 2.501 . . . . 100.0 115.145 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.604 ' HA ' ' HB2' ' A' ' 193' ' ' LEU 0.338 63.2 m-20 71.6 12.62 0.0 OUTLIER Pre-proline 0 C--N 1.365 1.277 1 N-CA-C 124.788 5.107 . . . . 100.0 124.788 -179.557 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.85 -75.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.381 2.289 0 CA-C-N 124.886 2.781 . . . . 100.0 110.18 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.66 -37.26 86.02 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 126.012 1.725 . . . . 100.0 109.866 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 190' ' ' ASP . 88.7 mt -60.48 -41.5 94.32 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 116.11 1.893 . . . . 100.0 116.11 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.26 175.06 9.4 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 114.929 1.455 . . . . 100.0 114.929 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 74.04 -49.97 0.68 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 128.048 2.539 . . . . 100.0 115.726 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.09 -34.44 73.47 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 126.739 2.016 . . . . 100.0 112.032 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -59.93 -41.67 92.3 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 113.662 0.986 . . . . 100.0 113.662 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.36 -40.34 96.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 118.378 0.535 . . . . 100.0 111.921 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.44 -41.62 98.86 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.245 0.618 . . . . 100.0 110.006 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -64.69 -41.12 96.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.255 1.422 . . . . 100.0 111.431 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.4 -42.82 99.34 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.882 0.873 . . . . 100.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -63.0 -45.55 91.87 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 123.995 0.918 . . . . 100.0 111.801 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.259 34.5 m -62.9 -39.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.363 1.193 0 CA-C-O 119.025 -0.512 . . . . 100.0 110.377 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.69 92.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.916 1.286 . . . . 100.0 112.238 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -62.74 -39.69 94.88 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.523 1.129 . . . . 100.0 111.43 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 84.8 m -65.52 -42.54 91.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.697 1.599 . . . . 100.0 111.488 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.8 m -61.54 133.13 55.34 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.259 1.024 . . . . 100.0 112.329 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -69.77 144.03 52.81 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 115.019 -0.991 . . . . 100.0 108.973 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 mt -105.82 123.44 39.25 Favored Pre-proline 0 CA--C 1.492 -1.275 0 C-N-CA 120.736 -0.386 . . . . 100.0 111.191 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.37 143.61 89.14 Favored 'Trans proline' 0 N--CA 1.438 -1.756 0 C-N-CA 122.781 2.321 . . . . 100.0 109.493 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -80.89 106.78 13.16 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 104.958 -2.238 . . . . 100.0 104.958 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -121.49 -55.94 1.91 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.522 -1.217 . . . . 100.0 107.867 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 37.2 p30 -112.85 10.99 19.15 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 115.708 1.744 . . . . 100.0 115.708 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.98 -33.49 73.3 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 125.057 1.343 . . . . 100.0 113.42 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.24 -41.04 87.78 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.22 1.808 . . . . 100.0 112.284 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--O 1.258 1.524 0 CA-C-O 116.991 -1.481 . . . . 100.0 107.779 -179.561 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 120.601 0.238 . . . . 100.0 111.125 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.35 -38.89 85.23 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 125.212 1.405 . . . . 100.0 111.364 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.24 99.25 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.592 0.757 . . . . 100.0 110.131 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -67.96 -36.32 79.87 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.815 1.246 . . . . 100.0 111.147 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.63 39.89 Favored Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 108.475 -1.85 . . . . 100.0 108.475 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 10' ' ' GLN . 18.9 pt-20 -95.03 119.78 65.33 Favored Pre-proline 0 N--CA 1.405 -2.702 0 N-CA-C 109.149 -0.686 . . . . 100.0 109.149 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -82.56 73.9 5.33 Favored 'Trans proline' 0 C--N 1.373 1.843 1 N-CA-C 94.5 -6.769 . . . . 100.0 94.5 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 73.67 -59.58 0.56 Allowed 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 107.021 -1.474 . . . . 100.0 107.021 -169.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.25 127.07 51.09 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 N-CA-C 118.574 2.805 . . . . 100.0 118.574 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 6' ' ' GLU 0.267 19.1 tt0 -131.39 136.72 48.27 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.835 1.654 . . . . 100.0 108.237 177.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -128.33 131.93 48.61 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.877 -0.786 . . . . 100.0 108.877 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.468 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.2 tttt -90.44 115.35 27.54 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 105.294 -2.113 . . . . 100.0 105.294 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.478 ' HG ' ' SG ' ' A' ' 85' ' ' CYS . 2.8 tt -116.51 130.24 56.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.362 -1.348 . . . . 100.0 107.362 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -111.25 125.39 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 118.577 -1.249 . . . . 100.0 109.713 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 mp -102.08 120.45 40.45 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -128.87 161.19 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.057 -1.429 . . . . 100.0 111.235 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.14 172.59 20.92 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.555 -1.418 . . . . 100.0 109.555 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -71.0 160.12 33.5 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.777 0.799 . . . . 100.0 112.827 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.52 140.09 40.41 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 110.316 -1.114 . . . . 100.0 110.316 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.68 89.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 118.608 -1.107 . . . . 100.0 114.536 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 p -64.05 -39.4 93.99 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 118.802 1.301 . . . . 100.0 114.084 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.54 17.83 5.94 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 118.992 -0.893 . . . . 100.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.56 -47.75 84.35 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 118.923 1.361 . . . . 100.0 110.611 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 m -64.83 -43.23 93.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.209 1.403 . . . . 100.0 111.158 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.4 m -63.08 -41.59 99.45 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.369 1.068 . . . . 100.0 109.483 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.451 ' CG ' ' HE2' ' A' ' 89' ' ' MET . 89.6 t80 -61.3 -48.14 82.73 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.748 1.219 . . . . 100.0 110.429 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -43.08 96.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 122.739 0.415 . . . . 100.0 111.112 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.56 -41.96 98.14 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.885 0.874 . . . . 100.0 111.056 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.565 HH11 ' HG2' ' A' ' 29' ' ' ARG . 28.5 ttp85 -61.64 -43.21 99.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.041 0.937 . . . . 100.0 110.35 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -63.82 -41.32 97.89 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 112.829 0.677 . . . . 100.0 112.829 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -69.3 -44.44 71.76 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.355 1.613 . . . . 100.0 115.355 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.8 p -118.94 -23.1 7.03 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 117.708 2.484 . . . . 100.0 117.708 -176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.22 -7.74 72.46 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.582 -1.007 . . . . 100.0 110.582 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.12 153.93 31.71 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.857 1.663 . . . . 100.0 109.662 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -117.32 119.07 34.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.993 -2.966 . . . . 100.0 102.993 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.25 119.06 37.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.608 -0.837 . . . . 100.0 108.854 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.7 -13.85 33.35 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.87 1.063 . . . . 100.0 113.87 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.426 ' HD2' ' CE1' ' A' ' 199' ' ' HIS . 98.2 mttt -94.74 124.99 39.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.384 -1.339 . . . . 100.0 107.384 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -96.61 112.48 24.21 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.815 0.817 . . . . 100.0 109.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.33 124.33 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 102.453 -3.166 . . . . 100.0 102.453 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.97 142.43 57.46 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.172 1.175 . . . . 100.0 114.172 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.8 m -92.37 130.08 38.14 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.3 -2.111 . . . . 100.0 105.3 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -102.92 126.67 50.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.404 -0.961 . . . . 100.0 108.404 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.83 -121.89 18.03 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 109.543 -1.423 . . . . 100.0 109.543 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.08 141.73 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.216 -0.661 . . . . 100.0 109.216 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -124.26 125.1 43.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.084 -2.562 . . . . 100.0 104.084 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.85 121.52 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.561 -1.2 . . . . 100.0 108.169 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.86 122.14 25.57 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 115.583 -0.735 . . . . 100.0 111.269 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.12 128.35 7.28 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.561 2.841 . . . . 100.0 110.969 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -131.64 123.6 28.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.067 -1.086 . . . . 100.0 108.067 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.9 t -110.32 135.9 47.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 N-CA-C 108.863 -0.792 . . . . 100.0 108.863 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -124.35 138.52 54.37 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.495 -1.298 . . . . 100.0 107.495 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -98.59 126.28 44.12 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 107.208 -1.404 . . . . 100.0 107.208 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 p -124.11 -179.78 4.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.956 -1.02 . . . . 100.0 109.868 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.91 -35.6 73.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.052 2.141 . . . . 100.0 109.484 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.23 10.94 29.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 124.182 0.993 . . . . 100.0 113.554 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.53 176.1 25.03 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.758 -0.537 . . . . 100.0 111.758 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.71 136.8 40.13 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.365 2.71 . . . . 100.0 114.486 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.78 142.35 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.486 -1.672 . . . . 100.0 106.486 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -113.64 131.94 55.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.707 -0.797 . . . . 100.0 110.404 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -106.91 119.03 38.25 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.142 -2.54 . . . . 100.0 104.142 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -92.55 99.14 11.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 100.163 -4.014 . . . . 100.0 100.163 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 83.7 t -85.74 125.96 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-N 115.805 -0.634 . . . . 100.0 110.674 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.468 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 36.5 m95 -107.31 98.02 7.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.132 -2.173 . . . . 100.0 105.132 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -86.31 116.11 24.27 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 104.3 -2.481 . . . . 100.0 104.3 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.0 163.93 12.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 113.482 0.919 . . . . 100.0 113.482 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 133.02 35.13 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.28 1.032 . . . . 100.0 109.61 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.16 83.54 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 116.667 -0.242 . . . . 100.0 113.516 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -70.37 -40.69 73.85 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 127.243 2.217 . . . . 100.0 111.856 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.536 ' HB2' HH11 ' A' ' 76' ' ' ARG . 47.0 mt-10 -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.494 1.294 . . . . 100.0 114.494 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.32 151.65 45.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.313 -1.312 . . . . 100.0 109.765 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -68.24 131.59 45.64 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.242 -2.133 . . . . 100.0 105.242 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.44 -174.98 40.53 Favored Glycine 0 C--N 1.355 1.597 0 C-N-CA 118.728 -1.701 . . . . 100.0 114.818 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -22.26 65.03 Favored Glycine 0 C--N 1.353 1.498 0 C-N-CA 126.992 2.234 . . . . 100.0 113.552 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.67 -37.47 84.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.189 1.796 . . . . 100.0 110.03 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.536 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.4 mtp85 -88.64 7.72 32.08 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.431 1.892 . . . . 100.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.95 -38.57 89.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 116.615 2.08 . . . . 100.0 116.615 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -38.07 90.2 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.676 0.655 . . . . 100.0 112.839 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.251 22.0 m-30 -62.35 -43.28 99.18 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.985 1.314 . . . . 100.0 109.856 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 3.4 t80 -90.95 -19.99 22.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.934 1.457 . . . . 100.0 114.934 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.38 135.8 24.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-N 119.631 1.105 . . . . 100.0 108.843 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 66.72 18.22 10.68 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.51 1.924 . . . . 100.0 114.245 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.28 146.69 48.77 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.98 -1.118 . . . . 100.0 107.98 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -106.79 -21.74 12.94 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.698 -0.683 . . . . 100.0 111.2 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.478 ' SG ' ' HG ' ' A' ' 13' ' ' LEU . 7.5 p -160.38 164.96 31.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.718 0.807 . . . . 100.0 109.808 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.1 156.91 42.49 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 113.721 1.008 . . . . 100.0 113.721 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.19 127.17 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.316 -2.105 . . . . 100.0 105.316 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.2 mt -110.67 123.63 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 N-CA-C 103.113 -2.921 . . . . 100.0 103.113 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.562 ' HB3' HD22 ' A' ' 122' ' ' ASN . 57.2 mtt -113.75 135.03 54.39 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 116.542 2.053 . . . . 100.0 116.542 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -132.99 162.02 32.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.445 -1.707 . . . . 100.0 109.975 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -106.11 125.09 50.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.186 -1.783 . . . . 100.0 106.186 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -63.86 -19.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 N-CA-C 113.934 1.087 . . . . 100.0 113.934 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.3 p -90.1 -3.26 58.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 111.987 0.366 . . . . 100.0 111.987 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -124.69 115.08 20.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 122.527 1.156 . . . . 100.0 111.347 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -65.51 -39.55 91.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.742 -1.117 . . . . 100.0 111.078 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -61.64 -41.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 124.982 1.313 . . . . 100.0 109.19 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 96.6 m -62.49 -41.72 99.0 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.959 0.504 . . . . 100.0 110.147 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -65.31 -40.29 93.59 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.238 0.615 . . . . 100.0 110.962 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.475 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -59.79 -35.87 75.54 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.259 1.024 . . . . 100.0 111.237 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -74.01 -11.67 60.4 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 115.415 1.635 . . . . 100.0 115.415 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.39 -43.73 96.84 Favored Pre-proline 0 C--N 1.362 1.12 0 CA-C-O 116.141 -1.885 . . . . 100.0 111.792 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 86.5 Cg_exo -57.37 -35.11 98.87 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.529 2.153 . . . . 100.0 111.939 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.32 -41.9 84.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 123.453 0.701 . . . . 100.0 111.291 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -63.66 -45.73 88.81 Favored 'General case' 0 C--N 1.365 1.278 0 N-CA-C 109.197 -0.668 . . . . 100.0 109.197 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -90.79 69.81 6.55 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.838 -1.542 . . . . 100.0 106.838 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -167.75 -55.5 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 100.937 -3.727 . . . . 100.0 100.937 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.68 -43.27 99.24 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.674 -1.602 . . . . 100.0 106.674 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.439 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -63.31 -50.15 71.17 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.83 -23.59 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 113.287 0.847 . . . . 100.0 113.287 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -60.31 -41.24 93.04 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.674 0.79 . . . . 100.0 109.759 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.257 15.1 m -98.36 -34.43 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 115.958 1.836 . . . . 100.0 115.958 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.292 68.9 m -107.05 -4.62 18.75 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 117.823 2.527 . . . . 100.0 117.823 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.339 66.3 mt-10 53.59 -119.31 1.47 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.636 1.347 . . . . 100.0 114.636 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -95.94 112.11 23.93 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 118.386 -1.326 . . . . 100.0 111.872 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 pt -145.12 153.83 53.53 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -61.21 126.18 18.78 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.622 2.214 . . . . 100.0 111.78 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.407 ' HB ' HD21 ' A' ' 144' ' ' LEU . 61.1 mt -133.35 134.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.685 -1.228 . . . . 100.0 107.685 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -116.0 131.59 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.928 -1.487 . . . . 100.0 108.687 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.5 mt -100.03 126.4 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 104.957 -2.238 . . . . 100.0 104.957 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.476 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 70.9 m -118.18 125.0 49.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 122.026 0.917 . . . . 100.0 111.871 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.92 101.21 2.57 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 104.492 -3.443 . . . . 100.0 104.492 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.562 HD22 ' HB3' ' A' ' 89' ' ' MET . 70.6 m-80 -81.31 163.17 23.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.611 1.164 . . . . 100.0 112.17 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 57.78 42.02 24.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.877 2.471 . . . . 100.0 115.442 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.0 m -67.5 -13.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 112.051 0.389 . . . . 100.0 112.051 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.529 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 32.8 t70 -63.38 -38.86 92.8 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.641 1.976 . . . . 100.0 110.399 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.06 133.89 28.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 124.19 0.996 . . . . 100.0 110.583 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.59 -46.94 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.081 1.882 . . . . 100.0 116.081 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -85.26 77.11 10.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.587 0.63 . . . . 100.0 110.723 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -85.57 134.05 34.03 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.05 -40.87 6.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.681 -0.691 . . . . 100.0 112.355 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.07 106.7 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 106.028 -1.841 . . . . 100.0 106.028 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.69 146.86 37.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.951 -1.022 . . . . 100.0 109.375 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.0 88.57 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.412 1.085 . . . . 100.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.58 -40.09 95.8 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.71 1.204 . . . . 100.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.1 m -61.9 -38.24 87.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.358 1.463 . . . . 100.0 113.233 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.537 HG23 ' HD1' ' A' ' 139' ' ' HIS . 95.3 mt -63.73 122.37 14.48 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 122.389 1.09 . . . . 100.0 110.07 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.61 -6.55 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.848 0 CA-C-N 113.785 -1.552 . . . . 100.0 112.21 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -58.89 -39.66 82.12 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.86 1.264 . . . . 100.0 111.323 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.537 ' HD1' HG23 ' A' ' 136' ' ' ILE . 49.2 p-80 -61.07 -39.95 91.85 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 123.497 0.719 . . . . 100.0 111.616 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.08 -43.64 94.79 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 118.662 0.664 . . . . 100.0 112.101 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.369 1.067 . . . . 100.0 111.337 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.22 6.94 47.57 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 118.325 2.713 . . . . 100.0 118.325 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 54.63 46.41 24.81 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.058 1.343 . . . . 100.0 113.943 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.407 HD21 ' HB ' ' A' ' 117' ' ' ILE . 38.0 mt -109.57 159.47 17.07 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.618 -1.173 . . . . 100.0 108.464 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -96.47 141.67 29.49 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.414 -1.699 . . . . 100.0 106.414 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -118.32 133.52 55.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.159 0.504 . . . . 100.0 111.268 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.74 134.85 43.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.663 -0.698 . . . . 100.0 111.991 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -88.59 123.37 33.01 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 101.683 -3.451 . . . . 100.0 101.683 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.73 158.3 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 122.64 1.21 . . . . 100.0 112.302 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.529 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 28.7 t -143.12 111.32 6.13 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 105.751 -1.944 . . . . 100.0 105.751 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.89 92.14 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.549 -0.908 . . . . 100.0 108.549 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.17 -43.5 91.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 114.875 1.435 . . . . 100.0 114.875 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 87.5 p -100.89 -2.28 32.43 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 114.916 1.45 . . . . 100.0 114.916 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 70.79 9.53 6.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 125.774 1.629 . . . . 100.0 112.953 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -63.49 121.73 14.54 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.403 1.001 . . . . 100.0 108.945 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 53.34 34.58 18.23 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 127.271 2.228 . . . . 100.0 111.459 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 158' ' ' GLU . 10.8 p90 -59.67 -41.46 90.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.799 1.777 . . . . 100.0 115.799 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 157' ' ' PHE . 94.3 mt-10 -93.04 -3.48 54.25 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 115.503 1.668 . . . . 100.0 115.503 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 96.8 mttt -60.36 -44.31 95.56 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 116.969 2.211 . . . . 100.0 116.969 -177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.4 -43.11 42.78 Favored 'Trans proline' 0 C--N 1.375 1.956 0 CA-C-N 122.5 1.929 . . . . 100.0 113.095 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -64.65 -43.68 92.89 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.247 0.967 . . . . 100.0 111.863 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.28 -43.25 95.39 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 118.827 -0.606 . . . . 100.0 112.565 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -62.11 -46.62 88.24 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 123.487 0.492 . . . . 100.0 110.793 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.49 -42.77 97.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 124.131 0.895 . . . . 100.0 110.686 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.9 97.93 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.521 0.729 . . . . 100.0 111.154 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -63.48 -44.63 93.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 118.557 -0.735 . . . . 100.0 112.488 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -69.01 -43.14 75.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.406 0.441 . . . . 100.0 112.051 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.2 -46.91 75.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 113.239 0.829 . . . . 100.0 113.239 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.16 -38.42 77.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 125.29 1.436 . . . . 100.0 110.368 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.71 10.23 56.8 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 118.238 -1.312 . . . . 100.0 113.815 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -108.88 110.65 61.01 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.071 -1.455 . . . . 100.0 107.071 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.34 -22.22 66.36 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.912 3.074 . . . . 100.0 113.51 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -102.01 11.26 38.74 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 114.206 1.187 . . . . 100.0 114.206 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.45 133.16 54.62 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -135.77 152.27 50.94 Favored 'General case' 0 CA--C 1.484 -1.564 0 CA-C-O 121.337 0.589 . . . . 100.0 111.687 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -74.21 132.74 42.45 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 105.813 -1.921 . . . . 100.0 105.813 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.22 138.42 54.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 CA-C-O 121.362 0.601 . . . . 100.0 110.207 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 23.08 -91.1 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 129.681 3.192 . . . . 100.0 117.487 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 58.2 ttm 97.24 124.97 0.02 OUTLIER Pre-proline 0 C--N 1.37 1.467 0 C-N-CA 127.725 2.41 . . . . 100.0 107.985 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.77 143.73 99.57 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.005 2.47 . . . . 100.0 109.467 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -60.94 135.13 57.7 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 124.074 0.859 . . . . 100.0 112.976 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.89 145.07 52.26 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.51 -1.223 . . . . 100.0 107.753 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -75.13 127.48 86.52 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-O 119.367 -0.349 . . . . 100.0 110.4 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 94.2 Cg_endo -71.39 143.31 42.9 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.573 2.848 . . . . 100.0 110.023 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 28.0 Cg_exo -69.95 125.82 12.48 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.016 1.811 . . . . 100.0 110.254 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.57 -42.04 71.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 123.712 0.633 . . . . 100.0 110.864 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.566 33.9 m 52.55 63.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.113 0 N-CA-C 119.469 3.137 . . . . 100.0 119.469 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.03 -41.71 10.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.177 0 C-N-CA 124.818 1.247 . . . . 100.0 112.138 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 86.3 mtp -70.73 167.43 18.76 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.078 1.351 . . . . 100.0 113.476 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.441 ' H ' ' HD2' ' A' ' 191' ' ' PRO . 37.9 t70 -123.84 -53.37 0.03 OUTLIER Pre-proline 0 C--N 1.363 1.191 0 N-CA-C 118.75 2.87 . . . . 100.0 118.75 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.441 ' HD2' ' H ' ' A' ' 190' ' ' ASP 0.289 52.6 Cg_endo -57.22 -68.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 N-CA-C 122.312 3.928 . . . . 100.0 122.312 -174.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.19 96.64 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.908 1.231 . . . . 100.0 111.79 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.78 -36.56 83.49 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 115.976 1.843 . . . . 100.0 115.976 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.65 164.28 7.91 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 118.49 2.774 . . . . 100.0 118.49 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 74.62 -60.83 0.51 Allowed 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 130.841 3.657 . . . . 100.0 116.721 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -61.55 -36.22 79.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 115.106 1.521 . . . . 100.0 115.106 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 201' ' ' LEU . 52.5 t80 -61.56 -40.63 95.43 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 125.994 1.718 . . . . 100.0 112.813 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.99 -38.36 85.74 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 123.891 0.876 . . . . 100.0 112.309 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.426 ' CE1' ' HD2' ' A' ' 38' ' ' LYS . 39.3 t60 -59.02 -45.98 89.35 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.652 1.181 . . . . 100.0 110.724 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.75 -43.95 82.76 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.966 1.306 . . . . 100.0 112.073 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.423 HD12 ' CE2' ' A' ' 197' ' ' TYR . 94.4 mt -61.27 -44.63 96.92 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-O 118.567 -0.73 . . . . 100.0 112.81 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.79 -47.52 84.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 123.829 0.706 . . . . 100.0 112.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.08 -41.0 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 O-C-N 123.828 0.705 . . . . 100.0 111.996 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.56 -45.37 72.28 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.68 1.363 . . . . 100.0 114.68 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -63.83 -40.44 96.6 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.861 1.265 . . . . 100.0 113.497 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.7 m -66.45 -40.97 89.75 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.626 1.17 . . . . 100.0 111.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.2 m -71.58 122.73 21.04 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.628 1.204 . . . . 100.0 111.865 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -80.92 159.71 24.89 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.961 -1.866 . . . . 100.0 105.961 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 78.1 mt -104.39 108.32 60.13 Favored Pre-proline 0 N--CA 1.442 -0.865 0 C-N-CA 119.809 -0.757 . . . . 100.0 112.411 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -80.24 110.95 2.57 Favored 'Trans proline' 0 C--N 1.367 1.531 0 N-CA-C 102.545 -3.675 . . . . 100.0 102.545 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -75.73 114.98 14.94 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.879 -1.156 . . . . 100.0 107.879 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -118.04 -64.16 1.33 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.884 -1.895 . . . . 100.0 105.884 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -133.9 33.92 3.41 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.616 0.722 . . . . 100.0 109.503 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.67 -20.77 65.17 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 125.446 1.498 . . . . 100.0 112.635 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.54 -38.96 86.16 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.039 1.336 . . . . 100.0 109.991 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.0 tp . . . . . 0 C--O 1.256 1.446 0 N-CA-C 106.233 -1.766 . . . . 100.0 106.233 179.15 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mtt . . . . . 0 CA--C 1.491 -1.292 0 N-CA-C 109.632 -0.507 . . . . 100.0 109.632 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.11 81.19 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 125.611 1.564 . . . . 100.0 111.009 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.78 -43.51 98.7 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 123.386 0.674 . . . . 100.0 110.156 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -73.4 -24.57 60.31 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.914 0.709 . . . . 100.0 112.914 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . 86.17 22.26 49.14 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 109.091 -1.604 . . . . 100.0 109.091 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.362 37.7 tt0 -92.75 99.2 2.72 Favored Pre-proline 0 N--CA 1.412 -2.355 0 C-N-CA 129.312 3.045 . . . . 100.0 103.79 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 5' ' ' GLY . 76.0 Cg_endo -81.76 77.65 3.81 Favored 'Trans proline' 0 CA--C 1.479 -2.226 1 N-CA-C 96.28 -6.085 . . . . 100.0 96.28 177.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.256 89.8 mm-40 74.51 -60.75 0.51 Allowed 'General case' 0 N--CA 1.408 -2.553 0 CA-C-O 116.705 -1.617 . . . . 100.0 107.382 -169.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.1 130.46 63.27 Favored 'Isoleucine or valine' 0 C--N 1.365 1.279 0 N-CA-C 118.167 2.655 . . . . 100.0 118.167 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.288 45.9 tt0 -131.29 135.33 47.21 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.19 -2.152 . . . . 100.0 105.19 175.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . 0.278 80.9 m-85 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 106.439 -1.689 . . . . 100.0 106.439 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -92.38 118.28 30.77 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.341 -2.096 . . . . 100.0 105.341 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 85' ' ' CYS 0.362 4.3 mt -114.9 132.51 56.51 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 105.797 -1.927 . . . . 100.0 105.797 -178.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.8 t -110.24 127.75 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 116.47 -2.092 . . . . 100.0 106.823 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 tp -103.17 118.01 35.83 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.344 -1.354 . . . . 100.0 107.344 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.83 162.0 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 125.479 1.512 . . . . 100.0 112.93 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.57 171.07 17.75 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.05 -1.62 . . . . 100.0 109.05 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -70.42 159.27 34.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.97 0.89 . . . . 100.0 113.187 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.68 139.03 40.67 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.54 -1.024 . . . . 100.0 110.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 3.51 90.13 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-O 118.354 -1.248 . . . . 100.0 115.276 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 p -64.43 -38.75 92.13 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.095 1.448 . . . . 100.0 113.553 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 19.89 4.77 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 111.132 -0.787 . . . . 100.0 111.132 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.6 -48.72 80.55 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 124.334 1.054 . . . . 100.0 110.87 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.3 m -65.75 -43.42 88.96 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.228 1.411 . . . . 100.0 110.95 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.3 m -62.82 -41.66 99.4 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.393 1.077 . . . . 100.0 109.505 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.478 ' CD2' ' HE2' ' A' ' 89' ' ' MET . 87.3 t80 -61.72 -47.51 84.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 124.103 0.961 . . . . 100.0 110.696 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.56 -41.31 91.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 O-C-N 122.893 0.121 . . . . 100.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.0 -39.92 93.88 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.56 0.744 . . . . 100.0 111.097 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.84 -44.09 97.43 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.069 0.548 . . . . 100.0 110.313 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -62.21 -43.92 97.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.812 0.671 . . . . 100.0 112.812 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.69 -44.74 66.36 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.547 2.055 . . . . 100.0 116.547 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.5 p -117.4 -24.93 7.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 117.521 2.415 . . . . 100.0 117.521 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.01 -8.08 70.05 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.695 -0.962 . . . . 100.0 110.695 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.88 156.36 30.41 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.469 1.107 . . . . 100.0 109.671 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -115.8 116.56 28.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 101.087 -3.671 . . . . 100.0 101.087 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -96.88 118.96 34.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.154 -1.424 . . . . 100.0 107.154 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.64 -11.18 34.84 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.828 -1.078 . . . . 100.0 113.235 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -101.22 126.18 47.92 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.174 -1.047 . . . . 100.0 108.174 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -95.04 116.42 28.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.927 0.87 . . . . 100.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.05 121.08 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.784 -3.413 . . . . 100.0 101.784 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.95 141.9 58.55 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.371 0.668 . . . . 100.0 112.591 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.7 m -94.51 129.06 41.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 105.281 -2.118 . . . . 100.0 105.281 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.37 129.15 48.75 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.053 -1.091 . . . . 100.0 108.053 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.69 14.32 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 109.614 -1.395 . . . . 100.0 109.614 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.48 143.25 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 109.157 -0.682 . . . . 100.0 109.157 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -127.32 125.55 41.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.608 -2.738 . . . . 100.0 103.608 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -99.04 125.46 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.509 -0.922 . . . . 100.0 108.509 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -121.45 123.71 27.51 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-N 114.803 -1.09 . . . . 100.0 111.176 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' CB ' ' HE3' ' A' ' 60' ' ' LYS . 75.8 Cg_endo -80.08 126.64 6.46 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.702 3.602 . . . . 100.0 111.91 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 tp -133.45 130.12 38.19 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.927 -1.138 . . . . 100.0 107.927 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -118.25 134.61 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.775 -0.824 . . . . 100.0 108.775 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -124.98 142.61 51.37 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.374 -0.973 . . . . 100.0 108.374 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -98.43 124.0 42.89 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.851 -0.796 . . . . 100.0 108.851 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.1 p -121.36 -177.67 3.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.336 -0.847 . . . . 100.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.22 -35.61 73.95 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.388 2.275 . . . . 100.0 109.333 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -88.21 3.25 50.06 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.13 1.372 . . . . 100.0 113.266 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.59 -179.5 22.73 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.117 -1.193 . . . . 100.0 110.117 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.66 137.29 45.4 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.348 2.698 . . . . 100.0 113.919 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -130.84 137.47 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.488 -1.301 . . . . 100.0 107.488 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' HE3' ' CB ' ' A' ' 49' ' ' PRO . 85.4 tttt -105.1 133.51 49.76 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.967 0.889 . . . . 100.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.94 116.85 31.92 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 103.098 -2.927 . . . . 100.0 103.098 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.06 99.25 11.89 Favored 'General case' 0 N--CA 1.434 -1.238 1 N-CA-C 99.979 -4.082 . . . . 100.0 99.979 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.53 125.69 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.768 -0.827 . . . . 100.0 108.768 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -102.74 97.75 7.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 105.089 -2.189 . . . . 100.0 105.089 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -85.84 116.32 24.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 104.938 -2.245 . . . . 100.0 104.938 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -99.53 166.06 11.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 114.576 1.324 . . . . 100.0 114.576 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.21 131.75 34.16 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.625 0.77 . . . . 100.0 109.301 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.71 -8.47 82.77 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.45 0.54 . . . . 100.0 114.45 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -70.6 -39.67 73.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.462 1.505 . . . . 100.0 112.731 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' HB2' HH11 ' A' ' 76' ' ' ARG . 49.0 mt-10 -62.33 134.56 56.66 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.472 1.509 . . . . 100.0 113.689 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.24 154.51 40.18 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.04 -0.982 . . . . 100.0 109.984 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -67.21 132.73 48.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 125.95 1.7 . . . . 100.0 107.673 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.72 -175.51 40.68 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.001 -1.571 . . . . 100.0 114.14 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.78 -23.28 65.23 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 126.747 2.118 . . . . 100.0 113.6 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.95 -28.34 69.75 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.416 1.087 . . . . 100.0 110.86 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.5 HH11 ' HB2' ' A' ' 70' ' ' GLU . 75.5 mtp85 -92.29 9.31 34.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.68 1.592 . . . . 100.0 114.562 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.59 -38.51 84.87 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 115.687 1.736 . . . . 100.0 115.687 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.95 89.89 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 124.271 0.939 . . . . 100.0 113.433 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -61.54 -48.32 81.52 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.129 0.972 . . . . 100.0 109.086 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.463 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU 0.423 25.7 m-85 -70.64 -37.43 73.76 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 120.223 3.416 . . . . 100.0 120.223 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -54.03 131.97 16.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.78 0.8 . . . . 100.0 109.963 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 68.55 14.37 9.06 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.19 145.73 54.05 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-N 118.882 0.764 . . . . 100.0 109.864 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -102.87 -30.72 10.66 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.369 -0.832 . . . . 100.0 110.51 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.476 ' SG ' HD21 ' A' ' 13' ' ' LEU . 31.9 p -160.81 170.08 21.42 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.315 0.646 . . . . 100.0 109.472 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.48 157.46 43.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 113.333 0.864 . . . . 100.0 113.333 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.23 126.62 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.482 -2.414 . . . . 100.0 104.482 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.2 mt -109.59 123.97 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 103.286 -2.857 . . . . 100.0 103.286 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.478 ' HE2' ' CD2' ' A' ' 26' ' ' PHE . 40.4 mtt -114.09 135.28 54.2 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 115.322 1.601 . . . . 100.0 115.322 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -132.75 159.62 39.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.926 -1.943 . . . . 100.0 110.003 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -103.72 125.07 49.95 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.105 -1.813 . . . . 100.0 106.105 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.51 -19.79 24.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 114.117 1.154 . . . . 100.0 114.117 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.4 p -88.45 -6.55 57.57 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 119.072 -0.49 . . . . 100.0 111.51 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -123.18 114.29 20.09 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.804 1.287 . . . . 100.0 112.238 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -65.43 -38.49 90.04 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.398 -1.274 . . . . 100.0 111.327 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.996 1.318 . . . . 100.0 109.154 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.8 m -62.76 -41.32 99.16 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.94 0.496 . . . . 100.0 110.16 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.23 -39.84 93.28 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.541 0.736 . . . . 100.0 110.973 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.478 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -59.33 -36.71 76.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.687 1.195 . . . . 100.0 111.101 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.28 -10.67 59.82 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 115.782 1.771 . . . . 100.0 115.782 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.43 -43.82 96.86 Favored Pre-proline 0 C--N 1.36 1.034 0 CA-C-O 116.128 -1.891 . . . . 100.0 111.621 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.8 Cg_exo -58.35 -33.6 97.91 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.576 2.184 . . . . 100.0 112.503 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -67.23 -42.99 83.12 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.782 0.833 . . . . 100.0 109.862 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -63.26 -46.98 84.32 Favored 'General case' 0 C--N 1.368 1.375 0 N-CA-C 108.649 -0.871 . . . . 100.0 108.649 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -89.53 70.75 7.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.892 1.33 . . . . 100.0 107.776 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -168.4 -55.54 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 100.315 -3.957 . . . . 100.0 100.315 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.267 -1.383 . . . . 100.0 107.267 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.463 ' HG ' ' CZ ' ' A' ' 80' ' ' TYR . 7.1 mp -61.88 -50.35 72.57 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.396 1.078 . . . . 100.0 112.806 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.259 32.8 m -70.15 -19.66 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 113.799 1.037 . . . . 100.0 113.799 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -60.55 -39.61 88.55 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.787 0.435 . . . . 100.0 110.511 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.89 -47.13 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-O 120.757 0.313 . . . . 100.0 110.792 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.404 ' SG ' ' HD1' ' A' ' 80' ' ' TYR . 95.9 m -70.87 -36.9 73.0 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 119.478 3.14 . . . . 100.0 119.478 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 61.72 -122.22 0.77 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 126.053 1.741 . . . . 100.0 109.31 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -93.41 113.02 25.08 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.294 1.861 . . . . 100.0 112.273 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 36.3 pt -144.4 149.16 43.4 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.133 -2.173 . . . . 100.0 105.133 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.431 ' HG2' ' HB3' ' A' ' 85' ' ' CYS . 41.5 Cg_endo -64.31 128.99 22.78 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.018 1.812 . . . . 100.0 110.437 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.428 ' HB ' HD21 ' A' ' 144' ' ' LEU . 76.6 mt -131.91 135.09 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.316 -1.364 . . . . 100.0 107.316 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.33 131.69 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 114.402 -1.272 . . . . 100.0 107.799 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.9 126.55 43.34 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.388 -2.079 . . . . 100.0 105.388 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.95 125.93 50.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 122.055 0.931 . . . . 100.0 111.71 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.47 2.57 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 104.711 -3.356 . . . . 100.0 104.711 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.47 161.91 24.65 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.765 1.226 . . . . 100.0 112.489 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.4 mttt 57.81 43.28 22.03 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 127.858 2.463 . . . . 100.0 115.023 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.7 m -68.9 -11.7 15.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 CA-C-N 115.983 -0.553 . . . . 100.0 111.603 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.542 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 35.1 t70 -63.51 -39.04 93.39 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.936 2.095 . . . . 100.0 109.74 177.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.06 132.02 29.82 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 C-N-CA 124.095 0.958 . . . . 100.0 110.132 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.83 -45.0 91.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 116.435 2.013 . . . . 100.0 116.435 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -84.93 77.51 10.09 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.648 0.737 . . . . 100.0 109.731 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -82.8 137.66 34.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.503 -0.925 . . . . 100.0 108.503 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.07 -42.69 5.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 119.4 -0.333 . . . . 100.0 111.496 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.1 107.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.59 -2.004 . . . . 100.0 105.59 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.62 148.86 36.68 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.104 -0.953 . . . . 100.0 109.349 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.22 90.32 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.165 0.986 . . . . 100.0 110.91 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -62.4 -40.8 97.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.661 1.184 . . . . 100.0 110.907 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 65.4 m -61.49 -37.64 84.39 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.686 1.594 . . . . 100.0 113.556 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.554 HG23 ' HD1' ' A' ' 139' ' ' HIS . 93.1 mt -62.42 123.52 15.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 CA-C-O 122.523 1.154 . . . . 100.0 110.035 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.587 HG13 HH21 ' A' ' 140' ' ' ARG . 27.4 m -127.52 -10.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 CA-C-N 113.531 -1.668 . . . . 100.0 112.592 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -58.49 -40.34 82.49 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.1 1.36 . . . . 100.0 111.864 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.554 ' HD1' HG23 ' A' ' 136' ' ' ILE . 46.1 p-80 -61.17 -40.01 92.28 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 118.679 -0.677 . . . . 100.0 111.601 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.587 HH21 HG13 ' A' ' 137' ' ' VAL . 87.0 mtm-85 -64.04 -43.6 95.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 112.806 0.669 . . . . 100.0 112.806 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.65 -42.21 95.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 123.566 0.746 . . . . 100.0 111.853 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -97.28 6.81 47.74 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 117.902 2.556 . . . . 100.0 117.902 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.26 71.2 m-20 53.23 50.75 16.97 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-O 123.062 1.41 . . . . 100.0 114.279 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.428 HD21 ' HB ' ' A' ' 117' ' ' ILE . 35.3 mt -114.38 158.29 21.71 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.981 -1.463 . . . . 100.0 107.092 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -98.78 143.77 28.76 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.259 -1.015 . . . . 100.0 108.259 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -117.34 136.06 53.41 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.25 0.548 . . . . 100.0 112.344 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.05 137.74 44.87 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.356 -0.838 . . . . 100.0 112.838 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -89.42 123.88 33.97 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 101.583 -3.488 . . . . 100.0 101.583 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.3 pt -133.85 157.44 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.623 1.201 . . . . 100.0 112.084 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.542 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 32.4 t -143.91 111.36 5.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 176.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.066 0.946 . . . . 100.0 108.553 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.34 -46.79 84.95 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 126.637 1.975 . . . . 100.0 113.365 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.2 p -100.75 -2.84 31.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 115.44 1.645 . . . . 100.0 115.44 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 70.47 11.47 7.36 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.337 1.855 . . . . 100.0 113.353 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.2 118.33 10.45 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.686 -1.227 . . . . 100.0 107.686 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 54.31 29.31 10.58 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 128.756 2.822 . . . . 100.0 111.952 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . 0.413 3.7 p90 -62.53 -35.92 80.95 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 114.216 1.191 . . . . 100.0 114.216 -175.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.272 40.6 mt-10 -85.93 -8.33 58.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.304 1.964 . . . . 100.0 116.304 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.303 95.3 mttt -60.6 -44.11 94.45 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 117.149 2.278 . . . . 100.0 117.149 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -59.45 -40.48 66.53 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-N 122.333 1.869 . . . . 100.0 112.962 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.31 -44.36 95.18 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 124.608 1.163 . . . . 100.0 111.194 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.89 -43.71 92.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 112.661 0.615 . . . . 100.0 112.661 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -61.92 -45.86 91.86 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 123.28 0.362 . . . . 100.0 110.577 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.411 HD11 ' SG ' ' A' ' 85' ' ' CYS . 89.6 mt -61.04 -42.8 99.17 Favored 'General case' 0 CA--C 1.495 -1.167 0 O-C-N 123.959 0.787 . . . . 100.0 110.442 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.3 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.554 0.741 . . . . 100.0 110.955 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -62.52 -45.33 93.49 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 123.147 0.579 . . . . 100.0 112.401 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.33 -43.55 77.29 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 112.119 0.415 . . . . 100.0 112.119 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.69 -47.2 76.25 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.776 1.028 . . . . 100.0 113.776 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.26 -38.7 75.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 124.162 0.985 . . . . 100.0 109.852 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.22 9.63 55.38 Favored Glycine 0 C--N 1.353 1.472 0 CA-C-O 118.306 -1.274 . . . . 100.0 114.051 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.463 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 59.9 t0 -109.74 113.02 58.03 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 106.665 -1.606 . . . . 100.0 106.665 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.99 -16.91 50.81 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 123.87 3.047 . . . . 100.0 113.092 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -97.39 8.38 44.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 57.1 mt -60.89 134.13 56.78 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 119.233 0.924 . . . . 100.0 112.568 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.41 149.25 48.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.839 -1.073 . . . . 100.0 109.857 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.01 131.13 40.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 105.576 -2.009 . . . . 100.0 105.576 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.18 135.07 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 CA-C-O 121.426 0.631 . . . . 100.0 111.496 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 49.36 -127.94 2.1 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.952 1.701 . . . . 100.0 112.583 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 50.9 tpp 136.12 121.71 0.0 OUTLIER Pre-proline 0 CA--C 1.497 -1.082 0 N-CA-C 101.035 -3.691 . . . . 100.0 101.035 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -55.02 128.96 32.8 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.568 2.179 . . . . 100.0 110.921 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.27 131.85 35.23 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 106.918 -1.512 . . . . 100.0 106.918 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.1 mt -84.26 111.91 19.81 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 105.914 -1.884 . . . . 100.0 105.914 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -132.78 144.76 54.26 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -64.53 148.15 90.49 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.778 2.319 . . . . 100.0 110.626 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.33 154.4 68.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 123.701 2.934 . . . . 100.0 114.144 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -61.6 -49.13 77.83 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.17 0.918 . . . . 100.0 111.19 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.301 5.9 m 52.35 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 128.214 2.605 . . . . 100.0 117.848 177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.84 -67.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.387 0 N-CA-C 107.819 -1.178 . . . . 100.0 107.819 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.1 ptp -70.57 156.33 39.56 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 114.657 1.355 . . . . 100.0 114.657 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -128.18 -51.95 0.03 OUTLIER Pre-proline 0 C--N 1.36 1.034 0 N-CA-C 116.475 2.028 . . . . 100.0 116.475 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.91 -54.77 4.52 Favored 'Trans proline' 0 C--N 1.377 2.067 0 N-CA-C 121.33 3.55 . . . . 100.0 121.33 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.9 77.29 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 119.518 1.054 . . . . 100.0 111.153 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 31.5 tp -75.65 -8.56 57.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 126.259 1.824 . . . . 100.0 113.534 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.67 175.63 4.08 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.579 1.152 . . . . 100.0 110.334 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 79.45 -47.99 0.38 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.575 1.95 . . . . 100.0 111.591 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -60.38 -28.02 67.88 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.447 1.899 . . . . 100.0 111.155 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -61.28 -38.99 88.74 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 113.286 0.847 . . . . 100.0 113.286 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.93 -39.62 90.12 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 123.395 0.678 . . . . 100.0 110.304 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.09 -44.05 97.96 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.55 0.74 . . . . 100.0 111.156 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -64.73 -43.16 94.28 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.042 0.937 . . . . 100.0 111.529 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.49 -41.8 97.83 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 124.312 1.045 . . . . 100.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.37 -42.54 98.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.424 1.09 . . . . 100.0 110.963 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.12 -43.65 96.72 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 108.325 -0.991 . . . . 100.0 108.325 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.0 90.1 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.269 1.027 . . . . 100.0 113.333 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -63.3 -40.39 97.22 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 125.11 1.364 . . . . 100.0 112.713 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 66.4 m -65.89 -41.79 91.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.879 1.672 . . . . 100.0 110.265 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m -69.55 119.2 13.44 Favored 'General case' 0 C--N 1.361 1.102 0 CA-C-O 122.991 1.377 . . . . 100.0 107.87 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -103.49 138.15 40.6 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 105.208 -2.145 . . . . 100.0 105.208 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 97.4 mt -71.37 143.3 87.8 Favored Pre-proline 0 N--CA 1.435 -1.203 0 O-C-N 124.143 0.902 . . . . 100.0 109.021 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 209' ' ' LEU . 67.6 Cg_exo -53.93 122.11 10.8 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 N-CA-C 117.032 1.897 . . . . 100.0 117.032 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.52 121.26 44.79 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 102.343 -3.206 . . . . 100.0 102.343 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -91.86 -67.94 0.82 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 103.058 -2.942 . . . . 100.0 103.058 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -150.27 34.89 0.65 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 123.052 1.406 . . . . 100.0 107.547 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -61.67 -34.15 75.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 128.605 2.762 . . . . 100.0 110.812 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -59.6 -39.15 83.23 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.987 1.315 . . . . 100.0 111.943 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--O 1.255 1.357 0 CA-C-O 117.307 -1.33 . . . . 100.0 107.614 179.198 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mtt . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 110.607 -0.146 . . . . 100.0 110.607 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.94 -42.18 97.72 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 124.598 1.159 . . . . 100.0 112.439 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.45 99.43 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.542 0.737 . . . . 100.0 110.66 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -65.32 -35.6 81.49 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.817 1.647 . . . . 100.0 111.633 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.498 ' HA3' ' HZ2' ' A' ' 60' ' ' LYS . . . 95.43 15.9 42.12 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 107.801 -2.12 . . . . 100.0 107.801 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.257 36.4 tt0 -88.74 95.69 0.59 Allowed Pre-proline 0 N--CA 1.425 -1.689 0 C-N-CA 128.142 2.577 . . . . 100.0 104.153 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -61.13 -45.3 19.85 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.468 1.445 . . . . 100.0 108.354 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -131.91 -62.63 0.85 Allowed 'General case' 0 N--CA 1.419 -2.022 1 N-CA-C 99.345 -4.317 . . . . 100.0 99.345 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.4 m -123.57 145.06 31.18 Favored 'Isoleucine or valine' 0 C--N 1.37 1.468 0 N-CA-C 115.259 1.577 . . . . 100.0 115.259 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.262 23.5 tt0 -125.87 131.71 52.32 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.448 -2.427 . . . . 100.0 104.448 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' CD1' HD11 ' A' ' 168' ' ' LEU . 90.7 m-85 -125.71 134.12 51.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.268 -0.641 . . . . 100.0 109.268 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.0 tttt -90.69 116.3 28.46 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.016 -1.105 . . . . 100.0 108.016 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.5 ' CD2' ' HB2' ' A' ' 85' ' ' CYS . 41.5 mt -113.6 131.56 56.07 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.059 -1.459 . . . . 100.0 107.059 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 t -109.3 123.36 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.521 -1.659 . . . . 100.0 106.521 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.462 HD12 ' SD ' ' A' ' 89' ' ' MET . 64.6 tp -103.25 115.65 30.97 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.667 -1.605 . . . . 100.0 106.667 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.68 162.59 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 113.777 -1.556 . . . . 100.0 110.625 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.05 168.07 14.87 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 108.098 -2.001 . . . . 100.0 108.098 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -72.1 159.94 33.3 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 140.24 40.89 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.756 -1.338 . . . . 100.0 109.756 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.84 1.77 89.81 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-O 118.913 -0.937 . . . . 100.0 114.344 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.2 m -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.59 1.195 . . . . 100.0 112.303 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.08 15.49 7.79 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.956 -0.858 . . . . 100.0 110.956 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -60.94 -44.12 97.7 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.289 1.435 . . . . 100.0 111.436 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -65.17 -42.33 93.79 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.224 1.41 . . . . 100.0 109.738 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.16 -41.59 99.29 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.13 1.372 . . . . 100.0 109.369 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.15 -48.11 83.12 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.137 1.775 . . . . 100.0 109.769 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.87 -43.52 96.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 122.568 0.347 . . . . 100.0 111.491 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -40.13 95.22 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.211 0.604 . . . . 100.0 112.099 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.477 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 35.1 ttp180 -62.15 -44.13 97.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.543 1.137 . . . . 100.0 109.482 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.84 -42.9 97.49 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.331 0.514 . . . . 100.0 112.081 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.4 -48.41 75.53 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.508 1.67 . . . . 100.0 115.508 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.1 p -121.55 -21.62 6.16 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.06 -7.56 69.74 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 110.586 -1.006 . . . . 100.0 110.586 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 149.95 39.59 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.351 1.06 . . . . 100.0 109.666 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 98.3 m-85 -111.91 125.69 54.32 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.546 -2.761 . . . . 100.0 103.546 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.06 114.17 28.07 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 118.925 -1.11 . . . . 100.0 110.575 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.66 -43.29 63.36 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.659 -1.155 . . . . 100.0 113.047 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.02 135.45 44.91 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.514 1.525 . . . . 100.0 111.397 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -103.1 119.12 38.27 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.007 -1.479 . . . . 100.0 107.007 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.3 123.69 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 102.92 -2.993 . . . . 100.0 102.92 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 139.0 58.72 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.596 0.712 . . . . 100.0 112.198 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.0 m -97.07 125.06 41.26 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.326 -2.472 . . . . 100.0 104.326 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -106.09 130.11 54.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.464 -1.68 . . . . 100.0 106.464 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.8 -127.1 33.16 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 109.547 -1.421 . . . . 100.0 109.547 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -128.09 139.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 121.22 0.533 . . . . 100.0 109.89 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -115.53 123.16 47.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 103.58 -2.748 . . . . 100.0 103.58 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.65 120.4 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 106.894 -1.521 . . . . 100.0 106.894 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -124.6 121.72 25.79 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.273 -0.876 . . . . 100.0 111.007 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -78.71 130.43 9.7 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 123.598 2.866 . . . . 100.0 111.03 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.58 128.52 48.05 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.873 -1.529 . . . . 100.0 106.873 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.04 128.56 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.583 -1.636 . . . . 100.0 106.583 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.14 131.45 56.41 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -99.33 122.54 42.61 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.228 -1.767 . . . . 100.0 106.228 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.8 p -122.42 -179.99 4.38 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.633 -0.712 . . . . 100.0 111.459 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -59.07 -37.36 76.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.913 1.685 . . . . 100.0 109.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -87.67 2.93 49.72 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.065 0.765 . . . . 100.0 113.065 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.27 -179.9 19.14 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 121.557 -0.715 . . . . 100.0 111.399 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.3 140.87 54.57 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.263 2.642 . . . . 100.0 113.794 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.9 mt -130.35 138.58 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 103.565 -2.754 . . . . 100.0 103.565 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' HZ2' ' HA3' ' A' ' 5' ' ' GLY . 40.0 ttmt -116.27 128.66 55.77 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 118.972 -1.091 . . . . 100.0 108.692 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.64 118.06 35.81 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.077 -2.194 . . . . 100.0 105.077 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -91.94 106.46 18.48 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 101.889 -3.374 . . . . 100.0 101.889 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.84 124.95 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 107.966 -1.124 . . . . 100.0 107.966 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.435 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 19.2 m0 -103.56 106.8 17.41 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.304 -1.739 . . . . 100.0 106.304 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -86.04 116.29 24.17 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 104.136 -2.542 . . . . 100.0 104.136 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.6 ' HG1' HH22 ' A' ' 76' ' ' ARG . 56.3 p -98.44 163.11 12.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.46 0.911 . . . . 100.0 113.46 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.66 130.95 34.98 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.312 -0.995 . . . . 100.0 108.312 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.5 -11.0 80.94 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 116.624 -0.262 . . . . 100.0 112.56 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -67.6 -39.74 84.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.796 2.039 . . . . 100.0 111.809 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -61.32 141.73 57.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.275 1.43 . . . . 100.0 114.616 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.01 150.73 46.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.213 1.405 . . . . 100.0 110.982 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -72.95 132.22 43.17 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.236 -1.394 . . . . 100.0 107.236 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.3 -167.25 33.91 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 119.077 -1.535 . . . . 100.0 115.007 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.69 -22.0 63.57 Favored Glycine 0 C--N 1.355 1.585 0 C-N-CA 127.541 2.496 . . . . 100.0 114.49 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.78 -38.41 87.96 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.236 1.814 . . . . 100.0 109.293 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.6 HH22 ' HG1' ' A' ' 66' ' ' THR . 20.9 mmm180 -82.77 -2.21 53.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.301 2.64 . . . . 100.0 113.959 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.29 -42.93 96.51 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -37.87 91.55 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 123.907 0.765 . . . . 100.0 113.489 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -62.18 -43.52 98.65 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.236 1.814 . . . . 100.0 108.983 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.61 ' HH ' ' HB3' ' A' ' 86' ' ' ALA . 8.2 t80 -90.89 -13.94 32.68 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 114.296 1.221 . . . . 100.0 114.296 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.8 mt -60.69 134.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 CA-C-N 119.333 0.969 . . . . 100.0 109.876 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.29 24.55 14.32 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.498 1.919 . . . . 100.0 114.196 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.24 138.94 45.86 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 108.218 -1.03 . . . . 100.0 108.218 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.02 -34.61 13.64 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.138 -0.937 . . . . 100.0 108.676 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.5 ' HB2' ' CD2' ' A' ' 13' ' ' LEU . 64.7 m -153.94 164.04 39.07 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 123.026 0.53 . . . . 100.0 110.978 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.61 ' HB3' ' HH ' ' A' ' 80' ' ' TYR . . . -139.98 153.32 46.84 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 113.838 1.051 . . . . 100.0 113.838 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.25 123.92 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 103.293 -2.854 . . . . 100.0 103.293 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.2 mt -110.21 122.38 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 102.579 -3.119 . . . . 100.0 102.579 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.477 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 58.5 mtp -112.23 132.99 54.62 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 113.574 0.953 . . . . 100.0 113.574 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.38 159.22 37.66 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 113.631 -1.622 . . . . 100.0 108.742 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -101.72 124.97 48.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.15 -2.167 . . . . 100.0 105.15 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.75 -21.87 29.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 113.683 0.994 . . . . 100.0 113.683 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.1 p -89.98 -4.58 57.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 118.888 -0.577 . . . . 100.0 111.591 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.16 115.78 24.33 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 122.464 1.126 . . . . 100.0 111.569 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.85 -38.44 86.38 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 114.362 -1.29 . . . . 100.0 110.554 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.76 -43.04 96.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 C-N-CA 125.394 1.478 . . . . 100.0 109.892 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 92.2 m -63.16 -42.38 99.41 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.086 -0.709 . . . . 100.0 109.086 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.568 ' HH ' HG21 ' A' ' 136' ' ' ILE . 81.4 t80 -63.45 -40.23 96.58 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.29 0.636 . . . . 100.0 110.207 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.492 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -60.69 -37.41 81.55 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.314 1.046 . . . . 100.0 111.762 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.32 -12.03 60.7 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 114.502 1.297 . . . . 100.0 114.502 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.07 -43.4 94.01 Favored Pre-proline 0 C--N 1.364 1.203 0 CA-C-O 116.252 -1.832 . . . . 100.0 111.509 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 87.1 Cg_exo -58.65 -34.63 99.03 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.347 2.031 . . . . 100.0 112.645 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.38 -43.63 85.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.951 0.782 . . . . 100.0 110.106 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -62.98 -46.6 86.95 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -91.01 63.86 5.25 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.947 1.356 . . . . 100.0 109.524 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.0 ttm105 -157.93 -57.81 0.08 Allowed 'General case' 0 CA--C 1.485 -1.533 1 N-CA-C 100.155 -4.017 . . . . 100.0 100.155 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.66 -41.17 98.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.395 -0.965 . . . . 100.0 108.395 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.532 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 6.5 mp -62.04 -46.24 90.04 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.936 0.895 . . . . 100.0 111.492 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.55 -38.95 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 126.267 1.827 . . . . 100.0 109.543 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -59.7 -46.2 89.8 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.817 -0.438 . . . . 100.0 109.817 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.91 -49.25 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 115.494 1.665 . . . . 100.0 115.494 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.8 m -113.45 9.13 18.05 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 120.788 3.625 . . . . 100.0 120.788 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 55.45 -124.79 2.09 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.473 1.109 . . . . 100.0 112.561 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -102.74 115.74 31.19 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 120.276 1.398 . . . . 100.0 109.667 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 41.7 pt -141.68 152.6 63.37 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 103.76 -2.681 . . . . 100.0 103.76 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.06 127.6 22.73 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.155 1.904 . . . . 100.0 112.412 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' HB ' HD21 ' A' ' 144' ' ' LEU . 67.2 mt -131.26 135.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 107.209 -1.404 . . . . 100.0 107.209 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.13 131.57 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.672 -1.233 . . . . 100.0 107.672 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 86.5 mt -98.87 125.6 44.31 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.491 -2.411 . . . . 100.0 104.491 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.477 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.5 m -115.84 123.36 47.97 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.334 -0.848 . . . . 100.0 109.468 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.61 101.49 2.63 Favored Glycine 0 CA--C 1.485 -1.806 1 N-CA-C 102.8 -4.12 . . . . 100.0 102.8 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -86.73 165.72 15.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.985 0.898 . . . . 100.0 110.61 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 60.48 41.72 15.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 128.515 2.726 . . . . 100.0 113.521 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.5 m -67.52 -15.54 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 CA-C-N 115.866 -0.606 . . . . 100.0 111.937 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 38.1 t70 -61.74 -39.42 91.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.034 2.134 . . . . 100.0 110.355 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.01 130.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 124.12 0.968 . . . . 100.0 108.498 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.46 -39.24 88.72 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 117.022 2.23 . . . . 100.0 117.022 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -83.04 76.78 9.82 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.892 0.853 . . . . 100.0 109.049 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -88.5 129.27 35.49 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.533 -1.284 . . . . 100.0 107.533 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.51 -41.25 7.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 115.407 -0.815 . . . . 100.0 111.216 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.69 108.26 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 103.803 -2.666 . . . . 100.0 103.803 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.47 151.31 23.62 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.777 -1.101 . . . . 100.0 110.665 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.45 96.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.165 0.986 . . . . 100.0 112.245 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.94 -41.16 99.41 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.331 1.053 . . . . 100.0 110.801 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.4 m -63.03 -38.13 89.96 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.999 1.72 . . . . 100.0 114.072 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.585 HG23 ' HD1' ' A' ' 139' ' ' HIS . 91.1 mt -63.46 123.54 16.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 122.128 0.966 . . . . 100.0 109.204 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.25 -9.0 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.567 1.547 . . . . 100.0 111.464 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -59.17 -45.05 92.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.061 1.344 . . . . 100.0 111.935 -176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.585 ' HD1' HG23 ' A' ' 136' ' ' ILE . 52.5 p-80 -62.51 -41.02 98.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.799 0.666 . . . . 100.0 112.799 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.64 -45.86 90.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.168 1.387 . . . . 100.0 110.377 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.98 -42.62 89.6 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.498 0.719 . . . . 100.0 112.759 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -90.84 1.92 56.56 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 115.715 1.746 . . . . 100.0 115.715 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 55.92 47.17 20.6 Favored 'General case' 0 C--N 1.361 1.092 0 CA-C-O 122.922 1.344 . . . . 100.0 113.025 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 117' ' ' ILE . 40.6 mt -112.59 160.07 18.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.323 -1.362 . . . . 100.0 107.323 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -96.6 140.6 30.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.14 -1.059 . . . . 100.0 108.14 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -117.24 131.41 56.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.176 0.513 . . . . 100.0 111.469 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . 0.255 81.4 m-85 -128.75 138.3 52.03 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 114.979 -1.01 . . . . 100.0 111.616 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.39 121.34 31.54 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 101.973 -3.343 . . . . 100.0 101.973 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.17 152.97 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 CA-C-O 122.537 1.161 . . . . 100.0 111.535 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.421 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 37.1 t -134.8 117.09 15.57 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.116 -2.55 . . . . 100.0 104.116 175.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -63.43 -45.94 88.63 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.703 0.627 . . . . 100.0 109.617 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.64 -41.16 79.8 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 115.426 1.639 . . . . 100.0 115.426 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -90.92 -4.63 56.37 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 115.275 1.584 . . . . 100.0 115.275 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.477 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 65.7 m-80 63.7 22.74 13.23 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.018 1.327 . . . . 100.0 112.484 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -76.0 123.6 26.01 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.239 -1.763 . . . . 100.0 106.239 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 53.27 40.54 31.44 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.141 2.176 . . . . 100.0 111.76 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.59 -49.31 76.81 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 126.227 1.811 . . . . 100.0 114.487 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -94.68 -6.82 42.42 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 115.424 1.639 . . . . 100.0 115.424 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.284 96.1 mttt -59.72 -45.3 98.48 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 118.857 2.91 . . . . 100.0 118.857 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -60.16 -41.67 49.54 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 122.782 2.029 . . . . 100.0 112.756 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -63.82 -45.04 91.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 124.235 0.959 . . . . 100.0 111.229 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.91 -42.9 97.3 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 118.699 -0.667 . . . . 100.0 112.793 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.19 -44.4 95.47 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 123.736 0.648 . . . . 100.0 109.955 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.402 HD21 ' SG ' ' A' ' 85' ' ' CYS . 87.7 mt -61.4 -44.14 97.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.498 0.719 . . . . 100.0 110.693 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.36 99.01 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 124.061 0.944 . . . . 100.0 111.369 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -61.9 -45.3 94.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.216 1.007 . . . . 100.0 110.998 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.1 -44.66 83.72 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 113.598 0.962 . . . . 100.0 113.598 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.402 HD11 ' CD1' ' A' ' 11' ' ' PHE . 74.0 mt -63.48 -47.31 82.28 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 123.412 0.685 . . . . 100.0 112.061 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 91.8 mt -70.09 -39.15 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 124.191 0.996 . . . . 100.0 111.217 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.97 10.96 58.21 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-O 118.562 -1.132 . . . . 100.0 111.874 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -108.47 109.46 61.52 Favored Pre-proline 0 C--N 1.362 1.111 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.14 -22.89 53.61 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.718 2.946 . . . . 100.0 113.933 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -92.03 3.91 54.23 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.118 1.367 . . . . 100.0 113.521 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.39 130.75 47.63 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-N 118.411 0.55 . . . . 100.0 110.175 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -136.4 153.16 51.18 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.323 0.582 . . . . 100.0 111.169 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -75.78 134.67 40.37 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 125.734 1.614 . . . . 100.0 109.114 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.44 156.66 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 106.083 -1.821 . . . . 100.0 106.083 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.22 -85.51 0.01 OUTLIER 'General case' 0 C--N 1.356 0.891 0 N-CA-C 116.656 2.095 . . . . 100.0 116.656 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 54.5 tpp -157.71 100.59 1.83 Allowed Pre-proline 0 C--N 1.361 1.087 0 CA-C-N 119.471 1.032 . . . . 100.0 113.614 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.55 152.61 54.29 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 123.047 2.498 . . . . 100.0 107.382 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.23 115.24 22.34 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.344 -2.095 . . . . 100.0 105.344 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.4 154.52 17.42 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.786 -1.097 . . . . 100.0 108.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -80.12 125.96 80.46 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.429 -1.322 . . . . 100.0 107.429 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.85 145.06 90.07 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 123.558 2.838 . . . . 100.0 113.261 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.96 166.27 30.08 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.532 2.821 . . . . 100.0 111.849 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -60.93 -43.86 98.05 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.446 1.098 . . . . 100.0 112.182 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.8 t 57.46 70.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.27 0 C-N-CA 126.484 1.913 . . . . 100.0 110.102 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.9 m -82.99 164.4 2.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 115.003 1.482 . . . . 100.0 115.003 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.305 61.5 mtm 51.42 -124.49 2.25 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 127.873 2.469 . . . . 100.0 116.816 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 57.27 42.97 0.96 Allowed Pre-proline 0 C--N 1.369 1.421 0 N-CA-C 118.371 2.73 . . . . 100.0 118.371 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.51 -48.9 8.36 Favored 'Trans proline' 0 C--N 1.382 2.293 0 CA-C-N 122.5 1.928 . . . . 100.0 112.926 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.92 72.55 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 124.192 0.997 . . . . 100.0 110.671 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.79 -37.7 88.34 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 116.154 1.909 . . . . 100.0 116.154 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.24 165.21 24.12 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 113.075 0.769 . . . . 100.0 113.075 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 74.28 -44.38 0.56 Allowed 'General case' 0 C--N 1.368 1.41 0 C-N-CA 127.462 2.305 . . . . 100.0 115.024 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.87 -36.13 76.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.386 1.874 . . . . 100.0 111.666 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -60.05 -39.98 87.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.183 0.993 . . . . 100.0 110.921 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -62.37 -43.13 99.55 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.038 0.935 . . . . 100.0 110.338 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -63.13 -41.24 99.28 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.54 1.136 . . . . 100.0 110.203 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -62.88 -40.93 99.03 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.97 1.308 . . . . 100.0 109.929 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.2 mt -62.9 -40.51 97.78 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.846 0.858 . . . . 100.0 110.316 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.37 -42.17 99.2 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.016 0.927 . . . . 100.0 110.871 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.71 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 C-N-CA 124.204 1.001 . . . . 100.0 108.418 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.13 98.82 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 124.419 1.088 . . . . 100.0 110.958 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.89 -42.7 99.39 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.943 1.297 . . . . 100.0 110.433 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.6 m -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.682 1.193 . . . . 100.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.4 m -62.35 135.14 57.32 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.205 1.002 . . . . 100.0 112.551 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -71.78 144.38 49.21 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.107 0.963 . . . . 100.0 110.048 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.88 125.64 39.58 Favored Pre-proline 0 N--CA 1.434 -1.27 0 N-CA-C 108.138 -1.06 . . . . 100.0 108.138 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.44 166.37 29.55 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.502 2.801 . . . . 100.0 110.113 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -77.11 109.78 11.24 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 106.807 -1.553 . . . . 100.0 106.807 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -126.09 -60.25 1.29 Allowed 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.042 -1.435 . . . . 100.0 107.282 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.481 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 53.9 p30 -111.53 13.13 21.37 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 114.711 1.374 . . . . 100.0 114.711 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -61.53 -37.59 84.3 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 124.024 0.93 . . . . 100.0 113.454 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.92 -41.75 96.76 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 113.31 0.855 . . . . 100.0 113.31 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 C--O 1.258 1.508 0 CA-C-O 117.192 -1.385 . . . . 100.0 108.853 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 8.1 ttp . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 108.976 -0.75 . . . . 100.0 108.976 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.46 96.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.215 1.406 . . . . 100.0 112.062 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.61 96.57 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 123.896 0.879 . . . . 100.0 110.651 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.48 -37.48 86.96 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 123.706 0.802 . . . . 100.0 111.738 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.643 ' HA3' ' HZ3' ' A' ' 60' ' ' LYS . . . 95.41 21.75 23.73 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 106.698 -2.561 . . . . 100.0 106.698 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 1' ' ' MET 0.293 34.3 tt0 -87.59 100.24 1.63 Allowed Pre-proline 0 N--CA 1.422 -1.829 0 N-CA-C 102.049 -3.315 . . . . 100.0 102.049 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.27 -47.07 8.56 Favored 'Trans proline' 0 C--N 1.377 2.067 0 N-CA-C 106.072 -2.319 . . . . 100.0 106.072 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -128.92 -63.56 0.96 Allowed 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 100.478 -3.897 . . . . 100.0 100.478 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.45 145.03 36.22 Favored 'Isoleucine or valine' 0 C--N 1.373 1.599 0 CA-C-O 121.871 0.843 . . . . 100.0 110.504 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 50.2 tt0 -124.46 132.42 53.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.968 -2.234 . . . . 100.0 104.968 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -118.05 135.27 54.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.995 -1.113 . . . . 100.0 107.995 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -91.31 112.59 24.56 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.302 -1.74 . . . . 100.0 106.302 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.4 tp -108.01 124.43 50.15 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.11 -1.859 . . . . 100.0 107.829 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 t -108.94 123.68 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.225 -1.769 . . . . 100.0 106.225 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.98 117.97 35.41 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.696 -1.594 . . . . 100.0 106.696 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -127.21 162.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 C-N-CA 125.11 1.364 . . . . 100.0 110.896 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.46 171.77 19.71 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 108.404 -1.878 . . . . 100.0 108.404 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -73.46 162.65 29.05 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.762 0.653 . . . . 100.0 112.762 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 140.52 36.18 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 110.079 -1.208 . . . . 100.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.12 1.63 90.54 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.667 0.651 . . . . 100.0 113.728 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.578 HG23 HD22 ' A' ' 122' ' ' ASN . 56.2 m -63.92 -41.57 97.63 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 117.817 0.809 . . . . 100.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.6 17.75 5.94 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.211 -0.995 . . . . 100.0 112.06 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.29 -46.62 89.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.122 1.369 . . . . 100.0 110.125 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.0 m -63.92 -43.39 96.07 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.395 1.478 . . . . 100.0 109.5 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -63.61 -41.07 98.34 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.265 1.026 . . . . 100.0 110.044 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.13 -48.34 82.12 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.306 1.442 . . . . 100.0 109.727 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.74 -43.76 96.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 C-N-CA 123.08 0.552 . . . . 100.0 111.217 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.09 -39.25 94.14 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 112.477 0.547 . . . . 100.0 112.477 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.439 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 39.9 ttp180 -61.49 -44.61 96.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 124.321 1.048 . . . . 100.0 108.99 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -63.56 -44.34 94.41 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 112.405 0.52 . . . . 100.0 112.405 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.96 -48.6 73.48 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 116.371 1.989 . . . . 100.0 116.371 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -119.23 -24.0 6.57 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.07 2.248 . . . . 100.0 117.07 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.92 73.4 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 110.434 -1.066 . . . . 100.0 110.434 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.43 151.71 38.07 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-N 118.017 0.908 . . . . 100.0 109.766 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.527 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 99.0 m-85 -110.61 127.2 55.14 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.111 -2.552 . . . . 100.0 104.111 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -104.55 116.92 32.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.798 -0.816 . . . . 100.0 108.798 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.0 -34.33 13.08 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 116.181 -0.463 . . . . 100.0 110.785 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -86.04 126.29 34.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.105 -1.072 . . . . 100.0 108.105 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -98.38 124.25 42.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.312 -1.355 . . . . 100.0 109.377 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.42 130.0 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 101.829 -3.397 . . . . 100.0 101.829 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.35 139.66 58.14 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.692 0.758 . . . . 100.0 112.861 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.2 m -93.58 123.46 36.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.075 -2.935 . . . . 100.0 103.075 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.17 125.98 50.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 105.959 -1.867 . . . . 100.0 105.959 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.26 -125.45 34.09 Favored Glycine 0 C--N 1.355 1.605 0 N-CA-C 109.147 -1.581 . . . . 100.0 109.147 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.82 139.1 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.559 0.695 . . . . 100.0 110.601 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -110.5 123.93 50.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.215 -2.883 . . . . 100.0 103.215 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.86 116.66 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 106.217 -1.772 . . . . 100.0 106.217 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.47 118.91 21.59 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 120.435 -0.506 . . . . 100.0 111.279 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -78.7 127.97 8.29 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.887 2.392 . . . . 100.0 109.658 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.24 126.84 45.81 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 106.248 -1.76 . . . . 100.0 106.248 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 128.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 100.0 105.875 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -118.66 131.74 56.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.649 -1.982 . . . . 100.0 105.649 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -97.28 123.98 41.25 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.0 p -124.19 179.71 4.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.815 -0.629 . . . . 100.0 110.85 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -58.79 -37.62 76.74 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.933 1.693 . . . . 100.0 110.208 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.45 -0.46 54.98 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 113.029 0.752 . . . . 100.0 113.029 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.53 -179.57 18.12 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 110.842 -0.903 . . . . 100.0 110.842 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.01 138.23 43.39 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.415 2.744 . . . . 100.0 113.437 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.98 140.41 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 103.258 -2.868 . . . . 100.0 103.258 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.643 ' HZ3' ' HA3' ' A' ' 5' ' ' GLY . 37.8 ttmt -115.5 127.97 55.67 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 118.649 -1.22 . . . . 100.0 109.35 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -104.77 118.65 37.09 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.56 -2.755 . . . . 100.0 103.56 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -92.48 109.42 20.82 Favored 'General case' 0 N--CA 1.427 -1.58 1 N-CA-C 98.798 -4.519 . . . . 100.0 98.798 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.9 t -95.04 126.52 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.947 -1.501 . . . . 100.0 106.947 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -107.76 102.04 11.29 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.23 117.98 26.34 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 103.441 -2.8 . . . . 100.0 103.441 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.9 p -100.06 160.38 14.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 112.943 0.719 . . . . 100.0 112.943 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.0 36.97 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.085 -0.709 . . . . 100.0 109.085 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.36 -12.39 75.97 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 112.109 -0.396 . . . . 100.0 112.109 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.68 -39.46 84.47 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.625 1.57 . . . . 100.0 111.699 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.43 139.71 58.57 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.544 1.138 . . . . 100.0 113.385 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -67.15 147.91 52.5 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.48 1.912 . . . . 100.0 111.151 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -70.38 132.26 45.36 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.236 -1.764 . . . . 100.0 106.236 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.57 -166.87 33.96 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 119.118 -1.515 . . . . 100.0 115.534 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.36 -22.7 63.66 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 127.599 2.523 . . . . 100.0 114.337 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.0 -38.43 88.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.704 2.002 . . . . 100.0 110.021 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -82.99 -1.0 51.42 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 127.509 2.323 . . . . 100.0 113.895 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -42.85 93.61 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.476 2.399 . . . . 100.0 117.476 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -38.53 93.01 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 118.672 0.669 . . . . 100.0 113.345 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -62.36 -43.43 98.84 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 125.9 1.68 . . . . 100.0 109.592 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.566 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 6.3 t80 -89.84 -14.26 34.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 114.173 1.175 . . . . 100.0 114.173 -175.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -61.24 134.92 26.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 119.369 0.986 . . . . 100.0 109.358 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 66.1 20.25 11.18 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 127.363 2.265 . . . . 100.0 113.296 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.09 139.1 52.5 Favored 'General case' 0 C--N 1.365 1.278 0 O-C-N 121.199 -0.938 . . . . 100.0 108.669 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -99.54 -31.7 11.48 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.514 -0.767 . . . . 100.0 109.008 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.2 p -148.75 160.35 43.28 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 120.733 0.301 . . . . 100.0 111.431 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -143.36 150.81 39.66 Favored 'General case' 0 CA--C 1.487 -1.479 0 C-N-CA 119.371 -0.931 . . . . 100.0 113.021 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.0 mt -125.74 126.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 103.592 -2.744 . . . . 100.0 103.592 176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.81 122.28 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.423 -3.177 . . . . 100.0 102.423 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.483 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 38.5 mtt -111.89 134.29 53.54 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 114.459 1.281 . . . . 100.0 114.459 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -130.14 157.17 43.16 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 112.546 -2.115 . . . . 100.0 109.229 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -102.18 125.53 48.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.08 -21.66 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.7 p -88.89 -5.84 57.73 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.996 -0.526 . . . . 100.0 111.62 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.1 t -119.79 116.79 26.61 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 122.859 1.314 . . . . 100.0 111.841 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.11 -39.71 86.73 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.887 -1.506 . . . . 100.0 110.804 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.79 -43.33 97.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 C-N-CA 125.24 1.416 . . . . 100.0 109.456 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.176 0.59 . . . . 100.0 109.914 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.44 -40.42 95.7 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.911 0.485 . . . . 100.0 110.723 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.2 mttt -60.77 -37.23 81.16 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.118 0.967 . . . . 100.0 111.445 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -73.43 -11.49 60.48 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 114.995 1.48 . . . . 100.0 114.995 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.35 -43.11 92.32 Favored Pre-proline 0 C--N 1.363 1.16 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.48 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 90.9 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.726 2.284 . . . . 100.0 112.702 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.55 -43.03 86.21 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.488 1.115 . . . . 100.0 109.901 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -63.16 -46.21 88.25 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -90.74 65.0 5.77 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 123.054 1.407 . . . . 100.0 107.883 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -159.69 -57.0 0.06 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 100.567 -3.864 . . . . 100.0 100.567 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.02 -43.72 98.24 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.107 1.363 . . . . 100.0 108.254 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -62.5 -46.34 88.88 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.267 1.027 . . . . 100.0 112.145 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.53 -39.84 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 126.498 1.919 . . . . 100.0 109.309 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -59.68 -45.19 92.83 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.113 0.565 . . . . 100.0 110.75 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.99 -50.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 72.3 m -115.03 9.4 15.99 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.989 3.329 . . . . 100.0 119.989 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.257 80.9 mm-40 53.82 -123.16 2.1 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.45 1.5 . . . . 100.0 113.943 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -98.13 112.97 24.74 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.631 1.105 . . . . 100.0 112.416 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.3 pt -143.35 151.75 55.56 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 104.161 -2.533 . . . . 100.0 104.161 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.52 127.97 22.27 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 121.982 1.788 . . . . 100.0 112.503 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.405 ' HB ' HD21 ' A' ' 144' ' ' LEU . 59.7 mt -130.56 136.0 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 107.271 -1.381 . . . . 100.0 107.271 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.84 131.39 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.175 -1.375 . . . . 100.0 107.922 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.9 mt -99.43 125.12 45.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 104.329 -2.471 . . . . 100.0 104.329 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.483 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.8 m -116.49 122.19 44.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.986 0.898 . . . . 100.0 110.328 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.53 101.84 2.69 Favored Glycine 0 CA--C 1.476 -2.394 1 N-CA-C 102.862 -4.095 . . . . 100.0 102.862 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.578 HD22 HG23 ' A' ' 21' ' ' THR 0.412 56.7 p30 -92.69 170.31 9.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 118.899 -1.12 . . . . 100.0 113.943 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 93.1 mttt 60.81 40.39 15.99 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 128.105 2.562 . . . . 100.0 112.155 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.77 -18.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.474 0.71 . . . . 100.0 112.893 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.419 ' HB2' ' HG ' ' A' ' 150' ' ' SER . 37.5 t70 -61.28 -39.14 89.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.054 1.742 . . . . 100.0 110.58 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.18 130.77 28.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 123.766 0.826 . . . . 100.0 109.109 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.35 -41.53 96.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.345 1.609 . . . . 100.0 115.345 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -84.26 81.39 8.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.482 0.658 . . . . 100.0 109.325 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -89.85 130.71 36.05 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.433 -1.321 . . . . 100.0 107.433 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.37 -44.36 7.26 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.598 -0.728 . . . . 100.0 109.821 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.95 112.16 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 105.026 -2.213 . . . . 100.0 105.026 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -86.38 150.87 24.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.787 -1.551 . . . . 100.0 110.106 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.25 94.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.171 0.989 . . . . 100.0 110.669 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.096 1.358 . . . . 100.0 110.839 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 m -62.66 -38.51 90.62 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 125.757 1.623 . . . . 100.0 112.695 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.588 HG23 ' HD1' ' A' ' 139' ' ' HIS . 76.4 mt -65.67 121.7 15.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.646 1.213 . . . . 100.0 110.358 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.58 -4.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 CA-C-N 113.627 -1.624 . . . . 100.0 111.07 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -59.77 -42.92 94.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.351 1.46 . . . . 100.0 111.339 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.588 ' HD1' HG23 ' A' ' 136' ' ' ILE . 48.1 p-80 -61.33 -42.19 98.28 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.534 0.733 . . . . 100.0 112.518 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -63.5 -45.07 92.37 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 123.937 0.895 . . . . 100.0 111.252 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.06 -41.19 95.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.512 0.725 . . . . 100.0 112.042 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.64 1.97 56.97 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 116.222 1.934 . . . . 100.0 116.222 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 55.58 49.23 16.97 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.227 1.411 . . . . 100.0 113.572 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.405 HD21 ' HB ' ' A' ' 117' ' ' ILE . 44.5 mt -118.7 159.11 24.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.676 -1.602 . . . . 100.0 106.676 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.308 78.9 mt-30 -101.63 140.23 36.2 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 118.609 -1.236 . . . . 100.0 110.578 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -109.38 131.15 55.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.987 0.736 . . . . 100.0 112.987 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.31 134.22 48.86 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.634 -1.166 . . . . 100.0 111.403 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -87.53 120.86 29.27 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 102.802 -3.036 . . . . 100.0 102.802 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 45.1 pt -130.93 154.4 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.355 1.074 . . . . 100.0 111.244 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.419 ' HG ' ' HB2' ' A' ' 125' ' ' ASP . 41.3 t -136.07 118.42 15.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.369 -2.456 . . . . 100.0 104.369 176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.439 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.81 -44.99 88.08 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 123.273 0.629 . . . . 100.0 109.435 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.11 -43.56 86.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 114.276 1.213 . . . . 100.0 114.276 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.1 m -92.25 -5.22 52.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.276 1.584 . . . . 100.0 115.276 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.444 HD22 ' HZ ' ' A' ' 35' ' ' PHE . 63.9 m-80 64.26 21.78 12.62 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 124.861 1.264 . . . . 100.0 112.167 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -75.72 125.1 28.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.189 -1.782 . . . . 100.0 106.189 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 53.31 40.39 31.24 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.064 2.146 . . . . 100.0 111.979 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -57.71 -48.6 79.1 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 126.706 2.003 . . . . 100.0 111.297 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.587 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 92.7 mt-10 -80.59 -24.75 38.93 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 118.396 2.739 . . . . 100.0 118.396 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.302 95.0 mttt -59.16 -45.31 99.34 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 121.456 3.872 . . . . 100.0 121.456 -173.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -60.04 -45.81 22.11 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 123.098 2.142 . . . . 100.0 112.74 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.587 ' CE2' ' HA ' ' A' ' 158' ' ' GLU 0.343 28.2 p90 -66.44 -40.72 89.63 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.346 1.029 . . . . 100.0 113.113 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.71 -43.23 97.18 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-O 118.403 -0.808 . . . . 100.0 112.877 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -63.89 -43.2 96.72 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 118.807 -0.616 . . . . 100.0 110.415 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.2 mt -60.78 -44.5 96.71 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.601 0.563 . . . . 100.0 110.806 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.0 99.91 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.891 0.876 . . . . 100.0 111.417 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -62.96 -45.27 93.25 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.364 0.666 . . . . 100.0 111.473 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -64.32 -47.02 81.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.798 0.839 . . . . 100.0 112.347 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.93 -46.48 81.44 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.234 0.827 . . . . 100.0 113.234 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.08 -39.17 76.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 123.694 0.798 . . . . 100.0 110.527 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.62 8.53 59.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-O 118.669 -1.073 . . . . 100.0 111.82 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -102.46 108.36 57.18 Favored Pre-proline 0 C--N 1.361 1.096 0 N-CA-C 106.655 -1.609 . . . . 100.0 106.655 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.12 -23.22 53.4 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.969 3.113 . . . . 100.0 113.569 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.6 6.72 47.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.161 1.384 . . . . 100.0 113.676 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.3 tp -63.05 128.75 37.31 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.648 0.658 . . . . 100.0 110.127 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -132.18 151.64 51.69 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.59 0.71 . . . . 100.0 110.509 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -81.15 135.02 35.73 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.273 1.429 . . . . 100.0 108.836 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -120.94 160.34 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.816 -1.179 . . . . 100.0 107.816 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.79 -91.4 0.0 OUTLIER 'General case' 0 C--N 1.357 0.898 0 N-CA-C 116.698 2.11 . . . . 100.0 116.698 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 56.8 tpp -155.8 97.58 2.3 Favored Pre-proline 0 C--N 1.36 1.057 0 CA-C-N 119.682 1.128 . . . . 100.0 113.611 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -75.02 156.43 42.89 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 123.356 2.704 . . . . 100.0 108.514 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.3 127.2 32.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.084 -1.821 . . . . 100.0 106.084 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.8 mt -112.17 134.96 53.41 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.798 -0.637 . . . . 100.0 110.4 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.58 127.55 67.55 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 103.429 -2.804 . . . . 100.0 103.429 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.66 141.18 90.08 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.175 2.583 . . . . 100.0 114.208 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.83 167.39 27.39 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.839 3.026 . . . . 100.0 112.514 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.72 -42.21 96.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.68 1.592 . . . . 100.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.2 t 68.08 101.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.022 0 C-N-CA 127.374 2.27 . . . . 100.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.1 m -129.25 166.99 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 113.956 -1.474 . . . . 100.0 108.809 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 82.7 mtp 53.21 -131.89 2.03 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 126.917 2.087 . . . . 100.0 115.4 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 51.11 46.8 3.98 Favored Pre-proline 0 C--N 1.373 1.607 0 C-N-CA 128.736 2.814 . . . . 100.0 118.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -63.65 -69.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 121.676 1.584 . . . . 100.0 113.219 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.03 -45.69 80.55 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 124.052 0.845 . . . . 100.0 113.009 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.356 89.3 mt -65.67 -41.27 92.68 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 120.921 3.674 . . . . 100.0 120.921 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.77 164.93 25.39 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 115.03 1.493 . . . . 100.0 115.03 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 71.92 -45.88 0.63 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 118.249 2.685 . . . . 100.0 118.249 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -58.21 -48.2 81.09 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 116.878 2.177 . . . . 100.0 116.878 -175.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -64.7 -45.15 87.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 114.647 1.351 . . . . 100.0 114.647 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -64.11 -40.08 95.44 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 123.636 0.774 . . . . 100.0 110.642 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -62.52 -42.3 99.42 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.595 1.158 . . . . 100.0 110.455 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -62.32 -43.87 97.82 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 123.911 0.884 . . . . 100.0 110.578 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.15 -43.83 97.97 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.384 0.674 . . . . 100.0 110.681 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.49 -44.58 96.02 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.552 1.141 . . . . 100.0 111.993 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.1 -42.55 97.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 C-N-CA 123.774 0.83 . . . . 100.0 109.295 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.89 97.88 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.642 0.777 . . . . 100.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -63.76 -40.76 97.49 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.357 1.063 . . . . 100.0 112.143 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -63.82 -42.96 97.55 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.732 1.213 . . . . 100.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.3 m -62.48 139.53 58.59 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 124.645 1.178 . . . . 100.0 111.688 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -67.06 131.01 44.96 Favored 'General case' 0 C--N 1.365 1.241 0 C-N-CA 123.958 0.903 . . . . 100.0 108.981 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.42 154.45 81.56 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 113.024 0.75 . . . . 100.0 113.024 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -73.26 -179.88 4.82 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 123.176 2.584 . . . . 100.0 108.71 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -62.63 120.9 12.08 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.154 0.978 . . . . 100.0 111.174 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -129.43 -57.16 1.14 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.593 -1.632 . . . . 100.0 106.593 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 54.7 p30 -110.88 5.2 20.35 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 114.5 1.296 . . . . 100.0 114.5 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.39 -35.58 79.63 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.459 1.104 . . . . 100.0 112.756 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.32 -41.88 90.11 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.619 1.567 . . . . 100.0 112.14 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.258 1.53 0 CA-C-O 117.136 -1.412 . . . . 100.0 108.605 -179.63 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 120.683 0.278 . . . . 100.0 110.546 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.75 91.78 Favored 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 124.293 1.037 . . . . 100.0 112.272 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.432 ' HB3' ' H ' ' A' ' 190' ' ' ASP . . . -59.82 -46.01 90.59 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 123.861 0.725 . . . . 100.0 111.175 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -68.43 -37.55 80.36 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.443 0.905 . . . . 100.0 113.443 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.73 20.86 12.06 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 106.23 -2.748 . . . . 100.0 106.23 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.308 27.8 tt0 -86.31 100.2 1.32 Allowed Pre-proline 0 N--CA 1.417 -2.114 0 N-CA-C 103.168 -2.901 . . . . 100.0 103.168 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -60.97 -46.09 17.38 Favored 'Trans proline' 0 C--N 1.38 2.219 0 N-CA-C 107.195 -1.886 . . . . 100.0 107.195 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.417 HE22 ' HA3' ' A' ' 57' ' ' GLY . 35.1 mt-30 -131.53 -60.3 0.94 Allowed 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 100.925 -3.732 . . . . 100.0 100.925 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.92 142.22 44.59 Favored 'Isoleucine or valine' 0 C--N 1.37 1.493 0 CA-C-O 121.458 0.647 . . . . 100.0 110.924 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 33.1 tt0 -128.36 136.22 50.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.827 -1.916 . . . . 100.0 105.827 176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -119.95 132.61 55.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.732 -1.581 . . . . 100.0 106.732 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.39 117.22 28.93 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -110.18 129.01 55.79 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.838 -1.528 . . . . 100.0 106.93 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -110.53 124.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 105.253 -2.129 . . . . 100.0 105.253 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.01 116.71 32.4 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.948 -1.871 . . . . 100.0 105.948 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.405 ' HA ' ' HZ1' ' A' ' 23' ' ' LYS . 32.9 m -125.31 162.16 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 113.696 -1.593 . . . . 100.0 110.496 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.91 168.2 15.39 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 107.476 -2.25 . . . . 100.0 107.476 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -71.82 162.45 29.43 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 113.215 0.82 . . . . 100.0 113.215 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.78 141.43 38.28 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.293 -1.123 . . . . 100.0 110.293 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.18 1.44 90.36 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.715 0.674 . . . . 100.0 113.982 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.8 m -65.02 -41.23 95.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.758 0.823 . . . . 100.0 111.648 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.43 15.77 6.86 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 120.57 -0.824 . . . . 100.0 112.087 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' HZ1' ' HA ' ' A' ' 16' ' ' VAL . 20.1 ptmt -61.5 -44.32 97.29 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.77 1.228 . . . . 100.0 111.713 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.5 m -64.96 -42.31 94.7 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.906 1.282 . . . . 100.0 109.659 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.7 m -63.47 -41.01 98.61 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.272 1.029 . . . . 100.0 109.353 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -60.25 -47.5 85.73 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.072 1.349 . . . . 100.0 110.013 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.08 -43.6 97.53 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 C-N-CA 123.591 0.756 . . . . 100.0 111.831 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.605 1.162 . . . . 100.0 109.734 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.461 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 36.8 ttp180 -61.72 -45.15 95.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 125.43 1.492 . . . . 100.0 110.462 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -63.9 -43.72 95.14 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.59 0.589 . . . . 100.0 112.59 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -65.05 -47.58 76.83 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 115.23 1.567 . . . . 100.0 115.23 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.0 p -120.01 -23.57 6.32 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 119.104 3.002 . . . . 100.0 119.104 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.91 -4.33 71.57 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 110.733 -0.947 . . . . 100.0 110.733 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -76.94 147.15 37.11 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 126.422 1.889 . . . . 100.0 108.563 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.447 ' HZ ' HD22 ' A' ' 154' ' ' ASN . 93.0 m-85 -114.29 126.32 54.9 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 105.391 -2.077 . . . . 100.0 105.391 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -105.49 113.93 27.79 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 120.071 -0.651 . . . . 100.0 111.907 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -72.96 -42.26 63.55 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.0 1.32 . . . . 100.0 112.511 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -84.75 130.91 34.62 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 125.904 1.682 . . . . 100.0 111.419 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -99.73 120.67 40.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 122.407 1.099 . . . . 100.0 110.77 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 1 N-CA-C 99.994 -4.076 . . . . 100.0 99.994 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.21 58.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 113.871 1.063 . . . . 100.0 113.871 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 m -91.45 126.18 36.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 103.708 -2.701 . . . . 100.0 103.708 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.74 128.79 53.91 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.77 -125.38 30.56 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.378 -1.489 . . . . 100.0 109.378 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.8 t -126.79 139.51 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 123.56 0.744 . . . . 100.0 109.987 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -113.87 124.57 52.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.276 -2.861 . . . . 100.0 103.276 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.56 113.35 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.899 -1.148 . . . . 100.0 107.899 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -125.97 120.77 24.09 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 113.018 0.747 . . . . 100.0 113.018 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.88 135.0 12.28 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 122.475 2.117 . . . . 100.0 111.148 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.58 132.67 53.94 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 105.414 -2.069 . . . . 100.0 105.414 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.457 HG21 ' HE3' ' A' ' 60' ' ' LYS . 19.6 t -109.44 126.58 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.554 -2.017 . . . . 100.0 105.554 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.31 129.45 54.01 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.269 -1.752 . . . . 100.0 106.269 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -98.83 122.9 42.66 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 105.749 -1.945 . . . . 100.0 105.749 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.9 p -122.67 -178.3 3.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.426 -0.806 . . . . 100.0 110.787 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -59.41 -37.34 77.79 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.7 1.6 . . . . 100.0 108.6 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.33 -3.41 52.56 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.206 1.802 . . . . 100.0 112.458 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' HA3' HE22 ' A' ' 8' ' ' GLN . . . 109.81 -177.02 19.7 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 110.829 -0.908 . . . . 100.0 110.829 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.33 137.16 50.22 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.972 3.115 . . . . 100.0 113.418 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.46 142.97 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.317 -2.105 . . . . 100.0 105.317 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HE3' HG21 ' A' ' 51' ' ' VAL 0.284 44.8 mttp -115.1 132.34 56.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 118.046 -1.462 . . . . 100.0 110.588 175.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.48 116.83 33.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.087 -2.931 . . . . 100.0 103.087 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -92.5 100.46 13.0 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 101.089 -3.671 . . . . 100.0 101.089 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.45 124.74 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.704 -0.68 . . . . 100.0 109.276 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -106.72 106.36 16.85 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 104.954 -2.239 . . . . 100.0 104.954 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.51 117.11 24.22 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 102.934 -2.987 . . . . 100.0 102.934 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.6 p -100.14 162.64 12.84 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 113.14 0.792 . . . . 100.0 113.14 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.97 128.74 34.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.682 -0.859 . . . . 100.0 108.682 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.14 -12.19 82.7 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 116.02 -0.536 . . . . 100.0 113.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -67.77 -39.16 84.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.399 1.48 . . . . 100.0 112.069 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.34 137.66 58.3 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.778 1.231 . . . . 100.0 112.45 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.76 153.9 41.68 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.869 -1.06 . . . . 100.0 112.427 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -68.08 131.99 46.43 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.818 1.647 . . . . 100.0 108.115 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.61 -171.4 34.78 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 119.237 -1.459 . . . . 100.0 115.446 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -21.04 62.85 Favored Glycine 0 C--N 1.356 1.692 0 C-N-CA 127.959 2.695 . . . . 100.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.23 -37.93 84.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.362 2.265 . . . . 100.0 109.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -87.86 6.82 33.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 126.269 1.828 . . . . 100.0 115.19 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 -42.24 90.35 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 115.487 1.662 . . . . 100.0 115.487 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.02 94.33 Favored Glycine 0 C--N 1.353 1.497 0 C-N-CA 123.804 0.716 . . . . 100.0 113.165 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -60.87 -45.56 94.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.448 1.499 . . . . 100.0 108.694 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.602 ' HH ' ' HB3' ' A' ' 86' ' ' ALA . 6.1 t80 -89.29 -11.05 44.57 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 115.076 1.51 . . . . 100.0 115.076 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.5 131.66 25.44 Favored 'Isoleucine or valine' 0 C--N 1.366 1.326 0 CA-C-N 119.924 1.238 . . . . 100.0 110.838 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.309 63.9 mt-30 57.21 36.9 28.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 128.197 2.599 . . . . 100.0 113.863 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.88 142.87 42.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 105.611 -1.996 . . . . 100.0 105.611 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -100.15 -31.31 11.47 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.076 -1.083 . . . . 100.0 108.076 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.4 p -153.89 160.86 42.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 122.783 0.433 . . . . 100.0 110.377 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.602 ' HB3' ' HH ' ' A' ' 80' ' ' TYR . . . -141.82 153.46 44.52 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 113.578 0.955 . . . . 100.0 113.578 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.5 mt -126.26 125.81 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 103.935 -2.617 . . . . 100.0 103.935 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 69.7 mt -109.95 124.48 66.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 101.23 -3.618 . . . . 100.0 101.23 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -119.05 133.26 55.92 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 118.358 -1.337 . . . . 100.0 111.322 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -128.57 158.9 37.17 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.741 -1.572 . . . . 100.0 110.017 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.65 123.98 44.43 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.883 -1.895 . . . . 100.0 105.883 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -65.03 -21.08 28.79 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 113.348 0.87 . . . . 100.0 113.348 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -90.57 -5.8 55.48 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 118.712 -0.661 . . . . 100.0 111.765 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.7 t -119.65 116.7 26.53 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.83 1.3 . . . . 100.0 111.167 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -66.27 -39.6 89.55 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.566 -1.652 . . . . 100.0 111.336 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -43.17 96.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 125.132 1.373 . . . . 100.0 109.326 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 96.9 m -62.66 -43.17 99.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 122.89 0.476 . . . . 100.0 109.905 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.57 ' HH ' HG21 ' A' ' 136' ' ' ILE . 76.5 t80 -63.89 -39.54 94.41 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 122.811 0.445 . . . . 100.0 110.524 178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 92.5 mttt -60.53 -38.33 84.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.271 1.429 . . . . 100.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.38 -12.07 60.7 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 114.569 1.322 . . . . 100.0 114.569 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.82 -43.09 94.17 Favored Pre-proline 0 C--N 1.364 1.236 0 CA-C-O 115.952 -1.975 . . . . 100.0 111.34 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 97.4 Cg_exo -57.41 -36.39 98.82 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.483 2.122 . . . . 100.0 112.517 177.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -66.35 -41.96 88.79 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.005 0.815 . . . . 100.0 111.164 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -62.6 -46.35 88.72 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 108.928 -0.768 . . . . 100.0 108.928 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.4 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 48.0 t-80 -91.62 65.9 5.21 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-O 123.0 1.381 . . . . 100.0 108.425 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -162.06 -56.6 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 101.103 -3.665 . . . . 100.0 101.103 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.23 -41.7 99.15 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.189 -1.041 . . . . 100.0 108.189 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.565 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -62.66 -46.04 90.04 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.86 0.864 . . . . 100.0 111.534 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.87 -39.23 82.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 126.378 1.871 . . . . 100.0 109.438 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -58.8 -45.6 89.52 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.34 1.056 . . . . 100.0 109.971 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.66 -50.38 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 115.512 1.671 . . . . 100.0 115.512 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.81 8.83 20.67 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 120.981 3.697 . . . . 100.0 120.981 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 53.98 -125.02 2.29 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 125.213 1.405 . . . . 100.0 113.241 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -97.88 113.98 25.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 120.289 1.404 . . . . 100.0 112.326 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.1 pt -142.73 152.74 60.18 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.03 127.15 20.47 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 122.231 1.954 . . . . 100.0 113.066 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.411 ' HB ' HD21 ' A' ' 144' ' ' LEU . 67.4 mt -131.28 134.8 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.693 1.235 . . . . 100.0 107.756 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.66 133.04 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 113.598 -1.637 . . . . 100.0 108.332 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . 0.272 88.3 mt -100.6 126.74 47.1 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 104.614 -2.365 . . . . 100.0 104.614 176.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -116.58 123.02 46.34 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.839 0.828 . . . . 100.0 109.696 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.09 102.57 2.68 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.33 -3.908 . . . . 100.0 103.33 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.412 54.0 p30 -94.45 173.36 7.66 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 114.584 1.328 . . . . 100.0 114.584 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 60.56 40.4 16.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 127.704 2.402 . . . . 100.0 111.323 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.45 -12.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 CA-C-N 115.717 -0.674 . . . . 100.0 112.417 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.82 -39.57 92.23 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.64 1.576 . . . . 100.0 109.588 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.22 130.28 29.03 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 124.232 1.013 . . . . 100.0 109.822 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.42 -40.01 89.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 115.4 1.629 . . . . 100.0 115.4 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -82.96 81.18 8.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.344 -0.984 . . . . 100.0 108.344 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -90.86 134.1 34.71 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.243 -1.762 . . . . 100.0 106.243 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -101.35 -40.85 6.91 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 110.011 -0.366 . . . . 100.0 110.011 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.15 109.89 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.948 -2.241 . . . . 100.0 104.948 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.27 145.44 29.11 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.648 -1.16 . . . . 100.0 110.833 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.21 98.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.08 0.952 . . . . 100.0 112.257 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.15 -39.87 95.92 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.07 0.548 . . . . 100.0 111.599 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.7 m -62.18 -36.57 82.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.524 1.93 . . . . 100.0 113.471 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.57 HG21 ' HH ' ' A' ' 98' ' ' TYR . 93.8 mt -63.66 123.64 16.83 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-O 122.336 1.065 . . . . 100.0 109.778 -178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 -4.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 125.583 1.553 . . . . 100.0 112.001 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -59.41 -43.43 93.03 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 125.098 1.359 . . . . 100.0 111.456 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.555 ' HD1' HG23 ' A' ' 136' ' ' ILE . 51.7 p-80 -62.18 -40.53 96.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 112.766 0.654 . . . . 100.0 112.766 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -62.97 -45.72 91.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.295 1.038 . . . . 100.0 110.547 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.56 -41.41 96.32 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.793 0.837 . . . . 100.0 111.686 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.84 4.46 53.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 117.284 2.328 . . . . 100.0 117.284 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 57.05 46.08 19.86 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 122.176 0.989 . . . . 100.0 112.403 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.411 HD21 ' HB ' ' A' ' 117' ' ' ILE . 45.2 mt -115.24 162.28 17.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 108.251 -1.018 . . . . 100.0 108.251 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -101.34 139.18 37.36 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.783 -1.192 . . . . 100.0 107.783 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -114.29 130.34 56.65 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.384 0.611 . . . . 100.0 111.542 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -128.12 134.68 49.15 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.263 -0.881 . . . . 100.0 110.629 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -89.06 121.23 31.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 102.711 -3.07 . . . . 100.0 102.711 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 48.3 pt -132.63 157.19 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 122.194 0.997 . . . . 100.0 112.144 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.7 t -139.9 119.12 12.8 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.225 -2.509 . . . . 100.0 104.225 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.426 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.87 -44.17 93.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.359 -0.837 . . . . 100.0 109.614 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -63.18 -46.31 87.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.605 1.962 . . . . 100.0 114.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -97.16 -1.06 45.87 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 115.93 1.826 . . . . 100.0 115.93 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.461 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 63.1 m-80 64.65 21.77 12.48 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 125.075 1.35 . . . . 100.0 113.296 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -72.42 123.2 22.6 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.289 -1.745 . . . . 100.0 106.289 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.1 40.58 31.44 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.507 2.323 . . . . 100.0 112.389 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.405 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 18.4 t80 -55.83 -49.92 71.97 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 126.968 2.107 . . . . 100.0 115.589 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -96.34 -2.85 44.93 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.271 96.6 mttt -59.88 -44.86 97.91 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 118.277 2.695 . . . . 100.0 118.277 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.14 -42.65 41.49 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 122.523 1.937 . . . . 100.0 112.503 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -64.24 -43.95 93.31 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.534 1.146 . . . . 100.0 112.297 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.64 -44.96 92.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 123.923 0.764 . . . . 100.0 112.869 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 88.2 t90 -64.09 -42.58 96.88 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 123.501 0.5 . . . . 100.0 110.296 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.42 -43.66 98.48 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 118.892 -0.575 . . . . 100.0 111.106 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.5 98.68 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.209 0.604 . . . . 100.0 111.478 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.414 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 89.5 mtt180 -62.44 -45.39 93.31 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.278 0.631 . . . . 100.0 111.546 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -65.02 -45.24 86.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.986 0.915 . . . . 100.0 111.714 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.89 -45.56 85.44 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 123.614 0.766 . . . . 100.0 112.947 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.47 -39.21 78.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 C-N-CA 123.545 0.738 . . . . 100.0 109.975 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.81 9.75 57.11 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-O 118.602 -1.11 . . . . 100.0 111.206 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -104.83 109.28 62.87 Favored Pre-proline 0 C--N 1.364 1.231 0 N-CA-C 107.705 -1.22 . . . . 100.0 107.705 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.51 -24.31 56.56 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 124.086 3.191 . . . . 100.0 113.994 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.36 3.62 51.59 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.609 1.964 . . . . 100.0 113.708 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.414 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 21.9 tp -62.85 130.75 46.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.451 0.537 . . . . 100.0 112.451 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -132.97 153.8 51.09 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.842 0.829 . . . . 100.0 110.595 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -80.08 132.79 36.03 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.943 -1.873 . . . . 100.0 105.943 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.4 m -118.08 158.59 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.969 -1.122 . . . . 100.0 107.969 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -42.47 -97.93 0.0 OUTLIER 'General case' 0 C--N 1.358 0.937 0 N-CA-C 118.929 2.937 . . . . 100.0 118.929 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 48.0 tpp -157.02 70.15 4.55 Favored Pre-proline 0 C--N 1.366 1.319 0 CA-C-N 120.321 1.418 . . . . 100.0 114.29 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.27 160.46 42.21 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 123.561 2.84 . . . . 100.0 109.82 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.63 144.98 56.57 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.394 0.616 . . . . 100.0 111.32 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.18 154.0 42.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 115.122 -0.944 . . . . 100.0 112.274 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.87 123.59 68.75 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 104.158 -2.534 . . . . 100.0 104.158 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -62.87 135.03 49.64 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 123.47 2.78 . . . . 100.0 113.175 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.81 157.32 43.66 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 123.28 2.654 . . . . 100.0 113.989 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.66 -38.73 92.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.868 1.667 . . . . 100.0 111.474 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.275 30.0 t 71.52 82.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 128.199 2.6 . . . . 100.0 109.836 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.24 163.57 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.945 2.098 . . . . 100.0 107.955 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 80.3 mtp 60.15 -114.02 0.63 Allowed 'General case' 0 C--N 1.355 0.847 0 N-CA-C 115.574 1.694 . . . . 100.0 115.574 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.432 ' H ' ' HB3' ' A' ' 3' ' ' ALA . 38.6 m-20 73.16 10.98 0.0 OUTLIER Pre-proline 0 C--N 1.371 1.512 1 N-CA-C 123.75 4.722 . . . . 100.0 123.75 -178.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.63 -85.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.042 0 CA-C-N 124.31 2.575 . . . . 100.0 112.855 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.25 -40.01 89.88 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.357 1.063 . . . . 100.0 112.214 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.81 -39.83 90.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 117.687 2.477 . . . . 100.0 117.687 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.92 165.92 24.02 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 119.078 0.854 . . . . 100.0 112.979 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 73.23 -42.24 0.52 Allowed 'General case' 0 C--N 1.359 1.016 0 N-CA-C 117.483 2.401 . . . . 100.0 117.483 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -60.05 -42.55 94.72 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 115.121 1.526 . . . . 100.0 115.121 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -61.06 -44.98 96.57 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.706 0.765 . . . . 100.0 111.343 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -61.55 -44.24 97.41 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 126.543 1.937 . . . . 100.0 110.067 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -61.05 -47.15 87.71 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.726 1.21 . . . . 100.0 111.874 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.01 -43.8 97.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 123.595 0.56 . . . . 100.0 111.882 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.7 -45.4 94.15 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 123.465 0.478 . . . . 100.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.4 -42.63 98.78 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 117.999 -1.0 . . . . 100.0 113.14 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.49 -45.0 99.54 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-N 118.613 0.642 . . . . 100.0 109.311 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.46 93.52 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 112.696 0.628 . . . . 100.0 112.696 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.28 -42.8 96.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.143 0.977 . . . . 100.0 112.877 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.7 m -63.95 -39.3 93.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.717 1.607 . . . . 100.0 111.913 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.7 m -53.93 127.5 26.49 Favored 'General case' 0 C--N 1.366 1.305 0 CA-C-O 122.295 1.045 . . . . 100.0 110.599 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.63 147.77 48.83 Favored 'General case' 0 CA--C 1.483 -1.604 0 CA-C-N 113.448 -1.705 . . . . 100.0 109.644 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 66.3 mt -108.1 125.32 32.28 Favored Pre-proline 0 N--CA 1.423 -1.809 0 CA-C-N 115.002 -0.999 . . . . 100.0 113.342 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -82.71 -152.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.104 3.203 . . . . 100.0 106.352 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -82.3 103.04 11.59 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 104.898 -2.26 . . . . 100.0 104.898 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -130.53 -57.69 1.06 Allowed 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.489 -0.778 . . . . 100.0 110.875 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -100.1 4.35 44.53 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.572 1.323 . . . . 100.0 114.572 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -61.29 -38.57 87.28 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 125.334 1.454 . . . . 100.0 112.417 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -60.6 -41.17 94.21 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.57 1.548 . . . . 100.0 112.323 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.257 1.458 0 CA-C-O 117.333 -1.318 . . . . 100.0 107.866 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.494 -1.174 0 CA-C-O 121.032 0.444 . . . . 100.0 110.222 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.701 ' HB2' ' H ' ' A' ' 187' ' ' VAL . . . -60.61 -42.44 96.8 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.459 1.504 . . . . 100.0 112.645 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.52 93.95 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.507 1.123 . . . . 100.0 110.934 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -64.65 -36.56 84.65 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 125.547 1.539 . . . . 100.0 111.454 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.533 ' HA3' ' HZ2' ' A' ' 60' ' ' LYS . . . 95.35 19.43 30.27 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.3 -2.32 . . . . 100.0 107.3 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 10' ' ' GLN 0.283 35.0 tt0 -87.29 96.05 0.53 Allowed Pre-proline 0 N--CA 1.424 -1.771 0 C-N-CA 129.38 3.072 . . . . 100.0 103.822 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -61.7 -46.07 15.25 Favored 'Trans proline' 0 C--N 1.378 2.12 0 N-CA-C 107.663 -1.707 . . . . 100.0 107.663 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -130.1 -63.22 0.91 Allowed 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 100.327 -3.953 . . . . 100.0 100.327 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.97 144.01 36.52 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 N-CA-C 114.236 1.198 . . . . 100.0 114.236 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 60' ' ' LYS 0.272 30.9 tt0 -126.6 134.51 50.78 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 103.811 -2.663 . . . . 100.0 103.811 177.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -124.27 136.44 54.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.765 -1.198 . . . . 100.0 107.765 177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.74 116.31 28.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.543 -2.021 . . . . 100.0 105.543 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.78 128.57 55.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.436 -1.711 . . . . 100.0 107.574 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.27 122.1 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 106.098 -1.815 . . . . 100.0 106.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -104.08 118.14 35.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.479 -1.674 . . . . 100.0 106.479 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.5 m -127.59 163.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 113.664 -1.607 . . . . 100.0 111.412 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.11 169.66 16.53 Favored Glycine 0 CA--C 1.493 -1.296 0 N-CA-C 108.053 -2.019 . . . . 100.0 108.053 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -71.28 160.65 32.42 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.892 0.853 . . . . 100.0 113.022 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.32 140.25 41.06 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.428 -1.069 . . . . 100.0 110.428 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.4 2.01 90.54 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.381 -0.677 . . . . 100.0 114.643 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.401 HG22 ' C ' ' A' ' 89' ' ' MET . 68.5 m -64.28 -42.27 96.51 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.225 1.012 . . . . 100.0 112.279 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.04 17.73 4.46 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.689 -0.767 . . . . 100.0 111.846 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -60.71 -47.54 85.83 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 125.927 1.691 . . . . 100.0 110.354 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.6 m -64.5 -42.88 95.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.402 1.481 . . . . 100.0 109.509 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.1 m -62.72 -41.96 99.42 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 125.012 1.325 . . . . 100.0 109.473 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.426 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 88.4 t80 -60.55 -48.49 81.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.956 1.302 . . . . 100.0 110.49 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.3 -42.03 90.04 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 123.333 0.396 . . . . 100.0 111.289 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.93 -40.09 94.29 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.274 0.63 . . . . 100.0 112.139 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' NH1' ' HA ' ' A' ' 26' ' ' PHE . 32.3 ttp-105 -62.14 -44.31 96.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 123.78 0.832 . . . . 100.0 109.058 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -62.8 -45.61 91.85 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 112.332 0.493 . . . . 100.0 112.332 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.83 -48.75 73.21 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 116.459 2.022 . . . . 100.0 116.459 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.4 p -118.9 -21.45 7.75 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 116.689 2.107 . . . . 100.0 116.689 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.72 71.8 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.524 -0.598 . . . . 100.0 112.128 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.04 146.88 45.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.924 1.29 . . . . 100.0 109.022 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.438 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 97.0 m-85 -111.36 120.38 42.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.05 -3.315 . . . . 100.0 102.05 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.73 114.22 28.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 119.13 -1.028 . . . . 100.0 111.622 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.73 -43.72 62.59 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 114.595 -1.184 . . . . 100.0 113.512 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -76.44 145.58 39.17 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 123.161 0.584 . . . . 100.0 111.414 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -107.03 124.09 49.14 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 119.227 -0.989 . . . . 100.0 108.435 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -115.64 125.85 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 101.474 -3.528 . . . . 100.0 101.474 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.38 138.84 58.67 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 112.924 0.713 . . . . 100.0 112.924 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.6 m -96.23 125.36 40.69 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 103.665 -2.717 . . . . 100.0 103.665 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.07 129.05 54.24 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.658 -1.608 . . . . 100.0 106.658 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.51 -126.33 32.69 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 109.742 -1.343 . . . . 100.0 109.742 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.75 137.58 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 123.135 0.574 . . . . 100.0 109.907 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -114.36 126.11 54.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 103.827 -2.657 . . . . 100.0 103.827 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.02 121.36 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.854 -1.536 . . . . 100.0 106.854 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -127.37 122.78 22.99 Favored Pre-proline 0 N--CA 1.431 -1.405 0 CA-C-N 115.458 -0.792 . . . . 100.0 110.9 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.18 125.29 5.78 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.968 2.445 . . . . 100.0 110.225 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -122.41 126.7 48.51 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.717 -1.586 . . . . 100.0 106.717 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.19 130.56 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 N-CA-C 106.821 -1.548 . . . . 100.0 106.821 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -118.36 132.42 56.27 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.513 -2.032 . . . . 100.0 105.513 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.487 ' HD1' ' HG3' ' A' ' 58' ' ' PRO . 97.8 m-70 -102.8 123.49 46.55 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 106.541 -1.652 . . . . 100.0 106.541 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 p -123.64 -177.42 3.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.024 -0.535 . . . . 100.0 111.791 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -58.98 -38.26 78.74 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.263 1.825 . . . . 100.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -86.55 -0.23 55.7 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.861 0.864 . . . . 100.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.63 -178.8 19.51 Favored Glycine 0 N--CA 1.432 -1.63 0 O-C-N 122.034 -0.416 . . . . 100.0 112.194 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.487 ' HG3' ' HD1' ' A' ' 53' ' ' HIS . 33.6 Cg_exo -64.99 139.46 61.62 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.092 3.195 . . . . 100.0 113.782 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.7 mt -129.66 138.43 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.472 -2.788 . . . . 100.0 103.472 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.533 ' HZ2' ' HA3' ' A' ' 5' ' ' GLY . 40.7 ttmt -118.68 128.94 54.99 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.4 -1.32 . . . . 100.0 108.889 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -108.63 117.58 34.56 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -92.25 106.53 18.52 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 102.519 -3.141 . . . . 100.0 102.519 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.37 124.4 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-N 112.447 -2.16 . . . . 100.0 109.198 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -104.77 105.9 16.17 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 104.715 -2.328 . . . . 100.0 104.715 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.76 118.7 27.45 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 104.339 -2.467 . . . . 100.0 104.339 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.1 p -96.54 162.27 13.54 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 114.041 1.126 . . . . 100.0 114.041 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.71 128.73 34.75 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.139 -1.43 . . . . 100.0 107.139 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.45 -13.39 80.44 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.948 -0.362 . . . . 100.0 112.386 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -65.81 -41.04 92.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.359 1.864 . . . . 100.0 112.13 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.71 137.73 58.2 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.828 0.851 . . . . 100.0 111.991 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -71.8 156.24 39.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.3 1.048 . . . . 100.0 113.019 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -66.85 132.71 48.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.413 1.885 . . . . 100.0 108.267 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.92 -171.77 34.43 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 119.608 -1.282 . . . . 100.0 114.548 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.04 -21.53 63.82 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 127.915 2.674 . . . . 100.0 113.824 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.65 -36.88 84.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.595 1.558 . . . . 100.0 110.649 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -87.45 1.21 54.08 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.742 1.617 . . . . 100.0 113.592 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.43 -39.78 92.06 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 116.044 1.868 . . . . 100.0 116.044 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.11 91.67 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 118.836 0.744 . . . . 100.0 113.436 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -62.91 -42.2 99.71 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.24 1.816 . . . . 100.0 108.912 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.578 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 8.8 t80 -89.32 -14.31 36.01 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 114.271 1.211 . . . . 100.0 114.271 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.6 mt -61.83 135.86 25.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 CA-C-N 119.108 0.867 . . . . 100.0 108.862 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 64.56 21.71 12.5 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 126.558 1.943 . . . . 100.0 114.441 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.51 141.29 50.16 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 108.158 -1.053 . . . . 100.0 108.158 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -100.0 -32.38 10.98 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.006 -1.109 . . . . 100.0 108.006 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.7 p -150.3 160.96 43.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.964 0.411 . . . . 100.0 111.391 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.479 ' HB3' ' HH ' ' A' ' 80' ' ' TYR . . . -143.52 152.43 41.46 Favored 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 119.616 -0.834 . . . . 100.0 113.114 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.0 mt -126.16 126.7 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.258 -2.497 . . . . 100.0 104.258 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.412 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 67.9 mt -109.27 124.26 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 N-CA-C 101.483 -3.525 . . . . 100.0 101.483 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.401 ' C ' HG22 ' A' ' 21' ' ' THR . 50.1 ttm -119.03 133.27 55.92 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.239 -1.384 . . . . 100.0 111.083 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -127.63 158.3 37.9 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.461 -1.7 . . . . 100.0 109.665 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -102.42 125.75 49.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 105.473 -2.047 . . . . 100.0 105.473 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.66 -22.96 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 114.167 1.173 . . . . 100.0 114.167 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -85.29 -10.83 55.97 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 118.736 -0.649 . . . . 100.0 111.072 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 t -116.17 116.71 28.31 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.272 1.511 . . . . 100.0 112.541 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -65.8 -41.45 91.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.938 -1.937 . . . . 100.0 109.223 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.08 -43.62 97.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 C-N-CA 125.431 1.492 . . . . 100.0 110.353 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.7 m -63.17 -43.23 98.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.101 0.561 . . . . 100.0 109.74 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.59 ' HH ' HG21 ' A' ' 136' ' ' ILE . 86.8 t80 -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.572 0.349 . . . . 100.0 110.289 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.4 mttt -60.25 -37.97 82.03 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 124.15 0.98 . . . . 100.0 111.335 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -73.27 -11.28 60.45 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.238 1.57 . . . . 100.0 115.238 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.97 -42.92 93.02 Favored Pre-proline 0 C--N 1.361 1.1 0 CA-C-O 116.58 -1.676 . . . . 100.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 92.9 Cg_exo -59.3 -34.27 97.87 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.488 2.125 . . . . 100.0 112.422 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.98 -43.38 88.02 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.07 0.948 . . . . 100.0 110.116 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -62.76 -47.11 84.95 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 109.111 -0.7 . . . . 100.0 109.111 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.549 ' HD1' ' NZ ' ' A' ' 142' ' ' LYS . 50.2 t-80 -91.46 64.52 5.06 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.78 1.276 . . . . 100.0 108.351 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -154.81 -60.59 0.12 Allowed 'General case' 0 CA--C 1.489 -1.387 1 N-CA-C 99.736 -4.172 . . . . 100.0 99.736 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.52 -39.99 95.32 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.192 0.597 . . . . 100.0 111.138 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.578 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -61.56 -45.85 92.39 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 122.998 0.519 . . . . 100.0 110.583 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.6 -39.08 83.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 126.395 1.878 . . . . 100.0 109.784 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.27 45.7 mtm105 -59.01 -44.52 91.71 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.048 0.539 . . . . 100.0 109.753 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.43 -51.84 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 115.563 1.69 . . . . 100.0 115.563 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -108.26 4.02 24.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 119.911 3.3 . . . . 100.0 119.911 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 54.11 -121.05 1.76 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.326 1.45 . . . . 100.0 111.28 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -95.19 112.88 24.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.884 1.22 . . . . 100.0 111.134 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.2 pt -144.79 153.09 53.81 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.942 -2.984 . . . . 100.0 102.942 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -62.31 126.0 17.57 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.311 2.007 . . . . 100.0 111.9 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.418 ' HB ' HD21 ' A' ' 144' ' ' LEU . 69.1 mt -130.69 133.81 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.461 -1.311 . . . . 100.0 107.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -115.38 133.12 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 114.044 -1.435 . . . . 100.0 108.077 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.89 124.8 47.11 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.69 -2.337 . . . . 100.0 104.69 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.8 m -116.94 122.34 44.0 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.75 0.786 . . . . 100.0 110.348 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.42 103.15 2.82 Favored Glycine 0 CA--C 1.478 -2.259 0 N-CA-C 103.626 -3.79 . . . . 100.0 103.626 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.41 54.0 p30 -93.09 170.62 9.5 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 114.817 1.414 . . . . 100.0 114.817 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.7 mttt 61.11 41.67 13.4 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.586 2.754 . . . . 100.0 112.201 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.8 m -64.76 -18.9 24.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.275 -0.875 . . . . 100.0 112.781 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.528 ' CG ' ' HG ' ' A' ' 150' ' ' SER . 93.1 m-20 -61.11 -38.25 85.67 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 123.624 0.77 . . . . 100.0 112.4 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.61 130.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.843 0.83 . . . . 100.0 108.981 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.61 -42.74 98.19 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.767 1.627 . . . . 100.0 114.84 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.32 77.03 10.06 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.51 1.147 . . . . 100.0 108.742 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.453 ' NH2' ' HH ' ' A' ' 146' ' ' TYR . 78.0 ttt180 -92.95 125.9 37.77 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.618 -1.623 . . . . 100.0 106.618 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -98.05 -39.17 9.06 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.32 -0.855 . . . . 100.0 112.302 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.96 107.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 103.908 -2.627 . . . . 100.0 103.908 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.9 144.34 31.04 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.422 -1.263 . . . . 100.0 109.962 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.84 -40.56 95.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.286 1.035 . . . . 100.0 111.348 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -40.76 98.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.909 1.284 . . . . 100.0 110.722 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.6 m -63.28 -38.09 89.8 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.124 1.77 . . . . 100.0 113.057 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.59 HG21 ' HH ' ' A' ' 98' ' ' TYR . 96.2 mt -62.01 123.76 15.34 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-O 122.553 1.168 . . . . 100.0 110.022 -178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.56 -5.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.434 -1.712 . . . . 100.0 110.701 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -59.61 -41.74 91.06 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.243 1.417 . . . . 100.0 111.4 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.586 ' HD1' HG23 ' A' ' 136' ' ' ILE . 45.0 p-80 -61.27 -42.71 99.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.403 0.681 . . . . 100.0 112.364 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -63.8 -44.23 93.95 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 124.195 0.998 . . . . 100.0 110.859 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.8 -42.31 97.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.937 0.895 . . . . 100.0 111.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.549 ' NZ ' ' HD1' ' A' ' 105' ' ' HIS . 33.8 mmtp -95.69 4.46 52.98 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.655 2.095 . . . . 100.0 116.655 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 55.54 46.89 22.05 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-O 122.898 1.333 . . . . 100.0 113.257 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 117' ' ' ILE . 40.7 mt -113.36 159.66 19.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.377 -1.342 . . . . 100.0 107.377 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.7 mm-40 -99.38 140.82 32.99 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 109.577 -0.527 . . . . 100.0 109.577 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.453 ' HH ' ' NH2' ' A' ' 129' ' ' ARG . 57.2 t80 -114.29 130.98 56.66 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.472 0.653 . . . . 100.0 112.067 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -129.06 135.1 48.47 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.027 -0.988 . . . . 100.0 111.401 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -90.04 120.83 31.57 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 101.872 -3.381 . . . . 100.0 101.872 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 48.8 pt -131.9 154.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.489 1.138 . . . . 100.0 112.07 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.528 ' HG ' ' CG ' ' A' ' 125' ' ' ASP . 33.1 t -138.95 118.2 12.71 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 104.497 -2.408 . . . . 100.0 104.497 175.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.239 -0.891 . . . . 100.0 109.142 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -44.26 87.62 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.061 1.504 . . . . 100.0 115.061 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -93.73 -2.17 54.15 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.022 1.49 . . . . 100.0 115.022 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 66.46 21.0 10.89 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 125.012 1.325 . . . . 100.0 111.133 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -73.9 118.09 16.45 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.778 -1.193 . . . . 100.0 107.778 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 52.29 36.8 20.53 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 127.955 2.502 . . . . 100.0 111.145 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -63.06 -40.71 98.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 115.613 1.709 . . . . 100.0 115.613 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.57 -10.24 49.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 113.75 1.018 . . . . 100.0 113.75 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.311 94.8 mttt -60.14 -43.98 95.25 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 118.605 2.817 . . . . 100.0 118.605 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -59.65 -41.32 56.99 Favored 'Trans proline' 0 C--N 1.372 1.787 0 CA-C-N 123.187 2.174 . . . . 100.0 112.344 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -63.38 -44.78 93.75 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 124.051 0.844 . . . . 100.0 111.278 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.28 -42.61 96.33 Favored 'General case' 0 CA--C 1.483 -1.609 0 CA-C-O 118.394 -0.812 . . . . 100.0 112.73 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.416 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.2 t90 -64.25 -42.61 96.43 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.711 0.632 . . . . 100.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 86.1 mt -60.72 -43.78 97.42 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 123.406 0.441 . . . . 100.0 110.651 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.85 99.93 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.59 0.756 . . . . 100.0 111.548 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -61.77 -46.14 90.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 124.199 1.0 . . . . 100.0 111.11 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -65.8 -45.98 80.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 123.71 0.804 . . . . 100.0 112.685 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.96 -45.73 84.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.513 0.725 . . . . 100.0 112.397 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 98.3 mt -70.79 -38.16 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 124.207 1.003 . . . . 100.0 111.052 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.74 10.07 55.71 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 118.589 -1.117 . . . . 100.0 113.365 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 110.62 61.7 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 106.733 -1.58 . . . . 100.0 106.733 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -70.78 -18.08 32.48 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.272 2.648 . . . . 100.0 113.783 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -97.24 9.14 43.03 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.088 0.955 . . . . 100.0 112.595 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 26.9 tp -63.31 129.27 39.55 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 109.055 -0.72 . . . . 100.0 109.055 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -129.24 152.26 49.01 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.42 0.629 . . . . 100.0 111.017 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -80.87 135.51 35.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.515 1.126 . . . . 100.0 109.231 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.17 156.46 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 106.045 -1.835 . . . . 100.0 106.045 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.08 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.356 0.888 0 N-CA-C 117.601 2.445 . . . . 100.0 117.601 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 53.9 tpp -156.57 100.07 2.05 Favored Pre-proline 0 C--N 1.359 1.004 0 CA-C-N 119.698 1.135 . . . . 100.0 110.31 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.88 157.03 52.14 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 123.437 2.758 . . . . 100.0 111.153 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.99 122.5 27.37 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 102.019 -3.326 . . . . 100.0 102.019 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.76 150.82 39.15 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 114.405 1.261 . . . . 100.0 114.405 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.52 120.7 68.92 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 101.094 -3.669 . . . . 100.0 101.094 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 66.9 Cg_endo -63.04 145.16 93.99 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.78 2.986 . . . . 100.0 116.224 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 24.7 Cg_exo -70.57 159.53 52.5 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.543 2.829 . . . . 100.0 111.57 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -61.14 -44.01 98.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.92 1.288 . . . . 100.0 112.581 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.701 ' H ' ' HB2' ' A' ' 2' ' ' ALA 0.27 24.9 t 62.97 84.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.08 0 C-N-CA 127.123 2.169 . . . . 100.0 110.515 -179.165 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 m -110.54 177.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 125.123 1.369 . . . . 100.0 109.548 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.277 85.9 mmm 54.44 -118.5 1.32 Allowed 'General case' 0 C--N 1.359 1.0 0 N-CA-C 117.862 2.542 . . . . 100.0 117.862 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.28 86.7 m-20 54.34 51.22 7.63 Favored Pre-proline 0 C--N 1.367 1.337 0 N-CA-C 121.225 3.787 . . . . 100.0 121.225 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -65.5 -67.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 120.965 1.38 . . . . 100.0 109.976 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.85 81.04 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 123.869 0.867 . . . . 100.0 112.418 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.317 93.2 mt -63.51 -37.6 87.92 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 117.202 2.297 . . . . 100.0 117.202 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.89 171.16 13.27 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 119.059 0.845 . . . . 100.0 112.3 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 76.78 -47.11 0.52 Allowed 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 127.126 2.17 . . . . 100.0 112.405 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.77 -44.35 93.91 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 114.656 1.354 . . . . 100.0 114.656 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . 0.265 21.0 m-30 -60.92 -50.45 73.37 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-O 122.114 0.959 . . . . 100.0 110.962 -177.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -64.7 -41.64 95.86 Favored 'General case' 0 CA--C 1.483 -1.602 0 C-N-CA 125.085 1.354 . . . . 100.0 111.878 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -61.47 -45.11 95.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.148 0.979 . . . . 100.0 111.03 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.2 -46.22 88.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 118.302 0.501 . . . . 100.0 111.908 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.88 -45.13 93.97 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.451 0.469 . . . . 100.0 112.145 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -64.66 -42.97 95.03 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 118.1 -0.952 . . . . 100.0 112.516 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.18 -43.13 98.66 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 CA-C-O 118.626 -0.702 . . . . 100.0 109.581 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.19 95.18 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 118.034 0.379 . . . . 100.0 111.244 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.35 -42.37 96.27 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.898 0.879 . . . . 100.0 113.169 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.5 m -64.81 -39.45 93.6 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.935 1.694 . . . . 100.0 111.744 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.4 m -57.81 131.19 49.59 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 123.624 0.77 . . . . 100.0 110.091 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.69 140.83 55.43 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 114.461 -1.245 . . . . 100.0 108.487 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 10.8 mp -102.68 123.2 43.38 Favored Pre-proline 0 N--CA 1.428 -1.574 0 N-CA-C 113.888 1.07 . . . . 100.0 113.888 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 209' ' ' LEU . 20.5 Cg_exo -89.13 -141.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.485 0 N-CA-C 103.436 -3.332 . . . . 100.0 103.436 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -87.06 104.08 15.98 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 103.994 -2.595 . . . . 100.0 103.994 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.14 -61.1 1.18 Allowed 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 109.17 -0.678 . . . . 100.0 109.17 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 43.4 p30 -111.57 11.92 21.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 113.26 0.837 . . . . 100.0 113.26 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.65 -38.27 84.3 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 125.905 1.682 . . . . 100.0 112.543 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.74 -40.67 93.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.8 1.24 . . . . 100.0 112.646 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--O 1.258 1.551 0 CA-C-O 117.136 -1.412 . . . . 100.0 108.878 -179.876 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 110.009 -0.367 . . . . 100.0 110.009 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.45 90.83 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 124.684 1.194 . . . . 100.0 112.031 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.19 97.52 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.911 0.884 . . . . 100.0 110.133 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -66.81 -37.01 83.69 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.697 1.199 . . . . 100.0 111.148 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.556 ' HA3' ' HZ2' ' A' ' 60' ' ' LYS . . . 96.1 18.51 31.34 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 107.197 -2.361 . . . . 100.0 107.197 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.27 36.0 tt0 -87.26 96.08 0.53 Allowed Pre-proline 0 N--CA 1.422 -1.839 0 N-CA-C 103.099 -2.926 . . . . 100.0 103.099 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.68 -44.12 23.2 Favored 'Trans proline' 0 C--N 1.379 2.172 0 N-CA-C 107.602 -1.73 . . . . 100.0 107.602 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -132.16 -62.79 0.83 Allowed 'General case' 0 N--CA 1.417 -2.105 1 N-CA-C 99.961 -4.088 . . . . 100.0 99.961 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.21 144.76 36.24 Favored 'Isoleucine or valine' 0 C--N 1.371 1.509 0 CA-C-O 122.091 0.948 . . . . 100.0 111.091 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 50.8 tt0 -125.26 131.77 53.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.387 -2.449 . . . . 100.0 104.387 175.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -119.49 135.43 54.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.102 -1.073 . . . . 100.0 108.102 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -92.85 120.58 33.34 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 123.176 1.465 . . . . 100.0 107.122 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 tt -110.47 128.72 55.74 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 112.638 -2.074 . . . . 100.0 106.526 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -109.82 123.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 105.926 -1.879 . . . . 100.0 105.926 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.0 tp -106.19 118.04 35.58 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.148 -1.427 . . . . 100.0 107.148 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.49 164.28 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 113.6 -1.636 . . . . 100.0 110.657 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 172.16 21.09 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.203 -1.959 . . . . 100.0 108.203 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -74.43 164.07 27.03 Favored 'General case' 0 CA--C 1.5 -0.98 0 O-C-N 122.207 -0.584 . . . . 100.0 112.153 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.18 142.01 36.83 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 109.392 -1.483 . . . . 100.0 109.392 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.28 90.48 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 123.781 0.705 . . . . 100.0 114.012 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.1 m -63.58 -42.69 98.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 117.922 0.861 . . . . 100.0 112.268 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.88 12.58 7.71 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.145 -1.026 . . . . 100.0 111.863 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -61.97 -41.83 98.45 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.043 0.937 . . . . 100.0 112.601 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.4 m -64.18 -43.17 95.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.71 1.204 . . . . 100.0 109.122 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.1 m -63.03 -41.78 99.61 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.4 1.48 . . . . 100.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.69 -48.54 81.28 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 126.017 1.727 . . . . 100.0 109.929 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.74 -42.91 93.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 119.253 -0.403 . . . . 100.0 111.608 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.16 -39.77 93.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 123.027 0.531 . . . . 100.0 111.656 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 28.1 ttp180 -61.81 -44.59 96.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.797 1.239 . . . . 100.0 109.586 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -62.77 -44.79 95.28 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.175 0.443 . . . . 100.0 111.914 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.06 -47.7 76.42 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 116.535 2.05 . . . . 100.0 116.535 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -118.47 -23.61 7.11 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 117.193 2.294 . . . . 100.0 117.193 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.46 71.76 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 110.751 -0.94 . . . . 100.0 110.751 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.71 151.19 36.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 118.08 0.94 . . . . 100.0 109.531 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.496 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 92.0 m-85 -112.07 124.69 52.95 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 102.084 -3.302 . . . . 100.0 102.084 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -104.8 113.56 27.22 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.66 -0.816 . . . . 100.0 110.311 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.41 ' HZ3' ' CG ' ' A' ' 215' ' ' ASP . 94.4 mttt -72.76 -43.39 62.92 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.057 1.343 . . . . 100.0 112.826 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -74.6 134.93 42.04 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 123.519 0.727 . . . . 100.0 111.344 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -102.88 119.71 39.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.264 -1.384 . . . . 100.0 107.264 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.33 127.14 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 103.301 -2.852 . . . . 100.0 103.301 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.14 58.74 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.563 0.697 . . . . 100.0 112.73 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.0 m -93.09 124.58 37.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 104.085 -2.561 . . . . 100.0 104.085 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD22 HE22 ' A' ' 69' ' ' GLN . 83.7 mt -104.59 127.51 52.35 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.09 -1.819 . . . . 100.0 106.09 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.71 -125.72 33.58 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.176 -1.17 . . . . 100.0 110.176 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.77 137.99 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.543 0.737 . . . . 100.0 110.038 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -114.43 124.87 53.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.084 -2.932 . . . . 100.0 103.084 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.18 117.4 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 124.855 1.262 . . . . 100.0 107.731 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -129.29 119.9 19.77 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 111.909 0.336 . . . . 100.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 22.2 Cg_exo -79.94 128.98 7.77 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.811 2.341 . . . . 100.0 112.232 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.8 mt -124.67 130.97 53.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.544 -1.28 . . . . 100.0 107.544 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.46 130.9 61.69 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.706 -1.22 . . . . 100.0 107.706 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.37 130.47 54.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.646 -1.983 . . . . 100.0 105.646 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -99.85 122.59 43.03 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.584 -2.006 . . . . 100.0 105.584 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.8 p -124.19 177.83 5.64 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.664 0.745 . . . . 100.0 110.891 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -59.54 -36.45 76.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.016 1.726 . . . . 100.0 109.7 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -85.4 0.9 50.78 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.329 1.051 . . . . 100.0 111.885 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.06 178.21 19.99 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 121.543 -0.723 . . . . 100.0 111.558 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -68.17 138.87 44.65 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 123.297 2.665 . . . . 100.0 112.769 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 mm -130.51 140.53 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.668 -2.345 . . . . 100.0 104.668 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.556 ' HZ2' ' HA3' ' A' ' 5' ' ' GLY . 36.8 ttmt -116.27 128.95 56.01 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.13 -1.028 . . . . 100.0 109.586 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.11 118.51 36.83 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.64 -2.356 . . . . 100.0 104.64 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -93.37 107.8 19.57 Favored 'General case' 0 N--CA 1.429 -1.514 1 N-CA-C 100.028 -4.064 . . . . 100.0 100.028 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.9 t -95.13 123.01 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.025 -0.989 . . . . 100.0 109.092 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -103.15 106.51 17.04 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -87.3 117.79 26.3 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.595 -2.742 . . . . 100.0 103.595 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.3 p -100.19 163.0 12.6 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.755 -0.657 . . . . 100.0 112.401 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.88 131.0 35.33 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.58 -0.526 . . . . 100.0 109.58 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.9 -11.57 81.23 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 112.238 -0.345 . . . . 100.0 112.238 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.435 HE22 HD22 ' A' ' 43' ' ' LEU . 53.8 mt-30 -65.07 -41.88 94.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.832 2.453 . . . . 100.0 111.102 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.46 141.29 58.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.939 1.296 . . . . 100.0 113.632 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 149.22 50.71 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.784 2.034 . . . . 100.0 111.297 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -71.33 130.5 41.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.884 -1.525 . . . . 100.0 106.884 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.53 -169.24 34.41 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.184 -1.484 . . . . 100.0 115.501 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.55 -21.87 63.11 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 127.78 2.61 . . . . 100.0 114.325 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.99 -37.66 85.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.8 1.64 . . . . 100.0 109.886 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.5 mmm-85 -86.16 2.46 46.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.047 1.739 . . . . 100.0 113.955 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.22 -41.8 93.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 115.514 1.672 . . . . 100.0 115.514 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.95 -38.22 92.41 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.858 0.742 . . . . 100.0 113.473 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -62.44 -43.51 98.64 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 125.745 1.618 . . . . 100.0 109.097 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.547 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 7.5 t80 -88.35 -14.25 38.65 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.266 1.21 . . . . 100.0 114.266 -176.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.27 134.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.364 1.229 0 CA-C-N 119.56 1.073 . . . . 100.0 109.378 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 63.27 26.36 15.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.174 2.19 . . . . 100.0 113.396 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.25 139.68 42.71 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 107.456 -1.313 . . . . 100.0 107.456 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -97.97 -34.88 10.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.4 p -148.37 161.05 42.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 120.709 0.29 . . . . 100.0 111.476 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB3' ' HH ' ' A' ' 80' ' ' TYR . . . -142.06 152.6 43.48 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.07 -1.052 . . . . 100.0 113.737 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.69 125.73 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 104.232 -2.507 . . . . 100.0 104.232 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.98 123.65 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 100.96 -3.719 . . . . 100.0 100.96 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -118.59 133.78 55.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.37 -1.332 . . . . 100.0 111.14 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -129.08 158.87 37.71 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 100.0 109.911 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -100.9 125.35 47.44 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 105.848 -1.908 . . . . 100.0 105.848 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.93 -22.26 30.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.71 1.004 . . . . 100.0 113.71 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -88.2 -7.48 56.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 118.953 -0.546 . . . . 100.0 111.568 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.1 t -117.86 116.55 27.19 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 122.891 1.329 . . . . 100.0 112.165 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.75 -40.18 88.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.553 -1.658 . . . . 100.0 110.141 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.92 -43.43 97.47 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 125.258 1.423 . . . . 100.0 109.754 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 95.0 m -63.06 -42.96 99.8 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 122.851 0.46 . . . . 100.0 109.954 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.566 ' HH ' HG21 ' A' ' 136' ' ' ILE . 76.7 t80 -64.34 -39.74 94.49 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 122.818 0.447 . . . . 100.0 110.504 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 93.6 mttt -60.71 -37.56 82.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.814 1.245 . . . . 100.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.91 -11.14 60.27 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.072 1.508 . . . . 100.0 115.072 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -59.97 -43.08 93.62 Favored Pre-proline 0 C--N 1.364 1.226 0 CA-C-O 116.208 -1.853 . . . . 100.0 111.199 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 93.7 Cg_exo -58.03 -35.45 98.74 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.626 2.217 . . . . 100.0 112.516 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -65.56 -43.75 88.86 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.135 0.974 . . . . 100.0 109.979 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -62.6 -47.31 84.33 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 109.507 -0.553 . . . . 100.0 109.507 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -91.11 64.62 5.35 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 123.055 1.407 . . . . 100.0 108.397 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -156.28 -62.12 0.1 Allowed 'General case' 0 CA--C 1.485 -1.527 1 N-CA-C 100.04 -4.059 . . . . 100.0 100.04 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -63.97 -39.75 94.83 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.376 -0.829 . . . . 100.0 110.428 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.547 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -62.03 -46.05 90.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.123 0.569 . . . . 100.0 110.762 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.54 -39.57 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 126.19 1.796 . . . . 100.0 109.675 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.11 -44.51 94.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 119.082 -0.485 . . . . 100.0 110.507 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.4 t -72.51 -49.37 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 114.958 1.466 . . . . 100.0 114.958 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.9 m -113.47 11.03 18.32 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 120.16 3.393 . . . . 100.0 120.16 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 54.18 -126.52 2.33 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 125.166 1.386 . . . . 100.0 112.367 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -102.54 115.75 31.21 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 117.772 -1.571 . . . . 100.0 109.986 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.94 150.42 67.43 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 102.453 -3.165 . . . . 100.0 102.453 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -60.82 128.5 25.8 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.917 1.745 . . . . 100.0 112.89 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.404 ' HB ' HD21 ' A' ' 144' ' ' LEU . 61.8 mt -131.16 135.17 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.479 -1.304 . . . . 100.0 107.479 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.77 131.63 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-N 113.579 -1.646 . . . . 100.0 108.169 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.6 mt -98.55 124.6 43.39 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 104.328 -2.471 . . . . 100.0 104.328 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 92.6 m -114.81 121.76 44.27 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.201 -0.909 . . . . 100.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.49 102.33 2.69 Favored Glycine 0 CA--C 1.479 -2.165 0 N-CA-C 103.099 -4.0 . . . . 100.0 103.099 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.386 55.4 p30 -92.67 171.61 8.89 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 114.326 1.232 . . . . 100.0 114.326 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 61.05 40.9 14.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 128.339 2.656 . . . . 100.0 111.95 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.34 -19.89 25.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.075 0 CA-C-N 115.517 -0.765 . . . . 100.0 112.669 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.547 ' CG ' ' HG ' ' A' ' 150' ' ' SER . 94.5 m-20 -61.0 -38.09 84.82 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.143 0.977 . . . . 100.0 112.549 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.66 129.82 26.44 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 N-CA-C 108.693 -0.855 . . . . 100.0 108.693 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.01 -41.25 95.49 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 116.357 1.984 . . . . 100.0 116.357 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.24 83.98 7.82 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.402 -1.333 . . . . 100.0 107.402 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.478 ' NH2' ' HH ' ' A' ' 146' ' ' TYR . 78.3 ttt180 -94.97 127.0 40.7 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.814 -1.921 . . . . 100.0 105.814 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.66 -38.66 9.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.994 -0.548 . . . . 100.0 112.304 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.33 105.93 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 103.804 -2.665 . . . . 100.0 103.804 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.37 151.32 25.58 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.265 -0.88 . . . . 100.0 111.187 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.4 -42.03 98.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.35 1.06 . . . . 100.0 111.555 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.11 -39.94 96.18 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.854 0.861 . . . . 100.0 111.102 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -62.54 -38.07 88.56 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.787 1.635 . . . . 100.0 112.982 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.608 HG23 ' HD1' ' A' ' 139' ' ' HIS . 90.4 mt -64.06 122.56 15.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 CA-C-O 122.421 1.105 . . . . 100.0 109.878 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.9 -7.25 4.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 C-N-CA 125.734 1.614 . . . . 100.0 111.598 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.394 1.478 . . . . 100.0 111.261 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.608 ' HD1' HG23 ' A' ' 136' ' ' ILE . 44.2 p-80 -61.7 -42.23 98.66 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 118.82 -0.61 . . . . 100.0 112.077 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -63.18 -45.31 92.37 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.656 0.782 . . . . 100.0 111.491 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.29 -40.63 94.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 123.611 0.764 . . . . 100.0 112.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.84 3.28 55.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 116.283 1.957 . . . . 100.0 116.283 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 57.6 t30 55.51 50.36 14.76 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.501 1.52 . . . . 100.0 112.624 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.404 HD21 ' HB ' ' A' ' 117' ' ' ILE . 49.9 mt -118.11 159.33 23.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.726 1.21 . . . . 100.0 108.048 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.403 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.2 mm-40 -98.29 140.19 32.94 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.478 ' HH ' ' NH2' ' A' ' 129' ' ' ARG . 61.0 t80 -114.58 130.62 56.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.554 0.692 . . . . 100.0 111.273 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -128.14 134.77 49.14 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.919 -1.037 . . . . 100.0 111.375 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -88.42 120.95 30.28 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 102.348 -3.205 . . . . 100.0 102.348 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 49.4 pt -131.16 154.43 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.652 1.215 . . . . 100.0 111.281 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.547 ' HG ' ' CG ' ' A' ' 125' ' ' ASP . 33.2 t -136.69 119.59 16.35 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 105.091 -2.188 . . . . 100.0 105.091 175.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.433 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.2 -45.1 89.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 124.211 0.944 . . . . 100.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.7 -44.68 89.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 115.145 1.535 . . . . 100.0 115.145 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 94.1 p -95.77 -0.26 51.54 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 115.537 1.68 . . . . 100.0 115.537 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.468 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 70.6 m-80 63.7 24.27 13.82 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.869 0.868 . . . . 100.0 112.638 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.76 123.25 24.61 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 106.046 -1.835 . . . . 100.0 106.046 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.05 40.57 31.42 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.939 2.095 . . . . 100.0 112.011 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.428 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 30.4 t80 -57.25 -49.04 77.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.369 1.867 . . . . 100.0 114.315 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.16 -9.02 40.85 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 115.463 1.653 . . . . 100.0 115.463 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.304 95.0 mttt -59.66 -44.44 97.44 Favored Pre-proline 0 CA--C 1.498 -1.045 0 N-CA-C 119.282 3.067 . . . . 100.0 119.282 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.1 -42.28 44.88 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.391 1.89 . . . . 100.0 111.678 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.95 -44.13 93.75 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 124.414 1.071 . . . . 100.0 111.794 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.62 -43.99 95.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 112.968 0.729 . . . . 100.0 112.968 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.403 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.5 t90 -64.61 -43.14 94.71 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.834 0.709 . . . . 100.0 109.975 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 88.9 mt -61.55 -43.06 99.55 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.448 0.468 . . . . 100.0 111.136 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.27 99.22 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 123.78 0.832 . . . . 100.0 110.765 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -61.96 -45.39 93.87 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.514 0.726 . . . . 100.0 111.667 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -64.6 -46.84 80.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.289 0.636 . . . . 100.0 111.879 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.35 -46.13 81.44 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 113.675 0.991 . . . . 100.0 113.675 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.85 -38.86 79.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.404 1.082 . . . . 100.0 109.388 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.67 8.9 59.17 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 118.635 -1.092 . . . . 100.0 112.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -107.62 110.15 62.64 Favored Pre-proline 0 C--N 1.361 1.074 0 N-CA-C 106.047 -1.834 . . . . 100.0 106.047 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.5 -18.85 43.33 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 123.842 3.028 . . . . 100.0 113.834 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -97.78 11.02 38.61 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.39 1.076 . . . . 100.0 112.611 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.5 tp -63.19 130.47 44.71 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.742 0.817 . . . . 100.0 109.145 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -130.8 152.41 50.17 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.367 0.603 . . . . 100.0 110.413 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -80.1 133.53 36.1 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.576 -1.268 . . . . 100.0 107.576 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.03 155.65 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.834 -1.173 . . . . 100.0 107.834 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -42.28 -97.2 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 118.839 2.903 . . . . 100.0 118.839 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 54.7 tpp -157.27 86.27 2.75 Favored Pre-proline 0 C--N 1.364 1.236 0 N-CA-C 115.561 1.689 . . . . 100.0 115.561 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.32 160.19 42.47 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 123.338 2.692 . . . . 100.0 107.762 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.74 130.36 42.76 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.355 0.598 . . . . 100.0 109.805 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.5 mt -95.61 145.87 24.91 Favored 'General case' 0 CA--C 1.484 -1.583 0 CA-C-N 114.995 -1.002 . . . . 100.0 110.961 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -84.32 124.35 73.93 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 102.697 -3.075 . . . . 100.0 102.697 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 60.8 Cg_endo -62.08 140.51 84.48 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 123.397 2.732 . . . . 100.0 113.905 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 31.2 Cg_exo -67.18 155.18 71.76 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.244 2.629 . . . . 100.0 112.188 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.41 -45.3 94.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.32 1.048 . . . . 100.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.0 t 68.56 102.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.243 0 C-N-CA 126.651 1.98 . . . . 100.0 106.747 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.7 m -92.51 157.01 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 115.331 1.604 . . . . 100.0 115.331 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.368 85.3 mmm 52.71 -118.44 1.33 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.989 2.515 . . . . 100.0 117.548 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 57.13 47.62 2.67 Favored Pre-proline 0 C--N 1.365 1.269 0 N-CA-C 117.705 2.483 . . . . 100.0 117.705 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.38 -70.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.054 1.836 . . . . 100.0 110.005 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.04 90.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.658 1.583 . . . . 100.0 109.249 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.1 mt -63.14 -21.66 66.35 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 115.886 1.81 . . . . 100.0 115.886 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.76 157.7 36.82 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 119.532 1.06 . . . . 100.0 110.887 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 75.42 -32.13 0.21 Allowed 'General case' 0 C--N 1.363 1.185 0 C-N-CA 127.739 2.416 . . . . 100.0 114.035 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -61.15 -37.93 84.63 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 127.031 2.132 . . . . 100.0 110.323 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -59.45 -43.73 93.11 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.101 0.96 . . . . 100.0 111.508 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -62.77 -43.04 99.84 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.634 0.774 . . . . 100.0 111.522 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.71 -44.5 96.81 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.756 1.222 . . . . 100.0 110.608 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -63.16 -41.94 99.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.803 1.241 . . . . 100.0 111.234 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.63 -42.6 99.68 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.519 0.728 . . . . 100.0 111.084 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.77 -44.37 96.37 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.472 0.709 . . . . 100.0 111.239 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.76 -42.99 98.34 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 C-N-CA 123.844 0.857 . . . . 100.0 109.077 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.83 99.59 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.274 1.029 . . . . 100.0 111.673 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -62.66 -42.7 99.75 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.921 0.888 . . . . 100.0 110.803 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.5 m -63.82 -42.69 97.61 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.734 1.214 . . . . 100.0 111.631 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 m -62.87 136.37 57.81 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 124.454 1.102 . . . . 100.0 113.454 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.24 143.88 52.02 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 124.805 1.242 . . . . 100.0 108.523 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 34.6 tp -97.68 124.49 48.13 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 116.205 -0.452 . . . . 100.0 111.562 -177.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 209' ' ' LEU . 38.0 Cg_exo -71.54 166.26 29.94 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.856 3.038 . . . . 100.0 109.066 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -76.08 113.27 13.42 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.443 -1.317 . . . . 100.0 107.443 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -126.55 -56.48 1.39 Allowed 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.627 -1.624 . . . . 100.0 106.698 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.496 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 25.7 p30 -111.64 5.66 19.44 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 115.442 1.645 . . . . 100.0 115.442 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -61.24 -38.8 87.98 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 114.133 1.16 . . . . 100.0 114.133 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.41 ' CG ' ' HZ3' ' A' ' 37' ' ' LYS . 80.0 m-20 -61.16 -40.07 92.49 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 113.544 0.942 . . . . 100.0 113.544 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 C--O 1.259 1.556 0 CA-C-O 117.147 -1.406 . . . . 100.0 109.777 -179.002 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 115.065 1.506 . . . . 100.0 115.065 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -122.81 134.75 54.4 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.001 1.721 . . . . 100.0 106.694 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.53 132.4 53.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.647 -0.871 . . . . 100.0 108.647 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 87.8 tttt -89.04 116.94 27.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.23 129.22 56.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-N 114.251 -1.34 . . . . 100.0 107.874 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.12 124.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.155 -1.424 . . . . 100.0 107.155 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.5 tp -105.27 117.72 34.74 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.771 -1.566 . . . . 100.0 106.771 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.97 162.72 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.259 -1.337 . . . . 100.0 112.567 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.91 172.49 20.68 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 109.629 -1.388 . . . . 100.0 109.629 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.479 ' HB2' HG23 ' A' ' 97' ' ' THR . 85.2 m-20 -71.1 159.62 34.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.831 0.824 . . . . 100.0 112.778 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 139.44 39.69 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 110.173 -1.171 . . . . 100.0 110.173 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.65 2.8 89.88 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 118.592 -1.116 . . . . 100.0 114.774 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 p -64.06 -39.72 94.69 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 118.767 1.283 . . . . 100.0 113.887 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.18 19.32 5.17 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-O 118.941 -0.922 . . . . 100.0 111.477 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -60.08 -47.64 85.04 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 118.889 1.344 . . . . 100.0 111.143 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.3 m -64.55 -42.99 95.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.096 1.358 . . . . 100.0 110.671 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.2 m -63.12 -40.77 98.59 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.665 1.186 . . . . 100.0 109.177 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' HD1' HH22 ' A' ' 29' ' ' ARG . 68.1 t80 -60.67 -48.12 83.19 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.335 1.454 . . . . 100.0 110.369 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.28 -43.25 97.18 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 O-C-N 123.55 0.531 . . . . 100.0 111.025 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.71 -39.83 92.91 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.79 0.663 . . . . 100.0 112.79 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.775 HH21 ' HA ' ' A' ' 151' ' ' ALA . 13.1 ttm180 -60.48 -45.86 92.2 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.262 1.025 . . . . 100.0 109.086 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -64.35 -42.38 96.26 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.296 0.85 . . . . 100.0 113.296 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.61 -44.6 66.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.3 p -119.36 -23.3 6.73 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 117.826 2.528 . . . . 100.0 117.826 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.92 -7.73 73.45 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 110.992 -0.843 . . . . 100.0 110.992 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.0 156.58 30.06 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.765 1.226 . . . . 100.0 109.142 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -114.65 118.26 33.15 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 102.612 -3.107 . . . . 100.0 102.612 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -87.81 110.21 20.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.905 0.86 . . . . 100.0 111.085 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.06 -40.12 68.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.107 1.363 . . . . 100.0 113.85 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HE3' HG21 ' A' ' 206' ' ' THR . 96.3 mttt -80.06 131.17 35.72 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.389 1.076 . . . . 100.0 112.218 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -99.41 110.45 22.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.142 -1.023 . . . . 100.0 108.266 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.7 122.46 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 102.418 -3.178 . . . . 100.0 102.418 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.27 142.33 57.79 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.282 0.845 . . . . 100.0 113.282 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.5 m -92.95 127.22 38.38 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 104.431 -2.433 . . . . 100.0 104.431 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -105.34 127.14 52.81 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 107.916 -1.142 . . . . 100.0 107.916 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.32 -121.19 12.83 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.007 -1.637 . . . . 100.0 109.007 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.23 142.92 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.162 0.506 . . . . 100.0 110.197 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -121.13 123.59 42.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 105.007 -2.22 . . . . 100.0 105.007 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.6 t -100.31 122.02 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.675 -1.231 . . . . 100.0 107.675 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -126.65 124.45 24.19 Favored Pre-proline 0 N--CA 1.434 -1.238 0 CA-C-N 115.924 -0.58 . . . . 100.0 112.016 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.74 127.58 8.01 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 124.612 3.541 . . . . 100.0 112.81 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.0 tp -133.17 126.83 32.5 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.987 -1.116 . . . . 100.0 107.987 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.6 t -114.99 135.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 O-C-N 121.604 -0.685 . . . . 100.0 110.268 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -124.3 143.86 50.32 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.051 0.941 . . . . 100.0 109.102 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -102.35 127.38 49.37 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.022 -1.473 . . . . 100.0 107.022 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.7 p -122.0 179.24 4.58 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.982 0.896 . . . . 100.0 109.249 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -58.16 -36.62 73.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.875 2.07 . . . . 100.0 109.617 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -91.54 8.07 38.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 113.864 1.061 . . . . 100.0 113.864 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.74 176.19 20.07 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 121.907 -0.496 . . . . 100.0 112.074 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.61 138.21 29.0 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 123.271 2.647 . . . . 100.0 113.554 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -131.09 142.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 124.11 0.881 . . . . 100.0 109.003 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -106.76 132.65 52.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.473 -0.785 . . . . 100.0 112.112 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.62 117.8 34.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.527 -2.768 . . . . 100.0 103.527 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -94.8 100.76 12.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 100.508 -3.886 . . . . 100.0 100.508 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.74 126.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 CA-C-N 115.387 -0.824 . . . . 100.0 110.171 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.467 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 21.1 m95 -104.64 99.53 9.2 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.162 -2.162 . . . . 100.0 105.162 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.23 116.79 24.63 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.32 164.06 11.97 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.321 0.86 . . . . 100.0 113.321 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.04 131.62 35.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.212 1.005 . . . . 100.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.23 -10.5 80.15 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 114.492 0.557 . . . . 100.0 114.492 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -70.24 -38.76 75.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.15 2.18 . . . . 100.0 112.314 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HB2' HH11 ' A' ' 76' ' ' ARG . 96.6 mt-10 -62.29 137.03 58.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 124.973 1.309 . . . . 100.0 113.536 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.494 -1.23 . . . . 100.0 109.525 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -67.38 131.74 46.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.752 -1.944 . . . . 100.0 105.752 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.29 -176.1 40.27 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 118.788 -1.672 . . . . 100.0 114.474 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.72 64.38 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 127.188 2.327 . . . . 100.0 113.835 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.65 -37.72 85.09 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.21 1.804 . . . . 100.0 109.573 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.432 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.6 mtp85 -89.36 10.34 22.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 126.413 1.885 . . . . 100.0 115.762 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.8 -39.09 90.49 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 115.844 1.794 . . . . 100.0 115.844 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.79 86.16 Favored Glycine 0 C--N 1.355 1.631 0 C-N-CA 124.171 0.891 . . . . 100.0 113.26 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -62.47 -43.0 99.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.721 1.208 . . . . 100.0 109.819 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.4 t80 -88.81 -18.99 26.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 114.905 1.446 . . . . 100.0 114.905 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.25 131.65 21.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 CA-C-N 119.316 0.962 . . . . 100.0 109.667 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.279 91.6 mt-30 60.23 27.32 16.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 127.249 2.22 . . . . 100.0 115.377 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.3 46.75 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 107.029 -1.471 . . . . 100.0 107.029 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -106.35 -24.75 12.17 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 116.342 -0.39 . . . . 100.0 110.908 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.441 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -158.11 165.0 36.08 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.767 0.827 . . . . 100.0 109.233 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -148.78 155.79 41.45 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 119.627 -0.829 . . . . 100.0 112.863 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.39 126.81 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.714 -2.328 . . . . 100.0 104.714 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.52 124.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 103.789 -2.671 . . . . 100.0 103.789 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.462 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 55.7 mtt -112.64 135.4 53.41 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 116.549 2.055 . . . . 100.0 116.549 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -132.49 161.27 34.16 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 113.035 -1.893 . . . . 100.0 109.696 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.74 123.67 48.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.002 -1.851 . . . . 100.0 106.002 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -63.72 -20.38 26.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 114.063 1.134 . . . . 100.0 114.063 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -90.18 -2.46 58.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 118.896 -0.573 . . . . 100.0 111.479 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.5 t -125.79 113.43 17.27 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 122.578 1.18 . . . . 100.0 111.678 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -65.22 -38.67 91.15 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 114.896 -1.047 . . . . 100.0 111.934 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.25 -41.89 91.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 124.836 1.254 . . . . 100.0 108.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.6 m -62.62 -41.54 99.07 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 122.769 0.428 . . . . 100.0 110.532 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.381 0.672 . . . . 100.0 110.841 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.45 -35.34 73.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 124.679 1.192 . . . . 100.0 111.578 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -76.03 -9.78 58.89 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 115.848 1.795 . . . . 100.0 115.848 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 78.6 t -59.24 -44.99 99.21 Favored Pre-proline 0 C--N 1.363 1.174 0 CA-C-O 116.03 -1.938 . . . . 100.0 112.115 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 30.2 Cg_endo -59.08 -31.64 95.93 Favored 'Trans proline' 0 C--N 1.376 2.022 0 CA-C-N 122.747 2.017 . . . . 100.0 113.058 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.65 -42.95 81.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.783 0.72 . . . . 100.0 109.818 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.471 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.1 m95 -63.91 -45.79 87.75 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 109.565 -0.532 . . . . 100.0 109.565 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -90.72 70.17 6.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.543 -1.28 . . . . 100.0 107.543 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -168.02 -55.2 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 100.329 -3.952 . . . . 100.0 100.329 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.61 -43.82 98.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.691 -1.596 . . . . 100.0 106.691 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.6 mp -63.02 -50.14 71.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 113.366 0.876 . . . . 100.0 113.366 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.267 33.3 m -67.25 -22.81 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.267 90.9 mtt180 -61.24 -39.89 92.0 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.705 -0.85 . . . . 100.0 108.705 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.01 -47.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 113.735 1.013 . . . . 100.0 113.735 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.295 63.5 m -105.04 -2.28 24.62 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 119.405 3.113 . . . . 100.0 119.405 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.285 41.3 mt-10 54.96 -119.31 1.43 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.94 1.089 . . . . 100.0 113.94 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.49 110.73 22.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 120.151 1.341 . . . . 100.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.8 152.05 51.2 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 104.754 -2.313 . . . . 100.0 104.754 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.43 126.67 18.95 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.337 2.025 . . . . 100.0 112.251 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' HD22 ' A' ' 144' ' ' LEU . 64.5 mt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.747 -1.205 . . . . 100.0 107.747 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.46 132.15 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.416 -1.265 . . . . 100.0 108.417 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.36 124.75 44.74 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.387 -2.079 . . . . 100.0 105.387 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -116.74 124.73 50.36 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 122.259 1.028 . . . . 100.0 111.577 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.09 102.73 2.84 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 104.911 -3.276 . . . . 100.0 104.911 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -81.17 163.15 23.28 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 124.954 1.302 . . . . 100.0 111.865 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.71 38.51 24.94 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 128.386 2.674 . . . . 100.0 114.826 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.57 -14.7 18.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 113.787 1.032 . . . . 100.0 113.787 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.38 -37.1 86.31 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.755 1.222 . . . . 100.0 109.597 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.27 131.32 29.94 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-O 122.127 0.965 . . . . 100.0 109.82 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.68 -45.5 92.51 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -85.36 77.08 10.03 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.599 0.714 . . . . 100.0 110.29 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.94 138.79 38.24 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.615 -1.254 . . . . 100.0 107.615 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.67 -43.62 6.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.489 -0.56 . . . . 100.0 109.489 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.13 107.8 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.225 -2.139 . . . . 100.0 105.225 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -77.78 148.54 34.74 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.088 -1.415 . . . . 100.0 109.158 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.77 88.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.169 0.988 . . . . 100.0 110.161 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.11 -41.1 97.89 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.111 1.364 . . . . 100.0 111.066 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.9 m -62.43 -37.8 87.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.717 1.607 . . . . 100.0 113.465 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.19 120.09 11.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-O 122.382 1.087 . . . . 100.0 110.099 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.44 -7.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 125.626 1.571 . . . . 100.0 112.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 73.3 t80 -58.85 -41.36 86.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.124 1.37 . . . . 100.0 111.161 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -61.28 -38.66 87.56 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 123.795 0.838 . . . . 100.0 111.716 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.92 -46.1 89.4 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.528 0.731 . . . . 100.0 111.367 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.57 -40.97 89.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.039 0.936 . . . . 100.0 112.838 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 72.9 mmtt -92.83 2.23 56.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 116.808 2.151 . . . . 100.0 116.808 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 54.96 47.83 21.28 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-O 123.13 1.443 . . . . 100.0 113.672 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.626 HD22 ' HB ' ' A' ' 117' ' ' ILE . 44.9 mt -110.55 159.85 17.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.91 -1.495 . . . . 100.0 107.481 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.442 ' HG3' ' CD1' ' A' ' 163' ' ' TRP . 92.3 mm-40 -97.14 141.9 29.71 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.421 -1.326 . . . . 100.0 107.421 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -118.0 132.78 56.35 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 120.977 0.417 . . . . 100.0 111.701 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.23 135.13 42.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.594 -0.73 . . . . 100.0 112.448 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -86.66 123.42 31.82 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.517 -3.512 . . . . 100.0 101.517 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.5 pt -135.07 157.14 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 122.384 1.088 . . . . 100.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.3 t -141.19 114.01 8.39 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.853 -1.906 . . . . 100.0 105.853 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.775 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -64.0 -39.36 93.94 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.809 0.844 . . . . 100.0 108.776 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.97 -46.8 85.99 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.682 1.993 . . . . 100.0 114.261 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.8 p -103.86 -0.46 29.11 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 114.962 1.467 . . . . 100.0 114.962 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 65.72 21.33 11.57 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.145 1.778 . . . . 100.0 114.048 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -70.58 120.29 16.0 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.142 -1.429 . . . . 100.0 107.142 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 54.02 33.64 18.0 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.175 2.19 . . . . 100.0 111.867 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -60.29 -38.68 84.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.678 1.362 . . . . 100.0 114.678 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -88.49 -10.74 47.97 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 115.786 1.773 . . . . 100.0 115.786 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.267 95.5 mttt -59.87 -45.57 98.26 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 118.768 2.877 . . . . 100.0 118.768 -176.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -58.98 -41.99 56.29 Favored 'Trans proline' 0 C--N 1.372 1.79 0 CA-C-N 122.626 1.973 . . . . 100.0 113.696 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.9 -43.04 94.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 124.083 0.865 . . . . 100.0 112.013 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.85 -43.1 94.13 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 112.96 0.726 . . . . 100.0 112.96 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.516 ' HE1' ' HE3' ' A' ' 167' ' ' LYS . 60.6 t-105 -63.21 -44.67 94.65 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 123.597 0.561 . . . . 100.0 110.408 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 85' ' ' CYS . 84.7 mt -61.16 -41.38 96.66 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 123.483 0.49 . . . . 100.0 110.806 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.85 99.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 123.705 0.802 . . . . 100.0 110.611 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 174' ' ' LEU . 93.8 mtt180 -61.7 -47.07 86.95 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 118.654 -0.689 . . . . 100.0 111.402 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.516 ' HE3' ' HE1' ' A' ' 163' ' ' TRP 0.26 92.9 mttt -66.95 -42.79 84.66 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 114.911 1.449 . . . . 100.0 114.911 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.43 -46.88 78.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.247 0.832 . . . . 100.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.5 -38.28 73.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.018 0.927 . . . . 100.0 109.963 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.52 10.23 55.81 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-O 118.436 -1.202 . . . . 100.0 113.861 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.529 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 52.2 t0 -111.58 112.51 53.95 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 106.018 -1.845 . . . . 100.0 106.018 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.07 -15.73 43.65 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.648 2.898 . . . . 100.0 112.67 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -92.78 2.77 56.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.941 1.296 . . . . 100.0 113.816 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 69.5 mt -59.19 133.21 55.89 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 119.576 1.08 . . . . 100.0 113.339 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.432 -1.37 0 CA-C-N 114.156 -1.384 . . . . 100.0 109.009 -178.351 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 104.162 -2.532 . . . . 100.0 104.162 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -63.63 132.0 95.05 Favored Pre-proline 0 N--CA 1.439 -0.997 0 C-N-CA 122.754 0.422 . . . . 100.0 111.887 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 183' ' ' ALA . 45.5 Cg_exo -65.64 147.16 85.91 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.819 3.013 . . . . 100.0 112.78 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 32.2 Cg_exo -63.93 147.6 91.93 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 123.505 2.803 . . . . 100.0 111.012 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -63.26 -43.55 97.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 123.816 0.846 . . . . 100.0 112.584 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.8 t 68.99 99.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 127.112 2.165 . . . . 100.0 111.81 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.48 -71.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 103.08 -2.933 . . . . 100.0 103.08 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.256 77.1 mtp 9.34 -128.72 0.0 OUTLIER 'General case' 0 C--N 1.367 1.348 0 C-N-CA 131.396 3.879 . . . . 100.0 119.374 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.326 85.6 m-20 . . . . . 0 C--N 1.377 1.799 0 C-N-CA 131.383 3.873 . . . . 100.0 115.71 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.439 -1.012 0 CA-C-O 118.813 -0.613 . . . . 100.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -65.9 -42.41 90.23 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.833 0.853 . . . . 100.0 112.255 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.0 mt -60.88 -41.63 96.38 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.751 0.82 . . . . 100.0 111.553 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.97 -43.39 98.93 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.348 1.059 . . . . 100.0 111.347 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.14 -45.51 98.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 108.193 -1.04 . . . . 100.0 108.193 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.69 95.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 113.928 1.084 . . . . 100.0 113.928 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -61.76 -44.36 97.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.738 1.215 . . . . 100.0 111.96 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.409 HG21 ' HE3' ' A' ' 38' ' ' LYS . 97.4 m -64.72 -43.64 92.75 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.459 1.504 . . . . 100.0 110.427 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 124.316 2.008 . . . . 100.0 115.079 -177.951 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 118.533 2.79 . . . . 100.0 118.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -126.01 134.61 51.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.698 -2.046 . . . . 100.0 107.639 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.29 130.62 53.33 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.476 -0.935 . . . . 100.0 108.476 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.18 114.04 26.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.203 -1.777 . . . . 100.0 106.203 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 86' ' ' ALA . 39.5 tp -113.21 129.2 56.59 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 114.374 -1.284 . . . . 100.0 109.612 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -112.25 125.73 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 118.563 -1.255 . . . . 100.0 109.363 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 HG13 ' A' ' 63' ' ' VAL . 9.0 mp -101.81 121.33 41.89 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 108.074 -1.084 . . . . 100.0 108.074 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.76 160.38 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 113.613 -1.631 . . . . 100.0 110.814 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.08 172.35 20.65 Favored Glycine 0 CA--C 1.493 -1.311 0 N-CA-C 109.893 -1.283 . . . . 100.0 109.893 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HB2' HG23 ' A' ' 97' ' ' THR . 85.3 m-20 -71.58 159.86 33.71 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.115 0.96 . . . . 100.0 113.189 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.07 139.8 40.92 Favored Glycine 0 C--N 1.353 1.495 0 N-CA-C 109.94 -1.264 . . . . 100.0 109.94 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.09 2.16 89.48 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 118.864 -0.964 . . . . 100.0 114.892 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.1 p -63.32 -39.32 94.25 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 114.31 1.226 . . . . 100.0 114.31 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.03 16.51 6.73 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 118.666 -1.074 . . . . 100.0 112.003 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HG2' ' SD ' ' A' ' 89' ' ' MET . 10.2 mtmp? -60.0 -46.47 89.38 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 119.045 1.422 . . . . 100.0 111.664 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.0 m -64.13 -44.59 91.74 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.83 1.252 . . . . 100.0 110.967 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -63.47 -40.62 97.6 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.037 0.935 . . . . 100.0 109.954 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.36 -48.04 83.1 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.277 1.031 . . . . 100.0 111.227 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.54 -42.02 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 123.123 0.265 . . . . 100.0 111.026 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.69 -40.35 94.68 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.547 0.739 . . . . 100.0 111.188 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.627 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.8 tmm_? -61.62 -43.46 98.82 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 123.606 0.762 . . . . 100.0 110.192 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -63.04 -42.17 99.69 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.352 0.501 . . . . 100.0 112.352 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -70.1 -43.96 70.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.912 1.819 . . . . 100.0 115.912 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.1 p -120.14 -24.88 5.87 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.891 2.552 . . . . 100.0 117.891 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.93 68.19 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.816 -0.914 . . . . 100.0 110.816 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.9 152.36 35.41 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.137 0.975 . . . . 100.0 109.198 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.31 117.67 31.75 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 102.074 -3.306 . . . . 100.0 102.074 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -92.61 117.92 30.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.4 -0.963 . . . . 100.0 108.4 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.08 -11.97 29.5 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.633 -1.167 . . . . 100.0 112.976 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.31 123.74 47.36 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.591 -0.892 . . . . 100.0 108.591 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.79 115.45 27.44 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.261 1.029 . . . . 100.0 111.117 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -121.25 123.96 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 101.216 -3.624 . . . . 100.0 101.216 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.2 139.29 58.49 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 113.942 1.09 . . . . 100.0 113.942 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.0 m -84.76 130.01 34.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.25 127.32 51.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 106.857 -1.534 . . . . 100.0 106.857 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.57 -120.61 15.26 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.808 -1.317 . . . . 100.0 109.808 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.99 144.82 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 120.931 0.396 . . . . 100.0 110.415 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -119.91 124.0 44.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 103.172 -2.899 . . . . 100.0 103.172 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.1 t -101.31 120.82 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.26 -1.385 . . . . 100.0 107.26 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -127.11 123.02 23.31 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.85 -0.614 . . . . 100.0 111.772 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -80.81 129.81 7.31 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 124.165 3.243 . . . . 100.0 111.204 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -132.23 128.84 38.75 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.169 -1.048 . . . . 100.0 108.169 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.82 134.85 54.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 108.462 -0.94 . . . . 100.0 108.462 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 52' ' ' PHE . 6.6 m-30 -124.8 140.86 52.54 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.675 1.59 . . . . 100.0 109.073 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -105.33 124.01 48.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.326 1.06 . . . . 100.0 108.884 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.5 p -119.58 -179.99 4.05 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.354 -1.294 . . . . 100.0 111.432 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.08 -36.36 74.96 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 127.281 2.233 . . . . 100.0 109.512 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.01 7.38 40.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.384 0.883 . . . . 100.0 113.384 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.03 179.6 20.78 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 118.853 0.751 . . . . 100.0 111.948 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.19 140.0 36.51 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.14 2.56 . . . . 100.0 113.225 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 pt -130.27 140.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.811 -1.552 . . . . 100.0 106.811 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -113.72 132.77 55.69 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.994 -1.082 . . . . 100.0 110.884 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.51 118.88 37.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.288 -2.116 . . . . 100.0 105.288 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.72 97.7 10.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 100.74 -3.8 . . . . 100.0 100.74 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG13 HD13 ' A' ' 15' ' ' LEU . 46.3 t -86.65 126.82 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 121.297 0.57 . . . . 100.0 110.968 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -108.1 99.38 8.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.188 -1.782 . . . . 100.0 106.188 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -89.13 117.52 28.18 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.004 -2.221 . . . . 100.0 105.004 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -97.67 164.87 12.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.805 1.039 . . . . 100.0 113.805 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.1 131.85 34.75 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.154 0.982 . . . . 100.0 109.304 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.09 -10.45 84.87 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.352 0.501 . . . . 100.0 114.352 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.97 -39.77 75.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.393 1.877 . . . . 100.0 112.485 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -62.92 134.82 56.8 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.035 0.934 . . . . 100.0 113.365 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.49 154.65 40.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.975 -1.012 . . . . 100.0 110.263 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -66.76 132.26 47.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.707 1.603 . . . . 100.0 106.949 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.41 -176.8 38.74 Favored Glycine 0 C--N 1.356 1.642 0 C-N-CA 119.212 -1.47 . . . . 100.0 114.621 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.52 -23.64 65.08 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 127.057 2.265 . . . . 100.0 113.744 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -62.43 -31.86 72.62 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.488 1.115 . . . . 100.0 111.527 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.4 mtp-105 -92.33 10.21 30.75 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.631 1.572 . . . . 100.0 114.409 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.69 -38.02 86.28 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 116.082 1.882 . . . . 100.0 116.082 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.68 -38.68 92.24 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.77 0.7 . . . . 100.0 113.457 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -63.26 -42.72 99.17 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.157 0.983 . . . . 100.0 110.217 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.483 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 3.0 t80 -91.35 -18.59 24.04 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 114.726 1.38 . . . . 100.0 114.726 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.6 pt -61.18 136.42 24.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 CA-C-N 119.787 1.176 . . . . 100.0 111.19 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 63.66 21.93 12.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.719 2.008 . . . . 100.0 113.824 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.87 145.56 46.81 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 107.368 -1.345 . . . . 100.0 107.368 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -103.76 -24.02 13.37 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.883 -0.599 . . . . 100.0 110.71 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.489 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.6 p -159.38 165.51 33.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 123.536 0.735 . . . . 100.0 110.391 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -148.71 156.31 42.2 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 113.309 0.855 . . . . 100.0 113.309 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.416 HG13 HD11 ' A' ' 13' ' ' LEU . 96.2 mt -126.5 126.45 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 104.752 -2.314 . . . . 100.0 104.752 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 65.2 mt -108.21 124.22 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 102.343 -3.206 . . . . 100.0 102.343 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.585 ' HB3' HD21 ' A' ' 122' ' ' ASN . 94.8 mtp -114.41 132.31 56.28 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.805 -1.089 . . . . 100.0 113.22 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -132.84 161.44 34.15 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.87 -1.513 . . . . 100.0 109.374 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -104.26 125.47 50.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.847 -1.538 . . . . 100.0 106.847 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.9 -19.42 24.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.952 1.093 . . . . 100.0 113.952 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -89.25 -4.87 58.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 119.262 -0.399 . . . . 100.0 111.474 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -125.56 115.23 19.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.737 1.256 . . . . 100.0 112.035 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.15 -39.49 93.07 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 114.491 -1.231 . . . . 100.0 110.984 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.08 -41.6 89.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 C-N-CA 125.073 1.349 . . . . 100.0 109.22 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 18' ' ' ASP . 94.5 m -62.87 -41.78 99.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.161 0.584 . . . . 100.0 109.807 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -65.27 -39.79 93.06 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.246 0.618 . . . . 100.0 111.038 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -59.34 -36.72 76.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.738 1.215 . . . . 100.0 111.057 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.41 -10.88 60.01 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.552 1.686 . . . . 100.0 115.552 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -59.43 -44.02 97.22 Favored Pre-proline 0 C--N 1.361 1.072 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.777 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 85.9 Cg_exo -57.4 -35.29 98.87 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.759 2.306 . . . . 100.0 112.466 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.73 -43.08 85.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.884 0.874 . . . . 100.0 110.356 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.444 ' O ' HD13 ' A' ' 108' ' ' LEU . 87.4 m95 -63.79 -45.39 89.9 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 51.0 t-80 -90.68 69.62 6.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.639 -1.245 . . . . 100.0 107.639 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -169.4 -53.09 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 100.592 -3.855 . . . . 100.0 100.592 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.81 -43.89 97.59 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.579 -1.638 . . . . 100.0 106.579 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.483 ' HG ' ' CZ ' ' A' ' 80' ' ' TYR . 6.6 mp -62.81 -48.64 78.25 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.303 1.041 . . . . 100.0 113.139 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.22 -34.26 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 C-N-CA 127.358 2.263 . . . . 100.0 110.696 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.25 -40.17 81.07 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 118.657 -0.687 . . . . 100.0 111.253 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.262 11.8 m -97.33 -34.95 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 116.009 1.855 . . . . 100.0 116.009 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.294 70.6 m -105.13 -3.19 23.34 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 118.23 2.678 . . . . 100.0 118.23 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 54.38 -121.8 1.86 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.309 1.444 . . . . 100.0 113.462 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -94.48 109.2 21.1 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.335 1.064 . . . . 100.0 113.617 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.28 149.92 50.03 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 104.434 -2.432 . . . . 100.0 104.434 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.64 128.6 25.06 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.15 1.9 . . . . 100.0 113.138 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.563 ' HB ' HD22 ' A' ' 144' ' ' LEU . 70.7 mt -132.42 135.4 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.439 -1.319 . . . . 100.0 107.439 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.45 132.07 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.168 -1.378 . . . . 100.0 108.738 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.0 mt -98.15 125.64 43.26 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.686 -1.968 . . . . 100.0 105.686 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -118.05 125.22 49.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.017 0.913 . . . . 100.0 112.53 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.97 102.24 2.72 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 105.277 -3.129 . . . . 100.0 105.277 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.585 HD21 ' HB3' ' A' ' 89' ' ' MET . 70.1 m-80 -81.5 162.92 23.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.517 1.527 . . . . 100.0 112.865 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 57.86 42.3 23.41 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.65 2.38 . . . . 100.0 115.122 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 148' ' ' ASP . 34.1 m -65.02 -16.24 19.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 CA-C-N 115.902 -0.59 . . . . 100.0 112.348 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -62.29 -37.91 87.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 124.216 1.006 . . . . 100.0 112.41 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.24 132.38 27.93 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 CA-C-O 121.844 0.83 . . . . 100.0 109.82 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.93 -45.5 92.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 116.76 2.133 . . . . 100.0 116.76 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -86.07 77.47 9.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.305 0.574 . . . . 100.0 110.706 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -81.43 132.75 35.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.849 -0.797 . . . . 100.0 108.849 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -99.06 -41.95 7.31 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 115.976 -0.556 . . . . 100.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.21 106.23 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.42 155.52 25.85 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.129 -0.942 . . . . 100.0 109.253 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.02 83.19 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.527 1.131 . . . . 100.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.56 -40.91 96.41 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.216 1.006 . . . . 100.0 111.755 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.6 m -61.51 -38.54 87.72 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 125.615 1.566 . . . . 100.0 113.22 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.56 121.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 122.074 0.94 . . . . 100.0 110.319 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.34 -9.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.093 -1.412 . . . . 100.0 112.009 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 71.4 t80 -58.57 -39.51 80.5 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.305 1.442 . . . . 100.0 111.746 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -60.89 -39.87 90.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 123.931 0.892 . . . . 100.0 111.695 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.19 -44.29 92.46 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.304 0.642 . . . . 100.0 112.147 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.08 -42.28 94.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.464 1.106 . . . . 100.0 111.53 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 72.9 mmtt -94.62 3.1 55.51 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 118.109 2.633 . . . . 100.0 118.109 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 55.08 47.18 22.53 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 123.137 1.446 . . . . 100.0 113.59 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.563 HD22 ' HB ' ' A' ' 117' ' ' ILE . 50.3 mt -110.63 160.02 17.05 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 113.9 -1.5 . . . . 100.0 107.369 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -101.98 140.76 35.84 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.25 -1.389 . . . . 100.0 107.25 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -115.2 134.81 54.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.204 0.526 . . . . 100.0 112.184 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.99 136.18 41.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.624 -0.716 . . . . 100.0 112.529 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.511 ' HB3' HG11 ' A' ' 124' ' ' VAL . 22.4 m-20 -87.55 123.77 32.79 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 101.724 -3.436 . . . . 100.0 101.724 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.4 pt -134.43 157.53 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.309 1.052 . . . . 100.0 111.914 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.4 t -141.9 115.87 9.3 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 105.942 -1.873 . . . . 100.0 105.942 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.06 -38.94 93.17 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.964 0.905 . . . . 100.0 108.908 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.41 -43.84 93.13 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.832 1.653 . . . . 100.0 115.126 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -102.52 -4.16 25.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.604 1.335 . . . . 100.0 114.604 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 68.94 17.02 8.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.851 1.66 . . . . 100.0 113.25 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -66.97 119.64 12.29 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 107.59 -1.263 . . . . 100.0 107.59 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 54.48 30.85 13.64 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 127.048 2.139 . . . . 100.0 112.083 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -60.64 -38.23 84.11 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.372 1.249 . . . . 100.0 114.372 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -86.42 -13.86 45.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.598 1.703 . . . . 100.0 115.598 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.27 62.8 mttp -59.93 -45.68 98.16 Favored Pre-proline 0 C--N 1.358 0.952 0 N-CA-C 118.759 2.874 . . . . 100.0 118.759 -175.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.35 -41.28 60.05 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 122.455 1.912 . . . . 100.0 113.573 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.83 -44.15 94.06 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.962 0.905 . . . . 100.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.06 -42.5 94.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.856 0.687 . . . . 100.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -62.07 -45.53 93.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 123.374 0.422 . . . . 100.0 110.41 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.489 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.1 mt -61.23 -41.7 97.33 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 123.803 0.689 . . . . 100.0 110.854 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 123.56 0.744 . . . . 100.0 110.556 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.05 -45.87 91.64 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 118.568 -0.729 . . . . 100.0 112.233 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -68.99 -42.69 76.18 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 119.981 -0.688 . . . . 100.0 112.582 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.48 -46.33 80.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 113.666 0.987 . . . . 100.0 113.666 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.02 -38.23 74.64 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.536 1.135 . . . . 100.0 109.56 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.39 9.93 54.59 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 118.371 -1.239 . . . . 100.0 114.6 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.499 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 57.8 t0 -113.61 112.48 48.4 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 106.969 -1.493 . . . . 100.0 106.969 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.31 -15.36 45.62 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.831 3.02 . . . . 100.0 113.025 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -93.04 1.43 57.26 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 114.411 1.263 . . . . 100.0 114.411 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 92.9 mt -60.97 133.88 56.54 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 119.452 1.024 . . . . 100.0 113.647 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 . . . . . 0 N--CA 1.432 -1.372 0 CA-C-N 114.683 -1.144 . . . . 100.0 109.802 179.676 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 CA--C 1.5 -0.946 0 CA-C-O 122.36 1.076 . . . . 100.0 112.354 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -104.09 146.95 33.54 Favored Pre-proline 0 N--CA 1.425 -1.687 0 CA-C-N 114.014 -1.448 . . . . 100.0 112.59 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 183' ' ' ALA . 31.8 Cg_exo -65.8 157.88 56.63 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 124.382 3.388 . . . . 100.0 110.045 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -60.55 148.36 91.37 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 123.188 2.592 . . . . 100.0 113.561 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.62 138.24 58.29 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.723 1.264 . . . . 100.0 110.683 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.0 135.87 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 106.607 -1.627 . . . . 100.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.38 -76.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 107.973 -1.121 . . . . 100.0 107.973 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.7 ptm -80.8 -176.01 5.62 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 116.91 -1.519 . . . . 100.0 111.463 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--N 1.361 1.103 0 O-C-N 118.342 -2.723 . . . . 100.0 118.146 -179.124 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 N--CA 1.439 -1.016 0 CA-C-O 119.16 -0.448 . . . . 100.0 110.515 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -64.06 -43.35 95.73 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.642 1.177 . . . . 100.0 111.484 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.53 -43.55 98.66 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 123.432 0.693 . . . . 100.0 111.678 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.5 -44.94 92.89 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 123.79 0.836 . . . . 100.0 112.334 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.25 35.7 m -62.89 -39.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.196 0 CA-C-O 118.657 -0.687 . . . . 100.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.2 -44.25 88.99 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.089 0.955 . . . . 100.0 112.928 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -62.89 -41.6 99.48 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.709 1.204 . . . . 100.0 111.863 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 86.7 m -66.31 -42.27 88.5 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.795 1.638 . . . . 100.0 111.934 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 96.1 m . . . . . 0 C--N 1.359 0.998 0 CA-C-O 121.97 0.891 . . . . 100.0 111.184 -178.318 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.435 -1.194 0 N-CA-C 115.568 1.692 . . . . 100.0 115.568 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -125.43 133.93 52.29 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -121.95 130.72 53.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.88 116.07 28.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.96 -1.496 . . . . 100.0 106.96 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD11 HG13 ' A' ' 87' ' ' ILE . 57.2 tp -110.31 127.07 54.84 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 113.964 -1.471 . . . . 100.0 107.999 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.83 124.86 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 N-CA-C 107.024 -1.472 . . . . 100.0 107.024 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.9 tp -105.73 116.9 32.73 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 106.734 -1.58 . . . . 100.0 106.734 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.58 162.09 36.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 114.481 -1.236 . . . . 100.0 112.414 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.46 170.87 18.16 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 109.605 -1.398 . . . . 100.0 109.605 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.496 ' HB2' HG23 ' A' ' 97' ' ' THR . 84.0 m-20 -70.52 160.7 31.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.479 0.918 . . . . 100.0 113.479 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.63 140.19 40.34 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 110.865 -0.894 . . . . 100.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 2.76 90.44 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.646 -1.085 . . . . 100.0 114.303 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.0 p -63.55 -39.17 93.7 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 118.522 1.161 . . . . 100.0 114.131 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 16.8 6.28 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.711 -0.757 . . . . 100.0 111.926 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.91 -47.9 83.9 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 118.58 1.19 . . . . 100.0 111.461 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.4 m -64.67 -43.35 93.87 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.986 1.314 . . . . 100.0 111.034 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.9 m -63.47 -40.62 97.59 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.163 0.985 . . . . 100.0 109.5 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -61.14 -48.29 82.31 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 124.677 1.191 . . . . 100.0 110.319 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.76 -41.89 93.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.919 0 O-C-N 123.277 0.36 . . . . 100.0 111.699 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.02 -42.34 98.28 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.624 0.769 . . . . 100.0 110.718 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.584 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.2 tmm_? -62.28 -42.91 99.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.305 0.642 . . . . 100.0 110.706 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -63.96 -41.83 97.46 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 113.191 0.811 . . . . 100.0 113.191 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.28 -44.45 68.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 115.232 1.567 . . . . 100.0 115.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -120.02 -23.67 6.28 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 118.317 2.71 . . . . 100.0 118.317 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.65 -7.67 71.05 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.311 -0.716 . . . . 100.0 111.311 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.04 154.38 37.99 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.85 1.26 . . . . 100.0 109.456 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 91.3 m-85 -115.61 120.52 39.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.322 -2.844 . . . . 100.0 103.322 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -94.73 115.95 28.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.51 0.724 . . . . 100.0 109.16 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -91.39 -31.81 15.89 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.989 -0.284 . . . . 100.0 111.603 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.13 129.83 34.88 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.375 0.607 . . . . 100.0 111.379 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.97 116.51 29.32 Favored 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.116 0.96 . . . . 100.0 112.265 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.61 121.95 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 101.048 -3.686 . . . . 100.0 101.048 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.09 142.25 57.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.708 0.803 . . . . 100.0 113.077 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.6 m -92.61 127.83 38.25 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.99 126.26 50.98 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.387 -1.338 . . . . 100.0 107.387 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.48 -121.69 15.83 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.949 -1.261 . . . . 100.0 109.949 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.3 142.6 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.138 0.495 . . . . 100.0 110.602 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.91 122.89 43.33 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.721 -3.066 . . . . 100.0 102.721 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.39 116.68 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.168 -1.419 . . . . 100.0 107.168 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -124.4 121.69 25.97 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 112.403 0.52 . . . . 100.0 112.403 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 60' ' ' LYS . 90.1 Cg_endo -80.05 129.4 7.87 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 124.067 3.178 . . . . 100.0 112.602 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 tp -132.75 126.59 32.79 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.126 -1.435 . . . . 100.0 107.126 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.18 135.36 49.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.351 -0.611 . . . . 100.0 109.351 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.13 137.51 54.12 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 125.138 1.375 . . . . 100.0 107.407 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -103.52 125.24 49.96 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.708 -2.33 . . . . 100.0 104.708 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.2 p -124.71 176.97 6.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.751 0.786 . . . . 100.0 110.421 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -60.41 -27.0 67.12 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.295 1.438 . . . . 100.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -94.4 7.11 46.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 126.785 2.034 . . . . 100.0 112.974 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.0 175.85 25.58 Favored Glycine 0 C--N 1.357 1.7 0 N-CA-C 111.133 -0.787 . . . . 100.0 111.133 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.36 138.88 33.76 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.423 2.748 . . . . 100.0 113.444 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -132.04 142.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 106.974 -1.491 . . . . 100.0 106.974 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.429 ' HD2' ' HB2' ' A' ' 49' ' ' PRO . 33.9 ttpt -116.97 131.32 56.98 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 118.074 -1.45 . . . . 100.0 111.403 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.87 119.17 38.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 105.325 -2.102 . . . . 100.0 105.325 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' ND2' ' HE1' ' A' ' 64' ' ' TRP . 46.5 t30 -94.37 100.8 12.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 100.344 -3.947 . . . . 100.0 100.344 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.4 t -87.9 125.77 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-N 115.309 -0.86 . . . . 100.0 109.251 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.488 ' HE1' ' ND2' ' A' ' 62' ' ' ASN . 19.7 m0 -107.34 103.88 13.35 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.05 116.88 23.69 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.584 -2.376 . . . . 100.0 104.584 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 p -103.5 163.05 12.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 113.393 0.886 . . . . 100.0 113.393 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.28 36.14 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 123.78 0.832 . . . . 100.0 110.778 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.52 -8.07 77.98 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 113.834 0.294 . . . . 100.0 113.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -70.41 -39.56 74.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.73 2.012 . . . . 100.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.481 ' HB2' HH11 ' A' ' 76' ' ' ARG . 95.1 mt-10 -62.96 137.75 58.36 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 125.035 1.334 . . . . 100.0 112.459 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.41 151.65 44.94 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.468 -1.242 . . . . 100.0 111.011 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -65.55 131.17 45.71 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.607 1.963 . . . . 100.0 107.547 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.12 -173.81 36.01 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 118.895 -1.622 . . . . 100.0 115.632 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -20.15 62.64 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 127.699 2.571 . . . . 100.0 113.383 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.16 -38.14 82.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.039 2.135 . . . . 100.0 109.104 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.481 HH11 ' HB2' ' A' ' 70' ' ' GLU . 78.2 mtp85 -92.18 12.85 20.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.653 1.981 . . . . 100.0 115.599 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.11 -39.18 91.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.417 1.636 . . . . 100.0 115.417 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.5 90.83 Favored Glycine 0 C--N 1.357 1.695 0 C-N-CA 123.956 0.788 . . . . 100.0 113.731 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -62.13 -43.3 99.14 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.514 1.126 . . . . 100.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.596 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.5 t80 -87.02 -22.69 25.34 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.204 1.557 . . . . 100.0 115.204 -174.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.5 mt -57.21 133.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 0 CA-C-N 119.342 0.973 . . . . 100.0 109.732 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 63.45 23.18 13.58 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.141 2.176 . . . . 100.0 114.858 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 147.53 45.35 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.139 -1.06 . . . . 100.0 108.139 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -108.2 -22.13 12.49 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 116.419 -0.355 . . . . 100.0 111.261 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.411 ' HB2' HD22 ' A' ' 164' ' ' LEU . 16.4 p -156.63 164.41 38.21 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.752 -0.462 . . . . 100.0 109.752 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -148.53 155.65 41.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.308 0.855 . . . . 100.0 113.308 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.403 HG13 HD11 ' A' ' 13' ' ' LEU . 96.5 mt -127.74 126.88 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 104.319 -2.474 . . . . 100.0 104.319 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 68.1 mt -109.96 122.44 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 103.243 -2.873 . . . . 100.0 103.243 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 46.8 mtt -112.05 134.75 53.41 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 115.977 1.843 . . . . 100.0 115.977 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -131.49 159.83 36.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.556 -1.656 . . . . 100.0 109.181 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -103.98 124.66 49.41 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.847 -1.909 . . . . 100.0 105.847 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.46 -20.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 N-CA-C 113.79 1.033 . . . . 100.0 113.79 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.3 p -91.35 -2.93 57.22 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 119.146 -0.454 . . . . 100.0 112.014 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -122.67 115.04 21.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 122.92 1.343 . . . . 100.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -64.27 -41.96 96.67 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.095 -1.411 . . . . 100.0 110.689 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.15 -42.31 92.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 125.244 1.417 . . . . 100.0 109.35 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 18' ' ' ASP . 98.2 m -62.96 -41.43 99.52 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.475 0.31 . . . . 100.0 110.981 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -65.15 -41.06 95.1 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.636 0.775 . . . . 100.0 111.037 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 95.1 mttt -60.47 -35.18 75.26 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.106 1.362 . . . . 100.0 111.304 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -76.88 -9.28 58.58 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 115.827 1.788 . . . . 100.0 115.827 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.58 -43.26 95.36 Favored Pre-proline 0 C--N 1.361 1.103 0 CA-C-O 116.365 -1.779 . . . . 100.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 71.8 Cg_exo -57.37 -35.17 98.87 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.7 2.267 . . . . 100.0 112.685 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.7 -43.13 85.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 118.683 0.674 . . . . 100.0 110.826 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.495 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.7 m95 -63.61 -46.38 86.0 Favored 'General case' 0 C--N 1.366 1.296 0 N-CA-C 109.556 -0.535 . . . . 100.0 109.556 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -90.8 70.14 6.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.843 1.306 . . . . 100.0 107.768 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -165.07 -59.12 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 99.536 -4.246 . . . . 100.0 99.536 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -63.05 -39.72 95.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 123.877 0.736 . . . . 100.0 109.224 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.596 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -61.91 -50.31 72.68 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.757 0.661 . . . . 100.0 112.123 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.264 34.2 m -66.35 -27.86 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 113.046 0.758 . . . . 100.0 113.046 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -60.94 -39.14 88.36 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 118.247 0.476 . . . . 100.0 109.951 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.3 t -86.89 -47.98 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 113.909 1.077 . . . . 100.0 113.909 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.304 62.1 m -106.46 1.76 25.8 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 120.074 3.361 . . . . 100.0 120.074 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 55.56 -121.39 1.69 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.377 1.071 . . . . 100.0 113.241 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -97.43 112.58 24.36 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.911 1.232 . . . . 100.0 111.6 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 41.4 pt -144.62 149.5 43.85 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 104.49 -2.411 . . . . 100.0 104.49 176.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.27 129.26 27.73 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.28 1.987 . . . . 100.0 112.608 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.72 ' HB ' HD22 ' A' ' 144' ' ' LEU . 66.9 mt -133.12 135.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.275 -1.379 . . . . 100.0 107.275 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.08 131.67 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 114.303 -1.317 . . . . 100.0 108.389 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 139' ' ' HIS 0.261 86.0 mt -98.82 127.31 44.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.461 -2.051 . . . . 100.0 105.461 177.373 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.74 125.34 49.43 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.871 0.843 . . . . 100.0 111.686 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.68 101.1 2.57 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 104.026 -3.629 . . . . 100.0 104.026 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.83 162.02 24.19 Favored 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 124.966 1.306 . . . . 100.0 112.532 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 58.1 40.81 24.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 127.76 2.424 . . . . 100.0 115.324 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.39 -15.0 18.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 112.634 0.605 . . . . 100.0 112.634 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.43 -38.87 91.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.051 1.74 . . . . 100.0 110.35 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.45 131.58 29.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 124.024 0.93 . . . . 100.0 109.8 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.56 -42.88 91.35 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 116.593 2.072 . . . . 100.0 116.593 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.45 74.56 10.36 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-O 121.697 0.761 . . . . 100.0 110.121 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -83.73 137.42 33.76 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 115.669 -0.696 . . . . 100.0 110.557 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.66 -44.91 4.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.009 -0.541 . . . . 100.0 110.724 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.4 t -95.55 107.16 19.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 105.765 -1.939 . . . . 100.0 105.765 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -81.35 150.14 28.57 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.756 -1.111 . . . . 100.0 109.755 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.46 87.73 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.658 1.183 . . . . 100.0 111.988 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -62.4 -40.82 97.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.021 0.928 . . . . 100.0 111.267 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.3 m -62.15 -35.55 79.13 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.897 1.679 . . . . 100.0 113.511 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.37 121.36 13.24 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 CA-C-O 122.66 1.219 . . . . 100.0 109.774 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.604 HG12 HH21 ' A' ' 140' ' ' ARG . 29.2 m -128.49 -9.59 3.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-N 113.331 -1.759 . . . . 100.0 112.812 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.19 -41.85 84.82 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 125.233 1.413 . . . . 100.0 111.789 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.45 ' HB3' HD12 ' A' ' 119' ' ' LEU . 45.2 p-80 -61.47 -40.29 94.0 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.65 -0.691 . . . . 100.0 112.687 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.604 HH21 HG12 ' A' ' 137' ' ' VAL . 91.8 mtm-85 -64.41 -43.16 95.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.687 0.676 . . . . 100.0 112.301 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.47 -41.3 93.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.31 1.044 . . . . 100.0 111.638 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.2 7.2 47.08 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 117.488 2.403 . . . . 100.0 117.488 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.44 49.38 16.94 Favored 'General case' 0 C--N 1.362 1.144 0 CA-C-O 122.756 1.265 . . . . 100.0 112.813 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.72 HD22 ' HB ' ' A' ' 117' ' ' ILE . 43.7 mt -116.96 160.98 20.08 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.048 -1.093 . . . . 100.0 108.048 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.44 ' HG3' ' NE1' ' A' ' 163' ' ' TRP . 97.5 mm-40 -98.87 140.54 32.89 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -117.05 134.83 54.26 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.557 0.694 . . . . 100.0 112.41 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -134.15 136.87 44.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.328 -0.851 . . . . 100.0 111.999 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -88.29 125.45 34.67 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 101.165 -3.643 . . . . 100.0 101.165 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.93 157.29 38.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 CA-C-O 122.138 0.971 . . . . 100.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.3 t -141.86 116.43 9.67 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 105.285 -2.117 . . . . 100.0 105.285 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.43 -40.8 98.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.651 0.78 . . . . 100.0 109.651 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.32 -42.29 75.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.151 1.537 . . . . 100.0 115.151 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 m -93.16 -7.74 44.48 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 114.291 1.219 . . . . 100.0 114.291 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.471 HD21 ' HZ ' ' A' ' 35' ' ' PHE . 87.4 m-20 66.56 18.63 10.81 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.147 1.779 . . . . 100.0 112.81 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -69.66 118.92 13.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.45 -1.315 . . . . 100.0 107.45 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.52 33.16 15.57 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 127.383 2.273 . . . . 100.0 111.701 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.47 -39.31 90.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.324 1.601 . . . . 100.0 115.324 -175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -89.47 -8.12 53.58 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 115.616 1.71 . . . . 100.0 115.616 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 95.8 mttt -61.03 -44.27 93.85 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 118.189 2.663 . . . . 100.0 118.189 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.11 -41.3 61.94 Favored 'Trans proline' 0 C--N 1.374 1.894 0 CA-C-N 122.459 1.914 . . . . 100.0 112.994 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -64.5 -43.97 92.44 Favored 'General case' 0 CA--C 1.495 -1.141 0 O-C-N 124.055 0.847 . . . . 100.0 112.062 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.0 -42.86 94.11 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 113.098 0.777 . . . . 100.0 113.098 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.44 ' NE1' ' HG3' ' A' ' 145' ' ' GLN . 62.9 t-105 -62.82 -45.89 90.5 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 123.453 0.471 . . . . 100.0 110.224 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 85' ' ' CYS . 79.1 mt -60.65 -42.83 97.78 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 123.653 0.595 . . . . 100.0 110.819 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.32 99.08 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 123.668 0.787 . . . . 100.0 111.107 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.05 -45.12 94.95 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.609 0.764 . . . . 100.0 112.024 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.64 -43.4 76.36 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 112.469 0.544 . . . . 100.0 112.469 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.17 -46.64 80.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.195 0.813 . . . . 100.0 113.195 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.85 -38.62 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 125.127 1.371 . . . . 100.0 110.455 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.96 11.82 57.25 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 118.678 -1.068 . . . . 100.0 112.818 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -109.62 109.25 59.85 Favored Pre-proline 0 C--N 1.361 1.075 0 N-CA-C 106.719 -1.586 . . . . 100.0 106.719 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.35 -22.23 66.32 Favored 'Trans proline' 0 C--N 1.365 1.396 0 C-N-CA 124.087 3.191 . . . . 100.0 113.462 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -100.17 12.0 38.02 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 114.079 1.14 . . . . 100.0 114.079 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.16 131.65 51.17 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.516 0.726 . . . . 100.0 109.946 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--N 1.357 0.906 0 CA-C-N 115.883 -0.599 . . . . 100.0 111.158 -178.203 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 108.273 -1.01 . . . . 100.0 108.273 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.12 118.26 71.13 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.677 -2.342 . . . . 100.0 104.677 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.43 143.09 62.05 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 123.687 2.925 . . . . 100.0 116.211 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.26 160.58 48.46 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 123.626 2.884 . . . . 100.0 108.889 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.95 -48.15 83.17 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 112.927 0.714 . . . . 100.0 112.927 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.254 39.0 t 60.47 96.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.871 2.068 . . . . 100.0 112.603 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.18 -91.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 102.191 -3.263 . . . . 100.0 102.191 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.8 mtm 50.19 -130.35 2.06 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 127.951 2.501 . . . . 100.0 115.145 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.338 63.2 m-20 . . . . . 0 C--N 1.365 1.277 1 N-CA-C 124.788 5.107 . . . . 100.0 124.788 -179.557 . . . . . . . . 2 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 110.006 -0.368 . . . . 100.0 110.006 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -64.69 -41.12 96.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.255 1.422 . . . . 100.0 111.431 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.4 -42.82 99.34 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.882 0.873 . . . . 100.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -63.0 -45.55 91.87 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 123.995 0.918 . . . . 100.0 111.801 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.259 34.5 m -62.9 -39.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.363 1.193 0 CA-C-O 119.025 -0.512 . . . . 100.0 110.377 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.69 92.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.916 1.286 . . . . 100.0 112.238 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -62.74 -39.69 94.88 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.523 1.129 . . . . 100.0 111.43 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 84.8 m -65.52 -42.54 91.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.697 1.599 . . . . 100.0 111.488 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--N 1.358 0.949 0 C-N-CA 124.259 1.024 . . . . 100.0 112.329 -177.882 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 118.574 2.805 . . . . 100.0 118.574 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.267 19.1 tt0 -131.39 136.72 48.27 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.835 1.654 . . . . 100.0 108.237 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -128.33 131.93 48.61 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.877 -0.786 . . . . 100.0 108.877 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.2 tttt -90.44 115.35 27.54 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 105.294 -2.113 . . . . 100.0 105.294 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 14' ' ' VAL . 2.8 tt -116.51 130.24 56.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.362 -1.348 . . . . 100.0 107.362 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.556 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.7 t -111.25 125.39 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 118.577 -1.249 . . . . 100.0 109.713 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' CD1' HD22 ' A' ' 13' ' ' LEU . 7.6 mp -102.08 120.45 40.45 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -128.87 161.19 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.057 -1.429 . . . . 100.0 111.235 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.14 172.59 20.92 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.555 -1.418 . . . . 100.0 109.555 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.497 ' HB2' HG23 ' A' ' 97' ' ' THR . 87.9 m-20 -71.0 160.12 33.5 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.777 0.799 . . . . 100.0 112.827 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.52 140.09 40.41 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 110.316 -1.114 . . . . 100.0 110.316 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.68 89.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 118.608 -1.107 . . . . 100.0 114.536 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 p -64.05 -39.4 93.99 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 118.802 1.301 . . . . 100.0 114.084 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.54 17.83 5.94 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 118.992 -0.893 . . . . 100.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.56 -47.75 84.35 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 118.923 1.361 . . . . 100.0 110.611 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 m -64.83 -43.23 93.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.209 1.403 . . . . 100.0 111.158 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.4 m -63.08 -41.59 99.45 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.369 1.068 . . . . 100.0 109.483 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -61.3 -48.14 82.73 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.748 1.219 . . . . 100.0 110.429 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -43.08 96.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 122.739 0.415 . . . . 100.0 111.112 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HD3' ' HB2' ' A' ' 36' ' ' GLU . 87.9 tttt -61.56 -41.96 98.14 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.885 0.874 . . . . 100.0 111.056 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HG2' HH11 ' A' ' 29' ' ' ARG . 28.5 ttp85 -61.64 -43.21 99.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.041 0.937 . . . . 100.0 110.35 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -63.82 -41.32 97.89 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 112.829 0.677 . . . . 100.0 112.829 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -69.3 -44.44 71.76 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.355 1.613 . . . . 100.0 115.355 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.8 p -118.94 -23.1 7.03 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 117.708 2.484 . . . . 100.0 117.708 -176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.22 -7.74 72.46 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.582 -1.007 . . . . 100.0 110.582 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.12 153.93 31.71 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.857 1.663 . . . . 100.0 109.662 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -117.32 119.07 34.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.993 -2.966 . . . . 100.0 102.993 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 43.4 tt0 -99.25 119.06 37.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.608 -0.837 . . . . 100.0 108.854 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.7 -13.85 33.35 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.87 1.063 . . . . 100.0 113.87 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 199' ' ' HIS . 98.2 mttt -94.74 124.99 39.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.384 -1.339 . . . . 100.0 107.384 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -96.61 112.48 24.21 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.815 0.817 . . . . 100.0 109.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.33 124.33 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 102.453 -3.166 . . . . 100.0 102.453 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.97 142.43 57.46 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.172 1.175 . . . . 100.0 114.172 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.8 m -92.37 130.08 38.14 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.3 -2.111 . . . . 100.0 105.3 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -102.92 126.67 50.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.404 -0.961 . . . . 100.0 108.404 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.83 -121.89 18.03 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 109.543 -1.423 . . . . 100.0 109.543 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.08 141.73 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.216 -0.661 . . . . 100.0 109.216 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -124.26 125.1 43.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.084 -2.562 . . . . 100.0 104.084 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.85 121.52 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.561 -1.2 . . . . 100.0 108.169 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.86 122.14 25.57 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 115.583 -0.735 . . . . 100.0 111.269 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.12 128.35 7.28 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.561 2.841 . . . . 100.0 110.969 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -131.64 123.6 28.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.067 -1.086 . . . . 100.0 108.067 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.9 t -110.32 135.9 47.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 N-CA-C 108.863 -0.792 . . . . 100.0 108.863 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -124.35 138.52 54.37 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.495 -1.298 . . . . 100.0 107.495 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -98.59 126.28 44.12 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 107.208 -1.404 . . . . 100.0 107.208 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 p -124.11 -179.78 4.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.956 -1.02 . . . . 100.0 109.868 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.91 -35.6 73.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.052 2.141 . . . . 100.0 109.484 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.23 10.94 29.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 124.182 0.993 . . . . 100.0 113.554 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.53 176.1 25.03 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.758 -0.537 . . . . 100.0 111.758 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.71 136.8 40.13 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.365 2.71 . . . . 100.0 114.486 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.78 142.35 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.486 -1.672 . . . . 100.0 106.486 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -113.64 131.94 55.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.707 -0.797 . . . . 100.0 110.404 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -106.91 119.03 38.25 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.142 -2.54 . . . . 100.0 104.142 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -92.55 99.14 11.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 100.163 -4.014 . . . . 100.0 100.163 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 83.7 t -85.74 125.96 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-N 115.805 -0.634 . . . . 100.0 110.674 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.467 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 36.5 m95 -107.31 98.02 7.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.132 -2.173 . . . . 100.0 105.132 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -86.31 116.11 24.27 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 104.3 -2.481 . . . . 100.0 104.3 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.0 163.93 12.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 113.482 0.919 . . . . 100.0 113.482 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 133.02 35.13 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.28 1.032 . . . . 100.0 109.61 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.16 83.54 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 116.667 -0.242 . . . . 100.0 113.516 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -70.37 -40.69 73.85 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 127.243 2.217 . . . . 100.0 111.856 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.562 ' HB2' HH11 ' A' ' 76' ' ' ARG . 47.0 mt-10 -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.494 1.294 . . . . 100.0 114.494 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.32 151.65 45.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.313 -1.312 . . . . 100.0 109.765 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -68.24 131.59 45.64 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.242 -2.133 . . . . 100.0 105.242 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.44 -174.98 40.53 Favored Glycine 0 C--N 1.355 1.597 0 C-N-CA 118.728 -1.701 . . . . 100.0 114.818 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -22.26 65.03 Favored Glycine 0 C--N 1.353 1.498 0 C-N-CA 126.992 2.234 . . . . 100.0 113.552 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.67 -37.47 84.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.189 1.796 . . . . 100.0 110.03 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.562 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.4 mtp85 -88.64 7.72 32.08 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.431 1.892 . . . . 100.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.95 -38.57 89.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 116.615 2.08 . . . . 100.0 116.615 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -38.07 90.2 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.676 0.655 . . . . 100.0 112.839 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.251 22.0 m-30 -62.35 -43.28 99.18 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.985 1.314 . . . . 100.0 109.856 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 3.4 t80 -90.95 -19.99 22.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.934 1.457 . . . . 100.0 114.934 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.38 135.8 24.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-N 119.631 1.105 . . . . 100.0 108.843 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 66.72 18.22 10.68 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.51 1.924 . . . . 100.0 114.245 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.28 146.69 48.77 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.98 -1.118 . . . . 100.0 107.98 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -106.79 -21.74 12.94 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.698 -0.683 . . . . 100.0 111.2 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.486 ' SG ' ' HG ' ' A' ' 13' ' ' LEU . 7.5 p -160.38 164.96 31.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.718 0.807 . . . . 100.0 109.808 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -150.1 156.91 42.49 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 113.721 1.008 . . . . 100.0 113.721 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.19 127.17 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.316 -2.105 . . . . 100.0 105.316 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.2 mt -110.67 123.63 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 N-CA-C 103.113 -2.921 . . . . 100.0 103.113 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.49 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 57.2 mtt -113.75 135.03 54.39 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 116.542 2.053 . . . . 100.0 116.542 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -132.99 162.02 32.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.445 -1.707 . . . . 100.0 109.975 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -106.11 125.09 50.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.186 -1.783 . . . . 100.0 106.186 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -63.86 -19.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 N-CA-C 113.934 1.087 . . . . 100.0 113.934 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.3 p -90.1 -3.26 58.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 111.987 0.366 . . . . 100.0 111.987 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -124.69 115.08 20.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 122.527 1.156 . . . . 100.0 111.347 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -65.51 -39.55 91.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.742 -1.117 . . . . 100.0 111.078 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -61.64 -41.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 124.982 1.313 . . . . 100.0 109.19 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 18' ' ' ASP . 96.6 m -62.49 -41.72 99.0 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.959 0.504 . . . . 100.0 110.147 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -65.31 -40.29 93.59 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.238 0.615 . . . . 100.0 110.962 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -59.79 -35.87 75.54 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.259 1.024 . . . . 100.0 111.237 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -74.01 -11.67 60.4 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 115.415 1.635 . . . . 100.0 115.415 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.39 -43.73 96.84 Favored Pre-proline 0 C--N 1.362 1.12 0 CA-C-O 116.141 -1.885 . . . . 100.0 111.792 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 86.5 Cg_exo -57.37 -35.11 98.87 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.529 2.153 . . . . 100.0 111.939 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.32 -41.9 84.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 123.453 0.701 . . . . 100.0 111.291 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' O ' HD13 ' A' ' 108' ' ' LEU . 85.8 m95 -63.66 -45.73 88.81 Favored 'General case' 0 C--N 1.365 1.278 0 N-CA-C 109.197 -0.668 . . . . 100.0 109.197 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -90.79 69.81 6.55 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.838 -1.542 . . . . 100.0 106.838 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -167.75 -55.5 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 100.937 -3.727 . . . . 100.0 100.937 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.68 -43.27 99.24 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.674 -1.602 . . . . 100.0 106.674 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.415 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -63.31 -50.15 71.17 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.83 -23.59 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 113.287 0.847 . . . . 100.0 113.287 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -60.31 -41.24 93.04 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.674 0.79 . . . . 100.0 109.759 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.257 15.1 m -98.36 -34.43 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 115.958 1.836 . . . . 100.0 115.958 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.292 68.9 m -107.05 -4.62 18.75 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 117.823 2.527 . . . . 100.0 117.823 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.339 66.3 mt-10 53.59 -119.31 1.47 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.636 1.347 . . . . 100.0 114.636 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -95.94 112.11 23.93 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 118.386 -1.326 . . . . 100.0 111.872 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 pt -145.12 153.83 53.53 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -61.21 126.18 18.78 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.622 2.214 . . . . 100.0 111.78 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.643 ' HB ' HD22 ' A' ' 144' ' ' LEU . 61.1 mt -133.35 134.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.685 -1.228 . . . . 100.0 107.685 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -116.0 131.59 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.928 -1.487 . . . . 100.0 108.687 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.5 mt -100.03 126.4 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 104.957 -2.238 . . . . 100.0 104.957 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 70.9 m -118.18 125.0 49.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 122.026 0.917 . . . . 100.0 111.871 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.92 101.21 2.57 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 104.492 -3.443 . . . . 100.0 104.492 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -81.31 163.17 23.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.611 1.164 . . . . 100.0 112.17 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 57.78 42.02 24.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.877 2.471 . . . . 100.0 115.442 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 148' ' ' ASP . 31.0 m -67.5 -13.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 112.051 0.389 . . . . 100.0 112.051 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.38 -38.86 92.8 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.641 1.976 . . . . 100.0 110.399 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.06 133.89 28.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 124.19 0.996 . . . . 100.0 110.583 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.59 -46.94 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.081 1.882 . . . . 100.0 116.081 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -85.26 77.11 10.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.587 0.63 . . . . 100.0 110.723 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -85.57 134.05 34.03 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.05 -40.87 6.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.681 -0.691 . . . . 100.0 112.355 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.07 106.7 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 106.028 -1.841 . . . . 100.0 106.028 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.69 146.86 37.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.951 -1.022 . . . . 100.0 109.375 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.0 88.57 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.412 1.085 . . . . 100.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.58 -40.09 95.8 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.71 1.204 . . . . 100.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.1 m -61.9 -38.24 87.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.358 1.463 . . . . 100.0 113.233 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.73 122.37 14.48 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 122.389 1.09 . . . . 100.0 110.07 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.61 -6.55 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.848 0 CA-C-N 113.785 -1.552 . . . . 100.0 112.21 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -58.89 -39.66 82.12 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.86 1.264 . . . . 100.0 111.323 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -61.07 -39.95 91.85 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 123.497 0.719 . . . . 100.0 111.616 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.08 -43.64 94.79 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 118.662 0.664 . . . . 100.0 112.101 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.369 1.067 . . . . 100.0 111.337 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.22 6.94 47.57 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 118.325 2.713 . . . . 100.0 118.325 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 54.63 46.41 24.81 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.058 1.343 . . . . 100.0 113.943 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.643 HD22 ' HB ' ' A' ' 117' ' ' ILE . 38.0 mt -109.57 159.47 17.07 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.618 -1.173 . . . . 100.0 108.464 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -96.47 141.67 29.49 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.414 -1.699 . . . . 100.0 106.414 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -118.32 133.52 55.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.159 0.504 . . . . 100.0 111.268 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.74 134.85 43.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.663 -0.698 . . . . 100.0 111.991 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.436 ' HB3' HG11 ' A' ' 124' ' ' VAL . 43.3 m-20 -88.59 123.37 33.01 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 101.683 -3.451 . . . . 100.0 101.683 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.73 158.3 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 122.64 1.21 . . . . 100.0 112.302 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.7 t -143.12 111.32 6.13 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 105.751 -1.944 . . . . 100.0 105.751 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.89 92.14 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.549 -0.908 . . . . 100.0 108.549 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.17 -43.5 91.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 114.875 1.435 . . . . 100.0 114.875 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 87.5 p -100.89 -2.28 32.43 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 114.916 1.45 . . . . 100.0 114.916 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 70.79 9.53 6.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 125.774 1.629 . . . . 100.0 112.953 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -63.49 121.73 14.54 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.403 1.001 . . . . 100.0 108.945 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 53.34 34.58 18.23 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 127.271 2.228 . . . . 100.0 111.459 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 158' ' ' GLU . 10.8 p90 -59.67 -41.46 90.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.799 1.777 . . . . 100.0 115.799 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.44 ' HG3' ' CE2' ' A' ' 157' ' ' PHE . 94.3 mt-10 -93.04 -3.48 54.25 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 115.503 1.668 . . . . 100.0 115.503 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 96.8 mttt -60.36 -44.31 95.56 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 116.969 2.211 . . . . 100.0 116.969 -177.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.4 -43.11 42.78 Favored 'Trans proline' 0 C--N 1.375 1.956 0 CA-C-N 122.5 1.929 . . . . 100.0 113.095 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -64.65 -43.68 92.89 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.247 0.967 . . . . 100.0 111.863 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.28 -43.25 95.39 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 118.827 -0.606 . . . . 100.0 112.565 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -62.11 -46.62 88.24 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 123.487 0.492 . . . . 100.0 110.793 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 85' ' ' CYS . 83.5 mt -60.49 -42.77 97.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 124.131 0.895 . . . . 100.0 110.686 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.9 97.93 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.521 0.729 . . . . 100.0 111.154 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.434 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 72.2 mtt85 -63.48 -44.63 93.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 118.557 -0.735 . . . . 100.0 112.488 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -69.01 -43.14 75.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.406 0.441 . . . . 100.0 112.051 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.2 -46.91 75.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 113.239 0.829 . . . . 100.0 113.239 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.16 -38.42 77.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 125.29 1.436 . . . . 100.0 110.368 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.71 10.23 56.8 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 118.238 -1.312 . . . . 100.0 113.815 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -108.88 110.65 61.01 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.071 -1.455 . . . . 100.0 107.071 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.34 -22.22 66.36 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.912 3.074 . . . . 100.0 113.51 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -102.01 11.26 38.74 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 114.206 1.187 . . . . 100.0 114.206 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 25.4 tp -62.45 133.16 54.62 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 CA--C 1.484 -1.564 0 CA-C-O 121.337 0.589 . . . . 100.0 111.687 -179.328 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 107.753 -1.203 . . . . 100.0 107.753 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -75.13 127.48 86.52 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-O 119.367 -0.349 . . . . 100.0 110.4 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.39 143.31 42.9 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.573 2.848 . . . . 100.0 110.023 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -69.95 125.82 12.48 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.016 1.811 . . . . 100.0 110.254 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.57 -42.04 71.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 123.712 0.633 . . . . 100.0 110.864 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.566 33.9 m 52.55 63.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.113 0 N-CA-C 119.469 3.137 . . . . 100.0 119.469 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.03 -41.71 10.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.177 0 C-N-CA 124.818 1.247 . . . . 100.0 112.138 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 86.3 mtp -70.73 167.43 18.76 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.078 1.351 . . . . 100.0 113.476 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.363 1.191 0 N-CA-C 118.75 2.87 . . . . 100.0 118.75 -179.078 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 199' ' ' HIS . . . . . 0.453 ' CE1' ' HD2' ' A' ' 38' ' ' LYS . 39.3 t60 . . . . . 0 N--CA 1.442 -0.868 0 CA-C-O 119.756 -0.164 . . . . 100.0 110.724 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.75 -43.95 82.76 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.966 1.306 . . . . 100.0 112.073 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.27 -44.63 96.92 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-O 118.567 -0.73 . . . . 100.0 112.81 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.79 -47.52 84.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 123.829 0.706 . . . . 100.0 112.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.08 -41.0 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 O-C-N 123.828 0.705 . . . . 100.0 111.996 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.56 -45.37 72.28 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.68 1.363 . . . . 100.0 114.68 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -63.83 -40.44 96.6 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.861 1.265 . . . . 100.0 113.497 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.7 m -66.45 -40.97 89.75 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.626 1.17 . . . . 100.0 111.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 122.628 1.204 . . . . 100.0 111.865 -176.499 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 118.167 2.655 . . . . 100.0 118.167 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.288 45.9 tt0 -131.29 135.33 47.21 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.19 -2.152 . . . . 100.0 105.19 175.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . 0.278 80.9 m-85 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 106.439 -1.689 . . . . 100.0 106.439 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -92.38 118.28 30.77 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.341 -2.096 . . . . 100.0 105.341 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.845 HD22 ' SG ' ' A' ' 85' ' ' CYS 0.362 4.3 mt -114.9 132.51 56.51 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 105.797 -1.927 . . . . 100.0 105.797 -178.052 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 64' ' ' TRP . 39.8 t -110.24 127.75 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 116.47 -2.092 . . . . 100.0 106.823 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 tp -103.17 118.01 35.83 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.344 -1.354 . . . . 100.0 107.344 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 108' ' ' LEU . 29.4 m -127.83 162.0 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 125.479 1.512 . . . . 100.0 112.93 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.57 171.07 17.75 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.05 -1.62 . . . . 100.0 109.05 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HB2' HG23 ' A' ' 97' ' ' THR . 84.3 m-20 -70.42 159.27 34.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.97 0.89 . . . . 100.0 113.187 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.68 139.03 40.67 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.54 -1.024 . . . . 100.0 110.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 3.51 90.13 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-O 118.354 -1.248 . . . . 100.0 115.276 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 p -64.43 -38.75 92.13 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.095 1.448 . . . . 100.0 113.553 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 19.89 4.77 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 111.132 -0.787 . . . . 100.0 111.132 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.6 -48.72 80.55 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 124.334 1.054 . . . . 100.0 110.87 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.3 m -65.75 -43.42 88.96 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.228 1.411 . . . . 100.0 110.95 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.3 m -62.82 -41.66 99.4 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.393 1.077 . . . . 100.0 109.505 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.72 -47.51 84.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 124.103 0.961 . . . . 100.0 110.696 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.56 -41.31 91.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 O-C-N 122.893 0.121 . . . . 100.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.0 -39.92 93.88 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.56 0.744 . . . . 100.0 111.097 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.84 -44.09 97.43 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.069 0.548 . . . . 100.0 110.313 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -62.21 -43.92 97.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.812 0.671 . . . . 100.0 112.812 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.69 -44.74 66.36 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.547 2.055 . . . . 100.0 116.547 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.5 p -117.4 -24.93 7.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 117.521 2.415 . . . . 100.0 117.521 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.01 -8.08 70.05 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.695 -0.962 . . . . 100.0 110.695 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.88 156.36 30.41 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.469 1.107 . . . . 100.0 109.671 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -115.8 116.56 28.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 101.087 -3.671 . . . . 100.0 101.087 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -96.88 118.96 34.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.154 -1.424 . . . . 100.0 107.154 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.64 -11.18 34.84 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.828 -1.078 . . . . 100.0 113.235 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -101.22 126.18 47.92 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.174 -1.047 . . . . 100.0 108.174 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -95.04 116.42 28.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.927 0.87 . . . . 100.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.05 121.08 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.784 -3.413 . . . . 100.0 101.784 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.95 141.9 58.55 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.371 0.668 . . . . 100.0 112.591 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.7 m -94.51 129.06 41.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 105.281 -2.118 . . . . 100.0 105.281 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.37 129.15 48.75 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.053 -1.091 . . . . 100.0 108.053 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.69 14.32 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 109.614 -1.395 . . . . 100.0 109.614 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.48 143.25 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 109.157 -0.682 . . . . 100.0 109.157 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -127.32 125.55 41.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.608 -2.738 . . . . 100.0 103.608 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -99.04 125.46 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.509 -0.922 . . . . 100.0 108.509 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -121.45 123.71 27.51 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-N 114.803 -1.09 . . . . 100.0 111.176 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.423 ' CB ' ' HE3' ' A' ' 60' ' ' LYS . 75.8 Cg_endo -80.08 126.64 6.46 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.702 3.602 . . . . 100.0 111.91 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 tp -133.45 130.12 38.19 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.927 -1.138 . . . . 100.0 107.927 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -118.25 134.61 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.775 -0.824 . . . . 100.0 108.775 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -124.98 142.61 51.37 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.374 -0.973 . . . . 100.0 108.374 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -98.43 124.0 42.89 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.851 -0.796 . . . . 100.0 108.851 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.1 p -121.36 -177.67 3.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.336 -0.847 . . . . 100.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.22 -35.61 73.95 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.388 2.275 . . . . 100.0 109.333 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -88.21 3.25 50.06 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.13 1.372 . . . . 100.0 113.266 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.59 -179.5 22.73 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.117 -1.193 . . . . 100.0 110.117 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.66 137.29 45.4 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.348 2.698 . . . . 100.0 113.919 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -130.84 137.47 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.488 -1.301 . . . . 100.0 107.488 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HE3' ' CB ' ' A' ' 49' ' ' PRO . 85.4 tttt -105.1 133.51 49.76 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.967 0.889 . . . . 100.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.587 ' HD2' HD21 ' A' ' 13' ' ' LEU . 93.1 m-85 -110.94 116.85 31.92 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 103.098 -2.927 . . . . 100.0 103.098 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.06 99.25 11.89 Favored 'General case' 0 N--CA 1.434 -1.238 1 N-CA-C 99.979 -4.082 . . . . 100.0 99.979 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.53 125.69 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.768 -0.827 . . . . 100.0 108.768 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 31.2 m95 -102.74 97.75 7.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 105.089 -2.189 . . . . 100.0 105.089 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -85.84 116.32 24.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 104.938 -2.245 . . . . 100.0 104.938 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -99.53 166.06 11.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 114.576 1.324 . . . . 100.0 114.576 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.21 131.75 34.16 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.625 0.77 . . . . 100.0 109.301 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.71 -8.47 82.77 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.45 0.54 . . . . 100.0 114.45 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -70.6 -39.67 73.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.462 1.505 . . . . 100.0 112.731 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.534 ' HB2' HH11 ' A' ' 76' ' ' ARG . 49.0 mt-10 -62.33 134.56 56.66 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.472 1.509 . . . . 100.0 113.689 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.24 154.51 40.18 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.04 -0.982 . . . . 100.0 109.984 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -67.21 132.73 48.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 125.95 1.7 . . . . 100.0 107.673 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.72 -175.51 40.68 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.001 -1.571 . . . . 100.0 114.14 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.78 -23.28 65.23 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 126.747 2.118 . . . . 100.0 113.6 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.95 -28.34 69.75 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.416 1.087 . . . . 100.0 110.86 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.534 HH11 ' HB2' ' A' ' 70' ' ' GLU . 75.5 mtp85 -92.29 9.31 34.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.68 1.592 . . . . 100.0 114.562 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.59 -38.51 84.87 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 115.687 1.736 . . . . 100.0 115.687 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.95 89.89 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 124.271 0.939 . . . . 100.0 113.433 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -61.54 -48.32 81.52 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.129 0.972 . . . . 100.0 109.086 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HD1' ' HG ' ' A' ' 112' ' ' CYS 0.423 25.7 m-85 -70.64 -37.43 73.76 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 120.223 3.416 . . . . 100.0 120.223 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -54.03 131.97 16.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.78 0.8 . . . . 100.0 109.963 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 68.55 14.37 9.06 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.19 145.73 54.05 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-N 118.882 0.764 . . . . 100.0 109.864 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -102.87 -30.72 10.66 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.369 -0.832 . . . . 100.0 110.51 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.845 ' SG ' HD22 ' A' ' 13' ' ' LEU . 31.9 p -160.81 170.08 21.42 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.315 0.646 . . . . 100.0 109.472 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.48 157.46 43.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 113.333 0.864 . . . . 100.0 113.333 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.23 126.62 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.482 -2.414 . . . . 100.0 104.482 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.2 mt -109.59 123.97 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 103.286 -2.857 . . . . 100.0 103.286 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.455 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 40.4 mtt -114.09 135.28 54.2 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 115.322 1.601 . . . . 100.0 115.322 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -132.75 159.62 39.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.926 -1.943 . . . . 100.0 110.003 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -103.72 125.07 49.95 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.105 -1.813 . . . . 100.0 106.105 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.51 -19.79 24.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 114.117 1.154 . . . . 100.0 114.117 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.4 p -88.45 -6.55 57.57 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 119.072 -0.49 . . . . 100.0 111.51 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -123.18 114.29 20.09 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.804 1.287 . . . . 100.0 112.238 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -65.43 -38.49 90.04 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.398 -1.274 . . . . 100.0 111.327 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.996 1.318 . . . . 100.0 109.154 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.54 HG23 ' HB2' ' A' ' 18' ' ' ASP . 99.8 m -62.76 -41.32 99.16 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.94 0.496 . . . . 100.0 110.16 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.23 -39.84 93.28 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.541 0.736 . . . . 100.0 110.973 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.501 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -59.33 -36.71 76.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.687 1.195 . . . . 100.0 111.101 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.28 -10.67 59.82 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 115.782 1.771 . . . . 100.0 115.782 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.43 -43.82 96.86 Favored Pre-proline 0 C--N 1.36 1.034 0 CA-C-O 116.128 -1.891 . . . . 100.0 111.621 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.8 Cg_exo -58.35 -33.6 97.91 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.576 2.184 . . . . 100.0 112.503 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -67.23 -42.99 83.12 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.782 0.833 . . . . 100.0 109.862 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.567 ' O ' HD13 ' A' ' 108' ' ' LEU . 85.3 m95 -63.26 -46.98 84.32 Favored 'General case' 0 C--N 1.368 1.375 0 N-CA-C 108.649 -0.871 . . . . 100.0 108.649 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -89.53 70.75 7.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.892 1.33 . . . . 100.0 107.776 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -168.4 -55.54 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 100.315 -3.957 . . . . 100.0 100.315 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.267 -1.383 . . . . 100.0 107.267 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.567 HD13 ' O ' ' A' ' 104' ' ' TRP . 7.1 mp -61.88 -50.35 72.57 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.396 1.078 . . . . 100.0 112.806 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.259 32.8 m -70.15 -19.66 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 113.799 1.037 . . . . 100.0 113.799 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -60.55 -39.61 88.55 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.787 0.435 . . . . 100.0 110.511 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.89 -47.13 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-O 120.757 0.313 . . . . 100.0 110.792 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.549 ' HG ' ' HD1' ' A' ' 80' ' ' TYR . 95.9 m -70.87 -36.9 73.0 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 119.478 3.14 . . . . 100.0 119.478 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 61.72 -122.22 0.77 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 126.053 1.741 . . . . 100.0 109.31 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -93.41 113.02 25.08 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.294 1.861 . . . . 100.0 112.273 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 36.3 pt -144.4 149.16 43.4 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.133 -2.173 . . . . 100.0 105.133 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 85' ' ' CYS . 41.5 Cg_endo -64.31 128.99 22.78 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.018 1.812 . . . . 100.0 110.437 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.733 ' HB ' HD22 ' A' ' 144' ' ' LEU . 76.6 mt -131.91 135.09 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.316 -1.364 . . . . 100.0 107.316 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.33 131.69 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 114.402 -1.272 . . . . 100.0 107.799 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.9 126.55 43.34 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.388 -2.079 . . . . 100.0 105.388 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.455 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.95 125.93 50.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 122.055 0.931 . . . . 100.0 111.71 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.47 2.57 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 104.711 -3.356 . . . . 100.0 104.711 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.47 161.91 24.65 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.765 1.226 . . . . 100.0 112.489 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.4 mttt 57.81 43.28 22.03 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 127.858 2.463 . . . . 100.0 115.023 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 148' ' ' ASP . 28.7 m -68.9 -11.7 15.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 CA-C-N 115.983 -0.553 . . . . 100.0 111.603 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.51 -39.04 93.39 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.936 2.095 . . . . 100.0 109.74 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.06 132.02 29.82 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 C-N-CA 124.095 0.958 . . . . 100.0 110.132 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.83 -45.0 91.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 116.435 2.013 . . . . 100.0 116.435 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -84.93 77.51 10.09 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.648 0.737 . . . . 100.0 109.731 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -82.8 137.66 34.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.503 -0.925 . . . . 100.0 108.503 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.07 -42.69 5.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 119.4 -0.333 . . . . 100.0 111.496 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.1 107.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.59 -2.004 . . . . 100.0 105.59 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.62 148.86 36.68 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.104 -0.953 . . . . 100.0 109.349 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.22 90.32 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.165 0.986 . . . . 100.0 110.91 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -62.4 -40.8 97.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.661 1.184 . . . . 100.0 110.907 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 65.4 m -61.49 -37.64 84.39 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.686 1.594 . . . . 100.0 113.556 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.42 123.52 15.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 CA-C-O 122.523 1.154 . . . . 100.0 110.035 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.64 HG12 HH21 ' A' ' 140' ' ' ARG . 27.4 m -127.52 -10.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 CA-C-N 113.531 -1.668 . . . . 100.0 112.592 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -58.49 -40.34 82.49 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.1 1.36 . . . . 100.0 111.864 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -61.17 -40.01 92.28 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 118.679 -0.677 . . . . 100.0 111.601 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.64 HH21 HG12 ' A' ' 137' ' ' VAL . 87.0 mtm-85 -64.04 -43.6 95.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 112.806 0.669 . . . . 100.0 112.806 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.65 -42.21 95.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 123.566 0.746 . . . . 100.0 111.853 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -97.28 6.81 47.74 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 117.902 2.556 . . . . 100.0 117.902 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.26 71.2 m-20 53.23 50.75 16.97 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-O 123.062 1.41 . . . . 100.0 114.279 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.733 HD22 ' HB ' ' A' ' 117' ' ' ILE . 35.3 mt -114.38 158.29 21.71 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.981 -1.463 . . . . 100.0 107.092 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.413 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 97.0 mm-40 -98.78 143.77 28.76 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.259 -1.015 . . . . 100.0 108.259 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -117.34 136.06 53.41 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.25 0.548 . . . . 100.0 112.344 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.05 137.74 44.87 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.356 -0.838 . . . . 100.0 112.838 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.423 ' HB3' HG11 ' A' ' 124' ' ' VAL . 48.8 m-20 -89.42 123.88 33.97 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 101.583 -3.488 . . . . 100.0 101.583 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.3 pt -133.85 157.44 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.623 1.201 . . . . 100.0 112.084 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -143.91 111.36 5.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.066 0.946 . . . . 100.0 108.553 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.34 -46.79 84.95 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 126.637 1.975 . . . . 100.0 113.365 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.2 p -100.75 -2.84 31.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 115.44 1.645 . . . . 100.0 115.44 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 70.47 11.47 7.36 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.337 1.855 . . . . 100.0 113.353 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.2 118.33 10.45 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.686 -1.227 . . . . 100.0 107.686 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 54.31 29.31 10.58 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 128.756 2.822 . . . . 100.0 111.952 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . 0.413 3.7 p90 -62.53 -35.92 80.95 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 114.216 1.191 . . . . 100.0 114.216 -175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.272 40.6 mt-10 -85.93 -8.33 58.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.304 1.964 . . . . 100.0 116.304 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.303 95.3 mttt -60.6 -44.11 94.45 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 117.149 2.278 . . . . 100.0 117.149 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -59.45 -40.48 66.53 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-N 122.333 1.869 . . . . 100.0 112.962 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.31 -44.36 95.18 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 124.608 1.163 . . . . 100.0 111.194 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.89 -43.71 92.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 112.661 0.615 . . . . 100.0 112.661 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.413 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 67.9 t-105 -61.92 -45.86 91.86 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 123.28 0.362 . . . . 100.0 110.577 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 85' ' ' CYS . 89.6 mt -61.04 -42.8 99.17 Favored 'General case' 0 CA--C 1.495 -1.167 0 O-C-N 123.959 0.787 . . . . 100.0 110.442 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.3 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.554 0.741 . . . . 100.0 110.955 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.436 ' HG2' ' HB2' ' A' ' 174' ' ' LEU . 71.5 mtt85 -62.52 -45.33 93.49 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 123.147 0.579 . . . . 100.0 112.401 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.33 -43.55 77.29 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 112.119 0.415 . . . . 100.0 112.119 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.69 -47.2 76.25 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.776 1.028 . . . . 100.0 113.776 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.26 -38.7 75.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 124.162 0.985 . . . . 100.0 109.852 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.22 9.63 55.38 Favored Glycine 0 C--N 1.353 1.472 0 CA-C-O 118.306 -1.274 . . . . 100.0 114.051 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.536 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 59.9 t0 -109.74 113.02 58.03 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 106.665 -1.606 . . . . 100.0 106.665 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.99 -16.91 50.81 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 123.87 3.047 . . . . 100.0 113.092 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -97.39 8.38 44.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 57.1 mt -60.89 134.13 56.78 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 119.233 0.924 . . . . 100.0 112.568 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.43 -1.427 0 CA-C-N 114.839 -1.073 . . . . 100.0 109.857 -179.174 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.1 mt . . . . . 0 N--CA 1.436 -1.156 0 N-CA-C 105.914 -1.884 . . . . 100.0 105.914 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -132.78 144.76 54.26 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -64.53 148.15 90.49 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.778 2.319 . . . . 100.0 110.626 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.33 154.4 68.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 123.701 2.934 . . . . 100.0 114.144 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -61.6 -49.13 77.83 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.17 0.918 . . . . 100.0 111.19 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.301 5.9 m 52.35 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 128.214 2.605 . . . . 100.0 117.848 177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.84 -67.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.387 0 N-CA-C 107.819 -1.178 . . . . 100.0 107.819 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.1 ptp -70.57 156.33 39.56 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 114.657 1.355 . . . . 100.0 114.657 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.6 t70 . . . . . 0 C--N 1.36 1.034 0 N-CA-C 116.475 2.028 . . . . 100.0 116.475 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.438 -1.036 0 CA-C-O 118.794 -0.622 . . . . 100.0 111.156 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -64.73 -43.16 94.28 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.042 0.937 . . . . 100.0 111.529 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.49 -41.8 97.83 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 124.312 1.045 . . . . 100.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.37 -42.54 98.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.424 1.09 . . . . 100.0 110.963 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.12 -43.65 96.72 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 108.325 -0.991 . . . . 100.0 108.325 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.0 90.1 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.269 1.027 . . . . 100.0 113.333 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -63.3 -40.39 97.22 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 125.11 1.364 . . . . 100.0 112.713 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 66.4 m -65.89 -41.79 91.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.879 1.672 . . . . 100.0 110.265 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m . . . . . 0 C--N 1.361 1.102 0 CA-C-O 122.991 1.377 . . . . 100.0 107.87 -178.281 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.413 HG23 HG23 ' A' ' 59' ' ' ILE . 23.4 m . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 115.259 1.577 . . . . 100.0 115.259 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.262 11.1 tt0 -125.87 131.71 52.32 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.448 -2.427 . . . . 100.0 104.448 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.407 ' CD1' HD13 ' A' ' 168' ' ' LEU . 90.7 m-85 -125.71 134.12 51.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.268 -0.641 . . . . 100.0 109.268 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.0 tttt -90.69 116.3 28.46 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.016 -1.105 . . . . 100.0 108.016 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 85' ' ' CYS . 41.5 mt -113.6 131.56 56.07 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.059 -1.459 . . . . 100.0 107.059 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 t -109.3 123.36 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.521 -1.659 . . . . 100.0 106.521 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.468 HD11 ' SD ' ' A' ' 89' ' ' MET . 64.6 tp -103.25 115.65 30.97 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.667 -1.605 . . . . 100.0 106.667 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.68 162.59 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 113.777 -1.556 . . . . 100.0 110.625 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.05 168.07 14.87 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 108.098 -2.001 . . . . 100.0 108.098 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 97' ' ' THR . 71.1 m-20 -72.1 159.94 33.3 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 140.24 40.89 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.756 -1.338 . . . . 100.0 109.756 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.84 1.77 89.81 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-O 118.913 -0.937 . . . . 100.0 114.344 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.2 m -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.59 1.195 . . . . 100.0 112.303 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.08 15.49 7.79 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.956 -0.858 . . . . 100.0 110.956 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -60.94 -44.12 97.7 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.289 1.435 . . . . 100.0 111.436 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -65.17 -42.33 93.79 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.224 1.41 . . . . 100.0 109.738 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.16 -41.59 99.29 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.13 1.372 . . . . 100.0 109.369 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.15 -48.11 83.12 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.137 1.775 . . . . 100.0 109.769 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.87 -43.52 96.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 122.568 0.347 . . . . 100.0 111.491 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -40.13 95.22 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.211 0.604 . . . . 100.0 112.099 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 35.1 ttp180 -62.15 -44.13 97.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.543 1.137 . . . . 100.0 109.482 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.84 -42.9 97.49 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.331 0.514 . . . . 100.0 112.081 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.4 -48.41 75.53 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.508 1.67 . . . . 100.0 115.508 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.1 p -121.55 -21.62 6.16 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.06 -7.56 69.74 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 110.586 -1.006 . . . . 100.0 110.586 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 149.95 39.59 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.351 1.06 . . . . 100.0 109.666 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.435 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 98.3 m-85 -111.91 125.69 54.32 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.546 -2.761 . . . . 100.0 103.546 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.06 114.17 28.07 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 118.925 -1.11 . . . . 100.0 110.575 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.66 -43.29 63.36 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.659 -1.155 . . . . 100.0 113.047 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.02 135.45 44.91 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.514 1.525 . . . . 100.0 111.397 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -103.1 119.12 38.27 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.007 -1.479 . . . . 100.0 107.007 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.3 123.69 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 102.92 -2.993 . . . . 100.0 102.92 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 139.0 58.72 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.596 0.712 . . . . 100.0 112.198 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.0 m -97.07 125.06 41.26 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.326 -2.472 . . . . 100.0 104.326 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -106.09 130.11 54.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.464 -1.68 . . . . 100.0 106.464 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.8 -127.1 33.16 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 109.547 -1.421 . . . . 100.0 109.547 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -128.09 139.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 121.22 0.533 . . . . 100.0 109.89 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -115.53 123.16 47.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 103.58 -2.748 . . . . 100.0 103.58 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.65 120.4 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 106.894 -1.521 . . . . 100.0 106.894 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -124.6 121.72 25.79 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.273 -0.876 . . . . 100.0 111.007 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -78.71 130.43 9.7 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 123.598 2.866 . . . . 100.0 111.03 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.58 128.52 48.05 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.873 -1.529 . . . . 100.0 106.873 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.04 128.56 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.583 -1.636 . . . . 100.0 106.583 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.14 131.45 56.41 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -99.33 122.54 42.61 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.228 -1.767 . . . . 100.0 106.228 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.8 p -122.42 -179.99 4.38 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.633 -0.712 . . . . 100.0 111.459 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -59.07 -37.36 76.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.913 1.685 . . . . 100.0 109.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -87.67 2.93 49.72 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.065 0.765 . . . . 100.0 113.065 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.27 -179.9 19.14 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 121.557 -0.715 . . . . 100.0 111.399 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.3 140.87 54.57 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.263 2.642 . . . . 100.0 113.794 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 9' ' ' VAL . 86.9 mt -130.35 138.58 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 103.565 -2.754 . . . . 100.0 103.565 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -116.27 128.66 55.77 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 118.972 -1.091 . . . . 100.0 108.692 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.64 118.06 35.81 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.077 -2.194 . . . . 100.0 105.077 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -91.94 106.46 18.48 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 101.889 -3.374 . . . . 100.0 101.889 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.84 124.95 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 107.966 -1.124 . . . . 100.0 107.966 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.429 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 19.2 m0 -103.56 106.8 17.41 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.304 -1.739 . . . . 100.0 106.304 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -86.04 116.29 24.17 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 104.136 -2.542 . . . . 100.0 104.136 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.3 p -98.44 163.11 12.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.46 0.911 . . . . 100.0 113.46 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.66 130.95 34.98 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.312 -0.995 . . . . 100.0 108.312 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.5 -11.0 80.94 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 116.624 -0.262 . . . . 100.0 112.56 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -67.6 -39.74 84.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.796 2.039 . . . . 100.0 111.809 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -61.32 141.73 57.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.275 1.43 . . . . 100.0 114.616 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.01 150.73 46.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.213 1.405 . . . . 100.0 110.982 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -72.95 132.22 43.17 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.236 -1.394 . . . . 100.0 107.236 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.3 -167.25 33.91 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 119.077 -1.535 . . . . 100.0 115.007 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.69 -22.0 63.57 Favored Glycine 0 C--N 1.355 1.585 0 C-N-CA 127.541 2.496 . . . . 100.0 114.49 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.78 -38.41 87.96 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.236 1.814 . . . . 100.0 109.293 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -82.77 -2.21 53.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.301 2.64 . . . . 100.0 113.959 -176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.29 -42.93 96.51 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -37.87 91.55 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 123.907 0.765 . . . . 100.0 113.489 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -62.18 -43.52 98.65 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.236 1.814 . . . . 100.0 108.983 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 8.2 t80 -90.89 -13.94 32.68 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 114.296 1.221 . . . . 100.0 114.296 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.8 mt -60.69 134.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 CA-C-N 119.333 0.969 . . . . 100.0 109.876 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.29 24.55 14.32 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.498 1.919 . . . . 100.0 114.196 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.24 138.94 45.86 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 108.218 -1.03 . . . . 100.0 108.218 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.02 -34.61 13.64 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.138 -0.937 . . . . 100.0 108.676 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 13' ' ' LEU . 64.7 m -153.94 164.04 39.07 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 123.026 0.53 . . . . 100.0 110.978 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -139.98 153.32 46.84 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 113.838 1.051 . . . . 100.0 113.838 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.25 123.92 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 103.293 -2.854 . . . . 100.0 103.293 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.2 mt -110.21 122.38 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 102.579 -3.119 . . . . 100.0 102.579 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.492 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 58.5 mtp -112.23 132.99 54.62 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 113.574 0.953 . . . . 100.0 113.574 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.38 159.22 37.66 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 113.631 -1.622 . . . . 100.0 108.742 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -101.72 124.97 48.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.15 -2.167 . . . . 100.0 105.15 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.75 -21.87 29.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 113.683 0.994 . . . . 100.0 113.683 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.1 p -89.98 -4.58 57.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 118.888 -0.577 . . . . 100.0 111.591 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.16 115.78 24.33 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 122.464 1.126 . . . . 100.0 111.569 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.85 -38.44 86.38 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 114.362 -1.29 . . . . 100.0 110.554 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.76 -43.04 96.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 C-N-CA 125.394 1.478 . . . . 100.0 109.892 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 18' ' ' ASP . 92.2 m -63.16 -42.38 99.41 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.086 -0.709 . . . . 100.0 109.086 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -63.45 -40.23 96.58 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.29 0.636 . . . . 100.0 110.207 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -60.69 -37.41 81.55 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.314 1.046 . . . . 100.0 111.762 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.32 -12.03 60.7 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 114.502 1.297 . . . . 100.0 114.502 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.07 -43.4 94.01 Favored Pre-proline 0 C--N 1.364 1.203 0 CA-C-O 116.252 -1.832 . . . . 100.0 111.509 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 87.1 Cg_exo -58.65 -34.63 99.03 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.347 2.031 . . . . 100.0 112.645 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.38 -43.63 85.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.951 0.782 . . . . 100.0 110.106 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.426 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.8 m95 -62.98 -46.6 86.95 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -91.01 63.86 5.25 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.947 1.356 . . . . 100.0 109.524 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.0 ttm105 -157.93 -57.81 0.08 Allowed 'General case' 0 CA--C 1.485 -1.533 1 N-CA-C 100.155 -4.017 . . . . 100.0 100.155 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.66 -41.17 98.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.395 -0.965 . . . . 100.0 108.395 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.512 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 6.5 mp -62.04 -46.24 90.04 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.936 0.895 . . . . 100.0 111.492 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.55 -38.95 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 126.267 1.827 . . . . 100.0 109.543 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -59.7 -46.2 89.8 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.817 -0.438 . . . . 100.0 109.817 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.91 -49.25 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 115.494 1.665 . . . . 100.0 115.494 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.8 m -113.45 9.13 18.05 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 120.788 3.625 . . . . 100.0 120.788 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 55.45 -124.79 2.09 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.473 1.109 . . . . 100.0 112.561 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -102.74 115.74 31.19 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 120.276 1.398 . . . . 100.0 109.667 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 41.7 pt -141.68 152.6 63.37 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 103.76 -2.681 . . . . 100.0 103.76 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.06 127.6 22.73 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.155 1.904 . . . . 100.0 112.412 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.705 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.2 mt -131.26 135.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 107.209 -1.404 . . . . 100.0 107.209 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.13 131.57 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.672 -1.233 . . . . 100.0 107.672 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 139' ' ' HIS . 86.5 mt -98.87 125.6 44.31 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.491 -2.411 . . . . 100.0 104.491 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.492 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.5 m -115.84 123.36 47.97 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.334 -0.848 . . . . 100.0 109.468 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.61 101.49 2.63 Favored Glycine 0 CA--C 1.485 -1.806 1 N-CA-C 102.8 -4.12 . . . . 100.0 102.8 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -86.73 165.72 15.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.985 0.898 . . . . 100.0 110.61 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 60.48 41.72 15.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 128.515 2.726 . . . . 100.0 113.521 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.5 m -67.52 -15.54 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 CA-C-N 115.866 -0.606 . . . . 100.0 111.937 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.74 -39.42 91.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.034 2.134 . . . . 100.0 110.355 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.01 130.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 124.12 0.968 . . . . 100.0 108.498 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.46 -39.24 88.72 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 117.022 2.23 . . . . 100.0 117.022 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -83.04 76.78 9.82 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.892 0.853 . . . . 100.0 109.049 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -88.5 129.27 35.49 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.533 -1.284 . . . . 100.0 107.533 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.51 -41.25 7.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 115.407 -0.815 . . . . 100.0 111.216 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.69 108.26 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 103.803 -2.666 . . . . 100.0 103.803 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.47 151.31 23.62 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.777 -1.101 . . . . 100.0 110.665 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.45 96.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.165 0.986 . . . . 100.0 112.245 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.94 -41.16 99.41 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.331 1.053 . . . . 100.0 110.801 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.4 m -63.03 -38.13 89.96 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.999 1.72 . . . . 100.0 114.072 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.46 123.54 16.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 122.128 0.966 . . . . 100.0 109.204 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.25 -9.0 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.567 1.547 . . . . 100.0 111.464 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -59.17 -45.05 92.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.061 1.344 . . . . 100.0 111.935 -176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.479 ' HB3' HD12 ' A' ' 119' ' ' LEU . 52.5 p-80 -62.51 -41.02 98.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.799 0.666 . . . . 100.0 112.799 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.64 -45.86 90.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.168 1.387 . . . . 100.0 110.377 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.98 -42.62 89.6 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.498 0.719 . . . . 100.0 112.759 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -90.84 1.92 56.56 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 115.715 1.746 . . . . 100.0 115.715 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 55.92 47.17 20.6 Favored 'General case' 0 C--N 1.361 1.092 0 CA-C-O 122.922 1.344 . . . . 100.0 113.025 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.705 HD22 ' HB ' ' A' ' 117' ' ' ILE . 40.6 mt -112.59 160.07 18.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.323 -1.362 . . . . 100.0 107.323 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -96.6 140.6 30.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.14 -1.059 . . . . 100.0 108.14 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -117.24 131.41 56.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.176 0.513 . . . . 100.0 111.469 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . 0.255 81.4 m-85 -128.75 138.3 52.03 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 114.979 -1.01 . . . . 100.0 111.616 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.39 121.34 31.54 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 101.973 -3.343 . . . . 100.0 101.973 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.17 152.97 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 CA-C-O 122.537 1.161 . . . . 100.0 111.535 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.1 t -134.8 117.09 15.57 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.116 -2.55 . . . . 100.0 104.116 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.94 88.63 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.703 0.627 . . . . 100.0 109.617 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.64 -41.16 79.8 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 115.426 1.639 . . . . 100.0 115.426 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -90.92 -4.63 56.37 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 115.275 1.584 . . . . 100.0 115.275 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.51 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 65.7 m-80 63.7 22.74 13.23 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.018 1.327 . . . . 100.0 112.484 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -76.0 123.6 26.01 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.239 -1.763 . . . . 100.0 106.239 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 53.27 40.54 31.44 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.141 2.176 . . . . 100.0 111.76 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.59 -49.31 76.81 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 126.227 1.811 . . . . 100.0 114.487 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -94.68 -6.82 42.42 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 115.424 1.639 . . . . 100.0 115.424 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.284 96.1 mttt -59.72 -45.3 98.48 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 118.857 2.91 . . . . 100.0 118.857 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -60.16 -41.67 49.54 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 122.782 2.029 . . . . 100.0 112.756 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -63.82 -45.04 91.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 124.235 0.959 . . . . 100.0 111.229 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 162' ' ' LEU . 96.9 mt -63.91 -42.9 97.3 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 118.699 -0.667 . . . . 100.0 112.793 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.19 -44.4 95.47 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 123.736 0.648 . . . . 100.0 109.955 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 85' ' ' CYS . 87.7 mt -61.4 -44.14 97.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.498 0.719 . . . . 100.0 110.693 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.36 99.01 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 124.061 0.944 . . . . 100.0 111.369 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -61.9 -45.3 94.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.216 1.007 . . . . 100.0 110.998 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.1 -44.66 83.72 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 113.598 0.962 . . . . 100.0 113.598 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.407 HD13 ' CD1' ' A' ' 11' ' ' PHE . 74.0 mt -63.48 -47.31 82.28 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 123.412 0.685 . . . . 100.0 112.061 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 91.8 mt -70.09 -39.15 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 124.191 0.996 . . . . 100.0 111.217 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.97 10.96 58.21 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-O 118.562 -1.132 . . . . 100.0 111.874 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -108.47 109.46 61.52 Favored Pre-proline 0 C--N 1.362 1.111 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.14 -22.89 53.61 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.718 2.946 . . . . 100.0 113.933 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -92.03 3.91 54.23 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.118 1.367 . . . . 100.0 113.521 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.39 130.75 47.63 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-N 118.411 0.55 . . . . 100.0 110.175 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 . . . . . 0 N--CA 1.438 -1.032 0 CA-C-O 121.323 0.582 . . . . 100.0 111.169 -178.977 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 108.403 -0.962 . . . . 100.0 108.403 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -80.12 125.96 80.46 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.429 -1.322 . . . . 100.0 107.429 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.85 145.06 90.07 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 123.558 2.838 . . . . 100.0 113.261 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.96 166.27 30.08 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.532 2.821 . . . . 100.0 111.849 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -60.93 -43.86 98.05 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.446 1.098 . . . . 100.0 112.182 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.8 t 57.46 70.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.27 0 C-N-CA 126.484 1.913 . . . . 100.0 110.102 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.9 m -82.99 164.4 2.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 115.003 1.482 . . . . 100.0 115.003 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.305 61.5 mtm 51.42 -124.49 2.25 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 127.873 2.469 . . . . 100.0 116.816 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 . . . . . 0 C--N 1.369 1.421 0 N-CA-C 118.371 2.73 . . . . 100.0 118.371 -179.217 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 110.203 -0.295 . . . . 100.0 110.203 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -62.88 -40.93 99.03 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.97 1.308 . . . . 100.0 109.929 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.2 mt -62.9 -40.51 97.78 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.846 0.858 . . . . 100.0 110.316 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.37 -42.17 99.2 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.016 0.927 . . . . 100.0 110.871 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.71 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 C-N-CA 124.204 1.001 . . . . 100.0 108.418 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.13 98.82 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 124.419 1.088 . . . . 100.0 110.958 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -61.89 -42.7 99.39 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.943 1.297 . . . . 100.0 110.433 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.6 m -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.682 1.193 . . . . 100.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.4 m . . . . . 0 C--N 1.357 0.923 0 C-N-CA 124.205 1.002 . . . . 100.0 112.551 -178.541 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 121.871 0.843 . . . . 100.0 110.504 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -124.46 132.42 53.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.968 -2.234 . . . . 100.0 104.968 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -118.05 135.27 54.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.995 -1.113 . . . . 100.0 107.995 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -91.31 112.59 24.56 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.302 -1.74 . . . . 100.0 106.302 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 63' ' ' VAL . 41.4 tp -108.01 124.43 50.15 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.11 -1.859 . . . . 100.0 107.829 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 t -108.94 123.68 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.225 -1.769 . . . . 100.0 106.225 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.98 117.97 35.41 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.696 -1.594 . . . . 100.0 106.696 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -127.21 162.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 C-N-CA 125.11 1.364 . . . . 100.0 110.896 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.46 171.77 19.71 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 108.404 -1.878 . . . . 100.0 108.404 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.466 ' HB2' HG23 ' A' ' 97' ' ' THR . 65.4 m-20 -73.46 162.65 29.05 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.762 0.653 . . . . 100.0 112.762 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 140.52 36.18 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 110.079 -1.208 . . . . 100.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.12 1.63 90.54 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.667 0.651 . . . . 100.0 113.728 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.654 HG22 HD21 ' A' ' 122' ' ' ASN . 56.2 m -63.92 -41.57 97.63 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 117.817 0.809 . . . . 100.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.6 17.75 5.94 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.211 -0.995 . . . . 100.0 112.06 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.29 -46.62 89.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.122 1.369 . . . . 100.0 110.125 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.0 m -63.92 -43.39 96.07 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.395 1.478 . . . . 100.0 109.5 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -63.61 -41.07 98.34 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.265 1.026 . . . . 100.0 110.044 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.13 -48.34 82.12 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.306 1.442 . . . . 100.0 109.727 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.74 -43.76 96.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 C-N-CA 123.08 0.552 . . . . 100.0 111.217 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.09 -39.25 94.14 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 112.477 0.547 . . . . 100.0 112.477 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.459 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 39.9 ttp180 -61.49 -44.61 96.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 124.321 1.048 . . . . 100.0 108.99 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -63.56 -44.34 94.41 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 112.405 0.52 . . . . 100.0 112.405 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.96 -48.6 73.48 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 116.371 1.989 . . . . 100.0 116.371 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -119.23 -24.0 6.57 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.07 2.248 . . . . 100.0 117.07 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.92 73.4 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 110.434 -1.066 . . . . 100.0 110.434 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.43 151.71 38.07 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-N 118.017 0.908 . . . . 100.0 109.766 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.463 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 99.0 m-85 -110.61 127.2 55.14 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.111 -2.552 . . . . 100.0 104.111 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -104.55 116.92 32.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.798 -0.816 . . . . 100.0 108.798 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.0 -34.33 13.08 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 116.181 -0.463 . . . . 100.0 110.785 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -86.04 126.29 34.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.105 -1.072 . . . . 100.0 108.105 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -98.38 124.25 42.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.312 -1.355 . . . . 100.0 109.377 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.42 130.0 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 101.829 -3.397 . . . . 100.0 101.829 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.35 139.66 58.14 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.692 0.758 . . . . 100.0 112.861 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.2 m -93.58 123.46 36.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.075 -2.935 . . . . 100.0 103.075 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.17 125.98 50.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 105.959 -1.867 . . . . 100.0 105.959 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.26 -125.45 34.09 Favored Glycine 0 C--N 1.355 1.605 0 N-CA-C 109.147 -1.581 . . . . 100.0 109.147 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.82 139.1 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.559 0.695 . . . . 100.0 110.601 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -110.5 123.93 50.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.215 -2.883 . . . . 100.0 103.215 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.86 116.66 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 106.217 -1.772 . . . . 100.0 106.217 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.47 118.91 21.59 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 120.435 -0.506 . . . . 100.0 111.279 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -78.7 127.97 8.29 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.887 2.392 . . . . 100.0 109.658 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.24 126.84 45.81 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 106.248 -1.76 . . . . 100.0 106.248 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 128.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 100.0 105.875 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -118.66 131.74 56.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.649 -1.982 . . . . 100.0 105.649 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -97.28 123.98 41.25 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.0 p -124.19 179.71 4.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.815 -0.629 . . . . 100.0 110.85 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -58.79 -37.62 76.74 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.933 1.693 . . . . 100.0 110.208 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.45 -0.46 54.98 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 113.029 0.752 . . . . 100.0 113.029 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.53 -179.57 18.12 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 110.842 -0.903 . . . . 100.0 110.842 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.01 138.23 43.39 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.415 2.744 . . . . 100.0 113.437 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.98 140.41 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 103.258 -2.868 . . . . 100.0 103.258 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -115.5 127.97 55.67 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 118.649 -1.22 . . . . 100.0 109.35 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -104.77 118.65 37.09 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.56 -2.755 . . . . 100.0 103.56 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -92.48 109.42 20.82 Favored 'General case' 0 N--CA 1.427 -1.58 1 N-CA-C 98.798 -4.519 . . . . 100.0 98.798 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 13' ' ' LEU . 39.9 t -95.04 126.52 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.947 -1.501 . . . . 100.0 106.947 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -107.76 102.04 11.29 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.23 117.98 26.34 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 103.441 -2.8 . . . . 100.0 103.441 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.9 p -100.06 160.38 14.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 112.943 0.719 . . . . 100.0 112.943 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.0 36.97 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.085 -0.709 . . . . 100.0 109.085 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.36 -12.39 75.97 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 112.109 -0.396 . . . . 100.0 112.109 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.68 -39.46 84.47 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.625 1.57 . . . . 100.0 111.699 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.43 139.71 58.57 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.544 1.138 . . . . 100.0 113.385 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -67.15 147.91 52.5 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.48 1.912 . . . . 100.0 111.151 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -70.38 132.26 45.36 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.236 -1.764 . . . . 100.0 106.236 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.57 -166.87 33.96 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 119.118 -1.515 . . . . 100.0 115.534 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.36 -22.7 63.66 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 127.599 2.523 . . . . 100.0 114.337 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.0 -38.43 88.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.704 2.002 . . . . 100.0 110.021 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -82.99 -1.0 51.42 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 127.509 2.323 . . . . 100.0 113.895 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -42.85 93.61 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.476 2.399 . . . . 100.0 117.476 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -38.53 93.01 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 118.672 0.669 . . . . 100.0 113.345 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -62.36 -43.43 98.84 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 125.9 1.68 . . . . 100.0 109.592 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.546 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 6.3 t80 -89.84 -14.26 34.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 114.173 1.175 . . . . 100.0 114.173 -175.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -61.24 134.92 26.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 119.369 0.986 . . . . 100.0 109.358 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 66.1 20.25 11.18 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 127.363 2.265 . . . . 100.0 113.296 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.09 139.1 52.5 Favored 'General case' 0 C--N 1.365 1.278 0 O-C-N 121.199 -0.938 . . . . 100.0 108.669 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -99.54 -31.7 11.48 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.514 -0.767 . . . . 100.0 109.008 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.501 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.2 p -148.75 160.35 43.28 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 120.733 0.301 . . . . 100.0 111.431 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -143.36 150.81 39.66 Favored 'General case' 0 CA--C 1.487 -1.479 0 C-N-CA 119.371 -0.931 . . . . 100.0 113.021 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.413 HG13 HD11 ' A' ' 13' ' ' LEU . 97.0 mt -125.74 126.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 103.592 -2.744 . . . . 100.0 103.592 176.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.81 122.28 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.423 -3.177 . . . . 100.0 102.423 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.482 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 38.5 mtt -111.89 134.29 53.54 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 114.459 1.281 . . . . 100.0 114.459 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -130.14 157.17 43.16 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 112.546 -2.115 . . . . 100.0 109.229 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -102.18 125.53 48.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.08 -21.66 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.7 p -88.89 -5.84 57.73 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.996 -0.526 . . . . 100.0 111.62 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.1 t -119.79 116.79 26.61 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 122.859 1.314 . . . . 100.0 111.841 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.11 -39.71 86.73 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.887 -1.506 . . . . 100.0 110.804 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.79 -43.33 97.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 C-N-CA 125.24 1.416 . . . . 100.0 109.456 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.176 0.59 . . . . 100.0 109.914 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.44 -40.42 95.7 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.911 0.485 . . . . 100.0 110.723 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.2 mttt -60.77 -37.23 81.16 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.118 0.967 . . . . 100.0 111.445 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -73.43 -11.49 60.48 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 114.995 1.48 . . . . 100.0 114.995 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.35 -43.11 92.32 Favored Pre-proline 0 C--N 1.363 1.16 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.48 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 90.9 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.726 2.284 . . . . 100.0 112.702 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.55 -43.03 86.21 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.488 1.115 . . . . 100.0 109.901 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.441 ' O ' HD13 ' A' ' 108' ' ' LEU . 81.0 m95 -63.16 -46.21 88.25 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -90.74 65.0 5.77 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 123.054 1.407 . . . . 100.0 107.883 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -159.69 -57.0 0.06 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 100.567 -3.864 . . . . 100.0 100.567 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.02 -43.72 98.24 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.107 1.363 . . . . 100.0 108.254 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -62.5 -46.34 88.88 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.267 1.027 . . . . 100.0 112.145 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.53 -39.84 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 126.498 1.919 . . . . 100.0 109.309 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -59.68 -45.19 92.83 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.113 0.565 . . . . 100.0 110.75 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.99 -50.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 72.3 m -115.03 9.4 15.99 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.989 3.329 . . . . 100.0 119.989 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.257 80.9 mm-40 53.82 -123.16 2.1 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.45 1.5 . . . . 100.0 113.943 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -98.13 112.97 24.74 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.631 1.105 . . . . 100.0 112.416 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.3 pt -143.35 151.75 55.56 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 104.161 -2.533 . . . . 100.0 104.161 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.52 127.97 22.27 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 121.982 1.788 . . . . 100.0 112.503 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 144' ' ' LEU . 59.7 mt -130.56 136.0 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 107.271 -1.381 . . . . 100.0 107.271 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.84 131.39 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.175 -1.375 . . . . 100.0 107.922 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 139' ' ' HIS . 87.9 mt -99.43 125.12 45.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 104.329 -2.471 . . . . 100.0 104.329 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.8 m -116.49 122.19 44.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.986 0.898 . . . . 100.0 110.328 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.53 101.84 2.69 Favored Glycine 0 CA--C 1.476 -2.394 1 N-CA-C 102.862 -4.095 . . . . 100.0 102.862 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.654 HD21 HG22 ' A' ' 21' ' ' THR 0.412 56.7 p30 -92.69 170.31 9.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 118.899 -1.12 . . . . 100.0 113.943 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 93.1 mttt 60.81 40.39 15.99 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 128.105 2.562 . . . . 100.0 112.155 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 148' ' ' ASP . 33.5 m -65.77 -18.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.474 0.71 . . . . 100.0 112.893 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.28 -39.14 89.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.054 1.742 . . . . 100.0 110.58 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.18 130.77 28.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 123.766 0.826 . . . . 100.0 109.109 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.35 -41.53 96.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.345 1.609 . . . . 100.0 115.345 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -84.26 81.39 8.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.482 0.658 . . . . 100.0 109.325 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -89.85 130.71 36.05 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.433 -1.321 . . . . 100.0 107.433 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.37 -44.36 7.26 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.598 -0.728 . . . . 100.0 109.821 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.95 112.16 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 105.026 -2.213 . . . . 100.0 105.026 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -86.38 150.87 24.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.787 -1.551 . . . . 100.0 110.106 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.25 94.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.171 0.989 . . . . 100.0 110.669 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.096 1.358 . . . . 100.0 110.839 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 m -62.66 -38.51 90.62 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 125.757 1.623 . . . . 100.0 112.695 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 76.4 mt -65.67 121.7 15.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.646 1.213 . . . . 100.0 110.358 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.58 -4.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 CA-C-N 113.627 -1.624 . . . . 100.0 111.07 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 66.3 t80 -59.77 -42.92 94.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.351 1.46 . . . . 100.0 111.339 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.469 ' HB3' HD12 ' A' ' 119' ' ' LEU . 48.1 p-80 -61.33 -42.19 98.28 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.534 0.733 . . . . 100.0 112.518 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -63.5 -45.07 92.37 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 123.937 0.895 . . . . 100.0 111.252 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.06 -41.19 95.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.512 0.725 . . . . 100.0 112.042 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 74.6 mmtt -92.64 1.97 56.97 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 116.222 1.934 . . . . 100.0 116.222 -177.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 55.58 49.23 16.97 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.227 1.411 . . . . 100.0 113.572 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 117' ' ' ILE . 44.5 mt -118.7 159.11 24.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.676 -1.602 . . . . 100.0 106.676 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.308 78.9 mt-30 -101.63 140.23 36.2 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 118.609 -1.236 . . . . 100.0 110.578 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -109.38 131.15 55.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.987 0.736 . . . . 100.0 112.987 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.31 134.22 48.86 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.634 -1.166 . . . . 100.0 111.403 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.4 ' HB3' HG11 ' A' ' 124' ' ' VAL . 32.1 m-20 -87.53 120.86 29.27 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 102.802 -3.036 . . . . 100.0 102.802 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.1 pt -130.93 154.4 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.355 1.074 . . . . 100.0 111.244 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.3 t -136.07 118.42 15.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.369 -2.456 . . . . 100.0 104.369 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.433 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.81 -44.99 88.08 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 123.273 0.629 . . . . 100.0 109.435 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.11 -43.56 86.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 114.276 1.213 . . . . 100.0 114.276 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.1 m -92.25 -5.22 52.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.276 1.584 . . . . 100.0 115.276 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.463 HD21 ' HZ ' ' A' ' 35' ' ' PHE . 63.9 m-80 64.26 21.78 12.62 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 124.861 1.264 . . . . 100.0 112.167 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -75.72 125.1 28.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.189 -1.782 . . . . 100.0 106.189 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 53.31 40.39 31.24 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.064 2.146 . . . . 100.0 111.979 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -57.71 -48.6 79.1 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 126.706 2.003 . . . . 100.0 111.297 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.501 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 92.7 mt-10 -80.59 -24.75 38.93 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 118.396 2.739 . . . . 100.0 118.396 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.302 95.0 mttt -59.16 -45.31 99.34 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 121.456 3.872 . . . . 100.0 121.456 -173.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -60.04 -45.81 22.11 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 123.098 2.142 . . . . 100.0 112.74 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 158' ' ' GLU 0.343 28.2 p90 -66.44 -40.72 89.63 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.346 1.029 . . . . 100.0 113.113 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 162' ' ' LEU . 94.9 mt -63.71 -43.23 97.18 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-O 118.403 -0.808 . . . . 100.0 112.877 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -63.89 -43.2 96.72 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 118.807 -0.616 . . . . 100.0 110.415 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 85' ' ' CYS . 77.2 mt -60.78 -44.5 96.71 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.601 0.563 . . . . 100.0 110.806 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.0 99.91 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.891 0.876 . . . . 100.0 111.417 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 97.8 mtt180 -62.96 -45.27 93.25 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.364 0.666 . . . . 100.0 111.473 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -64.32 -47.02 81.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.798 0.839 . . . . 100.0 112.347 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.93 -46.48 81.44 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.234 0.827 . . . . 100.0 113.234 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.08 -39.17 76.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 123.694 0.798 . . . . 100.0 110.527 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.62 8.53 59.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-O 118.669 -1.073 . . . . 100.0 111.82 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -102.46 108.36 57.18 Favored Pre-proline 0 C--N 1.361 1.096 0 N-CA-C 106.655 -1.609 . . . . 100.0 106.655 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.12 -23.22 53.4 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.969 3.113 . . . . 100.0 113.569 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.6 6.72 47.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.161 1.384 . . . . 100.0 113.676 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 23.3 tp -63.05 128.75 37.31 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.648 0.658 . . . . 100.0 110.127 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 . . . . . 0 CA--C 1.499 -1.012 0 CA-C-O 121.59 0.71 . . . . 100.0 110.509 -179.125 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 CA--C 1.484 -1.567 0 CA-C-O 121.317 0.579 . . . . 100.0 110.4 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.58 127.55 67.55 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 103.429 -2.804 . . . . 100.0 103.429 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.66 141.18 90.08 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.175 2.583 . . . . 100.0 114.208 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.83 167.39 27.39 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.839 3.026 . . . . 100.0 112.514 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.72 -42.21 96.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.68 1.592 . . . . 100.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.2 t 68.08 101.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.022 0 C-N-CA 127.374 2.27 . . . . 100.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.1 m -129.25 166.99 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 113.956 -1.474 . . . . 100.0 108.809 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 82.7 mtp 53.21 -131.89 2.03 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 126.917 2.087 . . . . 100.0 115.4 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 . . . . . 0 C--N 1.373 1.607 0 C-N-CA 128.736 2.814 . . . . 100.0 118.521 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 118.839 -0.6 . . . . 100.0 110.455 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -62.32 -43.87 97.82 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 123.911 0.884 . . . . 100.0 110.578 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.15 -43.83 97.97 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.384 0.674 . . . . 100.0 110.681 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.49 -44.58 96.02 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.552 1.141 . . . . 100.0 111.993 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.1 -42.55 97.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 C-N-CA 123.774 0.83 . . . . 100.0 109.295 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.89 97.88 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.642 0.777 . . . . 100.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -63.76 -40.76 97.49 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.357 1.063 . . . . 100.0 112.143 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -63.82 -42.96 97.55 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.732 1.213 . . . . 100.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.3 m . . . . . 0 C--N 1.358 0.975 0 C-N-CA 124.645 1.178 . . . . 100.0 111.688 -178.765 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.444 -0.746 0 CA-C-O 121.458 0.647 . . . . 100.0 110.924 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -128.36 136.22 50.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.827 -1.916 . . . . 100.0 105.827 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -119.95 132.61 55.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.732 -1.581 . . . . 100.0 106.732 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.39 117.22 28.93 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -110.18 129.01 55.79 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.838 -1.528 . . . . 100.0 106.93 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -110.53 124.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 105.253 -2.129 . . . . 100.0 105.253 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.01 116.71 32.4 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.948 -1.871 . . . . 100.0 105.948 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.415 ' HA ' ' HZ1' ' A' ' 23' ' ' LYS . 32.9 m -125.31 162.16 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 113.696 -1.593 . . . . 100.0 110.496 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.91 168.2 15.39 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 107.476 -2.25 . . . . 100.0 107.476 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HB2' HG23 ' A' ' 97' ' ' THR . 76.6 m-20 -71.82 162.45 29.43 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 113.215 0.82 . . . . 100.0 113.215 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.78 141.43 38.28 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.293 -1.123 . . . . 100.0 110.293 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.18 1.44 90.36 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.715 0.674 . . . . 100.0 113.982 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.8 m -65.02 -41.23 95.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.758 0.823 . . . . 100.0 111.648 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.43 15.77 6.86 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 120.57 -0.824 . . . . 100.0 112.087 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HZ1' ' HA ' ' A' ' 16' ' ' VAL . 20.1 ptmt -61.5 -44.32 97.29 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.77 1.228 . . . . 100.0 111.713 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.5 m -64.96 -42.31 94.7 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.906 1.282 . . . . 100.0 109.659 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.7 m -63.47 -41.01 98.61 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.272 1.029 . . . . 100.0 109.353 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -60.25 -47.5 85.73 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.072 1.349 . . . . 100.0 110.013 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.08 -43.6 97.53 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 C-N-CA 123.591 0.756 . . . . 100.0 111.831 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.605 1.162 . . . . 100.0 109.734 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 36.8 ttp180 -61.72 -45.15 95.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 125.43 1.492 . . . . 100.0 110.462 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -63.9 -43.72 95.14 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.59 0.589 . . . . 100.0 112.59 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -65.05 -47.58 76.83 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 115.23 1.567 . . . . 100.0 115.23 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.0 p -120.01 -23.57 6.32 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 119.104 3.002 . . . . 100.0 119.104 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.91 -4.33 71.57 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 110.733 -0.947 . . . . 100.0 110.733 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -76.94 147.15 37.11 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 126.422 1.889 . . . . 100.0 108.563 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 93.0 m-85 -114.29 126.32 54.9 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 105.391 -2.077 . . . . 100.0 105.391 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -105.49 113.93 27.79 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 120.071 -0.651 . . . . 100.0 111.907 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -72.96 -42.26 63.55 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.0 1.32 . . . . 100.0 112.511 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -84.75 130.91 34.62 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 125.904 1.682 . . . . 100.0 111.419 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -99.73 120.67 40.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 122.407 1.099 . . . . 100.0 110.77 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 1 N-CA-C 99.994 -4.076 . . . . 100.0 99.994 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.21 58.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 113.871 1.063 . . . . 100.0 113.871 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 m -91.45 126.18 36.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 103.708 -2.701 . . . . 100.0 103.708 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.74 128.79 53.91 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.77 -125.38 30.56 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.378 -1.489 . . . . 100.0 109.378 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.8 t -126.79 139.51 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 123.56 0.744 . . . . 100.0 109.987 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -113.87 124.57 52.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.276 -2.861 . . . . 100.0 103.276 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.56 113.35 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.899 -1.148 . . . . 100.0 107.899 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -125.97 120.77 24.09 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 113.018 0.747 . . . . 100.0 113.018 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.88 135.0 12.28 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 122.475 2.117 . . . . 100.0 111.148 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.58 132.67 53.94 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 105.414 -2.069 . . . . 100.0 105.414 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.514 HG22 ' HE3' ' A' ' 60' ' ' LYS . 19.6 t -109.44 126.58 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.554 -2.017 . . . . 100.0 105.554 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.31 129.45 54.01 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.269 -1.752 . . . . 100.0 106.269 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -98.83 122.9 42.66 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 105.749 -1.945 . . . . 100.0 105.749 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.44 ' HB ' HD11 ' A' ' 174' ' ' LEU . 69.9 p -122.67 -178.3 3.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.426 -0.806 . . . . 100.0 110.787 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -59.41 -37.34 77.79 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.7 1.6 . . . . 100.0 108.6 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.33 -3.41 52.56 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.206 1.802 . . . . 100.0 112.458 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.81 -177.02 19.7 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 110.829 -0.908 . . . . 100.0 110.829 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.33 137.16 50.22 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.972 3.115 . . . . 100.0 113.418 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.46 142.97 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.317 -2.105 . . . . 100.0 105.317 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' HE3' HG22 ' A' ' 51' ' ' VAL 0.284 44.8 mttp -115.1 132.34 56.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 118.046 -1.462 . . . . 100.0 110.588 175.407 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.48 116.83 33.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.087 -2.931 . . . . 100.0 103.087 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -92.5 100.46 13.0 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 101.089 -3.671 . . . . 100.0 101.089 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.45 124.74 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.704 -0.68 . . . . 100.0 109.276 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -106.72 106.36 16.85 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 104.954 -2.239 . . . . 100.0 104.954 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.51 117.11 24.22 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 102.934 -2.987 . . . . 100.0 102.934 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.6 p -100.14 162.64 12.84 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 113.14 0.792 . . . . 100.0 113.14 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.97 128.74 34.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.682 -0.859 . . . . 100.0 108.682 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.14 -12.19 82.7 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 116.02 -0.536 . . . . 100.0 113.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -67.77 -39.16 84.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.399 1.48 . . . . 100.0 112.069 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.34 137.66 58.3 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.778 1.231 . . . . 100.0 112.45 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.76 153.9 41.68 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.869 -1.06 . . . . 100.0 112.427 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -68.08 131.99 46.43 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.818 1.647 . . . . 100.0 108.115 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.61 -171.4 34.78 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 119.237 -1.459 . . . . 100.0 115.446 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -21.04 62.85 Favored Glycine 0 C--N 1.356 1.692 0 C-N-CA 127.959 2.695 . . . . 100.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.23 -37.93 84.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.362 2.265 . . . . 100.0 109.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -87.86 6.82 33.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 126.269 1.828 . . . . 100.0 115.19 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 -42.24 90.35 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 115.487 1.662 . . . . 100.0 115.487 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.02 94.33 Favored Glycine 0 C--N 1.353 1.497 0 C-N-CA 123.804 0.716 . . . . 100.0 113.165 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -60.87 -45.56 94.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.448 1.499 . . . . 100.0 108.694 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 6.1 t80 -89.29 -11.05 44.57 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 115.076 1.51 . . . . 100.0 115.076 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.5 131.66 25.44 Favored 'Isoleucine or valine' 0 C--N 1.366 1.326 0 CA-C-N 119.924 1.238 . . . . 100.0 110.838 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.309 63.9 mt-30 57.21 36.9 28.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 128.197 2.599 . . . . 100.0 113.863 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.88 142.87 42.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 105.611 -1.996 . . . . 100.0 105.611 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -100.15 -31.31 11.47 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.076 -1.083 . . . . 100.0 108.076 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.485 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -153.89 160.86 42.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 122.783 0.433 . . . . 100.0 110.377 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -141.82 153.46 44.52 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 113.578 0.955 . . . . 100.0 113.578 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.5 mt -126.26 125.81 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 103.935 -2.617 . . . . 100.0 103.935 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.7 mt -109.95 124.48 66.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 101.23 -3.618 . . . . 100.0 101.23 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -119.05 133.26 55.92 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 118.358 -1.337 . . . . 100.0 111.322 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -128.57 158.9 37.17 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.741 -1.572 . . . . 100.0 110.017 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.65 123.98 44.43 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.883 -1.895 . . . . 100.0 105.883 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -65.03 -21.08 28.79 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 113.348 0.87 . . . . 100.0 113.348 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -90.57 -5.8 55.48 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 118.712 -0.661 . . . . 100.0 111.765 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.7 t -119.65 116.7 26.53 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.83 1.3 . . . . 100.0 111.167 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -66.27 -39.6 89.55 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.566 -1.652 . . . . 100.0 111.336 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -43.17 96.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 125.132 1.373 . . . . 100.0 109.326 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 18' ' ' ASP . 96.9 m -62.66 -43.17 99.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 122.89 0.476 . . . . 100.0 109.905 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -63.89 -39.54 94.41 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 122.811 0.445 . . . . 100.0 110.524 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 92.5 mttt -60.53 -38.33 84.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.271 1.429 . . . . 100.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.38 -12.07 60.7 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 114.569 1.322 . . . . 100.0 114.569 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.82 -43.09 94.17 Favored Pre-proline 0 C--N 1.364 1.236 0 CA-C-O 115.952 -1.975 . . . . 100.0 111.34 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 97.4 Cg_exo -57.41 -36.39 98.82 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.483 2.122 . . . . 100.0 112.517 177.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -66.35 -41.96 88.79 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.005 0.815 . . . . 100.0 111.164 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.417 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.6 m95 -62.6 -46.35 88.72 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 108.928 -0.768 . . . . 100.0 108.928 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -91.62 65.9 5.21 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-O 123.0 1.381 . . . . 100.0 108.425 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -162.06 -56.6 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 101.103 -3.665 . . . . 100.0 101.103 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.23 -41.7 99.15 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.189 -1.041 . . . . 100.0 108.189 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.544 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -62.66 -46.04 90.04 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.86 0.864 . . . . 100.0 111.534 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.87 -39.23 82.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 126.378 1.871 . . . . 100.0 109.438 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -58.8 -45.6 89.52 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.34 1.056 . . . . 100.0 109.971 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.66 -50.38 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 115.512 1.671 . . . . 100.0 115.512 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.81 8.83 20.67 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 120.981 3.697 . . . . 100.0 120.981 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 53.98 -125.02 2.29 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 125.213 1.405 . . . . 100.0 113.241 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -97.88 113.98 25.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 120.289 1.404 . . . . 100.0 112.326 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.1 pt -142.73 152.74 60.18 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.03 127.15 20.47 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 122.231 1.954 . . . . 100.0 113.066 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.4 mt -131.28 134.8 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.693 1.235 . . . . 100.0 107.756 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.66 133.04 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 113.598 -1.637 . . . . 100.0 108.332 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.408 HD12 ' HB3' ' A' ' 139' ' ' HIS 0.272 88.3 mt -100.6 126.74 47.1 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 104.614 -2.365 . . . . 100.0 104.614 176.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -116.58 123.02 46.34 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.839 0.828 . . . . 100.0 109.696 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.09 102.57 2.68 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.33 -3.908 . . . . 100.0 103.33 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.412 54.0 p30 -94.45 173.36 7.66 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 114.584 1.328 . . . . 100.0 114.584 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 60.56 40.4 16.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 127.704 2.402 . . . . 100.0 111.323 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.45 -12.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 CA-C-N 115.717 -0.674 . . . . 100.0 112.417 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.82 -39.57 92.23 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.64 1.576 . . . . 100.0 109.588 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.22 130.28 29.03 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 124.232 1.013 . . . . 100.0 109.822 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.42 -40.01 89.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 115.4 1.629 . . . . 100.0 115.4 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -82.96 81.18 8.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.344 -0.984 . . . . 100.0 108.344 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -90.86 134.1 34.71 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.243 -1.762 . . . . 100.0 106.243 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -101.35 -40.85 6.91 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 110.011 -0.366 . . . . 100.0 110.011 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.15 109.89 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.948 -2.241 . . . . 100.0 104.948 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.27 145.44 29.11 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.648 -1.16 . . . . 100.0 110.833 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.21 98.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.08 0.952 . . . . 100.0 112.257 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.15 -39.87 95.92 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.07 0.548 . . . . 100.0 111.599 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.7 m -62.18 -36.57 82.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.524 1.93 . . . . 100.0 113.471 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.8 mt -63.66 123.64 16.83 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-O 122.336 1.065 . . . . 100.0 109.778 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 -4.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 125.583 1.553 . . . . 100.0 112.001 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -59.41 -43.43 93.03 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 125.098 1.359 . . . . 100.0 111.456 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.408 ' HB3' HD12 ' A' ' 119' ' ' LEU . 51.7 p-80 -62.18 -40.53 96.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 112.766 0.654 . . . . 100.0 112.766 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -62.97 -45.72 91.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.295 1.038 . . . . 100.0 110.547 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.56 -41.41 96.32 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.793 0.837 . . . . 100.0 111.686 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.84 4.46 53.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 117.284 2.328 . . . . 100.0 117.284 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 57.05 46.08 19.86 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 122.176 0.989 . . . . 100.0 112.403 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 117' ' ' ILE . 45.2 mt -115.24 162.28 17.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 108.251 -1.018 . . . . 100.0 108.251 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.408 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 97.3 mm-40 -101.34 139.18 37.36 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.783 -1.192 . . . . 100.0 107.783 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -114.29 130.34 56.65 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.384 0.611 . . . . 100.0 111.542 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -128.12 134.68 49.15 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.263 -0.881 . . . . 100.0 110.629 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -89.06 121.23 31.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 102.711 -3.07 . . . . 100.0 102.711 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 48.3 pt -132.63 157.19 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 122.194 0.997 . . . . 100.0 112.144 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.7 t -139.9 119.12 12.8 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.225 -2.509 . . . . 100.0 104.225 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.87 -44.17 93.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.359 -0.837 . . . . 100.0 109.614 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -63.18 -46.31 87.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.605 1.962 . . . . 100.0 114.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -97.16 -1.06 45.87 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 115.93 1.826 . . . . 100.0 115.93 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.49 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 63.1 m-80 64.65 21.77 12.48 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 125.075 1.35 . . . . 100.0 113.296 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -72.42 123.2 22.6 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.289 -1.745 . . . . 100.0 106.289 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.1 40.58 31.44 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.507 2.323 . . . . 100.0 112.389 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.418 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 18.4 t80 -55.83 -49.92 71.97 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 126.968 2.107 . . . . 100.0 115.589 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -96.34 -2.85 44.93 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.271 96.6 mttt -59.88 -44.86 97.91 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 118.277 2.695 . . . . 100.0 118.277 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.14 -42.65 41.49 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 122.523 1.937 . . . . 100.0 112.503 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -64.24 -43.95 93.31 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.534 1.146 . . . . 100.0 112.297 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.64 -44.96 92.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 123.923 0.764 . . . . 100.0 112.869 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.408 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 88.2 t90 -64.09 -42.58 96.88 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 123.501 0.5 . . . . 100.0 110.296 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 85' ' ' CYS . 85.7 mt -61.42 -43.66 98.48 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 118.892 -0.575 . . . . 100.0 111.106 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.5 98.68 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.209 0.604 . . . . 100.0 111.478 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.49 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 89.5 mtt180 -62.44 -45.39 93.31 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.278 0.631 . . . . 100.0 111.546 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -65.02 -45.24 86.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.986 0.915 . . . . 100.0 111.714 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.89 -45.56 85.44 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 123.614 0.766 . . . . 100.0 112.947 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.47 -39.21 78.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 C-N-CA 123.545 0.738 . . . . 100.0 109.975 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.81 9.75 57.11 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-O 118.602 -1.11 . . . . 100.0 111.206 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -104.83 109.28 62.87 Favored Pre-proline 0 C--N 1.364 1.231 0 N-CA-C 107.705 -1.22 . . . . 100.0 107.705 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.51 -24.31 56.56 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 124.086 3.191 . . . . 100.0 113.994 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.36 3.62 51.59 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.609 1.964 . . . . 100.0 113.708 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 21.9 tp -62.85 130.75 46.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.451 0.537 . . . . 100.0 112.451 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 . . . . . 0 CA--C 1.496 -1.118 0 CA-C-O 121.842 0.829 . . . . 100.0 110.595 178.797 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 121.414 0.625 . . . . 100.0 112.274 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.87 123.59 68.75 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 104.158 -2.534 . . . . 100.0 104.158 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -62.87 135.03 49.64 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 123.47 2.78 . . . . 100.0 113.175 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.81 157.32 43.66 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 123.28 2.654 . . . . 100.0 113.989 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.66 -38.73 92.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.868 1.667 . . . . 100.0 111.474 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.275 30.0 t 71.52 82.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 128.199 2.6 . . . . 100.0 109.836 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.24 163.57 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.945 2.098 . . . . 100.0 107.955 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 80.3 mtp 60.15 -114.02 0.63 Allowed 'General case' 0 C--N 1.355 0.847 0 N-CA-C 115.574 1.694 . . . . 100.0 115.574 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 . . . . . 0 C--N 1.371 1.512 1 N-CA-C 123.75 4.722 . . . . 100.0 123.75 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 118.443 -0.789 . . . . 100.0 111.874 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.01 -43.8 97.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 123.595 0.56 . . . . 100.0 111.882 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.7 -45.4 94.15 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 123.465 0.478 . . . . 100.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.4 -42.63 98.78 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 117.999 -1.0 . . . . 100.0 113.14 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.49 -45.0 99.54 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-N 118.613 0.642 . . . . 100.0 109.311 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.46 93.52 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 112.696 0.628 . . . . 100.0 112.696 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.28 -42.8 96.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.143 0.977 . . . . 100.0 112.877 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.7 m -63.95 -39.3 93.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.717 1.607 . . . . 100.0 111.913 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--N 1.366 1.305 0 CA-C-O 122.295 1.045 . . . . 100.0 110.599 -177.558 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.438 -1.039 0 N-CA-C 114.236 1.198 . . . . 100.0 114.236 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 11' ' ' PHE 0.272 9.2 tt0 -126.6 134.51 50.78 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 103.811 -2.663 . . . . 100.0 103.811 177.361 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.4 ' N ' ' HG2' ' A' ' 10' ' ' GLN . 80.0 m-85 -124.27 136.44 54.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.765 -1.198 . . . . 100.0 107.765 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.74 116.31 28.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.543 -2.021 . . . . 100.0 105.543 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.78 128.57 55.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.436 -1.711 . . . . 100.0 107.574 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.27 122.1 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 106.098 -1.815 . . . . 100.0 106.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -104.08 118.14 35.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.479 -1.674 . . . . 100.0 106.479 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.5 m -127.59 163.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 113.664 -1.607 . . . . 100.0 111.412 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.11 169.66 16.53 Favored Glycine 0 CA--C 1.493 -1.296 0 N-CA-C 108.053 -2.019 . . . . 100.0 108.053 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 97' ' ' THR . 82.0 m-20 -71.28 160.65 32.42 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.892 0.853 . . . . 100.0 113.022 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.32 140.25 41.06 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.428 -1.069 . . . . 100.0 110.428 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.4 2.01 90.54 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.381 -0.677 . . . . 100.0 114.643 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.409 HG21 ' C ' ' A' ' 89' ' ' MET . 68.5 m -64.28 -42.27 96.51 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.225 1.012 . . . . 100.0 112.279 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.04 17.73 4.46 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.689 -0.767 . . . . 100.0 111.846 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -60.71 -47.54 85.83 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 125.927 1.691 . . . . 100.0 110.354 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.6 m -64.5 -42.88 95.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.402 1.481 . . . . 100.0 109.509 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.1 m -62.72 -41.96 99.42 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 125.012 1.325 . . . . 100.0 109.473 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.435 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 88.4 t80 -60.55 -48.49 81.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.956 1.302 . . . . 100.0 110.49 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.3 -42.03 90.04 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 123.333 0.396 . . . . 100.0 111.289 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.93 -40.09 94.29 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.274 0.63 . . . . 100.0 112.139 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.435 ' NH1' ' HA ' ' A' ' 26' ' ' PHE . 32.3 ttp-105 -62.14 -44.31 96.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 123.78 0.832 . . . . 100.0 109.058 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -62.8 -45.61 91.85 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 112.332 0.493 . . . . 100.0 112.332 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.83 -48.75 73.21 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 116.459 2.022 . . . . 100.0 116.459 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.4 p -118.9 -21.45 7.75 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 116.689 2.107 . . . . 100.0 116.689 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.72 71.8 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.524 -0.598 . . . . 100.0 112.128 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.04 146.88 45.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.924 1.29 . . . . 100.0 109.022 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.36 120.38 42.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.05 -3.315 . . . . 100.0 102.05 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.73 114.22 28.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 119.13 -1.028 . . . . 100.0 111.622 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.73 -43.72 62.59 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 114.595 -1.184 . . . . 100.0 113.512 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -76.44 145.58 39.17 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 123.161 0.584 . . . . 100.0 111.414 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -107.03 124.09 49.14 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 119.227 -0.989 . . . . 100.0 108.435 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -115.64 125.85 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 101.474 -3.528 . . . . 100.0 101.474 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.38 138.84 58.67 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 112.924 0.713 . . . . 100.0 112.924 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.6 m -96.23 125.36 40.69 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 103.665 -2.717 . . . . 100.0 103.665 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.07 129.05 54.24 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.658 -1.608 . . . . 100.0 106.658 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.51 -126.33 32.69 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 109.742 -1.343 . . . . 100.0 109.742 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.75 137.58 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 123.135 0.574 . . . . 100.0 109.907 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -114.36 126.11 54.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 103.827 -2.657 . . . . 100.0 103.827 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.02 121.36 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.854 -1.536 . . . . 100.0 106.854 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -127.37 122.78 22.99 Favored Pre-proline 0 N--CA 1.431 -1.405 0 CA-C-N 115.458 -0.792 . . . . 100.0 110.9 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.18 125.29 5.78 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.968 2.445 . . . . 100.0 110.225 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -122.41 126.7 48.51 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.717 -1.586 . . . . 100.0 106.717 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.19 130.56 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 N-CA-C 106.821 -1.548 . . . . 100.0 106.821 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -118.36 132.42 56.27 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.513 -2.032 . . . . 100.0 105.513 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.8 123.49 46.55 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 106.541 -1.652 . . . . 100.0 106.541 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 p -123.64 -177.42 3.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.024 -0.535 . . . . 100.0 111.791 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -58.98 -38.26 78.74 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.263 1.825 . . . . 100.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -86.55 -0.23 55.7 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.861 0.864 . . . . 100.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.63 -178.8 19.51 Favored Glycine 0 N--CA 1.432 -1.63 0 O-C-N 122.034 -0.416 . . . . 100.0 112.194 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.99 139.46 61.62 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.092 3.195 . . . . 100.0 113.782 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.7 mt -129.66 138.43 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.472 -2.788 . . . . 100.0 103.472 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -118.68 128.94 54.99 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.4 -1.32 . . . . 100.0 108.889 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -108.63 117.58 34.56 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -92.25 106.53 18.52 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 102.519 -3.141 . . . . 100.0 102.519 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.37 124.4 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-N 112.447 -2.16 . . . . 100.0 109.198 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -104.77 105.9 16.17 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 104.715 -2.328 . . . . 100.0 104.715 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.76 118.7 27.45 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 104.339 -2.467 . . . . 100.0 104.339 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.1 p -96.54 162.27 13.54 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 114.041 1.126 . . . . 100.0 114.041 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.71 128.73 34.75 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.139 -1.43 . . . . 100.0 107.139 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.45 -13.39 80.44 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.948 -0.362 . . . . 100.0 112.386 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -65.81 -41.04 92.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.359 1.864 . . . . 100.0 112.13 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.71 137.73 58.2 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.828 0.851 . . . . 100.0 111.991 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -71.8 156.24 39.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.3 1.048 . . . . 100.0 113.019 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -66.85 132.71 48.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.413 1.885 . . . . 100.0 108.267 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.92 -171.77 34.43 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 119.608 -1.282 . . . . 100.0 114.548 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.04 -21.53 63.82 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 127.915 2.674 . . . . 100.0 113.824 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.65 -36.88 84.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.595 1.558 . . . . 100.0 110.649 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -87.45 1.21 54.08 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.742 1.617 . . . . 100.0 113.592 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.43 -39.78 92.06 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 116.044 1.868 . . . . 100.0 116.044 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.11 91.67 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 118.836 0.744 . . . . 100.0 113.436 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -62.91 -42.2 99.71 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.24 1.816 . . . . 100.0 108.912 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.564 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 8.8 t80 -89.32 -14.31 36.01 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 114.271 1.211 . . . . 100.0 114.271 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.6 mt -61.83 135.86 25.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 CA-C-N 119.108 0.867 . . . . 100.0 108.862 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 64.56 21.71 12.5 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 126.558 1.943 . . . . 100.0 114.441 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.51 141.29 50.16 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 108.158 -1.053 . . . . 100.0 108.158 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -100.0 -32.38 10.98 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.006 -1.109 . . . . 100.0 108.006 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.534 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.7 p -150.3 160.96 43.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.964 0.411 . . . . 100.0 111.391 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.434 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -143.52 152.43 41.46 Favored 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 119.616 -0.834 . . . . 100.0 113.114 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.0 mt -126.16 126.7 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.258 -2.497 . . . . 100.0 104.258 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 67.9 mt -109.27 124.26 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 N-CA-C 101.483 -3.525 . . . . 100.0 101.483 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.409 ' C ' HG21 ' A' ' 21' ' ' THR . 50.1 ttm -119.03 133.27 55.92 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.239 -1.384 . . . . 100.0 111.083 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -127.63 158.3 37.9 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.461 -1.7 . . . . 100.0 109.665 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -102.42 125.75 49.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 105.473 -2.047 . . . . 100.0 105.473 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.66 -22.96 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 114.167 1.173 . . . . 100.0 114.167 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -85.29 -10.83 55.97 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 118.736 -0.649 . . . . 100.0 111.072 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 t -116.17 116.71 28.31 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.272 1.511 . . . . 100.0 112.541 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -65.8 -41.45 91.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.938 -1.937 . . . . 100.0 109.223 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.08 -43.62 97.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 C-N-CA 125.431 1.492 . . . . 100.0 110.353 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.7 m -63.17 -43.23 98.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.101 0.561 . . . . 100.0 109.74 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.572 0.349 . . . . 100.0 110.289 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.505 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.4 mttt -60.25 -37.97 82.03 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 124.15 0.98 . . . . 100.0 111.335 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -73.27 -11.28 60.45 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.238 1.57 . . . . 100.0 115.238 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.97 -42.92 93.02 Favored Pre-proline 0 C--N 1.361 1.1 0 CA-C-O 116.58 -1.676 . . . . 100.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 92.9 Cg_exo -59.3 -34.27 97.87 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.488 2.125 . . . . 100.0 112.422 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.98 -43.38 88.02 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.07 0.948 . . . . 100.0 110.116 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' O ' HD13 ' A' ' 108' ' ' LEU . 83.7 m95 -62.76 -47.11 84.95 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 109.111 -0.7 . . . . 100.0 109.111 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 50.2 t-80 -91.46 64.52 5.06 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.78 1.276 . . . . 100.0 108.351 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -154.81 -60.59 0.12 Allowed 'General case' 0 CA--C 1.489 -1.387 1 N-CA-C 99.736 -4.172 . . . . 100.0 99.736 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.52 -39.99 95.32 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.192 0.597 . . . . 100.0 111.138 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -61.56 -45.85 92.39 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 122.998 0.519 . . . . 100.0 110.583 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.6 -39.08 83.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 126.395 1.878 . . . . 100.0 109.784 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.27 45.7 mtm105 -59.01 -44.52 91.71 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.048 0.539 . . . . 100.0 109.753 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.43 -51.84 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 115.563 1.69 . . . . 100.0 115.563 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -108.26 4.02 24.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 119.911 3.3 . . . . 100.0 119.911 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 54.11 -121.05 1.76 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.326 1.45 . . . . 100.0 111.28 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -95.19 112.88 24.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.884 1.22 . . . . 100.0 111.134 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 115' ' ' ILE . 46.2 pt -144.79 153.09 53.81 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.942 -2.984 . . . . 100.0 102.942 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -62.31 126.0 17.57 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.311 2.007 . . . . 100.0 111.9 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.699 ' HB ' HD22 ' A' ' 144' ' ' LEU . 69.1 mt -130.69 133.81 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.461 -1.311 . . . . 100.0 107.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 160' ' ' PRO . 57.6 t -115.38 133.12 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 114.044 -1.435 . . . . 100.0 108.077 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.89 124.8 47.11 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.69 -2.337 . . . . 100.0 104.69 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.8 m -116.94 122.34 44.0 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.75 0.786 . . . . 100.0 110.348 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.42 103.15 2.82 Favored Glycine 0 CA--C 1.478 -2.259 0 N-CA-C 103.626 -3.79 . . . . 100.0 103.626 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . 0.41 54.0 p30 -93.09 170.62 9.5 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 114.817 1.414 . . . . 100.0 114.817 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.7 mttt 61.11 41.67 13.4 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.586 2.754 . . . . 100.0 112.201 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 148' ' ' ASP . 33.8 m -64.76 -18.9 24.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.275 -0.875 . . . . 100.0 112.781 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -61.11 -38.25 85.67 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 123.624 0.77 . . . . 100.0 112.4 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.61 130.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.843 0.83 . . . . 100.0 108.981 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.61 -42.74 98.19 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.767 1.627 . . . . 100.0 114.84 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.32 77.03 10.06 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.51 1.147 . . . . 100.0 108.742 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -92.95 125.9 37.77 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.618 -1.623 . . . . 100.0 106.618 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -98.05 -39.17 9.06 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.32 -0.855 . . . . 100.0 112.302 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.96 107.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 103.908 -2.627 . . . . 100.0 103.908 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.9 144.34 31.04 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.422 -1.263 . . . . 100.0 109.962 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.84 -40.56 95.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.286 1.035 . . . . 100.0 111.348 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -40.76 98.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.909 1.284 . . . . 100.0 110.722 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.6 m -63.28 -38.09 89.8 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.124 1.77 . . . . 100.0 113.057 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.01 123.76 15.34 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-O 122.553 1.168 . . . . 100.0 110.022 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.56 -5.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.434 -1.712 . . . . 100.0 110.701 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -59.61 -41.74 91.06 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.243 1.417 . . . . 100.0 111.4 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -61.27 -42.71 99.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.403 0.681 . . . . 100.0 112.364 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -63.8 -44.23 93.95 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 124.195 0.998 . . . . 100.0 110.859 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.8 -42.31 97.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.937 0.895 . . . . 100.0 111.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -95.69 4.46 52.98 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.655 2.095 . . . . 100.0 116.655 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 55.54 46.89 22.05 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-O 122.898 1.333 . . . . 100.0 113.257 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.699 HD22 ' HB ' ' A' ' 117' ' ' ILE . 40.7 mt -113.36 159.66 19.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.377 -1.342 . . . . 100.0 107.377 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.7 mm-40 -99.38 140.82 32.99 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 109.577 -0.527 . . . . 100.0 109.577 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -114.29 130.98 56.66 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.472 0.653 . . . . 100.0 112.067 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -129.06 135.1 48.47 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.027 -0.988 . . . . 100.0 111.401 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB3' HG11 ' A' ' 124' ' ' VAL . 36.4 m-20 -90.04 120.83 31.57 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 101.872 -3.381 . . . . 100.0 101.872 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.8 pt -131.9 154.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.489 1.138 . . . . 100.0 112.07 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.1 t -138.95 118.2 12.71 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 104.497 -2.408 . . . . 100.0 104.497 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.239 -0.891 . . . . 100.0 109.142 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -44.26 87.62 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.061 1.504 . . . . 100.0 115.061 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -93.73 -2.17 54.15 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.022 1.49 . . . . 100.0 115.022 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 66.46 21.0 10.89 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 125.012 1.325 . . . . 100.0 111.133 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -73.9 118.09 16.45 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.778 -1.193 . . . . 100.0 107.778 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 52.29 36.8 20.53 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 127.955 2.502 . . . . 100.0 111.145 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -63.06 -40.71 98.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 115.613 1.709 . . . . 100.0 115.613 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.57 -10.24 49.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 113.75 1.018 . . . . 100.0 113.75 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.311 94.8 mttt -60.14 -43.98 95.25 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 118.605 2.817 . . . . 100.0 118.605 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.424 ' HB3' HG11 ' A' ' 118' ' ' VAL . 50.4 Cg_endo -59.65 -41.32 56.99 Favored 'Trans proline' 0 C--N 1.372 1.787 0 CA-C-N 123.187 2.174 . . . . 100.0 112.344 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -63.38 -44.78 93.75 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 124.051 0.844 . . . . 100.0 111.278 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.28 -42.61 96.33 Favored 'General case' 0 CA--C 1.483 -1.609 0 CA-C-O 118.394 -0.812 . . . . 100.0 112.73 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.44 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.2 t90 -64.25 -42.61 96.43 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.711 0.632 . . . . 100.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 85' ' ' CYS . 86.1 mt -60.72 -43.78 97.42 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 123.406 0.441 . . . . 100.0 110.651 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.85 99.93 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.59 0.756 . . . . 100.0 111.548 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.456 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 87.5 mtt180 -61.77 -46.14 90.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 124.199 1.0 . . . . 100.0 111.11 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -65.8 -45.98 80.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 123.71 0.804 . . . . 100.0 112.685 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.96 -45.73 84.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.513 0.725 . . . . 100.0 112.397 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 98.3 mt -70.79 -38.16 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 124.207 1.003 . . . . 100.0 111.052 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.74 10.07 55.71 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 118.589 -1.117 . . . . 100.0 113.365 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 110.62 61.7 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 106.733 -1.58 . . . . 100.0 106.733 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -70.78 -18.08 32.48 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.272 2.648 . . . . 100.0 113.783 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -97.24 9.14 43.03 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.088 0.955 . . . . 100.0 112.595 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 26.9 tp -63.31 129.27 39.55 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 109.055 -0.72 . . . . 100.0 109.055 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 . . . . . 0 CA--C 1.493 -1.237 0 CA-C-O 121.42 0.629 . . . . 100.0 111.017 -178.503 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 CA--C 1.484 -1.562 0 N-CA-C 114.405 1.261 . . . . 100.0 114.405 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.52 120.7 68.92 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 101.094 -3.669 . . . . 100.0 101.094 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.52 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 66.9 Cg_endo -63.04 145.16 93.99 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.78 2.986 . . . . 100.0 116.224 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 24.7 Cg_exo -70.57 159.53 52.5 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.543 2.829 . . . . 100.0 111.57 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -61.14 -44.01 98.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.92 1.288 . . . . 100.0 112.581 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.27 24.9 t 62.97 84.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.08 0 C-N-CA 127.123 2.169 . . . . 100.0 110.515 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 m -110.54 177.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 125.123 1.369 . . . . 100.0 109.548 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.277 85.9 mmm 54.44 -118.5 1.32 Allowed 'General case' 0 C--N 1.359 1.0 0 N-CA-C 117.862 2.542 . . . . 100.0 117.862 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.28 86.7 m-20 . . . . . 0 C--N 1.367 1.337 0 N-CA-C 121.225 3.787 . . . . 100.0 121.225 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 N--CA 1.436 -1.169 0 CA-C-O 118.407 -0.806 . . . . 100.0 111.03 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.2 -46.22 88.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 118.302 0.501 . . . . 100.0 111.908 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.88 -45.13 93.97 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.451 0.469 . . . . 100.0 112.145 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -64.66 -42.97 95.03 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 118.1 -0.952 . . . . 100.0 112.516 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.18 -43.13 98.66 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 CA-C-O 118.626 -0.702 . . . . 100.0 109.581 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.19 95.18 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 118.034 0.379 . . . . 100.0 111.244 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.35 -42.37 96.27 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.898 0.879 . . . . 100.0 113.169 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.5 m -64.81 -39.45 93.6 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.935 1.694 . . . . 100.0 111.744 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.362 1.126 0 C-N-CA 123.624 0.77 . . . . 100.0 110.091 -178.741 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.442 -0.839 0 CA-C-O 122.091 0.948 . . . . 100.0 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -125.26 131.77 53.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.387 -2.449 . . . . 100.0 104.387 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -119.49 135.43 54.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.102 -1.073 . . . . 100.0 108.102 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -92.85 120.58 33.34 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 123.176 1.465 . . . . 100.0 107.122 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 tt -110.47 128.72 55.74 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 112.638 -2.074 . . . . 100.0 106.526 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -109.82 123.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 105.926 -1.879 . . . . 100.0 105.926 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 23' ' ' LYS . 68.0 tp -106.19 118.04 35.58 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.148 -1.427 . . . . 100.0 107.148 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.49 164.28 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 113.6 -1.636 . . . . 100.0 110.657 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 172.16 21.09 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.203 -1.959 . . . . 100.0 108.203 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' HB2' HG23 ' A' ' 97' ' ' THR . 68.0 m-20 -74.43 164.07 27.03 Favored 'General case' 0 CA--C 1.5 -0.98 0 O-C-N 122.207 -0.584 . . . . 100.0 112.153 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.18 142.01 36.83 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 109.392 -1.483 . . . . 100.0 109.392 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.28 90.48 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 123.781 0.705 . . . . 100.0 114.012 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.437 HG22 HD21 ' A' ' 122' ' ' ASN . 60.1 m -63.58 -42.69 98.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 117.922 0.861 . . . . 100.0 112.268 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.88 12.58 7.71 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.145 -1.026 . . . . 100.0 111.863 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HB2' HD21 ' A' ' 15' ' ' LEU . 59.0 pttt -61.97 -41.83 98.45 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.043 0.937 . . . . 100.0 112.601 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.4 m -64.18 -43.17 95.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.71 1.204 . . . . 100.0 109.122 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.1 m -63.03 -41.78 99.61 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.4 1.48 . . . . 100.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.69 -48.54 81.28 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 126.017 1.727 . . . . 100.0 109.929 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.74 -42.91 93.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 119.253 -0.403 . . . . 100.0 111.608 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.16 -39.77 93.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 123.027 0.531 . . . . 100.0 111.656 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.502 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 28.1 ttp180 -61.81 -44.59 96.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.797 1.239 . . . . 100.0 109.586 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -62.77 -44.79 95.28 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.175 0.443 . . . . 100.0 111.914 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.06 -47.7 76.42 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 116.535 2.05 . . . . 100.0 116.535 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -118.47 -23.61 7.11 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 117.193 2.294 . . . . 100.0 117.193 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.46 71.76 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 110.751 -0.94 . . . . 100.0 110.751 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.71 151.19 36.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 118.08 0.94 . . . . 100.0 109.531 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 92.0 m-85 -112.07 124.69 52.95 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 102.084 -3.302 . . . . 100.0 102.084 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -104.8 113.56 27.22 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.66 -0.816 . . . . 100.0 110.311 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.76 -43.39 62.92 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.057 1.343 . . . . 100.0 112.826 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -74.6 134.93 42.04 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 123.519 0.727 . . . . 100.0 111.344 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -102.88 119.71 39.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.264 -1.384 . . . . 100.0 107.264 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.33 127.14 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 103.301 -2.852 . . . . 100.0 103.301 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.14 58.74 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.563 0.697 . . . . 100.0 112.73 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.0 m -93.09 124.58 37.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 104.085 -2.561 . . . . 100.0 104.085 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.7 mt -104.59 127.51 52.35 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.09 -1.819 . . . . 100.0 106.09 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.71 -125.72 33.58 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.176 -1.17 . . . . 100.0 110.176 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.77 137.99 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.543 0.737 . . . . 100.0 110.038 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -114.43 124.87 53.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.084 -2.932 . . . . 100.0 103.084 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.18 117.4 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 124.855 1.262 . . . . 100.0 107.731 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -129.29 119.9 19.77 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 111.909 0.336 . . . . 100.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 22.2 Cg_exo -79.94 128.98 7.77 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.811 2.341 . . . . 100.0 112.232 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.8 mt -124.67 130.97 53.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.544 -1.28 . . . . 100.0 107.544 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.46 130.9 61.69 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.706 -1.22 . . . . 100.0 107.706 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.37 130.47 54.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.646 -1.983 . . . . 100.0 105.646 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -99.85 122.59 43.03 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.584 -2.006 . . . . 100.0 105.584 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.8 p -124.19 177.83 5.64 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.664 0.745 . . . . 100.0 110.891 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -59.54 -36.45 76.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.016 1.726 . . . . 100.0 109.7 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -85.4 0.9 50.78 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.329 1.051 . . . . 100.0 111.885 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.06 178.21 19.99 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 121.543 -0.723 . . . . 100.0 111.558 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -68.17 138.87 44.65 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 123.297 2.665 . . . . 100.0 112.769 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 mm -130.51 140.53 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.668 -2.345 . . . . 100.0 104.668 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.431 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.8 ttmt -116.27 128.95 56.01 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.13 -1.028 . . . . 100.0 109.586 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.11 118.51 36.83 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.64 -2.356 . . . . 100.0 104.64 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -93.37 107.8 19.57 Favored 'General case' 0 N--CA 1.429 -1.514 1 N-CA-C 100.028 -4.064 . . . . 100.0 100.028 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.9 t -95.13 123.01 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.025 -0.989 . . . . 100.0 109.092 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -103.15 106.51 17.04 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -87.3 117.79 26.3 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.595 -2.742 . . . . 100.0 103.595 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.3 p -100.19 163.0 12.6 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.755 -0.657 . . . . 100.0 112.401 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.88 131.0 35.33 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.58 -0.526 . . . . 100.0 109.58 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.9 -11.57 81.23 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 112.238 -0.345 . . . . 100.0 112.238 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -65.07 -41.88 94.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.832 2.453 . . . . 100.0 111.102 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.46 141.29 58.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.939 1.296 . . . . 100.0 113.632 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 149.22 50.71 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.784 2.034 . . . . 100.0 111.297 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -71.33 130.5 41.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.884 -1.525 . . . . 100.0 106.884 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.53 -169.24 34.41 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.184 -1.484 . . . . 100.0 115.501 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.55 -21.87 63.11 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 127.78 2.61 . . . . 100.0 114.325 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.99 -37.66 85.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.8 1.64 . . . . 100.0 109.886 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.5 mmm-85 -86.16 2.46 46.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.047 1.739 . . . . 100.0 113.955 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.22 -41.8 93.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 115.514 1.672 . . . . 100.0 115.514 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.95 -38.22 92.41 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.858 0.742 . . . . 100.0 113.473 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -62.44 -43.51 98.64 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 125.745 1.618 . . . . 100.0 109.097 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.527 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 7.5 t80 -88.35 -14.25 38.65 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.266 1.21 . . . . 100.0 114.266 -176.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.27 134.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.364 1.229 0 CA-C-N 119.56 1.073 . . . . 100.0 109.378 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 63.27 26.36 15.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.174 2.19 . . . . 100.0 113.396 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.25 139.68 42.71 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 107.456 -1.313 . . . . 100.0 107.456 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -97.97 -34.88 10.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.448 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -148.37 161.05 42.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 120.709 0.29 . . . . 100.0 111.476 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.44 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -142.06 152.6 43.48 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.07 -1.052 . . . . 100.0 113.737 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.69 125.73 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 104.232 -2.507 . . . . 100.0 104.232 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.98 123.65 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 100.96 -3.719 . . . . 100.0 100.96 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -118.59 133.78 55.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.37 -1.332 . . . . 100.0 111.14 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -129.08 158.87 37.71 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 100.0 109.911 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -100.9 125.35 47.44 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 105.848 -1.908 . . . . 100.0 105.848 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.93 -22.26 30.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.71 1.004 . . . . 100.0 113.71 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -88.2 -7.48 56.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 118.953 -0.546 . . . . 100.0 111.568 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.1 t -117.86 116.55 27.19 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 122.891 1.329 . . . . 100.0 112.165 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.75 -40.18 88.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.553 -1.658 . . . . 100.0 110.141 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.92 -43.43 97.47 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 125.258 1.423 . . . . 100.0 109.754 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 18' ' ' ASP . 95.0 m -63.06 -42.96 99.8 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 122.851 0.46 . . . . 100.0 109.954 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -64.34 -39.74 94.49 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 122.818 0.447 . . . . 100.0 110.504 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 93.6 mttt -60.71 -37.56 82.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.814 1.245 . . . . 100.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.91 -11.14 60.27 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.072 1.508 . . . . 100.0 115.072 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -59.97 -43.08 93.62 Favored Pre-proline 0 C--N 1.364 1.226 0 CA-C-O 116.208 -1.853 . . . . 100.0 111.199 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 93.7 Cg_exo -58.03 -35.45 98.74 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.626 2.217 . . . . 100.0 112.516 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -65.56 -43.75 88.86 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.135 0.974 . . . . 100.0 109.979 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.433 ' O ' HD13 ' A' ' 108' ' ' LEU . 83.9 m95 -62.6 -47.31 84.33 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 109.507 -0.553 . . . . 100.0 109.507 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -91.11 64.62 5.35 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 123.055 1.407 . . . . 100.0 108.397 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -156.28 -62.12 0.1 Allowed 'General case' 0 CA--C 1.485 -1.527 1 N-CA-C 100.04 -4.059 . . . . 100.0 100.04 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -63.97 -39.75 94.83 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.376 -0.829 . . . . 100.0 110.428 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.527 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -62.03 -46.05 90.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.123 0.569 . . . . 100.0 110.762 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.54 -39.57 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 126.19 1.796 . . . . 100.0 109.675 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.11 -44.51 94.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 119.082 -0.485 . . . . 100.0 110.507 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.4 t -72.51 -49.37 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 114.958 1.466 . . . . 100.0 114.958 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.9 m -113.47 11.03 18.32 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 120.16 3.393 . . . . 100.0 120.16 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 54.18 -126.52 2.33 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 125.166 1.386 . . . . 100.0 112.367 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -102.54 115.75 31.21 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 117.772 -1.571 . . . . 100.0 109.986 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.94 150.42 67.43 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 102.453 -3.165 . . . . 100.0 102.453 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -60.82 128.5 25.8 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.917 1.745 . . . . 100.0 112.89 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.659 ' HB ' HD22 ' A' ' 144' ' ' LEU . 61.8 mt -131.16 135.17 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.479 -1.304 . . . . 100.0 107.479 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.77 131.63 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-N 113.579 -1.646 . . . . 100.0 108.169 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 139' ' ' HIS . 88.6 mt -98.55 124.6 43.39 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 104.328 -2.471 . . . . 100.0 104.328 176.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 92.6 m -114.81 121.76 44.27 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.201 -0.909 . . . . 100.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.49 102.33 2.69 Favored Glycine 0 CA--C 1.479 -2.165 0 N-CA-C 103.099 -4.0 . . . . 100.0 103.099 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.437 HD21 HG22 ' A' ' 21' ' ' THR 0.386 55.4 p30 -92.67 171.61 8.89 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 114.326 1.232 . . . . 100.0 114.326 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 61.05 40.9 14.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 128.339 2.656 . . . . 100.0 111.95 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 148' ' ' ASP . 34.0 m -64.34 -19.89 25.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.075 0 CA-C-N 115.517 -0.765 . . . . 100.0 112.669 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -61.0 -38.09 84.82 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.143 0.977 . . . . 100.0 112.549 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.66 129.82 26.44 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 N-CA-C 108.693 -0.855 . . . . 100.0 108.693 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.01 -41.25 95.49 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 116.357 1.984 . . . . 100.0 116.357 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.24 83.98 7.82 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.402 -1.333 . . . . 100.0 107.402 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -94.97 127.0 40.7 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.814 -1.921 . . . . 100.0 105.814 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.66 -38.66 9.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.994 -0.548 . . . . 100.0 112.304 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.33 105.93 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 103.804 -2.665 . . . . 100.0 103.804 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.37 151.32 25.58 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.265 -0.88 . . . . 100.0 111.187 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.4 -42.03 98.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.35 1.06 . . . . 100.0 111.555 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.11 -39.94 96.18 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.854 0.861 . . . . 100.0 111.102 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -62.54 -38.07 88.56 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.787 1.635 . . . . 100.0 112.982 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 90.4 mt -64.06 122.56 15.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 CA-C-O 122.421 1.105 . . . . 100.0 109.878 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.9 -7.25 4.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 C-N-CA 125.734 1.614 . . . . 100.0 111.598 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.394 1.478 . . . . 100.0 111.261 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.409 ' HB3' HD12 ' A' ' 119' ' ' LEU . 44.2 p-80 -61.7 -42.23 98.66 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 118.82 -0.61 . . . . 100.0 112.077 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -63.18 -45.31 92.37 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.656 0.782 . . . . 100.0 111.491 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.29 -40.63 94.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 123.611 0.764 . . . . 100.0 112.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.84 3.28 55.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 116.283 1.957 . . . . 100.0 116.283 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 57.6 t30 55.51 50.36 14.76 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.501 1.52 . . . . 100.0 112.624 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.659 HD22 ' HB ' ' A' ' 117' ' ' ILE . 49.9 mt -118.11 159.33 23.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.726 1.21 . . . . 100.0 108.048 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.2 mm-40 -98.29 140.19 32.94 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -114.58 130.62 56.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.554 0.692 . . . . 100.0 111.273 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -128.14 134.77 49.14 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.919 -1.037 . . . . 100.0 111.375 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.411 ' HB3' HG11 ' A' ' 124' ' ' VAL . 47.7 m-20 -88.42 120.95 30.28 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 102.348 -3.205 . . . . 100.0 102.348 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.4 pt -131.16 154.43 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.652 1.215 . . . . 100.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.2 t -136.69 119.59 16.35 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 105.091 -2.188 . . . . 100.0 105.091 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.426 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.2 -45.1 89.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 124.211 0.944 . . . . 100.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.7 -44.68 89.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 115.145 1.535 . . . . 100.0 115.145 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 94.1 p -95.77 -0.26 51.54 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 115.537 1.68 . . . . 100.0 115.537 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.502 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 70.6 m-80 63.7 24.27 13.82 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.869 0.868 . . . . 100.0 112.638 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.76 123.25 24.61 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 106.046 -1.835 . . . . 100.0 106.046 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.05 40.57 31.42 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.939 2.095 . . . . 100.0 112.011 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.44 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 30.4 t80 -57.25 -49.04 77.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.369 1.867 . . . . 100.0 114.315 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.16 -9.02 40.85 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 115.463 1.653 . . . . 100.0 115.463 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.304 95.0 mttt -59.66 -44.44 97.44 Favored Pre-proline 0 CA--C 1.498 -1.045 0 N-CA-C 119.282 3.067 . . . . 100.0 119.282 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.1 -42.28 44.88 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.391 1.89 . . . . 100.0 111.678 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.95 -44.13 93.75 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 124.414 1.071 . . . . 100.0 111.794 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.62 -43.99 95.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 112.968 0.729 . . . . 100.0 112.968 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.424 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.5 t90 -64.61 -43.14 94.71 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.834 0.709 . . . . 100.0 109.975 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 85' ' ' CYS . 88.9 mt -61.55 -43.06 99.55 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.448 0.468 . . . . 100.0 111.136 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.27 99.22 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 123.78 0.832 . . . . 100.0 110.765 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.445 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 96.2 mtt180 -61.96 -45.39 93.87 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.514 0.726 . . . . 100.0 111.667 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -64.6 -46.84 80.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.289 0.636 . . . . 100.0 111.879 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.35 -46.13 81.44 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 113.675 0.991 . . . . 100.0 113.675 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.85 -38.86 79.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.404 1.082 . . . . 100.0 109.388 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.67 8.9 59.17 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 118.635 -1.092 . . . . 100.0 112.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -107.62 110.15 62.64 Favored Pre-proline 0 C--N 1.361 1.074 0 N-CA-C 106.047 -1.834 . . . . 100.0 106.047 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.5 -18.85 43.33 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 123.842 3.028 . . . . 100.0 113.834 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -97.78 11.02 38.61 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.39 1.076 . . . . 100.0 112.611 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.445 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 23.5 tp -63.19 130.47 44.71 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.742 0.817 . . . . 100.0 109.145 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 . . . . . 0 CA--C 1.496 -1.118 0 CA-C-O 121.367 0.603 . . . . 100.0 110.413 -178.827 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 CA--C 1.484 -1.583 0 CA-C-O 121.473 0.654 . . . . 100.0 110.961 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -84.32 124.35 73.93 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 102.697 -3.075 . . . . 100.0 102.697 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 60.8 Cg_endo -62.08 140.51 84.48 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 123.397 2.732 . . . . 100.0 113.905 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 31.2 Cg_exo -67.18 155.18 71.76 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.244 2.629 . . . . 100.0 112.188 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.41 -45.3 94.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.32 1.048 . . . . 100.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.0 t 68.56 102.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.243 0 C-N-CA 126.651 1.98 . . . . 100.0 106.747 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.7 m -92.51 157.01 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 115.331 1.604 . . . . 100.0 115.331 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.368 85.3 mmm 52.71 -118.44 1.33 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.989 2.515 . . . . 100.0 117.548 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 . . . . . 0 C--N 1.365 1.269 0 N-CA-C 117.705 2.483 . . . . 100.0 117.705 -178.384 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 N--CA 1.442 -0.855 0 N-CA-C 110.608 -0.145 . . . . 100.0 110.608 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -63.16 -41.94 99.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.803 1.241 . . . . 100.0 111.234 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.63 -42.6 99.68 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.519 0.728 . . . . 100.0 111.084 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.77 -44.37 96.37 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.472 0.709 . . . . 100.0 111.239 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.76 -42.99 98.34 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 C-N-CA 123.844 0.857 . . . . 100.0 109.077 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.83 99.59 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.274 1.029 . . . . 100.0 111.673 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -62.66 -42.7 99.75 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.921 0.888 . . . . 100.0 110.803 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.5 m -63.82 -42.69 97.61 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.734 1.214 . . . . 100.0 111.631 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.356 0.858 0 C-N-CA 124.454 1.102 . . . . 100.0 113.454 -177.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.492 -1.258 0 CA-C-O 120.492 0.187 . . . . 100.0 110.568 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.99 95.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.733 1.213 . . . . 100.0 111.204 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.43 98.88 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 123.869 0.867 . . . . 100.0 109.713 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -66.54 -37.26 84.61 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.335 1.054 . . . . 100.0 111.82 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.6 15.9 35.88 Favored Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 109.23 -1.548 . . . . 100.0 109.23 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 10' ' ' GLN . 24.1 pt-20 -90.06 114.95 62.73 Favored Pre-proline 0 N--CA 1.414 -2.236 0 N-CA-C 106.128 -1.804 . . . . 100.0 106.128 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.63 -50.34 5.64 Favored 'Trans proline' 0 C--N 1.377 2.069 0 N-CA-C 103.215 -3.417 . . . . 100.0 103.215 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -123.68 -71.25 0.73 Allowed 'General case' 0 N--CA 1.379 -3.993 1 N-CA-C 99.148 -4.39 . . . . 100.0 99.148 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.7 145.12 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 115.065 1.506 . . . . 100.0 115.065 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 17.2 tt0 -122.81 134.75 54.4 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.001 1.721 . . . . 100.0 106.694 176.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.53 132.4 53.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.647 -0.871 . . . . 100.0 108.647 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 87.8 tttt -89.04 116.94 27.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.23 129.22 56.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-N 114.251 -1.34 . . . . 100.0 107.874 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.12 124.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.155 -1.424 . . . . 100.0 107.155 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.5 tp -105.27 117.72 34.74 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.771 -1.566 . . . . 100.0 106.771 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.97 162.72 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.259 -1.337 . . . . 100.0 112.567 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.91 172.49 20.68 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 109.629 -1.388 . . . . 100.0 109.629 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' HB2' HG23 ' A' ' 97' ' ' THR . 85.2 m-20 -71.1 159.62 34.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.831 0.824 . . . . 100.0 112.778 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 139.44 39.69 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 110.173 -1.171 . . . . 100.0 110.173 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.65 2.8 89.88 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 118.592 -1.116 . . . . 100.0 114.774 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 p -64.06 -39.72 94.69 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 118.767 1.283 . . . . 100.0 113.887 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.18 19.32 5.17 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-O 118.941 -0.922 . . . . 100.0 111.477 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -60.08 -47.64 85.04 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 118.889 1.344 . . . . 100.0 111.143 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.3 m -64.55 -42.99 95.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.096 1.358 . . . . 100.0 110.671 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.2 m -63.12 -40.77 98.59 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.665 1.186 . . . . 100.0 109.177 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' HD1' HH22 ' A' ' 29' ' ' ARG . 68.1 t80 -60.67 -48.12 83.19 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.335 1.454 . . . . 100.0 110.369 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.28 -43.25 97.18 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 O-C-N 123.55 0.531 . . . . 100.0 111.025 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.71 -39.83 92.91 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.79 0.663 . . . . 100.0 112.79 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.775 HH21 ' HA ' ' A' ' 151' ' ' ALA . 13.1 ttm180 -60.48 -45.86 92.2 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.262 1.025 . . . . 100.0 109.086 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -64.35 -42.38 96.26 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.296 0.85 . . . . 100.0 113.296 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.61 -44.6 66.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.3 p -119.36 -23.3 6.73 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 117.826 2.528 . . . . 100.0 117.826 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.92 -7.73 73.45 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 110.992 -0.843 . . . . 100.0 110.992 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.0 156.58 30.06 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.765 1.226 . . . . 100.0 109.142 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -114.65 118.26 33.15 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 102.612 -3.107 . . . . 100.0 102.612 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -87.81 110.21 20.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.905 0.86 . . . . 100.0 111.085 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.06 -40.12 68.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.107 1.363 . . . . 100.0 113.85 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HE3' HG21 ' A' ' 206' ' ' THR . 96.3 mttt -80.06 131.17 35.72 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.389 1.076 . . . . 100.0 112.218 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -99.41 110.45 22.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.142 -1.023 . . . . 100.0 108.266 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.7 122.46 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 102.418 -3.178 . . . . 100.0 102.418 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.27 142.33 57.79 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.282 0.845 . . . . 100.0 113.282 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.5 m -92.95 127.22 38.38 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 104.431 -2.433 . . . . 100.0 104.431 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -105.34 127.14 52.81 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 107.916 -1.142 . . . . 100.0 107.916 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.32 -121.19 12.83 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.007 -1.637 . . . . 100.0 109.007 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.23 142.92 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.162 0.506 . . . . 100.0 110.197 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -121.13 123.59 42.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 105.007 -2.22 . . . . 100.0 105.007 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.6 t -100.31 122.02 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.675 -1.231 . . . . 100.0 107.675 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -126.65 124.45 24.19 Favored Pre-proline 0 N--CA 1.434 -1.238 0 CA-C-N 115.924 -0.58 . . . . 100.0 112.016 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.74 127.58 8.01 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 124.612 3.541 . . . . 100.0 112.81 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.0 tp -133.17 126.83 32.5 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.987 -1.116 . . . . 100.0 107.987 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.6 t -114.99 135.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 O-C-N 121.604 -0.685 . . . . 100.0 110.268 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -124.3 143.86 50.32 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.051 0.941 . . . . 100.0 109.102 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -102.35 127.38 49.37 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.022 -1.473 . . . . 100.0 107.022 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.7 p -122.0 179.24 4.58 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.982 0.896 . . . . 100.0 109.249 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -58.16 -36.62 73.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.875 2.07 . . . . 100.0 109.617 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -91.54 8.07 38.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 113.864 1.061 . . . . 100.0 113.864 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.74 176.19 20.07 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 121.907 -0.496 . . . . 100.0 112.074 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.61 138.21 29.0 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 123.271 2.647 . . . . 100.0 113.554 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -131.09 142.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 124.11 0.881 . . . . 100.0 109.003 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -106.76 132.65 52.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.473 -0.785 . . . . 100.0 112.112 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.62 117.8 34.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.527 -2.768 . . . . 100.0 103.527 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -94.8 100.76 12.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 100.508 -3.886 . . . . 100.0 100.508 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.74 126.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 CA-C-N 115.387 -0.824 . . . . 100.0 110.171 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.467 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 21.1 m95 -104.64 99.53 9.2 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.162 -2.162 . . . . 100.0 105.162 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.23 116.79 24.63 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.32 164.06 11.97 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.321 0.86 . . . . 100.0 113.321 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.04 131.62 35.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.212 1.005 . . . . 100.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.23 -10.5 80.15 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 114.492 0.557 . . . . 100.0 114.492 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -70.24 -38.76 75.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.15 2.18 . . . . 100.0 112.314 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HB2' HH11 ' A' ' 76' ' ' ARG . 96.6 mt-10 -62.29 137.03 58.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 124.973 1.309 . . . . 100.0 113.536 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.494 -1.23 . . . . 100.0 109.525 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -67.38 131.74 46.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.752 -1.944 . . . . 100.0 105.752 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.29 -176.1 40.27 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 118.788 -1.672 . . . . 100.0 114.474 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.72 64.38 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 127.188 2.327 . . . . 100.0 113.835 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.65 -37.72 85.09 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.21 1.804 . . . . 100.0 109.573 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.432 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.6 mtp85 -89.36 10.34 22.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 126.413 1.885 . . . . 100.0 115.762 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.8 -39.09 90.49 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 115.844 1.794 . . . . 100.0 115.844 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.79 86.16 Favored Glycine 0 C--N 1.355 1.631 0 C-N-CA 124.171 0.891 . . . . 100.0 113.26 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -62.47 -43.0 99.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.721 1.208 . . . . 100.0 109.819 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.4 t80 -88.81 -18.99 26.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 114.905 1.446 . . . . 100.0 114.905 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.25 131.65 21.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 CA-C-N 119.316 0.962 . . . . 100.0 109.667 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.279 91.6 mt-30 60.23 27.32 16.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 127.249 2.22 . . . . 100.0 115.377 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.3 46.75 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 107.029 -1.471 . . . . 100.0 107.029 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -106.35 -24.75 12.17 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 116.342 -0.39 . . . . 100.0 110.908 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.441 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -158.11 165.0 36.08 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.767 0.827 . . . . 100.0 109.233 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -148.78 155.79 41.45 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 119.627 -0.829 . . . . 100.0 112.863 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.39 126.81 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.714 -2.328 . . . . 100.0 104.714 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.52 124.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 103.789 -2.671 . . . . 100.0 103.789 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.462 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 55.7 mtt -112.64 135.4 53.41 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 116.549 2.055 . . . . 100.0 116.549 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -132.49 161.27 34.16 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 113.035 -1.893 . . . . 100.0 109.696 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.74 123.67 48.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.002 -1.851 . . . . 100.0 106.002 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -63.72 -20.38 26.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 114.063 1.134 . . . . 100.0 114.063 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -90.18 -2.46 58.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 118.896 -0.573 . . . . 100.0 111.479 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.5 t -125.79 113.43 17.27 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 122.578 1.18 . . . . 100.0 111.678 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -65.22 -38.67 91.15 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 114.896 -1.047 . . . . 100.0 111.934 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.25 -41.89 91.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 124.836 1.254 . . . . 100.0 108.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.6 m -62.62 -41.54 99.07 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 122.769 0.428 . . . . 100.0 110.532 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.381 0.672 . . . . 100.0 110.841 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.45 -35.34 73.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 124.679 1.192 . . . . 100.0 111.578 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -76.03 -9.78 58.89 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 115.848 1.795 . . . . 100.0 115.848 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 78.6 t -59.24 -44.99 99.21 Favored Pre-proline 0 C--N 1.363 1.174 0 CA-C-O 116.03 -1.938 . . . . 100.0 112.115 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 30.2 Cg_endo -59.08 -31.64 95.93 Favored 'Trans proline' 0 C--N 1.376 2.022 0 CA-C-N 122.747 2.017 . . . . 100.0 113.058 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.65 -42.95 81.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.783 0.72 . . . . 100.0 109.818 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.471 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.1 m95 -63.91 -45.79 87.75 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 109.565 -0.532 . . . . 100.0 109.565 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -90.72 70.17 6.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.543 -1.28 . . . . 100.0 107.543 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -168.02 -55.2 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 100.329 -3.952 . . . . 100.0 100.329 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.61 -43.82 98.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.691 -1.596 . . . . 100.0 106.691 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.6 mp -63.02 -50.14 71.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 113.366 0.876 . . . . 100.0 113.366 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.267 33.3 m -67.25 -22.81 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.267 90.9 mtt180 -61.24 -39.89 92.0 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.705 -0.85 . . . . 100.0 108.705 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.01 -47.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 113.735 1.013 . . . . 100.0 113.735 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.295 63.5 m -105.04 -2.28 24.62 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 119.405 3.113 . . . . 100.0 119.405 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.285 41.3 mt-10 54.96 -119.31 1.43 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.94 1.089 . . . . 100.0 113.94 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.49 110.73 22.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 120.151 1.341 . . . . 100.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.8 152.05 51.2 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 104.754 -2.313 . . . . 100.0 104.754 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.43 126.67 18.95 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.337 2.025 . . . . 100.0 112.251 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' HD22 ' A' ' 144' ' ' LEU . 64.5 mt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.747 -1.205 . . . . 100.0 107.747 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.46 132.15 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.416 -1.265 . . . . 100.0 108.417 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.36 124.75 44.74 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.387 -2.079 . . . . 100.0 105.387 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -116.74 124.73 50.36 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 122.259 1.028 . . . . 100.0 111.577 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.09 102.73 2.84 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 104.911 -3.276 . . . . 100.0 104.911 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -81.17 163.15 23.28 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 124.954 1.302 . . . . 100.0 111.865 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.71 38.51 24.94 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 128.386 2.674 . . . . 100.0 114.826 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.57 -14.7 18.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 113.787 1.032 . . . . 100.0 113.787 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.38 -37.1 86.31 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.755 1.222 . . . . 100.0 109.597 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.27 131.32 29.94 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-O 122.127 0.965 . . . . 100.0 109.82 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.68 -45.5 92.51 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -85.36 77.08 10.03 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.599 0.714 . . . . 100.0 110.29 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.94 138.79 38.24 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.615 -1.254 . . . . 100.0 107.615 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.67 -43.62 6.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.489 -0.56 . . . . 100.0 109.489 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.13 107.8 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.225 -2.139 . . . . 100.0 105.225 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -77.78 148.54 34.74 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.088 -1.415 . . . . 100.0 109.158 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.77 88.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.169 0.988 . . . . 100.0 110.161 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.11 -41.1 97.89 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.111 1.364 . . . . 100.0 111.066 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.9 m -62.43 -37.8 87.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.717 1.607 . . . . 100.0 113.465 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.19 120.09 11.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-O 122.382 1.087 . . . . 100.0 110.099 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.44 -7.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 125.626 1.571 . . . . 100.0 112.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 73.3 t80 -58.85 -41.36 86.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.124 1.37 . . . . 100.0 111.161 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -61.28 -38.66 87.56 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 123.795 0.838 . . . . 100.0 111.716 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.92 -46.1 89.4 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.528 0.731 . . . . 100.0 111.367 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.57 -40.97 89.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.039 0.936 . . . . 100.0 112.838 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 72.9 mmtt -92.83 2.23 56.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 116.808 2.151 . . . . 100.0 116.808 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 54.96 47.83 21.28 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-O 123.13 1.443 . . . . 100.0 113.672 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.626 HD22 ' HB ' ' A' ' 117' ' ' ILE . 44.9 mt -110.55 159.85 17.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.91 -1.495 . . . . 100.0 107.481 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.442 ' HG3' ' CD1' ' A' ' 163' ' ' TRP . 92.3 mm-40 -97.14 141.9 29.71 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.421 -1.326 . . . . 100.0 107.421 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -118.0 132.78 56.35 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 120.977 0.417 . . . . 100.0 111.701 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.23 135.13 42.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.594 -0.73 . . . . 100.0 112.448 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -86.66 123.42 31.82 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.517 -3.512 . . . . 100.0 101.517 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.5 pt -135.07 157.14 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 122.384 1.088 . . . . 100.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.3 t -141.19 114.01 8.39 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.853 -1.906 . . . . 100.0 105.853 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.775 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -64.0 -39.36 93.94 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.809 0.844 . . . . 100.0 108.776 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 210' ' ' PRO . 99.3 mttt -62.97 -46.8 85.99 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.682 1.993 . . . . 100.0 114.261 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.8 p -103.86 -0.46 29.11 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 114.962 1.467 . . . . 100.0 114.962 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 65.72 21.33 11.57 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.145 1.778 . . . . 100.0 114.048 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -70.58 120.29 16.0 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.142 -1.429 . . . . 100.0 107.142 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 54.02 33.64 18.0 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.175 2.19 . . . . 100.0 111.867 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -60.29 -38.68 84.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.678 1.362 . . . . 100.0 114.678 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -88.49 -10.74 47.97 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 115.786 1.773 . . . . 100.0 115.786 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.267 95.5 mttt -59.87 -45.57 98.26 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 118.768 2.877 . . . . 100.0 118.768 -176.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -58.98 -41.99 56.29 Favored 'Trans proline' 0 C--N 1.372 1.79 0 CA-C-N 122.626 1.973 . . . . 100.0 113.696 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.9 -43.04 94.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 124.083 0.865 . . . . 100.0 112.013 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.85 -43.1 94.13 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 112.96 0.726 . . . . 100.0 112.96 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.516 ' HE1' ' HE3' ' A' ' 167' ' ' LYS . 60.6 t-105 -63.21 -44.67 94.65 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 123.597 0.561 . . . . 100.0 110.408 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 85' ' ' CYS . 84.7 mt -61.16 -41.38 96.66 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 123.483 0.49 . . . . 100.0 110.806 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.85 99.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 123.705 0.802 . . . . 100.0 110.611 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 174' ' ' LEU . 93.8 mtt180 -61.7 -47.07 86.95 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 118.654 -0.689 . . . . 100.0 111.402 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.516 ' HE3' ' HE1' ' A' ' 163' ' ' TRP 0.26 92.9 mttt -66.95 -42.79 84.66 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 114.911 1.449 . . . . 100.0 114.911 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.43 -46.88 78.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.247 0.832 . . . . 100.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.5 -38.28 73.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.018 0.927 . . . . 100.0 109.963 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.52 10.23 55.81 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-O 118.436 -1.202 . . . . 100.0 113.861 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.529 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 52.2 t0 -111.58 112.51 53.95 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 106.018 -1.845 . . . . 100.0 106.018 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.07 -15.73 43.65 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.648 2.898 . . . . 100.0 112.67 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -92.78 2.77 56.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.941 1.296 . . . . 100.0 113.816 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 69.5 mt -59.19 133.21 55.89 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 119.576 1.08 . . . . 100.0 113.339 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -132.86 148.31 52.3 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.156 -1.384 . . . . 100.0 109.009 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -76.21 136.84 39.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.812 -1.551 . . . . 100.0 106.812 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.91 146.76 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 102.481 -3.155 . . . . 100.0 102.481 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.32 -46.2 83.47 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 115.387 1.625 . . . . 100.0 115.387 -175.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 55.6 ttm 94.98 122.84 0.02 OUTLIER Pre-proline 0 C--N 1.359 1.014 0 C-N-CA 127.647 2.379 . . . . 100.0 108.895 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -58.17 135.62 69.56 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.736 2.291 . . . . 100.0 110.366 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.62 127.65 33.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.711 1.257 . . . . 100.0 111.911 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.14 137.23 37.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 104.162 -2.532 . . . . 100.0 104.162 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -63.63 132.0 95.05 Favored Pre-proline 0 N--CA 1.439 -0.997 0 C-N-CA 122.754 0.422 . . . . 100.0 111.887 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 183' ' ' ALA . 45.5 Cg_exo -65.64 147.16 85.91 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.819 3.013 . . . . 100.0 112.78 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 32.2 Cg_exo -63.93 147.6 91.93 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 123.505 2.803 . . . . 100.0 111.012 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -63.26 -43.55 97.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 123.816 0.846 . . . . 100.0 112.584 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.8 t 68.99 99.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 127.112 2.165 . . . . 100.0 111.81 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.48 -71.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 103.08 -2.933 . . . . 100.0 103.08 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.463 ' HB2' HD12 ' A' ' 193' ' ' LEU 0.256 77.1 mtp 9.34 -128.72 0.0 OUTLIER 'General case' 0 C--N 1.367 1.348 0 C-N-CA 131.396 3.879 . . . . 100.0 119.374 177.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.326 85.6 m-20 142.43 -39.71 0.0 OUTLIER Pre-proline 0 C--N 1.377 1.799 0 C-N-CA 131.383 3.873 . . . . 100.0 115.71 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.13 -75.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.966 0 CA-C-N 123.885 2.423 . . . . 100.0 117.164 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.71 94.39 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 123.953 0.901 . . . . 100.0 110.973 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 189' ' ' MET . 52.1 mt -62.33 -38.2 88.55 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 117.468 2.396 . . . . 100.0 117.468 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.26 169.39 13.84 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 115.41 1.633 . . . . 100.0 115.41 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 73.96 -47.55 0.65 Allowed 'General case' 0 C--N 1.359 1.014 0 C-N-CA 127.956 2.502 . . . . 100.0 116.44 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -60.17 -35.72 75.98 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 126.758 2.023 . . . . 100.0 112.17 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -59.97 -39.26 85.05 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.35 1.06 . . . . 100.0 112.218 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -59.44 -38.36 80.49 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 124.614 1.166 . . . . 100.0 111.151 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.49 -45.4 93.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 118.813 -0.613 . . . . 100.0 110.912 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -65.9 -42.41 90.23 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.833 0.853 . . . . 100.0 112.255 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.0 mt -60.88 -41.63 96.38 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.751 0.82 . . . . 100.0 111.553 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.97 -43.39 98.93 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.348 1.059 . . . . 100.0 111.347 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.14 -45.51 98.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 108.193 -1.04 . . . . 100.0 108.193 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.69 95.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 113.928 1.084 . . . . 100.0 113.928 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -61.76 -44.36 97.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.738 1.215 . . . . 100.0 111.96 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.409 HG21 ' HE3' ' A' ' 38' ' ' LYS . 97.4 m -64.72 -43.64 92.75 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.459 1.504 . . . . 100.0 110.427 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.7 m -65.25 127.06 30.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 124.316 2.008 . . . . 100.0 115.079 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -115.54 148.87 39.02 Favored 'General case' 0 N--CA 1.428 -1.55 1 N-CA-C 99.344 -4.317 . . . . 100.0 99.344 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 93.3 mt -64.08 130.08 94.33 Favored Pre-proline 0 C--N 1.355 0.837 0 N-CA-C 112.599 0.592 . . . . 100.0 112.599 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.418 ' HB2' ' HB3' ' A' ' 152' ' ' LYS . 25.3 Cg_exo -76.1 85.07 1.71 Allowed 'Trans proline' 0 CA--C 1.492 -1.611 0 N-CA-C 117.963 2.255 . . . . 100.0 117.963 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -96.04 103.58 15.47 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 101.261 -3.607 . . . . 100.0 101.261 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -101.95 -74.82 0.61 Allowed 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 103.149 -2.908 . . . . 100.0 103.149 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -134.51 42.98 2.81 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 122.118 0.961 . . . . 100.0 108.727 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.91 -37.17 83.62 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 125.318 1.447 . . . . 100.0 110.04 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.02 -40.12 92.37 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.297 1.439 . . . . 100.0 111.964 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--O 1.256 1.447 0 CA-C-O 117.067 -1.444 . . . . 100.0 107.853 179.865 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttt . . . . . 0 CA--C 1.499 -1.013 0 CA-C-O 120.389 0.138 . . . . 100.0 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.01 95.41 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.096 1.358 . . . . 100.0 111.999 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.26 99.24 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.593 0.757 . . . . 100.0 109.785 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -66.94 -36.31 81.96 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 125.104 1.361 . . . . 100.0 111.627 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.63 22.5 31.11 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 108.589 -1.804 . . . . 100.0 108.589 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 9' ' ' VAL 0.386 24.7 tt0 -92.04 98.95 2.22 Favored Pre-proline 0 N--CA 1.42 -1.952 1 N-CA-C 100.13 -4.026 . . . . 100.0 100.13 -178.703 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -60.57 -50.8 6.07 Favored 'Trans proline' 0 C--N 1.387 2.6 0 N-CA-C 105.321 -2.607 . . . . 100.0 105.321 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 99.8 mm-40 -122.82 -69.77 0.81 Allowed 'General case' 0 N--CA 1.38 -3.963 1 N-CA-C 96.151 -5.5 . . . . 100.0 96.151 173.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.58 ' HA ' ' HG2' ' A' ' 6' ' ' GLU . 21.6 m -118.8 152.07 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 118.533 2.79 . . . . 100.0 118.533 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 15.6 tt0 -126.01 134.61 51.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.698 -2.046 . . . . 100.0 107.639 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.29 130.62 53.33 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.476 -0.935 . . . . 100.0 108.476 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.18 114.04 26.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.203 -1.777 . . . . 100.0 106.203 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 86' ' ' ALA . 39.5 tp -113.21 129.2 56.59 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 114.374 -1.284 . . . . 100.0 109.612 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -112.25 125.73 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 118.563 -1.255 . . . . 100.0 109.363 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 HG13 ' A' ' 63' ' ' VAL . 9.0 mp -101.81 121.33 41.89 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 108.074 -1.084 . . . . 100.0 108.074 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.76 160.38 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 113.613 -1.631 . . . . 100.0 110.814 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.08 172.35 20.65 Favored Glycine 0 CA--C 1.493 -1.311 0 N-CA-C 109.893 -1.283 . . . . 100.0 109.893 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HB2' HG23 ' A' ' 97' ' ' THR . 85.3 m-20 -71.58 159.86 33.71 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.115 0.96 . . . . 100.0 113.189 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.07 139.8 40.92 Favored Glycine 0 C--N 1.353 1.495 0 N-CA-C 109.94 -1.264 . . . . 100.0 109.94 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.09 2.16 89.48 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 118.864 -0.964 . . . . 100.0 114.892 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.1 p -63.32 -39.32 94.25 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 114.31 1.226 . . . . 100.0 114.31 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.03 16.51 6.73 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 118.666 -1.074 . . . . 100.0 112.003 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HG2' ' SD ' ' A' ' 89' ' ' MET . 10.2 mtmp? -60.0 -46.47 89.38 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 119.045 1.422 . . . . 100.0 111.664 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.0 m -64.13 -44.59 91.74 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.83 1.252 . . . . 100.0 110.967 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -63.47 -40.62 97.6 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.037 0.935 . . . . 100.0 109.954 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.36 -48.04 83.1 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.277 1.031 . . . . 100.0 111.227 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.54 -42.02 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 123.123 0.265 . . . . 100.0 111.026 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.69 -40.35 94.68 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.547 0.739 . . . . 100.0 111.188 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.627 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.8 tmm_? -61.62 -43.46 98.82 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 123.606 0.762 . . . . 100.0 110.192 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -63.04 -42.17 99.69 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.352 0.501 . . . . 100.0 112.352 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -70.1 -43.96 70.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.912 1.819 . . . . 100.0 115.912 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.1 p -120.14 -24.88 5.87 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.891 2.552 . . . . 100.0 117.891 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.93 68.19 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.816 -0.914 . . . . 100.0 110.816 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HA ' ' HD2' ' A' ' 210' ' ' PRO . 49.3 mt-10 -76.9 152.36 35.41 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.137 0.975 . . . . 100.0 109.198 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.31 117.67 31.75 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 102.074 -3.306 . . . . 100.0 102.074 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -92.61 117.92 30.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.4 -0.963 . . . . 100.0 108.4 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.08 -11.97 29.5 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.633 -1.167 . . . . 100.0 112.976 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.31 123.74 47.36 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.591 -0.892 . . . . 100.0 108.591 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.79 115.45 27.44 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.261 1.029 . . . . 100.0 111.117 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -121.25 123.96 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 101.216 -3.624 . . . . 100.0 101.216 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.2 139.29 58.49 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 113.942 1.09 . . . . 100.0 113.942 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.0 m -84.76 130.01 34.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.25 127.32 51.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 106.857 -1.534 . . . . 100.0 106.857 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.57 -120.61 15.26 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.808 -1.317 . . . . 100.0 109.808 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.99 144.82 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 120.931 0.396 . . . . 100.0 110.415 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -119.91 124.0 44.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 103.172 -2.899 . . . . 100.0 103.172 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.1 t -101.31 120.82 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.26 -1.385 . . . . 100.0 107.26 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -127.11 123.02 23.31 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.85 -0.614 . . . . 100.0 111.772 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -80.81 129.81 7.31 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 124.165 3.243 . . . . 100.0 111.204 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -132.23 128.84 38.75 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.169 -1.048 . . . . 100.0 108.169 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.82 134.85 54.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 108.462 -0.94 . . . . 100.0 108.462 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 52' ' ' PHE . 6.6 m-30 -124.8 140.86 52.54 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.675 1.59 . . . . 100.0 109.073 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -105.33 124.01 48.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.326 1.06 . . . . 100.0 108.884 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.5 p -119.58 -179.99 4.05 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.354 -1.294 . . . . 100.0 111.432 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.08 -36.36 74.96 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 127.281 2.233 . . . . 100.0 109.512 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.01 7.38 40.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.384 0.883 . . . . 100.0 113.384 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.03 179.6 20.78 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 118.853 0.751 . . . . 100.0 111.948 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.19 140.0 36.51 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.14 2.56 . . . . 100.0 113.225 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 pt -130.27 140.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.811 -1.552 . . . . 100.0 106.811 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -113.72 132.77 55.69 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.994 -1.082 . . . . 100.0 110.884 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.51 118.88 37.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.288 -2.116 . . . . 100.0 105.288 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.72 97.7 10.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 100.74 -3.8 . . . . 100.0 100.74 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG13 HD13 ' A' ' 15' ' ' LEU . 46.3 t -86.65 126.82 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 121.297 0.57 . . . . 100.0 110.968 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -108.1 99.38 8.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.188 -1.782 . . . . 100.0 106.188 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -89.13 117.52 28.18 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.004 -2.221 . . . . 100.0 105.004 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -97.67 164.87 12.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.805 1.039 . . . . 100.0 113.805 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.1 131.85 34.75 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.154 0.982 . . . . 100.0 109.304 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.09 -10.45 84.87 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.352 0.501 . . . . 100.0 114.352 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.97 -39.77 75.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.393 1.877 . . . . 100.0 112.485 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -62.92 134.82 56.8 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.035 0.934 . . . . 100.0 113.365 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.49 154.65 40.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.975 -1.012 . . . . 100.0 110.263 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -66.76 132.26 47.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.707 1.603 . . . . 100.0 106.949 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.41 -176.8 38.74 Favored Glycine 0 C--N 1.356 1.642 0 C-N-CA 119.212 -1.47 . . . . 100.0 114.621 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.52 -23.64 65.08 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 127.057 2.265 . . . . 100.0 113.744 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -62.43 -31.86 72.62 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.488 1.115 . . . . 100.0 111.527 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.4 mtp-105 -92.33 10.21 30.75 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.631 1.572 . . . . 100.0 114.409 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.69 -38.02 86.28 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 116.082 1.882 . . . . 100.0 116.082 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.68 -38.68 92.24 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.77 0.7 . . . . 100.0 113.457 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -63.26 -42.72 99.17 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.157 0.983 . . . . 100.0 110.217 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.483 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 3.0 t80 -91.35 -18.59 24.04 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 114.726 1.38 . . . . 100.0 114.726 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.6 pt -61.18 136.42 24.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 CA-C-N 119.787 1.176 . . . . 100.0 111.19 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 63.66 21.93 12.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.719 2.008 . . . . 100.0 113.824 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.87 145.56 46.81 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 107.368 -1.345 . . . . 100.0 107.368 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -103.76 -24.02 13.37 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.883 -0.599 . . . . 100.0 110.71 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.489 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.6 p -159.38 165.51 33.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 123.536 0.735 . . . . 100.0 110.391 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -148.71 156.31 42.2 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 113.309 0.855 . . . . 100.0 113.309 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.416 HG13 HD11 ' A' ' 13' ' ' LEU . 96.2 mt -126.5 126.45 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 104.752 -2.314 . . . . 100.0 104.752 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 65.2 mt -108.21 124.22 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 102.343 -3.206 . . . . 100.0 102.343 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.585 ' HB3' HD21 ' A' ' 122' ' ' ASN . 94.8 mtp -114.41 132.31 56.28 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.805 -1.089 . . . . 100.0 113.22 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -132.84 161.44 34.15 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.87 -1.513 . . . . 100.0 109.374 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -104.26 125.47 50.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.847 -1.538 . . . . 100.0 106.847 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.9 -19.42 24.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.952 1.093 . . . . 100.0 113.952 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -89.25 -4.87 58.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 119.262 -0.399 . . . . 100.0 111.474 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -125.56 115.23 19.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.737 1.256 . . . . 100.0 112.035 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.15 -39.49 93.07 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 114.491 -1.231 . . . . 100.0 110.984 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.08 -41.6 89.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 C-N-CA 125.073 1.349 . . . . 100.0 109.22 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 18' ' ' ASP . 94.5 m -62.87 -41.78 99.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.161 0.584 . . . . 100.0 109.807 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -65.27 -39.79 93.06 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.246 0.618 . . . . 100.0 111.038 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -59.34 -36.72 76.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.738 1.215 . . . . 100.0 111.057 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.41 -10.88 60.01 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.552 1.686 . . . . 100.0 115.552 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -59.43 -44.02 97.22 Favored Pre-proline 0 C--N 1.361 1.072 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.777 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 85.9 Cg_exo -57.4 -35.29 98.87 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.759 2.306 . . . . 100.0 112.466 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.73 -43.08 85.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.884 0.874 . . . . 100.0 110.356 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.444 ' O ' HD13 ' A' ' 108' ' ' LEU . 87.4 m95 -63.79 -45.39 89.9 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 51.0 t-80 -90.68 69.62 6.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.639 -1.245 . . . . 100.0 107.639 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -169.4 -53.09 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 100.592 -3.855 . . . . 100.0 100.592 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.81 -43.89 97.59 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.579 -1.638 . . . . 100.0 106.579 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.483 ' HG ' ' CZ ' ' A' ' 80' ' ' TYR . 6.6 mp -62.81 -48.64 78.25 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.303 1.041 . . . . 100.0 113.139 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.22 -34.26 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 C-N-CA 127.358 2.263 . . . . 100.0 110.696 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.25 -40.17 81.07 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 118.657 -0.687 . . . . 100.0 111.253 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.262 11.8 m -97.33 -34.95 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 116.009 1.855 . . . . 100.0 116.009 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.294 70.6 m -105.13 -3.19 23.34 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 118.23 2.678 . . . . 100.0 118.23 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 54.38 -121.8 1.86 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.309 1.444 . . . . 100.0 113.462 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -94.48 109.2 21.1 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.335 1.064 . . . . 100.0 113.617 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.28 149.92 50.03 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 104.434 -2.432 . . . . 100.0 104.434 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.64 128.6 25.06 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.15 1.9 . . . . 100.0 113.138 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.563 ' HB ' HD22 ' A' ' 144' ' ' LEU . 70.7 mt -132.42 135.4 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.439 -1.319 . . . . 100.0 107.439 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.45 132.07 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.168 -1.378 . . . . 100.0 108.738 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.0 mt -98.15 125.64 43.26 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.686 -1.968 . . . . 100.0 105.686 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -118.05 125.22 49.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.017 0.913 . . . . 100.0 112.53 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.97 102.24 2.72 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 105.277 -3.129 . . . . 100.0 105.277 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.585 HD21 ' HB3' ' A' ' 89' ' ' MET . 70.1 m-80 -81.5 162.92 23.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.517 1.527 . . . . 100.0 112.865 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 57.86 42.3 23.41 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.65 2.38 . . . . 100.0 115.122 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 148' ' ' ASP . 34.1 m -65.02 -16.24 19.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 CA-C-N 115.902 -0.59 . . . . 100.0 112.348 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -62.29 -37.91 87.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 124.216 1.006 . . . . 100.0 112.41 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.24 132.38 27.93 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 CA-C-O 121.844 0.83 . . . . 100.0 109.82 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.93 -45.5 92.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 116.76 2.133 . . . . 100.0 116.76 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -86.07 77.47 9.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.305 0.574 . . . . 100.0 110.706 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -81.43 132.75 35.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.849 -0.797 . . . . 100.0 108.849 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -99.06 -41.95 7.31 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 115.976 -0.556 . . . . 100.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.21 106.23 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.42 155.52 25.85 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.129 -0.942 . . . . 100.0 109.253 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.02 83.19 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.527 1.131 . . . . 100.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.56 -40.91 96.41 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.216 1.006 . . . . 100.0 111.755 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.6 m -61.51 -38.54 87.72 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 125.615 1.566 . . . . 100.0 113.22 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.56 121.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 122.074 0.94 . . . . 100.0 110.319 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.34 -9.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.093 -1.412 . . . . 100.0 112.009 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 71.4 t80 -58.57 -39.51 80.5 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.305 1.442 . . . . 100.0 111.746 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -60.89 -39.87 90.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 123.931 0.892 . . . . 100.0 111.695 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.19 -44.29 92.46 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.304 0.642 . . . . 100.0 112.147 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.08 -42.28 94.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.464 1.106 . . . . 100.0 111.53 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 72.9 mmtt -94.62 3.1 55.51 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 118.109 2.633 . . . . 100.0 118.109 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 55.08 47.18 22.53 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 123.137 1.446 . . . . 100.0 113.59 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.563 HD22 ' HB ' ' A' ' 117' ' ' ILE . 50.3 mt -110.63 160.02 17.05 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 113.9 -1.5 . . . . 100.0 107.369 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -101.98 140.76 35.84 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.25 -1.389 . . . . 100.0 107.25 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -115.2 134.81 54.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.204 0.526 . . . . 100.0 112.184 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.99 136.18 41.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.624 -0.716 . . . . 100.0 112.529 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.511 ' HB3' HG11 ' A' ' 124' ' ' VAL . 22.4 m-20 -87.55 123.77 32.79 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 101.724 -3.436 . . . . 100.0 101.724 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.4 pt -134.43 157.53 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.309 1.052 . . . . 100.0 111.914 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.4 t -141.9 115.87 9.3 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 105.942 -1.873 . . . . 100.0 105.942 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.06 -38.94 93.17 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.964 0.905 . . . . 100.0 108.908 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.41 -43.84 93.13 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.832 1.653 . . . . 100.0 115.126 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -102.52 -4.16 25.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.604 1.335 . . . . 100.0 114.604 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 68.94 17.02 8.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.851 1.66 . . . . 100.0 113.25 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -66.97 119.64 12.29 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 107.59 -1.263 . . . . 100.0 107.59 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 54.48 30.85 13.64 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 127.048 2.139 . . . . 100.0 112.083 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -60.64 -38.23 84.11 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.372 1.249 . . . . 100.0 114.372 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -86.42 -13.86 45.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.598 1.703 . . . . 100.0 115.598 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.27 62.8 mttp -59.93 -45.68 98.16 Favored Pre-proline 0 C--N 1.358 0.952 0 N-CA-C 118.759 2.874 . . . . 100.0 118.759 -175.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.35 -41.28 60.05 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 122.455 1.912 . . . . 100.0 113.573 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.83 -44.15 94.06 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.962 0.905 . . . . 100.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.06 -42.5 94.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.856 0.687 . . . . 100.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -62.07 -45.53 93.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 123.374 0.422 . . . . 100.0 110.41 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.489 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.1 mt -61.23 -41.7 97.33 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 123.803 0.689 . . . . 100.0 110.854 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 123.56 0.744 . . . . 100.0 110.556 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.05 -45.87 91.64 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 118.568 -0.729 . . . . 100.0 112.233 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -68.99 -42.69 76.18 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 119.981 -0.688 . . . . 100.0 112.582 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.48 -46.33 80.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 113.666 0.987 . . . . 100.0 113.666 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.02 -38.23 74.64 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.536 1.135 . . . . 100.0 109.56 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.39 9.93 54.59 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 118.371 -1.239 . . . . 100.0 114.6 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.499 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 57.8 t0 -113.61 112.48 48.4 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 106.969 -1.493 . . . . 100.0 106.969 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.31 -15.36 45.62 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.831 3.02 . . . . 100.0 113.025 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -93.04 1.43 57.26 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 114.411 1.263 . . . . 100.0 114.411 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 92.9 mt -60.97 133.88 56.54 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 119.452 1.024 . . . . 100.0 113.647 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -134.14 153.46 51.81 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.683 -1.144 . . . . 100.0 109.802 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -81.24 130.71 35.15 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 105.253 -2.129 . . . . 100.0 105.253 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.0 m -131.68 141.33 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 112.535 0.569 . . . . 100.0 112.535 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 49.03 -121.39 1.53 Allowed 'General case' 0 C--N 1.361 1.088 0 C-N-CA 126.121 1.768 . . . . 100.0 112.111 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . 0.29 58.9 tpp 117.35 107.44 0.0 OUTLIER Pre-proline 0 CA--C 1.491 -1.305 0 C-N-CA 130.135 3.374 . . . . 100.0 109.506 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.82 167.57 26.89 Favored 'Trans proline' 0 N--CA 1.437 -1.813 0 C-N-CA 123.081 2.52 . . . . 100.0 108.4 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.98 145.7 52.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.171 0.51 . . . . 100.0 110.972 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.8 132.0 51.0 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.677 1.191 . . . . 100.0 112.354 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -104.09 146.95 33.54 Favored Pre-proline 0 N--CA 1.425 -1.687 0 CA-C-N 114.014 -1.448 . . . . 100.0 112.59 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 183' ' ' ALA . 31.8 Cg_exo -65.8 157.88 56.63 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 124.382 3.388 . . . . 100.0 110.045 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -60.55 148.36 91.37 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 123.188 2.592 . . . . 100.0 113.561 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.62 138.24 58.29 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.723 1.264 . . . . 100.0 110.683 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.0 135.87 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 106.607 -1.627 . . . . 100.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.38 -76.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 107.973 -1.121 . . . . 100.0 107.973 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.7 ptm -80.8 -176.01 5.62 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 116.91 -1.519 . . . . 100.0 111.463 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -122.55 -46.96 0.04 OUTLIER Pre-proline 0 C--N 1.361 1.103 0 O-C-N 118.342 -2.723 . . . . 100.0 118.146 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.91 -62.66 0.26 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 121.339 3.553 . . . . 100.0 121.339 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.08 88.71 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 118.878 0.763 . . . . 100.0 111.441 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.22 -37.01 85.57 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 116.242 1.941 . . . . 100.0 116.242 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.2 167.29 8.43 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 115.125 1.528 . . . . 100.0 115.125 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 75.79 -49.74 0.61 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 128.44 2.696 . . . . 100.0 115.426 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -60.31 -35.3 75.28 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 126.023 1.729 . . . . 100.0 112.62 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -59.7 -38.58 82.01 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 113.925 1.083 . . . . 100.0 113.925 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.75 -40.35 92.12 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 123.632 0.773 . . . . 100.0 110.577 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -61.8 -42.62 99.24 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.389 0.676 . . . . 100.0 110.515 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -64.06 -43.35 95.73 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.642 1.177 . . . . 100.0 111.484 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.53 -43.55 98.66 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 123.432 0.693 . . . . 100.0 111.678 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.5 -44.94 92.89 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 123.79 0.836 . . . . 100.0 112.334 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.25 35.7 m -62.89 -39.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.196 0 CA-C-O 118.657 -0.687 . . . . 100.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.2 -44.25 88.99 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.089 0.955 . . . . 100.0 112.928 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -62.89 -41.6 99.48 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.709 1.204 . . . . 100.0 111.863 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 86.7 m -66.31 -42.27 88.5 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.795 1.638 . . . . 100.0 111.934 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 96.1 m -62.19 130.58 46.08 Favored 'General case' 0 C--N 1.359 0.998 0 CA-C-O 121.97 0.891 . . . . 100.0 111.184 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -84.05 134.15 34.63 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.496 -2.039 . . . . 100.0 105.496 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 69.4 mt -114.41 128.32 25.95 Favored Pre-proline 0 N--CA 1.433 -1.325 0 N-CA-C 107.834 -1.173 . . . . 100.0 107.834 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.596 ' HD2' ' HA ' ' A' ' 34' ' ' GLU . 38.9 Cg_exo -79.59 67.99 8.43 Favored 'Trans proline' 0 C--N 1.367 1.545 0 N-CA-C 106.23 -2.258 . . . . 100.0 106.23 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -80.13 121.12 25.16 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-O 121.833 0.825 . . . . 100.0 109.684 -176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -99.14 -58.41 1.94 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 104.999 -2.223 . . . . 100.0 104.999 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 57.7 p30 -149.94 11.43 0.74 Allowed 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 124.636 1.175 . . . . 100.0 111.193 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -59.88 -35.84 75.65 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.493 2.317 . . . . 100.0 115.923 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.09 -43.88 95.21 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.234 0.614 . . . . 100.0 111.569 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--O 1.259 1.577 0 CA-C-O 115.915 -1.993 . . . . 100.0 105.731 179.833 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 CA--C 1.492 -1.262 0 N-CA-C 110.042 -0.355 . . . . 100.0 110.042 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.17 95.45 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.075 1.35 . . . . 100.0 111.799 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.78 -42.53 99.12 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.615 0.766 . . . . 100.0 109.714 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.87 -38.04 85.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.609 1.564 . . . . 100.0 111.093 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.29 23.01 30.41 Favored Glycine 0 C--N 1.359 1.843 0 N-CA-C 108.592 -1.803 . . . . 100.0 108.592 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 8' ' ' GLN 0.391 32.6 tt0 -91.32 103.52 7.7 Favored Pre-proline 0 N--CA 1.421 -1.883 0 N-CA-C 100.588 -3.856 . . . . 100.0 100.588 -179.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.78 -52.65 2.78 Favored 'Trans proline' 0 C--N 1.388 2.61 0 N-CA-C 103.517 -3.301 . . . . 100.0 103.517 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 10.8 tp-100 -125.1 -63.19 1.17 Allowed 'General case' 1 N--CA 1.375 -4.197 1 N-CA-C 97.435 -5.024 . . . . 100.0 97.435 174.672 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.2 t -117.77 144.61 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 115.568 1.692 . . . . 100.0 115.568 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 49.1 tt0 -125.43 133.93 52.29 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 176.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -121.95 130.72 53.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.88 116.07 28.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.96 -1.496 . . . . 100.0 106.96 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD11 HG13 ' A' ' 87' ' ' ILE . 57.2 tp -110.31 127.07 54.84 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 113.964 -1.471 . . . . 100.0 107.999 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.83 124.86 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 N-CA-C 107.024 -1.472 . . . . 100.0 107.024 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.9 tp -105.73 116.9 32.73 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 106.734 -1.58 . . . . 100.0 106.734 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.58 162.09 36.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 114.481 -1.236 . . . . 100.0 112.414 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.46 170.87 18.16 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 109.605 -1.398 . . . . 100.0 109.605 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.496 ' HB2' HG23 ' A' ' 97' ' ' THR . 84.0 m-20 -70.52 160.7 31.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.479 0.918 . . . . 100.0 113.479 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.63 140.19 40.34 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 110.865 -0.894 . . . . 100.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 2.76 90.44 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.646 -1.085 . . . . 100.0 114.303 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.0 p -63.55 -39.17 93.7 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 118.522 1.161 . . . . 100.0 114.131 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 16.8 6.28 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.711 -0.757 . . . . 100.0 111.926 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.91 -47.9 83.9 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 118.58 1.19 . . . . 100.0 111.461 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.4 m -64.67 -43.35 93.87 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.986 1.314 . . . . 100.0 111.034 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.9 m -63.47 -40.62 97.59 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.163 0.985 . . . . 100.0 109.5 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -61.14 -48.29 82.31 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 124.677 1.191 . . . . 100.0 110.319 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.76 -41.89 93.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.919 0 O-C-N 123.277 0.36 . . . . 100.0 111.699 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.02 -42.34 98.28 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.624 0.769 . . . . 100.0 110.718 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.584 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.2 tmm_? -62.28 -42.91 99.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.305 0.642 . . . . 100.0 110.706 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -63.96 -41.83 97.46 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 113.191 0.811 . . . . 100.0 113.191 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.28 -44.45 68.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 115.232 1.567 . . . . 100.0 115.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -120.02 -23.67 6.28 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 118.317 2.71 . . . . 100.0 118.317 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.65 -7.67 71.05 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.311 -0.716 . . . . 100.0 111.311 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.04 154.38 37.99 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.85 1.26 . . . . 100.0 109.456 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.491 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 91.3 m-85 -115.61 120.52 39.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.322 -2.844 . . . . 100.0 103.322 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -94.73 115.95 28.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.51 0.724 . . . . 100.0 109.16 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -91.39 -31.81 15.89 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.989 -0.284 . . . . 100.0 111.603 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.13 129.83 34.88 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.375 0.607 . . . . 100.0 111.379 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.97 116.51 29.32 Favored 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.116 0.96 . . . . 100.0 112.265 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.61 121.95 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 101.048 -3.686 . . . . 100.0 101.048 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.09 142.25 57.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.708 0.803 . . . . 100.0 113.077 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.6 m -92.61 127.83 38.25 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.99 126.26 50.98 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.387 -1.338 . . . . 100.0 107.387 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.48 -121.69 15.83 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.949 -1.261 . . . . 100.0 109.949 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.3 142.6 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.138 0.495 . . . . 100.0 110.602 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.91 122.89 43.33 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.721 -3.066 . . . . 100.0 102.721 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.39 116.68 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.168 -1.419 . . . . 100.0 107.168 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -124.4 121.69 25.97 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 112.403 0.52 . . . . 100.0 112.403 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 60' ' ' LYS . 90.1 Cg_endo -80.05 129.4 7.87 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 124.067 3.178 . . . . 100.0 112.602 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 tp -132.75 126.59 32.79 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.126 -1.435 . . . . 100.0 107.126 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.18 135.36 49.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.351 -0.611 . . . . 100.0 109.351 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.13 137.51 54.12 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 125.138 1.375 . . . . 100.0 107.407 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -103.52 125.24 49.96 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.708 -2.33 . . . . 100.0 104.708 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.2 p -124.71 176.97 6.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.751 0.786 . . . . 100.0 110.421 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -60.41 -27.0 67.12 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.295 1.438 . . . . 100.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -94.4 7.11 46.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 126.785 2.034 . . . . 100.0 112.974 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.0 175.85 25.58 Favored Glycine 0 C--N 1.357 1.7 0 N-CA-C 111.133 -0.787 . . . . 100.0 111.133 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.36 138.88 33.76 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.423 2.748 . . . . 100.0 113.444 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -132.04 142.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 106.974 -1.491 . . . . 100.0 106.974 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' HD2' ' HB2' ' A' ' 49' ' ' PRO . 33.9 ttpt -116.97 131.32 56.98 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 118.074 -1.45 . . . . 100.0 111.403 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.87 119.17 38.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 105.325 -2.102 . . . . 100.0 105.325 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' ND2' ' HE1' ' A' ' 64' ' ' TRP . 46.5 t30 -94.37 100.8 12.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 100.344 -3.947 . . . . 100.0 100.344 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.4 t -87.9 125.77 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-N 115.309 -0.86 . . . . 100.0 109.251 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.488 ' HE1' ' ND2' ' A' ' 62' ' ' ASN . 19.7 m0 -107.34 103.88 13.35 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.05 116.88 23.69 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.584 -2.376 . . . . 100.0 104.584 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 p -103.5 163.05 12.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 113.393 0.886 . . . . 100.0 113.393 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.28 36.14 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 123.78 0.832 . . . . 100.0 110.778 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.52 -8.07 77.98 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 113.834 0.294 . . . . 100.0 113.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -70.41 -39.56 74.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.73 2.012 . . . . 100.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.481 ' HB2' HH11 ' A' ' 76' ' ' ARG . 95.1 mt-10 -62.96 137.75 58.36 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 125.035 1.334 . . . . 100.0 112.459 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.41 151.65 44.94 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.468 -1.242 . . . . 100.0 111.011 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -65.55 131.17 45.71 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.607 1.963 . . . . 100.0 107.547 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.12 -173.81 36.01 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 118.895 -1.622 . . . . 100.0 115.632 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -20.15 62.64 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 127.699 2.571 . . . . 100.0 113.383 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.16 -38.14 82.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.039 2.135 . . . . 100.0 109.104 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.481 HH11 ' HB2' ' A' ' 70' ' ' GLU . 78.2 mtp85 -92.18 12.85 20.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.653 1.981 . . . . 100.0 115.599 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.11 -39.18 91.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.417 1.636 . . . . 100.0 115.417 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.5 90.83 Favored Glycine 0 C--N 1.357 1.695 0 C-N-CA 123.956 0.788 . . . . 100.0 113.731 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -62.13 -43.3 99.14 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.514 1.126 . . . . 100.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.596 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.5 t80 -87.02 -22.69 25.34 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.204 1.557 . . . . 100.0 115.204 -174.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.5 mt -57.21 133.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 0 CA-C-N 119.342 0.973 . . . . 100.0 109.732 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 63.45 23.18 13.58 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.141 2.176 . . . . 100.0 114.858 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 147.53 45.35 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.139 -1.06 . . . . 100.0 108.139 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -108.2 -22.13 12.49 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 116.419 -0.355 . . . . 100.0 111.261 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.411 ' HB2' HD22 ' A' ' 164' ' ' LEU . 16.4 p -156.63 164.41 38.21 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.752 -0.462 . . . . 100.0 109.752 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -148.53 155.65 41.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.308 0.855 . . . . 100.0 113.308 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.403 HG13 HD11 ' A' ' 13' ' ' LEU . 96.5 mt -127.74 126.88 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 104.319 -2.474 . . . . 100.0 104.319 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 68.1 mt -109.96 122.44 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 103.243 -2.873 . . . . 100.0 103.243 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 46.8 mtt -112.05 134.75 53.41 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 115.977 1.843 . . . . 100.0 115.977 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -131.49 159.83 36.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.556 -1.656 . . . . 100.0 109.181 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -103.98 124.66 49.41 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.847 -1.909 . . . . 100.0 105.847 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.46 -20.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 N-CA-C 113.79 1.033 . . . . 100.0 113.79 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.3 p -91.35 -2.93 57.22 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 119.146 -0.454 . . . . 100.0 112.014 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -122.67 115.04 21.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 122.92 1.343 . . . . 100.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -64.27 -41.96 96.67 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.095 -1.411 . . . . 100.0 110.689 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.15 -42.31 92.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 125.244 1.417 . . . . 100.0 109.35 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 18' ' ' ASP . 98.2 m -62.96 -41.43 99.52 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.475 0.31 . . . . 100.0 110.981 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -65.15 -41.06 95.1 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.636 0.775 . . . . 100.0 111.037 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 95.1 mttt -60.47 -35.18 75.26 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.106 1.362 . . . . 100.0 111.304 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -76.88 -9.28 58.58 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 115.827 1.788 . . . . 100.0 115.827 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.58 -43.26 95.36 Favored Pre-proline 0 C--N 1.361 1.103 0 CA-C-O 116.365 -1.779 . . . . 100.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 71.8 Cg_exo -57.37 -35.17 98.87 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.7 2.267 . . . . 100.0 112.685 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.7 -43.13 85.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 118.683 0.674 . . . . 100.0 110.826 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.495 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.7 m95 -63.61 -46.38 86.0 Favored 'General case' 0 C--N 1.366 1.296 0 N-CA-C 109.556 -0.535 . . . . 100.0 109.556 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -90.8 70.14 6.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.843 1.306 . . . . 100.0 107.768 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -165.07 -59.12 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 99.536 -4.246 . . . . 100.0 99.536 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -63.05 -39.72 95.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 123.877 0.736 . . . . 100.0 109.224 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.596 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -61.91 -50.31 72.68 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.757 0.661 . . . . 100.0 112.123 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.264 34.2 m -66.35 -27.86 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 113.046 0.758 . . . . 100.0 113.046 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -60.94 -39.14 88.36 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 118.247 0.476 . . . . 100.0 109.951 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.3 t -86.89 -47.98 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 113.909 1.077 . . . . 100.0 113.909 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.304 62.1 m -106.46 1.76 25.8 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 120.074 3.361 . . . . 100.0 120.074 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 55.56 -121.39 1.69 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.377 1.071 . . . . 100.0 113.241 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -97.43 112.58 24.36 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.911 1.232 . . . . 100.0 111.6 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 41.4 pt -144.62 149.5 43.85 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 104.49 -2.411 . . . . 100.0 104.49 176.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.27 129.26 27.73 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.28 1.987 . . . . 100.0 112.608 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.72 ' HB ' HD22 ' A' ' 144' ' ' LEU . 66.9 mt -133.12 135.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.275 -1.379 . . . . 100.0 107.275 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.08 131.67 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 114.303 -1.317 . . . . 100.0 108.389 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 139' ' ' HIS 0.261 86.0 mt -98.82 127.31 44.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.461 -2.051 . . . . 100.0 105.461 177.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.74 125.34 49.43 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.871 0.843 . . . . 100.0 111.686 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.68 101.1 2.57 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 104.026 -3.629 . . . . 100.0 104.026 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.83 162.02 24.19 Favored 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 124.966 1.306 . . . . 100.0 112.532 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 58.1 40.81 24.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 127.76 2.424 . . . . 100.0 115.324 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.39 -15.0 18.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 112.634 0.605 . . . . 100.0 112.634 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.43 -38.87 91.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.051 1.74 . . . . 100.0 110.35 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.45 131.58 29.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 124.024 0.93 . . . . 100.0 109.8 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.56 -42.88 91.35 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 116.593 2.072 . . . . 100.0 116.593 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.45 74.56 10.36 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-O 121.697 0.761 . . . . 100.0 110.121 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -83.73 137.42 33.76 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 115.669 -0.696 . . . . 100.0 110.557 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.66 -44.91 4.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.009 -0.541 . . . . 100.0 110.724 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.4 t -95.55 107.16 19.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 105.765 -1.939 . . . . 100.0 105.765 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -81.35 150.14 28.57 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.756 -1.111 . . . . 100.0 109.755 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.46 87.73 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.658 1.183 . . . . 100.0 111.988 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -62.4 -40.82 97.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.021 0.928 . . . . 100.0 111.267 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.3 m -62.15 -35.55 79.13 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.897 1.679 . . . . 100.0 113.511 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.37 121.36 13.24 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 CA-C-O 122.66 1.219 . . . . 100.0 109.774 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.604 HG12 HH21 ' A' ' 140' ' ' ARG . 29.2 m -128.49 -9.59 3.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-N 113.331 -1.759 . . . . 100.0 112.812 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.19 -41.85 84.82 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 125.233 1.413 . . . . 100.0 111.789 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.45 ' HB3' HD12 ' A' ' 119' ' ' LEU . 45.2 p-80 -61.47 -40.29 94.0 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.65 -0.691 . . . . 100.0 112.687 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.604 HH21 HG12 ' A' ' 137' ' ' VAL . 91.8 mtm-85 -64.41 -43.16 95.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.687 0.676 . . . . 100.0 112.301 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.47 -41.3 93.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.31 1.044 . . . . 100.0 111.638 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.2 7.2 47.08 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 117.488 2.403 . . . . 100.0 117.488 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.44 49.38 16.94 Favored 'General case' 0 C--N 1.362 1.144 0 CA-C-O 122.756 1.265 . . . . 100.0 112.813 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.72 HD22 ' HB ' ' A' ' 117' ' ' ILE . 43.7 mt -116.96 160.98 20.08 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.048 -1.093 . . . . 100.0 108.048 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.44 ' HG3' ' NE1' ' A' ' 163' ' ' TRP . 97.5 mm-40 -98.87 140.54 32.89 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -117.05 134.83 54.26 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.557 0.694 . . . . 100.0 112.41 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -134.15 136.87 44.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.328 -0.851 . . . . 100.0 111.999 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -88.29 125.45 34.67 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 101.165 -3.643 . . . . 100.0 101.165 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.93 157.29 38.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 CA-C-O 122.138 0.971 . . . . 100.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.3 t -141.86 116.43 9.67 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 105.285 -2.117 . . . . 100.0 105.285 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.43 -40.8 98.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.651 0.78 . . . . 100.0 109.651 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.32 -42.29 75.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.151 1.537 . . . . 100.0 115.151 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 m -93.16 -7.74 44.48 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 114.291 1.219 . . . . 100.0 114.291 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.471 HD21 ' HZ ' ' A' ' 35' ' ' PHE . 87.4 m-20 66.56 18.63 10.81 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.147 1.779 . . . . 100.0 112.81 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -69.66 118.92 13.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.45 -1.315 . . . . 100.0 107.45 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.52 33.16 15.57 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 127.383 2.273 . . . . 100.0 111.701 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.47 -39.31 90.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.324 1.601 . . . . 100.0 115.324 -175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -89.47 -8.12 53.58 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 115.616 1.71 . . . . 100.0 115.616 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 95.8 mttt -61.03 -44.27 93.85 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 118.189 2.663 . . . . 100.0 118.189 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.11 -41.3 61.94 Favored 'Trans proline' 0 C--N 1.374 1.894 0 CA-C-N 122.459 1.914 . . . . 100.0 112.994 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -64.5 -43.97 92.44 Favored 'General case' 0 CA--C 1.495 -1.141 0 O-C-N 124.055 0.847 . . . . 100.0 112.062 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.0 -42.86 94.11 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 113.098 0.777 . . . . 100.0 113.098 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.44 ' NE1' ' HG3' ' A' ' 145' ' ' GLN . 62.9 t-105 -62.82 -45.89 90.5 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 123.453 0.471 . . . . 100.0 110.224 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 85' ' ' CYS . 79.1 mt -60.65 -42.83 97.78 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 123.653 0.595 . . . . 100.0 110.819 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.32 99.08 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 123.668 0.787 . . . . 100.0 111.107 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.05 -45.12 94.95 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.609 0.764 . . . . 100.0 112.024 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.64 -43.4 76.36 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 112.469 0.544 . . . . 100.0 112.469 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.17 -46.64 80.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.195 0.813 . . . . 100.0 113.195 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.85 -38.62 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 125.127 1.371 . . . . 100.0 110.455 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.96 11.82 57.25 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 118.678 -1.068 . . . . 100.0 112.818 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -109.62 109.25 59.85 Favored Pre-proline 0 C--N 1.361 1.075 0 N-CA-C 106.719 -1.586 . . . . 100.0 106.719 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.35 -22.23 66.32 Favored 'Trans proline' 0 C--N 1.365 1.396 0 C-N-CA 124.087 3.191 . . . . 100.0 113.462 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -100.17 12.0 38.02 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 114.079 1.14 . . . . 100.0 114.079 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.16 131.65 51.17 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.516 0.726 . . . . 100.0 109.946 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -134.72 149.57 50.48 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 115.883 -0.599 . . . . 100.0 111.158 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -77.24 136.27 38.52 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.632 -1.248 . . . . 100.0 107.632 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.97 155.43 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.731 -1.211 . . . . 100.0 107.731 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -40.67 -96.33 0.0 OUTLIER 'General case' 0 C--N 1.355 0.827 0 N-CA-C 118.178 2.658 . . . . 100.0 118.178 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.496 ' SD ' ' HD2' ' A' ' 180' ' ' PRO . 46.0 tpp -160.57 142.03 9.08 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 106.499 -1.667 . . . . 100.0 106.499 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.496 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 40.5 Cg_endo -63.92 138.6 63.71 Favored 'Trans proline' 0 CA--C 1.49 -1.675 0 C-N-CA 122.997 2.465 . . . . 100.0 110.787 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -95.37 105.66 17.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.728 -2.323 . . . . 100.0 104.728 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.8 mt -101.12 157.19 16.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.882 -1.053 . . . . 100.0 108.273 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.12 118.26 71.13 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.677 -2.342 . . . . 100.0 104.677 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.43 143.09 62.05 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 123.687 2.925 . . . . 100.0 116.211 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.26 160.58 48.46 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 123.626 2.884 . . . . 100.0 108.889 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.95 -48.15 83.17 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 112.927 0.714 . . . . 100.0 112.927 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.254 39.0 t 60.47 96.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.871 2.068 . . . . 100.0 112.603 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.18 -91.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 102.191 -3.263 . . . . 100.0 102.191 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.8 mtm 50.19 -130.35 2.06 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 127.951 2.501 . . . . 100.0 115.145 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 193' ' ' LEU 0.338 63.2 m-20 71.6 12.62 0.0 OUTLIER Pre-proline 0 C--N 1.365 1.277 1 N-CA-C 124.788 5.107 . . . . 100.0 124.788 -179.557 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.85 -75.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.381 2.289 0 CA-C-N 124.886 2.781 . . . . 100.0 110.18 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.66 -37.26 86.02 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 126.012 1.725 . . . . 100.0 109.866 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 190' ' ' ASP . 88.7 mt -60.48 -41.5 94.32 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 116.11 1.893 . . . . 100.0 116.11 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.26 175.06 9.4 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 114.929 1.455 . . . . 100.0 114.929 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 74.04 -49.97 0.68 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 128.048 2.539 . . . . 100.0 115.726 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.09 -34.44 73.47 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 126.739 2.016 . . . . 100.0 112.032 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -59.93 -41.67 92.3 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 113.662 0.986 . . . . 100.0 113.662 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.36 -40.34 96.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 118.378 0.535 . . . . 100.0 111.921 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.44 -41.62 98.86 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.245 0.618 . . . . 100.0 110.006 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -64.69 -41.12 96.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.255 1.422 . . . . 100.0 111.431 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.4 -42.82 99.34 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.882 0.873 . . . . 100.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -63.0 -45.55 91.87 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 123.995 0.918 . . . . 100.0 111.801 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.259 34.5 m -62.9 -39.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.363 1.193 0 CA-C-O 119.025 -0.512 . . . . 100.0 110.377 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.69 92.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.916 1.286 . . . . 100.0 112.238 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -62.74 -39.69 94.88 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.523 1.129 . . . . 100.0 111.43 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 84.8 m -65.52 -42.54 91.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.697 1.599 . . . . 100.0 111.488 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.8 m -61.54 133.13 55.34 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.259 1.024 . . . . 100.0 112.329 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -69.77 144.03 52.81 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 115.019 -0.991 . . . . 100.0 108.973 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 mt -105.82 123.44 39.25 Favored Pre-proline 0 CA--C 1.492 -1.275 0 C-N-CA 120.736 -0.386 . . . . 100.0 111.191 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.37 143.61 89.14 Favored 'Trans proline' 0 N--CA 1.438 -1.756 0 C-N-CA 122.781 2.321 . . . . 100.0 109.493 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -80.89 106.78 13.16 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 104.958 -2.238 . . . . 100.0 104.958 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -121.49 -55.94 1.91 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.522 -1.217 . . . . 100.0 107.867 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.491 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 37.2 p30 -112.85 10.99 19.15 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 115.708 1.744 . . . . 100.0 115.708 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.98 -33.49 73.3 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 125.057 1.343 . . . . 100.0 113.42 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.24 -41.04 87.78 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.22 1.808 . . . . 100.0 112.284 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--O 1.258 1.524 0 CA-C-O 116.991 -1.481 . . . . 100.0 107.779 -179.561 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 120.601 0.238 . . . . 100.0 111.125 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.35 -38.89 85.23 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 125.212 1.405 . . . . 100.0 111.364 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.24 99.25 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.592 0.757 . . . . 100.0 110.131 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -67.96 -36.32 79.87 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.815 1.246 . . . . 100.0 111.147 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.63 39.89 Favored Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 108.475 -1.85 . . . . 100.0 108.475 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.657 ' HB3' ' HB2' ' A' ' 10' ' ' GLN . 18.9 pt-20 -95.03 119.78 65.33 Favored Pre-proline 0 N--CA 1.405 -2.702 0 N-CA-C 109.149 -0.686 . . . . 100.0 109.149 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -82.56 73.9 5.33 Favored 'Trans proline' 0 C--N 1.373 1.843 1 N-CA-C 94.5 -6.769 . . . . 100.0 94.5 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 73.67 -59.58 0.56 Allowed 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 107.021 -1.474 . . . . 100.0 107.021 -169.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.25 127.07 51.09 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 N-CA-C 118.574 2.805 . . . . 100.0 118.574 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.657 ' HB2' ' HB3' ' A' ' 6' ' ' GLU 0.267 19.8 tt0 -131.39 136.72 48.27 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.835 1.654 . . . . 100.0 108.237 177.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -128.33 131.93 48.61 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.877 -0.786 . . . . 100.0 108.877 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.2 tttt -90.44 115.35 27.54 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 105.294 -2.113 . . . . 100.0 105.294 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 14' ' ' VAL . 2.8 tt -116.51 130.24 56.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.362 -1.348 . . . . 100.0 107.362 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.556 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.7 t -111.25 125.39 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 118.577 -1.249 . . . . 100.0 109.713 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' CD1' HD22 ' A' ' 13' ' ' LEU . 7.6 mp -102.08 120.45 40.45 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -128.87 161.19 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.057 -1.429 . . . . 100.0 111.235 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.14 172.59 20.92 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.555 -1.418 . . . . 100.0 109.555 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.497 ' HB2' HG23 ' A' ' 97' ' ' THR . 87.9 m-20 -71.0 160.12 33.5 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.777 0.799 . . . . 100.0 112.827 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.52 140.09 40.41 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 110.316 -1.114 . . . . 100.0 110.316 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.68 89.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 118.608 -1.107 . . . . 100.0 114.536 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 p -64.05 -39.4 93.99 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 118.802 1.301 . . . . 100.0 114.084 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.54 17.83 5.94 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 118.992 -0.893 . . . . 100.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.56 -47.75 84.35 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 118.923 1.361 . . . . 100.0 110.611 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 m -64.83 -43.23 93.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.209 1.403 . . . . 100.0 111.158 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.4 m -63.08 -41.59 99.45 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.369 1.068 . . . . 100.0 109.483 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -61.3 -48.14 82.73 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.748 1.219 . . . . 100.0 110.429 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -43.08 96.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 122.739 0.415 . . . . 100.0 111.112 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HD3' ' HB2' ' A' ' 36' ' ' GLU . 87.9 tttt -61.56 -41.96 98.14 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.885 0.874 . . . . 100.0 111.056 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HG2' HH11 ' A' ' 29' ' ' ARG . 28.5 ttp85 -61.64 -43.21 99.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.041 0.937 . . . . 100.0 110.35 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -63.82 -41.32 97.89 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 112.829 0.677 . . . . 100.0 112.829 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -69.3 -44.44 71.76 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.355 1.613 . . . . 100.0 115.355 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.8 p -118.94 -23.1 7.03 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 117.708 2.484 . . . . 100.0 117.708 -176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.22 -7.74 72.46 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.582 -1.007 . . . . 100.0 110.582 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.12 153.93 31.71 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.857 1.663 . . . . 100.0 109.662 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -117.32 119.07 34.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.993 -2.966 . . . . 100.0 102.993 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 43.4 tt0 -99.25 119.06 37.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.608 -0.837 . . . . 100.0 108.854 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.7 -13.85 33.35 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.87 1.063 . . . . 100.0 113.87 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 199' ' ' HIS . 98.2 mttt -94.74 124.99 39.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.384 -1.339 . . . . 100.0 107.384 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -96.61 112.48 24.21 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.815 0.817 . . . . 100.0 109.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.33 124.33 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 102.453 -3.166 . . . . 100.0 102.453 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.97 142.43 57.46 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.172 1.175 . . . . 100.0 114.172 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.8 m -92.37 130.08 38.14 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.3 -2.111 . . . . 100.0 105.3 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -102.92 126.67 50.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.404 -0.961 . . . . 100.0 108.404 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.83 -121.89 18.03 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 109.543 -1.423 . . . . 100.0 109.543 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.08 141.73 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.216 -0.661 . . . . 100.0 109.216 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -124.26 125.1 43.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.084 -2.562 . . . . 100.0 104.084 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.85 121.52 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.561 -1.2 . . . . 100.0 108.169 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.86 122.14 25.57 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 115.583 -0.735 . . . . 100.0 111.269 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.12 128.35 7.28 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.561 2.841 . . . . 100.0 110.969 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -131.64 123.6 28.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.067 -1.086 . . . . 100.0 108.067 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.9 t -110.32 135.9 47.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 N-CA-C 108.863 -0.792 . . . . 100.0 108.863 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -124.35 138.52 54.37 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.495 -1.298 . . . . 100.0 107.495 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -98.59 126.28 44.12 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 107.208 -1.404 . . . . 100.0 107.208 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 p -124.11 -179.78 4.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.956 -1.02 . . . . 100.0 109.868 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.91 -35.6 73.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.052 2.141 . . . . 100.0 109.484 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.23 10.94 29.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 124.182 0.993 . . . . 100.0 113.554 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.53 176.1 25.03 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.758 -0.537 . . . . 100.0 111.758 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.71 136.8 40.13 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.365 2.71 . . . . 100.0 114.486 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.78 142.35 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.486 -1.672 . . . . 100.0 106.486 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -113.64 131.94 55.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.707 -0.797 . . . . 100.0 110.404 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -106.91 119.03 38.25 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.142 -2.54 . . . . 100.0 104.142 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -92.55 99.14 11.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 100.163 -4.014 . . . . 100.0 100.163 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 83.7 t -85.74 125.96 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-N 115.805 -0.634 . . . . 100.0 110.674 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.467 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 36.5 m95 -107.31 98.02 7.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.132 -2.173 . . . . 100.0 105.132 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -86.31 116.11 24.27 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 104.3 -2.481 . . . . 100.0 104.3 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.0 163.93 12.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 113.482 0.919 . . . . 100.0 113.482 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 133.02 35.13 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.28 1.032 . . . . 100.0 109.61 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.16 83.54 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 116.667 -0.242 . . . . 100.0 113.516 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -70.37 -40.69 73.85 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 127.243 2.217 . . . . 100.0 111.856 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.562 ' HB2' HH11 ' A' ' 76' ' ' ARG . 47.0 mt-10 -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.494 1.294 . . . . 100.0 114.494 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.32 151.65 45.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.313 -1.312 . . . . 100.0 109.765 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -68.24 131.59 45.64 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.242 -2.133 . . . . 100.0 105.242 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.44 -174.98 40.53 Favored Glycine 0 C--N 1.355 1.597 0 C-N-CA 118.728 -1.701 . . . . 100.0 114.818 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -22.26 65.03 Favored Glycine 0 C--N 1.353 1.498 0 C-N-CA 126.992 2.234 . . . . 100.0 113.552 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.67 -37.47 84.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.189 1.796 . . . . 100.0 110.03 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.562 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.4 mtp85 -88.64 7.72 32.08 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.431 1.892 . . . . 100.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.95 -38.57 89.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 116.615 2.08 . . . . 100.0 116.615 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -38.07 90.2 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.676 0.655 . . . . 100.0 112.839 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.251 22.0 m-30 -62.35 -43.28 99.18 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.985 1.314 . . . . 100.0 109.856 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 3.4 t80 -90.95 -19.99 22.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.934 1.457 . . . . 100.0 114.934 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.38 135.8 24.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-N 119.631 1.105 . . . . 100.0 108.843 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 66.72 18.22 10.68 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.51 1.924 . . . . 100.0 114.245 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.28 146.69 48.77 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.98 -1.118 . . . . 100.0 107.98 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -106.79 -21.74 12.94 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.698 -0.683 . . . . 100.0 111.2 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.486 ' SG ' ' HG ' ' A' ' 13' ' ' LEU . 7.5 p -160.38 164.96 31.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.718 0.807 . . . . 100.0 109.808 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -150.1 156.91 42.49 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 113.721 1.008 . . . . 100.0 113.721 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.19 127.17 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.316 -2.105 . . . . 100.0 105.316 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.2 mt -110.67 123.63 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 N-CA-C 103.113 -2.921 . . . . 100.0 103.113 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.49 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 57.2 mtt -113.75 135.03 54.39 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 116.542 2.053 . . . . 100.0 116.542 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -132.99 162.02 32.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.445 -1.707 . . . . 100.0 109.975 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -106.11 125.09 50.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.186 -1.783 . . . . 100.0 106.186 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -63.86 -19.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 N-CA-C 113.934 1.087 . . . . 100.0 113.934 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.3 p -90.1 -3.26 58.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 111.987 0.366 . . . . 100.0 111.987 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -124.69 115.08 20.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 122.527 1.156 . . . . 100.0 111.347 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -65.51 -39.55 91.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.742 -1.117 . . . . 100.0 111.078 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -61.64 -41.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 124.982 1.313 . . . . 100.0 109.19 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 18' ' ' ASP . 96.6 m -62.49 -41.72 99.0 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.959 0.504 . . . . 100.0 110.147 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -65.31 -40.29 93.59 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.238 0.615 . . . . 100.0 110.962 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -59.79 -35.87 75.54 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.259 1.024 . . . . 100.0 111.237 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -74.01 -11.67 60.4 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 115.415 1.635 . . . . 100.0 115.415 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.39 -43.73 96.84 Favored Pre-proline 0 C--N 1.362 1.12 0 CA-C-O 116.141 -1.885 . . . . 100.0 111.792 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 86.5 Cg_exo -57.37 -35.11 98.87 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.529 2.153 . . . . 100.0 111.939 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.32 -41.9 84.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 123.453 0.701 . . . . 100.0 111.291 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' O ' HD13 ' A' ' 108' ' ' LEU . 85.8 m95 -63.66 -45.73 88.81 Favored 'General case' 0 C--N 1.365 1.278 0 N-CA-C 109.197 -0.668 . . . . 100.0 109.197 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -90.79 69.81 6.55 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.838 -1.542 . . . . 100.0 106.838 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -167.75 -55.5 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 100.937 -3.727 . . . . 100.0 100.937 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.68 -43.27 99.24 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.674 -1.602 . . . . 100.0 106.674 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.415 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -63.31 -50.15 71.17 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.83 -23.59 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 113.287 0.847 . . . . 100.0 113.287 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -60.31 -41.24 93.04 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.674 0.79 . . . . 100.0 109.759 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.257 15.1 m -98.36 -34.43 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 115.958 1.836 . . . . 100.0 115.958 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.292 68.9 m -107.05 -4.62 18.75 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 117.823 2.527 . . . . 100.0 117.823 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.339 66.3 mt-10 53.59 -119.31 1.47 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.636 1.347 . . . . 100.0 114.636 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -95.94 112.11 23.93 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 118.386 -1.326 . . . . 100.0 111.872 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 pt -145.12 153.83 53.53 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -61.21 126.18 18.78 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.622 2.214 . . . . 100.0 111.78 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.643 ' HB ' HD22 ' A' ' 144' ' ' LEU . 61.1 mt -133.35 134.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.685 -1.228 . . . . 100.0 107.685 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -116.0 131.59 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.928 -1.487 . . . . 100.0 108.687 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.5 mt -100.03 126.4 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 104.957 -2.238 . . . . 100.0 104.957 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 70.9 m -118.18 125.0 49.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 122.026 0.917 . . . . 100.0 111.871 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.92 101.21 2.57 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 104.492 -3.443 . . . . 100.0 104.492 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -81.31 163.17 23.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.611 1.164 . . . . 100.0 112.17 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 57.78 42.02 24.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.877 2.471 . . . . 100.0 115.442 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 148' ' ' ASP . 31.0 m -67.5 -13.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 112.051 0.389 . . . . 100.0 112.051 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.38 -38.86 92.8 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.641 1.976 . . . . 100.0 110.399 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.06 133.89 28.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 124.19 0.996 . . . . 100.0 110.583 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.59 -46.94 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.081 1.882 . . . . 100.0 116.081 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -85.26 77.11 10.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.587 0.63 . . . . 100.0 110.723 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -85.57 134.05 34.03 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.05 -40.87 6.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.681 -0.691 . . . . 100.0 112.355 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.07 106.7 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 106.028 -1.841 . . . . 100.0 106.028 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.69 146.86 37.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.951 -1.022 . . . . 100.0 109.375 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.0 88.57 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.412 1.085 . . . . 100.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.58 -40.09 95.8 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.71 1.204 . . . . 100.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.1 m -61.9 -38.24 87.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.358 1.463 . . . . 100.0 113.233 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.73 122.37 14.48 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 122.389 1.09 . . . . 100.0 110.07 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.61 -6.55 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.848 0 CA-C-N 113.785 -1.552 . . . . 100.0 112.21 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -58.89 -39.66 82.12 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.86 1.264 . . . . 100.0 111.323 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -61.07 -39.95 91.85 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 123.497 0.719 . . . . 100.0 111.616 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.08 -43.64 94.79 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 118.662 0.664 . . . . 100.0 112.101 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.369 1.067 . . . . 100.0 111.337 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.22 6.94 47.57 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 118.325 2.713 . . . . 100.0 118.325 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 54.63 46.41 24.81 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.058 1.343 . . . . 100.0 113.943 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.643 HD22 ' HB ' ' A' ' 117' ' ' ILE . 38.0 mt -109.57 159.47 17.07 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.618 -1.173 . . . . 100.0 108.464 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -96.47 141.67 29.49 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.414 -1.699 . . . . 100.0 106.414 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -118.32 133.52 55.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.159 0.504 . . . . 100.0 111.268 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.74 134.85 43.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.663 -0.698 . . . . 100.0 111.991 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.436 ' HB3' HG11 ' A' ' 124' ' ' VAL . 43.3 m-20 -88.59 123.37 33.01 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 101.683 -3.451 . . . . 100.0 101.683 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.73 158.3 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 122.64 1.21 . . . . 100.0 112.302 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.7 t -143.12 111.32 6.13 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 105.751 -1.944 . . . . 100.0 105.751 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.89 92.14 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.549 -0.908 . . . . 100.0 108.549 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.17 -43.5 91.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 114.875 1.435 . . . . 100.0 114.875 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 87.5 p -100.89 -2.28 32.43 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 114.916 1.45 . . . . 100.0 114.916 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 70.79 9.53 6.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 125.774 1.629 . . . . 100.0 112.953 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -63.49 121.73 14.54 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.403 1.001 . . . . 100.0 108.945 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 53.34 34.58 18.23 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 127.271 2.228 . . . . 100.0 111.459 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 158' ' ' GLU . 10.8 p90 -59.67 -41.46 90.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.799 1.777 . . . . 100.0 115.799 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.44 ' HG3' ' CE2' ' A' ' 157' ' ' PHE . 94.3 mt-10 -93.04 -3.48 54.25 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 115.503 1.668 . . . . 100.0 115.503 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 96.8 mttt -60.36 -44.31 95.56 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 116.969 2.211 . . . . 100.0 116.969 -177.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.4 -43.11 42.78 Favored 'Trans proline' 0 C--N 1.375 1.956 0 CA-C-N 122.5 1.929 . . . . 100.0 113.095 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -64.65 -43.68 92.89 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.247 0.967 . . . . 100.0 111.863 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 176' ' ' PHE . 96.1 mt -64.28 -43.25 95.39 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 118.827 -0.606 . . . . 100.0 112.565 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -62.11 -46.62 88.24 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 123.487 0.492 . . . . 100.0 110.793 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 85' ' ' CYS . 83.5 mt -60.49 -42.77 97.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 124.131 0.895 . . . . 100.0 110.686 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.9 97.93 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.521 0.729 . . . . 100.0 111.154 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.434 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 72.2 mtt85 -63.48 -44.63 93.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 118.557 -0.735 . . . . 100.0 112.488 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -69.01 -43.14 75.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.406 0.441 . . . . 100.0 112.051 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.2 -46.91 75.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 113.239 0.829 . . . . 100.0 113.239 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.16 -38.42 77.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 125.29 1.436 . . . . 100.0 110.368 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.71 10.23 56.8 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 118.238 -1.312 . . . . 100.0 113.815 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -108.88 110.65 61.01 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.071 -1.455 . . . . 100.0 107.071 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.34 -22.22 66.36 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.912 3.074 . . . . 100.0 113.51 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -102.01 11.26 38.74 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 114.206 1.187 . . . . 100.0 114.206 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 25.4 tp -62.45 133.16 54.62 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -135.77 152.27 50.94 Favored 'General case' 0 CA--C 1.484 -1.564 0 CA-C-O 121.337 0.589 . . . . 100.0 111.687 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.438 ' HB2' HD21 ' A' ' 162' ' ' LEU . 80.1 t80 -74.21 132.74 42.45 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 105.813 -1.921 . . . . 100.0 105.813 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.22 138.42 54.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 CA-C-O 121.362 0.601 . . . . 100.0 110.207 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 23.08 -91.1 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 129.681 3.192 . . . . 100.0 117.487 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 58.2 ttm 97.24 124.97 0.02 OUTLIER Pre-proline 0 C--N 1.37 1.467 0 C-N-CA 127.725 2.41 . . . . 100.0 107.985 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.77 143.73 99.57 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.005 2.47 . . . . 100.0 109.467 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -60.94 135.13 57.7 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 124.074 0.859 . . . . 100.0 112.976 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.89 145.07 52.26 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.51 -1.223 . . . . 100.0 107.753 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -75.13 127.48 86.52 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-O 119.367 -0.349 . . . . 100.0 110.4 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.39 143.31 42.9 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.573 2.848 . . . . 100.0 110.023 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -69.95 125.82 12.48 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.016 1.811 . . . . 100.0 110.254 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.57 -42.04 71.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 123.712 0.633 . . . . 100.0 110.864 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.566 33.9 m 52.55 63.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.113 0 N-CA-C 119.469 3.137 . . . . 100.0 119.469 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.03 -41.71 10.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.177 0 C-N-CA 124.818 1.247 . . . . 100.0 112.138 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 86.3 mtp -70.73 167.43 18.76 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.078 1.351 . . . . 100.0 113.476 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.448 ' H ' ' HD2' ' A' ' 191' ' ' PRO . 37.9 t70 -123.84 -53.37 0.03 OUTLIER Pre-proline 0 C--N 1.363 1.191 0 N-CA-C 118.75 2.87 . . . . 100.0 118.75 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.448 ' HD2' ' H ' ' A' ' 190' ' ' ASP 0.289 52.6 Cg_endo -57.22 -68.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 N-CA-C 122.312 3.928 . . . . 100.0 122.312 -174.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.19 96.64 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.908 1.231 . . . . 100.0 111.79 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.78 -36.56 83.49 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 115.976 1.843 . . . . 100.0 115.976 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.65 164.28 7.91 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 118.49 2.774 . . . . 100.0 118.49 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 74.62 -60.83 0.51 Allowed 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 130.841 3.657 . . . . 100.0 116.721 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -61.55 -36.22 79.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 115.106 1.521 . . . . 100.0 115.106 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.438 ' CE2' HD11 ' A' ' 201' ' ' LEU . 52.5 t80 -61.56 -40.63 95.43 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 125.994 1.718 . . . . 100.0 112.813 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.99 -38.36 85.74 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 123.891 0.876 . . . . 100.0 112.309 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.453 ' CE1' ' HD2' ' A' ' 38' ' ' LYS . 39.3 t60 -59.02 -45.98 89.35 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.652 1.181 . . . . 100.0 110.724 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.75 -43.95 82.76 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.966 1.306 . . . . 100.0 112.073 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' A' ' 197' ' ' TYR . 94.4 mt -61.27 -44.63 96.92 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-O 118.567 -0.73 . . . . 100.0 112.81 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.79 -47.52 84.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 123.829 0.706 . . . . 100.0 112.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.08 -41.0 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 O-C-N 123.828 0.705 . . . . 100.0 111.996 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.56 -45.37 72.28 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.68 1.363 . . . . 100.0 114.68 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -63.83 -40.44 96.6 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.861 1.265 . . . . 100.0 113.497 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.7 m -66.45 -40.97 89.75 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.626 1.17 . . . . 100.0 111.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.2 m -71.58 122.73 21.04 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.628 1.204 . . . . 100.0 111.865 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -80.92 159.71 24.89 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.961 -1.866 . . . . 100.0 105.961 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 78.1 mt -104.39 108.32 60.13 Favored Pre-proline 0 N--CA 1.442 -0.865 0 C-N-CA 119.809 -0.757 . . . . 100.0 112.411 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -80.24 110.95 2.57 Favored 'Trans proline' 0 C--N 1.367 1.531 0 N-CA-C 102.545 -3.675 . . . . 100.0 102.545 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -75.73 114.98 14.94 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.879 -1.156 . . . . 100.0 107.879 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -118.04 -64.16 1.33 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.884 -1.895 . . . . 100.0 105.884 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -133.9 33.92 3.41 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.616 0.722 . . . . 100.0 109.503 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.67 -20.77 65.17 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 125.446 1.498 . . . . 100.0 112.635 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.54 -38.96 86.16 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.039 1.336 . . . . 100.0 109.991 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.0 tp . . . . . 0 C--O 1.256 1.446 0 N-CA-C 106.233 -1.766 . . . . 100.0 106.233 179.15 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mtt . . . . . 0 CA--C 1.491 -1.292 0 N-CA-C 109.632 -0.507 . . . . 100.0 109.632 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.11 81.19 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 125.611 1.564 . . . . 100.0 111.009 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.78 -43.51 98.7 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 123.386 0.674 . . . . 100.0 110.156 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -73.4 -24.57 60.31 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.914 0.709 . . . . 100.0 112.914 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . 86.17 22.26 49.14 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 109.091 -1.604 . . . . 100.0 109.091 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 10' ' ' GLN 0.362 37.7 tt0 -92.75 99.2 2.72 Favored Pre-proline 0 N--CA 1.412 -2.355 0 C-N-CA 129.312 3.045 . . . . 100.0 103.79 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 5' ' ' GLY . 76.0 Cg_endo -81.76 77.65 3.81 Favored 'Trans proline' 0 CA--C 1.479 -2.226 1 N-CA-C 96.28 -6.085 . . . . 100.0 96.28 177.172 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 6' ' ' GLU 0.256 89.8 mm-40 74.51 -60.75 0.51 Allowed 'General case' 0 N--CA 1.408 -2.553 0 CA-C-O 116.705 -1.617 . . . . 100.0 107.382 -169.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.1 130.46 63.27 Favored 'Isoleucine or valine' 0 C--N 1.365 1.279 0 N-CA-C 118.167 2.655 . . . . 100.0 118.167 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 6' ' ' GLU 0.288 45.9 tt0 -131.29 135.33 47.21 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.19 -2.152 . . . . 100.0 105.19 175.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . 0.278 80.9 m-85 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 106.439 -1.689 . . . . 100.0 106.439 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -92.38 118.28 30.77 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.341 -2.096 . . . . 100.0 105.341 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.845 HD22 ' SG ' ' A' ' 85' ' ' CYS 0.362 4.3 mt -114.9 132.51 56.51 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 105.797 -1.927 . . . . 100.0 105.797 -178.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 64' ' ' TRP . 39.8 t -110.24 127.75 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 116.47 -2.092 . . . . 100.0 106.823 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 tp -103.17 118.01 35.83 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.344 -1.354 . . . . 100.0 107.344 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 108' ' ' LEU . 29.4 m -127.83 162.0 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 125.479 1.512 . . . . 100.0 112.93 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.57 171.07 17.75 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.05 -1.62 . . . . 100.0 109.05 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HB2' HG23 ' A' ' 97' ' ' THR . 84.3 m-20 -70.42 159.27 34.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.97 0.89 . . . . 100.0 113.187 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.68 139.03 40.67 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.54 -1.024 . . . . 100.0 110.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 3.51 90.13 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-O 118.354 -1.248 . . . . 100.0 115.276 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 p -64.43 -38.75 92.13 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.095 1.448 . . . . 100.0 113.553 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 19.89 4.77 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 111.132 -0.787 . . . . 100.0 111.132 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.6 -48.72 80.55 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 124.334 1.054 . . . . 100.0 110.87 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.3 m -65.75 -43.42 88.96 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.228 1.411 . . . . 100.0 110.95 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.3 m -62.82 -41.66 99.4 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.393 1.077 . . . . 100.0 109.505 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.72 -47.51 84.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 124.103 0.961 . . . . 100.0 110.696 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.56 -41.31 91.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 O-C-N 122.893 0.121 . . . . 100.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.0 -39.92 93.88 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.56 0.744 . . . . 100.0 111.097 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.84 -44.09 97.43 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.069 0.548 . . . . 100.0 110.313 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -62.21 -43.92 97.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.812 0.671 . . . . 100.0 112.812 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.69 -44.74 66.36 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.547 2.055 . . . . 100.0 116.547 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.5 p -117.4 -24.93 7.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 117.521 2.415 . . . . 100.0 117.521 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.01 -8.08 70.05 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.695 -0.962 . . . . 100.0 110.695 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.88 156.36 30.41 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.469 1.107 . . . . 100.0 109.671 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -115.8 116.56 28.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 101.087 -3.671 . . . . 100.0 101.087 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -96.88 118.96 34.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.154 -1.424 . . . . 100.0 107.154 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.64 -11.18 34.84 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.828 -1.078 . . . . 100.0 113.235 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -101.22 126.18 47.92 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.174 -1.047 . . . . 100.0 108.174 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -95.04 116.42 28.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.927 0.87 . . . . 100.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.05 121.08 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.784 -3.413 . . . . 100.0 101.784 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.95 141.9 58.55 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.371 0.668 . . . . 100.0 112.591 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.7 m -94.51 129.06 41.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 105.281 -2.118 . . . . 100.0 105.281 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.37 129.15 48.75 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.053 -1.091 . . . . 100.0 108.053 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.69 14.32 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 109.614 -1.395 . . . . 100.0 109.614 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.48 143.25 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 109.157 -0.682 . . . . 100.0 109.157 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -127.32 125.55 41.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.608 -2.738 . . . . 100.0 103.608 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -99.04 125.46 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.509 -0.922 . . . . 100.0 108.509 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -121.45 123.71 27.51 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-N 114.803 -1.09 . . . . 100.0 111.176 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.423 ' CB ' ' HE3' ' A' ' 60' ' ' LYS . 75.8 Cg_endo -80.08 126.64 6.46 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.702 3.602 . . . . 100.0 111.91 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 tp -133.45 130.12 38.19 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.927 -1.138 . . . . 100.0 107.927 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -118.25 134.61 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.775 -0.824 . . . . 100.0 108.775 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -124.98 142.61 51.37 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.374 -0.973 . . . . 100.0 108.374 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -98.43 124.0 42.89 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.851 -0.796 . . . . 100.0 108.851 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.1 p -121.36 -177.67 3.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.336 -0.847 . . . . 100.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.22 -35.61 73.95 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.388 2.275 . . . . 100.0 109.333 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -88.21 3.25 50.06 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.13 1.372 . . . . 100.0 113.266 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.59 -179.5 22.73 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.117 -1.193 . . . . 100.0 110.117 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 7' ' ' PRO . 72.4 Cg_endo -66.66 137.29 45.4 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.348 2.698 . . . . 100.0 113.919 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -130.84 137.47 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.488 -1.301 . . . . 100.0 107.488 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HE3' ' CB ' ' A' ' 49' ' ' PRO . 85.4 tttt -105.1 133.51 49.76 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.967 0.889 . . . . 100.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.587 ' HD2' HD21 ' A' ' 13' ' ' LEU . 93.1 m-85 -110.94 116.85 31.92 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 103.098 -2.927 . . . . 100.0 103.098 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.06 99.25 11.89 Favored 'General case' 0 N--CA 1.434 -1.238 1 N-CA-C 99.979 -4.082 . . . . 100.0 99.979 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.53 125.69 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.768 -0.827 . . . . 100.0 108.768 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 31.2 m95 -102.74 97.75 7.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 105.089 -2.189 . . . . 100.0 105.089 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -85.84 116.32 24.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 104.938 -2.245 . . . . 100.0 104.938 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -99.53 166.06 11.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 114.576 1.324 . . . . 100.0 114.576 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.21 131.75 34.16 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.625 0.77 . . . . 100.0 109.301 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.71 -8.47 82.77 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.45 0.54 . . . . 100.0 114.45 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -70.6 -39.67 73.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.462 1.505 . . . . 100.0 112.731 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.534 ' HB2' HH11 ' A' ' 76' ' ' ARG . 49.0 mt-10 -62.33 134.56 56.66 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.472 1.509 . . . . 100.0 113.689 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.24 154.51 40.18 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.04 -0.982 . . . . 100.0 109.984 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -67.21 132.73 48.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 125.95 1.7 . . . . 100.0 107.673 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.72 -175.51 40.68 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.001 -1.571 . . . . 100.0 114.14 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.78 -23.28 65.23 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 126.747 2.118 . . . . 100.0 113.6 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.95 -28.34 69.75 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.416 1.087 . . . . 100.0 110.86 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.534 HH11 ' HB2' ' A' ' 70' ' ' GLU . 75.5 mtp85 -92.29 9.31 34.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.68 1.592 . . . . 100.0 114.562 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.59 -38.51 84.87 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 115.687 1.736 . . . . 100.0 115.687 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.95 89.89 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 124.271 0.939 . . . . 100.0 113.433 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -61.54 -48.32 81.52 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.129 0.972 . . . . 100.0 109.086 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HD1' ' HG ' ' A' ' 112' ' ' CYS 0.423 25.7 m-85 -70.64 -37.43 73.76 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 120.223 3.416 . . . . 100.0 120.223 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -54.03 131.97 16.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.78 0.8 . . . . 100.0 109.963 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 68.55 14.37 9.06 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.19 145.73 54.05 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-N 118.882 0.764 . . . . 100.0 109.864 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -102.87 -30.72 10.66 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.369 -0.832 . . . . 100.0 110.51 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.845 ' SG ' HD22 ' A' ' 13' ' ' LEU . 31.9 p -160.81 170.08 21.42 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.315 0.646 . . . . 100.0 109.472 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.48 157.46 43.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 113.333 0.864 . . . . 100.0 113.333 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.23 126.62 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.482 -2.414 . . . . 100.0 104.482 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.2 mt -109.59 123.97 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 103.286 -2.857 . . . . 100.0 103.286 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.455 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 40.4 mtt -114.09 135.28 54.2 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 115.322 1.601 . . . . 100.0 115.322 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -132.75 159.62 39.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.926 -1.943 . . . . 100.0 110.003 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -103.72 125.07 49.95 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.105 -1.813 . . . . 100.0 106.105 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.51 -19.79 24.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 114.117 1.154 . . . . 100.0 114.117 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.4 p -88.45 -6.55 57.57 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 119.072 -0.49 . . . . 100.0 111.51 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -123.18 114.29 20.09 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.804 1.287 . . . . 100.0 112.238 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -65.43 -38.49 90.04 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.398 -1.274 . . . . 100.0 111.327 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.996 1.318 . . . . 100.0 109.154 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.54 HG23 ' HB2' ' A' ' 18' ' ' ASP . 99.8 m -62.76 -41.32 99.16 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.94 0.496 . . . . 100.0 110.16 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.23 -39.84 93.28 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.541 0.736 . . . . 100.0 110.973 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.501 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -59.33 -36.71 76.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.687 1.195 . . . . 100.0 111.101 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.28 -10.67 59.82 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 115.782 1.771 . . . . 100.0 115.782 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.43 -43.82 96.86 Favored Pre-proline 0 C--N 1.36 1.034 0 CA-C-O 116.128 -1.891 . . . . 100.0 111.621 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.8 Cg_exo -58.35 -33.6 97.91 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.576 2.184 . . . . 100.0 112.503 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -67.23 -42.99 83.12 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.782 0.833 . . . . 100.0 109.862 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.567 ' O ' HD13 ' A' ' 108' ' ' LEU . 85.3 m95 -63.26 -46.98 84.32 Favored 'General case' 0 C--N 1.368 1.375 0 N-CA-C 108.649 -0.871 . . . . 100.0 108.649 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -89.53 70.75 7.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.892 1.33 . . . . 100.0 107.776 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -168.4 -55.54 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 100.315 -3.957 . . . . 100.0 100.315 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.267 -1.383 . . . . 100.0 107.267 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.567 HD13 ' O ' ' A' ' 104' ' ' TRP . 7.1 mp -61.88 -50.35 72.57 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.396 1.078 . . . . 100.0 112.806 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.259 32.8 m -70.15 -19.66 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 113.799 1.037 . . . . 100.0 113.799 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -60.55 -39.61 88.55 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.787 0.435 . . . . 100.0 110.511 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.89 -47.13 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-O 120.757 0.313 . . . . 100.0 110.792 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.549 ' HG ' ' HD1' ' A' ' 80' ' ' TYR . 95.9 m -70.87 -36.9 73.0 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 119.478 3.14 . . . . 100.0 119.478 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 61.72 -122.22 0.77 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 126.053 1.741 . . . . 100.0 109.31 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -93.41 113.02 25.08 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.294 1.861 . . . . 100.0 112.273 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 36.3 pt -144.4 149.16 43.4 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.133 -2.173 . . . . 100.0 105.133 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 85' ' ' CYS . 41.5 Cg_endo -64.31 128.99 22.78 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.018 1.812 . . . . 100.0 110.437 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.733 ' HB ' HD22 ' A' ' 144' ' ' LEU . 76.6 mt -131.91 135.09 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.316 -1.364 . . . . 100.0 107.316 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.33 131.69 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 114.402 -1.272 . . . . 100.0 107.799 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.9 126.55 43.34 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.388 -2.079 . . . . 100.0 105.388 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.455 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.95 125.93 50.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 122.055 0.931 . . . . 100.0 111.71 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.47 2.57 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 104.711 -3.356 . . . . 100.0 104.711 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.47 161.91 24.65 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.765 1.226 . . . . 100.0 112.489 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.4 mttt 57.81 43.28 22.03 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 127.858 2.463 . . . . 100.0 115.023 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 148' ' ' ASP . 28.7 m -68.9 -11.7 15.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 CA-C-N 115.983 -0.553 . . . . 100.0 111.603 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.51 -39.04 93.39 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.936 2.095 . . . . 100.0 109.74 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.06 132.02 29.82 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 C-N-CA 124.095 0.958 . . . . 100.0 110.132 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.83 -45.0 91.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 116.435 2.013 . . . . 100.0 116.435 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -84.93 77.51 10.09 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.648 0.737 . . . . 100.0 109.731 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -82.8 137.66 34.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.503 -0.925 . . . . 100.0 108.503 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.07 -42.69 5.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 119.4 -0.333 . . . . 100.0 111.496 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.1 107.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.59 -2.004 . . . . 100.0 105.59 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.62 148.86 36.68 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.104 -0.953 . . . . 100.0 109.349 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.22 90.32 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.165 0.986 . . . . 100.0 110.91 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -62.4 -40.8 97.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.661 1.184 . . . . 100.0 110.907 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 65.4 m -61.49 -37.64 84.39 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.686 1.594 . . . . 100.0 113.556 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.42 123.52 15.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 CA-C-O 122.523 1.154 . . . . 100.0 110.035 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.64 HG12 HH21 ' A' ' 140' ' ' ARG . 27.4 m -127.52 -10.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 CA-C-N 113.531 -1.668 . . . . 100.0 112.592 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -58.49 -40.34 82.49 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.1 1.36 . . . . 100.0 111.864 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -61.17 -40.01 92.28 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 118.679 -0.677 . . . . 100.0 111.601 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.64 HH21 HG12 ' A' ' 137' ' ' VAL . 87.0 mtm-85 -64.04 -43.6 95.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 112.806 0.669 . . . . 100.0 112.806 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.65 -42.21 95.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 123.566 0.746 . . . . 100.0 111.853 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -97.28 6.81 47.74 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 117.902 2.556 . . . . 100.0 117.902 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.26 71.2 m-20 53.23 50.75 16.97 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-O 123.062 1.41 . . . . 100.0 114.279 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.733 HD22 ' HB ' ' A' ' 117' ' ' ILE . 35.3 mt -114.38 158.29 21.71 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.981 -1.463 . . . . 100.0 107.092 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.413 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 97.0 mm-40 -98.78 143.77 28.76 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.259 -1.015 . . . . 100.0 108.259 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -117.34 136.06 53.41 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.25 0.548 . . . . 100.0 112.344 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.05 137.74 44.87 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.356 -0.838 . . . . 100.0 112.838 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.423 ' HB3' HG11 ' A' ' 124' ' ' VAL . 48.8 m-20 -89.42 123.88 33.97 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 101.583 -3.488 . . . . 100.0 101.583 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.3 pt -133.85 157.44 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.623 1.201 . . . . 100.0 112.084 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -143.91 111.36 5.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.066 0.946 . . . . 100.0 108.553 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.34 -46.79 84.95 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 126.637 1.975 . . . . 100.0 113.365 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.2 p -100.75 -2.84 31.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 115.44 1.645 . . . . 100.0 115.44 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 70.47 11.47 7.36 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.337 1.855 . . . . 100.0 113.353 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.2 118.33 10.45 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.686 -1.227 . . . . 100.0 107.686 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 54.31 29.31 10.58 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 128.756 2.822 . . . . 100.0 111.952 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . 0.413 3.7 p90 -62.53 -35.92 80.95 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 114.216 1.191 . . . . 100.0 114.216 -175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.272 40.6 mt-10 -85.93 -8.33 58.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.304 1.964 . . . . 100.0 116.304 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.303 95.3 mttt -60.6 -44.11 94.45 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 117.149 2.278 . . . . 100.0 117.149 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -59.45 -40.48 66.53 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-N 122.333 1.869 . . . . 100.0 112.962 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.31 -44.36 95.18 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 124.608 1.163 . . . . 100.0 111.194 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.89 -43.71 92.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 112.661 0.615 . . . . 100.0 112.661 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.413 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 67.9 t-105 -61.92 -45.86 91.86 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 123.28 0.362 . . . . 100.0 110.577 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 85' ' ' CYS . 89.6 mt -61.04 -42.8 99.17 Favored 'General case' 0 CA--C 1.495 -1.167 0 O-C-N 123.959 0.787 . . . . 100.0 110.442 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.3 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.554 0.741 . . . . 100.0 110.955 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.436 ' HG2' ' HB2' ' A' ' 174' ' ' LEU . 71.5 mtt85 -62.52 -45.33 93.49 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 123.147 0.579 . . . . 100.0 112.401 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.33 -43.55 77.29 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 112.119 0.415 . . . . 100.0 112.119 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.69 -47.2 76.25 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.776 1.028 . . . . 100.0 113.776 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.26 -38.7 75.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 124.162 0.985 . . . . 100.0 109.852 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.22 9.63 55.38 Favored Glycine 0 C--N 1.353 1.472 0 CA-C-O 118.306 -1.274 . . . . 100.0 114.051 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.536 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 59.9 t0 -109.74 113.02 58.03 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 106.665 -1.606 . . . . 100.0 106.665 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.99 -16.91 50.81 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 123.87 3.047 . . . . 100.0 113.092 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -97.39 8.38 44.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 57.1 mt -60.89 134.13 56.78 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 119.233 0.924 . . . . 100.0 112.568 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.41 149.25 48.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.839 -1.073 . . . . 100.0 109.857 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.01 131.13 40.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 105.576 -2.009 . . . . 100.0 105.576 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.18 135.07 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 CA-C-O 121.426 0.631 . . . . 100.0 111.496 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 49.36 -127.94 2.1 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.952 1.701 . . . . 100.0 112.583 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 50.9 tpp 136.12 121.71 0.0 OUTLIER Pre-proline 0 CA--C 1.497 -1.082 0 N-CA-C 101.035 -3.691 . . . . 100.0 101.035 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -55.02 128.96 32.8 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.568 2.179 . . . . 100.0 110.921 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.27 131.85 35.23 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 106.918 -1.512 . . . . 100.0 106.918 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.1 mt -84.26 111.91 19.81 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 105.914 -1.884 . . . . 100.0 105.914 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -132.78 144.76 54.26 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -64.53 148.15 90.49 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.778 2.319 . . . . 100.0 110.626 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.33 154.4 68.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 123.701 2.934 . . . . 100.0 114.144 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -61.6 -49.13 77.83 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.17 0.918 . . . . 100.0 111.19 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.301 5.9 m 52.35 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 128.214 2.605 . . . . 100.0 117.848 177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.84 -67.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.387 0 N-CA-C 107.819 -1.178 . . . . 100.0 107.819 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.1 ptp -70.57 156.33 39.56 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 114.657 1.355 . . . . 100.0 114.657 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -128.18 -51.95 0.03 OUTLIER Pre-proline 0 C--N 1.36 1.034 0 N-CA-C 116.475 2.028 . . . . 100.0 116.475 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.91 -54.77 4.52 Favored 'Trans proline' 0 C--N 1.377 2.067 0 N-CA-C 121.33 3.55 . . . . 100.0 121.33 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.9 77.29 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 119.518 1.054 . . . . 100.0 111.153 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 31.5 tp -75.65 -8.56 57.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 126.259 1.824 . . . . 100.0 113.534 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.67 175.63 4.08 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.579 1.152 . . . . 100.0 110.334 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 79.45 -47.99 0.38 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.575 1.95 . . . . 100.0 111.591 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -60.38 -28.02 67.88 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.447 1.899 . . . . 100.0 111.155 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -61.28 -38.99 88.74 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 113.286 0.847 . . . . 100.0 113.286 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.93 -39.62 90.12 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 123.395 0.678 . . . . 100.0 110.304 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.09 -44.05 97.96 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.55 0.74 . . . . 100.0 111.156 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -64.73 -43.16 94.28 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.042 0.937 . . . . 100.0 111.529 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.49 -41.8 97.83 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 124.312 1.045 . . . . 100.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.37 -42.54 98.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.424 1.09 . . . . 100.0 110.963 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.12 -43.65 96.72 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 108.325 -0.991 . . . . 100.0 108.325 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.0 90.1 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.269 1.027 . . . . 100.0 113.333 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -63.3 -40.39 97.22 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 125.11 1.364 . . . . 100.0 112.713 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 66.4 m -65.89 -41.79 91.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.879 1.672 . . . . 100.0 110.265 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m -69.55 119.2 13.44 Favored 'General case' 0 C--N 1.361 1.102 0 CA-C-O 122.991 1.377 . . . . 100.0 107.87 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -103.49 138.15 40.6 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 105.208 -2.145 . . . . 100.0 105.208 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 97.4 mt -71.37 143.3 87.8 Favored Pre-proline 0 N--CA 1.435 -1.203 0 O-C-N 124.143 0.902 . . . . 100.0 109.021 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 209' ' ' LEU . 67.6 Cg_exo -53.93 122.11 10.8 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 N-CA-C 117.032 1.897 . . . . 100.0 117.032 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.52 121.26 44.79 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 102.343 -3.206 . . . . 100.0 102.343 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -91.86 -67.94 0.82 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 103.058 -2.942 . . . . 100.0 103.058 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -150.27 34.89 0.65 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 123.052 1.406 . . . . 100.0 107.547 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -61.67 -34.15 75.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 128.605 2.762 . . . . 100.0 110.812 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -59.6 -39.15 83.23 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.987 1.315 . . . . 100.0 111.943 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--O 1.255 1.357 0 CA-C-O 117.307 -1.33 . . . . 100.0 107.614 179.198 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mtt . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 110.607 -0.146 . . . . 100.0 110.607 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.94 -42.18 97.72 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 124.598 1.159 . . . . 100.0 112.439 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.45 99.43 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.542 0.737 . . . . 100.0 110.66 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -65.32 -35.6 81.49 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.817 1.647 . . . . 100.0 111.633 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.43 15.9 42.12 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 107.801 -2.12 . . . . 100.0 107.801 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 10' ' ' GLN 0.257 36.4 tt0 -88.74 95.69 0.59 Allowed Pre-proline 0 N--CA 1.425 -1.689 0 C-N-CA 128.142 2.577 . . . . 100.0 104.153 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -61.13 -45.3 19.85 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.468 1.445 . . . . 100.0 108.354 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -131.91 -62.63 0.85 Allowed 'General case' 0 N--CA 1.419 -2.022 1 N-CA-C 99.345 -4.317 . . . . 100.0 99.345 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.413 HG23 HG23 ' A' ' 59' ' ' ILE . 23.4 m -123.57 145.06 31.18 Favored 'Isoleucine or valine' 0 C--N 1.37 1.468 0 N-CA-C 115.259 1.577 . . . . 100.0 115.259 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 6' ' ' GLU 0.262 11.1 tt0 -125.87 131.71 52.32 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.448 -2.427 . . . . 100.0 104.448 178.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.407 ' CD1' HD13 ' A' ' 168' ' ' LEU . 90.7 m-85 -125.71 134.12 51.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.268 -0.641 . . . . 100.0 109.268 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.0 tttt -90.69 116.3 28.46 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.016 -1.105 . . . . 100.0 108.016 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 85' ' ' CYS . 41.5 mt -113.6 131.56 56.07 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.059 -1.459 . . . . 100.0 107.059 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 t -109.3 123.36 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.521 -1.659 . . . . 100.0 106.521 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.468 HD11 ' SD ' ' A' ' 89' ' ' MET . 64.6 tp -103.25 115.65 30.97 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.667 -1.605 . . . . 100.0 106.667 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.68 162.59 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 113.777 -1.556 . . . . 100.0 110.625 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.05 168.07 14.87 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 108.098 -2.001 . . . . 100.0 108.098 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 97' ' ' THR . 71.1 m-20 -72.1 159.94 33.3 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 140.24 40.89 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.756 -1.338 . . . . 100.0 109.756 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.84 1.77 89.81 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-O 118.913 -0.937 . . . . 100.0 114.344 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.2 m -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.59 1.195 . . . . 100.0 112.303 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.08 15.49 7.79 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.956 -0.858 . . . . 100.0 110.956 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -60.94 -44.12 97.7 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.289 1.435 . . . . 100.0 111.436 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -65.17 -42.33 93.79 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.224 1.41 . . . . 100.0 109.738 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.16 -41.59 99.29 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.13 1.372 . . . . 100.0 109.369 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.15 -48.11 83.12 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.137 1.775 . . . . 100.0 109.769 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.87 -43.52 96.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 122.568 0.347 . . . . 100.0 111.491 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -40.13 95.22 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.211 0.604 . . . . 100.0 112.099 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 35.1 ttp180 -62.15 -44.13 97.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.543 1.137 . . . . 100.0 109.482 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.84 -42.9 97.49 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.331 0.514 . . . . 100.0 112.081 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.4 -48.41 75.53 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.508 1.67 . . . . 100.0 115.508 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.1 p -121.55 -21.62 6.16 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.06 -7.56 69.74 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 110.586 -1.006 . . . . 100.0 110.586 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 149.95 39.59 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.351 1.06 . . . . 100.0 109.666 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.527 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 98.3 m-85 -111.91 125.69 54.32 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.546 -2.761 . . . . 100.0 103.546 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.06 114.17 28.07 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 118.925 -1.11 . . . . 100.0 110.575 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.66 -43.29 63.36 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.659 -1.155 . . . . 100.0 113.047 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.02 135.45 44.91 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.514 1.525 . . . . 100.0 111.397 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -103.1 119.12 38.27 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.007 -1.479 . . . . 100.0 107.007 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.3 123.69 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 102.92 -2.993 . . . . 100.0 102.92 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 139.0 58.72 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.596 0.712 . . . . 100.0 112.198 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.0 m -97.07 125.06 41.26 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.326 -2.472 . . . . 100.0 104.326 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -106.09 130.11 54.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.464 -1.68 . . . . 100.0 106.464 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.8 -127.1 33.16 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 109.547 -1.421 . . . . 100.0 109.547 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -128.09 139.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 121.22 0.533 . . . . 100.0 109.89 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -115.53 123.16 47.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 103.58 -2.748 . . . . 100.0 103.58 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.65 120.4 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 106.894 -1.521 . . . . 100.0 106.894 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -124.6 121.72 25.79 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.273 -0.876 . . . . 100.0 111.007 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -78.71 130.43 9.7 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 123.598 2.866 . . . . 100.0 111.03 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.58 128.52 48.05 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.873 -1.529 . . . . 100.0 106.873 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.04 128.56 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.583 -1.636 . . . . 100.0 106.583 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.14 131.45 56.41 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -99.33 122.54 42.61 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.228 -1.767 . . . . 100.0 106.228 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.8 p -122.42 -179.99 4.38 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.633 -0.712 . . . . 100.0 111.459 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -59.07 -37.36 76.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.913 1.685 . . . . 100.0 109.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -87.67 2.93 49.72 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.065 0.765 . . . . 100.0 113.065 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.27 -179.9 19.14 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 121.557 -0.715 . . . . 100.0 111.399 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.3 140.87 54.57 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.263 2.642 . . . . 100.0 113.794 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 9' ' ' VAL . 86.9 mt -130.35 138.58 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 103.565 -2.754 . . . . 100.0 103.565 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -116.27 128.66 55.77 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 118.972 -1.091 . . . . 100.0 108.692 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.64 118.06 35.81 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.077 -2.194 . . . . 100.0 105.077 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -91.94 106.46 18.48 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 101.889 -3.374 . . . . 100.0 101.889 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.84 124.95 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 107.966 -1.124 . . . . 100.0 107.966 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.429 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 19.2 m0 -103.56 106.8 17.41 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.304 -1.739 . . . . 100.0 106.304 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -86.04 116.29 24.17 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 104.136 -2.542 . . . . 100.0 104.136 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.3 p -98.44 163.11 12.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.46 0.911 . . . . 100.0 113.46 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.66 130.95 34.98 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.312 -0.995 . . . . 100.0 108.312 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.5 -11.0 80.94 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 116.624 -0.262 . . . . 100.0 112.56 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -67.6 -39.74 84.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.796 2.039 . . . . 100.0 111.809 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -61.32 141.73 57.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.275 1.43 . . . . 100.0 114.616 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.01 150.73 46.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.213 1.405 . . . . 100.0 110.982 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -72.95 132.22 43.17 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.236 -1.394 . . . . 100.0 107.236 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.3 -167.25 33.91 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 119.077 -1.535 . . . . 100.0 115.007 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.69 -22.0 63.57 Favored Glycine 0 C--N 1.355 1.585 0 C-N-CA 127.541 2.496 . . . . 100.0 114.49 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.78 -38.41 87.96 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.236 1.814 . . . . 100.0 109.293 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -82.77 -2.21 53.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.301 2.64 . . . . 100.0 113.959 -176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.29 -42.93 96.51 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -37.87 91.55 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 123.907 0.765 . . . . 100.0 113.489 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -62.18 -43.52 98.65 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.236 1.814 . . . . 100.0 108.983 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 8.2 t80 -90.89 -13.94 32.68 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 114.296 1.221 . . . . 100.0 114.296 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.8 mt -60.69 134.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 CA-C-N 119.333 0.969 . . . . 100.0 109.876 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.29 24.55 14.32 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.498 1.919 . . . . 100.0 114.196 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.24 138.94 45.86 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 108.218 -1.03 . . . . 100.0 108.218 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.02 -34.61 13.64 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.138 -0.937 . . . . 100.0 108.676 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 13' ' ' LEU . 64.7 m -153.94 164.04 39.07 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 123.026 0.53 . . . . 100.0 110.978 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -139.98 153.32 46.84 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 113.838 1.051 . . . . 100.0 113.838 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.25 123.92 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 103.293 -2.854 . . . . 100.0 103.293 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.2 mt -110.21 122.38 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 102.579 -3.119 . . . . 100.0 102.579 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.492 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 58.5 mtp -112.23 132.99 54.62 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 113.574 0.953 . . . . 100.0 113.574 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.38 159.22 37.66 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 113.631 -1.622 . . . . 100.0 108.742 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -101.72 124.97 48.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.15 -2.167 . . . . 100.0 105.15 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.75 -21.87 29.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 113.683 0.994 . . . . 100.0 113.683 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.1 p -89.98 -4.58 57.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 118.888 -0.577 . . . . 100.0 111.591 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.16 115.78 24.33 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 122.464 1.126 . . . . 100.0 111.569 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.85 -38.44 86.38 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 114.362 -1.29 . . . . 100.0 110.554 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.76 -43.04 96.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 C-N-CA 125.394 1.478 . . . . 100.0 109.892 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 18' ' ' ASP . 92.2 m -63.16 -42.38 99.41 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.086 -0.709 . . . . 100.0 109.086 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -63.45 -40.23 96.58 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.29 0.636 . . . . 100.0 110.207 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -60.69 -37.41 81.55 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.314 1.046 . . . . 100.0 111.762 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.32 -12.03 60.7 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 114.502 1.297 . . . . 100.0 114.502 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.07 -43.4 94.01 Favored Pre-proline 0 C--N 1.364 1.203 0 CA-C-O 116.252 -1.832 . . . . 100.0 111.509 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 87.1 Cg_exo -58.65 -34.63 99.03 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.347 2.031 . . . . 100.0 112.645 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.38 -43.63 85.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.951 0.782 . . . . 100.0 110.106 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.426 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.8 m95 -62.98 -46.6 86.95 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -91.01 63.86 5.25 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.947 1.356 . . . . 100.0 109.524 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.0 ttm105 -157.93 -57.81 0.08 Allowed 'General case' 0 CA--C 1.485 -1.533 1 N-CA-C 100.155 -4.017 . . . . 100.0 100.155 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.66 -41.17 98.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.395 -0.965 . . . . 100.0 108.395 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.512 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 6.5 mp -62.04 -46.24 90.04 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.936 0.895 . . . . 100.0 111.492 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.55 -38.95 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 126.267 1.827 . . . . 100.0 109.543 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -59.7 -46.2 89.8 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.817 -0.438 . . . . 100.0 109.817 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.91 -49.25 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 115.494 1.665 . . . . 100.0 115.494 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.8 m -113.45 9.13 18.05 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 120.788 3.625 . . . . 100.0 120.788 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 55.45 -124.79 2.09 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.473 1.109 . . . . 100.0 112.561 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -102.74 115.74 31.19 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 120.276 1.398 . . . . 100.0 109.667 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 41.7 pt -141.68 152.6 63.37 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 103.76 -2.681 . . . . 100.0 103.76 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.06 127.6 22.73 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.155 1.904 . . . . 100.0 112.412 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.705 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.2 mt -131.26 135.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 107.209 -1.404 . . . . 100.0 107.209 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.13 131.57 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.672 -1.233 . . . . 100.0 107.672 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 139' ' ' HIS . 86.5 mt -98.87 125.6 44.31 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.491 -2.411 . . . . 100.0 104.491 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.492 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.5 m -115.84 123.36 47.97 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.334 -0.848 . . . . 100.0 109.468 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.61 101.49 2.63 Favored Glycine 0 CA--C 1.485 -1.806 1 N-CA-C 102.8 -4.12 . . . . 100.0 102.8 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -86.73 165.72 15.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.985 0.898 . . . . 100.0 110.61 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 60.48 41.72 15.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 128.515 2.726 . . . . 100.0 113.521 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.5 m -67.52 -15.54 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 CA-C-N 115.866 -0.606 . . . . 100.0 111.937 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.74 -39.42 91.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.034 2.134 . . . . 100.0 110.355 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.01 130.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 124.12 0.968 . . . . 100.0 108.498 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.46 -39.24 88.72 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 117.022 2.23 . . . . 100.0 117.022 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -83.04 76.78 9.82 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.892 0.853 . . . . 100.0 109.049 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -88.5 129.27 35.49 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.533 -1.284 . . . . 100.0 107.533 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.51 -41.25 7.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 115.407 -0.815 . . . . 100.0 111.216 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.69 108.26 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 103.803 -2.666 . . . . 100.0 103.803 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.47 151.31 23.62 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.777 -1.101 . . . . 100.0 110.665 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.45 96.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.165 0.986 . . . . 100.0 112.245 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.94 -41.16 99.41 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.331 1.053 . . . . 100.0 110.801 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.4 m -63.03 -38.13 89.96 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.999 1.72 . . . . 100.0 114.072 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.46 123.54 16.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 122.128 0.966 . . . . 100.0 109.204 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.25 -9.0 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.567 1.547 . . . . 100.0 111.464 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -59.17 -45.05 92.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.061 1.344 . . . . 100.0 111.935 -176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.479 ' HB3' HD12 ' A' ' 119' ' ' LEU . 52.5 p-80 -62.51 -41.02 98.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.799 0.666 . . . . 100.0 112.799 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.64 -45.86 90.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.168 1.387 . . . . 100.0 110.377 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.98 -42.62 89.6 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.498 0.719 . . . . 100.0 112.759 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -90.84 1.92 56.56 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 115.715 1.746 . . . . 100.0 115.715 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 55.92 47.17 20.6 Favored 'General case' 0 C--N 1.361 1.092 0 CA-C-O 122.922 1.344 . . . . 100.0 113.025 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.705 HD22 ' HB ' ' A' ' 117' ' ' ILE . 40.6 mt -112.59 160.07 18.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.323 -1.362 . . . . 100.0 107.323 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -96.6 140.6 30.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.14 -1.059 . . . . 100.0 108.14 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -117.24 131.41 56.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.176 0.513 . . . . 100.0 111.469 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . 0.255 81.4 m-85 -128.75 138.3 52.03 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 114.979 -1.01 . . . . 100.0 111.616 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.39 121.34 31.54 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 101.973 -3.343 . . . . 100.0 101.973 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.17 152.97 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 CA-C-O 122.537 1.161 . . . . 100.0 111.535 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.1 t -134.8 117.09 15.57 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.116 -2.55 . . . . 100.0 104.116 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.94 88.63 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.703 0.627 . . . . 100.0 109.617 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.64 -41.16 79.8 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 115.426 1.639 . . . . 100.0 115.426 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -90.92 -4.63 56.37 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 115.275 1.584 . . . . 100.0 115.275 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.51 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 65.7 m-80 63.7 22.74 13.23 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.018 1.327 . . . . 100.0 112.484 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -76.0 123.6 26.01 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.239 -1.763 . . . . 100.0 106.239 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 53.27 40.54 31.44 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.141 2.176 . . . . 100.0 111.76 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.59 -49.31 76.81 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 126.227 1.811 . . . . 100.0 114.487 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -94.68 -6.82 42.42 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 115.424 1.639 . . . . 100.0 115.424 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.284 96.1 mttt -59.72 -45.3 98.48 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 118.857 2.91 . . . . 100.0 118.857 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -60.16 -41.67 49.54 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 122.782 2.029 . . . . 100.0 112.756 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -63.82 -45.04 91.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 124.235 0.959 . . . . 100.0 111.229 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 162' ' ' LEU . 96.9 mt -63.91 -42.9 97.3 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 118.699 -0.667 . . . . 100.0 112.793 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.19 -44.4 95.47 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 123.736 0.648 . . . . 100.0 109.955 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 85' ' ' CYS . 87.7 mt -61.4 -44.14 97.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.498 0.719 . . . . 100.0 110.693 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.36 99.01 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 124.061 0.944 . . . . 100.0 111.369 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -61.9 -45.3 94.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.216 1.007 . . . . 100.0 110.998 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.1 -44.66 83.72 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 113.598 0.962 . . . . 100.0 113.598 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.407 HD13 ' CD1' ' A' ' 11' ' ' PHE . 74.0 mt -63.48 -47.31 82.28 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 123.412 0.685 . . . . 100.0 112.061 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 91.8 mt -70.09 -39.15 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 124.191 0.996 . . . . 100.0 111.217 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.97 10.96 58.21 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-O 118.562 -1.132 . . . . 100.0 111.874 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -108.47 109.46 61.52 Favored Pre-proline 0 C--N 1.362 1.111 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.14 -22.89 53.61 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.718 2.946 . . . . 100.0 113.933 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -92.03 3.91 54.23 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.118 1.367 . . . . 100.0 113.521 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.39 130.75 47.63 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-N 118.411 0.55 . . . . 100.0 110.175 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -136.4 153.16 51.18 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.323 0.582 . . . . 100.0 111.169 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -75.78 134.67 40.37 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 125.734 1.614 . . . . 100.0 109.114 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.44 156.66 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 106.083 -1.821 . . . . 100.0 106.083 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.22 -85.51 0.01 OUTLIER 'General case' 0 C--N 1.356 0.891 0 N-CA-C 116.656 2.095 . . . . 100.0 116.656 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 54.5 tpp -157.71 100.59 1.83 Allowed Pre-proline 0 C--N 1.361 1.087 0 CA-C-N 119.471 1.032 . . . . 100.0 113.614 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.55 152.61 54.29 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 123.047 2.498 . . . . 100.0 107.382 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.23 115.24 22.34 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.344 -2.095 . . . . 100.0 105.344 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.4 154.52 17.42 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.786 -1.097 . . . . 100.0 108.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -80.12 125.96 80.46 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.429 -1.322 . . . . 100.0 107.429 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.85 145.06 90.07 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 123.558 2.838 . . . . 100.0 113.261 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.96 166.27 30.08 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.532 2.821 . . . . 100.0 111.849 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -60.93 -43.86 98.05 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.446 1.098 . . . . 100.0 112.182 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.8 t 57.46 70.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.27 0 C-N-CA 126.484 1.913 . . . . 100.0 110.102 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.9 m -82.99 164.4 2.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 115.003 1.482 . . . . 100.0 115.003 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.305 61.5 mtm 51.42 -124.49 2.25 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 127.873 2.469 . . . . 100.0 116.816 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.417 ' N ' ' HD3' ' A' ' 191' ' ' PRO . 77.1 m-20 57.27 42.97 0.96 Allowed Pre-proline 0 C--N 1.369 1.421 0 N-CA-C 118.371 2.73 . . . . 100.0 118.371 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 190' ' ' ASP . 32.5 Cg_exo -61.51 -48.9 8.36 Favored 'Trans proline' 0 C--N 1.382 2.293 0 CA-C-N 122.5 1.928 . . . . 100.0 112.926 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.92 72.55 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 124.192 0.997 . . . . 100.0 110.671 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.79 -37.7 88.34 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 116.154 1.909 . . . . 100.0 116.154 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.24 165.21 24.12 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 113.075 0.769 . . . . 100.0 113.075 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 74.28 -44.38 0.56 Allowed 'General case' 0 C--N 1.368 1.41 0 C-N-CA 127.462 2.305 . . . . 100.0 115.024 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.87 -36.13 76.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.386 1.874 . . . . 100.0 111.666 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -60.05 -39.98 87.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.183 0.993 . . . . 100.0 110.921 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -62.37 -43.13 99.55 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.038 0.935 . . . . 100.0 110.338 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -63.13 -41.24 99.28 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.54 1.136 . . . . 100.0 110.203 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -62.88 -40.93 99.03 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.97 1.308 . . . . 100.0 109.929 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.2 mt -62.9 -40.51 97.78 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.846 0.858 . . . . 100.0 110.316 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.37 -42.17 99.2 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.016 0.927 . . . . 100.0 110.871 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.71 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 C-N-CA 124.204 1.001 . . . . 100.0 108.418 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.13 98.82 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 124.419 1.088 . . . . 100.0 110.958 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -61.89 -42.7 99.39 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.943 1.297 . . . . 100.0 110.433 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.6 m -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.682 1.193 . . . . 100.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.4 m -62.35 135.14 57.32 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.205 1.002 . . . . 100.0 112.551 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -71.78 144.38 49.21 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.107 0.963 . . . . 100.0 110.048 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.88 125.64 39.58 Favored Pre-proline 0 N--CA 1.434 -1.27 0 N-CA-C 108.138 -1.06 . . . . 100.0 108.138 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.44 166.37 29.55 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.502 2.801 . . . . 100.0 110.113 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -77.11 109.78 11.24 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 106.807 -1.553 . . . . 100.0 106.807 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -126.09 -60.25 1.29 Allowed 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.042 -1.435 . . . . 100.0 107.282 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 53.9 p30 -111.53 13.13 21.37 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 114.711 1.374 . . . . 100.0 114.711 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -61.53 -37.59 84.3 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 124.024 0.93 . . . . 100.0 113.454 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.92 -41.75 96.76 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 113.31 0.855 . . . . 100.0 113.31 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 C--O 1.258 1.508 0 CA-C-O 117.192 -1.385 . . . . 100.0 108.853 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 8.1 ttp . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 108.976 -0.75 . . . . 100.0 108.976 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.46 96.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.215 1.406 . . . . 100.0 112.062 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.516 ' HB2' HG23 ' A' ' 188' ' ' VAL . . . -61.74 -44.61 96.57 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 123.896 0.879 . . . . 100.0 110.651 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.48 -37.48 86.96 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 123.706 0.802 . . . . 100.0 111.738 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.41 21.75 23.73 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 106.698 -2.561 . . . . 100.0 106.698 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 1' ' ' MET 0.293 34.3 tt0 -87.59 100.24 1.63 Allowed Pre-proline 0 N--CA 1.422 -1.829 0 N-CA-C 102.049 -3.315 . . . . 100.0 102.049 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.27 -47.07 8.56 Favored 'Trans proline' 0 C--N 1.377 2.067 0 N-CA-C 106.072 -2.319 . . . . 100.0 106.072 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -128.92 -63.56 0.96 Allowed 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 100.478 -3.897 . . . . 100.0 100.478 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.419 ' HA ' ' HG3' ' A' ' 6' ' ' GLU . 60.3 t -130.45 145.03 36.22 Favored 'Isoleucine or valine' 0 C--N 1.373 1.599 0 CA-C-O 121.871 0.843 . . . . 100.0 110.504 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -124.46 132.42 53.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.968 -2.234 . . . . 100.0 104.968 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -118.05 135.27 54.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.995 -1.113 . . . . 100.0 107.995 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -91.31 112.59 24.56 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.302 -1.74 . . . . 100.0 106.302 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 63' ' ' VAL . 41.4 tp -108.01 124.43 50.15 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.11 -1.859 . . . . 100.0 107.829 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 t -108.94 123.68 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.225 -1.769 . . . . 100.0 106.225 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.98 117.97 35.41 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.696 -1.594 . . . . 100.0 106.696 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -127.21 162.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 C-N-CA 125.11 1.364 . . . . 100.0 110.896 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.46 171.77 19.71 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 108.404 -1.878 . . . . 100.0 108.404 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.466 ' HB2' HG23 ' A' ' 97' ' ' THR . 65.4 m-20 -73.46 162.65 29.05 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.762 0.653 . . . . 100.0 112.762 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 140.52 36.18 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 110.079 -1.208 . . . . 100.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.12 1.63 90.54 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.667 0.651 . . . . 100.0 113.728 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.654 HG22 HD21 ' A' ' 122' ' ' ASN . 56.2 m -63.92 -41.57 97.63 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 117.817 0.809 . . . . 100.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.6 17.75 5.94 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.211 -0.995 . . . . 100.0 112.06 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.29 -46.62 89.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.122 1.369 . . . . 100.0 110.125 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.0 m -63.92 -43.39 96.07 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.395 1.478 . . . . 100.0 109.5 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -63.61 -41.07 98.34 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.265 1.026 . . . . 100.0 110.044 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.13 -48.34 82.12 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.306 1.442 . . . . 100.0 109.727 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.74 -43.76 96.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 C-N-CA 123.08 0.552 . . . . 100.0 111.217 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.09 -39.25 94.14 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 112.477 0.547 . . . . 100.0 112.477 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 39.9 ttp180 -61.49 -44.61 96.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 124.321 1.048 . . . . 100.0 108.99 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -63.56 -44.34 94.41 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 112.405 0.52 . . . . 100.0 112.405 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.96 -48.6 73.48 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 116.371 1.989 . . . . 100.0 116.371 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -119.23 -24.0 6.57 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.07 2.248 . . . . 100.0 117.07 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.92 73.4 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 110.434 -1.066 . . . . 100.0 110.434 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.43 151.71 38.07 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-N 118.017 0.908 . . . . 100.0 109.766 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.575 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 99.0 m-85 -110.61 127.2 55.14 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.111 -2.552 . . . . 100.0 104.111 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -104.55 116.92 32.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.798 -0.816 . . . . 100.0 108.798 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.0 -34.33 13.08 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 116.181 -0.463 . . . . 100.0 110.785 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -86.04 126.29 34.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.105 -1.072 . . . . 100.0 108.105 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -98.38 124.25 42.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.312 -1.355 . . . . 100.0 109.377 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.42 130.0 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 101.829 -3.397 . . . . 100.0 101.829 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.35 139.66 58.14 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.692 0.758 . . . . 100.0 112.861 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.2 m -93.58 123.46 36.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.075 -2.935 . . . . 100.0 103.075 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.17 125.98 50.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 105.959 -1.867 . . . . 100.0 105.959 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.26 -125.45 34.09 Favored Glycine 0 C--N 1.355 1.605 0 N-CA-C 109.147 -1.581 . . . . 100.0 109.147 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.82 139.1 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.559 0.695 . . . . 100.0 110.601 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -110.5 123.93 50.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.215 -2.883 . . . . 100.0 103.215 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.86 116.66 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 106.217 -1.772 . . . . 100.0 106.217 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.47 118.91 21.59 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 120.435 -0.506 . . . . 100.0 111.279 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -78.7 127.97 8.29 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.887 2.392 . . . . 100.0 109.658 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.24 126.84 45.81 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 106.248 -1.76 . . . . 100.0 106.248 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 128.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 100.0 105.875 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -118.66 131.74 56.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.649 -1.982 . . . . 100.0 105.649 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -97.28 123.98 41.25 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.0 p -124.19 179.71 4.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.815 -0.629 . . . . 100.0 110.85 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -58.79 -37.62 76.74 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.933 1.693 . . . . 100.0 110.208 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.45 -0.46 54.98 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 113.029 0.752 . . . . 100.0 113.029 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.53 -179.57 18.12 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 110.842 -0.903 . . . . 100.0 110.842 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.01 138.23 43.39 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.415 2.744 . . . . 100.0 113.437 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.98 140.41 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 103.258 -2.868 . . . . 100.0 103.258 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -115.5 127.97 55.67 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 118.649 -1.22 . . . . 100.0 109.35 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -104.77 118.65 37.09 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.56 -2.755 . . . . 100.0 103.56 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -92.48 109.42 20.82 Favored 'General case' 0 N--CA 1.427 -1.58 1 N-CA-C 98.798 -4.519 . . . . 100.0 98.798 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 13' ' ' LEU . 39.9 t -95.04 126.52 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.947 -1.501 . . . . 100.0 106.947 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -107.76 102.04 11.29 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.23 117.98 26.34 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 103.441 -2.8 . . . . 100.0 103.441 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.9 p -100.06 160.38 14.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 112.943 0.719 . . . . 100.0 112.943 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.0 36.97 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.085 -0.709 . . . . 100.0 109.085 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.36 -12.39 75.97 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 112.109 -0.396 . . . . 100.0 112.109 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.68 -39.46 84.47 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.625 1.57 . . . . 100.0 111.699 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.43 139.71 58.57 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.544 1.138 . . . . 100.0 113.385 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -67.15 147.91 52.5 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.48 1.912 . . . . 100.0 111.151 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -70.38 132.26 45.36 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.236 -1.764 . . . . 100.0 106.236 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.57 -166.87 33.96 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 119.118 -1.515 . . . . 100.0 115.534 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.36 -22.7 63.66 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 127.599 2.523 . . . . 100.0 114.337 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.0 -38.43 88.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.704 2.002 . . . . 100.0 110.021 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -82.99 -1.0 51.42 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 127.509 2.323 . . . . 100.0 113.895 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -42.85 93.61 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.476 2.399 . . . . 100.0 117.476 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -38.53 93.01 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 118.672 0.669 . . . . 100.0 113.345 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -62.36 -43.43 98.84 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 125.9 1.68 . . . . 100.0 109.592 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.546 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 6.3 t80 -89.84 -14.26 34.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 114.173 1.175 . . . . 100.0 114.173 -175.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -61.24 134.92 26.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 119.369 0.986 . . . . 100.0 109.358 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 66.1 20.25 11.18 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 127.363 2.265 . . . . 100.0 113.296 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.09 139.1 52.5 Favored 'General case' 0 C--N 1.365 1.278 0 O-C-N 121.199 -0.938 . . . . 100.0 108.669 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -99.54 -31.7 11.48 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.514 -0.767 . . . . 100.0 109.008 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.501 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.2 p -148.75 160.35 43.28 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 120.733 0.301 . . . . 100.0 111.431 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -143.36 150.81 39.66 Favored 'General case' 0 CA--C 1.487 -1.479 0 C-N-CA 119.371 -0.931 . . . . 100.0 113.021 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.413 HG13 HD11 ' A' ' 13' ' ' LEU . 97.0 mt -125.74 126.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 103.592 -2.744 . . . . 100.0 103.592 176.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.81 122.28 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.423 -3.177 . . . . 100.0 102.423 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.482 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 38.5 mtt -111.89 134.29 53.54 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 114.459 1.281 . . . . 100.0 114.459 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -130.14 157.17 43.16 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 112.546 -2.115 . . . . 100.0 109.229 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -102.18 125.53 48.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.08 -21.66 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.7 p -88.89 -5.84 57.73 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.996 -0.526 . . . . 100.0 111.62 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.1 t -119.79 116.79 26.61 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 122.859 1.314 . . . . 100.0 111.841 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.11 -39.71 86.73 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.887 -1.506 . . . . 100.0 110.804 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.79 -43.33 97.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 C-N-CA 125.24 1.416 . . . . 100.0 109.456 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.176 0.59 . . . . 100.0 109.914 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.44 -40.42 95.7 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.911 0.485 . . . . 100.0 110.723 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.2 mttt -60.77 -37.23 81.16 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.118 0.967 . . . . 100.0 111.445 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -73.43 -11.49 60.48 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 114.995 1.48 . . . . 100.0 114.995 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.35 -43.11 92.32 Favored Pre-proline 0 C--N 1.363 1.16 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.48 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 90.9 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.726 2.284 . . . . 100.0 112.702 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.55 -43.03 86.21 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.488 1.115 . . . . 100.0 109.901 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.441 ' O ' HD13 ' A' ' 108' ' ' LEU . 81.0 m95 -63.16 -46.21 88.25 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -90.74 65.0 5.77 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 123.054 1.407 . . . . 100.0 107.883 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -159.69 -57.0 0.06 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 100.567 -3.864 . . . . 100.0 100.567 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.02 -43.72 98.24 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.107 1.363 . . . . 100.0 108.254 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -62.5 -46.34 88.88 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.267 1.027 . . . . 100.0 112.145 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.53 -39.84 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 126.498 1.919 . . . . 100.0 109.309 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -59.68 -45.19 92.83 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.113 0.565 . . . . 100.0 110.75 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.99 -50.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 72.3 m -115.03 9.4 15.99 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.989 3.329 . . . . 100.0 119.989 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.257 80.9 mm-40 53.82 -123.16 2.1 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.45 1.5 . . . . 100.0 113.943 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -98.13 112.97 24.74 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.631 1.105 . . . . 100.0 112.416 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.3 pt -143.35 151.75 55.56 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 104.161 -2.533 . . . . 100.0 104.161 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.52 127.97 22.27 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 121.982 1.788 . . . . 100.0 112.503 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 144' ' ' LEU . 59.7 mt -130.56 136.0 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 107.271 -1.381 . . . . 100.0 107.271 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.84 131.39 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.175 -1.375 . . . . 100.0 107.922 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 139' ' ' HIS . 87.9 mt -99.43 125.12 45.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 104.329 -2.471 . . . . 100.0 104.329 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.8 m -116.49 122.19 44.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.986 0.898 . . . . 100.0 110.328 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.53 101.84 2.69 Favored Glycine 0 CA--C 1.476 -2.394 1 N-CA-C 102.862 -4.095 . . . . 100.0 102.862 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.654 HD21 HG22 ' A' ' 21' ' ' THR 0.412 56.7 p30 -92.69 170.31 9.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 118.899 -1.12 . . . . 100.0 113.943 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 93.1 mttt 60.81 40.39 15.99 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 128.105 2.562 . . . . 100.0 112.155 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 148' ' ' ASP . 33.5 m -65.77 -18.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.474 0.71 . . . . 100.0 112.893 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.28 -39.14 89.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.054 1.742 . . . . 100.0 110.58 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.18 130.77 28.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 123.766 0.826 . . . . 100.0 109.109 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.35 -41.53 96.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.345 1.609 . . . . 100.0 115.345 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -84.26 81.39 8.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.482 0.658 . . . . 100.0 109.325 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -89.85 130.71 36.05 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.433 -1.321 . . . . 100.0 107.433 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.37 -44.36 7.26 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.598 -0.728 . . . . 100.0 109.821 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.95 112.16 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 105.026 -2.213 . . . . 100.0 105.026 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -86.38 150.87 24.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.787 -1.551 . . . . 100.0 110.106 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.25 94.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.171 0.989 . . . . 100.0 110.669 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.096 1.358 . . . . 100.0 110.839 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 m -62.66 -38.51 90.62 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 125.757 1.623 . . . . 100.0 112.695 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 76.4 mt -65.67 121.7 15.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.646 1.213 . . . . 100.0 110.358 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.58 -4.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 CA-C-N 113.627 -1.624 . . . . 100.0 111.07 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 66.3 t80 -59.77 -42.92 94.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.351 1.46 . . . . 100.0 111.339 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.469 ' HB3' HD12 ' A' ' 119' ' ' LEU . 48.1 p-80 -61.33 -42.19 98.28 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.534 0.733 . . . . 100.0 112.518 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -63.5 -45.07 92.37 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 123.937 0.895 . . . . 100.0 111.252 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.06 -41.19 95.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.512 0.725 . . . . 100.0 112.042 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 74.6 mmtt -92.64 1.97 56.97 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 116.222 1.934 . . . . 100.0 116.222 -177.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 55.58 49.23 16.97 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.227 1.411 . . . . 100.0 113.572 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 117' ' ' ILE . 44.5 mt -118.7 159.11 24.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.676 -1.602 . . . . 100.0 106.676 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.308 78.9 mt-30 -101.63 140.23 36.2 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 118.609 -1.236 . . . . 100.0 110.578 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -109.38 131.15 55.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.987 0.736 . . . . 100.0 112.987 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.31 134.22 48.86 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.634 -1.166 . . . . 100.0 111.403 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.4 ' HB3' HG11 ' A' ' 124' ' ' VAL . 32.1 m-20 -87.53 120.86 29.27 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 102.802 -3.036 . . . . 100.0 102.802 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.1 pt -130.93 154.4 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.355 1.074 . . . . 100.0 111.244 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.3 t -136.07 118.42 15.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.369 -2.456 . . . . 100.0 104.369 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.433 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.81 -44.99 88.08 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 123.273 0.629 . . . . 100.0 109.435 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.11 -43.56 86.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 114.276 1.213 . . . . 100.0 114.276 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.1 m -92.25 -5.22 52.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.276 1.584 . . . . 100.0 115.276 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.463 HD21 ' HZ ' ' A' ' 35' ' ' PHE . 63.9 m-80 64.26 21.78 12.62 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 124.861 1.264 . . . . 100.0 112.167 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -75.72 125.1 28.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.189 -1.782 . . . . 100.0 106.189 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 53.31 40.39 31.24 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.064 2.146 . . . . 100.0 111.979 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -57.71 -48.6 79.1 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 126.706 2.003 . . . . 100.0 111.297 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.501 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 92.7 mt-10 -80.59 -24.75 38.93 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 118.396 2.739 . . . . 100.0 118.396 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.302 95.0 mttt -59.16 -45.31 99.34 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 121.456 3.872 . . . . 100.0 121.456 -173.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -60.04 -45.81 22.11 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 123.098 2.142 . . . . 100.0 112.74 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 158' ' ' GLU 0.343 28.2 p90 -66.44 -40.72 89.63 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.346 1.029 . . . . 100.0 113.113 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 176' ' ' PHE . 94.9 mt -63.71 -43.23 97.18 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-O 118.403 -0.808 . . . . 100.0 112.877 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -63.89 -43.2 96.72 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 118.807 -0.616 . . . . 100.0 110.415 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 85' ' ' CYS . 77.2 mt -60.78 -44.5 96.71 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.601 0.563 . . . . 100.0 110.806 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.0 99.91 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.891 0.876 . . . . 100.0 111.417 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 97.8 mtt180 -62.96 -45.27 93.25 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.364 0.666 . . . . 100.0 111.473 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -64.32 -47.02 81.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.798 0.839 . . . . 100.0 112.347 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.93 -46.48 81.44 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.234 0.827 . . . . 100.0 113.234 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.08 -39.17 76.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 123.694 0.798 . . . . 100.0 110.527 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.62 8.53 59.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-O 118.669 -1.073 . . . . 100.0 111.82 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -102.46 108.36 57.18 Favored Pre-proline 0 C--N 1.361 1.096 0 N-CA-C 106.655 -1.609 . . . . 100.0 106.655 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.12 -23.22 53.4 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.969 3.113 . . . . 100.0 113.569 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.6 6.72 47.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.161 1.384 . . . . 100.0 113.676 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 23.3 tp -63.05 128.75 37.31 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.648 0.658 . . . . 100.0 110.127 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -132.18 151.64 51.69 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.59 0.71 . . . . 100.0 110.509 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.439 ' HB2' HD21 ' A' ' 162' ' ' LEU . 67.6 t80 -81.15 135.02 35.73 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.273 1.429 . . . . 100.0 108.836 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -120.94 160.34 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.816 -1.179 . . . . 100.0 107.816 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.79 -91.4 0.0 OUTLIER 'General case' 0 C--N 1.357 0.898 0 N-CA-C 116.698 2.11 . . . . 100.0 116.698 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 56.8 tpp -155.8 97.58 2.3 Favored Pre-proline 0 C--N 1.36 1.057 0 CA-C-N 119.682 1.128 . . . . 100.0 113.611 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -75.02 156.43 42.89 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 123.356 2.704 . . . . 100.0 108.514 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.3 127.2 32.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.084 -1.821 . . . . 100.0 106.084 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.8 mt -112.17 134.96 53.41 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.798 -0.637 . . . . 100.0 110.4 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.58 127.55 67.55 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 103.429 -2.804 . . . . 100.0 103.429 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.66 141.18 90.08 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.175 2.583 . . . . 100.0 114.208 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.83 167.39 27.39 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.839 3.026 . . . . 100.0 112.514 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.72 -42.21 96.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.68 1.592 . . . . 100.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.2 t 68.08 101.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.022 0 C-N-CA 127.374 2.27 . . . . 100.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 3' ' ' ALA . 19.1 m -129.25 166.99 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 113.956 -1.474 . . . . 100.0 108.809 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 82.7 mtp 53.21 -131.89 2.03 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 126.917 2.087 . . . . 100.0 115.4 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 51.11 46.8 3.98 Favored Pre-proline 0 C--N 1.373 1.607 0 C-N-CA 128.736 2.814 . . . . 100.0 118.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -63.65 -69.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 121.676 1.584 . . . . 100.0 113.219 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.03 -45.69 80.55 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 124.052 0.845 . . . . 100.0 113.009 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.356 89.3 mt -65.67 -41.27 92.68 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 120.921 3.674 . . . . 100.0 120.921 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.77 164.93 25.39 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 115.03 1.493 . . . . 100.0 115.03 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 71.92 -45.88 0.63 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 118.249 2.685 . . . . 100.0 118.249 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -58.21 -48.2 81.09 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 116.878 2.177 . . . . 100.0 116.878 -175.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -64.7 -45.15 87.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 114.647 1.351 . . . . 100.0 114.647 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -64.11 -40.08 95.44 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 123.636 0.774 . . . . 100.0 110.642 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -62.52 -42.3 99.42 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.595 1.158 . . . . 100.0 110.455 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -62.32 -43.87 97.82 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 123.911 0.884 . . . . 100.0 110.578 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.15 -43.83 97.97 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.384 0.674 . . . . 100.0 110.681 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.49 -44.58 96.02 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.552 1.141 . . . . 100.0 111.993 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.1 -42.55 97.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 C-N-CA 123.774 0.83 . . . . 100.0 109.295 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.89 97.88 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.642 0.777 . . . . 100.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -63.76 -40.76 97.49 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.357 1.063 . . . . 100.0 112.143 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -63.82 -42.96 97.55 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.732 1.213 . . . . 100.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.3 m -62.48 139.53 58.59 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 124.645 1.178 . . . . 100.0 111.688 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -67.06 131.01 44.96 Favored 'General case' 0 C--N 1.365 1.241 0 C-N-CA 123.958 0.903 . . . . 100.0 108.981 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.42 154.45 81.56 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 113.024 0.75 . . . . 100.0 113.024 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -73.26 -179.88 4.82 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 123.176 2.584 . . . . 100.0 108.71 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -62.63 120.9 12.08 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.154 0.978 . . . . 100.0 111.174 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -129.43 -57.16 1.14 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.593 -1.632 . . . . 100.0 106.593 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.575 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 54.7 p30 -110.88 5.2 20.35 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 114.5 1.296 . . . . 100.0 114.5 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.39 -35.58 79.63 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.459 1.104 . . . . 100.0 112.756 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.32 -41.88 90.11 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.619 1.567 . . . . 100.0 112.14 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.258 1.53 0 CA-C-O 117.136 -1.412 . . . . 100.0 108.605 -179.63 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 120.683 0.278 . . . . 100.0 110.546 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.75 91.78 Favored 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 124.293 1.037 . . . . 100.0 112.272 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 190' ' ' ASP . . . -59.82 -46.01 90.59 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 123.861 0.725 . . . . 100.0 111.175 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -68.43 -37.55 80.36 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.443 0.905 . . . . 100.0 113.443 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.73 20.86 12.06 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 106.23 -2.748 . . . . 100.0 106.23 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.308 27.8 tt0 -86.31 100.2 1.32 Allowed Pre-proline 0 N--CA 1.417 -2.114 0 N-CA-C 103.168 -2.901 . . . . 100.0 103.168 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.404 ' HD3' ' HG3' ' A' ' 60' ' ' LYS . 61.5 Cg_endo -60.97 -46.09 17.38 Favored 'Trans proline' 0 C--N 1.38 2.219 0 N-CA-C 107.195 -1.886 . . . . 100.0 107.195 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -131.53 -60.3 0.94 Allowed 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 100.925 -3.732 . . . . 100.0 100.925 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.92 142.22 44.59 Favored 'Isoleucine or valine' 0 C--N 1.37 1.493 0 CA-C-O 121.458 0.647 . . . . 100.0 110.924 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -128.36 136.22 50.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.827 -1.916 . . . . 100.0 105.827 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -119.95 132.61 55.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.732 -1.581 . . . . 100.0 106.732 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.39 117.22 28.93 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -110.18 129.01 55.79 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.838 -1.528 . . . . 100.0 106.93 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -110.53 124.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 105.253 -2.129 . . . . 100.0 105.253 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.01 116.71 32.4 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.948 -1.871 . . . . 100.0 105.948 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.415 ' HA ' ' HZ1' ' A' ' 23' ' ' LYS . 32.9 m -125.31 162.16 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 113.696 -1.593 . . . . 100.0 110.496 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.91 168.2 15.39 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 107.476 -2.25 . . . . 100.0 107.476 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HB2' HG23 ' A' ' 97' ' ' THR . 76.6 m-20 -71.82 162.45 29.43 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 113.215 0.82 . . . . 100.0 113.215 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.78 141.43 38.28 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.293 -1.123 . . . . 100.0 110.293 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.18 1.44 90.36 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.715 0.674 . . . . 100.0 113.982 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.8 m -65.02 -41.23 95.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.758 0.823 . . . . 100.0 111.648 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.43 15.77 6.86 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 120.57 -0.824 . . . . 100.0 112.087 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HZ1' ' HA ' ' A' ' 16' ' ' VAL . 20.1 ptmt -61.5 -44.32 97.29 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.77 1.228 . . . . 100.0 111.713 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.5 m -64.96 -42.31 94.7 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.906 1.282 . . . . 100.0 109.659 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.7 m -63.47 -41.01 98.61 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.272 1.029 . . . . 100.0 109.353 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -60.25 -47.5 85.73 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.072 1.349 . . . . 100.0 110.013 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.08 -43.6 97.53 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 C-N-CA 123.591 0.756 . . . . 100.0 111.831 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.605 1.162 . . . . 100.0 109.734 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 36.8 ttp180 -61.72 -45.15 95.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 125.43 1.492 . . . . 100.0 110.462 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -63.9 -43.72 95.14 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.59 0.589 . . . . 100.0 112.59 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -65.05 -47.58 76.83 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 115.23 1.567 . . . . 100.0 115.23 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.0 p -120.01 -23.57 6.32 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 119.104 3.002 . . . . 100.0 119.104 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.91 -4.33 71.57 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 110.733 -0.947 . . . . 100.0 110.733 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -76.94 147.15 37.11 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 126.422 1.889 . . . . 100.0 108.563 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 93.0 m-85 -114.29 126.32 54.9 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 105.391 -2.077 . . . . 100.0 105.391 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -105.49 113.93 27.79 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 120.071 -0.651 . . . . 100.0 111.907 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -72.96 -42.26 63.55 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.0 1.32 . . . . 100.0 112.511 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -84.75 130.91 34.62 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 125.904 1.682 . . . . 100.0 111.419 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -99.73 120.67 40.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 122.407 1.099 . . . . 100.0 110.77 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 1 N-CA-C 99.994 -4.076 . . . . 100.0 99.994 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.21 58.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 113.871 1.063 . . . . 100.0 113.871 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 m -91.45 126.18 36.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 103.708 -2.701 . . . . 100.0 103.708 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.74 128.79 53.91 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.77 -125.38 30.56 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.378 -1.489 . . . . 100.0 109.378 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.8 t -126.79 139.51 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 123.56 0.744 . . . . 100.0 109.987 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -113.87 124.57 52.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.276 -2.861 . . . . 100.0 103.276 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.56 113.35 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.899 -1.148 . . . . 100.0 107.899 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -125.97 120.77 24.09 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 113.018 0.747 . . . . 100.0 113.018 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.88 135.0 12.28 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 122.475 2.117 . . . . 100.0 111.148 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.58 132.67 53.94 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 105.414 -2.069 . . . . 100.0 105.414 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.514 HG22 ' HE3' ' A' ' 60' ' ' LYS . 19.6 t -109.44 126.58 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.554 -2.017 . . . . 100.0 105.554 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.31 129.45 54.01 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.269 -1.752 . . . . 100.0 106.269 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -98.83 122.9 42.66 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 105.749 -1.945 . . . . 100.0 105.749 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.44 ' HB ' HD11 ' A' ' 174' ' ' LEU . 69.9 p -122.67 -178.3 3.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.426 -0.806 . . . . 100.0 110.787 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -59.41 -37.34 77.79 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.7 1.6 . . . . 100.0 108.6 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.33 -3.41 52.56 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.206 1.802 . . . . 100.0 112.458 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.81 -177.02 19.7 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 110.829 -0.908 . . . . 100.0 110.829 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.33 137.16 50.22 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.972 3.115 . . . . 100.0 113.418 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.46 142.97 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.317 -2.105 . . . . 100.0 105.317 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' HE3' HG22 ' A' ' 51' ' ' VAL 0.284 44.8 mttp -115.1 132.34 56.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 118.046 -1.462 . . . . 100.0 110.588 175.407 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.48 116.83 33.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.087 -2.931 . . . . 100.0 103.087 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -92.5 100.46 13.0 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 101.089 -3.671 . . . . 100.0 101.089 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.45 124.74 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.704 -0.68 . . . . 100.0 109.276 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -106.72 106.36 16.85 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 104.954 -2.239 . . . . 100.0 104.954 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.51 117.11 24.22 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 102.934 -2.987 . . . . 100.0 102.934 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.6 p -100.14 162.64 12.84 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 113.14 0.792 . . . . 100.0 113.14 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.97 128.74 34.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.682 -0.859 . . . . 100.0 108.682 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.14 -12.19 82.7 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 116.02 -0.536 . . . . 100.0 113.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -67.77 -39.16 84.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.399 1.48 . . . . 100.0 112.069 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.34 137.66 58.3 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.778 1.231 . . . . 100.0 112.45 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.76 153.9 41.68 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.869 -1.06 . . . . 100.0 112.427 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -68.08 131.99 46.43 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.818 1.647 . . . . 100.0 108.115 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.61 -171.4 34.78 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 119.237 -1.459 . . . . 100.0 115.446 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -21.04 62.85 Favored Glycine 0 C--N 1.356 1.692 0 C-N-CA 127.959 2.695 . . . . 100.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.23 -37.93 84.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.362 2.265 . . . . 100.0 109.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -87.86 6.82 33.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 126.269 1.828 . . . . 100.0 115.19 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 -42.24 90.35 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 115.487 1.662 . . . . 100.0 115.487 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.02 94.33 Favored Glycine 0 C--N 1.353 1.497 0 C-N-CA 123.804 0.716 . . . . 100.0 113.165 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -60.87 -45.56 94.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.448 1.499 . . . . 100.0 108.694 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 6.1 t80 -89.29 -11.05 44.57 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 115.076 1.51 . . . . 100.0 115.076 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.5 131.66 25.44 Favored 'Isoleucine or valine' 0 C--N 1.366 1.326 0 CA-C-N 119.924 1.238 . . . . 100.0 110.838 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.309 63.9 mt-30 57.21 36.9 28.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 128.197 2.599 . . . . 100.0 113.863 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.88 142.87 42.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 105.611 -1.996 . . . . 100.0 105.611 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -100.15 -31.31 11.47 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.076 -1.083 . . . . 100.0 108.076 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.485 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -153.89 160.86 42.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 122.783 0.433 . . . . 100.0 110.377 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -141.82 153.46 44.52 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 113.578 0.955 . . . . 100.0 113.578 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.5 mt -126.26 125.81 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 103.935 -2.617 . . . . 100.0 103.935 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.7 mt -109.95 124.48 66.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 101.23 -3.618 . . . . 100.0 101.23 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -119.05 133.26 55.92 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 118.358 -1.337 . . . . 100.0 111.322 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -128.57 158.9 37.17 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.741 -1.572 . . . . 100.0 110.017 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.65 123.98 44.43 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.883 -1.895 . . . . 100.0 105.883 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -65.03 -21.08 28.79 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 113.348 0.87 . . . . 100.0 113.348 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -90.57 -5.8 55.48 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 118.712 -0.661 . . . . 100.0 111.765 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.7 t -119.65 116.7 26.53 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.83 1.3 . . . . 100.0 111.167 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -66.27 -39.6 89.55 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.566 -1.652 . . . . 100.0 111.336 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -43.17 96.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 125.132 1.373 . . . . 100.0 109.326 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 18' ' ' ASP . 96.9 m -62.66 -43.17 99.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 122.89 0.476 . . . . 100.0 109.905 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -63.89 -39.54 94.41 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 122.811 0.445 . . . . 100.0 110.524 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 92.5 mttt -60.53 -38.33 84.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.271 1.429 . . . . 100.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.38 -12.07 60.7 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 114.569 1.322 . . . . 100.0 114.569 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.82 -43.09 94.17 Favored Pre-proline 0 C--N 1.364 1.236 0 CA-C-O 115.952 -1.975 . . . . 100.0 111.34 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 97.4 Cg_exo -57.41 -36.39 98.82 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.483 2.122 . . . . 100.0 112.517 177.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -66.35 -41.96 88.79 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.005 0.815 . . . . 100.0 111.164 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.417 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.6 m95 -62.6 -46.35 88.72 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 108.928 -0.768 . . . . 100.0 108.928 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -91.62 65.9 5.21 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-O 123.0 1.381 . . . . 100.0 108.425 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -162.06 -56.6 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 101.103 -3.665 . . . . 100.0 101.103 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.23 -41.7 99.15 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.189 -1.041 . . . . 100.0 108.189 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.544 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -62.66 -46.04 90.04 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.86 0.864 . . . . 100.0 111.534 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.87 -39.23 82.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 126.378 1.871 . . . . 100.0 109.438 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -58.8 -45.6 89.52 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.34 1.056 . . . . 100.0 109.971 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.66 -50.38 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 115.512 1.671 . . . . 100.0 115.512 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.81 8.83 20.67 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 120.981 3.697 . . . . 100.0 120.981 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 53.98 -125.02 2.29 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 125.213 1.405 . . . . 100.0 113.241 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -97.88 113.98 25.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 120.289 1.404 . . . . 100.0 112.326 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.1 pt -142.73 152.74 60.18 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.03 127.15 20.47 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 122.231 1.954 . . . . 100.0 113.066 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.4 mt -131.28 134.8 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.693 1.235 . . . . 100.0 107.756 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.66 133.04 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 113.598 -1.637 . . . . 100.0 108.332 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.408 HD12 ' HB3' ' A' ' 139' ' ' HIS 0.272 88.3 mt -100.6 126.74 47.1 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 104.614 -2.365 . . . . 100.0 104.614 176.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -116.58 123.02 46.34 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.839 0.828 . . . . 100.0 109.696 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.09 102.57 2.68 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.33 -3.908 . . . . 100.0 103.33 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.412 54.0 p30 -94.45 173.36 7.66 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 114.584 1.328 . . . . 100.0 114.584 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 60.56 40.4 16.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 127.704 2.402 . . . . 100.0 111.323 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.45 -12.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 CA-C-N 115.717 -0.674 . . . . 100.0 112.417 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.82 -39.57 92.23 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.64 1.576 . . . . 100.0 109.588 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.22 130.28 29.03 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 124.232 1.013 . . . . 100.0 109.822 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.42 -40.01 89.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 115.4 1.629 . . . . 100.0 115.4 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -82.96 81.18 8.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.344 -0.984 . . . . 100.0 108.344 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -90.86 134.1 34.71 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.243 -1.762 . . . . 100.0 106.243 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -101.35 -40.85 6.91 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 110.011 -0.366 . . . . 100.0 110.011 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.15 109.89 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.948 -2.241 . . . . 100.0 104.948 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.27 145.44 29.11 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.648 -1.16 . . . . 100.0 110.833 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.21 98.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.08 0.952 . . . . 100.0 112.257 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.15 -39.87 95.92 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.07 0.548 . . . . 100.0 111.599 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.7 m -62.18 -36.57 82.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.524 1.93 . . . . 100.0 113.471 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.8 mt -63.66 123.64 16.83 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-O 122.336 1.065 . . . . 100.0 109.778 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 -4.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 125.583 1.553 . . . . 100.0 112.001 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -59.41 -43.43 93.03 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 125.098 1.359 . . . . 100.0 111.456 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.408 ' HB3' HD12 ' A' ' 119' ' ' LEU . 51.7 p-80 -62.18 -40.53 96.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 112.766 0.654 . . . . 100.0 112.766 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -62.97 -45.72 91.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.295 1.038 . . . . 100.0 110.547 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.56 -41.41 96.32 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.793 0.837 . . . . 100.0 111.686 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.84 4.46 53.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 117.284 2.328 . . . . 100.0 117.284 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 57.05 46.08 19.86 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 122.176 0.989 . . . . 100.0 112.403 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 117' ' ' ILE . 45.2 mt -115.24 162.28 17.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 108.251 -1.018 . . . . 100.0 108.251 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.408 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 97.3 mm-40 -101.34 139.18 37.36 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.783 -1.192 . . . . 100.0 107.783 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -114.29 130.34 56.65 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.384 0.611 . . . . 100.0 111.542 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -128.12 134.68 49.15 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.263 -0.881 . . . . 100.0 110.629 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -89.06 121.23 31.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 102.711 -3.07 . . . . 100.0 102.711 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 48.3 pt -132.63 157.19 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 122.194 0.997 . . . . 100.0 112.144 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.7 t -139.9 119.12 12.8 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.225 -2.509 . . . . 100.0 104.225 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.87 -44.17 93.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.359 -0.837 . . . . 100.0 109.614 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -63.18 -46.31 87.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.605 1.962 . . . . 100.0 114.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -97.16 -1.06 45.87 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 115.93 1.826 . . . . 100.0 115.93 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.49 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 63.1 m-80 64.65 21.77 12.48 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 125.075 1.35 . . . . 100.0 113.296 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -72.42 123.2 22.6 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.289 -1.745 . . . . 100.0 106.289 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.1 40.58 31.44 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.507 2.323 . . . . 100.0 112.389 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.418 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 18.4 t80 -55.83 -49.92 71.97 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 126.968 2.107 . . . . 100.0 115.589 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -96.34 -2.85 44.93 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.271 96.6 mttt -59.88 -44.86 97.91 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 118.277 2.695 . . . . 100.0 118.277 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.14 -42.65 41.49 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 122.523 1.937 . . . . 100.0 112.503 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -64.24 -43.95 93.31 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.534 1.146 . . . . 100.0 112.297 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 176' ' ' PHE . 93.5 mt -63.64 -44.96 92.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 123.923 0.764 . . . . 100.0 112.869 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.408 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 88.2 t90 -64.09 -42.58 96.88 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 123.501 0.5 . . . . 100.0 110.296 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 85' ' ' CYS . 85.7 mt -61.42 -43.66 98.48 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 118.892 -0.575 . . . . 100.0 111.106 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.5 98.68 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.209 0.604 . . . . 100.0 111.478 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.49 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 89.5 mtt180 -62.44 -45.39 93.31 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.278 0.631 . . . . 100.0 111.546 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -65.02 -45.24 86.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.986 0.915 . . . . 100.0 111.714 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.89 -45.56 85.44 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 123.614 0.766 . . . . 100.0 112.947 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.47 -39.21 78.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 C-N-CA 123.545 0.738 . . . . 100.0 109.975 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.81 9.75 57.11 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-O 118.602 -1.11 . . . . 100.0 111.206 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -104.83 109.28 62.87 Favored Pre-proline 0 C--N 1.364 1.231 0 N-CA-C 107.705 -1.22 . . . . 100.0 107.705 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.51 -24.31 56.56 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 124.086 3.191 . . . . 100.0 113.994 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.36 3.62 51.59 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.609 1.964 . . . . 100.0 113.708 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 21.9 tp -62.85 130.75 46.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.451 0.537 . . . . 100.0 112.451 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -132.97 153.8 51.09 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.842 0.829 . . . . 100.0 110.595 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.407 ' HB2' HD21 ' A' ' 162' ' ' LEU . 87.7 t80 -80.08 132.79 36.03 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.943 -1.873 . . . . 100.0 105.943 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.4 m -118.08 158.59 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.969 -1.122 . . . . 100.0 107.969 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -42.47 -97.93 0.0 OUTLIER 'General case' 0 C--N 1.358 0.937 0 N-CA-C 118.929 2.937 . . . . 100.0 118.929 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 48.0 tpp -157.02 70.15 4.55 Favored Pre-proline 0 C--N 1.366 1.319 0 CA-C-N 120.321 1.418 . . . . 100.0 114.29 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.27 160.46 42.21 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 123.561 2.84 . . . . 100.0 109.82 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.63 144.98 56.57 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.394 0.616 . . . . 100.0 111.32 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.18 154.0 42.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 115.122 -0.944 . . . . 100.0 112.274 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.87 123.59 68.75 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 104.158 -2.534 . . . . 100.0 104.158 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -62.87 135.03 49.64 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 123.47 2.78 . . . . 100.0 113.175 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.81 157.32 43.66 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 123.28 2.654 . . . . 100.0 113.989 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.66 -38.73 92.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.868 1.667 . . . . 100.0 111.474 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.275 30.0 t 71.52 82.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 128.199 2.6 . . . . 100.0 109.836 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.24 163.57 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.945 2.098 . . . . 100.0 107.955 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 80.3 mtp 60.15 -114.02 0.63 Allowed 'General case' 0 C--N 1.355 0.847 0 N-CA-C 115.574 1.694 . . . . 100.0 115.574 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 3' ' ' ALA . 38.6 m-20 73.16 10.98 0.0 OUTLIER Pre-proline 0 C--N 1.371 1.512 1 N-CA-C 123.75 4.722 . . . . 100.0 123.75 -178.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.63 -85.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.042 0 CA-C-N 124.31 2.575 . . . . 100.0 112.855 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.25 -40.01 89.88 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.357 1.063 . . . . 100.0 112.214 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.81 -39.83 90.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 117.687 2.477 . . . . 100.0 117.687 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.92 165.92 24.02 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 119.078 0.854 . . . . 100.0 112.979 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 73.23 -42.24 0.52 Allowed 'General case' 0 C--N 1.359 1.016 0 N-CA-C 117.483 2.401 . . . . 100.0 117.483 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -60.05 -42.55 94.72 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 115.121 1.526 . . . . 100.0 115.121 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -61.06 -44.98 96.57 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.706 0.765 . . . . 100.0 111.343 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -61.55 -44.24 97.41 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 126.543 1.937 . . . . 100.0 110.067 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -61.05 -47.15 87.71 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.726 1.21 . . . . 100.0 111.874 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.01 -43.8 97.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 123.595 0.56 . . . . 100.0 111.882 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.7 -45.4 94.15 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 123.465 0.478 . . . . 100.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.4 -42.63 98.78 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 117.999 -1.0 . . . . 100.0 113.14 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.49 -45.0 99.54 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-N 118.613 0.642 . . . . 100.0 109.311 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.46 93.52 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 112.696 0.628 . . . . 100.0 112.696 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.28 -42.8 96.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.143 0.977 . . . . 100.0 112.877 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.7 m -63.95 -39.3 93.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.717 1.607 . . . . 100.0 111.913 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.7 m -53.93 127.5 26.49 Favored 'General case' 0 C--N 1.366 1.305 0 CA-C-O 122.295 1.045 . . . . 100.0 110.599 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.63 147.77 48.83 Favored 'General case' 0 CA--C 1.483 -1.604 0 CA-C-N 113.448 -1.705 . . . . 100.0 109.644 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 66.3 mt -108.1 125.32 32.28 Favored Pre-proline 0 N--CA 1.423 -1.809 0 CA-C-N 115.002 -0.999 . . . . 100.0 113.342 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -82.71 -152.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.104 3.203 . . . . 100.0 106.352 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -82.3 103.04 11.59 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 104.898 -2.26 . . . . 100.0 104.898 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -130.53 -57.69 1.06 Allowed 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.489 -0.778 . . . . 100.0 110.875 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -100.1 4.35 44.53 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.572 1.323 . . . . 100.0 114.572 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -61.29 -38.57 87.28 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 125.334 1.454 . . . . 100.0 112.417 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -60.6 -41.17 94.21 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.57 1.548 . . . . 100.0 112.323 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.257 1.458 0 CA-C-O 117.333 -1.318 . . . . 100.0 107.866 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.494 -1.174 0 CA-C-O 121.032 0.444 . . . . 100.0 110.222 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.766 ' HB1' ' H ' ' A' ' 187' ' ' VAL . . . -60.61 -42.44 96.8 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.459 1.504 . . . . 100.0 112.645 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.52 93.95 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.507 1.123 . . . . 100.0 110.934 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -64.65 -36.56 84.65 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 125.547 1.539 . . . . 100.0 111.454 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . 95.35 19.43 30.27 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.3 -2.32 . . . . 100.0 107.3 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 10' ' ' GLN 0.283 35.0 tt0 -87.29 96.05 0.53 Allowed Pre-proline 0 N--CA 1.424 -1.771 0 C-N-CA 129.38 3.072 . . . . 100.0 103.822 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 5' ' ' GLY . 73.0 Cg_endo -61.7 -46.07 15.25 Favored 'Trans proline' 0 C--N 1.378 2.12 0 N-CA-C 107.663 -1.707 . . . . 100.0 107.663 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -130.1 -63.22 0.91 Allowed 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 100.327 -3.953 . . . . 100.0 100.327 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.97 144.01 36.52 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 N-CA-C 114.236 1.198 . . . . 100.0 114.236 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 6' ' ' GLU 0.272 9.2 tt0 -126.6 134.51 50.78 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 103.811 -2.663 . . . . 100.0 103.811 177.361 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.4 ' N ' ' HG2' ' A' ' 10' ' ' GLN . 80.0 m-85 -124.27 136.44 54.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.765 -1.198 . . . . 100.0 107.765 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.74 116.31 28.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.543 -2.021 . . . . 100.0 105.543 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.78 128.57 55.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.436 -1.711 . . . . 100.0 107.574 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.27 122.1 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 106.098 -1.815 . . . . 100.0 106.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -104.08 118.14 35.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.479 -1.674 . . . . 100.0 106.479 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.5 m -127.59 163.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 113.664 -1.607 . . . . 100.0 111.412 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.11 169.66 16.53 Favored Glycine 0 CA--C 1.493 -1.296 0 N-CA-C 108.053 -2.019 . . . . 100.0 108.053 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 97' ' ' THR . 82.0 m-20 -71.28 160.65 32.42 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.892 0.853 . . . . 100.0 113.022 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.32 140.25 41.06 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.428 -1.069 . . . . 100.0 110.428 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.4 2.01 90.54 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.381 -0.677 . . . . 100.0 114.643 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.409 HG21 ' C ' ' A' ' 89' ' ' MET . 68.5 m -64.28 -42.27 96.51 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.225 1.012 . . . . 100.0 112.279 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.04 17.73 4.46 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.689 -0.767 . . . . 100.0 111.846 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -60.71 -47.54 85.83 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 125.927 1.691 . . . . 100.0 110.354 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.6 m -64.5 -42.88 95.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.402 1.481 . . . . 100.0 109.509 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.1 m -62.72 -41.96 99.42 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 125.012 1.325 . . . . 100.0 109.473 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.435 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 88.4 t80 -60.55 -48.49 81.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.956 1.302 . . . . 100.0 110.49 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.3 -42.03 90.04 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 123.333 0.396 . . . . 100.0 111.289 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.93 -40.09 94.29 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.274 0.63 . . . . 100.0 112.139 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.435 ' NH1' ' HA ' ' A' ' 26' ' ' PHE . 32.3 ttp-105 -62.14 -44.31 96.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 123.78 0.832 . . . . 100.0 109.058 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -62.8 -45.61 91.85 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 112.332 0.493 . . . . 100.0 112.332 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.83 -48.75 73.21 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 116.459 2.022 . . . . 100.0 116.459 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.4 p -118.9 -21.45 7.75 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 116.689 2.107 . . . . 100.0 116.689 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.72 71.8 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.524 -0.598 . . . . 100.0 112.128 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.04 146.88 45.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.924 1.29 . . . . 100.0 109.022 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.479 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 97.0 m-85 -111.36 120.38 42.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.05 -3.315 . . . . 100.0 102.05 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.73 114.22 28.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 119.13 -1.028 . . . . 100.0 111.622 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.73 -43.72 62.59 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 114.595 -1.184 . . . . 100.0 113.512 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -76.44 145.58 39.17 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 123.161 0.584 . . . . 100.0 111.414 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -107.03 124.09 49.14 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 119.227 -0.989 . . . . 100.0 108.435 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -115.64 125.85 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 101.474 -3.528 . . . . 100.0 101.474 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.38 138.84 58.67 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 112.924 0.713 . . . . 100.0 112.924 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.6 m -96.23 125.36 40.69 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 103.665 -2.717 . . . . 100.0 103.665 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.07 129.05 54.24 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.658 -1.608 . . . . 100.0 106.658 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.51 -126.33 32.69 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 109.742 -1.343 . . . . 100.0 109.742 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.75 137.58 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 123.135 0.574 . . . . 100.0 109.907 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -114.36 126.11 54.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 103.827 -2.657 . . . . 100.0 103.827 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.02 121.36 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.854 -1.536 . . . . 100.0 106.854 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -127.37 122.78 22.99 Favored Pre-proline 0 N--CA 1.431 -1.405 0 CA-C-N 115.458 -0.792 . . . . 100.0 110.9 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.18 125.29 5.78 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.968 2.445 . . . . 100.0 110.225 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -122.41 126.7 48.51 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.717 -1.586 . . . . 100.0 106.717 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.19 130.56 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 N-CA-C 106.821 -1.548 . . . . 100.0 106.821 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -118.36 132.42 56.27 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.513 -2.032 . . . . 100.0 105.513 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.8 123.49 46.55 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 106.541 -1.652 . . . . 100.0 106.541 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 p -123.64 -177.42 3.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.024 -0.535 . . . . 100.0 111.791 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -58.98 -38.26 78.74 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.263 1.825 . . . . 100.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -86.55 -0.23 55.7 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.861 0.864 . . . . 100.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.63 -178.8 19.51 Favored Glycine 0 N--CA 1.432 -1.63 0 O-C-N 122.034 -0.416 . . . . 100.0 112.194 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.99 139.46 61.62 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.092 3.195 . . . . 100.0 113.782 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.7 mt -129.66 138.43 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.472 -2.788 . . . . 100.0 103.472 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -118.68 128.94 54.99 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.4 -1.32 . . . . 100.0 108.889 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -108.63 117.58 34.56 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -92.25 106.53 18.52 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 102.519 -3.141 . . . . 100.0 102.519 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.37 124.4 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-N 112.447 -2.16 . . . . 100.0 109.198 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -104.77 105.9 16.17 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 104.715 -2.328 . . . . 100.0 104.715 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.76 118.7 27.45 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 104.339 -2.467 . . . . 100.0 104.339 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.1 p -96.54 162.27 13.54 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 114.041 1.126 . . . . 100.0 114.041 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.71 128.73 34.75 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.139 -1.43 . . . . 100.0 107.139 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.45 -13.39 80.44 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.948 -0.362 . . . . 100.0 112.386 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -65.81 -41.04 92.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.359 1.864 . . . . 100.0 112.13 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.71 137.73 58.2 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.828 0.851 . . . . 100.0 111.991 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -71.8 156.24 39.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.3 1.048 . . . . 100.0 113.019 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -66.85 132.71 48.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.413 1.885 . . . . 100.0 108.267 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.92 -171.77 34.43 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 119.608 -1.282 . . . . 100.0 114.548 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.04 -21.53 63.82 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 127.915 2.674 . . . . 100.0 113.824 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.65 -36.88 84.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.595 1.558 . . . . 100.0 110.649 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -87.45 1.21 54.08 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.742 1.617 . . . . 100.0 113.592 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.43 -39.78 92.06 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 116.044 1.868 . . . . 100.0 116.044 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.11 91.67 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 118.836 0.744 . . . . 100.0 113.436 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -62.91 -42.2 99.71 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.24 1.816 . . . . 100.0 108.912 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.564 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 8.8 t80 -89.32 -14.31 36.01 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 114.271 1.211 . . . . 100.0 114.271 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.6 mt -61.83 135.86 25.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 CA-C-N 119.108 0.867 . . . . 100.0 108.862 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 64.56 21.71 12.5 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 126.558 1.943 . . . . 100.0 114.441 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.51 141.29 50.16 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 108.158 -1.053 . . . . 100.0 108.158 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -100.0 -32.38 10.98 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.006 -1.109 . . . . 100.0 108.006 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.534 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.7 p -150.3 160.96 43.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.964 0.411 . . . . 100.0 111.391 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.434 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -143.52 152.43 41.46 Favored 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 119.616 -0.834 . . . . 100.0 113.114 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.0 mt -126.16 126.7 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.258 -2.497 . . . . 100.0 104.258 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 67.9 mt -109.27 124.26 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 N-CA-C 101.483 -3.525 . . . . 100.0 101.483 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.409 ' C ' HG21 ' A' ' 21' ' ' THR . 50.1 ttm -119.03 133.27 55.92 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.239 -1.384 . . . . 100.0 111.083 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -127.63 158.3 37.9 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.461 -1.7 . . . . 100.0 109.665 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -102.42 125.75 49.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 105.473 -2.047 . . . . 100.0 105.473 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.66 -22.96 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 114.167 1.173 . . . . 100.0 114.167 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -85.29 -10.83 55.97 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 118.736 -0.649 . . . . 100.0 111.072 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 t -116.17 116.71 28.31 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.272 1.511 . . . . 100.0 112.541 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -65.8 -41.45 91.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.938 -1.937 . . . . 100.0 109.223 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.08 -43.62 97.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 C-N-CA 125.431 1.492 . . . . 100.0 110.353 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.7 m -63.17 -43.23 98.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.101 0.561 . . . . 100.0 109.74 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.572 0.349 . . . . 100.0 110.289 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.505 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.4 mttt -60.25 -37.97 82.03 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 124.15 0.98 . . . . 100.0 111.335 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -73.27 -11.28 60.45 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.238 1.57 . . . . 100.0 115.238 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.97 -42.92 93.02 Favored Pre-proline 0 C--N 1.361 1.1 0 CA-C-O 116.58 -1.676 . . . . 100.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 92.9 Cg_exo -59.3 -34.27 97.87 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.488 2.125 . . . . 100.0 112.422 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.98 -43.38 88.02 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.07 0.948 . . . . 100.0 110.116 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' O ' HD13 ' A' ' 108' ' ' LEU . 83.7 m95 -62.76 -47.11 84.95 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 109.111 -0.7 . . . . 100.0 109.111 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 50.2 t-80 -91.46 64.52 5.06 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.78 1.276 . . . . 100.0 108.351 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -154.81 -60.59 0.12 Allowed 'General case' 0 CA--C 1.489 -1.387 1 N-CA-C 99.736 -4.172 . . . . 100.0 99.736 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.52 -39.99 95.32 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.192 0.597 . . . . 100.0 111.138 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -61.56 -45.85 92.39 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 122.998 0.519 . . . . 100.0 110.583 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.6 -39.08 83.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 126.395 1.878 . . . . 100.0 109.784 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.27 45.7 mtm105 -59.01 -44.52 91.71 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.048 0.539 . . . . 100.0 109.753 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.43 -51.84 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 115.563 1.69 . . . . 100.0 115.563 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -108.26 4.02 24.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 119.911 3.3 . . . . 100.0 119.911 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 54.11 -121.05 1.76 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.326 1.45 . . . . 100.0 111.28 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -95.19 112.88 24.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.884 1.22 . . . . 100.0 111.134 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 115' ' ' ILE . 46.2 pt -144.79 153.09 53.81 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.942 -2.984 . . . . 100.0 102.942 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -62.31 126.0 17.57 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.311 2.007 . . . . 100.0 111.9 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.699 ' HB ' HD22 ' A' ' 144' ' ' LEU . 69.1 mt -130.69 133.81 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.461 -1.311 . . . . 100.0 107.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 160' ' ' PRO . 57.6 t -115.38 133.12 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 114.044 -1.435 . . . . 100.0 108.077 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.89 124.8 47.11 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.69 -2.337 . . . . 100.0 104.69 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.8 m -116.94 122.34 44.0 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.75 0.786 . . . . 100.0 110.348 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.42 103.15 2.82 Favored Glycine 0 CA--C 1.478 -2.259 0 N-CA-C 103.626 -3.79 . . . . 100.0 103.626 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . 0.41 54.0 p30 -93.09 170.62 9.5 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 114.817 1.414 . . . . 100.0 114.817 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.7 mttt 61.11 41.67 13.4 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.586 2.754 . . . . 100.0 112.201 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 148' ' ' ASP . 33.8 m -64.76 -18.9 24.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.275 -0.875 . . . . 100.0 112.781 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -61.11 -38.25 85.67 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 123.624 0.77 . . . . 100.0 112.4 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.61 130.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.843 0.83 . . . . 100.0 108.981 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.61 -42.74 98.19 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.767 1.627 . . . . 100.0 114.84 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.32 77.03 10.06 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.51 1.147 . . . . 100.0 108.742 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -92.95 125.9 37.77 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.618 -1.623 . . . . 100.0 106.618 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -98.05 -39.17 9.06 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.32 -0.855 . . . . 100.0 112.302 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.96 107.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 103.908 -2.627 . . . . 100.0 103.908 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.9 144.34 31.04 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.422 -1.263 . . . . 100.0 109.962 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.84 -40.56 95.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.286 1.035 . . . . 100.0 111.348 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -40.76 98.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.909 1.284 . . . . 100.0 110.722 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.6 m -63.28 -38.09 89.8 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.124 1.77 . . . . 100.0 113.057 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.01 123.76 15.34 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-O 122.553 1.168 . . . . 100.0 110.022 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.56 -5.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.434 -1.712 . . . . 100.0 110.701 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -59.61 -41.74 91.06 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.243 1.417 . . . . 100.0 111.4 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -61.27 -42.71 99.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.403 0.681 . . . . 100.0 112.364 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -63.8 -44.23 93.95 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 124.195 0.998 . . . . 100.0 110.859 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.8 -42.31 97.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.937 0.895 . . . . 100.0 111.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -95.69 4.46 52.98 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.655 2.095 . . . . 100.0 116.655 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 55.54 46.89 22.05 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-O 122.898 1.333 . . . . 100.0 113.257 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.699 HD22 ' HB ' ' A' ' 117' ' ' ILE . 40.7 mt -113.36 159.66 19.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.377 -1.342 . . . . 100.0 107.377 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.7 mm-40 -99.38 140.82 32.99 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 109.577 -0.527 . . . . 100.0 109.577 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -114.29 130.98 56.66 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.472 0.653 . . . . 100.0 112.067 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -129.06 135.1 48.47 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.027 -0.988 . . . . 100.0 111.401 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB3' HG11 ' A' ' 124' ' ' VAL . 36.4 m-20 -90.04 120.83 31.57 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 101.872 -3.381 . . . . 100.0 101.872 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.8 pt -131.9 154.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.489 1.138 . . . . 100.0 112.07 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.1 t -138.95 118.2 12.71 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 104.497 -2.408 . . . . 100.0 104.497 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.239 -0.891 . . . . 100.0 109.142 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -44.26 87.62 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.061 1.504 . . . . 100.0 115.061 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -93.73 -2.17 54.15 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.022 1.49 . . . . 100.0 115.022 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 66.46 21.0 10.89 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 125.012 1.325 . . . . 100.0 111.133 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -73.9 118.09 16.45 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.778 -1.193 . . . . 100.0 107.778 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 52.29 36.8 20.53 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 127.955 2.502 . . . . 100.0 111.145 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -63.06 -40.71 98.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 115.613 1.709 . . . . 100.0 115.613 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.57 -10.24 49.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 113.75 1.018 . . . . 100.0 113.75 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.311 94.8 mttt -60.14 -43.98 95.25 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 118.605 2.817 . . . . 100.0 118.605 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.424 ' HB3' HG11 ' A' ' 118' ' ' VAL . 50.4 Cg_endo -59.65 -41.32 56.99 Favored 'Trans proline' 0 C--N 1.372 1.787 0 CA-C-N 123.187 2.174 . . . . 100.0 112.344 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -63.38 -44.78 93.75 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 124.051 0.844 . . . . 100.0 111.278 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.28 -42.61 96.33 Favored 'General case' 0 CA--C 1.483 -1.609 0 CA-C-O 118.394 -0.812 . . . . 100.0 112.73 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.44 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.2 t90 -64.25 -42.61 96.43 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.711 0.632 . . . . 100.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 85' ' ' CYS . 86.1 mt -60.72 -43.78 97.42 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 123.406 0.441 . . . . 100.0 110.651 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.85 99.93 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.59 0.756 . . . . 100.0 111.548 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.456 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 87.5 mtt180 -61.77 -46.14 90.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 124.199 1.0 . . . . 100.0 111.11 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -65.8 -45.98 80.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 123.71 0.804 . . . . 100.0 112.685 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.96 -45.73 84.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.513 0.725 . . . . 100.0 112.397 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 98.3 mt -70.79 -38.16 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 124.207 1.003 . . . . 100.0 111.052 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.74 10.07 55.71 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 118.589 -1.117 . . . . 100.0 113.365 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 110.62 61.7 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 106.733 -1.58 . . . . 100.0 106.733 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -70.78 -18.08 32.48 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.272 2.648 . . . . 100.0 113.783 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -97.24 9.14 43.03 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.088 0.955 . . . . 100.0 112.595 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 26.9 tp -63.31 129.27 39.55 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 109.055 -0.72 . . . . 100.0 109.055 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -129.24 152.26 49.01 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.42 0.629 . . . . 100.0 111.017 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -80.87 135.51 35.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.515 1.126 . . . . 100.0 109.231 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.17 156.46 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 106.045 -1.835 . . . . 100.0 106.045 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.08 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.356 0.888 0 N-CA-C 117.601 2.445 . . . . 100.0 117.601 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 53.9 tpp -156.57 100.07 2.05 Favored Pre-proline 0 C--N 1.359 1.004 0 CA-C-N 119.698 1.135 . . . . 100.0 110.31 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.88 157.03 52.14 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 123.437 2.758 . . . . 100.0 111.153 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.99 122.5 27.37 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 102.019 -3.326 . . . . 100.0 102.019 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.76 150.82 39.15 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 114.405 1.261 . . . . 100.0 114.405 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.52 120.7 68.92 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 101.094 -3.669 . . . . 100.0 101.094 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.52 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 66.9 Cg_endo -63.04 145.16 93.99 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.78 2.986 . . . . 100.0 116.224 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 24.7 Cg_exo -70.57 159.53 52.5 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.543 2.829 . . . . 100.0 111.57 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -61.14 -44.01 98.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.92 1.288 . . . . 100.0 112.581 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.766 ' H ' ' HB1' ' A' ' 2' ' ' ALA 0.27 24.9 t 62.97 84.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.08 0 C-N-CA 127.123 2.169 . . . . 100.0 110.515 -179.165 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 m -110.54 177.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 125.123 1.369 . . . . 100.0 109.548 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.277 85.9 mmm 54.44 -118.5 1.32 Allowed 'General case' 0 C--N 1.359 1.0 0 N-CA-C 117.862 2.542 . . . . 100.0 117.862 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.28 86.7 m-20 54.34 51.22 7.63 Favored Pre-proline 0 C--N 1.367 1.337 0 N-CA-C 121.225 3.787 . . . . 100.0 121.225 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -65.5 -67.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 120.965 1.38 . . . . 100.0 109.976 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.85 81.04 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 123.869 0.867 . . . . 100.0 112.418 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.317 93.2 mt -63.51 -37.6 87.92 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 117.202 2.297 . . . . 100.0 117.202 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.89 171.16 13.27 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 119.059 0.845 . . . . 100.0 112.3 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 76.78 -47.11 0.52 Allowed 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 127.126 2.17 . . . . 100.0 112.405 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.77 -44.35 93.91 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 114.656 1.354 . . . . 100.0 114.656 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . 0.265 21.0 m-30 -60.92 -50.45 73.37 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-O 122.114 0.959 . . . . 100.0 110.962 -177.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -64.7 -41.64 95.86 Favored 'General case' 0 CA--C 1.483 -1.602 0 C-N-CA 125.085 1.354 . . . . 100.0 111.878 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -61.47 -45.11 95.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.148 0.979 . . . . 100.0 111.03 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.2 -46.22 88.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 118.302 0.501 . . . . 100.0 111.908 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.88 -45.13 93.97 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.451 0.469 . . . . 100.0 112.145 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -64.66 -42.97 95.03 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 118.1 -0.952 . . . . 100.0 112.516 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.18 -43.13 98.66 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 CA-C-O 118.626 -0.702 . . . . 100.0 109.581 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.19 95.18 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 118.034 0.379 . . . . 100.0 111.244 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.35 -42.37 96.27 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.898 0.879 . . . . 100.0 113.169 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.5 m -64.81 -39.45 93.6 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.935 1.694 . . . . 100.0 111.744 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.4 m -57.81 131.19 49.59 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 123.624 0.77 . . . . 100.0 110.091 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.69 140.83 55.43 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 114.461 -1.245 . . . . 100.0 108.487 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 10.8 mp -102.68 123.2 43.38 Favored Pre-proline 0 N--CA 1.428 -1.574 0 N-CA-C 113.888 1.07 . . . . 100.0 113.888 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 209' ' ' LEU . 20.5 Cg_exo -89.13 -141.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.485 0 N-CA-C 103.436 -3.332 . . . . 100.0 103.436 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -87.06 104.08 15.98 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 103.994 -2.595 . . . . 100.0 103.994 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.14 -61.1 1.18 Allowed 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 109.17 -0.678 . . . . 100.0 109.17 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 43.4 p30 -111.57 11.92 21.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 113.26 0.837 . . . . 100.0 113.26 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.65 -38.27 84.3 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 125.905 1.682 . . . . 100.0 112.543 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.74 -40.67 93.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.8 1.24 . . . . 100.0 112.646 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--O 1.258 1.551 0 CA-C-O 117.136 -1.412 . . . . 100.0 108.878 -179.876 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 110.009 -0.367 . . . . 100.0 110.009 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.45 90.83 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 124.684 1.194 . . . . 100.0 112.031 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.19 97.52 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.911 0.884 . . . . 100.0 110.133 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -66.81 -37.01 83.69 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.697 1.199 . . . . 100.0 111.148 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.404 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . 96.1 18.51 31.34 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 107.197 -2.361 . . . . 100.0 107.197 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.27 36.0 tt0 -87.26 96.08 0.53 Allowed Pre-proline 0 N--CA 1.422 -1.839 0 N-CA-C 103.099 -2.926 . . . . 100.0 103.099 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 5' ' ' GLY . 72.4 Cg_endo -61.68 -44.12 23.2 Favored 'Trans proline' 0 C--N 1.379 2.172 0 N-CA-C 107.602 -1.73 . . . . 100.0 107.602 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -132.16 -62.79 0.83 Allowed 'General case' 0 N--CA 1.417 -2.105 1 N-CA-C 99.961 -4.088 . . . . 100.0 99.961 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.21 144.76 36.24 Favored 'Isoleucine or valine' 0 C--N 1.371 1.509 0 CA-C-O 122.091 0.948 . . . . 100.0 111.091 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -125.26 131.77 53.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.387 -2.449 . . . . 100.0 104.387 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -119.49 135.43 54.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.102 -1.073 . . . . 100.0 108.102 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -92.85 120.58 33.34 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 123.176 1.465 . . . . 100.0 107.122 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 tt -110.47 128.72 55.74 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 112.638 -2.074 . . . . 100.0 106.526 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -109.82 123.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 105.926 -1.879 . . . . 100.0 105.926 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 23' ' ' LYS . 68.0 tp -106.19 118.04 35.58 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.148 -1.427 . . . . 100.0 107.148 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.49 164.28 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 113.6 -1.636 . . . . 100.0 110.657 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 172.16 21.09 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.203 -1.959 . . . . 100.0 108.203 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' HB2' HG23 ' A' ' 97' ' ' THR . 68.0 m-20 -74.43 164.07 27.03 Favored 'General case' 0 CA--C 1.5 -0.98 0 O-C-N 122.207 -0.584 . . . . 100.0 112.153 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.18 142.01 36.83 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 109.392 -1.483 . . . . 100.0 109.392 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.28 90.48 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 123.781 0.705 . . . . 100.0 114.012 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.437 HG22 HD21 ' A' ' 122' ' ' ASN . 60.1 m -63.58 -42.69 98.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 117.922 0.861 . . . . 100.0 112.268 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.88 12.58 7.71 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.145 -1.026 . . . . 100.0 111.863 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HB2' HD21 ' A' ' 15' ' ' LEU . 59.0 pttt -61.97 -41.83 98.45 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.043 0.937 . . . . 100.0 112.601 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.4 m -64.18 -43.17 95.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.71 1.204 . . . . 100.0 109.122 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.1 m -63.03 -41.78 99.61 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.4 1.48 . . . . 100.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.69 -48.54 81.28 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 126.017 1.727 . . . . 100.0 109.929 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.74 -42.91 93.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 119.253 -0.403 . . . . 100.0 111.608 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.16 -39.77 93.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 123.027 0.531 . . . . 100.0 111.656 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.502 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 28.1 ttp180 -61.81 -44.59 96.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.797 1.239 . . . . 100.0 109.586 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -62.77 -44.79 95.28 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.175 0.443 . . . . 100.0 111.914 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.06 -47.7 76.42 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 116.535 2.05 . . . . 100.0 116.535 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -118.47 -23.61 7.11 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 117.193 2.294 . . . . 100.0 117.193 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.46 71.76 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 110.751 -0.94 . . . . 100.0 110.751 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.71 151.19 36.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 118.08 0.94 . . . . 100.0 109.531 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.536 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 92.0 m-85 -112.07 124.69 52.95 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 102.084 -3.302 . . . . 100.0 102.084 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -104.8 113.56 27.22 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.66 -0.816 . . . . 100.0 110.311 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.76 -43.39 62.92 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.057 1.343 . . . . 100.0 112.826 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -74.6 134.93 42.04 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 123.519 0.727 . . . . 100.0 111.344 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -102.88 119.71 39.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.264 -1.384 . . . . 100.0 107.264 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.33 127.14 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 103.301 -2.852 . . . . 100.0 103.301 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.14 58.74 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.563 0.697 . . . . 100.0 112.73 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.0 m -93.09 124.58 37.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 104.085 -2.561 . . . . 100.0 104.085 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.7 mt -104.59 127.51 52.35 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.09 -1.819 . . . . 100.0 106.09 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.71 -125.72 33.58 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.176 -1.17 . . . . 100.0 110.176 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.77 137.99 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.543 0.737 . . . . 100.0 110.038 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -114.43 124.87 53.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.084 -2.932 . . . . 100.0 103.084 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.18 117.4 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 124.855 1.262 . . . . 100.0 107.731 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -129.29 119.9 19.77 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 111.909 0.336 . . . . 100.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 22.2 Cg_exo -79.94 128.98 7.77 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.811 2.341 . . . . 100.0 112.232 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.8 mt -124.67 130.97 53.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.544 -1.28 . . . . 100.0 107.544 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.46 130.9 61.69 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.706 -1.22 . . . . 100.0 107.706 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.37 130.47 54.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.646 -1.983 . . . . 100.0 105.646 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -99.85 122.59 43.03 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.584 -2.006 . . . . 100.0 105.584 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.8 p -124.19 177.83 5.64 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.664 0.745 . . . . 100.0 110.891 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -59.54 -36.45 76.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.016 1.726 . . . . 100.0 109.7 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -85.4 0.9 50.78 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.329 1.051 . . . . 100.0 111.885 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.06 178.21 19.99 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 121.543 -0.723 . . . . 100.0 111.558 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -68.17 138.87 44.65 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 123.297 2.665 . . . . 100.0 112.769 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 mm -130.51 140.53 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.668 -2.345 . . . . 100.0 104.668 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.431 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.8 ttmt -116.27 128.95 56.01 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.13 -1.028 . . . . 100.0 109.586 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.11 118.51 36.83 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.64 -2.356 . . . . 100.0 104.64 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -93.37 107.8 19.57 Favored 'General case' 0 N--CA 1.429 -1.514 1 N-CA-C 100.028 -4.064 . . . . 100.0 100.028 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.9 t -95.13 123.01 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.025 -0.989 . . . . 100.0 109.092 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -103.15 106.51 17.04 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -87.3 117.79 26.3 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.595 -2.742 . . . . 100.0 103.595 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.3 p -100.19 163.0 12.6 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.755 -0.657 . . . . 100.0 112.401 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.88 131.0 35.33 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.58 -0.526 . . . . 100.0 109.58 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.9 -11.57 81.23 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 112.238 -0.345 . . . . 100.0 112.238 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -65.07 -41.88 94.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.832 2.453 . . . . 100.0 111.102 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.46 141.29 58.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.939 1.296 . . . . 100.0 113.632 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 149.22 50.71 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.784 2.034 . . . . 100.0 111.297 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -71.33 130.5 41.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.884 -1.525 . . . . 100.0 106.884 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.53 -169.24 34.41 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.184 -1.484 . . . . 100.0 115.501 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.55 -21.87 63.11 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 127.78 2.61 . . . . 100.0 114.325 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.99 -37.66 85.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.8 1.64 . . . . 100.0 109.886 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.5 mmm-85 -86.16 2.46 46.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.047 1.739 . . . . 100.0 113.955 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.22 -41.8 93.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 115.514 1.672 . . . . 100.0 115.514 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.95 -38.22 92.41 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.858 0.742 . . . . 100.0 113.473 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -62.44 -43.51 98.64 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 125.745 1.618 . . . . 100.0 109.097 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.527 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 7.5 t80 -88.35 -14.25 38.65 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.266 1.21 . . . . 100.0 114.266 -176.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.27 134.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.364 1.229 0 CA-C-N 119.56 1.073 . . . . 100.0 109.378 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 63.27 26.36 15.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.174 2.19 . . . . 100.0 113.396 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.25 139.68 42.71 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 107.456 -1.313 . . . . 100.0 107.456 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -97.97 -34.88 10.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.448 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -148.37 161.05 42.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 120.709 0.29 . . . . 100.0 111.476 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.44 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -142.06 152.6 43.48 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.07 -1.052 . . . . 100.0 113.737 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.69 125.73 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 104.232 -2.507 . . . . 100.0 104.232 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.98 123.65 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 100.96 -3.719 . . . . 100.0 100.96 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -118.59 133.78 55.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.37 -1.332 . . . . 100.0 111.14 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -129.08 158.87 37.71 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 100.0 109.911 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -100.9 125.35 47.44 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 105.848 -1.908 . . . . 100.0 105.848 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.93 -22.26 30.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.71 1.004 . . . . 100.0 113.71 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -88.2 -7.48 56.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 118.953 -0.546 . . . . 100.0 111.568 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.1 t -117.86 116.55 27.19 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 122.891 1.329 . . . . 100.0 112.165 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.75 -40.18 88.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.553 -1.658 . . . . 100.0 110.141 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.92 -43.43 97.47 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 125.258 1.423 . . . . 100.0 109.754 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 18' ' ' ASP . 95.0 m -63.06 -42.96 99.8 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 122.851 0.46 . . . . 100.0 109.954 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -64.34 -39.74 94.49 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 122.818 0.447 . . . . 100.0 110.504 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 93.6 mttt -60.71 -37.56 82.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.814 1.245 . . . . 100.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.91 -11.14 60.27 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.072 1.508 . . . . 100.0 115.072 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -59.97 -43.08 93.62 Favored Pre-proline 0 C--N 1.364 1.226 0 CA-C-O 116.208 -1.853 . . . . 100.0 111.199 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 93.7 Cg_exo -58.03 -35.45 98.74 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.626 2.217 . . . . 100.0 112.516 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -65.56 -43.75 88.86 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.135 0.974 . . . . 100.0 109.979 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.433 ' O ' HD13 ' A' ' 108' ' ' LEU . 83.9 m95 -62.6 -47.31 84.33 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 109.507 -0.553 . . . . 100.0 109.507 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -91.11 64.62 5.35 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 123.055 1.407 . . . . 100.0 108.397 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -156.28 -62.12 0.1 Allowed 'General case' 0 CA--C 1.485 -1.527 1 N-CA-C 100.04 -4.059 . . . . 100.0 100.04 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -63.97 -39.75 94.83 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.376 -0.829 . . . . 100.0 110.428 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.527 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -62.03 -46.05 90.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.123 0.569 . . . . 100.0 110.762 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.54 -39.57 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 126.19 1.796 . . . . 100.0 109.675 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.11 -44.51 94.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 119.082 -0.485 . . . . 100.0 110.507 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.4 t -72.51 -49.37 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 114.958 1.466 . . . . 100.0 114.958 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.9 m -113.47 11.03 18.32 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 120.16 3.393 . . . . 100.0 120.16 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 54.18 -126.52 2.33 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 125.166 1.386 . . . . 100.0 112.367 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -102.54 115.75 31.21 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 117.772 -1.571 . . . . 100.0 109.986 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.94 150.42 67.43 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 102.453 -3.165 . . . . 100.0 102.453 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -60.82 128.5 25.8 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.917 1.745 . . . . 100.0 112.89 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.659 ' HB ' HD22 ' A' ' 144' ' ' LEU . 61.8 mt -131.16 135.17 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.479 -1.304 . . . . 100.0 107.479 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.77 131.63 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-N 113.579 -1.646 . . . . 100.0 108.169 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 139' ' ' HIS . 88.6 mt -98.55 124.6 43.39 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 104.328 -2.471 . . . . 100.0 104.328 176.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 92.6 m -114.81 121.76 44.27 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.201 -0.909 . . . . 100.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.49 102.33 2.69 Favored Glycine 0 CA--C 1.479 -2.165 0 N-CA-C 103.099 -4.0 . . . . 100.0 103.099 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.437 HD21 HG22 ' A' ' 21' ' ' THR 0.386 55.4 p30 -92.67 171.61 8.89 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 114.326 1.232 . . . . 100.0 114.326 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 61.05 40.9 14.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 128.339 2.656 . . . . 100.0 111.95 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 148' ' ' ASP . 34.0 m -64.34 -19.89 25.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.075 0 CA-C-N 115.517 -0.765 . . . . 100.0 112.669 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -61.0 -38.09 84.82 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.143 0.977 . . . . 100.0 112.549 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.66 129.82 26.44 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 N-CA-C 108.693 -0.855 . . . . 100.0 108.693 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.01 -41.25 95.49 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 116.357 1.984 . . . . 100.0 116.357 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.24 83.98 7.82 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.402 -1.333 . . . . 100.0 107.402 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -94.97 127.0 40.7 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.814 -1.921 . . . . 100.0 105.814 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.66 -38.66 9.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.994 -0.548 . . . . 100.0 112.304 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.33 105.93 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 103.804 -2.665 . . . . 100.0 103.804 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.37 151.32 25.58 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.265 -0.88 . . . . 100.0 111.187 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.4 -42.03 98.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.35 1.06 . . . . 100.0 111.555 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.11 -39.94 96.18 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.854 0.861 . . . . 100.0 111.102 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -62.54 -38.07 88.56 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.787 1.635 . . . . 100.0 112.982 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 90.4 mt -64.06 122.56 15.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 CA-C-O 122.421 1.105 . . . . 100.0 109.878 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.9 -7.25 4.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 C-N-CA 125.734 1.614 . . . . 100.0 111.598 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.394 1.478 . . . . 100.0 111.261 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.409 ' HB3' HD12 ' A' ' 119' ' ' LEU . 44.2 p-80 -61.7 -42.23 98.66 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 118.82 -0.61 . . . . 100.0 112.077 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -63.18 -45.31 92.37 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.656 0.782 . . . . 100.0 111.491 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.29 -40.63 94.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 123.611 0.764 . . . . 100.0 112.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.84 3.28 55.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 116.283 1.957 . . . . 100.0 116.283 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 57.6 t30 55.51 50.36 14.76 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.501 1.52 . . . . 100.0 112.624 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.659 HD22 ' HB ' ' A' ' 117' ' ' ILE . 49.9 mt -118.11 159.33 23.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.726 1.21 . . . . 100.0 108.048 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.2 mm-40 -98.29 140.19 32.94 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -114.58 130.62 56.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.554 0.692 . . . . 100.0 111.273 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -128.14 134.77 49.14 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.919 -1.037 . . . . 100.0 111.375 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.411 ' HB3' HG11 ' A' ' 124' ' ' VAL . 47.7 m-20 -88.42 120.95 30.28 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 102.348 -3.205 . . . . 100.0 102.348 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.4 pt -131.16 154.43 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.652 1.215 . . . . 100.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.2 t -136.69 119.59 16.35 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 105.091 -2.188 . . . . 100.0 105.091 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.426 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.2 -45.1 89.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 124.211 0.944 . . . . 100.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.7 -44.68 89.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 115.145 1.535 . . . . 100.0 115.145 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 94.1 p -95.77 -0.26 51.54 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 115.537 1.68 . . . . 100.0 115.537 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.502 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 70.6 m-80 63.7 24.27 13.82 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.869 0.868 . . . . 100.0 112.638 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.76 123.25 24.61 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 106.046 -1.835 . . . . 100.0 106.046 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.05 40.57 31.42 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.939 2.095 . . . . 100.0 112.011 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.44 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 30.4 t80 -57.25 -49.04 77.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.369 1.867 . . . . 100.0 114.315 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.16 -9.02 40.85 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 115.463 1.653 . . . . 100.0 115.463 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.304 95.0 mttt -59.66 -44.44 97.44 Favored Pre-proline 0 CA--C 1.498 -1.045 0 N-CA-C 119.282 3.067 . . . . 100.0 119.282 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.1 -42.28 44.88 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.391 1.89 . . . . 100.0 111.678 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.95 -44.13 93.75 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 124.414 1.071 . . . . 100.0 111.794 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.62 -43.99 95.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 112.968 0.729 . . . . 100.0 112.968 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.424 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.5 t90 -64.61 -43.14 94.71 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.834 0.709 . . . . 100.0 109.975 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 85' ' ' CYS . 88.9 mt -61.55 -43.06 99.55 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.448 0.468 . . . . 100.0 111.136 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.27 99.22 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 123.78 0.832 . . . . 100.0 110.765 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.445 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 96.2 mtt180 -61.96 -45.39 93.87 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.514 0.726 . . . . 100.0 111.667 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -64.6 -46.84 80.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.289 0.636 . . . . 100.0 111.879 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.35 -46.13 81.44 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 113.675 0.991 . . . . 100.0 113.675 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.85 -38.86 79.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.404 1.082 . . . . 100.0 109.388 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.67 8.9 59.17 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 118.635 -1.092 . . . . 100.0 112.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -107.62 110.15 62.64 Favored Pre-proline 0 C--N 1.361 1.074 0 N-CA-C 106.047 -1.834 . . . . 100.0 106.047 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.5 -18.85 43.33 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 123.842 3.028 . . . . 100.0 113.834 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -97.78 11.02 38.61 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.39 1.076 . . . . 100.0 112.611 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.445 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 23.5 tp -63.19 130.47 44.71 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.742 0.817 . . . . 100.0 109.145 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -130.8 152.41 50.17 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.367 0.603 . . . . 100.0 110.413 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -80.1 133.53 36.1 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.576 -1.268 . . . . 100.0 107.576 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.03 155.65 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.834 -1.173 . . . . 100.0 107.834 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -42.28 -97.2 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 118.839 2.903 . . . . 100.0 118.839 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 54.7 tpp -157.27 86.27 2.75 Favored Pre-proline 0 C--N 1.364 1.236 0 N-CA-C 115.561 1.689 . . . . 100.0 115.561 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.32 160.19 42.47 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 123.338 2.692 . . . . 100.0 107.762 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.74 130.36 42.76 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.355 0.598 . . . . 100.0 109.805 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.5 mt -95.61 145.87 24.91 Favored 'General case' 0 CA--C 1.484 -1.583 0 CA-C-N 114.995 -1.002 . . . . 100.0 110.961 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -84.32 124.35 73.93 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 102.697 -3.075 . . . . 100.0 102.697 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 60.8 Cg_endo -62.08 140.51 84.48 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 123.397 2.732 . . . . 100.0 113.905 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 31.2 Cg_exo -67.18 155.18 71.76 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.244 2.629 . . . . 100.0 112.188 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.41 -45.3 94.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.32 1.048 . . . . 100.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.0 t 68.56 102.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.243 0 C-N-CA 126.651 1.98 . . . . 100.0 106.747 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.7 m -92.51 157.01 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 115.331 1.604 . . . . 100.0 115.331 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.368 85.3 mmm 52.71 -118.44 1.33 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.989 2.515 . . . . 100.0 117.548 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 57.13 47.62 2.67 Favored Pre-proline 0 C--N 1.365 1.269 0 N-CA-C 117.705 2.483 . . . . 100.0 117.705 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.38 -70.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.054 1.836 . . . . 100.0 110.005 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.04 90.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.658 1.583 . . . . 100.0 109.249 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.1 mt -63.14 -21.66 66.35 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 115.886 1.81 . . . . 100.0 115.886 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.76 157.7 36.82 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 119.532 1.06 . . . . 100.0 110.887 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 75.42 -32.13 0.21 Allowed 'General case' 0 C--N 1.363 1.185 0 C-N-CA 127.739 2.416 . . . . 100.0 114.035 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -61.15 -37.93 84.63 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 127.031 2.132 . . . . 100.0 110.323 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -59.45 -43.73 93.11 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.101 0.96 . . . . 100.0 111.508 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -62.77 -43.04 99.84 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.634 0.774 . . . . 100.0 111.522 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.71 -44.5 96.81 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.756 1.222 . . . . 100.0 110.608 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -63.16 -41.94 99.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.803 1.241 . . . . 100.0 111.234 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.63 -42.6 99.68 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.519 0.728 . . . . 100.0 111.084 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.77 -44.37 96.37 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.472 0.709 . . . . 100.0 111.239 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.76 -42.99 98.34 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 C-N-CA 123.844 0.857 . . . . 100.0 109.077 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.83 99.59 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.274 1.029 . . . . 100.0 111.673 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -62.66 -42.7 99.75 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.921 0.888 . . . . 100.0 110.803 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.5 m -63.82 -42.69 97.61 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.734 1.214 . . . . 100.0 111.631 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 m -62.87 136.37 57.81 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 124.454 1.102 . . . . 100.0 113.454 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.24 143.88 52.02 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 124.805 1.242 . . . . 100.0 108.523 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 34.6 tp -97.68 124.49 48.13 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 116.205 -0.452 . . . . 100.0 111.562 -177.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 209' ' ' LEU . 38.0 Cg_exo -71.54 166.26 29.94 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.856 3.038 . . . . 100.0 109.066 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -76.08 113.27 13.42 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.443 -1.317 . . . . 100.0 107.443 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -126.55 -56.48 1.39 Allowed 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.627 -1.624 . . . . 100.0 106.698 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.536 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 25.7 p30 -111.64 5.66 19.44 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 115.442 1.645 . . . . 100.0 115.442 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -61.24 -38.8 87.98 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 114.133 1.16 . . . . 100.0 114.133 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -61.16 -40.07 92.49 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 113.544 0.942 . . . . 100.0 113.544 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 C--O 1.259 1.556 0 CA-C-O 117.147 -1.406 . . . . 100.0 109.777 -179.002 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 115.065 1.506 . . . . 100.0 115.065 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -122.81 134.75 54.4 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.001 1.721 . . . . 100.0 106.694 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.53 132.4 53.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.647 -0.871 . . . . 100.0 108.647 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 87.8 tttt -89.04 116.94 27.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.23 129.22 56.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-N 114.251 -1.34 . . . . 100.0 107.874 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.12 124.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.155 -1.424 . . . . 100.0 107.155 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.5 tp -105.27 117.72 34.74 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.771 -1.566 . . . . 100.0 106.771 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.97 162.72 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.259 -1.337 . . . . 100.0 112.567 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.91 172.49 20.68 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 109.629 -1.388 . . . . 100.0 109.629 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.479 ' HB2' HG23 ' A' ' 97' ' ' THR . 85.2 m-20 -71.1 159.62 34.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.831 0.824 . . . . 100.0 112.778 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 139.44 39.69 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 110.173 -1.171 . . . . 100.0 110.173 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.65 2.8 89.88 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 118.592 -1.116 . . . . 100.0 114.774 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 p -64.06 -39.72 94.69 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 118.767 1.283 . . . . 100.0 113.887 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.18 19.32 5.17 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-O 118.941 -0.922 . . . . 100.0 111.477 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -60.08 -47.64 85.04 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 118.889 1.344 . . . . 100.0 111.143 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.3 m -64.55 -42.99 95.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.096 1.358 . . . . 100.0 110.671 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.2 m -63.12 -40.77 98.59 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.665 1.186 . . . . 100.0 109.177 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' HD1' HH22 ' A' ' 29' ' ' ARG . 68.1 t80 -60.67 -48.12 83.19 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.335 1.454 . . . . 100.0 110.369 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.28 -43.25 97.18 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 O-C-N 123.55 0.531 . . . . 100.0 111.025 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.71 -39.83 92.91 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.79 0.663 . . . . 100.0 112.79 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.775 HH21 ' HA ' ' A' ' 151' ' ' ALA . 13.1 ttm180 -60.48 -45.86 92.2 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.262 1.025 . . . . 100.0 109.086 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -64.35 -42.38 96.26 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.296 0.85 . . . . 100.0 113.296 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.61 -44.6 66.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.3 p -119.36 -23.3 6.73 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 117.826 2.528 . . . . 100.0 117.826 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.92 -7.73 73.45 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 110.992 -0.843 . . . . 100.0 110.992 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.0 156.58 30.06 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.765 1.226 . . . . 100.0 109.142 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -114.65 118.26 33.15 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 102.612 -3.107 . . . . 100.0 102.612 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -87.81 110.21 20.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.905 0.86 . . . . 100.0 111.085 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.06 -40.12 68.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.107 1.363 . . . . 100.0 113.85 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HE3' HG21 ' A' ' 206' ' ' THR . 96.3 mttt -80.06 131.17 35.72 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.389 1.076 . . . . 100.0 112.218 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -99.41 110.45 22.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.142 -1.023 . . . . 100.0 108.266 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.7 122.46 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 102.418 -3.178 . . . . 100.0 102.418 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.27 142.33 57.79 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.282 0.845 . . . . 100.0 113.282 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.5 m -92.95 127.22 38.38 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 104.431 -2.433 . . . . 100.0 104.431 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -105.34 127.14 52.81 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 107.916 -1.142 . . . . 100.0 107.916 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.32 -121.19 12.83 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.007 -1.637 . . . . 100.0 109.007 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.23 142.92 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.162 0.506 . . . . 100.0 110.197 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -121.13 123.59 42.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 105.007 -2.22 . . . . 100.0 105.007 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.6 t -100.31 122.02 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.675 -1.231 . . . . 100.0 107.675 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -126.65 124.45 24.19 Favored Pre-proline 0 N--CA 1.434 -1.238 0 CA-C-N 115.924 -0.58 . . . . 100.0 112.016 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.74 127.58 8.01 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 124.612 3.541 . . . . 100.0 112.81 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.0 tp -133.17 126.83 32.5 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.987 -1.116 . . . . 100.0 107.987 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.6 t -114.99 135.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 O-C-N 121.604 -0.685 . . . . 100.0 110.268 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -124.3 143.86 50.32 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.051 0.941 . . . . 100.0 109.102 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -102.35 127.38 49.37 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.022 -1.473 . . . . 100.0 107.022 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.7 p -122.0 179.24 4.58 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.982 0.896 . . . . 100.0 109.249 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -58.16 -36.62 73.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.875 2.07 . . . . 100.0 109.617 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -91.54 8.07 38.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 113.864 1.061 . . . . 100.0 113.864 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.74 176.19 20.07 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 121.907 -0.496 . . . . 100.0 112.074 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.61 138.21 29.0 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 123.271 2.647 . . . . 100.0 113.554 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -131.09 142.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 124.11 0.881 . . . . 100.0 109.003 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -106.76 132.65 52.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.473 -0.785 . . . . 100.0 112.112 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.62 117.8 34.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.527 -2.768 . . . . 100.0 103.527 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.524 HD22 ' HE1' ' A' ' 64' ' ' TRP . 55.5 t30 -94.8 100.76 12.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 100.508 -3.886 . . . . 100.0 100.508 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.74 126.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 CA-C-N 115.387 -0.824 . . . . 100.0 110.171 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.524 ' HE1' HD22 ' A' ' 62' ' ' ASN . 21.1 m95 -104.64 99.53 9.2 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.162 -2.162 . . . . 100.0 105.162 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.23 116.79 24.63 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.32 164.06 11.97 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.321 0.86 . . . . 100.0 113.321 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.04 131.62 35.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.212 1.005 . . . . 100.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.23 -10.5 80.15 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 114.492 0.557 . . . . 100.0 114.492 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -70.24 -38.76 75.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.15 2.18 . . . . 100.0 112.314 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HB2' HH11 ' A' ' 76' ' ' ARG . 96.6 mt-10 -62.29 137.03 58.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 124.973 1.309 . . . . 100.0 113.536 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.494 -1.23 . . . . 100.0 109.525 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -67.38 131.74 46.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.752 -1.944 . . . . 100.0 105.752 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.29 -176.1 40.27 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 118.788 -1.672 . . . . 100.0 114.474 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.72 64.38 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 127.188 2.327 . . . . 100.0 113.835 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.65 -37.72 85.09 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.21 1.804 . . . . 100.0 109.573 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.432 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.6 mtp85 -89.36 10.34 22.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 126.413 1.885 . . . . 100.0 115.762 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.8 -39.09 90.49 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 115.844 1.794 . . . . 100.0 115.844 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.79 86.16 Favored Glycine 0 C--N 1.355 1.631 0 C-N-CA 124.171 0.891 . . . . 100.0 113.26 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -62.47 -43.0 99.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.721 1.208 . . . . 100.0 109.819 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.4 t80 -88.81 -18.99 26.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 114.905 1.446 . . . . 100.0 114.905 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.25 131.65 21.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 CA-C-N 119.316 0.962 . . . . 100.0 109.667 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.279 91.6 mt-30 60.23 27.32 16.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 127.249 2.22 . . . . 100.0 115.377 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.3 46.75 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 107.029 -1.471 . . . . 100.0 107.029 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -106.35 -24.75 12.17 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 116.342 -0.39 . . . . 100.0 110.908 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.441 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -158.11 165.0 36.08 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.767 0.827 . . . . 100.0 109.233 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -148.78 155.79 41.45 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 119.627 -0.829 . . . . 100.0 112.863 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.39 126.81 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.714 -2.328 . . . . 100.0 104.714 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.52 124.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 103.789 -2.671 . . . . 100.0 103.789 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.565 ' HB3' HD21 ' A' ' 122' ' ' ASN . 55.7 mtt -112.64 135.4 53.41 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 116.549 2.055 . . . . 100.0 116.549 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -132.49 161.27 34.16 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 113.035 -1.893 . . . . 100.0 109.696 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.74 123.67 48.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.002 -1.851 . . . . 100.0 106.002 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -63.72 -20.38 26.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 114.063 1.134 . . . . 100.0 114.063 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -90.18 -2.46 58.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 118.896 -0.573 . . . . 100.0 111.479 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.5 t -125.79 113.43 17.27 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 122.578 1.18 . . . . 100.0 111.678 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -65.22 -38.67 91.15 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 114.896 -1.047 . . . . 100.0 111.934 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.25 -41.89 91.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 124.836 1.254 . . . . 100.0 108.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.6 m -62.62 -41.54 99.07 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 122.769 0.428 . . . . 100.0 110.532 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.381 0.672 . . . . 100.0 110.841 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.45 -35.34 73.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 124.679 1.192 . . . . 100.0 111.578 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -76.03 -9.78 58.89 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 115.848 1.795 . . . . 100.0 115.848 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 78.6 t -59.24 -44.99 99.21 Favored Pre-proline 0 C--N 1.363 1.174 0 CA-C-O 116.03 -1.938 . . . . 100.0 112.115 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 30.2 Cg_endo -59.08 -31.64 95.93 Favored 'Trans proline' 0 C--N 1.376 2.022 0 CA-C-N 122.747 2.017 . . . . 100.0 113.058 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.65 -42.95 81.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.783 0.72 . . . . 100.0 109.818 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.471 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.1 m95 -63.91 -45.79 87.75 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 109.565 -0.532 . . . . 100.0 109.565 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -90.72 70.17 6.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.543 -1.28 . . . . 100.0 107.543 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -168.02 -55.2 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 100.329 -3.952 . . . . 100.0 100.329 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.61 -43.82 98.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.691 -1.596 . . . . 100.0 106.691 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.6 mp -63.02 -50.14 71.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 113.366 0.876 . . . . 100.0 113.366 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.267 33.3 m -67.25 -22.81 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.267 90.9 mtt180 -61.24 -39.89 92.0 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.705 -0.85 . . . . 100.0 108.705 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.01 -47.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 113.735 1.013 . . . . 100.0 113.735 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.295 63.5 m -105.04 -2.28 24.62 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 119.405 3.113 . . . . 100.0 119.405 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.285 41.3 mt-10 54.96 -119.31 1.43 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.94 1.089 . . . . 100.0 113.94 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.49 110.73 22.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 120.151 1.341 . . . . 100.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.8 152.05 51.2 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 104.754 -2.313 . . . . 100.0 104.754 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.43 126.67 18.95 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.337 2.025 . . . . 100.0 112.251 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' HD22 ' A' ' 144' ' ' LEU . 64.5 mt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.747 -1.205 . . . . 100.0 107.747 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.46 132.15 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.416 -1.265 . . . . 100.0 108.417 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.36 124.75 44.74 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.387 -2.079 . . . . 100.0 105.387 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -116.74 124.73 50.36 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 122.259 1.028 . . . . 100.0 111.577 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.09 102.73 2.84 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 104.911 -3.276 . . . . 100.0 104.911 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.565 HD21 ' HB3' ' A' ' 89' ' ' MET . 72.7 m-80 -81.17 163.15 23.28 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 124.954 1.302 . . . . 100.0 111.865 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.71 38.51 24.94 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 128.386 2.674 . . . . 100.0 114.826 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.57 -14.7 18.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 113.787 1.032 . . . . 100.0 113.787 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.38 -37.1 86.31 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.755 1.222 . . . . 100.0 109.597 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.27 131.32 29.94 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-O 122.127 0.965 . . . . 100.0 109.82 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.68 -45.5 92.51 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -85.36 77.08 10.03 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.599 0.714 . . . . 100.0 110.29 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.94 138.79 38.24 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.615 -1.254 . . . . 100.0 107.615 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.67 -43.62 6.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.489 -0.56 . . . . 100.0 109.489 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.13 107.8 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.225 -2.139 . . . . 100.0 105.225 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -77.78 148.54 34.74 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.088 -1.415 . . . . 100.0 109.158 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.77 88.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.169 0.988 . . . . 100.0 110.161 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.11 -41.1 97.89 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.111 1.364 . . . . 100.0 111.066 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.9 m -62.43 -37.8 87.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.717 1.607 . . . . 100.0 113.465 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.19 120.09 11.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-O 122.382 1.087 . . . . 100.0 110.099 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.44 -7.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 125.626 1.571 . . . . 100.0 112.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 73.3 t80 -58.85 -41.36 86.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.124 1.37 . . . . 100.0 111.161 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -61.28 -38.66 87.56 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 123.795 0.838 . . . . 100.0 111.716 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.92 -46.1 89.4 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.528 0.731 . . . . 100.0 111.367 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.57 -40.97 89.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.039 0.936 . . . . 100.0 112.838 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 72.9 mmtt -92.83 2.23 56.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 116.808 2.151 . . . . 100.0 116.808 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 54.96 47.83 21.28 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-O 123.13 1.443 . . . . 100.0 113.672 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.626 HD22 ' HB ' ' A' ' 117' ' ' ILE . 44.9 mt -110.55 159.85 17.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.91 -1.495 . . . . 100.0 107.481 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.442 ' HG3' ' CD1' ' A' ' 163' ' ' TRP . 92.3 mm-40 -97.14 141.9 29.71 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.421 -1.326 . . . . 100.0 107.421 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -118.0 132.78 56.35 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 120.977 0.417 . . . . 100.0 111.701 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.23 135.13 42.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.594 -0.73 . . . . 100.0 112.448 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -86.66 123.42 31.82 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.517 -3.512 . . . . 100.0 101.517 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.5 pt -135.07 157.14 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 122.384 1.088 . . . . 100.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.3 t -141.19 114.01 8.39 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.853 -1.906 . . . . 100.0 105.853 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.775 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -64.0 -39.36 93.94 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.809 0.844 . . . . 100.0 108.776 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.97 -46.8 85.99 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.682 1.993 . . . . 100.0 114.261 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.8 p -103.86 -0.46 29.11 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 114.962 1.467 . . . . 100.0 114.962 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 65.72 21.33 11.57 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.145 1.778 . . . . 100.0 114.048 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -70.58 120.29 16.0 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.142 -1.429 . . . . 100.0 107.142 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 54.02 33.64 18.0 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.175 2.19 . . . . 100.0 111.867 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -60.29 -38.68 84.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.678 1.362 . . . . 100.0 114.678 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -88.49 -10.74 47.97 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 115.786 1.773 . . . . 100.0 115.786 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.267 95.5 mttt -59.87 -45.57 98.26 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 118.768 2.877 . . . . 100.0 118.768 -176.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -58.98 -41.99 56.29 Favored 'Trans proline' 0 C--N 1.372 1.79 0 CA-C-N 122.626 1.973 . . . . 100.0 113.696 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.9 -43.04 94.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 124.083 0.865 . . . . 100.0 112.013 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.85 -43.1 94.13 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 112.96 0.726 . . . . 100.0 112.96 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.516 ' HE1' ' HE3' ' A' ' 167' ' ' LYS . 60.6 t-105 -63.21 -44.67 94.65 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 123.597 0.561 . . . . 100.0 110.408 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 85' ' ' CYS . 84.7 mt -61.16 -41.38 96.66 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 123.483 0.49 . . . . 100.0 110.806 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.85 99.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 123.705 0.802 . . . . 100.0 110.611 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 174' ' ' LEU . 93.8 mtt180 -61.7 -47.07 86.95 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 118.654 -0.689 . . . . 100.0 111.402 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.516 ' HE3' ' HE1' ' A' ' 163' ' ' TRP 0.26 92.9 mttt -66.95 -42.79 84.66 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 114.911 1.449 . . . . 100.0 114.911 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.43 -46.88 78.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.247 0.832 . . . . 100.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.5 -38.28 73.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.018 0.927 . . . . 100.0 109.963 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.52 10.23 55.81 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-O 118.436 -1.202 . . . . 100.0 113.861 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.529 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 52.2 t0 -111.58 112.51 53.95 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 106.018 -1.845 . . . . 100.0 106.018 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.07 -15.73 43.65 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.648 2.898 . . . . 100.0 112.67 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -92.78 2.77 56.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.941 1.296 . . . . 100.0 113.816 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 69.5 mt -59.19 133.21 55.89 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 119.576 1.08 . . . . 100.0 113.339 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 N--CA 1.432 -1.37 0 CA-C-N 114.156 -1.384 . . . . 100.0 109.009 -178.351 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 N--CA 1.432 -1.355 0 N-CA-C 104.162 -2.532 . . . . 100.0 104.162 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -63.63 132.0 95.05 Favored Pre-proline 0 N--CA 1.439 -0.997 0 C-N-CA 122.754 0.422 . . . . 100.0 111.887 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 183' ' ' ALA . 45.5 Cg_exo -65.64 147.16 85.91 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.819 3.013 . . . . 100.0 112.78 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 32.2 Cg_exo -63.93 147.6 91.93 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 123.505 2.803 . . . . 100.0 111.012 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -63.26 -43.55 97.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 123.816 0.846 . . . . 100.0 112.584 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.8 t 68.99 99.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 127.112 2.165 . . . . 100.0 111.81 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.48 -71.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 103.08 -2.933 . . . . 100.0 103.08 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.256 77.1 mtp 9.34 -128.72 0.0 OUTLIER 'General case' 0 C--N 1.367 1.348 0 C-N-CA 131.396 3.879 . . . . 100.0 119.374 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.326 85.6 m-20 . . . . . 0 C--N 1.377 1.799 0 C-N-CA 131.383 3.873 . . . . 100.0 115.71 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.439 -1.012 0 CA-C-O 118.813 -0.613 . . . . 100.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -65.9 -42.41 90.23 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.833 0.853 . . . . 100.0 112.255 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.0 mt -60.88 -41.63 96.38 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.751 0.82 . . . . 100.0 111.553 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.97 -43.39 98.93 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.348 1.059 . . . . 100.0 111.347 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.14 -45.51 98.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 108.193 -1.04 . . . . 100.0 108.193 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.69 95.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 113.928 1.084 . . . . 100.0 113.928 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -61.76 -44.36 97.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.738 1.215 . . . . 100.0 111.96 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.409 HG21 ' HE3' ' A' ' 38' ' ' LYS . 97.4 m -64.72 -43.64 92.75 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.459 1.504 . . . . 100.0 110.427 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.7 m . . . . . 0 N--CA 1.43 -1.445 0 CA-C-O 124.316 2.008 . . . . 100.0 115.079 -177.951 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 m . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 118.533 2.79 . . . . 100.0 118.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -126.01 134.61 51.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.698 -2.046 . . . . 100.0 107.639 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.29 130.62 53.33 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.476 -0.935 . . . . 100.0 108.476 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.18 114.04 26.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.203 -1.777 . . . . 100.0 106.203 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 86' ' ' ALA . 39.5 tp -113.21 129.2 56.59 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 114.374 -1.284 . . . . 100.0 109.612 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -112.25 125.73 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 118.563 -1.255 . . . . 100.0 109.363 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 HG13 ' A' ' 63' ' ' VAL . 9.0 mp -101.81 121.33 41.89 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 108.074 -1.084 . . . . 100.0 108.074 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.76 160.38 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 113.613 -1.631 . . . . 100.0 110.814 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.08 172.35 20.65 Favored Glycine 0 CA--C 1.493 -1.311 0 N-CA-C 109.893 -1.283 . . . . 100.0 109.893 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HB2' HG23 ' A' ' 97' ' ' THR . 85.3 m-20 -71.58 159.86 33.71 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.115 0.96 . . . . 100.0 113.189 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.07 139.8 40.92 Favored Glycine 0 C--N 1.353 1.495 0 N-CA-C 109.94 -1.264 . . . . 100.0 109.94 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.09 2.16 89.48 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 118.864 -0.964 . . . . 100.0 114.892 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.1 p -63.32 -39.32 94.25 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 114.31 1.226 . . . . 100.0 114.31 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.03 16.51 6.73 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 118.666 -1.074 . . . . 100.0 112.003 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HG2' ' SD ' ' A' ' 89' ' ' MET . 10.2 mtmp? -60.0 -46.47 89.38 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 119.045 1.422 . . . . 100.0 111.664 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.0 m -64.13 -44.59 91.74 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.83 1.252 . . . . 100.0 110.967 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -63.47 -40.62 97.6 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.037 0.935 . . . . 100.0 109.954 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.36 -48.04 83.1 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.277 1.031 . . . . 100.0 111.227 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.54 -42.02 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 123.123 0.265 . . . . 100.0 111.026 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.69 -40.35 94.68 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.547 0.739 . . . . 100.0 111.188 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.627 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.8 tmm_? -61.62 -43.46 98.82 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 123.606 0.762 . . . . 100.0 110.192 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -63.04 -42.17 99.69 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.352 0.501 . . . . 100.0 112.352 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -70.1 -43.96 70.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.912 1.819 . . . . 100.0 115.912 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.1 p -120.14 -24.88 5.87 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.891 2.552 . . . . 100.0 117.891 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.93 68.19 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.816 -0.914 . . . . 100.0 110.816 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -76.9 152.36 35.41 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.137 0.975 . . . . 100.0 109.198 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.31 117.67 31.75 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 102.074 -3.306 . . . . 100.0 102.074 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -92.61 117.92 30.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.4 -0.963 . . . . 100.0 108.4 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.08 -11.97 29.5 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.633 -1.167 . . . . 100.0 112.976 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.31 123.74 47.36 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.591 -0.892 . . . . 100.0 108.591 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.79 115.45 27.44 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.261 1.029 . . . . 100.0 111.117 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -121.25 123.96 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 101.216 -3.624 . . . . 100.0 101.216 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.2 139.29 58.49 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 113.942 1.09 . . . . 100.0 113.942 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.0 m -84.76 130.01 34.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.25 127.32 51.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 106.857 -1.534 . . . . 100.0 106.857 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.57 -120.61 15.26 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.808 -1.317 . . . . 100.0 109.808 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.99 144.82 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 120.931 0.396 . . . . 100.0 110.415 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -119.91 124.0 44.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 103.172 -2.899 . . . . 100.0 103.172 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.1 t -101.31 120.82 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.26 -1.385 . . . . 100.0 107.26 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -127.11 123.02 23.31 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.85 -0.614 . . . . 100.0 111.772 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -80.81 129.81 7.31 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 124.165 3.243 . . . . 100.0 111.204 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -132.23 128.84 38.75 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.169 -1.048 . . . . 100.0 108.169 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.82 134.85 54.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 108.462 -0.94 . . . . 100.0 108.462 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 52' ' ' PHE . 6.6 m-30 -124.8 140.86 52.54 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.675 1.59 . . . . 100.0 109.073 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -105.33 124.01 48.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.326 1.06 . . . . 100.0 108.884 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.5 p -119.58 -179.99 4.05 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.354 -1.294 . . . . 100.0 111.432 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.08 -36.36 74.96 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 127.281 2.233 . . . . 100.0 109.512 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.01 7.38 40.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.384 0.883 . . . . 100.0 113.384 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.03 179.6 20.78 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 118.853 0.751 . . . . 100.0 111.948 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.19 140.0 36.51 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.14 2.56 . . . . 100.0 113.225 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 pt -130.27 140.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.811 -1.552 . . . . 100.0 106.811 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -113.72 132.77 55.69 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.994 -1.082 . . . . 100.0 110.884 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.51 118.88 37.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.288 -2.116 . . . . 100.0 105.288 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.72 97.7 10.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 100.74 -3.8 . . . . 100.0 100.74 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG13 HD13 ' A' ' 15' ' ' LEU . 46.3 t -86.65 126.82 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 121.297 0.57 . . . . 100.0 110.968 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -108.1 99.38 8.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.188 -1.782 . . . . 100.0 106.188 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -89.13 117.52 28.18 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.004 -2.221 . . . . 100.0 105.004 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -97.67 164.87 12.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.805 1.039 . . . . 100.0 113.805 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.1 131.85 34.75 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.154 0.982 . . . . 100.0 109.304 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.09 -10.45 84.87 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.352 0.501 . . . . 100.0 114.352 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.97 -39.77 75.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.393 1.877 . . . . 100.0 112.485 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -62.92 134.82 56.8 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.035 0.934 . . . . 100.0 113.365 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.49 154.65 40.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.975 -1.012 . . . . 100.0 110.263 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -66.76 132.26 47.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.707 1.603 . . . . 100.0 106.949 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.41 -176.8 38.74 Favored Glycine 0 C--N 1.356 1.642 0 C-N-CA 119.212 -1.47 . . . . 100.0 114.621 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.52 -23.64 65.08 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 127.057 2.265 . . . . 100.0 113.744 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -62.43 -31.86 72.62 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.488 1.115 . . . . 100.0 111.527 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.4 mtp-105 -92.33 10.21 30.75 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.631 1.572 . . . . 100.0 114.409 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.69 -38.02 86.28 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 116.082 1.882 . . . . 100.0 116.082 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.68 -38.68 92.24 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.77 0.7 . . . . 100.0 113.457 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -63.26 -42.72 99.17 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.157 0.983 . . . . 100.0 110.217 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.483 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 3.0 t80 -91.35 -18.59 24.04 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 114.726 1.38 . . . . 100.0 114.726 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.6 pt -61.18 136.42 24.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 CA-C-N 119.787 1.176 . . . . 100.0 111.19 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 63.66 21.93 12.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.719 2.008 . . . . 100.0 113.824 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.87 145.56 46.81 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 107.368 -1.345 . . . . 100.0 107.368 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -103.76 -24.02 13.37 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.883 -0.599 . . . . 100.0 110.71 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.489 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.6 p -159.38 165.51 33.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 123.536 0.735 . . . . 100.0 110.391 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -148.71 156.31 42.2 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 113.309 0.855 . . . . 100.0 113.309 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.416 HG13 HD11 ' A' ' 13' ' ' LEU . 96.2 mt -126.5 126.45 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 104.752 -2.314 . . . . 100.0 104.752 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 65.2 mt -108.21 124.22 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 102.343 -3.206 . . . . 100.0 102.343 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.585 ' HB3' HD21 ' A' ' 122' ' ' ASN . 94.8 mtp -114.41 132.31 56.28 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.805 -1.089 . . . . 100.0 113.22 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -132.84 161.44 34.15 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.87 -1.513 . . . . 100.0 109.374 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -104.26 125.47 50.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.847 -1.538 . . . . 100.0 106.847 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.9 -19.42 24.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.952 1.093 . . . . 100.0 113.952 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -89.25 -4.87 58.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 119.262 -0.399 . . . . 100.0 111.474 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -125.56 115.23 19.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.737 1.256 . . . . 100.0 112.035 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.15 -39.49 93.07 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 114.491 -1.231 . . . . 100.0 110.984 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.08 -41.6 89.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 C-N-CA 125.073 1.349 . . . . 100.0 109.22 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 18' ' ' ASP . 94.5 m -62.87 -41.78 99.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.161 0.584 . . . . 100.0 109.807 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -65.27 -39.79 93.06 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.246 0.618 . . . . 100.0 111.038 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -59.34 -36.72 76.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.738 1.215 . . . . 100.0 111.057 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.41 -10.88 60.01 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.552 1.686 . . . . 100.0 115.552 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -59.43 -44.02 97.22 Favored Pre-proline 0 C--N 1.361 1.072 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.777 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 85.9 Cg_exo -57.4 -35.29 98.87 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.759 2.306 . . . . 100.0 112.466 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.73 -43.08 85.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.884 0.874 . . . . 100.0 110.356 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.444 ' O ' HD13 ' A' ' 108' ' ' LEU . 87.4 m95 -63.79 -45.39 89.9 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 51.0 t-80 -90.68 69.62 6.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.639 -1.245 . . . . 100.0 107.639 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -169.4 -53.09 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 100.592 -3.855 . . . . 100.0 100.592 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.81 -43.89 97.59 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.579 -1.638 . . . . 100.0 106.579 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.483 ' HG ' ' CZ ' ' A' ' 80' ' ' TYR . 6.6 mp -62.81 -48.64 78.25 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.303 1.041 . . . . 100.0 113.139 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.22 -34.26 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 C-N-CA 127.358 2.263 . . . . 100.0 110.696 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.25 -40.17 81.07 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 118.657 -0.687 . . . . 100.0 111.253 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.262 11.8 m -97.33 -34.95 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 116.009 1.855 . . . . 100.0 116.009 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.294 70.6 m -105.13 -3.19 23.34 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 118.23 2.678 . . . . 100.0 118.23 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 54.38 -121.8 1.86 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.309 1.444 . . . . 100.0 113.462 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -94.48 109.2 21.1 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.335 1.064 . . . . 100.0 113.617 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.28 149.92 50.03 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 104.434 -2.432 . . . . 100.0 104.434 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.64 128.6 25.06 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.15 1.9 . . . . 100.0 113.138 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.563 ' HB ' HD22 ' A' ' 144' ' ' LEU . 70.7 mt -132.42 135.4 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.439 -1.319 . . . . 100.0 107.439 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.45 132.07 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.168 -1.378 . . . . 100.0 108.738 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.0 mt -98.15 125.64 43.26 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.686 -1.968 . . . . 100.0 105.686 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -118.05 125.22 49.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.017 0.913 . . . . 100.0 112.53 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.97 102.24 2.72 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 105.277 -3.129 . . . . 100.0 105.277 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.585 HD21 ' HB3' ' A' ' 89' ' ' MET . 70.1 m-80 -81.5 162.92 23.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.517 1.527 . . . . 100.0 112.865 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 57.86 42.3 23.41 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.65 2.38 . . . . 100.0 115.122 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 148' ' ' ASP . 34.1 m -65.02 -16.24 19.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 CA-C-N 115.902 -0.59 . . . . 100.0 112.348 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -62.29 -37.91 87.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 124.216 1.006 . . . . 100.0 112.41 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.24 132.38 27.93 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 CA-C-O 121.844 0.83 . . . . 100.0 109.82 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.93 -45.5 92.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 116.76 2.133 . . . . 100.0 116.76 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -86.07 77.47 9.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.305 0.574 . . . . 100.0 110.706 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -81.43 132.75 35.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.849 -0.797 . . . . 100.0 108.849 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -99.06 -41.95 7.31 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 115.976 -0.556 . . . . 100.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.21 106.23 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.42 155.52 25.85 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.129 -0.942 . . . . 100.0 109.253 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.02 83.19 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.527 1.131 . . . . 100.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.56 -40.91 96.41 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.216 1.006 . . . . 100.0 111.755 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.6 m -61.51 -38.54 87.72 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 125.615 1.566 . . . . 100.0 113.22 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.56 121.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 122.074 0.94 . . . . 100.0 110.319 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.34 -9.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.093 -1.412 . . . . 100.0 112.009 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 71.4 t80 -58.57 -39.51 80.5 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.305 1.442 . . . . 100.0 111.746 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -60.89 -39.87 90.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 123.931 0.892 . . . . 100.0 111.695 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.19 -44.29 92.46 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.304 0.642 . . . . 100.0 112.147 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.08 -42.28 94.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.464 1.106 . . . . 100.0 111.53 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 72.9 mmtt -94.62 3.1 55.51 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 118.109 2.633 . . . . 100.0 118.109 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 55.08 47.18 22.53 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 123.137 1.446 . . . . 100.0 113.59 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.563 HD22 ' HB ' ' A' ' 117' ' ' ILE . 50.3 mt -110.63 160.02 17.05 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 113.9 -1.5 . . . . 100.0 107.369 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -101.98 140.76 35.84 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.25 -1.389 . . . . 100.0 107.25 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -115.2 134.81 54.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.204 0.526 . . . . 100.0 112.184 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.99 136.18 41.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.624 -0.716 . . . . 100.0 112.529 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.511 ' HB3' HG11 ' A' ' 124' ' ' VAL . 22.4 m-20 -87.55 123.77 32.79 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 101.724 -3.436 . . . . 100.0 101.724 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.4 pt -134.43 157.53 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.309 1.052 . . . . 100.0 111.914 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.4 t -141.9 115.87 9.3 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 105.942 -1.873 . . . . 100.0 105.942 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.06 -38.94 93.17 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.964 0.905 . . . . 100.0 108.908 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.41 -43.84 93.13 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.832 1.653 . . . . 100.0 115.126 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -102.52 -4.16 25.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.604 1.335 . . . . 100.0 114.604 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 68.94 17.02 8.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.851 1.66 . . . . 100.0 113.25 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -66.97 119.64 12.29 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 107.59 -1.263 . . . . 100.0 107.59 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 54.48 30.85 13.64 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 127.048 2.139 . . . . 100.0 112.083 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -60.64 -38.23 84.11 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.372 1.249 . . . . 100.0 114.372 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -86.42 -13.86 45.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.598 1.703 . . . . 100.0 115.598 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.27 62.8 mttp -59.93 -45.68 98.16 Favored Pre-proline 0 C--N 1.358 0.952 0 N-CA-C 118.759 2.874 . . . . 100.0 118.759 -175.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.35 -41.28 60.05 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 122.455 1.912 . . . . 100.0 113.573 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.83 -44.15 94.06 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.962 0.905 . . . . 100.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.06 -42.5 94.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.856 0.687 . . . . 100.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -62.07 -45.53 93.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 123.374 0.422 . . . . 100.0 110.41 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.489 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.1 mt -61.23 -41.7 97.33 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 123.803 0.689 . . . . 100.0 110.854 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 123.56 0.744 . . . . 100.0 110.556 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.05 -45.87 91.64 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 118.568 -0.729 . . . . 100.0 112.233 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -68.99 -42.69 76.18 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 119.981 -0.688 . . . . 100.0 112.582 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.48 -46.33 80.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 113.666 0.987 . . . . 100.0 113.666 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.02 -38.23 74.64 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.536 1.135 . . . . 100.0 109.56 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.39 9.93 54.59 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 118.371 -1.239 . . . . 100.0 114.6 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.499 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 57.8 t0 -113.61 112.48 48.4 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 106.969 -1.493 . . . . 100.0 106.969 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.31 -15.36 45.62 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.831 3.02 . . . . 100.0 113.025 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -93.04 1.43 57.26 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 114.411 1.263 . . . . 100.0 114.411 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 92.9 mt -60.97 133.88 56.54 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 119.452 1.024 . . . . 100.0 113.647 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 . . . . . 0 N--CA 1.432 -1.372 0 CA-C-N 114.683 -1.144 . . . . 100.0 109.802 179.676 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 CA--C 1.5 -0.946 0 CA-C-O 122.36 1.076 . . . . 100.0 112.354 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -104.09 146.95 33.54 Favored Pre-proline 0 N--CA 1.425 -1.687 0 CA-C-N 114.014 -1.448 . . . . 100.0 112.59 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 183' ' ' ALA . 31.8 Cg_exo -65.8 157.88 56.63 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 124.382 3.388 . . . . 100.0 110.045 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -60.55 148.36 91.37 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 123.188 2.592 . . . . 100.0 113.561 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.62 138.24 58.29 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.723 1.264 . . . . 100.0 110.683 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.0 135.87 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 106.607 -1.627 . . . . 100.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.38 -76.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 107.973 -1.121 . . . . 100.0 107.973 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.7 ptm -80.8 -176.01 5.62 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 116.91 -1.519 . . . . 100.0 111.463 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--N 1.361 1.103 0 O-C-N 118.342 -2.723 . . . . 100.0 118.146 -179.124 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 . . . . . 0 N--CA 1.439 -1.016 0 CA-C-O 119.16 -0.448 . . . . 100.0 110.515 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -64.06 -43.35 95.73 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.642 1.177 . . . . 100.0 111.484 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.53 -43.55 98.66 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 123.432 0.693 . . . . 100.0 111.678 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.5 -44.94 92.89 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 123.79 0.836 . . . . 100.0 112.334 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.25 35.7 m -62.89 -39.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.196 0 CA-C-O 118.657 -0.687 . . . . 100.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.2 -44.25 88.99 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.089 0.955 . . . . 100.0 112.928 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -62.89 -41.6 99.48 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.709 1.204 . . . . 100.0 111.863 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 86.7 m -66.31 -42.27 88.5 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.795 1.638 . . . . 100.0 111.934 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 96.1 m . . . . . 0 C--N 1.359 0.998 0 CA-C-O 121.97 0.891 . . . . 100.0 111.184 -178.318 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.435 -1.194 0 N-CA-C 115.568 1.692 . . . . 100.0 115.568 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -125.43 133.93 52.29 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -121.95 130.72 53.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.88 116.07 28.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.96 -1.496 . . . . 100.0 106.96 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD11 HG13 ' A' ' 87' ' ' ILE . 57.2 tp -110.31 127.07 54.84 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 113.964 -1.471 . . . . 100.0 107.999 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.83 124.86 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 N-CA-C 107.024 -1.472 . . . . 100.0 107.024 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.9 tp -105.73 116.9 32.73 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 106.734 -1.58 . . . . 100.0 106.734 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.58 162.09 36.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 114.481 -1.236 . . . . 100.0 112.414 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.46 170.87 18.16 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 109.605 -1.398 . . . . 100.0 109.605 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.496 ' HB2' HG23 ' A' ' 97' ' ' THR . 84.0 m-20 -70.52 160.7 31.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.479 0.918 . . . . 100.0 113.479 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.63 140.19 40.34 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 110.865 -0.894 . . . . 100.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 2.76 90.44 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.646 -1.085 . . . . 100.0 114.303 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.0 p -63.55 -39.17 93.7 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 118.522 1.161 . . . . 100.0 114.131 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 16.8 6.28 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.711 -0.757 . . . . 100.0 111.926 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.91 -47.9 83.9 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 118.58 1.19 . . . . 100.0 111.461 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.4 m -64.67 -43.35 93.87 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.986 1.314 . . . . 100.0 111.034 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.9 m -63.47 -40.62 97.59 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.163 0.985 . . . . 100.0 109.5 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -61.14 -48.29 82.31 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 124.677 1.191 . . . . 100.0 110.319 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.76 -41.89 93.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.919 0 O-C-N 123.277 0.36 . . . . 100.0 111.699 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.02 -42.34 98.28 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.624 0.769 . . . . 100.0 110.718 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.584 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.2 tmm_? -62.28 -42.91 99.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.305 0.642 . . . . 100.0 110.706 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -63.96 -41.83 97.46 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 113.191 0.811 . . . . 100.0 113.191 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.28 -44.45 68.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 115.232 1.567 . . . . 100.0 115.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -120.02 -23.67 6.28 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 118.317 2.71 . . . . 100.0 118.317 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.65 -7.67 71.05 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.311 -0.716 . . . . 100.0 111.311 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.04 154.38 37.99 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.85 1.26 . . . . 100.0 109.456 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 91.3 m-85 -115.61 120.52 39.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.322 -2.844 . . . . 100.0 103.322 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -94.73 115.95 28.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.51 0.724 . . . . 100.0 109.16 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -91.39 -31.81 15.89 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.989 -0.284 . . . . 100.0 111.603 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.13 129.83 34.88 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.375 0.607 . . . . 100.0 111.379 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.97 116.51 29.32 Favored 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.116 0.96 . . . . 100.0 112.265 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.61 121.95 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 101.048 -3.686 . . . . 100.0 101.048 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.09 142.25 57.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.708 0.803 . . . . 100.0 113.077 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.6 m -92.61 127.83 38.25 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.99 126.26 50.98 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.387 -1.338 . . . . 100.0 107.387 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.48 -121.69 15.83 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.949 -1.261 . . . . 100.0 109.949 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.3 142.6 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.138 0.495 . . . . 100.0 110.602 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.91 122.89 43.33 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.721 -3.066 . . . . 100.0 102.721 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.39 116.68 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.168 -1.419 . . . . 100.0 107.168 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -124.4 121.69 25.97 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 112.403 0.52 . . . . 100.0 112.403 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 60' ' ' LYS . 90.1 Cg_endo -80.05 129.4 7.87 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 124.067 3.178 . . . . 100.0 112.602 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 tp -132.75 126.59 32.79 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.126 -1.435 . . . . 100.0 107.126 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.18 135.36 49.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.351 -0.611 . . . . 100.0 109.351 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.13 137.51 54.12 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 125.138 1.375 . . . . 100.0 107.407 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -103.52 125.24 49.96 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.708 -2.33 . . . . 100.0 104.708 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.2 p -124.71 176.97 6.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.751 0.786 . . . . 100.0 110.421 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -60.41 -27.0 67.12 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.295 1.438 . . . . 100.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -94.4 7.11 46.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 126.785 2.034 . . . . 100.0 112.974 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.0 175.85 25.58 Favored Glycine 0 C--N 1.357 1.7 0 N-CA-C 111.133 -0.787 . . . . 100.0 111.133 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.36 138.88 33.76 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.423 2.748 . . . . 100.0 113.444 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -132.04 142.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 106.974 -1.491 . . . . 100.0 106.974 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.429 ' HD2' ' HB2' ' A' ' 49' ' ' PRO . 33.9 ttpt -116.97 131.32 56.98 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 118.074 -1.45 . . . . 100.0 111.403 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.87 119.17 38.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 105.325 -2.102 . . . . 100.0 105.325 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' ND2' ' HE1' ' A' ' 64' ' ' TRP . 46.5 t30 -94.37 100.8 12.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 100.344 -3.947 . . . . 100.0 100.344 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.4 t -87.9 125.77 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-N 115.309 -0.86 . . . . 100.0 109.251 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.488 ' HE1' ' ND2' ' A' ' 62' ' ' ASN . 19.7 m0 -107.34 103.88 13.35 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.05 116.88 23.69 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.584 -2.376 . . . . 100.0 104.584 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 p -103.5 163.05 12.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 113.393 0.886 . . . . 100.0 113.393 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.28 36.14 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 123.78 0.832 . . . . 100.0 110.778 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.52 -8.07 77.98 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 113.834 0.294 . . . . 100.0 113.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -70.41 -39.56 74.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.73 2.012 . . . . 100.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.481 ' HB2' HH11 ' A' ' 76' ' ' ARG . 95.1 mt-10 -62.96 137.75 58.36 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 125.035 1.334 . . . . 100.0 112.459 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.41 151.65 44.94 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.468 -1.242 . . . . 100.0 111.011 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -65.55 131.17 45.71 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.607 1.963 . . . . 100.0 107.547 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.12 -173.81 36.01 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 118.895 -1.622 . . . . 100.0 115.632 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -20.15 62.64 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 127.699 2.571 . . . . 100.0 113.383 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.16 -38.14 82.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.039 2.135 . . . . 100.0 109.104 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.481 HH11 ' HB2' ' A' ' 70' ' ' GLU . 78.2 mtp85 -92.18 12.85 20.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.653 1.981 . . . . 100.0 115.599 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.11 -39.18 91.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.417 1.636 . . . . 100.0 115.417 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.5 90.83 Favored Glycine 0 C--N 1.357 1.695 0 C-N-CA 123.956 0.788 . . . . 100.0 113.731 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -62.13 -43.3 99.14 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.514 1.126 . . . . 100.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.596 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.5 t80 -87.02 -22.69 25.34 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.204 1.557 . . . . 100.0 115.204 -174.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.5 mt -57.21 133.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 0 CA-C-N 119.342 0.973 . . . . 100.0 109.732 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 63.45 23.18 13.58 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.141 2.176 . . . . 100.0 114.858 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 147.53 45.35 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.139 -1.06 . . . . 100.0 108.139 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -108.2 -22.13 12.49 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 116.419 -0.355 . . . . 100.0 111.261 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.411 ' HB2' HD22 ' A' ' 164' ' ' LEU . 16.4 p -156.63 164.41 38.21 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.752 -0.462 . . . . 100.0 109.752 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -148.53 155.65 41.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.308 0.855 . . . . 100.0 113.308 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.403 HG13 HD11 ' A' ' 13' ' ' LEU . 96.5 mt -127.74 126.88 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 104.319 -2.474 . . . . 100.0 104.319 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 68.1 mt -109.96 122.44 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 103.243 -2.873 . . . . 100.0 103.243 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 46.8 mtt -112.05 134.75 53.41 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 115.977 1.843 . . . . 100.0 115.977 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -131.49 159.83 36.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.556 -1.656 . . . . 100.0 109.181 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -103.98 124.66 49.41 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.847 -1.909 . . . . 100.0 105.847 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.46 -20.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 N-CA-C 113.79 1.033 . . . . 100.0 113.79 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.3 p -91.35 -2.93 57.22 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 119.146 -0.454 . . . . 100.0 112.014 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -122.67 115.04 21.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 122.92 1.343 . . . . 100.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -64.27 -41.96 96.67 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.095 -1.411 . . . . 100.0 110.689 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.15 -42.31 92.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 125.244 1.417 . . . . 100.0 109.35 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 18' ' ' ASP . 98.2 m -62.96 -41.43 99.52 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.475 0.31 . . . . 100.0 110.981 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -65.15 -41.06 95.1 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.636 0.775 . . . . 100.0 111.037 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 95.1 mttt -60.47 -35.18 75.26 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.106 1.362 . . . . 100.0 111.304 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -76.88 -9.28 58.58 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 115.827 1.788 . . . . 100.0 115.827 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.58 -43.26 95.36 Favored Pre-proline 0 C--N 1.361 1.103 0 CA-C-O 116.365 -1.779 . . . . 100.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 71.8 Cg_exo -57.37 -35.17 98.87 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.7 2.267 . . . . 100.0 112.685 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.7 -43.13 85.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 118.683 0.674 . . . . 100.0 110.826 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.495 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.7 m95 -63.61 -46.38 86.0 Favored 'General case' 0 C--N 1.366 1.296 0 N-CA-C 109.556 -0.535 . . . . 100.0 109.556 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -90.8 70.14 6.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.843 1.306 . . . . 100.0 107.768 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -165.07 -59.12 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 99.536 -4.246 . . . . 100.0 99.536 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -63.05 -39.72 95.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 123.877 0.736 . . . . 100.0 109.224 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.596 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -61.91 -50.31 72.68 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.757 0.661 . . . . 100.0 112.123 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.264 34.2 m -66.35 -27.86 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 113.046 0.758 . . . . 100.0 113.046 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -60.94 -39.14 88.36 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 118.247 0.476 . . . . 100.0 109.951 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.3 t -86.89 -47.98 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 113.909 1.077 . . . . 100.0 113.909 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.304 62.1 m -106.46 1.76 25.8 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 120.074 3.361 . . . . 100.0 120.074 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 55.56 -121.39 1.69 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.377 1.071 . . . . 100.0 113.241 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -97.43 112.58 24.36 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.911 1.232 . . . . 100.0 111.6 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 41.4 pt -144.62 149.5 43.85 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 104.49 -2.411 . . . . 100.0 104.49 176.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.27 129.26 27.73 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.28 1.987 . . . . 100.0 112.608 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.72 ' HB ' HD22 ' A' ' 144' ' ' LEU . 66.9 mt -133.12 135.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.275 -1.379 . . . . 100.0 107.275 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.08 131.67 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 114.303 -1.317 . . . . 100.0 108.389 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 139' ' ' HIS 0.261 86.0 mt -98.82 127.31 44.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.461 -2.051 . . . . 100.0 105.461 177.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.74 125.34 49.43 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.871 0.843 . . . . 100.0 111.686 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.68 101.1 2.57 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 104.026 -3.629 . . . . 100.0 104.026 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.83 162.02 24.19 Favored 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 124.966 1.306 . . . . 100.0 112.532 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 58.1 40.81 24.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 127.76 2.424 . . . . 100.0 115.324 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.39 -15.0 18.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 112.634 0.605 . . . . 100.0 112.634 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.43 -38.87 91.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.051 1.74 . . . . 100.0 110.35 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.45 131.58 29.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 124.024 0.93 . . . . 100.0 109.8 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.56 -42.88 91.35 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 116.593 2.072 . . . . 100.0 116.593 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.45 74.56 10.36 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-O 121.697 0.761 . . . . 100.0 110.121 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -83.73 137.42 33.76 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 115.669 -0.696 . . . . 100.0 110.557 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.66 -44.91 4.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.009 -0.541 . . . . 100.0 110.724 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.4 t -95.55 107.16 19.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 105.765 -1.939 . . . . 100.0 105.765 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -81.35 150.14 28.57 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.756 -1.111 . . . . 100.0 109.755 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.46 87.73 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.658 1.183 . . . . 100.0 111.988 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -62.4 -40.82 97.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.021 0.928 . . . . 100.0 111.267 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.3 m -62.15 -35.55 79.13 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.897 1.679 . . . . 100.0 113.511 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.37 121.36 13.24 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 CA-C-O 122.66 1.219 . . . . 100.0 109.774 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.604 HG12 HH21 ' A' ' 140' ' ' ARG . 29.2 m -128.49 -9.59 3.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-N 113.331 -1.759 . . . . 100.0 112.812 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.19 -41.85 84.82 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 125.233 1.413 . . . . 100.0 111.789 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.45 ' HB3' HD12 ' A' ' 119' ' ' LEU . 45.2 p-80 -61.47 -40.29 94.0 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.65 -0.691 . . . . 100.0 112.687 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.604 HH21 HG12 ' A' ' 137' ' ' VAL . 91.8 mtm-85 -64.41 -43.16 95.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.687 0.676 . . . . 100.0 112.301 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.47 -41.3 93.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.31 1.044 . . . . 100.0 111.638 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.2 7.2 47.08 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 117.488 2.403 . . . . 100.0 117.488 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.44 49.38 16.94 Favored 'General case' 0 C--N 1.362 1.144 0 CA-C-O 122.756 1.265 . . . . 100.0 112.813 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.72 HD22 ' HB ' ' A' ' 117' ' ' ILE . 43.7 mt -116.96 160.98 20.08 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.048 -1.093 . . . . 100.0 108.048 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.44 ' HG3' ' NE1' ' A' ' 163' ' ' TRP . 97.5 mm-40 -98.87 140.54 32.89 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -117.05 134.83 54.26 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.557 0.694 . . . . 100.0 112.41 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -134.15 136.87 44.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.328 -0.851 . . . . 100.0 111.999 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -88.29 125.45 34.67 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 101.165 -3.643 . . . . 100.0 101.165 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.93 157.29 38.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 CA-C-O 122.138 0.971 . . . . 100.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.3 t -141.86 116.43 9.67 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 105.285 -2.117 . . . . 100.0 105.285 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.43 -40.8 98.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.651 0.78 . . . . 100.0 109.651 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.32 -42.29 75.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.151 1.537 . . . . 100.0 115.151 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 m -93.16 -7.74 44.48 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 114.291 1.219 . . . . 100.0 114.291 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.471 HD21 ' HZ ' ' A' ' 35' ' ' PHE . 87.4 m-20 66.56 18.63 10.81 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.147 1.779 . . . . 100.0 112.81 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -69.66 118.92 13.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.45 -1.315 . . . . 100.0 107.45 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.52 33.16 15.57 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 127.383 2.273 . . . . 100.0 111.701 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.47 -39.31 90.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.324 1.601 . . . . 100.0 115.324 -175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -89.47 -8.12 53.58 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 115.616 1.71 . . . . 100.0 115.616 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 95.8 mttt -61.03 -44.27 93.85 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 118.189 2.663 . . . . 100.0 118.189 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.11 -41.3 61.94 Favored 'Trans proline' 0 C--N 1.374 1.894 0 CA-C-N 122.459 1.914 . . . . 100.0 112.994 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -64.5 -43.97 92.44 Favored 'General case' 0 CA--C 1.495 -1.141 0 O-C-N 124.055 0.847 . . . . 100.0 112.062 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.0 -42.86 94.11 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 113.098 0.777 . . . . 100.0 113.098 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.44 ' NE1' ' HG3' ' A' ' 145' ' ' GLN . 62.9 t-105 -62.82 -45.89 90.5 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 123.453 0.471 . . . . 100.0 110.224 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 85' ' ' CYS . 79.1 mt -60.65 -42.83 97.78 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 123.653 0.595 . . . . 100.0 110.819 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.32 99.08 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 123.668 0.787 . . . . 100.0 111.107 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.05 -45.12 94.95 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.609 0.764 . . . . 100.0 112.024 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.64 -43.4 76.36 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 112.469 0.544 . . . . 100.0 112.469 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.17 -46.64 80.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.195 0.813 . . . . 100.0 113.195 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.85 -38.62 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 125.127 1.371 . . . . 100.0 110.455 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.96 11.82 57.25 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 118.678 -1.068 . . . . 100.0 112.818 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -109.62 109.25 59.85 Favored Pre-proline 0 C--N 1.361 1.075 0 N-CA-C 106.719 -1.586 . . . . 100.0 106.719 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.35 -22.23 66.32 Favored 'Trans proline' 0 C--N 1.365 1.396 0 C-N-CA 124.087 3.191 . . . . 100.0 113.462 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -100.17 12.0 38.02 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 114.079 1.14 . . . . 100.0 114.079 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.16 131.65 51.17 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.516 0.726 . . . . 100.0 109.946 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 . . . . . 0 C--N 1.357 0.906 0 CA-C-N 115.883 -0.599 . . . . 100.0 111.158 -178.203 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 108.273 -1.01 . . . . 100.0 108.273 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.12 118.26 71.13 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.677 -2.342 . . . . 100.0 104.677 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.43 143.09 62.05 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 123.687 2.925 . . . . 100.0 116.211 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.26 160.58 48.46 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 123.626 2.884 . . . . 100.0 108.889 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.95 -48.15 83.17 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 112.927 0.714 . . . . 100.0 112.927 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.254 39.0 t 60.47 96.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.871 2.068 . . . . 100.0 112.603 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.18 -91.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 102.191 -3.263 . . . . 100.0 102.191 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.8 mtm 50.19 -130.35 2.06 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 127.951 2.501 . . . . 100.0 115.145 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.338 63.2 m-20 . . . . . 0 C--N 1.365 1.277 1 N-CA-C 124.788 5.107 . . . . 100.0 124.788 -179.557 . . . . . . . . 2 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 110.006 -0.368 . . . . 100.0 110.006 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -64.69 -41.12 96.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.255 1.422 . . . . 100.0 111.431 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.4 -42.82 99.34 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.882 0.873 . . . . 100.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -63.0 -45.55 91.87 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 123.995 0.918 . . . . 100.0 111.801 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.259 34.5 m -62.9 -39.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.363 1.193 0 CA-C-O 119.025 -0.512 . . . . 100.0 110.377 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.69 92.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.916 1.286 . . . . 100.0 112.238 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -62.74 -39.69 94.88 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.523 1.129 . . . . 100.0 111.43 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 84.8 m -65.52 -42.54 91.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.697 1.599 . . . . 100.0 111.488 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--N 1.358 0.949 0 C-N-CA 124.259 1.024 . . . . 100.0 112.329 -177.882 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 118.574 2.805 . . . . 100.0 118.574 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.267 19.1 tt0 -131.39 136.72 48.27 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.835 1.654 . . . . 100.0 108.237 177.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -128.33 131.93 48.61 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.877 -0.786 . . . . 100.0 108.877 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.2 tttt -90.44 115.35 27.54 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 105.294 -2.113 . . . . 100.0 105.294 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 14' ' ' VAL . 2.8 tt -116.51 130.24 56.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.362 -1.348 . . . . 100.0 107.362 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.556 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.7 t -111.25 125.39 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 118.577 -1.249 . . . . 100.0 109.713 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' CD1' HD22 ' A' ' 13' ' ' LEU . 7.6 mp -102.08 120.45 40.45 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -128.87 161.19 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.057 -1.429 . . . . 100.0 111.235 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.14 172.59 20.92 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.555 -1.418 . . . . 100.0 109.555 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.497 ' HB2' HG23 ' A' ' 97' ' ' THR . 87.9 m-20 -71.0 160.12 33.5 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.777 0.799 . . . . 100.0 112.827 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.52 140.09 40.41 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 110.316 -1.114 . . . . 100.0 110.316 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.68 89.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 118.608 -1.107 . . . . 100.0 114.536 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 p -64.05 -39.4 93.99 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 118.802 1.301 . . . . 100.0 114.084 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.54 17.83 5.94 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 118.992 -0.893 . . . . 100.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.56 -47.75 84.35 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 118.923 1.361 . . . . 100.0 110.611 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 m -64.83 -43.23 93.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.209 1.403 . . . . 100.0 111.158 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.4 m -63.08 -41.59 99.45 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.369 1.068 . . . . 100.0 109.483 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -61.3 -48.14 82.73 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.748 1.219 . . . . 100.0 110.429 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -43.08 96.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 122.739 0.415 . . . . 100.0 111.112 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HD3' ' HB2' ' A' ' 36' ' ' GLU . 87.9 tttt -61.56 -41.96 98.14 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.885 0.874 . . . . 100.0 111.056 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HG2' HH11 ' A' ' 29' ' ' ARG . 28.5 ttp85 -61.64 -43.21 99.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.041 0.937 . . . . 100.0 110.35 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -63.82 -41.32 97.89 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 112.829 0.677 . . . . 100.0 112.829 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -69.3 -44.44 71.76 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.355 1.613 . . . . 100.0 115.355 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.8 p -118.94 -23.1 7.03 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 117.708 2.484 . . . . 100.0 117.708 -176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.22 -7.74 72.46 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.582 -1.007 . . . . 100.0 110.582 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.12 153.93 31.71 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.857 1.663 . . . . 100.0 109.662 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -117.32 119.07 34.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.993 -2.966 . . . . 100.0 102.993 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 43.4 tt0 -99.25 119.06 37.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.608 -0.837 . . . . 100.0 108.854 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.7 -13.85 33.35 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.87 1.063 . . . . 100.0 113.87 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 199' ' ' HIS . 98.2 mttt -94.74 124.99 39.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.384 -1.339 . . . . 100.0 107.384 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -96.61 112.48 24.21 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.815 0.817 . . . . 100.0 109.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.33 124.33 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 102.453 -3.166 . . . . 100.0 102.453 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.97 142.43 57.46 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.172 1.175 . . . . 100.0 114.172 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.8 m -92.37 130.08 38.14 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.3 -2.111 . . . . 100.0 105.3 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -102.92 126.67 50.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.404 -0.961 . . . . 100.0 108.404 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.83 -121.89 18.03 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 109.543 -1.423 . . . . 100.0 109.543 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.08 141.73 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.216 -0.661 . . . . 100.0 109.216 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -124.26 125.1 43.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.084 -2.562 . . . . 100.0 104.084 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.85 121.52 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.561 -1.2 . . . . 100.0 108.169 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.86 122.14 25.57 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 115.583 -0.735 . . . . 100.0 111.269 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.12 128.35 7.28 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.561 2.841 . . . . 100.0 110.969 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -131.64 123.6 28.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.067 -1.086 . . . . 100.0 108.067 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.9 t -110.32 135.9 47.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 N-CA-C 108.863 -0.792 . . . . 100.0 108.863 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -124.35 138.52 54.37 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.495 -1.298 . . . . 100.0 107.495 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -98.59 126.28 44.12 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 107.208 -1.404 . . . . 100.0 107.208 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 p -124.11 -179.78 4.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.956 -1.02 . . . . 100.0 109.868 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.91 -35.6 73.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.052 2.141 . . . . 100.0 109.484 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.23 10.94 29.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 124.182 0.993 . . . . 100.0 113.554 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.53 176.1 25.03 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.758 -0.537 . . . . 100.0 111.758 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.71 136.8 40.13 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.365 2.71 . . . . 100.0 114.486 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.78 142.35 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.486 -1.672 . . . . 100.0 106.486 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -113.64 131.94 55.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.707 -0.797 . . . . 100.0 110.404 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -106.91 119.03 38.25 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.142 -2.54 . . . . 100.0 104.142 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -92.55 99.14 11.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 100.163 -4.014 . . . . 100.0 100.163 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 83.7 t -85.74 125.96 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-N 115.805 -0.634 . . . . 100.0 110.674 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.467 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 36.5 m95 -107.31 98.02 7.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.132 -2.173 . . . . 100.0 105.132 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -86.31 116.11 24.27 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 104.3 -2.481 . . . . 100.0 104.3 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.0 163.93 12.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 113.482 0.919 . . . . 100.0 113.482 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 133.02 35.13 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.28 1.032 . . . . 100.0 109.61 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.16 83.54 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 116.667 -0.242 . . . . 100.0 113.516 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -70.37 -40.69 73.85 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 127.243 2.217 . . . . 100.0 111.856 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.562 ' HB2' HH11 ' A' ' 76' ' ' ARG . 47.0 mt-10 -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.494 1.294 . . . . 100.0 114.494 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.32 151.65 45.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.313 -1.312 . . . . 100.0 109.765 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -68.24 131.59 45.64 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.242 -2.133 . . . . 100.0 105.242 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.44 -174.98 40.53 Favored Glycine 0 C--N 1.355 1.597 0 C-N-CA 118.728 -1.701 . . . . 100.0 114.818 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -22.26 65.03 Favored Glycine 0 C--N 1.353 1.498 0 C-N-CA 126.992 2.234 . . . . 100.0 113.552 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.67 -37.47 84.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.189 1.796 . . . . 100.0 110.03 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.562 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.4 mtp85 -88.64 7.72 32.08 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.431 1.892 . . . . 100.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.95 -38.57 89.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 116.615 2.08 . . . . 100.0 116.615 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -38.07 90.2 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.676 0.655 . . . . 100.0 112.839 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.251 22.0 m-30 -62.35 -43.28 99.18 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.985 1.314 . . . . 100.0 109.856 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 3.4 t80 -90.95 -19.99 22.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.934 1.457 . . . . 100.0 114.934 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.38 135.8 24.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-N 119.631 1.105 . . . . 100.0 108.843 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 66.72 18.22 10.68 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.51 1.924 . . . . 100.0 114.245 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.28 146.69 48.77 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.98 -1.118 . . . . 100.0 107.98 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -106.79 -21.74 12.94 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.698 -0.683 . . . . 100.0 111.2 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.486 ' SG ' ' HG ' ' A' ' 13' ' ' LEU . 7.5 p -160.38 164.96 31.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.718 0.807 . . . . 100.0 109.808 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -150.1 156.91 42.49 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 113.721 1.008 . . . . 100.0 113.721 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.19 127.17 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.316 -2.105 . . . . 100.0 105.316 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.2 mt -110.67 123.63 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 N-CA-C 103.113 -2.921 . . . . 100.0 103.113 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.58 ' HB3' HD21 ' A' ' 122' ' ' ASN . 57.2 mtt -113.75 135.03 54.39 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 116.542 2.053 . . . . 100.0 116.542 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -132.99 162.02 32.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.445 -1.707 . . . . 100.0 109.975 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -106.11 125.09 50.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.186 -1.783 . . . . 100.0 106.186 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -63.86 -19.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 N-CA-C 113.934 1.087 . . . . 100.0 113.934 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.3 p -90.1 -3.26 58.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 111.987 0.366 . . . . 100.0 111.987 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -124.69 115.08 20.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 122.527 1.156 . . . . 100.0 111.347 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -65.51 -39.55 91.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.742 -1.117 . . . . 100.0 111.078 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -61.64 -41.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 124.982 1.313 . . . . 100.0 109.19 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 18' ' ' ASP . 96.6 m -62.49 -41.72 99.0 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.959 0.504 . . . . 100.0 110.147 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -65.31 -40.29 93.59 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.238 0.615 . . . . 100.0 110.962 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -59.79 -35.87 75.54 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.259 1.024 . . . . 100.0 111.237 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -74.01 -11.67 60.4 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 115.415 1.635 . . . . 100.0 115.415 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.39 -43.73 96.84 Favored Pre-proline 0 C--N 1.362 1.12 0 CA-C-O 116.141 -1.885 . . . . 100.0 111.792 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 86.5 Cg_exo -57.37 -35.11 98.87 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.529 2.153 . . . . 100.0 111.939 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.32 -41.9 84.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 123.453 0.701 . . . . 100.0 111.291 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' O ' HD13 ' A' ' 108' ' ' LEU . 85.8 m95 -63.66 -45.73 88.81 Favored 'General case' 0 C--N 1.365 1.278 0 N-CA-C 109.197 -0.668 . . . . 100.0 109.197 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -90.79 69.81 6.55 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.838 -1.542 . . . . 100.0 106.838 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -167.75 -55.5 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 100.937 -3.727 . . . . 100.0 100.937 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.68 -43.27 99.24 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.674 -1.602 . . . . 100.0 106.674 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.415 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -63.31 -50.15 71.17 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.83 -23.59 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 113.287 0.847 . . . . 100.0 113.287 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -60.31 -41.24 93.04 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.674 0.79 . . . . 100.0 109.759 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.257 15.1 m -98.36 -34.43 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 115.958 1.836 . . . . 100.0 115.958 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.292 68.9 m -107.05 -4.62 18.75 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 117.823 2.527 . . . . 100.0 117.823 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.339 66.3 mt-10 53.59 -119.31 1.47 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.636 1.347 . . . . 100.0 114.636 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -95.94 112.11 23.93 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 118.386 -1.326 . . . . 100.0 111.872 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 pt -145.12 153.83 53.53 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -61.21 126.18 18.78 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.622 2.214 . . . . 100.0 111.78 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.643 ' HB ' HD22 ' A' ' 144' ' ' LEU . 61.1 mt -133.35 134.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.685 -1.228 . . . . 100.0 107.685 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -116.0 131.59 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.928 -1.487 . . . . 100.0 108.687 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.5 mt -100.03 126.4 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 104.957 -2.238 . . . . 100.0 104.957 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 70.9 m -118.18 125.0 49.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 122.026 0.917 . . . . 100.0 111.871 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.92 101.21 2.57 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 104.492 -3.443 . . . . 100.0 104.492 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.58 HD21 ' HB3' ' A' ' 89' ' ' MET . 70.6 m-80 -81.31 163.17 23.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.611 1.164 . . . . 100.0 112.17 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 57.78 42.02 24.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.877 2.471 . . . . 100.0 115.442 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 148' ' ' ASP . 31.0 m -67.5 -13.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 112.051 0.389 . . . . 100.0 112.051 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.38 -38.86 92.8 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.641 1.976 . . . . 100.0 110.399 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.06 133.89 28.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 124.19 0.996 . . . . 100.0 110.583 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.59 -46.94 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.081 1.882 . . . . 100.0 116.081 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -85.26 77.11 10.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.587 0.63 . . . . 100.0 110.723 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -85.57 134.05 34.03 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.05 -40.87 6.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.681 -0.691 . . . . 100.0 112.355 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.07 106.7 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 106.028 -1.841 . . . . 100.0 106.028 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.69 146.86 37.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.951 -1.022 . . . . 100.0 109.375 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.0 88.57 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.412 1.085 . . . . 100.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.58 -40.09 95.8 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.71 1.204 . . . . 100.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.1 m -61.9 -38.24 87.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.358 1.463 . . . . 100.0 113.233 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.73 122.37 14.48 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 122.389 1.09 . . . . 100.0 110.07 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.61 -6.55 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.848 0 CA-C-N 113.785 -1.552 . . . . 100.0 112.21 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -58.89 -39.66 82.12 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.86 1.264 . . . . 100.0 111.323 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -61.07 -39.95 91.85 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 123.497 0.719 . . . . 100.0 111.616 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.08 -43.64 94.79 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 118.662 0.664 . . . . 100.0 112.101 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.369 1.067 . . . . 100.0 111.337 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.22 6.94 47.57 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 118.325 2.713 . . . . 100.0 118.325 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 54.63 46.41 24.81 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.058 1.343 . . . . 100.0 113.943 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.643 HD22 ' HB ' ' A' ' 117' ' ' ILE . 38.0 mt -109.57 159.47 17.07 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.618 -1.173 . . . . 100.0 108.464 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -96.47 141.67 29.49 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.414 -1.699 . . . . 100.0 106.414 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -118.32 133.52 55.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.159 0.504 . . . . 100.0 111.268 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.74 134.85 43.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.663 -0.698 . . . . 100.0 111.991 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.436 ' HB3' HG11 ' A' ' 124' ' ' VAL . 43.3 m-20 -88.59 123.37 33.01 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 101.683 -3.451 . . . . 100.0 101.683 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.73 158.3 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 122.64 1.21 . . . . 100.0 112.302 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.7 t -143.12 111.32 6.13 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 105.751 -1.944 . . . . 100.0 105.751 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.89 92.14 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.549 -0.908 . . . . 100.0 108.549 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.17 -43.5 91.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 114.875 1.435 . . . . 100.0 114.875 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 87.5 p -100.89 -2.28 32.43 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 114.916 1.45 . . . . 100.0 114.916 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 70.79 9.53 6.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 125.774 1.629 . . . . 100.0 112.953 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -63.49 121.73 14.54 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.403 1.001 . . . . 100.0 108.945 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 53.34 34.58 18.23 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 127.271 2.228 . . . . 100.0 111.459 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 158' ' ' GLU . 10.8 p90 -59.67 -41.46 90.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.799 1.777 . . . . 100.0 115.799 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.44 ' HG3' ' CE2' ' A' ' 157' ' ' PHE . 94.3 mt-10 -93.04 -3.48 54.25 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 115.503 1.668 . . . . 100.0 115.503 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 96.8 mttt -60.36 -44.31 95.56 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 116.969 2.211 . . . . 100.0 116.969 -177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.4 -43.11 42.78 Favored 'Trans proline' 0 C--N 1.375 1.956 0 CA-C-N 122.5 1.929 . . . . 100.0 113.095 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -64.65 -43.68 92.89 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.247 0.967 . . . . 100.0 111.863 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.28 -43.25 95.39 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 118.827 -0.606 . . . . 100.0 112.565 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -62.11 -46.62 88.24 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 123.487 0.492 . . . . 100.0 110.793 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 85' ' ' CYS . 83.5 mt -60.49 -42.77 97.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 124.131 0.895 . . . . 100.0 110.686 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.9 97.93 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.521 0.729 . . . . 100.0 111.154 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.434 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 72.2 mtt85 -63.48 -44.63 93.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 118.557 -0.735 . . . . 100.0 112.488 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -69.01 -43.14 75.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.406 0.441 . . . . 100.0 112.051 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.2 -46.91 75.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 113.239 0.829 . . . . 100.0 113.239 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.16 -38.42 77.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 125.29 1.436 . . . . 100.0 110.368 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.71 10.23 56.8 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 118.238 -1.312 . . . . 100.0 113.815 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -108.88 110.65 61.01 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.071 -1.455 . . . . 100.0 107.071 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.34 -22.22 66.36 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.912 3.074 . . . . 100.0 113.51 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -102.01 11.26 38.74 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 114.206 1.187 . . . . 100.0 114.206 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 25.4 tp -62.45 133.16 54.62 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 CA--C 1.484 -1.564 0 CA-C-O 121.337 0.589 . . . . 100.0 111.687 -179.328 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 107.753 -1.203 . . . . 100.0 107.753 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -75.13 127.48 86.52 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-O 119.367 -0.349 . . . . 100.0 110.4 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.39 143.31 42.9 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.573 2.848 . . . . 100.0 110.023 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -69.95 125.82 12.48 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.016 1.811 . . . . 100.0 110.254 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.57 -42.04 71.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 123.712 0.633 . . . . 100.0 110.864 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.566 33.9 m 52.55 63.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.113 0 N-CA-C 119.469 3.137 . . . . 100.0 119.469 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.03 -41.71 10.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.177 0 C-N-CA 124.818 1.247 . . . . 100.0 112.138 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 86.3 mtp -70.73 167.43 18.76 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.078 1.351 . . . . 100.0 113.476 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 C--N 1.363 1.191 0 N-CA-C 118.75 2.87 . . . . 100.0 118.75 -179.078 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . 0.453 ' CE1' ' HD2' ' A' ' 38' ' ' LYS . 39.3 t60 . . . . . 0 N--CA 1.442 -0.868 0 CA-C-O 119.756 -0.164 . . . . 100.0 110.724 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.75 -43.95 82.76 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.966 1.306 . . . . 100.0 112.073 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.27 -44.63 96.92 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-O 118.567 -0.73 . . . . 100.0 112.81 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.79 -47.52 84.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 123.829 0.706 . . . . 100.0 112.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.08 -41.0 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 O-C-N 123.828 0.705 . . . . 100.0 111.996 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.56 -45.37 72.28 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.68 1.363 . . . . 100.0 114.68 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -63.83 -40.44 96.6 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.861 1.265 . . . . 100.0 113.497 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.7 m -66.45 -40.97 89.75 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.626 1.17 . . . . 100.0 111.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.435 -1.184 0 CA-C-O 122.628 1.204 . . . . 100.0 111.865 -176.499 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 118.167 2.655 . . . . 100.0 118.167 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.288 45.9 tt0 -131.29 135.33 47.21 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.19 -2.152 . . . . 100.0 105.19 175.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . 0.278 80.9 m-85 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 106.439 -1.689 . . . . 100.0 106.439 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -92.38 118.28 30.77 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.341 -2.096 . . . . 100.0 105.341 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.845 HD22 ' SG ' ' A' ' 85' ' ' CYS 0.362 4.3 mt -114.9 132.51 56.51 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 105.797 -1.927 . . . . 100.0 105.797 -178.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 64' ' ' TRP . 39.8 t -110.24 127.75 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 116.47 -2.092 . . . . 100.0 106.823 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 tp -103.17 118.01 35.83 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.344 -1.354 . . . . 100.0 107.344 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 108' ' ' LEU . 29.4 m -127.83 162.0 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 125.479 1.512 . . . . 100.0 112.93 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.57 171.07 17.75 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.05 -1.62 . . . . 100.0 109.05 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HB2' HG23 ' A' ' 97' ' ' THR . 84.3 m-20 -70.42 159.27 34.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.97 0.89 . . . . 100.0 113.187 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.68 139.03 40.67 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.54 -1.024 . . . . 100.0 110.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 3.51 90.13 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-O 118.354 -1.248 . . . . 100.0 115.276 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 p -64.43 -38.75 92.13 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.095 1.448 . . . . 100.0 113.553 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 19.89 4.77 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 111.132 -0.787 . . . . 100.0 111.132 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.6 -48.72 80.55 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 124.334 1.054 . . . . 100.0 110.87 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.3 m -65.75 -43.42 88.96 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.228 1.411 . . . . 100.0 110.95 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.3 m -62.82 -41.66 99.4 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.393 1.077 . . . . 100.0 109.505 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.72 -47.51 84.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 124.103 0.961 . . . . 100.0 110.696 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.56 -41.31 91.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 O-C-N 122.893 0.121 . . . . 100.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.0 -39.92 93.88 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.56 0.744 . . . . 100.0 111.097 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.84 -44.09 97.43 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.069 0.548 . . . . 100.0 110.313 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -62.21 -43.92 97.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.812 0.671 . . . . 100.0 112.812 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.69 -44.74 66.36 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.547 2.055 . . . . 100.0 116.547 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.5 p -117.4 -24.93 7.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 117.521 2.415 . . . . 100.0 117.521 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.01 -8.08 70.05 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.695 -0.962 . . . . 100.0 110.695 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.88 156.36 30.41 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.469 1.107 . . . . 100.0 109.671 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -115.8 116.56 28.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 101.087 -3.671 . . . . 100.0 101.087 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -96.88 118.96 34.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.154 -1.424 . . . . 100.0 107.154 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.64 -11.18 34.84 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.828 -1.078 . . . . 100.0 113.235 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -101.22 126.18 47.92 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.174 -1.047 . . . . 100.0 108.174 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -95.04 116.42 28.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.927 0.87 . . . . 100.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.05 121.08 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.784 -3.413 . . . . 100.0 101.784 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.95 141.9 58.55 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.371 0.668 . . . . 100.0 112.591 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.7 m -94.51 129.06 41.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 105.281 -2.118 . . . . 100.0 105.281 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.37 129.15 48.75 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.053 -1.091 . . . . 100.0 108.053 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.69 14.32 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 109.614 -1.395 . . . . 100.0 109.614 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.48 143.25 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 109.157 -0.682 . . . . 100.0 109.157 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -127.32 125.55 41.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.608 -2.738 . . . . 100.0 103.608 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -99.04 125.46 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.509 -0.922 . . . . 100.0 108.509 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -121.45 123.71 27.51 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-N 114.803 -1.09 . . . . 100.0 111.176 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.423 ' CB ' ' HE3' ' A' ' 60' ' ' LYS . 75.8 Cg_endo -80.08 126.64 6.46 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.702 3.602 . . . . 100.0 111.91 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 tp -133.45 130.12 38.19 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.927 -1.138 . . . . 100.0 107.927 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -118.25 134.61 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.775 -0.824 . . . . 100.0 108.775 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -124.98 142.61 51.37 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.374 -0.973 . . . . 100.0 108.374 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -98.43 124.0 42.89 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.851 -0.796 . . . . 100.0 108.851 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.1 p -121.36 -177.67 3.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.336 -0.847 . . . . 100.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.22 -35.61 73.95 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.388 2.275 . . . . 100.0 109.333 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -88.21 3.25 50.06 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.13 1.372 . . . . 100.0 113.266 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.59 -179.5 22.73 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.117 -1.193 . . . . 100.0 110.117 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.66 137.29 45.4 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.348 2.698 . . . . 100.0 113.919 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -130.84 137.47 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.488 -1.301 . . . . 100.0 107.488 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HE3' ' CB ' ' A' ' 49' ' ' PRO . 85.4 tttt -105.1 133.51 49.76 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.967 0.889 . . . . 100.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.587 ' HD2' HD21 ' A' ' 13' ' ' LEU . 93.1 m-85 -110.94 116.85 31.92 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 103.098 -2.927 . . . . 100.0 103.098 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.06 99.25 11.89 Favored 'General case' 0 N--CA 1.434 -1.238 1 N-CA-C 99.979 -4.082 . . . . 100.0 99.979 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.53 125.69 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.768 -0.827 . . . . 100.0 108.768 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 31.2 m95 -102.74 97.75 7.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 105.089 -2.189 . . . . 100.0 105.089 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -85.84 116.32 24.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 104.938 -2.245 . . . . 100.0 104.938 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -99.53 166.06 11.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 114.576 1.324 . . . . 100.0 114.576 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.21 131.75 34.16 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.625 0.77 . . . . 100.0 109.301 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.71 -8.47 82.77 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.45 0.54 . . . . 100.0 114.45 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -70.6 -39.67 73.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.462 1.505 . . . . 100.0 112.731 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.534 ' HB2' HH11 ' A' ' 76' ' ' ARG . 49.0 mt-10 -62.33 134.56 56.66 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.472 1.509 . . . . 100.0 113.689 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.24 154.51 40.18 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.04 -0.982 . . . . 100.0 109.984 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -67.21 132.73 48.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 125.95 1.7 . . . . 100.0 107.673 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.72 -175.51 40.68 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.001 -1.571 . . . . 100.0 114.14 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.78 -23.28 65.23 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 126.747 2.118 . . . . 100.0 113.6 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.95 -28.34 69.75 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.416 1.087 . . . . 100.0 110.86 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.534 HH11 ' HB2' ' A' ' 70' ' ' GLU . 75.5 mtp85 -92.29 9.31 34.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.68 1.592 . . . . 100.0 114.562 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.59 -38.51 84.87 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 115.687 1.736 . . . . 100.0 115.687 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.95 89.89 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 124.271 0.939 . . . . 100.0 113.433 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -61.54 -48.32 81.52 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.129 0.972 . . . . 100.0 109.086 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HD1' ' HG ' ' A' ' 112' ' ' CYS 0.423 25.7 m-85 -70.64 -37.43 73.76 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 120.223 3.416 . . . . 100.0 120.223 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -54.03 131.97 16.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.78 0.8 . . . . 100.0 109.963 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 68.55 14.37 9.06 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.19 145.73 54.05 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-N 118.882 0.764 . . . . 100.0 109.864 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -102.87 -30.72 10.66 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.369 -0.832 . . . . 100.0 110.51 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.845 ' SG ' HD22 ' A' ' 13' ' ' LEU . 31.9 p -160.81 170.08 21.42 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.315 0.646 . . . . 100.0 109.472 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.48 157.46 43.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 113.333 0.864 . . . . 100.0 113.333 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.23 126.62 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.482 -2.414 . . . . 100.0 104.482 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.2 mt -109.59 123.97 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 103.286 -2.857 . . . . 100.0 103.286 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.455 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 40.4 mtt -114.09 135.28 54.2 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 115.322 1.601 . . . . 100.0 115.322 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -132.75 159.62 39.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.926 -1.943 . . . . 100.0 110.003 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -103.72 125.07 49.95 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.105 -1.813 . . . . 100.0 106.105 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.51 -19.79 24.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 114.117 1.154 . . . . 100.0 114.117 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.4 p -88.45 -6.55 57.57 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 119.072 -0.49 . . . . 100.0 111.51 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -123.18 114.29 20.09 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.804 1.287 . . . . 100.0 112.238 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -65.43 -38.49 90.04 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.398 -1.274 . . . . 100.0 111.327 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.996 1.318 . . . . 100.0 109.154 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.54 HG23 ' HB2' ' A' ' 18' ' ' ASP . 99.8 m -62.76 -41.32 99.16 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.94 0.496 . . . . 100.0 110.16 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.23 -39.84 93.28 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.541 0.736 . . . . 100.0 110.973 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.501 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -59.33 -36.71 76.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.687 1.195 . . . . 100.0 111.101 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.28 -10.67 59.82 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 115.782 1.771 . . . . 100.0 115.782 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.43 -43.82 96.86 Favored Pre-proline 0 C--N 1.36 1.034 0 CA-C-O 116.128 -1.891 . . . . 100.0 111.621 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.8 Cg_exo -58.35 -33.6 97.91 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.576 2.184 . . . . 100.0 112.503 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -67.23 -42.99 83.12 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.782 0.833 . . . . 100.0 109.862 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.567 ' O ' HD13 ' A' ' 108' ' ' LEU . 85.3 m95 -63.26 -46.98 84.32 Favored 'General case' 0 C--N 1.368 1.375 0 N-CA-C 108.649 -0.871 . . . . 100.0 108.649 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -89.53 70.75 7.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.892 1.33 . . . . 100.0 107.776 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -168.4 -55.54 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 100.315 -3.957 . . . . 100.0 100.315 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.267 -1.383 . . . . 100.0 107.267 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.567 HD13 ' O ' ' A' ' 104' ' ' TRP . 7.1 mp -61.88 -50.35 72.57 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.396 1.078 . . . . 100.0 112.806 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.259 32.8 m -70.15 -19.66 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 113.799 1.037 . . . . 100.0 113.799 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -60.55 -39.61 88.55 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.787 0.435 . . . . 100.0 110.511 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.89 -47.13 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-O 120.757 0.313 . . . . 100.0 110.792 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.549 ' HG ' ' HD1' ' A' ' 80' ' ' TYR . 95.9 m -70.87 -36.9 73.0 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 119.478 3.14 . . . . 100.0 119.478 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 61.72 -122.22 0.77 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 126.053 1.741 . . . . 100.0 109.31 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -93.41 113.02 25.08 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.294 1.861 . . . . 100.0 112.273 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 36.3 pt -144.4 149.16 43.4 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.133 -2.173 . . . . 100.0 105.133 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 85' ' ' CYS . 41.5 Cg_endo -64.31 128.99 22.78 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.018 1.812 . . . . 100.0 110.437 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.733 ' HB ' HD22 ' A' ' 144' ' ' LEU . 76.6 mt -131.91 135.09 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.316 -1.364 . . . . 100.0 107.316 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.33 131.69 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 114.402 -1.272 . . . . 100.0 107.799 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.9 126.55 43.34 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.388 -2.079 . . . . 100.0 105.388 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.455 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.95 125.93 50.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 122.055 0.931 . . . . 100.0 111.71 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.47 2.57 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 104.711 -3.356 . . . . 100.0 104.711 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.47 161.91 24.65 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.765 1.226 . . . . 100.0 112.489 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.4 mttt 57.81 43.28 22.03 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 127.858 2.463 . . . . 100.0 115.023 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 148' ' ' ASP . 28.7 m -68.9 -11.7 15.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 CA-C-N 115.983 -0.553 . . . . 100.0 111.603 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.51 -39.04 93.39 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.936 2.095 . . . . 100.0 109.74 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.06 132.02 29.82 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 C-N-CA 124.095 0.958 . . . . 100.0 110.132 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.83 -45.0 91.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 116.435 2.013 . . . . 100.0 116.435 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -84.93 77.51 10.09 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.648 0.737 . . . . 100.0 109.731 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -82.8 137.66 34.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.503 -0.925 . . . . 100.0 108.503 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.07 -42.69 5.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 119.4 -0.333 . . . . 100.0 111.496 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.1 107.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.59 -2.004 . . . . 100.0 105.59 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.62 148.86 36.68 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.104 -0.953 . . . . 100.0 109.349 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.22 90.32 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.165 0.986 . . . . 100.0 110.91 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -62.4 -40.8 97.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.661 1.184 . . . . 100.0 110.907 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 65.4 m -61.49 -37.64 84.39 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.686 1.594 . . . . 100.0 113.556 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.42 123.52 15.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 CA-C-O 122.523 1.154 . . . . 100.0 110.035 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.64 HG12 HH21 ' A' ' 140' ' ' ARG . 27.4 m -127.52 -10.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 CA-C-N 113.531 -1.668 . . . . 100.0 112.592 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -58.49 -40.34 82.49 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.1 1.36 . . . . 100.0 111.864 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -61.17 -40.01 92.28 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 118.679 -0.677 . . . . 100.0 111.601 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.64 HH21 HG12 ' A' ' 137' ' ' VAL . 87.0 mtm-85 -64.04 -43.6 95.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 112.806 0.669 . . . . 100.0 112.806 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.65 -42.21 95.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 123.566 0.746 . . . . 100.0 111.853 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -97.28 6.81 47.74 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 117.902 2.556 . . . . 100.0 117.902 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.26 71.2 m-20 53.23 50.75 16.97 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-O 123.062 1.41 . . . . 100.0 114.279 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.733 HD22 ' HB ' ' A' ' 117' ' ' ILE . 35.3 mt -114.38 158.29 21.71 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.981 -1.463 . . . . 100.0 107.092 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.413 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 97.0 mm-40 -98.78 143.77 28.76 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.259 -1.015 . . . . 100.0 108.259 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -117.34 136.06 53.41 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.25 0.548 . . . . 100.0 112.344 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.05 137.74 44.87 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.356 -0.838 . . . . 100.0 112.838 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.423 ' HB3' HG11 ' A' ' 124' ' ' VAL . 48.8 m-20 -89.42 123.88 33.97 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 101.583 -3.488 . . . . 100.0 101.583 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.3 pt -133.85 157.44 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.623 1.201 . . . . 100.0 112.084 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -143.91 111.36 5.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.066 0.946 . . . . 100.0 108.553 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.34 -46.79 84.95 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 126.637 1.975 . . . . 100.0 113.365 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.2 p -100.75 -2.84 31.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 115.44 1.645 . . . . 100.0 115.44 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 70.47 11.47 7.36 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.337 1.855 . . . . 100.0 113.353 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.2 118.33 10.45 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.686 -1.227 . . . . 100.0 107.686 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 54.31 29.31 10.58 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 128.756 2.822 . . . . 100.0 111.952 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . 0.413 3.7 p90 -62.53 -35.92 80.95 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 114.216 1.191 . . . . 100.0 114.216 -175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.272 40.6 mt-10 -85.93 -8.33 58.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.304 1.964 . . . . 100.0 116.304 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.303 95.3 mttt -60.6 -44.11 94.45 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 117.149 2.278 . . . . 100.0 117.149 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -59.45 -40.48 66.53 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-N 122.333 1.869 . . . . 100.0 112.962 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.31 -44.36 95.18 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 124.608 1.163 . . . . 100.0 111.194 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.89 -43.71 92.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 112.661 0.615 . . . . 100.0 112.661 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.413 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 67.9 t-105 -61.92 -45.86 91.86 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 123.28 0.362 . . . . 100.0 110.577 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 85' ' ' CYS . 89.6 mt -61.04 -42.8 99.17 Favored 'General case' 0 CA--C 1.495 -1.167 0 O-C-N 123.959 0.787 . . . . 100.0 110.442 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.3 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.554 0.741 . . . . 100.0 110.955 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.436 ' HG2' ' HB2' ' A' ' 174' ' ' LEU . 71.5 mtt85 -62.52 -45.33 93.49 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 123.147 0.579 . . . . 100.0 112.401 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.33 -43.55 77.29 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 112.119 0.415 . . . . 100.0 112.119 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.69 -47.2 76.25 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.776 1.028 . . . . 100.0 113.776 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.26 -38.7 75.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 124.162 0.985 . . . . 100.0 109.852 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.22 9.63 55.38 Favored Glycine 0 C--N 1.353 1.472 0 CA-C-O 118.306 -1.274 . . . . 100.0 114.051 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.536 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 59.9 t0 -109.74 113.02 58.03 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 106.665 -1.606 . . . . 100.0 106.665 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.99 -16.91 50.81 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 123.87 3.047 . . . . 100.0 113.092 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -97.39 8.38 44.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 57.1 mt -60.89 134.13 56.78 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 119.233 0.924 . . . . 100.0 112.568 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.43 -1.427 0 CA-C-N 114.839 -1.073 . . . . 100.0 109.857 -179.174 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.1 mt . . . . . 0 N--CA 1.436 -1.156 0 N-CA-C 105.914 -1.884 . . . . 100.0 105.914 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -132.78 144.76 54.26 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -64.53 148.15 90.49 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.778 2.319 . . . . 100.0 110.626 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.33 154.4 68.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 123.701 2.934 . . . . 100.0 114.144 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -61.6 -49.13 77.83 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.17 0.918 . . . . 100.0 111.19 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.301 5.9 m 52.35 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 128.214 2.605 . . . . 100.0 117.848 177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.84 -67.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.387 0 N-CA-C 107.819 -1.178 . . . . 100.0 107.819 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.1 ptp -70.57 156.33 39.56 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 114.657 1.355 . . . . 100.0 114.657 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.6 t70 . . . . . 0 C--N 1.36 1.034 0 N-CA-C 116.475 2.028 . . . . 100.0 116.475 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.438 -1.036 0 CA-C-O 118.794 -0.622 . . . . 100.0 111.156 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -64.73 -43.16 94.28 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.042 0.937 . . . . 100.0 111.529 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.49 -41.8 97.83 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 124.312 1.045 . . . . 100.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.37 -42.54 98.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.424 1.09 . . . . 100.0 110.963 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.12 -43.65 96.72 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 108.325 -0.991 . . . . 100.0 108.325 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.0 90.1 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.269 1.027 . . . . 100.0 113.333 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -63.3 -40.39 97.22 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 125.11 1.364 . . . . 100.0 112.713 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 66.4 m -65.89 -41.79 91.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.879 1.672 . . . . 100.0 110.265 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m . . . . . 0 C--N 1.361 1.102 0 CA-C-O 122.991 1.377 . . . . 100.0 107.87 -178.281 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.413 HG23 HG23 ' A' ' 59' ' ' ILE . 23.4 m . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 115.259 1.577 . . . . 100.0 115.259 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . 0.262 23.5 tt0 -125.87 131.71 52.32 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.448 -2.427 . . . . 100.0 104.448 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.407 ' CD1' HD13 ' A' ' 168' ' ' LEU . 90.7 m-85 -125.71 134.12 51.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.268 -0.641 . . . . 100.0 109.268 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.0 tttt -90.69 116.3 28.46 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.016 -1.105 . . . . 100.0 108.016 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 85' ' ' CYS . 41.5 mt -113.6 131.56 56.07 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.059 -1.459 . . . . 100.0 107.059 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 t -109.3 123.36 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.521 -1.659 . . . . 100.0 106.521 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.468 HD11 ' SD ' ' A' ' 89' ' ' MET . 64.6 tp -103.25 115.65 30.97 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.667 -1.605 . . . . 100.0 106.667 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.68 162.59 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 113.777 -1.556 . . . . 100.0 110.625 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.05 168.07 14.87 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 108.098 -2.001 . . . . 100.0 108.098 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 97' ' ' THR . 71.1 m-20 -72.1 159.94 33.3 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 140.24 40.89 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.756 -1.338 . . . . 100.0 109.756 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.84 1.77 89.81 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-O 118.913 -0.937 . . . . 100.0 114.344 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.2 m -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.59 1.195 . . . . 100.0 112.303 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.08 15.49 7.79 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.956 -0.858 . . . . 100.0 110.956 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -60.94 -44.12 97.7 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.289 1.435 . . . . 100.0 111.436 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -65.17 -42.33 93.79 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.224 1.41 . . . . 100.0 109.738 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.16 -41.59 99.29 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.13 1.372 . . . . 100.0 109.369 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.15 -48.11 83.12 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.137 1.775 . . . . 100.0 109.769 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.87 -43.52 96.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 122.568 0.347 . . . . 100.0 111.491 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -40.13 95.22 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.211 0.604 . . . . 100.0 112.099 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 35.1 ttp180 -62.15 -44.13 97.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.543 1.137 . . . . 100.0 109.482 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.84 -42.9 97.49 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.331 0.514 . . . . 100.0 112.081 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.4 -48.41 75.53 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.508 1.67 . . . . 100.0 115.508 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.1 p -121.55 -21.62 6.16 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.06 -7.56 69.74 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 110.586 -1.006 . . . . 100.0 110.586 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 149.95 39.59 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.351 1.06 . . . . 100.0 109.666 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.435 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 98.3 m-85 -111.91 125.69 54.32 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.546 -2.761 . . . . 100.0 103.546 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.06 114.17 28.07 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 118.925 -1.11 . . . . 100.0 110.575 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.66 -43.29 63.36 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.659 -1.155 . . . . 100.0 113.047 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.02 135.45 44.91 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.514 1.525 . . . . 100.0 111.397 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -103.1 119.12 38.27 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.007 -1.479 . . . . 100.0 107.007 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.3 123.69 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 102.92 -2.993 . . . . 100.0 102.92 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 139.0 58.72 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.596 0.712 . . . . 100.0 112.198 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.0 m -97.07 125.06 41.26 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.326 -2.472 . . . . 100.0 104.326 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -106.09 130.11 54.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.464 -1.68 . . . . 100.0 106.464 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.8 -127.1 33.16 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 109.547 -1.421 . . . . 100.0 109.547 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -128.09 139.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 121.22 0.533 . . . . 100.0 109.89 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -115.53 123.16 47.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 103.58 -2.748 . . . . 100.0 103.58 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.65 120.4 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 106.894 -1.521 . . . . 100.0 106.894 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -124.6 121.72 25.79 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.273 -0.876 . . . . 100.0 111.007 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -78.71 130.43 9.7 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 123.598 2.866 . . . . 100.0 111.03 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.58 128.52 48.05 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.873 -1.529 . . . . 100.0 106.873 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.04 128.56 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.583 -1.636 . . . . 100.0 106.583 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.14 131.45 56.41 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -99.33 122.54 42.61 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.228 -1.767 . . . . 100.0 106.228 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.8 p -122.42 -179.99 4.38 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.633 -0.712 . . . . 100.0 111.459 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -59.07 -37.36 76.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.913 1.685 . . . . 100.0 109.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -87.67 2.93 49.72 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.065 0.765 . . . . 100.0 113.065 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.27 -179.9 19.14 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 121.557 -0.715 . . . . 100.0 111.399 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.3 140.87 54.57 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.263 2.642 . . . . 100.0 113.794 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 9' ' ' VAL . 86.9 mt -130.35 138.58 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 103.565 -2.754 . . . . 100.0 103.565 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -116.27 128.66 55.77 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 118.972 -1.091 . . . . 100.0 108.692 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.64 118.06 35.81 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.077 -2.194 . . . . 100.0 105.077 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -91.94 106.46 18.48 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 101.889 -3.374 . . . . 100.0 101.889 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.84 124.95 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 107.966 -1.124 . . . . 100.0 107.966 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.429 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 19.2 m0 -103.56 106.8 17.41 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.304 -1.739 . . . . 100.0 106.304 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -86.04 116.29 24.17 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 104.136 -2.542 . . . . 100.0 104.136 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.3 p -98.44 163.11 12.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.46 0.911 . . . . 100.0 113.46 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.66 130.95 34.98 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.312 -0.995 . . . . 100.0 108.312 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.5 -11.0 80.94 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 116.624 -0.262 . . . . 100.0 112.56 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -67.6 -39.74 84.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.796 2.039 . . . . 100.0 111.809 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -61.32 141.73 57.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.275 1.43 . . . . 100.0 114.616 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.01 150.73 46.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.213 1.405 . . . . 100.0 110.982 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -72.95 132.22 43.17 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.236 -1.394 . . . . 100.0 107.236 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.3 -167.25 33.91 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 119.077 -1.535 . . . . 100.0 115.007 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.69 -22.0 63.57 Favored Glycine 0 C--N 1.355 1.585 0 C-N-CA 127.541 2.496 . . . . 100.0 114.49 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.78 -38.41 87.96 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.236 1.814 . . . . 100.0 109.293 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -82.77 -2.21 53.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.301 2.64 . . . . 100.0 113.959 -176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.29 -42.93 96.51 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -37.87 91.55 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 123.907 0.765 . . . . 100.0 113.489 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -62.18 -43.52 98.65 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.236 1.814 . . . . 100.0 108.983 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 8.2 t80 -90.89 -13.94 32.68 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 114.296 1.221 . . . . 100.0 114.296 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.8 mt -60.69 134.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 CA-C-N 119.333 0.969 . . . . 100.0 109.876 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.29 24.55 14.32 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.498 1.919 . . . . 100.0 114.196 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.24 138.94 45.86 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 108.218 -1.03 . . . . 100.0 108.218 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.02 -34.61 13.64 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.138 -0.937 . . . . 100.0 108.676 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 13' ' ' LEU . 64.7 m -153.94 164.04 39.07 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 123.026 0.53 . . . . 100.0 110.978 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -139.98 153.32 46.84 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 113.838 1.051 . . . . 100.0 113.838 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.25 123.92 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 103.293 -2.854 . . . . 100.0 103.293 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.2 mt -110.21 122.38 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 102.579 -3.119 . . . . 100.0 102.579 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.492 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 58.5 mtp -112.23 132.99 54.62 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 113.574 0.953 . . . . 100.0 113.574 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.38 159.22 37.66 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 113.631 -1.622 . . . . 100.0 108.742 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -101.72 124.97 48.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.15 -2.167 . . . . 100.0 105.15 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.75 -21.87 29.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 113.683 0.994 . . . . 100.0 113.683 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.1 p -89.98 -4.58 57.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 118.888 -0.577 . . . . 100.0 111.591 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.16 115.78 24.33 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 122.464 1.126 . . . . 100.0 111.569 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.85 -38.44 86.38 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 114.362 -1.29 . . . . 100.0 110.554 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.76 -43.04 96.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 C-N-CA 125.394 1.478 . . . . 100.0 109.892 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 18' ' ' ASP . 92.2 m -63.16 -42.38 99.41 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.086 -0.709 . . . . 100.0 109.086 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -63.45 -40.23 96.58 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.29 0.636 . . . . 100.0 110.207 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -60.69 -37.41 81.55 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.314 1.046 . . . . 100.0 111.762 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.32 -12.03 60.7 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 114.502 1.297 . . . . 100.0 114.502 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.07 -43.4 94.01 Favored Pre-proline 0 C--N 1.364 1.203 0 CA-C-O 116.252 -1.832 . . . . 100.0 111.509 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 87.1 Cg_exo -58.65 -34.63 99.03 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.347 2.031 . . . . 100.0 112.645 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.38 -43.63 85.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.951 0.782 . . . . 100.0 110.106 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.426 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.8 m95 -62.98 -46.6 86.95 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -91.01 63.86 5.25 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.947 1.356 . . . . 100.0 109.524 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.0 ttm105 -157.93 -57.81 0.08 Allowed 'General case' 0 CA--C 1.485 -1.533 1 N-CA-C 100.155 -4.017 . . . . 100.0 100.155 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.66 -41.17 98.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.395 -0.965 . . . . 100.0 108.395 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.512 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 6.5 mp -62.04 -46.24 90.04 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.936 0.895 . . . . 100.0 111.492 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.55 -38.95 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 126.267 1.827 . . . . 100.0 109.543 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -59.7 -46.2 89.8 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.817 -0.438 . . . . 100.0 109.817 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.91 -49.25 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 115.494 1.665 . . . . 100.0 115.494 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.8 m -113.45 9.13 18.05 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 120.788 3.625 . . . . 100.0 120.788 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 55.45 -124.79 2.09 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.473 1.109 . . . . 100.0 112.561 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -102.74 115.74 31.19 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 120.276 1.398 . . . . 100.0 109.667 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 41.7 pt -141.68 152.6 63.37 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 103.76 -2.681 . . . . 100.0 103.76 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.06 127.6 22.73 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.155 1.904 . . . . 100.0 112.412 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.705 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.2 mt -131.26 135.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 107.209 -1.404 . . . . 100.0 107.209 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.13 131.57 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.672 -1.233 . . . . 100.0 107.672 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 139' ' ' HIS . 86.5 mt -98.87 125.6 44.31 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.491 -2.411 . . . . 100.0 104.491 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.492 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.5 m -115.84 123.36 47.97 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.334 -0.848 . . . . 100.0 109.468 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.61 101.49 2.63 Favored Glycine 0 CA--C 1.485 -1.806 1 N-CA-C 102.8 -4.12 . . . . 100.0 102.8 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -86.73 165.72 15.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.985 0.898 . . . . 100.0 110.61 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 60.48 41.72 15.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 128.515 2.726 . . . . 100.0 113.521 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.5 m -67.52 -15.54 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 CA-C-N 115.866 -0.606 . . . . 100.0 111.937 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.74 -39.42 91.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.034 2.134 . . . . 100.0 110.355 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.01 130.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 124.12 0.968 . . . . 100.0 108.498 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.46 -39.24 88.72 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 117.022 2.23 . . . . 100.0 117.022 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -83.04 76.78 9.82 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.892 0.853 . . . . 100.0 109.049 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -88.5 129.27 35.49 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.533 -1.284 . . . . 100.0 107.533 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.51 -41.25 7.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 115.407 -0.815 . . . . 100.0 111.216 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.69 108.26 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 103.803 -2.666 . . . . 100.0 103.803 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.47 151.31 23.62 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.777 -1.101 . . . . 100.0 110.665 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.45 96.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.165 0.986 . . . . 100.0 112.245 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.94 -41.16 99.41 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.331 1.053 . . . . 100.0 110.801 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.4 m -63.03 -38.13 89.96 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.999 1.72 . . . . 100.0 114.072 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.46 123.54 16.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 122.128 0.966 . . . . 100.0 109.204 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.25 -9.0 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.567 1.547 . . . . 100.0 111.464 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -59.17 -45.05 92.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.061 1.344 . . . . 100.0 111.935 -176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.479 ' HB3' HD12 ' A' ' 119' ' ' LEU . 52.5 p-80 -62.51 -41.02 98.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.799 0.666 . . . . 100.0 112.799 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.64 -45.86 90.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.168 1.387 . . . . 100.0 110.377 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.98 -42.62 89.6 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.498 0.719 . . . . 100.0 112.759 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -90.84 1.92 56.56 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 115.715 1.746 . . . . 100.0 115.715 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 55.92 47.17 20.6 Favored 'General case' 0 C--N 1.361 1.092 0 CA-C-O 122.922 1.344 . . . . 100.0 113.025 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.705 HD22 ' HB ' ' A' ' 117' ' ' ILE . 40.6 mt -112.59 160.07 18.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.323 -1.362 . . . . 100.0 107.323 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -96.6 140.6 30.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.14 -1.059 . . . . 100.0 108.14 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -117.24 131.41 56.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.176 0.513 . . . . 100.0 111.469 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . 0.255 81.4 m-85 -128.75 138.3 52.03 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 114.979 -1.01 . . . . 100.0 111.616 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.39 121.34 31.54 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 101.973 -3.343 . . . . 100.0 101.973 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.17 152.97 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 CA-C-O 122.537 1.161 . . . . 100.0 111.535 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.1 t -134.8 117.09 15.57 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.116 -2.55 . . . . 100.0 104.116 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.94 88.63 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.703 0.627 . . . . 100.0 109.617 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.64 -41.16 79.8 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 115.426 1.639 . . . . 100.0 115.426 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -90.92 -4.63 56.37 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 115.275 1.584 . . . . 100.0 115.275 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.51 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 65.7 m-80 63.7 22.74 13.23 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.018 1.327 . . . . 100.0 112.484 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -76.0 123.6 26.01 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.239 -1.763 . . . . 100.0 106.239 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 53.27 40.54 31.44 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.141 2.176 . . . . 100.0 111.76 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.59 -49.31 76.81 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 126.227 1.811 . . . . 100.0 114.487 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -94.68 -6.82 42.42 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 115.424 1.639 . . . . 100.0 115.424 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.284 96.1 mttt -59.72 -45.3 98.48 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 118.857 2.91 . . . . 100.0 118.857 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -60.16 -41.67 49.54 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 122.782 2.029 . . . . 100.0 112.756 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -63.82 -45.04 91.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 124.235 0.959 . . . . 100.0 111.229 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 162' ' ' LEU . 96.9 mt -63.91 -42.9 97.3 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 118.699 -0.667 . . . . 100.0 112.793 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.19 -44.4 95.47 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 123.736 0.648 . . . . 100.0 109.955 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 85' ' ' CYS . 87.7 mt -61.4 -44.14 97.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.498 0.719 . . . . 100.0 110.693 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.36 99.01 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 124.061 0.944 . . . . 100.0 111.369 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -61.9 -45.3 94.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.216 1.007 . . . . 100.0 110.998 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.1 -44.66 83.72 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 113.598 0.962 . . . . 100.0 113.598 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.407 HD13 ' CD1' ' A' ' 11' ' ' PHE . 74.0 mt -63.48 -47.31 82.28 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 123.412 0.685 . . . . 100.0 112.061 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 91.8 mt -70.09 -39.15 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 124.191 0.996 . . . . 100.0 111.217 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.97 10.96 58.21 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-O 118.562 -1.132 . . . . 100.0 111.874 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -108.47 109.46 61.52 Favored Pre-proline 0 C--N 1.362 1.111 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.14 -22.89 53.61 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.718 2.946 . . . . 100.0 113.933 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -92.03 3.91 54.23 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.118 1.367 . . . . 100.0 113.521 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.39 130.75 47.63 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-N 118.411 0.55 . . . . 100.0 110.175 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 . . . . . 0 N--CA 1.438 -1.032 0 CA-C-O 121.323 0.582 . . . . 100.0 111.169 -178.977 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.0 mt . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 108.403 -0.962 . . . . 100.0 108.403 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -80.12 125.96 80.46 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.429 -1.322 . . . . 100.0 107.429 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.85 145.06 90.07 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 123.558 2.838 . . . . 100.0 113.261 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.96 166.27 30.08 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.532 2.821 . . . . 100.0 111.849 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -60.93 -43.86 98.05 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.446 1.098 . . . . 100.0 112.182 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.8 t 57.46 70.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.27 0 C-N-CA 126.484 1.913 . . . . 100.0 110.102 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.9 m -82.99 164.4 2.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 115.003 1.482 . . . . 100.0 115.003 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.305 61.5 mtm 51.42 -124.49 2.25 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 127.873 2.469 . . . . 100.0 116.816 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 . . . . . 0 C--N 1.369 1.421 0 N-CA-C 118.371 2.73 . . . . 100.0 118.371 -179.217 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 110.203 -0.295 . . . . 100.0 110.203 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -62.88 -40.93 99.03 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.97 1.308 . . . . 100.0 109.929 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.2 mt -62.9 -40.51 97.78 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.846 0.858 . . . . 100.0 110.316 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.37 -42.17 99.2 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.016 0.927 . . . . 100.0 110.871 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.71 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 C-N-CA 124.204 1.001 . . . . 100.0 108.418 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.13 98.82 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 124.419 1.088 . . . . 100.0 110.958 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.89 -42.7 99.39 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.943 1.297 . . . . 100.0 110.433 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.6 m -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.682 1.193 . . . . 100.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.4 m . . . . . 0 C--N 1.357 0.923 0 C-N-CA 124.205 1.002 . . . . 100.0 112.551 -178.541 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.44 -0.926 0 CA-C-O 121.871 0.843 . . . . 100.0 110.504 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -124.46 132.42 53.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.968 -2.234 . . . . 100.0 104.968 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -118.05 135.27 54.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.995 -1.113 . . . . 100.0 107.995 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -91.31 112.59 24.56 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.302 -1.74 . . . . 100.0 106.302 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 63' ' ' VAL . 41.4 tp -108.01 124.43 50.15 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.11 -1.859 . . . . 100.0 107.829 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 t -108.94 123.68 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.225 -1.769 . . . . 100.0 106.225 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.98 117.97 35.41 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.696 -1.594 . . . . 100.0 106.696 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -127.21 162.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 C-N-CA 125.11 1.364 . . . . 100.0 110.896 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.46 171.77 19.71 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 108.404 -1.878 . . . . 100.0 108.404 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.466 ' HB2' HG23 ' A' ' 97' ' ' THR . 65.4 m-20 -73.46 162.65 29.05 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.762 0.653 . . . . 100.0 112.762 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 140.52 36.18 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 110.079 -1.208 . . . . 100.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.12 1.63 90.54 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.667 0.651 . . . . 100.0 113.728 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.654 HG22 HD21 ' A' ' 122' ' ' ASN . 56.2 m -63.92 -41.57 97.63 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 117.817 0.809 . . . . 100.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.6 17.75 5.94 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.211 -0.995 . . . . 100.0 112.06 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.29 -46.62 89.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.122 1.369 . . . . 100.0 110.125 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.0 m -63.92 -43.39 96.07 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.395 1.478 . . . . 100.0 109.5 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -63.61 -41.07 98.34 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.265 1.026 . . . . 100.0 110.044 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.13 -48.34 82.12 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.306 1.442 . . . . 100.0 109.727 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.74 -43.76 96.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 C-N-CA 123.08 0.552 . . . . 100.0 111.217 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.09 -39.25 94.14 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 112.477 0.547 . . . . 100.0 112.477 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.459 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 39.9 ttp180 -61.49 -44.61 96.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 124.321 1.048 . . . . 100.0 108.99 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -63.56 -44.34 94.41 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 112.405 0.52 . . . . 100.0 112.405 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.96 -48.6 73.48 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 116.371 1.989 . . . . 100.0 116.371 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -119.23 -24.0 6.57 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.07 2.248 . . . . 100.0 117.07 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.92 73.4 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 110.434 -1.066 . . . . 100.0 110.434 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.43 151.71 38.07 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-N 118.017 0.908 . . . . 100.0 109.766 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.463 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 99.0 m-85 -110.61 127.2 55.14 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.111 -2.552 . . . . 100.0 104.111 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -104.55 116.92 32.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.798 -0.816 . . . . 100.0 108.798 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.0 -34.33 13.08 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 116.181 -0.463 . . . . 100.0 110.785 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -86.04 126.29 34.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.105 -1.072 . . . . 100.0 108.105 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -98.38 124.25 42.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.312 -1.355 . . . . 100.0 109.377 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.42 130.0 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 101.829 -3.397 . . . . 100.0 101.829 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.35 139.66 58.14 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.692 0.758 . . . . 100.0 112.861 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.2 m -93.58 123.46 36.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.075 -2.935 . . . . 100.0 103.075 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.17 125.98 50.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 105.959 -1.867 . . . . 100.0 105.959 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.26 -125.45 34.09 Favored Glycine 0 C--N 1.355 1.605 0 N-CA-C 109.147 -1.581 . . . . 100.0 109.147 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.82 139.1 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.559 0.695 . . . . 100.0 110.601 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -110.5 123.93 50.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.215 -2.883 . . . . 100.0 103.215 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.86 116.66 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 106.217 -1.772 . . . . 100.0 106.217 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.47 118.91 21.59 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 120.435 -0.506 . . . . 100.0 111.279 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -78.7 127.97 8.29 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.887 2.392 . . . . 100.0 109.658 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.24 126.84 45.81 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 106.248 -1.76 . . . . 100.0 106.248 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 128.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 100.0 105.875 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -118.66 131.74 56.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.649 -1.982 . . . . 100.0 105.649 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -97.28 123.98 41.25 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.0 p -124.19 179.71 4.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.815 -0.629 . . . . 100.0 110.85 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -58.79 -37.62 76.74 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.933 1.693 . . . . 100.0 110.208 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.45 -0.46 54.98 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 113.029 0.752 . . . . 100.0 113.029 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.53 -179.57 18.12 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 110.842 -0.903 . . . . 100.0 110.842 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.01 138.23 43.39 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.415 2.744 . . . . 100.0 113.437 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.98 140.41 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 103.258 -2.868 . . . . 100.0 103.258 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -115.5 127.97 55.67 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 118.649 -1.22 . . . . 100.0 109.35 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -104.77 118.65 37.09 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.56 -2.755 . . . . 100.0 103.56 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -92.48 109.42 20.82 Favored 'General case' 0 N--CA 1.427 -1.58 1 N-CA-C 98.798 -4.519 . . . . 100.0 98.798 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 13' ' ' LEU . 39.9 t -95.04 126.52 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.947 -1.501 . . . . 100.0 106.947 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -107.76 102.04 11.29 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.23 117.98 26.34 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 103.441 -2.8 . . . . 100.0 103.441 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.9 p -100.06 160.38 14.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 112.943 0.719 . . . . 100.0 112.943 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.0 36.97 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.085 -0.709 . . . . 100.0 109.085 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.36 -12.39 75.97 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 112.109 -0.396 . . . . 100.0 112.109 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.68 -39.46 84.47 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.625 1.57 . . . . 100.0 111.699 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.43 139.71 58.57 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.544 1.138 . . . . 100.0 113.385 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -67.15 147.91 52.5 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.48 1.912 . . . . 100.0 111.151 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -70.38 132.26 45.36 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.236 -1.764 . . . . 100.0 106.236 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.57 -166.87 33.96 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 119.118 -1.515 . . . . 100.0 115.534 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.36 -22.7 63.66 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 127.599 2.523 . . . . 100.0 114.337 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.0 -38.43 88.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.704 2.002 . . . . 100.0 110.021 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -82.99 -1.0 51.42 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 127.509 2.323 . . . . 100.0 113.895 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -42.85 93.61 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.476 2.399 . . . . 100.0 117.476 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -38.53 93.01 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 118.672 0.669 . . . . 100.0 113.345 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -62.36 -43.43 98.84 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 125.9 1.68 . . . . 100.0 109.592 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.546 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 6.3 t80 -89.84 -14.26 34.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 114.173 1.175 . . . . 100.0 114.173 -175.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -61.24 134.92 26.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 119.369 0.986 . . . . 100.0 109.358 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 66.1 20.25 11.18 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 127.363 2.265 . . . . 100.0 113.296 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.09 139.1 52.5 Favored 'General case' 0 C--N 1.365 1.278 0 O-C-N 121.199 -0.938 . . . . 100.0 108.669 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -99.54 -31.7 11.48 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.514 -0.767 . . . . 100.0 109.008 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.501 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.2 p -148.75 160.35 43.28 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 120.733 0.301 . . . . 100.0 111.431 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -143.36 150.81 39.66 Favored 'General case' 0 CA--C 1.487 -1.479 0 C-N-CA 119.371 -0.931 . . . . 100.0 113.021 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.413 HG13 HD11 ' A' ' 13' ' ' LEU . 97.0 mt -125.74 126.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 103.592 -2.744 . . . . 100.0 103.592 176.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.81 122.28 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.423 -3.177 . . . . 100.0 102.423 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.482 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 38.5 mtt -111.89 134.29 53.54 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 114.459 1.281 . . . . 100.0 114.459 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -130.14 157.17 43.16 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 112.546 -2.115 . . . . 100.0 109.229 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -102.18 125.53 48.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.08 -21.66 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.7 p -88.89 -5.84 57.73 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.996 -0.526 . . . . 100.0 111.62 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.1 t -119.79 116.79 26.61 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 122.859 1.314 . . . . 100.0 111.841 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.11 -39.71 86.73 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.887 -1.506 . . . . 100.0 110.804 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.79 -43.33 97.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 C-N-CA 125.24 1.416 . . . . 100.0 109.456 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.176 0.59 . . . . 100.0 109.914 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.44 -40.42 95.7 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.911 0.485 . . . . 100.0 110.723 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.512 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.2 mttt -60.77 -37.23 81.16 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.118 0.967 . . . . 100.0 111.445 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -73.43 -11.49 60.48 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 114.995 1.48 . . . . 100.0 114.995 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.35 -43.11 92.32 Favored Pre-proline 0 C--N 1.363 1.16 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.48 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 90.9 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.726 2.284 . . . . 100.0 112.702 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.55 -43.03 86.21 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.488 1.115 . . . . 100.0 109.901 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.441 ' O ' HD13 ' A' ' 108' ' ' LEU . 81.0 m95 -63.16 -46.21 88.25 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -90.74 65.0 5.77 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 123.054 1.407 . . . . 100.0 107.883 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -159.69 -57.0 0.06 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 100.567 -3.864 . . . . 100.0 100.567 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.02 -43.72 98.24 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.107 1.363 . . . . 100.0 108.254 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -62.5 -46.34 88.88 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.267 1.027 . . . . 100.0 112.145 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.53 -39.84 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 126.498 1.919 . . . . 100.0 109.309 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -59.68 -45.19 92.83 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.113 0.565 . . . . 100.0 110.75 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.99 -50.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 72.3 m -115.03 9.4 15.99 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.989 3.329 . . . . 100.0 119.989 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.257 80.9 mm-40 53.82 -123.16 2.1 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.45 1.5 . . . . 100.0 113.943 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -98.13 112.97 24.74 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.631 1.105 . . . . 100.0 112.416 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.3 pt -143.35 151.75 55.56 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 104.161 -2.533 . . . . 100.0 104.161 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.52 127.97 22.27 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 121.982 1.788 . . . . 100.0 112.503 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 144' ' ' LEU . 59.7 mt -130.56 136.0 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 107.271 -1.381 . . . . 100.0 107.271 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.84 131.39 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.175 -1.375 . . . . 100.0 107.922 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 139' ' ' HIS . 87.9 mt -99.43 125.12 45.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 104.329 -2.471 . . . . 100.0 104.329 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.8 m -116.49 122.19 44.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.986 0.898 . . . . 100.0 110.328 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.53 101.84 2.69 Favored Glycine 0 CA--C 1.476 -2.394 1 N-CA-C 102.862 -4.095 . . . . 100.0 102.862 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.654 HD21 HG22 ' A' ' 21' ' ' THR 0.412 56.7 p30 -92.69 170.31 9.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 118.899 -1.12 . . . . 100.0 113.943 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 93.1 mttt 60.81 40.39 15.99 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 128.105 2.562 . . . . 100.0 112.155 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 148' ' ' ASP . 33.5 m -65.77 -18.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.474 0.71 . . . . 100.0 112.893 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.28 -39.14 89.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.054 1.742 . . . . 100.0 110.58 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.18 130.77 28.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 123.766 0.826 . . . . 100.0 109.109 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.35 -41.53 96.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.345 1.609 . . . . 100.0 115.345 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -84.26 81.39 8.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.482 0.658 . . . . 100.0 109.325 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -89.85 130.71 36.05 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.433 -1.321 . . . . 100.0 107.433 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.37 -44.36 7.26 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.598 -0.728 . . . . 100.0 109.821 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.95 112.16 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 105.026 -2.213 . . . . 100.0 105.026 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -86.38 150.87 24.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.787 -1.551 . . . . 100.0 110.106 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.25 94.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.171 0.989 . . . . 100.0 110.669 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.096 1.358 . . . . 100.0 110.839 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 m -62.66 -38.51 90.62 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 125.757 1.623 . . . . 100.0 112.695 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 76.4 mt -65.67 121.7 15.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.646 1.213 . . . . 100.0 110.358 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.58 -4.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 CA-C-N 113.627 -1.624 . . . . 100.0 111.07 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 66.3 t80 -59.77 -42.92 94.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.351 1.46 . . . . 100.0 111.339 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.469 ' HB3' HD12 ' A' ' 119' ' ' LEU . 48.1 p-80 -61.33 -42.19 98.28 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.534 0.733 . . . . 100.0 112.518 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -63.5 -45.07 92.37 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 123.937 0.895 . . . . 100.0 111.252 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.06 -41.19 95.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.512 0.725 . . . . 100.0 112.042 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 74.6 mmtt -92.64 1.97 56.97 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 116.222 1.934 . . . . 100.0 116.222 -177.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 55.58 49.23 16.97 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.227 1.411 . . . . 100.0 113.572 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 117' ' ' ILE . 44.5 mt -118.7 159.11 24.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.676 -1.602 . . . . 100.0 106.676 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.308 78.9 mt-30 -101.63 140.23 36.2 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 118.609 -1.236 . . . . 100.0 110.578 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -109.38 131.15 55.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.987 0.736 . . . . 100.0 112.987 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.31 134.22 48.86 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.634 -1.166 . . . . 100.0 111.403 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.4 ' HB3' HG11 ' A' ' 124' ' ' VAL . 32.1 m-20 -87.53 120.86 29.27 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 102.802 -3.036 . . . . 100.0 102.802 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.1 pt -130.93 154.4 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.355 1.074 . . . . 100.0 111.244 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.3 t -136.07 118.42 15.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.369 -2.456 . . . . 100.0 104.369 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.433 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.81 -44.99 88.08 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 123.273 0.629 . . . . 100.0 109.435 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.11 -43.56 86.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 114.276 1.213 . . . . 100.0 114.276 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.1 m -92.25 -5.22 52.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.276 1.584 . . . . 100.0 115.276 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.463 HD21 ' HZ ' ' A' ' 35' ' ' PHE . 63.9 m-80 64.26 21.78 12.62 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 124.861 1.264 . . . . 100.0 112.167 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -75.72 125.1 28.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.189 -1.782 . . . . 100.0 106.189 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 53.31 40.39 31.24 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.064 2.146 . . . . 100.0 111.979 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -57.71 -48.6 79.1 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 126.706 2.003 . . . . 100.0 111.297 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.501 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 92.7 mt-10 -80.59 -24.75 38.93 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 118.396 2.739 . . . . 100.0 118.396 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.302 95.0 mttt -59.16 -45.31 99.34 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 121.456 3.872 . . . . 100.0 121.456 -173.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -60.04 -45.81 22.11 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 123.098 2.142 . . . . 100.0 112.74 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 158' ' ' GLU 0.343 28.2 p90 -66.44 -40.72 89.63 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.346 1.029 . . . . 100.0 113.113 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 162' ' ' LEU . 94.9 mt -63.71 -43.23 97.18 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-O 118.403 -0.808 . . . . 100.0 112.877 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -63.89 -43.2 96.72 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 118.807 -0.616 . . . . 100.0 110.415 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 85' ' ' CYS . 77.2 mt -60.78 -44.5 96.71 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.601 0.563 . . . . 100.0 110.806 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.0 99.91 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.891 0.876 . . . . 100.0 111.417 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 97.8 mtt180 -62.96 -45.27 93.25 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.364 0.666 . . . . 100.0 111.473 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -64.32 -47.02 81.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.798 0.839 . . . . 100.0 112.347 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.93 -46.48 81.44 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.234 0.827 . . . . 100.0 113.234 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.08 -39.17 76.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 123.694 0.798 . . . . 100.0 110.527 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.62 8.53 59.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-O 118.669 -1.073 . . . . 100.0 111.82 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -102.46 108.36 57.18 Favored Pre-proline 0 C--N 1.361 1.096 0 N-CA-C 106.655 -1.609 . . . . 100.0 106.655 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.12 -23.22 53.4 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.969 3.113 . . . . 100.0 113.569 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.6 6.72 47.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.161 1.384 . . . . 100.0 113.676 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 23.3 tp -63.05 128.75 37.31 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.648 0.658 . . . . 100.0 110.127 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 . . . . . 0 CA--C 1.499 -1.012 0 CA-C-O 121.59 0.71 . . . . 100.0 110.509 -179.125 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 CA--C 1.484 -1.567 0 CA-C-O 121.317 0.579 . . . . 100.0 110.4 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.58 127.55 67.55 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 103.429 -2.804 . . . . 100.0 103.429 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.66 141.18 90.08 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.175 2.583 . . . . 100.0 114.208 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.83 167.39 27.39 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.839 3.026 . . . . 100.0 112.514 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.72 -42.21 96.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.68 1.592 . . . . 100.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.2 t 68.08 101.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.022 0 C-N-CA 127.374 2.27 . . . . 100.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.1 m -129.25 166.99 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 113.956 -1.474 . . . . 100.0 108.809 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 82.7 mtp 53.21 -131.89 2.03 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 126.917 2.087 . . . . 100.0 115.4 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 . . . . . 0 C--N 1.373 1.607 0 C-N-CA 128.736 2.814 . . . . 100.0 118.521 -179.974 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 118.839 -0.6 . . . . 100.0 110.455 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -62.32 -43.87 97.82 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 123.911 0.884 . . . . 100.0 110.578 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.15 -43.83 97.97 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.384 0.674 . . . . 100.0 110.681 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.49 -44.58 96.02 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.552 1.141 . . . . 100.0 111.993 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.1 -42.55 97.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 C-N-CA 123.774 0.83 . . . . 100.0 109.295 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.89 97.88 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.642 0.777 . . . . 100.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -63.76 -40.76 97.49 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.357 1.063 . . . . 100.0 112.143 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -63.82 -42.96 97.55 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.732 1.213 . . . . 100.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.3 m . . . . . 0 C--N 1.358 0.975 0 C-N-CA 124.645 1.178 . . . . 100.0 111.688 -178.765 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.444 -0.746 0 CA-C-O 121.458 0.647 . . . . 100.0 110.924 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -128.36 136.22 50.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.827 -1.916 . . . . 100.0 105.827 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -119.95 132.61 55.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.732 -1.581 . . . . 100.0 106.732 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.39 117.22 28.93 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -110.18 129.01 55.79 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.838 -1.528 . . . . 100.0 106.93 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -110.53 124.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 105.253 -2.129 . . . . 100.0 105.253 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.01 116.71 32.4 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.948 -1.871 . . . . 100.0 105.948 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.415 ' HA ' ' HZ1' ' A' ' 23' ' ' LYS . 32.9 m -125.31 162.16 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 113.696 -1.593 . . . . 100.0 110.496 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.91 168.2 15.39 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 107.476 -2.25 . . . . 100.0 107.476 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HB2' HG23 ' A' ' 97' ' ' THR . 76.6 m-20 -71.82 162.45 29.43 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 113.215 0.82 . . . . 100.0 113.215 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.78 141.43 38.28 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.293 -1.123 . . . . 100.0 110.293 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.18 1.44 90.36 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.715 0.674 . . . . 100.0 113.982 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.8 m -65.02 -41.23 95.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.758 0.823 . . . . 100.0 111.648 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.43 15.77 6.86 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 120.57 -0.824 . . . . 100.0 112.087 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HZ1' ' HA ' ' A' ' 16' ' ' VAL . 20.1 ptmt -61.5 -44.32 97.29 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.77 1.228 . . . . 100.0 111.713 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.5 m -64.96 -42.31 94.7 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.906 1.282 . . . . 100.0 109.659 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.7 m -63.47 -41.01 98.61 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.272 1.029 . . . . 100.0 109.353 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -60.25 -47.5 85.73 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.072 1.349 . . . . 100.0 110.013 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.08 -43.6 97.53 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 C-N-CA 123.591 0.756 . . . . 100.0 111.831 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.605 1.162 . . . . 100.0 109.734 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 36.8 ttp180 -61.72 -45.15 95.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 125.43 1.492 . . . . 100.0 110.462 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -63.9 -43.72 95.14 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.59 0.589 . . . . 100.0 112.59 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -65.05 -47.58 76.83 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 115.23 1.567 . . . . 100.0 115.23 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.0 p -120.01 -23.57 6.32 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 119.104 3.002 . . . . 100.0 119.104 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.91 -4.33 71.57 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 110.733 -0.947 . . . . 100.0 110.733 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -76.94 147.15 37.11 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 126.422 1.889 . . . . 100.0 108.563 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 93.0 m-85 -114.29 126.32 54.9 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 105.391 -2.077 . . . . 100.0 105.391 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -105.49 113.93 27.79 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 120.071 -0.651 . . . . 100.0 111.907 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -72.96 -42.26 63.55 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.0 1.32 . . . . 100.0 112.511 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -84.75 130.91 34.62 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 125.904 1.682 . . . . 100.0 111.419 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -99.73 120.67 40.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 122.407 1.099 . . . . 100.0 110.77 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 1 N-CA-C 99.994 -4.076 . . . . 100.0 99.994 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.21 58.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 113.871 1.063 . . . . 100.0 113.871 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 m -91.45 126.18 36.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 103.708 -2.701 . . . . 100.0 103.708 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.74 128.79 53.91 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.77 -125.38 30.56 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.378 -1.489 . . . . 100.0 109.378 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.8 t -126.79 139.51 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 123.56 0.744 . . . . 100.0 109.987 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -113.87 124.57 52.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.276 -2.861 . . . . 100.0 103.276 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.56 113.35 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.899 -1.148 . . . . 100.0 107.899 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -125.97 120.77 24.09 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 113.018 0.747 . . . . 100.0 113.018 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.88 135.0 12.28 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 122.475 2.117 . . . . 100.0 111.148 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.58 132.67 53.94 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 105.414 -2.069 . . . . 100.0 105.414 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.514 HG22 ' HE3' ' A' ' 60' ' ' LYS . 19.6 t -109.44 126.58 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.554 -2.017 . . . . 100.0 105.554 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.31 129.45 54.01 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.269 -1.752 . . . . 100.0 106.269 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -98.83 122.9 42.66 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 105.749 -1.945 . . . . 100.0 105.749 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.44 ' HB ' HD11 ' A' ' 174' ' ' LEU . 69.9 p -122.67 -178.3 3.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.426 -0.806 . . . . 100.0 110.787 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -59.41 -37.34 77.79 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.7 1.6 . . . . 100.0 108.6 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.33 -3.41 52.56 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.206 1.802 . . . . 100.0 112.458 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.81 -177.02 19.7 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 110.829 -0.908 . . . . 100.0 110.829 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.33 137.16 50.22 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.972 3.115 . . . . 100.0 113.418 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.46 142.97 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.317 -2.105 . . . . 100.0 105.317 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' HE3' HG22 ' A' ' 51' ' ' VAL 0.284 44.8 mttp -115.1 132.34 56.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 118.046 -1.462 . . . . 100.0 110.588 175.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.48 116.83 33.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.087 -2.931 . . . . 100.0 103.087 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -92.5 100.46 13.0 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 101.089 -3.671 . . . . 100.0 101.089 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.45 124.74 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.704 -0.68 . . . . 100.0 109.276 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -106.72 106.36 16.85 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 104.954 -2.239 . . . . 100.0 104.954 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.51 117.11 24.22 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 102.934 -2.987 . . . . 100.0 102.934 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.6 p -100.14 162.64 12.84 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 113.14 0.792 . . . . 100.0 113.14 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.97 128.74 34.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.682 -0.859 . . . . 100.0 108.682 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.14 -12.19 82.7 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 116.02 -0.536 . . . . 100.0 113.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -67.77 -39.16 84.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.399 1.48 . . . . 100.0 112.069 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.34 137.66 58.3 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.778 1.231 . . . . 100.0 112.45 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.76 153.9 41.68 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.869 -1.06 . . . . 100.0 112.427 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -68.08 131.99 46.43 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.818 1.647 . . . . 100.0 108.115 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.61 -171.4 34.78 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 119.237 -1.459 . . . . 100.0 115.446 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -21.04 62.85 Favored Glycine 0 C--N 1.356 1.692 0 C-N-CA 127.959 2.695 . . . . 100.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.23 -37.93 84.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.362 2.265 . . . . 100.0 109.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -87.86 6.82 33.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 126.269 1.828 . . . . 100.0 115.19 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 -42.24 90.35 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 115.487 1.662 . . . . 100.0 115.487 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.02 94.33 Favored Glycine 0 C--N 1.353 1.497 0 C-N-CA 123.804 0.716 . . . . 100.0 113.165 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -60.87 -45.56 94.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.448 1.499 . . . . 100.0 108.694 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 6.1 t80 -89.29 -11.05 44.57 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 115.076 1.51 . . . . 100.0 115.076 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.5 131.66 25.44 Favored 'Isoleucine or valine' 0 C--N 1.366 1.326 0 CA-C-N 119.924 1.238 . . . . 100.0 110.838 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.309 63.9 mt-30 57.21 36.9 28.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 128.197 2.599 . . . . 100.0 113.863 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.88 142.87 42.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 105.611 -1.996 . . . . 100.0 105.611 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -100.15 -31.31 11.47 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.076 -1.083 . . . . 100.0 108.076 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.485 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -153.89 160.86 42.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 122.783 0.433 . . . . 100.0 110.377 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -141.82 153.46 44.52 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 113.578 0.955 . . . . 100.0 113.578 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.5 mt -126.26 125.81 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 103.935 -2.617 . . . . 100.0 103.935 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.7 mt -109.95 124.48 66.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 101.23 -3.618 . . . . 100.0 101.23 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -119.05 133.26 55.92 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 118.358 -1.337 . . . . 100.0 111.322 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -128.57 158.9 37.17 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.741 -1.572 . . . . 100.0 110.017 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.65 123.98 44.43 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.883 -1.895 . . . . 100.0 105.883 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -65.03 -21.08 28.79 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 113.348 0.87 . . . . 100.0 113.348 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -90.57 -5.8 55.48 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 118.712 -0.661 . . . . 100.0 111.765 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.7 t -119.65 116.7 26.53 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.83 1.3 . . . . 100.0 111.167 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -66.27 -39.6 89.55 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.566 -1.652 . . . . 100.0 111.336 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -43.17 96.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 125.132 1.373 . . . . 100.0 109.326 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 18' ' ' ASP . 96.9 m -62.66 -43.17 99.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 122.89 0.476 . . . . 100.0 109.905 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -63.89 -39.54 94.41 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 122.811 0.445 . . . . 100.0 110.524 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 92.5 mttt -60.53 -38.33 84.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.271 1.429 . . . . 100.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.38 -12.07 60.7 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 114.569 1.322 . . . . 100.0 114.569 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.82 -43.09 94.17 Favored Pre-proline 0 C--N 1.364 1.236 0 CA-C-O 115.952 -1.975 . . . . 100.0 111.34 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 97.4 Cg_exo -57.41 -36.39 98.82 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.483 2.122 . . . . 100.0 112.517 177.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -66.35 -41.96 88.79 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.005 0.815 . . . . 100.0 111.164 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.417 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.6 m95 -62.6 -46.35 88.72 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 108.928 -0.768 . . . . 100.0 108.928 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -91.62 65.9 5.21 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-O 123.0 1.381 . . . . 100.0 108.425 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -162.06 -56.6 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 101.103 -3.665 . . . . 100.0 101.103 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.23 -41.7 99.15 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.189 -1.041 . . . . 100.0 108.189 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.544 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -62.66 -46.04 90.04 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.86 0.864 . . . . 100.0 111.534 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.87 -39.23 82.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 126.378 1.871 . . . . 100.0 109.438 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -58.8 -45.6 89.52 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.34 1.056 . . . . 100.0 109.971 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.66 -50.38 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 115.512 1.671 . . . . 100.0 115.512 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.81 8.83 20.67 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 120.981 3.697 . . . . 100.0 120.981 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 53.98 -125.02 2.29 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 125.213 1.405 . . . . 100.0 113.241 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -97.88 113.98 25.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 120.289 1.404 . . . . 100.0 112.326 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.1 pt -142.73 152.74 60.18 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.03 127.15 20.47 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 122.231 1.954 . . . . 100.0 113.066 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.4 mt -131.28 134.8 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.693 1.235 . . . . 100.0 107.756 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.66 133.04 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 113.598 -1.637 . . . . 100.0 108.332 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.408 HD12 ' HB3' ' A' ' 139' ' ' HIS 0.272 88.3 mt -100.6 126.74 47.1 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 104.614 -2.365 . . . . 100.0 104.614 176.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -116.58 123.02 46.34 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.839 0.828 . . . . 100.0 109.696 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.09 102.57 2.68 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.33 -3.908 . . . . 100.0 103.33 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.412 54.0 p30 -94.45 173.36 7.66 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 114.584 1.328 . . . . 100.0 114.584 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 60.56 40.4 16.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 127.704 2.402 . . . . 100.0 111.323 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.45 -12.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 CA-C-N 115.717 -0.674 . . . . 100.0 112.417 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.82 -39.57 92.23 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.64 1.576 . . . . 100.0 109.588 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.22 130.28 29.03 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 124.232 1.013 . . . . 100.0 109.822 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.42 -40.01 89.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 115.4 1.629 . . . . 100.0 115.4 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -82.96 81.18 8.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.344 -0.984 . . . . 100.0 108.344 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -90.86 134.1 34.71 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.243 -1.762 . . . . 100.0 106.243 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -101.35 -40.85 6.91 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 110.011 -0.366 . . . . 100.0 110.011 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.15 109.89 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.948 -2.241 . . . . 100.0 104.948 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.27 145.44 29.11 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.648 -1.16 . . . . 100.0 110.833 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.21 98.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.08 0.952 . . . . 100.0 112.257 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.15 -39.87 95.92 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.07 0.548 . . . . 100.0 111.599 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.7 m -62.18 -36.57 82.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.524 1.93 . . . . 100.0 113.471 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.8 mt -63.66 123.64 16.83 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-O 122.336 1.065 . . . . 100.0 109.778 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 -4.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 125.583 1.553 . . . . 100.0 112.001 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -59.41 -43.43 93.03 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 125.098 1.359 . . . . 100.0 111.456 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.408 ' HB3' HD12 ' A' ' 119' ' ' LEU . 51.7 p-80 -62.18 -40.53 96.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 112.766 0.654 . . . . 100.0 112.766 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -62.97 -45.72 91.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.295 1.038 . . . . 100.0 110.547 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.56 -41.41 96.32 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.793 0.837 . . . . 100.0 111.686 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.84 4.46 53.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 117.284 2.328 . . . . 100.0 117.284 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 57.05 46.08 19.86 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 122.176 0.989 . . . . 100.0 112.403 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 117' ' ' ILE . 45.2 mt -115.24 162.28 17.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 108.251 -1.018 . . . . 100.0 108.251 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.408 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 97.3 mm-40 -101.34 139.18 37.36 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.783 -1.192 . . . . 100.0 107.783 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -114.29 130.34 56.65 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.384 0.611 . . . . 100.0 111.542 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -128.12 134.68 49.15 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.263 -0.881 . . . . 100.0 110.629 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -89.06 121.23 31.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 102.711 -3.07 . . . . 100.0 102.711 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 48.3 pt -132.63 157.19 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 122.194 0.997 . . . . 100.0 112.144 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.7 t -139.9 119.12 12.8 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.225 -2.509 . . . . 100.0 104.225 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.87 -44.17 93.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.359 -0.837 . . . . 100.0 109.614 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -63.18 -46.31 87.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.605 1.962 . . . . 100.0 114.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -97.16 -1.06 45.87 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 115.93 1.826 . . . . 100.0 115.93 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.49 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 63.1 m-80 64.65 21.77 12.48 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 125.075 1.35 . . . . 100.0 113.296 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -72.42 123.2 22.6 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.289 -1.745 . . . . 100.0 106.289 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.1 40.58 31.44 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.507 2.323 . . . . 100.0 112.389 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.418 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 18.4 t80 -55.83 -49.92 71.97 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 126.968 2.107 . . . . 100.0 115.589 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -96.34 -2.85 44.93 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.271 96.6 mttt -59.88 -44.86 97.91 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 118.277 2.695 . . . . 100.0 118.277 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.14 -42.65 41.49 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 122.523 1.937 . . . . 100.0 112.503 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -64.24 -43.95 93.31 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.534 1.146 . . . . 100.0 112.297 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.64 -44.96 92.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 123.923 0.764 . . . . 100.0 112.869 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.408 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 88.2 t90 -64.09 -42.58 96.88 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 123.501 0.5 . . . . 100.0 110.296 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 85' ' ' CYS . 85.7 mt -61.42 -43.66 98.48 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 118.892 -0.575 . . . . 100.0 111.106 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.5 98.68 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.209 0.604 . . . . 100.0 111.478 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.49 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 89.5 mtt180 -62.44 -45.39 93.31 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.278 0.631 . . . . 100.0 111.546 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -65.02 -45.24 86.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.986 0.915 . . . . 100.0 111.714 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.89 -45.56 85.44 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 123.614 0.766 . . . . 100.0 112.947 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.47 -39.21 78.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 C-N-CA 123.545 0.738 . . . . 100.0 109.975 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.81 9.75 57.11 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-O 118.602 -1.11 . . . . 100.0 111.206 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -104.83 109.28 62.87 Favored Pre-proline 0 C--N 1.364 1.231 0 N-CA-C 107.705 -1.22 . . . . 100.0 107.705 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.51 -24.31 56.56 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 124.086 3.191 . . . . 100.0 113.994 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.36 3.62 51.59 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.609 1.964 . . . . 100.0 113.708 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 21.9 tp -62.85 130.75 46.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.451 0.537 . . . . 100.0 112.451 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 . . . . . 0 CA--C 1.496 -1.118 0 CA-C-O 121.842 0.829 . . . . 100.0 110.595 178.797 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 121.414 0.625 . . . . 100.0 112.274 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.87 123.59 68.75 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 104.158 -2.534 . . . . 100.0 104.158 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -62.87 135.03 49.64 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 123.47 2.78 . . . . 100.0 113.175 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.81 157.32 43.66 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 123.28 2.654 . . . . 100.0 113.989 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.66 -38.73 92.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.868 1.667 . . . . 100.0 111.474 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.275 30.0 t 71.52 82.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 128.199 2.6 . . . . 100.0 109.836 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.24 163.57 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.945 2.098 . . . . 100.0 107.955 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 80.3 mtp 60.15 -114.02 0.63 Allowed 'General case' 0 C--N 1.355 0.847 0 N-CA-C 115.574 1.694 . . . . 100.0 115.574 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 . . . . . 0 C--N 1.371 1.512 1 N-CA-C 123.75 4.722 . . . . 100.0 123.75 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 118.443 -0.789 . . . . 100.0 111.874 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.01 -43.8 97.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 123.595 0.56 . . . . 100.0 111.882 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.7 -45.4 94.15 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 123.465 0.478 . . . . 100.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.4 -42.63 98.78 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 117.999 -1.0 . . . . 100.0 113.14 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.49 -45.0 99.54 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-N 118.613 0.642 . . . . 100.0 109.311 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.46 93.52 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 112.696 0.628 . . . . 100.0 112.696 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.28 -42.8 96.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.143 0.977 . . . . 100.0 112.877 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.7 m -63.95 -39.3 93.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.717 1.607 . . . . 100.0 111.913 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--N 1.366 1.305 0 CA-C-O 122.295 1.045 . . . . 100.0 110.599 -177.558 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.438 -1.039 0 N-CA-C 114.236 1.198 . . . . 100.0 114.236 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 11' ' ' PHE 0.272 30.9 tt0 -126.6 134.51 50.78 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 103.811 -2.663 . . . . 100.0 103.811 177.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.4 ' N ' ' HG2' ' A' ' 10' ' ' GLN . 80.0 m-85 -124.27 136.44 54.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.765 -1.198 . . . . 100.0 107.765 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.74 116.31 28.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.543 -2.021 . . . . 100.0 105.543 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.78 128.57 55.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.436 -1.711 . . . . 100.0 107.574 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.27 122.1 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 106.098 -1.815 . . . . 100.0 106.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -104.08 118.14 35.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.479 -1.674 . . . . 100.0 106.479 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.5 m -127.59 163.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 113.664 -1.607 . . . . 100.0 111.412 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.11 169.66 16.53 Favored Glycine 0 CA--C 1.493 -1.296 0 N-CA-C 108.053 -2.019 . . . . 100.0 108.053 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 97' ' ' THR . 82.0 m-20 -71.28 160.65 32.42 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.892 0.853 . . . . 100.0 113.022 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.32 140.25 41.06 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.428 -1.069 . . . . 100.0 110.428 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.4 2.01 90.54 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.381 -0.677 . . . . 100.0 114.643 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.409 HG21 ' C ' ' A' ' 89' ' ' MET . 68.5 m -64.28 -42.27 96.51 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.225 1.012 . . . . 100.0 112.279 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.04 17.73 4.46 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.689 -0.767 . . . . 100.0 111.846 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -60.71 -47.54 85.83 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 125.927 1.691 . . . . 100.0 110.354 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.6 m -64.5 -42.88 95.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.402 1.481 . . . . 100.0 109.509 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.1 m -62.72 -41.96 99.42 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 125.012 1.325 . . . . 100.0 109.473 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.435 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 88.4 t80 -60.55 -48.49 81.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.956 1.302 . . . . 100.0 110.49 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.3 -42.03 90.04 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 123.333 0.396 . . . . 100.0 111.289 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.93 -40.09 94.29 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.274 0.63 . . . . 100.0 112.139 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.435 ' NH1' ' HA ' ' A' ' 26' ' ' PHE . 32.3 ttp-105 -62.14 -44.31 96.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 123.78 0.832 . . . . 100.0 109.058 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -62.8 -45.61 91.85 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 112.332 0.493 . . . . 100.0 112.332 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.83 -48.75 73.21 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 116.459 2.022 . . . . 100.0 116.459 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.4 p -118.9 -21.45 7.75 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 116.689 2.107 . . . . 100.0 116.689 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.72 71.8 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.524 -0.598 . . . . 100.0 112.128 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.04 146.88 45.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.924 1.29 . . . . 100.0 109.022 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.36 120.38 42.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.05 -3.315 . . . . 100.0 102.05 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.73 114.22 28.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 119.13 -1.028 . . . . 100.0 111.622 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.73 -43.72 62.59 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 114.595 -1.184 . . . . 100.0 113.512 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -76.44 145.58 39.17 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 123.161 0.584 . . . . 100.0 111.414 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -107.03 124.09 49.14 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 119.227 -0.989 . . . . 100.0 108.435 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -115.64 125.85 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 101.474 -3.528 . . . . 100.0 101.474 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.38 138.84 58.67 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 112.924 0.713 . . . . 100.0 112.924 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.6 m -96.23 125.36 40.69 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 103.665 -2.717 . . . . 100.0 103.665 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.07 129.05 54.24 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.658 -1.608 . . . . 100.0 106.658 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.51 -126.33 32.69 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 109.742 -1.343 . . . . 100.0 109.742 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.75 137.58 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 123.135 0.574 . . . . 100.0 109.907 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -114.36 126.11 54.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 103.827 -2.657 . . . . 100.0 103.827 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.02 121.36 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.854 -1.536 . . . . 100.0 106.854 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -127.37 122.78 22.99 Favored Pre-proline 0 N--CA 1.431 -1.405 0 CA-C-N 115.458 -0.792 . . . . 100.0 110.9 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.18 125.29 5.78 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.968 2.445 . . . . 100.0 110.225 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -122.41 126.7 48.51 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.717 -1.586 . . . . 100.0 106.717 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.19 130.56 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 N-CA-C 106.821 -1.548 . . . . 100.0 106.821 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -118.36 132.42 56.27 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.513 -2.032 . . . . 100.0 105.513 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.8 123.49 46.55 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 106.541 -1.652 . . . . 100.0 106.541 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 p -123.64 -177.42 3.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.024 -0.535 . . . . 100.0 111.791 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -58.98 -38.26 78.74 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.263 1.825 . . . . 100.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -86.55 -0.23 55.7 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.861 0.864 . . . . 100.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.63 -178.8 19.51 Favored Glycine 0 N--CA 1.432 -1.63 0 O-C-N 122.034 -0.416 . . . . 100.0 112.194 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.99 139.46 61.62 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.092 3.195 . . . . 100.0 113.782 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.7 mt -129.66 138.43 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.472 -2.788 . . . . 100.0 103.472 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -118.68 128.94 54.99 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.4 -1.32 . . . . 100.0 108.889 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -108.63 117.58 34.56 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -92.25 106.53 18.52 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 102.519 -3.141 . . . . 100.0 102.519 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.37 124.4 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-N 112.447 -2.16 . . . . 100.0 109.198 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -104.77 105.9 16.17 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 104.715 -2.328 . . . . 100.0 104.715 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.76 118.7 27.45 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 104.339 -2.467 . . . . 100.0 104.339 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.1 p -96.54 162.27 13.54 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 114.041 1.126 . . . . 100.0 114.041 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.71 128.73 34.75 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.139 -1.43 . . . . 100.0 107.139 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.45 -13.39 80.44 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.948 -0.362 . . . . 100.0 112.386 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -65.81 -41.04 92.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.359 1.864 . . . . 100.0 112.13 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.71 137.73 58.2 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.828 0.851 . . . . 100.0 111.991 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -71.8 156.24 39.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.3 1.048 . . . . 100.0 113.019 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -66.85 132.71 48.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.413 1.885 . . . . 100.0 108.267 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.92 -171.77 34.43 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 119.608 -1.282 . . . . 100.0 114.548 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.04 -21.53 63.82 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 127.915 2.674 . . . . 100.0 113.824 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.65 -36.88 84.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.595 1.558 . . . . 100.0 110.649 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -87.45 1.21 54.08 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.742 1.617 . . . . 100.0 113.592 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.43 -39.78 92.06 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 116.044 1.868 . . . . 100.0 116.044 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.11 91.67 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 118.836 0.744 . . . . 100.0 113.436 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -62.91 -42.2 99.71 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.24 1.816 . . . . 100.0 108.912 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.564 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 8.8 t80 -89.32 -14.31 36.01 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 114.271 1.211 . . . . 100.0 114.271 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.6 mt -61.83 135.86 25.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 CA-C-N 119.108 0.867 . . . . 100.0 108.862 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 64.56 21.71 12.5 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 126.558 1.943 . . . . 100.0 114.441 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.51 141.29 50.16 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 108.158 -1.053 . . . . 100.0 108.158 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -100.0 -32.38 10.98 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.006 -1.109 . . . . 100.0 108.006 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.534 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.7 p -150.3 160.96 43.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.964 0.411 . . . . 100.0 111.391 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.434 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -143.52 152.43 41.46 Favored 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 119.616 -0.834 . . . . 100.0 113.114 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.0 mt -126.16 126.7 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.258 -2.497 . . . . 100.0 104.258 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 67.9 mt -109.27 124.26 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 N-CA-C 101.483 -3.525 . . . . 100.0 101.483 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.409 ' C ' HG21 ' A' ' 21' ' ' THR . 50.1 ttm -119.03 133.27 55.92 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.239 -1.384 . . . . 100.0 111.083 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -127.63 158.3 37.9 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.461 -1.7 . . . . 100.0 109.665 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -102.42 125.75 49.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 105.473 -2.047 . . . . 100.0 105.473 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.66 -22.96 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 114.167 1.173 . . . . 100.0 114.167 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -85.29 -10.83 55.97 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 118.736 -0.649 . . . . 100.0 111.072 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 t -116.17 116.71 28.31 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.272 1.511 . . . . 100.0 112.541 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -65.8 -41.45 91.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.938 -1.937 . . . . 100.0 109.223 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.08 -43.62 97.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 C-N-CA 125.431 1.492 . . . . 100.0 110.353 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.7 m -63.17 -43.23 98.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.101 0.561 . . . . 100.0 109.74 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.572 0.349 . . . . 100.0 110.289 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.505 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.4 mttt -60.25 -37.97 82.03 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 124.15 0.98 . . . . 100.0 111.335 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -73.27 -11.28 60.45 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.238 1.57 . . . . 100.0 115.238 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.97 -42.92 93.02 Favored Pre-proline 0 C--N 1.361 1.1 0 CA-C-O 116.58 -1.676 . . . . 100.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 92.9 Cg_exo -59.3 -34.27 97.87 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.488 2.125 . . . . 100.0 112.422 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.98 -43.38 88.02 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.07 0.948 . . . . 100.0 110.116 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' O ' HD13 ' A' ' 108' ' ' LEU . 83.7 m95 -62.76 -47.11 84.95 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 109.111 -0.7 . . . . 100.0 109.111 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 50.2 t-80 -91.46 64.52 5.06 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.78 1.276 . . . . 100.0 108.351 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -154.81 -60.59 0.12 Allowed 'General case' 0 CA--C 1.489 -1.387 1 N-CA-C 99.736 -4.172 . . . . 100.0 99.736 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.52 -39.99 95.32 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.192 0.597 . . . . 100.0 111.138 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -61.56 -45.85 92.39 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 122.998 0.519 . . . . 100.0 110.583 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.6 -39.08 83.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 126.395 1.878 . . . . 100.0 109.784 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.27 45.7 mtm105 -59.01 -44.52 91.71 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.048 0.539 . . . . 100.0 109.753 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.43 -51.84 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 115.563 1.69 . . . . 100.0 115.563 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -108.26 4.02 24.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 119.911 3.3 . . . . 100.0 119.911 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 54.11 -121.05 1.76 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.326 1.45 . . . . 100.0 111.28 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -95.19 112.88 24.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.884 1.22 . . . . 100.0 111.134 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 115' ' ' ILE . 46.2 pt -144.79 153.09 53.81 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.942 -2.984 . . . . 100.0 102.942 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -62.31 126.0 17.57 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.311 2.007 . . . . 100.0 111.9 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.699 ' HB ' HD22 ' A' ' 144' ' ' LEU . 69.1 mt -130.69 133.81 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.461 -1.311 . . . . 100.0 107.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 160' ' ' PRO . 57.6 t -115.38 133.12 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 114.044 -1.435 . . . . 100.0 108.077 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.89 124.8 47.11 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.69 -2.337 . . . . 100.0 104.69 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.8 m -116.94 122.34 44.0 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.75 0.786 . . . . 100.0 110.348 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.42 103.15 2.82 Favored Glycine 0 CA--C 1.478 -2.259 0 N-CA-C 103.626 -3.79 . . . . 100.0 103.626 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . 0.41 54.0 p30 -93.09 170.62 9.5 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 114.817 1.414 . . . . 100.0 114.817 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.7 mttt 61.11 41.67 13.4 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.586 2.754 . . . . 100.0 112.201 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 148' ' ' ASP . 33.8 m -64.76 -18.9 24.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.275 -0.875 . . . . 100.0 112.781 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -61.11 -38.25 85.67 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 123.624 0.77 . . . . 100.0 112.4 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.61 130.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.843 0.83 . . . . 100.0 108.981 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.61 -42.74 98.19 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.767 1.627 . . . . 100.0 114.84 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.32 77.03 10.06 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.51 1.147 . . . . 100.0 108.742 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -92.95 125.9 37.77 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.618 -1.623 . . . . 100.0 106.618 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -98.05 -39.17 9.06 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.32 -0.855 . . . . 100.0 112.302 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.96 107.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 103.908 -2.627 . . . . 100.0 103.908 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.9 144.34 31.04 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.422 -1.263 . . . . 100.0 109.962 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.84 -40.56 95.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.286 1.035 . . . . 100.0 111.348 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -40.76 98.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.909 1.284 . . . . 100.0 110.722 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.6 m -63.28 -38.09 89.8 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.124 1.77 . . . . 100.0 113.057 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.01 123.76 15.34 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-O 122.553 1.168 . . . . 100.0 110.022 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.56 -5.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.434 -1.712 . . . . 100.0 110.701 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -59.61 -41.74 91.06 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.243 1.417 . . . . 100.0 111.4 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -61.27 -42.71 99.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.403 0.681 . . . . 100.0 112.364 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -63.8 -44.23 93.95 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 124.195 0.998 . . . . 100.0 110.859 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.8 -42.31 97.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.937 0.895 . . . . 100.0 111.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -95.69 4.46 52.98 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.655 2.095 . . . . 100.0 116.655 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 55.54 46.89 22.05 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-O 122.898 1.333 . . . . 100.0 113.257 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.699 HD22 ' HB ' ' A' ' 117' ' ' ILE . 40.7 mt -113.36 159.66 19.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.377 -1.342 . . . . 100.0 107.377 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.7 mm-40 -99.38 140.82 32.99 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 109.577 -0.527 . . . . 100.0 109.577 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -114.29 130.98 56.66 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.472 0.653 . . . . 100.0 112.067 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -129.06 135.1 48.47 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.027 -0.988 . . . . 100.0 111.401 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB3' HG11 ' A' ' 124' ' ' VAL . 36.4 m-20 -90.04 120.83 31.57 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 101.872 -3.381 . . . . 100.0 101.872 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.8 pt -131.9 154.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.489 1.138 . . . . 100.0 112.07 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.1 t -138.95 118.2 12.71 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 104.497 -2.408 . . . . 100.0 104.497 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.239 -0.891 . . . . 100.0 109.142 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -44.26 87.62 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.061 1.504 . . . . 100.0 115.061 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -93.73 -2.17 54.15 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.022 1.49 . . . . 100.0 115.022 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 66.46 21.0 10.89 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 125.012 1.325 . . . . 100.0 111.133 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -73.9 118.09 16.45 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.778 -1.193 . . . . 100.0 107.778 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 52.29 36.8 20.53 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 127.955 2.502 . . . . 100.0 111.145 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -63.06 -40.71 98.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 115.613 1.709 . . . . 100.0 115.613 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.57 -10.24 49.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 113.75 1.018 . . . . 100.0 113.75 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.311 94.8 mttt -60.14 -43.98 95.25 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 118.605 2.817 . . . . 100.0 118.605 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.424 ' HB3' HG11 ' A' ' 118' ' ' VAL . 50.4 Cg_endo -59.65 -41.32 56.99 Favored 'Trans proline' 0 C--N 1.372 1.787 0 CA-C-N 123.187 2.174 . . . . 100.0 112.344 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -63.38 -44.78 93.75 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 124.051 0.844 . . . . 100.0 111.278 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.28 -42.61 96.33 Favored 'General case' 0 CA--C 1.483 -1.609 0 CA-C-O 118.394 -0.812 . . . . 100.0 112.73 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.44 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.2 t90 -64.25 -42.61 96.43 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.711 0.632 . . . . 100.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 85' ' ' CYS . 86.1 mt -60.72 -43.78 97.42 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 123.406 0.441 . . . . 100.0 110.651 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.85 99.93 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.59 0.756 . . . . 100.0 111.548 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.456 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 87.5 mtt180 -61.77 -46.14 90.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 124.199 1.0 . . . . 100.0 111.11 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -65.8 -45.98 80.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 123.71 0.804 . . . . 100.0 112.685 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.96 -45.73 84.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.513 0.725 . . . . 100.0 112.397 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 98.3 mt -70.79 -38.16 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 124.207 1.003 . . . . 100.0 111.052 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.74 10.07 55.71 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 118.589 -1.117 . . . . 100.0 113.365 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 110.62 61.7 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 106.733 -1.58 . . . . 100.0 106.733 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -70.78 -18.08 32.48 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.272 2.648 . . . . 100.0 113.783 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -97.24 9.14 43.03 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.088 0.955 . . . . 100.0 112.595 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 26.9 tp -63.31 129.27 39.55 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 109.055 -0.72 . . . . 100.0 109.055 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 . . . . . 0 CA--C 1.493 -1.237 0 CA-C-O 121.42 0.629 . . . . 100.0 111.017 -178.503 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 CA--C 1.484 -1.562 0 N-CA-C 114.405 1.261 . . . . 100.0 114.405 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.52 120.7 68.92 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 101.094 -3.669 . . . . 100.0 101.094 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.52 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 66.9 Cg_endo -63.04 145.16 93.99 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.78 2.986 . . . . 100.0 116.224 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 24.7 Cg_exo -70.57 159.53 52.5 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.543 2.829 . . . . 100.0 111.57 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -61.14 -44.01 98.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.92 1.288 . . . . 100.0 112.581 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.27 24.9 t 62.97 84.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.08 0 C-N-CA 127.123 2.169 . . . . 100.0 110.515 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 m -110.54 177.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 125.123 1.369 . . . . 100.0 109.548 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.277 85.9 mmm 54.44 -118.5 1.32 Allowed 'General case' 0 C--N 1.359 1.0 0 N-CA-C 117.862 2.542 . . . . 100.0 117.862 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.28 86.7 m-20 . . . . . 0 C--N 1.367 1.337 0 N-CA-C 121.225 3.787 . . . . 100.0 121.225 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 N--CA 1.436 -1.169 0 CA-C-O 118.407 -0.806 . . . . 100.0 111.03 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.2 -46.22 88.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 118.302 0.501 . . . . 100.0 111.908 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.88 -45.13 93.97 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.451 0.469 . . . . 100.0 112.145 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -64.66 -42.97 95.03 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 118.1 -0.952 . . . . 100.0 112.516 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.18 -43.13 98.66 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 CA-C-O 118.626 -0.702 . . . . 100.0 109.581 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.19 95.18 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 118.034 0.379 . . . . 100.0 111.244 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.35 -42.37 96.27 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.898 0.879 . . . . 100.0 113.169 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.5 m -64.81 -39.45 93.6 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.935 1.694 . . . . 100.0 111.744 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.362 1.126 0 C-N-CA 123.624 0.77 . . . . 100.0 110.091 -178.741 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.442 -0.839 0 CA-C-O 122.091 0.948 . . . . 100.0 111.091 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -125.26 131.77 53.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.387 -2.449 . . . . 100.0 104.387 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -119.49 135.43 54.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.102 -1.073 . . . . 100.0 108.102 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -92.85 120.58 33.34 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 123.176 1.465 . . . . 100.0 107.122 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 tt -110.47 128.72 55.74 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 112.638 -2.074 . . . . 100.0 106.526 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -109.82 123.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 105.926 -1.879 . . . . 100.0 105.926 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 23' ' ' LYS . 68.0 tp -106.19 118.04 35.58 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.148 -1.427 . . . . 100.0 107.148 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.49 164.28 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 113.6 -1.636 . . . . 100.0 110.657 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 172.16 21.09 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.203 -1.959 . . . . 100.0 108.203 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' HB2' HG23 ' A' ' 97' ' ' THR . 68.0 m-20 -74.43 164.07 27.03 Favored 'General case' 0 CA--C 1.5 -0.98 0 O-C-N 122.207 -0.584 . . . . 100.0 112.153 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.18 142.01 36.83 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 109.392 -1.483 . . . . 100.0 109.392 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.28 90.48 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 123.781 0.705 . . . . 100.0 114.012 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.437 HG22 HD21 ' A' ' 122' ' ' ASN . 60.1 m -63.58 -42.69 98.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 117.922 0.861 . . . . 100.0 112.268 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.88 12.58 7.71 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.145 -1.026 . . . . 100.0 111.863 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HB2' HD21 ' A' ' 15' ' ' LEU . 59.0 pttt -61.97 -41.83 98.45 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.043 0.937 . . . . 100.0 112.601 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.4 m -64.18 -43.17 95.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.71 1.204 . . . . 100.0 109.122 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.1 m -63.03 -41.78 99.61 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.4 1.48 . . . . 100.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.69 -48.54 81.28 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 126.017 1.727 . . . . 100.0 109.929 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.74 -42.91 93.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 119.253 -0.403 . . . . 100.0 111.608 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.16 -39.77 93.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 123.027 0.531 . . . . 100.0 111.656 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.502 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 28.1 ttp180 -61.81 -44.59 96.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.797 1.239 . . . . 100.0 109.586 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -62.77 -44.79 95.28 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.175 0.443 . . . . 100.0 111.914 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.06 -47.7 76.42 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 116.535 2.05 . . . . 100.0 116.535 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -118.47 -23.61 7.11 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 117.193 2.294 . . . . 100.0 117.193 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.46 71.76 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 110.751 -0.94 . . . . 100.0 110.751 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.71 151.19 36.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 118.08 0.94 . . . . 100.0 109.531 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 92.0 m-85 -112.07 124.69 52.95 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 102.084 -3.302 . . . . 100.0 102.084 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -104.8 113.56 27.22 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.66 -0.816 . . . . 100.0 110.311 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.76 -43.39 62.92 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.057 1.343 . . . . 100.0 112.826 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -74.6 134.93 42.04 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 123.519 0.727 . . . . 100.0 111.344 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -102.88 119.71 39.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.264 -1.384 . . . . 100.0 107.264 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.33 127.14 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 103.301 -2.852 . . . . 100.0 103.301 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.14 58.74 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.563 0.697 . . . . 100.0 112.73 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.0 m -93.09 124.58 37.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 104.085 -2.561 . . . . 100.0 104.085 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.42 HD23 HE22 ' A' ' 69' ' ' GLN . 83.7 mt -104.59 127.51 52.35 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.09 -1.819 . . . . 100.0 106.09 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.71 -125.72 33.58 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.176 -1.17 . . . . 100.0 110.176 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.77 137.99 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.543 0.737 . . . . 100.0 110.038 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -114.43 124.87 53.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.084 -2.932 . . . . 100.0 103.084 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.18 117.4 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 124.855 1.262 . . . . 100.0 107.731 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -129.29 119.9 19.77 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 111.909 0.336 . . . . 100.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 22.2 Cg_exo -79.94 128.98 7.77 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.811 2.341 . . . . 100.0 112.232 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.8 mt -124.67 130.97 53.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.544 -1.28 . . . . 100.0 107.544 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.46 130.9 61.69 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.706 -1.22 . . . . 100.0 107.706 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.37 130.47 54.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.646 -1.983 . . . . 100.0 105.646 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -99.85 122.59 43.03 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.584 -2.006 . . . . 100.0 105.584 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.8 p -124.19 177.83 5.64 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.664 0.745 . . . . 100.0 110.891 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -59.54 -36.45 76.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.016 1.726 . . . . 100.0 109.7 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -85.4 0.9 50.78 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.329 1.051 . . . . 100.0 111.885 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.06 178.21 19.99 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 121.543 -0.723 . . . . 100.0 111.558 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -68.17 138.87 44.65 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 123.297 2.665 . . . . 100.0 112.769 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 mm -130.51 140.53 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.668 -2.345 . . . . 100.0 104.668 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.431 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.8 ttmt -116.27 128.95 56.01 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.13 -1.028 . . . . 100.0 109.586 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.11 118.51 36.83 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.64 -2.356 . . . . 100.0 104.64 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -93.37 107.8 19.57 Favored 'General case' 0 N--CA 1.429 -1.514 1 N-CA-C 100.028 -4.064 . . . . 100.0 100.028 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.9 t -95.13 123.01 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.025 -0.989 . . . . 100.0 109.092 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -103.15 106.51 17.04 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -87.3 117.79 26.3 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.595 -2.742 . . . . 100.0 103.595 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.3 p -100.19 163.0 12.6 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.755 -0.657 . . . . 100.0 112.401 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.88 131.0 35.33 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.58 -0.526 . . . . 100.0 109.58 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.9 -11.57 81.23 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 112.238 -0.345 . . . . 100.0 112.238 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.42 HE22 HD23 ' A' ' 43' ' ' LEU . 53.8 mt-30 -65.07 -41.88 94.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.832 2.453 . . . . 100.0 111.102 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.46 141.29 58.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.939 1.296 . . . . 100.0 113.632 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 149.22 50.71 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.784 2.034 . . . . 100.0 111.297 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -71.33 130.5 41.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.884 -1.525 . . . . 100.0 106.884 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.53 -169.24 34.41 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.184 -1.484 . . . . 100.0 115.501 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.55 -21.87 63.11 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 127.78 2.61 . . . . 100.0 114.325 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.99 -37.66 85.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.8 1.64 . . . . 100.0 109.886 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.5 mmm-85 -86.16 2.46 46.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.047 1.739 . . . . 100.0 113.955 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.22 -41.8 93.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 115.514 1.672 . . . . 100.0 115.514 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.95 -38.22 92.41 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.858 0.742 . . . . 100.0 113.473 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -62.44 -43.51 98.64 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 125.745 1.618 . . . . 100.0 109.097 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.527 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 7.5 t80 -88.35 -14.25 38.65 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.266 1.21 . . . . 100.0 114.266 -176.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.27 134.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.364 1.229 0 CA-C-N 119.56 1.073 . . . . 100.0 109.378 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 63.27 26.36 15.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.174 2.19 . . . . 100.0 113.396 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.25 139.68 42.71 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 107.456 -1.313 . . . . 100.0 107.456 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -97.97 -34.88 10.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.448 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -148.37 161.05 42.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 120.709 0.29 . . . . 100.0 111.476 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.44 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -142.06 152.6 43.48 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.07 -1.052 . . . . 100.0 113.737 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.69 125.73 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 104.232 -2.507 . . . . 100.0 104.232 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.98 123.65 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 100.96 -3.719 . . . . 100.0 100.96 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -118.59 133.78 55.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.37 -1.332 . . . . 100.0 111.14 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -129.08 158.87 37.71 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 100.0 109.911 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -100.9 125.35 47.44 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 105.848 -1.908 . . . . 100.0 105.848 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.93 -22.26 30.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.71 1.004 . . . . 100.0 113.71 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -88.2 -7.48 56.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 118.953 -0.546 . . . . 100.0 111.568 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.1 t -117.86 116.55 27.19 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 122.891 1.329 . . . . 100.0 112.165 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.75 -40.18 88.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.553 -1.658 . . . . 100.0 110.141 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.92 -43.43 97.47 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 125.258 1.423 . . . . 100.0 109.754 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 18' ' ' ASP . 95.0 m -63.06 -42.96 99.8 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 122.851 0.46 . . . . 100.0 109.954 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -64.34 -39.74 94.49 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 122.818 0.447 . . . . 100.0 110.504 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 93.6 mttt -60.71 -37.56 82.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.814 1.245 . . . . 100.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.91 -11.14 60.27 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.072 1.508 . . . . 100.0 115.072 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -59.97 -43.08 93.62 Favored Pre-proline 0 C--N 1.364 1.226 0 CA-C-O 116.208 -1.853 . . . . 100.0 111.199 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 93.7 Cg_exo -58.03 -35.45 98.74 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.626 2.217 . . . . 100.0 112.516 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -65.56 -43.75 88.86 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.135 0.974 . . . . 100.0 109.979 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.433 ' O ' HD13 ' A' ' 108' ' ' LEU . 83.9 m95 -62.6 -47.31 84.33 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 109.507 -0.553 . . . . 100.0 109.507 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -91.11 64.62 5.35 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 123.055 1.407 . . . . 100.0 108.397 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -156.28 -62.12 0.1 Allowed 'General case' 0 CA--C 1.485 -1.527 1 N-CA-C 100.04 -4.059 . . . . 100.0 100.04 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -63.97 -39.75 94.83 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.376 -0.829 . . . . 100.0 110.428 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.527 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -62.03 -46.05 90.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.123 0.569 . . . . 100.0 110.762 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.54 -39.57 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 126.19 1.796 . . . . 100.0 109.675 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.11 -44.51 94.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 119.082 -0.485 . . . . 100.0 110.507 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.4 t -72.51 -49.37 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 114.958 1.466 . . . . 100.0 114.958 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.9 m -113.47 11.03 18.32 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 120.16 3.393 . . . . 100.0 120.16 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 54.18 -126.52 2.33 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 125.166 1.386 . . . . 100.0 112.367 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -102.54 115.75 31.21 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 117.772 -1.571 . . . . 100.0 109.986 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.94 150.42 67.43 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 102.453 -3.165 . . . . 100.0 102.453 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -60.82 128.5 25.8 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.917 1.745 . . . . 100.0 112.89 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.659 ' HB ' HD22 ' A' ' 144' ' ' LEU . 61.8 mt -131.16 135.17 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.479 -1.304 . . . . 100.0 107.479 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.77 131.63 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-N 113.579 -1.646 . . . . 100.0 108.169 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 139' ' ' HIS . 88.6 mt -98.55 124.6 43.39 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 104.328 -2.471 . . . . 100.0 104.328 176.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 92.6 m -114.81 121.76 44.27 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.201 -0.909 . . . . 100.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.49 102.33 2.69 Favored Glycine 0 CA--C 1.479 -2.165 0 N-CA-C 103.099 -4.0 . . . . 100.0 103.099 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.437 HD21 HG22 ' A' ' 21' ' ' THR 0.386 55.4 p30 -92.67 171.61 8.89 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 114.326 1.232 . . . . 100.0 114.326 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 61.05 40.9 14.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 128.339 2.656 . . . . 100.0 111.95 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 148' ' ' ASP . 34.0 m -64.34 -19.89 25.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.075 0 CA-C-N 115.517 -0.765 . . . . 100.0 112.669 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -61.0 -38.09 84.82 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.143 0.977 . . . . 100.0 112.549 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.66 129.82 26.44 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 N-CA-C 108.693 -0.855 . . . . 100.0 108.693 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.01 -41.25 95.49 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 116.357 1.984 . . . . 100.0 116.357 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.24 83.98 7.82 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.402 -1.333 . . . . 100.0 107.402 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -94.97 127.0 40.7 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.814 -1.921 . . . . 100.0 105.814 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.66 -38.66 9.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.994 -0.548 . . . . 100.0 112.304 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.33 105.93 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 103.804 -2.665 . . . . 100.0 103.804 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.37 151.32 25.58 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.265 -0.88 . . . . 100.0 111.187 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.4 -42.03 98.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.35 1.06 . . . . 100.0 111.555 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.11 -39.94 96.18 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.854 0.861 . . . . 100.0 111.102 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -62.54 -38.07 88.56 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.787 1.635 . . . . 100.0 112.982 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 90.4 mt -64.06 122.56 15.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 CA-C-O 122.421 1.105 . . . . 100.0 109.878 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.9 -7.25 4.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 C-N-CA 125.734 1.614 . . . . 100.0 111.598 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.394 1.478 . . . . 100.0 111.261 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.409 ' HB3' HD12 ' A' ' 119' ' ' LEU . 44.2 p-80 -61.7 -42.23 98.66 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 118.82 -0.61 . . . . 100.0 112.077 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -63.18 -45.31 92.37 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.656 0.782 . . . . 100.0 111.491 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.29 -40.63 94.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 123.611 0.764 . . . . 100.0 112.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.84 3.28 55.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 116.283 1.957 . . . . 100.0 116.283 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 57.6 t30 55.51 50.36 14.76 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.501 1.52 . . . . 100.0 112.624 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.659 HD22 ' HB ' ' A' ' 117' ' ' ILE . 49.9 mt -118.11 159.33 23.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.726 1.21 . . . . 100.0 108.048 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.2 mm-40 -98.29 140.19 32.94 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -114.58 130.62 56.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.554 0.692 . . . . 100.0 111.273 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -128.14 134.77 49.14 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.919 -1.037 . . . . 100.0 111.375 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.411 ' HB3' HG11 ' A' ' 124' ' ' VAL . 47.7 m-20 -88.42 120.95 30.28 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 102.348 -3.205 . . . . 100.0 102.348 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.4 pt -131.16 154.43 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.652 1.215 . . . . 100.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.2 t -136.69 119.59 16.35 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 105.091 -2.188 . . . . 100.0 105.091 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.426 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.2 -45.1 89.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 124.211 0.944 . . . . 100.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.7 -44.68 89.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 115.145 1.535 . . . . 100.0 115.145 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 94.1 p -95.77 -0.26 51.54 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 115.537 1.68 . . . . 100.0 115.537 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.502 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 70.6 m-80 63.7 24.27 13.82 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.869 0.868 . . . . 100.0 112.638 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.76 123.25 24.61 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 106.046 -1.835 . . . . 100.0 106.046 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.05 40.57 31.42 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.939 2.095 . . . . 100.0 112.011 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.44 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 30.4 t80 -57.25 -49.04 77.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.369 1.867 . . . . 100.0 114.315 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.16 -9.02 40.85 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 115.463 1.653 . . . . 100.0 115.463 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.304 95.0 mttt -59.66 -44.44 97.44 Favored Pre-proline 0 CA--C 1.498 -1.045 0 N-CA-C 119.282 3.067 . . . . 100.0 119.282 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.1 -42.28 44.88 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.391 1.89 . . . . 100.0 111.678 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.95 -44.13 93.75 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 124.414 1.071 . . . . 100.0 111.794 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.62 -43.99 95.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 112.968 0.729 . . . . 100.0 112.968 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.424 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.5 t90 -64.61 -43.14 94.71 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.834 0.709 . . . . 100.0 109.975 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 85' ' ' CYS . 88.9 mt -61.55 -43.06 99.55 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.448 0.468 . . . . 100.0 111.136 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.27 99.22 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 123.78 0.832 . . . . 100.0 110.765 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.445 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 96.2 mtt180 -61.96 -45.39 93.87 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.514 0.726 . . . . 100.0 111.667 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -64.6 -46.84 80.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.289 0.636 . . . . 100.0 111.879 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.35 -46.13 81.44 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 113.675 0.991 . . . . 100.0 113.675 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.85 -38.86 79.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.404 1.082 . . . . 100.0 109.388 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.67 8.9 59.17 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 118.635 -1.092 . . . . 100.0 112.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -107.62 110.15 62.64 Favored Pre-proline 0 C--N 1.361 1.074 0 N-CA-C 106.047 -1.834 . . . . 100.0 106.047 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.5 -18.85 43.33 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 123.842 3.028 . . . . 100.0 113.834 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -97.78 11.02 38.61 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.39 1.076 . . . . 100.0 112.611 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.445 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 23.5 tp -63.19 130.47 44.71 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.742 0.817 . . . . 100.0 109.145 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 . . . . . 0 CA--C 1.496 -1.118 0 CA-C-O 121.367 0.603 . . . . 100.0 110.413 -178.827 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 CA--C 1.484 -1.583 0 CA-C-O 121.473 0.654 . . . . 100.0 110.961 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -84.32 124.35 73.93 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 102.697 -3.075 . . . . 100.0 102.697 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 60.8 Cg_endo -62.08 140.51 84.48 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 123.397 2.732 . . . . 100.0 113.905 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 31.2 Cg_exo -67.18 155.18 71.76 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.244 2.629 . . . . 100.0 112.188 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.41 -45.3 94.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.32 1.048 . . . . 100.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.0 t 68.56 102.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.243 0 C-N-CA 126.651 1.98 . . . . 100.0 106.747 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.7 m -92.51 157.01 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 115.331 1.604 . . . . 100.0 115.331 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.368 85.3 mmm 52.71 -118.44 1.33 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.989 2.515 . . . . 100.0 117.548 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 . . . . . 0 C--N 1.365 1.269 0 N-CA-C 117.705 2.483 . . . . 100.0 117.705 -178.384 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 N--CA 1.442 -0.855 0 N-CA-C 110.608 -0.145 . . . . 100.0 110.608 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -63.16 -41.94 99.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.803 1.241 . . . . 100.0 111.234 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.63 -42.6 99.68 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.519 0.728 . . . . 100.0 111.084 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.77 -44.37 96.37 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.472 0.709 . . . . 100.0 111.239 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.76 -42.99 98.34 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 C-N-CA 123.844 0.857 . . . . 100.0 109.077 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.83 99.59 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.274 1.029 . . . . 100.0 111.673 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -62.66 -42.7 99.75 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.921 0.888 . . . . 100.0 110.803 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.5 m -63.82 -42.69 97.61 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.734 1.214 . . . . 100.0 111.631 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.356 0.858 0 C-N-CA 124.454 1.102 . . . . 100.0 113.454 -177.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.492 -1.258 0 CA-C-O 120.492 0.187 . . . . 100.0 110.568 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.6 -39.99 95.49 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 124.733 1.213 . . . . 100.0 111.204 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.53 -43.43 98.88 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 123.869 0.867 . . . . 100.0 109.713 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -66.54 -37.26 84.61 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.335 1.054 . . . . 100.0 111.82 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.6 15.9 35.88 Favored Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 109.23 -1.548 . . . . 100.0 109.23 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 10' ' ' GLN . 24.1 pt-20 -90.06 114.95 62.73 Favored Pre-proline 0 N--CA 1.414 -2.236 0 N-CA-C 106.128 -1.804 . . . . 100.0 106.128 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.63 -50.34 5.64 Favored 'Trans proline' 0 C--N 1.377 2.069 0 N-CA-C 103.215 -3.417 . . . . 100.0 103.215 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -123.68 -71.25 0.73 Allowed 'General case' 0 N--CA 1.379 -3.993 1 N-CA-C 99.148 -4.39 . . . . 100.0 99.148 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.9 t -116.7 145.12 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 115.065 1.506 . . . . 100.0 115.065 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 38.4 tt0 -122.81 134.75 54.4 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 126.001 1.721 . . . . 100.0 106.694 176.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -123.53 132.4 53.89 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.647 -0.871 . . . . 100.0 108.647 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 87.8 tttt -89.04 116.94 27.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -113.23 129.22 56.58 Favored 'General case' 0 CA--C 1.488 -1.417 0 CA-C-N 114.251 -1.34 . . . . 100.0 107.874 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -109.12 124.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.155 -1.424 . . . . 100.0 107.155 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.5 tp -105.27 117.72 34.74 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 106.771 -1.566 . . . . 100.0 106.771 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.97 162.72 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 114.259 -1.337 . . . . 100.0 112.567 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.91 172.49 20.68 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 109.629 -1.388 . . . . 100.0 109.629 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' HB2' HG23 ' A' ' 97' ' ' THR . 85.2 m-20 -71.1 159.62 34.37 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.831 0.824 . . . . 100.0 112.778 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 139.44 39.69 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 110.173 -1.171 . . . . 100.0 110.173 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.65 2.8 89.88 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 118.592 -1.116 . . . . 100.0 114.774 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 p -64.06 -39.72 94.69 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 118.767 1.283 . . . . 100.0 113.887 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.18 19.32 5.17 Favored Glycine 0 N--CA 1.428 -1.837 0 CA-C-O 118.941 -0.922 . . . . 100.0 111.477 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -60.08 -47.64 85.04 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 118.889 1.344 . . . . 100.0 111.143 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.3 m -64.55 -42.99 95.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.096 1.358 . . . . 100.0 110.671 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.2 m -63.12 -40.77 98.59 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.665 1.186 . . . . 100.0 109.177 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' HD1' HH22 ' A' ' 29' ' ' ARG . 68.1 t80 -60.67 -48.12 83.19 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.335 1.454 . . . . 100.0 110.369 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.28 -43.25 97.18 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 O-C-N 123.55 0.531 . . . . 100.0 111.025 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.71 -39.83 92.91 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.79 0.663 . . . . 100.0 112.79 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.775 HH21 ' HA ' ' A' ' 151' ' ' ALA . 13.1 ttm180 -60.48 -45.86 92.2 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.262 1.025 . . . . 100.0 109.086 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -64.35 -42.38 96.26 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 113.296 0.85 . . . . 100.0 113.296 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.61 -44.6 66.9 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.3 p -119.36 -23.3 6.73 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 117.826 2.528 . . . . 100.0 117.826 -176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.92 -7.73 73.45 Favored Glycine 0 C--N 1.348 1.235 0 N-CA-C 110.992 -0.843 . . . . 100.0 110.992 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.0 156.58 30.06 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 124.765 1.226 . . . . 100.0 109.142 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -114.65 118.26 33.15 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 102.612 -3.107 . . . . 100.0 102.612 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -87.81 110.21 20.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 121.905 0.86 . . . . 100.0 111.085 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.06 -40.12 68.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.107 1.363 . . . . 100.0 113.85 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HE3' HG21 ' A' ' 206' ' ' THR . 96.3 mttt -80.06 131.17 35.72 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.389 1.076 . . . . 100.0 112.218 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -99.41 110.45 22.93 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 119.142 -1.023 . . . . 100.0 108.266 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.1 t -118.7 122.46 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 0 N-CA-C 102.418 -3.178 . . . . 100.0 102.418 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.27 142.33 57.79 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.282 0.845 . . . . 100.0 113.282 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.5 m -92.95 127.22 38.38 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 104.431 -2.433 . . . . 100.0 104.431 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -105.34 127.14 52.81 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 107.916 -1.142 . . . . 100.0 107.916 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.32 -121.19 12.83 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.007 -1.637 . . . . 100.0 109.007 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 p -133.23 142.92 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-O 121.162 0.506 . . . . 100.0 110.197 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -121.13 123.59 42.69 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 105.007 -2.22 . . . . 100.0 105.007 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.6 t -100.31 122.02 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.675 -1.231 . . . . 100.0 107.675 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -126.65 124.45 24.19 Favored Pre-proline 0 N--CA 1.434 -1.238 0 CA-C-N 115.924 -0.58 . . . . 100.0 112.016 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.74 127.58 8.01 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 124.612 3.541 . . . . 100.0 112.81 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.0 tp -133.17 126.83 32.5 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.987 -1.116 . . . . 100.0 107.987 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.6 t -114.99 135.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 O-C-N 121.604 -0.685 . . . . 100.0 110.268 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -124.3 143.86 50.32 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 124.051 0.941 . . . . 100.0 109.102 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -102.35 127.38 49.37 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 107.022 -1.473 . . . . 100.0 107.022 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.7 p -122.0 179.24 4.58 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.982 0.896 . . . . 100.0 109.249 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -58.16 -36.62 73.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.875 2.07 . . . . 100.0 109.617 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -91.54 8.07 38.34 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 113.864 1.061 . . . . 100.0 113.864 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.74 176.19 20.07 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 121.907 -0.496 . . . . 100.0 112.074 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.61 138.21 29.0 Favored 'Trans proline' 0 N--CA 1.44 -1.654 0 C-N-CA 123.271 2.647 . . . . 100.0 113.554 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.5 pt -131.09 142.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 O-C-N 124.11 0.881 . . . . 100.0 109.003 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -106.76 132.65 52.49 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 115.473 -0.785 . . . . 100.0 112.112 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -110.62 117.8 34.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.527 -2.768 . . . . 100.0 103.527 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.524 HD22 ' HE1' ' A' ' 64' ' ' TRP . 55.5 t30 -94.8 100.76 12.6 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 100.508 -3.886 . . . . 100.0 100.508 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.74 126.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.036 0 CA-C-N 115.387 -0.824 . . . . 100.0 110.171 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.524 ' HE1' HD22 ' A' ' 62' ' ' ASN . 21.1 m95 -104.64 99.53 9.2 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.162 -2.162 . . . . 100.0 105.162 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -86.23 116.79 24.63 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.32 164.06 11.97 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.321 0.86 . . . . 100.0 113.321 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.04 131.62 35.32 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.212 1.005 . . . . 100.0 110.12 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.23 -10.5 80.15 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 114.492 0.557 . . . . 100.0 114.492 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -70.24 -38.76 75.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 127.15 2.18 . . . . 100.0 112.314 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HB2' HH11 ' A' ' 76' ' ' ARG . 96.6 mt-10 -62.29 137.03 58.19 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 124.973 1.309 . . . . 100.0 113.536 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.55 149.58 46.98 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.494 -1.23 . . . . 100.0 109.525 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -67.38 131.74 46.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.752 -1.944 . . . . 100.0 105.752 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.29 -176.1 40.27 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 118.788 -1.672 . . . . 100.0 114.474 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.72 64.38 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 127.188 2.327 . . . . 100.0 113.835 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.65 -37.72 85.09 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.21 1.804 . . . . 100.0 109.573 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.432 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.6 mtp85 -89.36 10.34 22.81 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 126.413 1.885 . . . . 100.0 115.762 -178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.8 -39.09 90.49 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 115.844 1.794 . . . . 100.0 115.844 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -57.89 -37.79 86.16 Favored Glycine 0 C--N 1.355 1.631 0 C-N-CA 124.171 0.891 . . . . 100.0 113.26 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -62.47 -43.0 99.87 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.721 1.208 . . . . 100.0 109.819 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.574 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.4 t80 -88.81 -18.99 26.54 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 114.905 1.446 . . . . 100.0 114.905 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.4 mt -57.25 131.65 21.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 CA-C-N 119.316 0.962 . . . . 100.0 109.667 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.279 91.6 mt-30 60.23 27.32 16.82 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 127.249 2.22 . . . . 100.0 115.377 -178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.3 46.75 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 107.029 -1.471 . . . . 100.0 107.029 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -106.35 -24.75 12.17 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-N 116.342 -0.39 . . . . 100.0 110.908 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.441 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -158.11 165.0 36.08 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.767 0.827 . . . . 100.0 109.233 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -148.78 155.79 41.45 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 119.627 -0.829 . . . . 100.0 112.863 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.8 mt -127.39 126.81 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.714 -2.328 . . . . 100.0 104.714 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 67.3 mt -110.52 124.85 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 103.789 -2.671 . . . . 100.0 103.789 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.565 ' HB3' HD21 ' A' ' 122' ' ' ASN . 55.7 mtt -112.64 135.4 53.41 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 116.549 2.055 . . . . 100.0 116.549 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -132.49 161.27 34.16 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 113.035 -1.893 . . . . 100.0 109.696 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.74 123.67 48.32 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.002 -1.851 . . . . 100.0 106.002 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -63.72 -20.38 26.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 N-CA-C 114.063 1.134 . . . . 100.0 114.063 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.6 p -90.18 -2.46 58.06 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 118.896 -0.573 . . . . 100.0 111.479 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.5 t -125.79 113.43 17.27 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 122.578 1.18 . . . . 100.0 111.678 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -65.22 -38.67 91.15 Favored 'General case' 0 CA--C 1.498 -1.026 0 CA-C-N 114.896 -1.047 . . . . 100.0 111.934 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.4 t -61.25 -41.89 91.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.882 0 C-N-CA 124.836 1.254 . . . . 100.0 108.956 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.479 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.6 m -62.62 -41.54 99.07 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 122.769 0.428 . . . . 100.0 110.532 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.01 -39.88 94.08 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.381 0.672 . . . . 100.0 110.841 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.45 -35.34 73.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 124.679 1.192 . . . . 100.0 111.578 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -76.03 -9.78 58.89 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 115.848 1.795 . . . . 100.0 115.848 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.4 ' N ' ' HD2' ' A' ' 102' ' ' PRO . 78.6 t -59.24 -44.99 99.21 Favored Pre-proline 0 C--N 1.363 1.174 0 CA-C-O 116.03 -1.938 . . . . 100.0 112.115 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 101' ' ' VAL . 30.2 Cg_endo -59.08 -31.64 95.93 Favored 'Trans proline' 0 C--N 1.376 2.022 0 CA-C-N 122.747 2.017 . . . . 100.0 113.058 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.65 -42.95 81.41 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.783 0.72 . . . . 100.0 109.818 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.471 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.1 m95 -63.91 -45.79 87.75 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 109.565 -0.532 . . . . 100.0 109.565 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -90.72 70.17 6.64 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.543 -1.28 . . . . 100.0 107.543 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -168.02 -55.2 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 100.329 -3.952 . . . . 100.0 100.329 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.61 -43.82 98.15 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 106.691 -1.596 . . . . 100.0 106.691 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.574 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.6 mp -63.02 -50.14 71.86 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 113.366 0.876 . . . . 100.0 113.366 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.267 33.3 m -67.25 -22.81 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.209 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.267 90.9 mtt180 -61.24 -39.89 92.0 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.705 -0.85 . . . . 100.0 108.705 178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.01 -47.54 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 113.735 1.013 . . . . 100.0 113.735 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.295 63.5 m -105.04 -2.28 24.62 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 119.405 3.113 . . . . 100.0 119.405 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.285 41.3 mt-10 54.96 -119.31 1.43 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.94 1.089 . . . . 100.0 113.94 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -94.49 110.73 22.5 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 120.151 1.341 . . . . 100.0 111.962 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.8 152.05 51.2 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 104.754 -2.313 . . . . 100.0 104.754 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.43 126.67 18.95 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.337 2.025 . . . . 100.0 112.251 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' HD22 ' A' ' 144' ' ' LEU . 64.5 mt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.747 -1.205 . . . . 100.0 107.747 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.46 132.15 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 114.416 -1.265 . . . . 100.0 108.417 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 79.2 mt -99.36 124.75 44.74 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.387 -2.079 . . . . 100.0 105.387 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -116.74 124.73 50.36 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 122.259 1.028 . . . . 100.0 111.577 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.09 102.73 2.84 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 104.911 -3.276 . . . . 100.0 104.911 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.565 HD21 ' HB3' ' A' ' 89' ' ' MET . 72.7 m-80 -81.17 163.15 23.28 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 124.954 1.302 . . . . 100.0 111.865 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.71 38.51 24.94 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 128.386 2.674 . . . . 100.0 114.826 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.57 -14.7 18.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 113.787 1.032 . . . . 100.0 113.787 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -64.38 -37.1 86.31 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.755 1.222 . . . . 100.0 109.597 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.27 131.32 29.94 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-O 122.127 0.965 . . . . 100.0 109.82 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.68 -45.5 92.51 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -85.36 77.08 10.03 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.599 0.714 . . . . 100.0 110.29 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -78.94 138.79 38.24 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.615 -1.254 . . . . 100.0 107.615 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -100.67 -43.62 6.09 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.489 -0.56 . . . . 100.0 109.489 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.13 107.8 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 105.225 -2.139 . . . . 100.0 105.225 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -77.78 148.54 34.74 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.088 -1.415 . . . . 100.0 109.158 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.42 -38.77 88.35 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.169 0.988 . . . . 100.0 110.161 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.11 -41.1 97.89 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.111 1.364 . . . . 100.0 111.066 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.9 m -62.43 -37.8 87.26 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.717 1.607 . . . . 100.0 113.465 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 88.9 mt -65.19 120.09 11.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 CA-C-O 122.382 1.087 . . . . 100.0 110.099 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.2 m -128.44 -7.89 3.63 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 125.626 1.571 . . . . 100.0 112.527 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.42 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 73.3 t80 -58.85 -41.36 86.81 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.124 1.37 . . . . 100.0 111.161 -176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 44.7 p-80 -61.28 -38.66 87.56 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 123.795 0.838 . . . . 100.0 111.716 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.92 -46.1 89.4 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.528 0.731 . . . . 100.0 111.367 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.57 -40.97 89.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.039 0.936 . . . . 100.0 112.838 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 72.9 mmtt -92.83 2.23 56.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 116.808 2.151 . . . . 100.0 116.808 -178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 54.96 47.83 21.28 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-O 123.13 1.443 . . . . 100.0 113.672 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.626 HD22 ' HB ' ' A' ' 117' ' ' ILE . 44.9 mt -110.55 159.85 17.17 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.91 -1.495 . . . . 100.0 107.481 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.442 ' HG3' ' CD1' ' A' ' 163' ' ' TRP . 92.3 mm-40 -97.14 141.9 29.71 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.421 -1.326 . . . . 100.0 107.421 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -118.0 132.78 56.35 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 120.977 0.417 . . . . 100.0 111.701 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.23 135.13 42.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.594 -0.73 . . . . 100.0 112.448 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -86.66 123.42 31.82 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.517 -3.512 . . . . 100.0 101.517 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.5 pt -135.07 157.14 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.966 0 CA-C-O 122.384 1.088 . . . . 100.0 111.263 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.3 t -141.19 114.01 8.39 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 105.853 -1.906 . . . . 100.0 105.853 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.775 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -64.0 -39.36 93.94 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 123.809 0.844 . . . . 100.0 108.776 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 210' ' ' PRO . 99.3 mttt -62.97 -46.8 85.99 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 126.682 1.993 . . . . 100.0 114.261 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.8 p -103.86 -0.46 29.11 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 114.962 1.467 . . . . 100.0 114.962 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 65.72 21.33 11.57 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 126.145 1.778 . . . . 100.0 114.048 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -70.58 120.29 16.0 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.142 -1.429 . . . . 100.0 107.142 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 54.02 33.64 18.0 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.175 2.19 . . . . 100.0 111.867 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -60.29 -38.68 84.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 114.678 1.362 . . . . 100.0 114.678 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -88.49 -10.74 47.97 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 115.786 1.773 . . . . 100.0 115.786 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.267 95.5 mttt -59.87 -45.57 98.26 Favored Pre-proline 0 C--N 1.358 0.962 0 N-CA-C 118.768 2.877 . . . . 100.0 118.768 -176.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -58.98 -41.99 56.29 Favored 'Trans proline' 0 C--N 1.372 1.79 0 CA-C-N 122.626 1.973 . . . . 100.0 113.696 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -64.9 -43.04 94.17 Favored 'General case' 0 CA--C 1.488 -1.405 0 O-C-N 124.083 0.865 . . . . 100.0 112.013 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.85 -43.1 94.13 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 112.96 0.726 . . . . 100.0 112.96 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.516 ' HE1' ' HE3' ' A' ' 167' ' ' LYS . 60.6 t-105 -63.21 -44.67 94.65 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 123.597 0.561 . . . . 100.0 110.408 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 85' ' ' CYS . 84.7 mt -61.16 -41.38 96.66 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 123.483 0.49 . . . . 100.0 110.806 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.85 99.36 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 123.705 0.802 . . . . 100.0 110.611 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 174' ' ' LEU . 93.8 mtt180 -61.7 -47.07 86.95 Favored 'General case' 0 CA--C 1.492 -1.261 0 CA-C-O 118.654 -0.689 . . . . 100.0 111.402 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.516 ' HE3' ' HE1' ' A' ' 163' ' ' TRP 0.26 92.9 mttt -66.95 -42.79 84.66 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 114.911 1.449 . . . . 100.0 114.911 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.4 mt -65.43 -46.88 78.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.247 0.832 . . . . 100.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.5 -38.28 73.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 124.018 0.927 . . . . 100.0 109.963 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.52 10.23 55.81 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-O 118.436 -1.202 . . . . 100.0 113.861 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.529 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 52.2 t0 -111.58 112.51 53.95 Favored Pre-proline 0 N--CA 1.437 -1.108 0 N-CA-C 106.018 -1.845 . . . . 100.0 106.018 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.07 -15.73 43.65 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.648 2.898 . . . . 100.0 112.67 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -92.78 2.77 56.57 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 124.941 1.296 . . . . 100.0 113.816 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 69.5 mt -59.19 133.21 55.89 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-N 119.576 1.08 . . . . 100.0 113.339 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -132.86 148.31 52.3 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.156 -1.384 . . . . 100.0 109.009 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -76.21 136.84 39.72 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.812 -1.551 . . . . 100.0 106.812 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.91 146.76 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 102.481 -3.155 . . . . 100.0 102.481 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.32 -46.2 83.47 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 115.387 1.625 . . . . 100.0 115.387 -175.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 55.6 ttm 94.98 122.84 0.02 OUTLIER Pre-proline 0 C--N 1.359 1.014 0 C-N-CA 127.647 2.379 . . . . 100.0 108.895 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -58.17 135.62 69.56 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.736 2.291 . . . . 100.0 110.366 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.62 127.65 33.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.711 1.257 . . . . 100.0 111.911 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.6 mt -98.14 137.23 37.22 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 104.162 -2.532 . . . . 100.0 104.162 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -63.63 132.0 95.05 Favored Pre-proline 0 N--CA 1.439 -0.997 0 C-N-CA 122.754 0.422 . . . . 100.0 111.887 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 183' ' ' ALA . 45.5 Cg_exo -65.64 147.16 85.91 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.819 3.013 . . . . 100.0 112.78 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 32.2 Cg_exo -63.93 147.6 91.93 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 123.505 2.803 . . . . 100.0 111.012 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -63.26 -43.55 97.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 123.816 0.846 . . . . 100.0 112.584 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.8 t 68.99 99.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 127.112 2.165 . . . . 100.0 111.81 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 79.0 t -119.48 -71.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 103.08 -2.933 . . . . 100.0 103.08 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.463 ' HB2' HD12 ' A' ' 193' ' ' LEU 0.256 77.1 mtp 9.34 -128.72 0.0 OUTLIER 'General case' 0 C--N 1.367 1.348 0 C-N-CA 131.396 3.879 . . . . 100.0 119.374 177.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.326 85.6 m-20 142.43 -39.71 0.0 OUTLIER Pre-proline 0 C--N 1.377 1.799 0 C-N-CA 131.383 3.873 . . . . 100.0 115.71 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.13 -75.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.966 0 CA-C-N 123.885 2.423 . . . . 100.0 117.164 -177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.38 -39.71 94.39 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 123.953 0.901 . . . . 100.0 110.973 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 189' ' ' MET . 52.1 mt -62.33 -38.2 88.55 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 117.468 2.396 . . . . 100.0 117.468 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.26 169.39 13.84 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 115.41 1.633 . . . . 100.0 115.41 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 73.96 -47.55 0.65 Allowed 'General case' 0 C--N 1.359 1.014 0 C-N-CA 127.956 2.502 . . . . 100.0 116.44 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -60.17 -35.72 75.98 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 126.758 2.023 . . . . 100.0 112.17 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -59.97 -39.26 85.05 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.35 1.06 . . . . 100.0 112.218 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -59.44 -38.36 80.49 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 124.614 1.166 . . . . 100.0 111.151 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.49 -45.4 93.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 118.813 -0.613 . . . . 100.0 110.912 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -65.9 -42.41 90.23 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 123.833 0.853 . . . . 100.0 112.255 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 91.0 mt -60.88 -41.63 96.38 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.751 0.82 . . . . 100.0 111.553 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -62.97 -43.39 98.93 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 124.348 1.059 . . . . 100.0 111.347 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.14 -45.51 98.44 Favored 'Isoleucine or valine' 0 C--N 1.362 1.114 0 N-CA-C 108.193 -1.04 . . . . 100.0 108.193 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.09 -44.69 95.03 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 113.928 1.084 . . . . 100.0 113.928 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -61.76 -44.36 97.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.738 1.215 . . . . 100.0 111.96 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.409 HG21 ' HE3' ' A' ' 38' ' ' LYS . 97.4 m -64.72 -43.64 92.75 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.459 1.504 . . . . 100.0 110.427 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 46.7 m -65.25 127.06 30.15 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 124.316 2.008 . . . . 100.0 115.079 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -115.54 148.87 39.02 Favored 'General case' 0 N--CA 1.428 -1.55 1 N-CA-C 99.344 -4.317 . . . . 100.0 99.344 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 93.3 mt -64.08 130.08 94.33 Favored Pre-proline 0 C--N 1.355 0.837 0 N-CA-C 112.599 0.592 . . . . 100.0 112.599 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.418 ' HB2' ' HB3' ' A' ' 152' ' ' LYS . 25.3 Cg_exo -76.1 85.07 1.71 Allowed 'Trans proline' 0 CA--C 1.492 -1.611 0 N-CA-C 117.963 2.255 . . . . 100.0 117.963 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -96.04 103.58 15.47 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 101.261 -3.607 . . . . 100.0 101.261 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -101.95 -74.82 0.61 Allowed 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 103.149 -2.908 . . . . 100.0 103.149 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -134.51 42.98 2.81 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 122.118 0.961 . . . . 100.0 108.727 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.91 -37.17 83.62 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 125.318 1.447 . . . . 100.0 110.04 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -61.02 -40.12 92.37 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.297 1.439 . . . . 100.0 111.964 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--O 1.256 1.447 0 CA-C-O 117.067 -1.444 . . . . 100.0 107.853 179.865 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttt . . . . . 0 CA--C 1.499 -1.013 0 CA-C-O 120.389 0.138 . . . . 100.0 110.642 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.01 95.41 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.096 1.358 . . . . 100.0 111.999 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.26 99.24 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.593 0.757 . . . . 100.0 109.785 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -66.94 -36.31 81.96 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 125.104 1.361 . . . . 100.0 111.627 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.63 22.5 31.11 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 108.589 -1.804 . . . . 100.0 108.589 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 9' ' ' VAL 0.386 24.7 tt0 -92.04 98.95 2.22 Favored Pre-proline 0 N--CA 1.42 -1.952 1 N-CA-C 100.13 -4.026 . . . . 100.0 100.13 -178.703 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -60.57 -50.8 6.07 Favored 'Trans proline' 0 C--N 1.387 2.6 0 N-CA-C 105.321 -2.607 . . . . 100.0 105.321 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 99.8 mm-40 -122.82 -69.77 0.81 Allowed 'General case' 0 N--CA 1.38 -3.963 1 N-CA-C 96.151 -5.5 . . . . 100.0 96.151 173.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.58 ' HA ' ' HG2' ' A' ' 6' ' ' GLU . 21.6 m -118.8 152.07 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 N-CA-C 118.533 2.79 . . . . 100.0 118.533 -176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' N ' ' HG3' ' A' ' 6' ' ' GLU . 51.9 tt0 -126.01 134.61 51.41 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 112.698 -2.046 . . . . 100.0 107.639 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -122.29 130.62 53.33 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 108.476 -0.935 . . . . 100.0 108.476 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.18 114.04 26.47 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.203 -1.777 . . . . 100.0 106.203 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 86' ' ' ALA . 39.5 tp -113.21 129.2 56.59 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-N 114.374 -1.284 . . . . 100.0 109.612 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -112.25 125.73 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 118.563 -1.255 . . . . 100.0 109.363 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 HG13 ' A' ' 63' ' ' VAL . 9.0 mp -101.81 121.33 41.89 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 108.074 -1.084 . . . . 100.0 108.074 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.76 160.38 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 CA-C-N 113.613 -1.631 . . . . 100.0 110.814 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.08 172.35 20.65 Favored Glycine 0 CA--C 1.493 -1.311 0 N-CA-C 109.893 -1.283 . . . . 100.0 109.893 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HB2' HG23 ' A' ' 97' ' ' THR . 85.3 m-20 -71.58 159.86 33.71 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.115 0.96 . . . . 100.0 113.189 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.07 139.8 40.92 Favored Glycine 0 C--N 1.353 1.495 0 N-CA-C 109.94 -1.264 . . . . 100.0 109.94 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.09 2.16 89.48 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-O 118.864 -0.964 . . . . 100.0 114.892 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.1 p -63.32 -39.32 94.25 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 114.31 1.226 . . . . 100.0 114.31 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.03 16.51 6.73 Favored Glycine 0 N--CA 1.431 -1.692 0 CA-C-O 118.666 -1.074 . . . . 100.0 112.003 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HG2' ' SD ' ' A' ' 89' ' ' MET . 10.2 mtmp? -60.0 -46.47 89.38 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 119.045 1.422 . . . . 100.0 111.664 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.0 m -64.13 -44.59 91.74 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.83 1.252 . . . . 100.0 110.967 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.1 m -63.47 -40.62 97.6 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 124.037 0.935 . . . . 100.0 109.954 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.36 -48.04 83.1 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 124.277 1.031 . . . . 100.0 111.227 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.54 -42.02 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 O-C-N 123.123 0.265 . . . . 100.0 111.026 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.69 -40.35 94.68 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 123.547 0.739 . . . . 100.0 111.188 -178.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.627 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.8 tmm_? -61.62 -43.46 98.82 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 123.606 0.762 . . . . 100.0 110.192 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -63.04 -42.17 99.69 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 112.352 0.501 . . . . 100.0 112.352 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -70.1 -43.96 70.0 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 115.912 1.819 . . . . 100.0 115.912 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.1 p -120.14 -24.88 5.87 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 117.891 2.552 . . . . 100.0 117.891 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.93 68.19 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.816 -0.914 . . . . 100.0 110.816 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HA ' ' HD2' ' A' ' 210' ' ' PRO . 49.3 mt-10 -76.9 152.36 35.41 Favored 'General case' 0 C--N 1.358 0.948 0 C-N-CA 124.137 0.975 . . . . 100.0 109.198 178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.31 117.67 31.75 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 102.074 -3.306 . . . . 100.0 102.074 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -92.61 117.92 30.47 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.4 -0.963 . . . . 100.0 108.4 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -94.08 -11.97 29.5 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.633 -1.167 . . . . 100.0 112.976 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.31 123.74 47.36 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.591 -0.892 . . . . 100.0 108.591 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -95.79 115.45 27.44 Favored 'General case' 0 CA--C 1.484 -1.592 0 CA-C-O 122.261 1.029 . . . . 100.0 111.117 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -121.25 123.96 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 101.216 -3.624 . . . . 100.0 101.216 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.2 139.29 58.49 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 113.942 1.09 . . . . 100.0 113.942 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 78.0 m -84.76 130.01 34.74 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.9 mt -104.25 127.32 51.87 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 106.857 -1.534 . . . . 100.0 106.857 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.57 -120.61 15.26 Favored Glycine 0 C--N 1.356 1.694 0 N-CA-C 109.808 -1.317 . . . . 100.0 109.808 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -133.99 144.82 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-O 120.931 0.396 . . . . 100.0 110.415 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -119.91 124.0 44.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 103.172 -2.899 . . . . 100.0 103.172 176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.1 t -101.31 120.82 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.26 -1.385 . . . . 100.0 107.26 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -127.11 123.02 23.31 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.85 -0.614 . . . . 100.0 111.772 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -80.81 129.81 7.31 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 124.165 3.243 . . . . 100.0 111.204 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -132.23 128.84 38.75 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.169 -1.048 . . . . 100.0 108.169 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.82 134.85 54.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.848 0 N-CA-C 108.462 -0.94 . . . . 100.0 108.462 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 52' ' ' PHE . 6.6 m-30 -124.8 140.86 52.54 Favored 'General case' 0 CA--C 1.497 -1.069 0 C-N-CA 125.675 1.59 . . . . 100.0 109.073 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -105.33 124.01 48.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.326 1.06 . . . . 100.0 108.884 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.5 p -119.58 -179.99 4.05 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.354 -1.294 . . . . 100.0 111.432 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -59.08 -36.36 74.96 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 127.281 2.233 . . . . 100.0 109.512 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -91.01 7.38 40.65 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 113.384 0.883 . . . . 100.0 113.384 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.03 179.6 20.78 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-N 118.853 0.751 . . . . 100.0 111.948 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -71.19 140.0 36.51 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 123.14 2.56 . . . . 100.0 113.225 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 pt -130.27 140.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.811 -1.552 . . . . 100.0 106.811 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -113.72 132.77 55.69 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.994 -1.082 . . . . 100.0 110.884 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -105.51 118.88 37.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.288 -2.116 . . . . 100.0 105.288 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -92.72 97.7 10.95 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 100.74 -3.8 . . . . 100.0 100.74 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG13 HD13 ' A' ' 15' ' ' LEU . 46.3 t -86.65 126.82 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 CA-C-O 121.297 0.57 . . . . 100.0 110.968 -177.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -108.1 99.38 8.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.188 -1.782 . . . . 100.0 106.188 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -89.13 117.52 28.18 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 105.004 -2.221 . . . . 100.0 105.004 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.8 p -97.67 164.87 12.23 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 113.805 1.039 . . . . 100.0 113.805 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.1 131.85 34.75 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 124.154 0.982 . . . . 100.0 109.304 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.09 -10.45 84.87 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 114.352 0.501 . . . . 100.0 114.352 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -69.97 -39.77 75.8 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 126.393 1.877 . . . . 100.0 112.485 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -62.92 134.82 56.8 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.035 0.934 . . . . 100.0 113.365 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -72.49 154.65 40.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.975 -1.012 . . . . 100.0 110.263 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -66.76 132.26 47.68 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.707 1.603 . . . . 100.0 106.949 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 162.41 -176.8 38.74 Favored Glycine 0 C--N 1.356 1.642 0 C-N-CA 119.212 -1.47 . . . . 100.0 114.621 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.52 -23.64 65.08 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 127.057 2.265 . . . . 100.0 113.744 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 75' ' ' LEU . 2.4 pt? -62.43 -31.86 72.62 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 124.488 1.115 . . . . 100.0 111.527 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.4 mtp-105 -92.33 10.21 30.75 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 125.631 1.572 . . . . 100.0 114.409 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -61.69 -38.02 86.28 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 116.082 1.882 . . . . 100.0 116.082 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.68 -38.68 92.24 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.77 0.7 . . . . 100.0 113.457 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -63.26 -42.72 99.17 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 124.157 0.983 . . . . 100.0 110.217 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.483 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 3.0 t80 -91.35 -18.59 24.04 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 114.726 1.38 . . . . 100.0 114.726 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.6 pt -61.18 136.42 24.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 CA-C-N 119.787 1.176 . . . . 100.0 111.19 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 63.66 21.93 12.91 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.719 2.008 . . . . 100.0 113.824 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.87 145.56 46.81 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 107.368 -1.345 . . . . 100.0 107.368 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -103.76 -24.02 13.37 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.883 -0.599 . . . . 100.0 110.71 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.489 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.6 p -159.38 165.51 33.11 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 123.536 0.735 . . . . 100.0 110.391 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.417 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -148.71 156.31 42.2 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 113.309 0.855 . . . . 100.0 113.309 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.416 HG13 HD11 ' A' ' 13' ' ' LEU . 96.2 mt -126.5 126.45 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 104.752 -2.314 . . . . 100.0 104.752 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 65.2 mt -108.21 124.22 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 N-CA-C 102.343 -3.206 . . . . 100.0 102.343 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.585 ' HB3' HD21 ' A' ' 122' ' ' ASN . 94.8 mtp -114.41 132.31 56.28 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.805 -1.089 . . . . 100.0 113.22 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -132.84 161.44 34.15 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.87 -1.513 . . . . 100.0 109.374 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -104.26 125.47 50.55 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.847 -1.538 . . . . 100.0 106.847 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.2 m -63.9 -19.42 24.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.952 1.093 . . . . 100.0 113.952 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.2 p -89.25 -4.87 58.02 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 119.262 -0.399 . . . . 100.0 111.474 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.0 t -125.56 115.23 19.86 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 122.737 1.256 . . . . 100.0 112.035 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.15 -39.49 93.07 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 114.491 -1.231 . . . . 100.0 110.984 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.08 -41.6 89.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.884 0 C-N-CA 125.073 1.349 . . . . 100.0 109.22 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.529 HG23 ' HB2' ' A' ' 18' ' ' ASP . 94.5 m -62.87 -41.78 99.52 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.161 0.584 . . . . 100.0 109.807 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -65.27 -39.79 93.06 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 123.246 0.618 . . . . 100.0 111.038 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -59.34 -36.72 76.21 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.738 1.215 . . . . 100.0 111.057 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.41 -10.88 60.01 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 115.552 1.686 . . . . 100.0 115.552 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -59.43 -44.02 97.22 Favored Pre-proline 0 C--N 1.361 1.072 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.777 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 85.9 Cg_exo -57.4 -35.29 98.87 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.759 2.306 . . . . 100.0 112.466 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -66.73 -43.08 85.15 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.884 0.874 . . . . 100.0 110.356 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.444 ' O ' HD13 ' A' ' 108' ' ' LEU . 87.4 m95 -63.79 -45.39 89.9 Favored 'General case' 0 C--N 1.367 1.343 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.458 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 51.0 t-80 -90.68 69.62 6.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.639 -1.245 . . . . 100.0 107.639 178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -169.4 -53.09 0.02 OUTLIER 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 100.592 -3.855 . . . . 100.0 100.592 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -60.81 -43.89 97.59 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.579 -1.638 . . . . 100.0 106.579 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.483 ' HG ' ' CZ ' ' A' ' 80' ' ' TYR . 6.6 mp -62.81 -48.64 78.25 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 124.303 1.041 . . . . 100.0 113.139 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.22 -34.26 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 C-N-CA 127.358 2.263 . . . . 100.0 110.696 -178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -58.25 -40.17 81.07 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 118.657 -0.687 . . . . 100.0 111.253 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.262 11.8 m -97.33 -34.95 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 116.009 1.855 . . . . 100.0 116.009 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.294 70.6 m -105.13 -3.19 23.34 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 118.23 2.678 . . . . 100.0 118.23 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 54.38 -121.8 1.86 Allowed 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.309 1.444 . . . . 100.0 113.462 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -94.48 109.2 21.1 Favored 'General case' 0 CA--C 1.489 -1.369 0 CA-C-O 122.335 1.064 . . . . 100.0 113.617 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.28 149.92 50.03 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 104.434 -2.432 . . . . 100.0 104.434 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -61.64 128.6 25.06 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.15 1.9 . . . . 100.0 113.138 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.563 ' HB ' HD22 ' A' ' 144' ' ' LEU . 70.7 mt -132.42 135.4 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.439 -1.319 . . . . 100.0 107.439 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.45 132.07 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 114.168 -1.378 . . . . 100.0 108.738 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.0 mt -98.15 125.64 43.26 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 105.686 -1.968 . . . . 100.0 105.686 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -118.05 125.22 49.9 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 122.017 0.913 . . . . 100.0 112.53 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.97 102.24 2.72 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 105.277 -3.129 . . . . 100.0 105.277 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.585 HD21 ' HB3' ' A' ' 89' ' ' MET . 70.1 m-80 -81.5 162.92 23.04 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 125.517 1.527 . . . . 100.0 112.865 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 57.86 42.3 23.41 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.65 2.38 . . . . 100.0 115.122 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' A' ' 148' ' ' ASP . 34.1 m -65.02 -16.24 19.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 CA-C-N 115.902 -0.59 . . . . 100.0 112.348 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -62.29 -37.91 87.35 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 124.216 1.006 . . . . 100.0 112.41 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.24 132.38 27.93 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 CA-C-O 121.844 0.83 . . . . 100.0 109.82 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.93 -45.5 92.18 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 116.76 2.133 . . . . 100.0 116.76 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -86.07 77.47 9.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.305 0.574 . . . . 100.0 110.706 -177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -81.43 132.75 35.34 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 108.849 -0.797 . . . . 100.0 108.849 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -99.06 -41.95 7.31 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 115.976 -0.556 . . . . 100.0 111.257 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.21 106.23 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.42 155.52 25.85 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.129 -0.942 . . . . 100.0 109.253 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.02 83.19 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.527 1.131 . . . . 100.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.56 -40.91 96.41 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 124.216 1.006 . . . . 100.0 111.755 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.6 m -61.51 -38.54 87.72 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 125.615 1.566 . . . . 100.0 113.22 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 86.3 mt -65.56 121.9 15.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.833 0 CA-C-O 122.074 0.94 . . . . 100.0 110.319 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.34 -9.61 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 114.093 -1.412 . . . . 100.0 112.009 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 71.4 t80 -58.57 -39.51 80.5 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.305 1.442 . . . . 100.0 111.746 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -60.89 -39.87 90.91 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 123.931 0.892 . . . . 100.0 111.695 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.19 -44.29 92.46 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.304 0.642 . . . . 100.0 112.147 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -65.08 -42.28 94.25 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.464 1.106 . . . . 100.0 111.53 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 72.9 mmtt -94.62 3.1 55.51 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 118.109 2.633 . . . . 100.0 118.109 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 55.08 47.18 22.53 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 123.137 1.446 . . . . 100.0 113.59 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.563 HD22 ' HB ' ' A' ' 117' ' ' ILE . 50.3 mt -110.63 160.02 17.05 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 113.9 -1.5 . . . . 100.0 107.369 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -101.98 140.76 35.84 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 107.25 -1.389 . . . . 100.0 107.25 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -115.2 134.81 54.81 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 121.204 0.526 . . . . 100.0 112.184 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.99 136.18 41.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 115.624 -0.716 . . . . 100.0 112.529 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.511 ' HB3' HG11 ' A' ' 124' ' ' VAL . 22.4 m-20 -87.55 123.77 32.79 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 101.724 -3.436 . . . . 100.0 101.724 175.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.4 pt -134.43 157.53 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.309 1.052 . . . . 100.0 111.914 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.4 t -141.9 115.87 9.3 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 105.942 -1.873 . . . . 100.0 105.942 176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.06 -38.94 93.17 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.964 0.905 . . . . 100.0 108.908 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.41 -43.84 93.13 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 125.832 1.653 . . . . 100.0 115.126 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.1 p -102.52 -4.16 25.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 114.604 1.335 . . . . 100.0 114.604 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 68.94 17.02 8.73 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.851 1.66 . . . . 100.0 113.25 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -66.97 119.64 12.29 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 107.59 -1.263 . . . . 100.0 107.59 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 54.48 30.85 13.64 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 127.048 2.139 . . . . 100.0 112.083 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -60.64 -38.23 84.11 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.372 1.249 . . . . 100.0 114.372 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -86.42 -13.86 45.01 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.598 1.703 . . . . 100.0 115.598 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.27 62.8 mttp -59.93 -45.68 98.16 Favored Pre-proline 0 C--N 1.358 0.952 0 N-CA-C 118.759 2.874 . . . . 100.0 118.759 -175.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.35 -41.28 60.05 Favored 'Trans proline' 0 C--N 1.372 1.766 0 CA-C-N 122.455 1.912 . . . . 100.0 113.573 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -63.83 -44.15 94.06 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.962 0.905 . . . . 100.0 110.945 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.06 -42.5 94.16 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 112.856 0.687 . . . . 100.0 112.856 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -62.07 -45.53 93.1 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 123.374 0.422 . . . . 100.0 110.41 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.489 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.1 mt -61.23 -41.7 97.33 Favored 'General case' 0 CA--C 1.494 -1.187 0 O-C-N 123.803 0.689 . . . . 100.0 110.854 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.61 -43.37 98.98 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 123.56 0.744 . . . . 100.0 110.556 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -62.05 -45.87 91.64 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 118.568 -0.729 . . . . 100.0 112.233 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -68.99 -42.69 76.18 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 119.981 -0.688 . . . . 100.0 112.582 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.48 -46.33 80.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 113.666 0.987 . . . . 100.0 113.666 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.02 -38.23 74.64 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 124.536 1.135 . . . . 100.0 109.56 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.39 9.93 54.59 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 118.371 -1.239 . . . . 100.0 114.6 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.499 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 57.8 t0 -113.61 112.48 48.4 Favored Pre-proline 0 N--CA 1.437 -1.125 0 N-CA-C 106.969 -1.493 . . . . 100.0 106.969 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.31 -15.36 45.62 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.831 3.02 . . . . 100.0 113.025 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -93.04 1.43 57.26 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 114.411 1.263 . . . . 100.0 114.411 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 92.9 mt -60.97 133.88 56.54 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 119.452 1.024 . . . . 100.0 113.647 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -134.14 153.46 51.81 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.683 -1.144 . . . . 100.0 109.802 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -81.24 130.71 35.15 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 105.253 -2.129 . . . . 100.0 105.253 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.0 m -131.68 141.33 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 N-CA-C 112.535 0.569 . . . . 100.0 112.535 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 49.03 -121.39 1.53 Allowed 'General case' 0 C--N 1.361 1.088 0 C-N-CA 126.121 1.768 . . . . 100.0 112.111 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . 0.29 58.9 tpp 117.35 107.44 0.0 OUTLIER Pre-proline 0 CA--C 1.491 -1.305 0 C-N-CA 130.135 3.374 . . . . 100.0 109.506 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.82 167.57 26.89 Favored 'Trans proline' 0 N--CA 1.437 -1.813 0 C-N-CA 123.081 2.52 . . . . 100.0 108.4 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -61.98 145.7 52.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.171 0.51 . . . . 100.0 110.972 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.8 132.0 51.0 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.677 1.191 . . . . 100.0 112.354 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -104.09 146.95 33.54 Favored Pre-proline 0 N--CA 1.425 -1.687 0 CA-C-N 114.014 -1.448 . . . . 100.0 112.59 -176.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 183' ' ' ALA . 31.8 Cg_exo -65.8 157.88 56.63 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 124.382 3.388 . . . . 100.0 110.045 178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -60.55 148.36 91.37 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 123.188 2.592 . . . . 100.0 113.561 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -61.62 138.24 58.29 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 124.723 1.264 . . . . 100.0 110.683 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.0 135.87 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 106.607 -1.627 . . . . 100.0 106.607 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.38 -76.52 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 107.973 -1.121 . . . . 100.0 107.973 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.7 ptm -80.8 -176.01 5.62 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 116.91 -1.519 . . . . 100.0 111.463 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -122.55 -46.96 0.04 OUTLIER Pre-proline 0 C--N 1.361 1.103 0 O-C-N 118.342 -2.723 . . . . 100.0 118.146 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.91 -62.66 0.26 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 N-CA-C 121.339 3.553 . . . . 100.0 121.339 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.67 -41.08 88.71 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 118.878 0.763 . . . . 100.0 111.441 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.22 -37.01 85.57 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 116.242 1.941 . . . . 100.0 116.242 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.2 167.29 8.43 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 115.125 1.528 . . . . 100.0 115.125 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 75.79 -49.74 0.61 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 128.44 2.696 . . . . 100.0 115.426 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -60.31 -35.3 75.28 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 126.023 1.729 . . . . 100.0 112.62 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -59.7 -38.58 82.01 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 113.925 1.083 . . . . 100.0 113.925 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.75 -40.35 92.12 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 123.632 0.773 . . . . 100.0 110.577 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -61.8 -42.62 99.24 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.389 0.676 . . . . 100.0 110.515 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -64.06 -43.35 95.73 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.642 1.177 . . . . 100.0 111.484 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.7 mt -61.53 -43.55 98.66 Favored 'General case' 0 CA--C 1.491 -1.315 0 C-N-CA 123.432 0.693 . . . . 100.0 111.678 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -63.5 -44.94 92.89 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 123.79 0.836 . . . . 100.0 112.334 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.25 35.7 m -62.89 -39.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.364 1.196 0 CA-C-O 118.657 -0.687 . . . . 100.0 110.441 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.2 -44.25 88.99 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.089 0.955 . . . . 100.0 112.928 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -62.89 -41.6 99.48 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 124.709 1.204 . . . . 100.0 111.863 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 86.7 m -66.31 -42.27 88.5 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 125.795 1.638 . . . . 100.0 111.934 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 96.1 m -62.19 130.58 46.08 Favored 'General case' 0 C--N 1.359 0.998 0 CA-C-O 121.97 0.891 . . . . 100.0 111.184 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -84.05 134.15 34.63 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 105.496 -2.039 . . . . 100.0 105.496 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 69.4 mt -114.41 128.32 25.95 Favored Pre-proline 0 N--CA 1.433 -1.325 0 N-CA-C 107.834 -1.173 . . . . 100.0 107.834 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.596 ' HD2' ' HA ' ' A' ' 34' ' ' GLU . 38.9 Cg_exo -79.59 67.99 8.43 Favored 'Trans proline' 0 C--N 1.367 1.545 0 N-CA-C 106.23 -2.258 . . . . 100.0 106.23 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -80.13 121.12 25.16 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-O 121.833 0.825 . . . . 100.0 109.684 -176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -99.14 -58.41 1.94 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 104.999 -2.223 . . . . 100.0 104.999 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 57.7 p30 -149.94 11.43 0.74 Allowed 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 124.636 1.175 . . . . 100.0 111.193 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -59.88 -35.84 75.65 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 127.493 2.317 . . . . 100.0 115.923 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.09 -43.88 95.21 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 123.234 0.614 . . . . 100.0 111.569 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--O 1.259 1.577 0 CA-C-O 115.915 -1.993 . . . . 100.0 105.731 179.833 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 CA--C 1.492 -1.262 0 N-CA-C 110.042 -0.355 . . . . 100.0 110.042 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.17 95.45 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.075 1.35 . . . . 100.0 111.799 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.78 -42.53 99.12 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.615 0.766 . . . . 100.0 109.714 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.87 -38.04 85.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.609 1.564 . . . . 100.0 111.093 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.29 23.01 30.41 Favored Glycine 0 C--N 1.359 1.843 0 N-CA-C 108.592 -1.803 . . . . 100.0 108.592 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 8' ' ' GLN 0.391 32.6 tt0 -91.32 103.52 7.7 Favored Pre-proline 0 N--CA 1.421 -1.883 0 N-CA-C 100.588 -3.856 . . . . 100.0 100.588 -179.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.78 -52.65 2.78 Favored 'Trans proline' 0 C--N 1.388 2.61 0 N-CA-C 103.517 -3.301 . . . . 100.0 103.517 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 10.8 tp-100 -125.1 -63.19 1.17 Allowed 'General case' 1 N--CA 1.375 -4.197 1 N-CA-C 97.435 -5.024 . . . . 100.0 97.435 174.672 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.2 t -117.77 144.61 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 115.568 1.692 . . . . 100.0 115.568 -174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 49.1 tt0 -125.43 133.93 52.29 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 176.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -121.95 130.72 53.55 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.88 116.07 28.41 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.96 -1.496 . . . . 100.0 106.96 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD11 HG13 ' A' ' 87' ' ' ILE . 57.2 tp -110.31 127.07 54.84 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 113.964 -1.471 . . . . 100.0 107.999 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -107.83 124.86 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 N-CA-C 107.024 -1.472 . . . . 100.0 107.024 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.9 tp -105.73 116.9 32.73 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 106.734 -1.58 . . . . 100.0 106.734 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.58 162.09 36.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 114.481 -1.236 . . . . 100.0 112.414 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.46 170.87 18.16 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 109.605 -1.398 . . . . 100.0 109.605 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.496 ' HB2' HG23 ' A' ' 97' ' ' THR . 84.0 m-20 -70.52 160.7 31.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.479 0.918 . . . . 100.0 113.479 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.63 140.19 40.34 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 110.865 -0.894 . . . . 100.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 2.76 90.44 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.646 -1.085 . . . . 100.0 114.303 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.0 p -63.55 -39.17 93.7 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 118.522 1.161 . . . . 100.0 114.131 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 16.8 6.28 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.711 -0.757 . . . . 100.0 111.926 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -59.91 -47.9 83.9 Favored 'General case' 0 C--N 1.356 0.882 0 CA-C-N 118.58 1.19 . . . . 100.0 111.461 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.4 m -64.67 -43.35 93.87 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.986 1.314 . . . . 100.0 111.034 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.9 m -63.47 -40.62 97.59 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.163 0.985 . . . . 100.0 109.5 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -61.14 -48.29 82.31 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 124.677 1.191 . . . . 100.0 110.319 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.76 -41.89 93.45 Favored 'Isoleucine or valine' 0 C--N 1.357 0.919 0 O-C-N 123.277 0.36 . . . . 100.0 111.699 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -61.02 -42.34 98.28 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.624 0.769 . . . . 100.0 110.718 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.584 HH21 ' HA ' ' A' ' 151' ' ' ALA . 3.2 tmm_? -62.28 -42.91 99.75 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.305 0.642 . . . . 100.0 110.706 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -63.96 -41.83 97.46 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 113.191 0.811 . . . . 100.0 113.191 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.28 -44.45 68.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 115.232 1.567 . . . . 100.0 115.232 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.8 p -120.02 -23.67 6.28 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 118.317 2.71 . . . . 100.0 118.317 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.65 -7.67 71.05 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.311 -0.716 . . . . 100.0 111.311 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.04 154.38 37.99 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.85 1.26 . . . . 100.0 109.456 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.491 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 91.3 m-85 -115.61 120.52 39.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 103.322 -2.844 . . . . 100.0 103.322 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -94.73 115.95 28.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.51 0.724 . . . . 100.0 109.16 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -91.39 -31.81 15.89 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.989 -0.284 . . . . 100.0 111.603 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.13 129.83 34.88 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-O 121.375 0.607 . . . . 100.0 111.379 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -96.97 116.51 29.32 Favored 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 122.116 0.96 . . . . 100.0 112.265 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.61 121.95 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 101.048 -3.686 . . . . 100.0 101.048 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.09 142.25 57.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 123.708 0.803 . . . . 100.0 113.077 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.6 m -92.61 127.83 38.25 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mp -103.99 126.26 50.98 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 107.387 -1.338 . . . . 100.0 107.387 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.48 -121.69 15.83 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.949 -1.261 . . . . 100.0 109.949 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.3 142.6 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-O 121.138 0.495 . . . . 100.0 110.602 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.91 122.89 43.33 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 102.721 -3.066 . . . . 100.0 102.721 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.39 116.68 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 107.168 -1.419 . . . . 100.0 107.168 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -124.4 121.69 25.97 Favored Pre-proline 0 N--CA 1.437 -1.079 0 N-CA-C 112.403 0.52 . . . . 100.0 112.403 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 60' ' ' LYS . 90.1 Cg_endo -80.05 129.4 7.87 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 124.067 3.178 . . . . 100.0 112.602 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.6 tp -132.75 126.59 32.79 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.126 -1.435 . . . . 100.0 107.126 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.18 135.36 49.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.351 -0.611 . . . . 100.0 109.351 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -120.13 137.51 54.12 Favored 'General case' 0 CA--C 1.488 -1.42 0 C-N-CA 125.138 1.375 . . . . 100.0 107.407 177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -103.52 125.24 49.96 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.708 -2.33 . . . . 100.0 104.708 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.2 p -124.71 176.97 6.22 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 121.751 0.786 . . . . 100.0 110.421 -178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -60.41 -27.0 67.12 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 125.295 1.438 . . . . 100.0 110.075 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -94.4 7.11 46.64 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 126.785 2.034 . . . . 100.0 112.974 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.0 175.85 25.58 Favored Glycine 0 C--N 1.357 1.7 0 N-CA-C 111.133 -0.787 . . . . 100.0 111.133 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -71.36 138.88 33.76 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 123.423 2.748 . . . . 100.0 113.444 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -132.04 142.37 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 106.974 -1.491 . . . . 100.0 106.974 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' HD2' ' HB2' ' A' ' 49' ' ' PRO . 33.9 ttpt -116.97 131.32 56.98 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 118.074 -1.45 . . . . 100.0 111.403 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -102.87 119.17 38.36 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 105.325 -2.102 . . . . 100.0 105.325 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' ND2' ' HE1' ' A' ' 64' ' ' TRP . 46.5 t30 -94.37 100.8 12.76 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 100.344 -3.947 . . . . 100.0 100.344 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.4 t -87.9 125.77 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.992 0 CA-C-N 115.309 -0.86 . . . . 100.0 109.251 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.488 ' HE1' ' ND2' ' A' ' 62' ' ' ASN . 19.7 m0 -107.34 103.88 13.35 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -85.05 116.88 23.69 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 104.584 -2.376 . . . . 100.0 104.584 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.7 p -103.5 163.05 12.54 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 113.393 0.886 . . . . 100.0 113.393 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.73 132.28 36.14 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 123.78 0.832 . . . . 100.0 110.778 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.52 -8.07 77.98 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 113.834 0.294 . . . . 100.0 113.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -70.41 -39.56 74.37 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.73 2.012 . . . . 100.0 112.396 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.481 ' HB2' HH11 ' A' ' 76' ' ' ARG . 95.1 mt-10 -62.96 137.75 58.36 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 125.035 1.334 . . . . 100.0 112.459 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -70.41 151.65 44.94 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.468 -1.242 . . . . 100.0 111.011 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -65.55 131.17 45.71 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 126.607 1.963 . . . . 100.0 107.547 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.12 -173.81 36.01 Favored Glycine 0 C--N 1.357 1.728 0 C-N-CA 118.895 -1.622 . . . . 100.0 115.632 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -20.15 62.64 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 127.699 2.571 . . . . 100.0 113.383 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.16 -38.14 82.27 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.039 2.135 . . . . 100.0 109.104 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.481 HH11 ' HB2' ' A' ' 70' ' ' GLU . 78.2 mtp85 -92.18 12.85 20.84 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.653 1.981 . . . . 100.0 115.599 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.11 -39.18 91.63 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 115.417 1.636 . . . . 100.0 115.417 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.5 90.83 Favored Glycine 0 C--N 1.357 1.695 0 C-N-CA 123.956 0.788 . . . . 100.0 113.731 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.4 m-30 -62.13 -43.3 99.14 Favored 'General case' 0 N--CA 1.434 -1.254 0 C-N-CA 124.514 1.126 . . . . 100.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.596 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 2.5 t80 -87.02 -22.69 25.34 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 115.204 1.557 . . . . 100.0 115.204 -174.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.5 mt -57.21 133.36 21.8 Favored 'Isoleucine or valine' 0 C--N 1.363 1.154 0 CA-C-N 119.342 0.973 . . . . 100.0 109.732 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 63.45 23.18 13.58 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 127.141 2.176 . . . . 100.0 114.858 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.83 147.53 45.35 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.139 -1.06 . . . . 100.0 108.139 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -108.2 -22.13 12.49 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 116.419 -0.355 . . . . 100.0 111.261 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.411 ' HB2' HD22 ' A' ' 164' ' ' LEU . 16.4 p -156.63 164.41 38.21 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.752 -0.462 . . . . 100.0 109.752 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -148.53 155.65 41.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 113.308 0.855 . . . . 100.0 113.308 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.403 HG13 HD11 ' A' ' 13' ' ' LEU . 96.5 mt -127.74 126.88 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 104.319 -2.474 . . . . 100.0 104.319 176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 68.1 mt -109.96 122.44 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 103.243 -2.873 . . . . 100.0 103.243 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 46.8 mtt -112.05 134.75 53.41 Favored 'General case' 0 CA--C 1.482 -1.639 0 N-CA-C 115.977 1.843 . . . . 100.0 115.977 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -131.49 159.83 36.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 113.556 -1.656 . . . . 100.0 109.181 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -103.98 124.66 49.41 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.847 -1.909 . . . . 100.0 105.847 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.46 -20.24 25.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 N-CA-C 113.79 1.033 . . . . 100.0 113.79 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.3 p -91.35 -2.93 57.22 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 119.146 -0.454 . . . . 100.0 112.014 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.2 t -122.67 115.04 21.41 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 122.92 1.343 . . . . 100.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -64.27 -41.96 96.67 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.095 -1.411 . . . . 100.0 110.689 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.15 -42.31 92.81 Favored 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 125.244 1.417 . . . . 100.0 109.35 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 18' ' ' ASP . 98.2 m -62.96 -41.43 99.52 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 122.475 0.31 . . . . 100.0 110.981 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -65.15 -41.06 95.1 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.636 0.775 . . . . 100.0 111.037 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 95.1 mttt -60.47 -35.18 75.26 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 125.106 1.362 . . . . 100.0 111.304 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -76.88 -9.28 58.58 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 115.827 1.788 . . . . 100.0 115.827 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.8 t -59.58 -43.26 95.36 Favored Pre-proline 0 C--N 1.361 1.103 0 CA-C-O 116.365 -1.779 . . . . 100.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 71.8 Cg_exo -57.37 -35.17 98.87 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.7 2.267 . . . . 100.0 112.685 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -66.7 -43.13 85.18 Favored 'General case' 0 C--N 1.355 0.827 0 CA-C-N 118.683 0.674 . . . . 100.0 110.826 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.495 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.7 m95 -63.61 -46.38 86.0 Favored 'General case' 0 C--N 1.366 1.296 0 N-CA-C 109.556 -0.535 . . . . 100.0 109.556 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -90.8 70.14 6.56 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.843 1.306 . . . . 100.0 107.768 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -165.07 -59.12 0.03 OUTLIER 'General case' 0 CA--C 1.479 -1.774 1 N-CA-C 99.536 -4.246 . . . . 100.0 99.536 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -63.05 -39.72 95.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 123.877 0.736 . . . . 100.0 109.224 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.596 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -61.91 -50.31 72.68 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 123.757 0.661 . . . . 100.0 112.123 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.264 34.2 m -66.35 -27.86 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 N-CA-C 113.046 0.758 . . . . 100.0 113.046 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -60.94 -39.14 88.36 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 118.247 0.476 . . . . 100.0 109.951 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 80.3 t -86.89 -47.98 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 113.909 1.077 . . . . 100.0 113.909 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.304 62.1 m -106.46 1.76 25.8 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 120.074 3.361 . . . . 100.0 120.074 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 55.56 -121.39 1.69 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.377 1.071 . . . . 100.0 113.241 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -97.43 112.58 24.36 Favored 'General case' 0 C--N 1.362 1.135 0 CA-C-N 119.911 1.232 . . . . 100.0 111.6 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 41.4 pt -144.62 149.5 43.85 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 104.49 -2.411 . . . . 100.0 104.49 176.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -61.27 129.26 27.73 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.28 1.987 . . . . 100.0 112.608 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.72 ' HB ' HD22 ' A' ' 144' ' ' LEU . 66.9 mt -133.12 135.92 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 107.275 -1.379 . . . . 100.0 107.275 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.08 131.67 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 114.303 -1.317 . . . . 100.0 108.389 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 139' ' ' HIS 0.261 86.0 mt -98.82 127.31 44.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.461 -2.051 . . . . 100.0 105.461 177.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.74 125.34 49.43 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.871 0.843 . . . . 100.0 111.686 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.68 101.1 2.57 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 104.026 -3.629 . . . . 100.0 104.026 178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.83 162.02 24.19 Favored 'General case' 0 CA--C 1.495 -1.164 0 C-N-CA 124.966 1.306 . . . . 100.0 112.532 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 58.1 40.81 24.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 127.76 2.424 . . . . 100.0 115.324 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.39 -15.0 18.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 112.634 0.605 . . . . 100.0 112.634 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.43 -38.87 91.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 126.051 1.74 . . . . 100.0 110.35 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.45 131.58 29.04 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 124.024 0.93 . . . . 100.0 109.8 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.56 -42.88 91.35 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 116.593 2.072 . . . . 100.0 116.593 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -84.45 74.56 10.36 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-O 121.697 0.761 . . . . 100.0 110.121 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -83.73 137.42 33.76 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 115.669 -0.696 . . . . 100.0 110.557 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.66 -44.91 4.96 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 116.009 -0.541 . . . . 100.0 110.724 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.4 t -95.55 107.16 19.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 105.765 -1.939 . . . . 100.0 105.765 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -81.35 150.14 28.57 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 114.756 -1.111 . . . . 100.0 109.755 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.46 87.73 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 124.658 1.183 . . . . 100.0 111.988 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -62.4 -40.82 97.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.021 0.928 . . . . 100.0 111.267 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.3 m -62.15 -35.55 79.13 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.897 1.679 . . . . 100.0 113.511 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.37 121.36 13.24 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 CA-C-O 122.66 1.219 . . . . 100.0 109.774 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.604 HG12 HH21 ' A' ' 140' ' ' ARG . 29.2 m -128.49 -9.59 3.46 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 CA-C-N 113.331 -1.759 . . . . 100.0 112.812 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.19 -41.85 84.82 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 125.233 1.413 . . . . 100.0 111.789 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.45 ' HB3' HD12 ' A' ' 119' ' ' LEU . 45.2 p-80 -61.47 -40.29 94.0 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 118.65 -0.691 . . . . 100.0 112.687 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.604 HH21 HG12 ' A' ' 137' ' ' VAL . 91.8 mtm-85 -64.41 -43.16 95.27 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 118.687 0.676 . . . . 100.0 112.301 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.47 -41.3 93.48 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 124.31 1.044 . . . . 100.0 111.638 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.2 7.2 47.08 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 117.488 2.403 . . . . 100.0 117.488 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.44 49.38 16.94 Favored 'General case' 0 C--N 1.362 1.144 0 CA-C-O 122.756 1.265 . . . . 100.0 112.813 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.72 HD22 ' HB ' ' A' ' 117' ' ' ILE . 43.7 mt -116.96 160.98 20.08 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.048 -1.093 . . . . 100.0 108.048 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.44 ' HG3' ' NE1' ' A' ' 163' ' ' TRP . 97.5 mm-40 -98.87 140.54 32.89 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -117.05 134.83 54.26 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.557 0.694 . . . . 100.0 112.41 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -134.15 136.87 44.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.328 -0.851 . . . . 100.0 111.999 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -88.29 125.45 34.67 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 101.165 -3.643 . . . . 100.0 101.165 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.93 157.29 38.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.883 0 CA-C-O 122.138 0.971 . . . . 100.0 111.978 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.3 t -141.86 116.43 9.67 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 105.285 -2.117 . . . . 100.0 105.285 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HA ' HH21 ' A' ' 29' ' ' ARG . . . -63.43 -40.8 98.13 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.651 0.78 . . . . 100.0 109.651 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -69.32 -42.29 75.54 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 115.151 1.537 . . . . 100.0 115.151 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 47.7 m -93.16 -7.74 44.48 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 114.291 1.219 . . . . 100.0 114.291 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.471 HD21 ' HZ ' ' A' ' 35' ' ' PHE . 87.4 m-20 66.56 18.63 10.81 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 126.147 1.779 . . . . 100.0 112.81 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -69.66 118.92 13.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 107.45 -1.315 . . . . 100.0 107.45 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.52 33.16 15.57 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 127.383 2.273 . . . . 100.0 111.701 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -61.47 -39.31 90.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 115.324 1.601 . . . . 100.0 115.324 -175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -89.47 -8.12 53.58 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 115.616 1.71 . . . . 100.0 115.616 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 95.8 mttt -61.03 -44.27 93.85 Favored Pre-proline 0 N--CA 1.439 -1.021 0 N-CA-C 118.189 2.663 . . . . 100.0 118.189 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.11 -41.3 61.94 Favored 'Trans proline' 0 C--N 1.374 1.894 0 CA-C-N 122.459 1.914 . . . . 100.0 112.994 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -64.5 -43.97 92.44 Favored 'General case' 0 CA--C 1.495 -1.141 0 O-C-N 124.055 0.847 . . . . 100.0 112.062 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.8 mt -65.0 -42.86 94.11 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 113.098 0.777 . . . . 100.0 113.098 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.44 ' NE1' ' HG3' ' A' ' 145' ' ' GLN . 62.9 t-105 -62.82 -45.89 90.5 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 123.453 0.471 . . . . 100.0 110.224 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' A' ' 85' ' ' CYS . 79.1 mt -60.65 -42.83 97.78 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 123.653 0.595 . . . . 100.0 110.819 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.32 99.08 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 123.668 0.787 . . . . 100.0 111.107 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.05 -45.12 94.95 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 123.609 0.764 . . . . 100.0 112.024 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -68.64 -43.4 76.36 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 112.469 0.544 . . . . 100.0 112.469 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.17 -46.64 80.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 113.195 0.813 . . . . 100.0 113.195 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.85 -38.62 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 C-N-CA 125.127 1.371 . . . . 100.0 110.455 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.96 11.82 57.25 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-O 118.678 -1.068 . . . . 100.0 112.818 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -109.62 109.25 59.85 Favored Pre-proline 0 C--N 1.361 1.075 0 N-CA-C 106.719 -1.586 . . . . 100.0 106.719 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.35 -22.23 66.32 Favored 'Trans proline' 0 C--N 1.365 1.396 0 C-N-CA 124.087 3.191 . . . . 100.0 113.462 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -100.17 12.0 38.02 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 114.079 1.14 . . . . 100.0 114.079 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.16 131.65 51.17 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.516 0.726 . . . . 100.0 109.946 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -134.72 149.57 50.48 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 115.883 -0.599 . . . . 100.0 111.158 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -77.24 136.27 38.52 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.632 -1.248 . . . . 100.0 107.632 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.97 155.43 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.731 -1.211 . . . . 100.0 107.731 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -40.67 -96.33 0.0 OUTLIER 'General case' 0 C--N 1.355 0.827 0 N-CA-C 118.178 2.658 . . . . 100.0 118.178 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.496 ' SD ' ' HD2' ' A' ' 180' ' ' PRO . 46.0 tpp -160.57 142.03 9.08 Favored Pre-proline 0 N--CA 1.442 -0.842 0 N-CA-C 106.499 -1.667 . . . . 100.0 106.499 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.496 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 40.5 Cg_endo -63.92 138.6 63.71 Favored 'Trans proline' 0 CA--C 1.49 -1.675 0 C-N-CA 122.997 2.465 . . . . 100.0 110.787 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -95.37 105.66 17.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.728 -2.323 . . . . 100.0 104.728 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 64.8 mt -101.12 157.19 16.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.882 -1.053 . . . . 100.0 108.273 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.12 118.26 71.13 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.677 -2.342 . . . . 100.0 104.677 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.43 143.09 62.05 Favored 'Trans proline' 0 N--CA 1.44 -1.663 0 C-N-CA 123.687 2.925 . . . . 100.0 116.211 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.26 160.58 48.46 Favored 'Trans proline' 0 C--N 1.364 1.358 0 C-N-CA 123.626 2.884 . . . . 100.0 108.889 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -60.95 -48.15 83.17 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 112.927 0.714 . . . . 100.0 112.927 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.254 39.0 t 60.47 96.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.871 2.068 . . . . 100.0 112.603 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.5 t -114.18 -91.05 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 102.191 -3.263 . . . . 100.0 102.191 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.8 mtm 50.19 -130.35 2.06 Favored 'General case' 0 C--N 1.364 1.227 0 C-N-CA 127.951 2.501 . . . . 100.0 115.145 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.684 ' HA ' ' HB2' ' A' ' 193' ' ' LEU 0.338 63.2 m-20 71.6 12.62 0.0 OUTLIER Pre-proline 0 C--N 1.365 1.277 1 N-CA-C 124.788 5.107 . . . . 100.0 124.788 -179.557 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.85 -75.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.381 2.289 0 CA-C-N 124.886 2.781 . . . . 100.0 110.18 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.66 -37.26 86.02 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 126.012 1.725 . . . . 100.0 109.866 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.684 ' HB2' ' HA ' ' A' ' 190' ' ' ASP . 88.7 mt -60.48 -41.5 94.32 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 116.11 1.893 . . . . 100.0 116.11 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.26 175.06 9.4 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 114.929 1.455 . . . . 100.0 114.929 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 74.04 -49.97 0.68 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 128.048 2.539 . . . . 100.0 115.726 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.09 -34.44 73.47 Favored 'General case' 0 CA--C 1.497 -1.068 0 C-N-CA 126.739 2.016 . . . . 100.0 112.032 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -59.93 -41.67 92.3 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 113.662 0.986 . . . . 100.0 113.662 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -62.36 -40.34 96.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 118.378 0.535 . . . . 100.0 111.921 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -62.44 -41.62 98.86 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 123.245 0.618 . . . . 100.0 110.006 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -64.69 -41.12 96.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.255 1.422 . . . . 100.0 111.431 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.4 -42.82 99.34 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 123.882 0.873 . . . . 100.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -63.0 -45.55 91.87 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 123.995 0.918 . . . . 100.0 111.801 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . 0.259 34.5 m -62.9 -39.26 84.37 Favored 'Isoleucine or valine' 0 C--N 1.363 1.193 0 CA-C-O 119.025 -0.512 . . . . 100.0 110.377 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.69 92.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.916 1.286 . . . . 100.0 112.238 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -62.74 -39.69 94.88 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.523 1.129 . . . . 100.0 111.43 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 84.8 m -65.52 -42.54 91.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.697 1.599 . . . . 100.0 111.488 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.8 m -61.54 133.13 55.34 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.259 1.024 . . . . 100.0 112.329 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -69.77 144.03 52.81 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 115.019 -0.991 . . . . 100.0 108.973 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 63.7 mt -105.82 123.44 39.25 Favored Pre-proline 0 CA--C 1.492 -1.275 0 C-N-CA 120.736 -0.386 . . . . 100.0 111.191 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -63.37 143.61 89.14 Favored 'Trans proline' 0 N--CA 1.438 -1.756 0 C-N-CA 122.781 2.321 . . . . 100.0 109.493 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -80.89 106.78 13.16 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 104.958 -2.238 . . . . 100.0 104.958 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -121.49 -55.94 1.91 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.522 -1.217 . . . . 100.0 107.867 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.491 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 37.2 p30 -112.85 10.99 19.15 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 115.708 1.744 . . . . 100.0 115.708 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -60.98 -33.49 73.3 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 125.057 1.343 . . . . 100.0 113.42 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -59.24 -41.04 87.78 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.22 1.808 . . . . 100.0 112.284 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--O 1.258 1.524 0 CA-C-O 116.991 -1.481 . . . . 100.0 107.779 -179.561 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 120.601 0.238 . . . . 100.0 111.125 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.35 -38.89 85.23 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 125.212 1.405 . . . . 100.0 111.364 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.24 99.25 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.592 0.757 . . . . 100.0 110.131 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -67.96 -36.32 79.87 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.815 1.246 . . . . 100.0 111.147 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.63 39.89 Favored Glycine 0 CA--C 1.486 -1.74 0 N-CA-C 108.475 -1.85 . . . . 100.0 108.475 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.657 ' HB3' ' HB2' ' A' ' 10' ' ' GLN . 18.9 pt-20 -95.03 119.78 65.33 Favored Pre-proline 0 N--CA 1.405 -2.702 0 N-CA-C 109.149 -0.686 . . . . 100.0 109.149 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -82.56 73.9 5.33 Favored 'Trans proline' 0 C--N 1.373 1.843 1 N-CA-C 94.5 -6.769 . . . . 100.0 94.5 175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 73.67 -59.58 0.56 Allowed 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 107.021 -1.474 . . . . 100.0 107.021 -169.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.25 127.07 51.09 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 N-CA-C 118.574 2.805 . . . . 100.0 118.574 -174.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.657 ' HB2' ' HB3' ' A' ' 6' ' ' GLU 0.267 19.1 tt0 -131.39 136.72 48.27 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 125.835 1.654 . . . . 100.0 108.237 177.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -128.33 131.93 48.61 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.877 -0.786 . . . . 100.0 108.877 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.2 tttt -90.44 115.35 27.54 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 105.294 -2.113 . . . . 100.0 105.294 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 14' ' ' VAL . 2.8 tt -116.51 130.24 56.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.362 -1.348 . . . . 100.0 107.362 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.556 ' N ' HD23 ' A' ' 13' ' ' LEU . 25.7 t -111.25 125.39 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 118.577 -1.249 . . . . 100.0 109.713 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' CD1' HD22 ' A' ' 13' ' ' LEU . 7.6 mp -102.08 120.45 40.45 Favored 'General case' 0 CA--C 1.489 -1.4 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -128.87 161.19 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 114.057 -1.429 . . . . 100.0 111.235 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.14 172.59 20.92 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.555 -1.418 . . . . 100.0 109.555 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.497 ' HB2' HG23 ' A' ' 97' ' ' THR . 87.9 m-20 -71.0 160.12 33.5 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 121.777 0.799 . . . . 100.0 112.827 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.52 140.09 40.41 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 110.316 -1.114 . . . . 100.0 110.316 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.68 89.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-O 118.608 -1.107 . . . . 100.0 114.536 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 p -64.05 -39.4 93.99 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 118.802 1.301 . . . . 100.0 114.084 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.54 17.83 5.94 Favored Glycine 0 N--CA 1.431 -1.655 0 CA-C-O 118.992 -0.893 . . . . 100.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -59.56 -47.75 84.35 Favored 'General case' 0 C--N 1.358 0.97 0 CA-C-N 118.923 1.361 . . . . 100.0 110.611 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.7 m -64.83 -43.23 93.75 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.209 1.403 . . . . 100.0 111.158 -179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.4 m -63.08 -41.59 99.45 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.369 1.068 . . . . 100.0 109.483 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -61.3 -48.14 82.73 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.748 1.219 . . . . 100.0 110.429 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.53 -43.08 96.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 122.739 0.415 . . . . 100.0 111.112 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' HD3' ' HB2' ' A' ' 36' ' ' GLU . 87.9 tttt -61.56 -41.96 98.14 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.885 0.874 . . . . 100.0 111.056 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HG2' HH11 ' A' ' 29' ' ' ARG . 28.5 ttp85 -61.64 -43.21 99.28 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 124.041 0.937 . . . . 100.0 110.35 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -63.82 -41.32 97.89 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 112.829 0.677 . . . . 100.0 112.829 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 76.0 mt -69.3 -44.44 71.76 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.355 1.613 . . . . 100.0 115.355 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.8 p -118.94 -23.1 7.03 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 117.708 2.484 . . . . 100.0 117.708 -176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.22 -7.74 72.46 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 110.582 -1.007 . . . . 100.0 110.582 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.12 153.93 31.71 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.857 1.663 . . . . 100.0 109.662 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -117.32 119.07 34.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.993 -2.966 . . . . 100.0 102.993 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' HD3' ' A' ' 28' ' ' LYS . 43.4 tt0 -99.25 119.06 37.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.608 -0.837 . . . . 100.0 108.854 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -90.7 -13.85 33.35 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.87 1.063 . . . . 100.0 113.87 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 199' ' ' HIS . 98.2 mttt -94.74 124.99 39.1 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.384 -1.339 . . . . 100.0 107.384 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -96.61 112.48 24.21 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-O 121.815 0.817 . . . . 100.0 109.442 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.33 124.33 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 102.453 -3.166 . . . . 100.0 102.453 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.97 142.43 57.46 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 114.172 1.175 . . . . 100.0 114.172 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.8 m -92.37 130.08 38.14 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 105.3 -2.111 . . . . 100.0 105.3 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.9 mt -102.92 126.67 50.17 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.404 -0.961 . . . . 100.0 108.404 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.83 -121.89 18.03 Favored Glycine 0 C--N 1.356 1.668 0 N-CA-C 109.543 -1.423 . . . . 100.0 109.543 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.08 141.73 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.216 -0.661 . . . . 100.0 109.216 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -124.26 125.1 43.81 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.084 -2.562 . . . . 100.0 104.084 177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.85 121.52 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 114.561 -1.2 . . . . 100.0 108.169 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -124.86 122.14 25.57 Favored Pre-proline 0 N--CA 1.435 -1.214 0 CA-C-N 115.583 -0.735 . . . . 100.0 111.269 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.12 128.35 7.28 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 123.561 2.841 . . . . 100.0 110.969 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.9 tp -131.64 123.6 28.17 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.067 -1.086 . . . . 100.0 108.067 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.9 t -110.32 135.9 47.97 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 N-CA-C 108.863 -0.792 . . . . 100.0 108.863 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -124.35 138.52 54.37 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 107.495 -1.298 . . . . 100.0 107.495 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -98.59 126.28 44.12 Favored 'General case' 0 CA--C 1.482 -1.645 0 N-CA-C 107.208 -1.404 . . . . 100.0 107.208 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 p -124.11 -179.78 4.56 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.956 -1.02 . . . . 100.0 109.868 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -58.91 -35.6 73.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.052 2.141 . . . . 100.0 109.484 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -93.23 10.94 29.77 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 124.182 0.993 . . . . 100.0 113.554 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.53 176.1 25.03 Favored Glycine 0 C--N 1.355 1.585 0 N-CA-C 111.758 -0.537 . . . . 100.0 111.758 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.71 136.8 40.13 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 123.365 2.71 . . . . 100.0 114.486 178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.78 142.35 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 106.486 -1.672 . . . . 100.0 106.486 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -113.64 131.94 55.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 119.707 -0.797 . . . . 100.0 110.404 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -106.91 119.03 38.25 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 104.142 -2.54 . . . . 100.0 104.142 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -92.55 99.14 11.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 100.163 -4.014 . . . . 100.0 100.163 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 83.7 t -85.74 125.96 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-N 115.805 -0.634 . . . . 100.0 110.674 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.467 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 36.5 m95 -107.31 98.02 7.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.132 -2.173 . . . . 100.0 105.132 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -86.31 116.11 24.27 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 104.3 -2.481 . . . . 100.0 104.3 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.2 p -101.0 163.93 12.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 113.482 0.919 . . . . 100.0 113.482 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.91 133.02 35.13 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 124.28 1.032 . . . . 100.0 109.61 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.62 -6.16 83.54 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 116.667 -0.242 . . . . 100.0 113.516 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -70.37 -40.69 73.85 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 127.243 2.217 . . . . 100.0 111.856 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.562 ' HB2' HH11 ' A' ' 76' ' ' ARG . 47.0 mt-10 -64.32 139.19 58.74 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.494 1.294 . . . . 100.0 114.494 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.32 151.65 45.03 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.313 -1.312 . . . . 100.0 109.765 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -68.24 131.59 45.64 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.242 -2.133 . . . . 100.0 105.242 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.44 -174.98 40.53 Favored Glycine 0 C--N 1.355 1.597 0 C-N-CA 118.728 -1.701 . . . . 100.0 114.818 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.23 -22.26 65.03 Favored Glycine 0 C--N 1.353 1.498 0 C-N-CA 126.992 2.234 . . . . 100.0 113.552 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.67 -37.47 84.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.189 1.796 . . . . 100.0 110.03 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.562 HH11 ' HB2' ' A' ' 70' ' ' GLU . 77.4 mtp85 -88.64 7.72 32.08 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.431 1.892 . . . . 100.0 115.041 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -61.95 -38.57 89.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 116.615 2.08 . . . . 100.0 116.615 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -38.07 90.2 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.676 0.655 . . . . 100.0 112.839 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . 0.251 22.0 m-30 -62.35 -43.28 99.18 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 124.985 1.314 . . . . 100.0 109.856 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 3.4 t80 -90.95 -19.99 22.66 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.934 1.457 . . . . 100.0 114.934 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.38 135.8 24.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-N 119.631 1.105 . . . . 100.0 108.843 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 66.72 18.22 10.68 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.51 1.924 . . . . 100.0 114.245 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.28 146.69 48.77 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.98 -1.118 . . . . 100.0 107.98 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -106.79 -21.74 12.94 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.698 -0.683 . . . . 100.0 111.2 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.486 ' SG ' ' HG ' ' A' ' 13' ' ' LEU . 7.5 p -160.38 164.96 31.98 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.718 0.807 . . . . 100.0 109.808 178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -150.1 156.91 42.49 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 113.721 1.008 . . . . 100.0 113.721 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.19 127.17 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 105.316 -2.105 . . . . 100.0 105.316 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 63.2 mt -110.67 123.63 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.068 0 N-CA-C 103.113 -2.921 . . . . 100.0 103.113 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.58 ' HB3' HD21 ' A' ' 122' ' ' ASN . 57.2 mtt -113.75 135.03 54.39 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 116.542 2.053 . . . . 100.0 116.542 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -132.99 162.02 32.78 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.445 -1.707 . . . . 100.0 109.975 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -106.11 125.09 50.58 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 106.186 -1.783 . . . . 100.0 106.186 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -63.86 -19.29 24.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.608 0 N-CA-C 113.934 1.087 . . . . 100.0 113.934 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.3 p -90.1 -3.26 58.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 111.987 0.366 . . . . 100.0 111.987 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -124.69 115.08 20.19 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 122.527 1.156 . . . . 100.0 111.347 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -65.51 -39.55 91.96 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.742 -1.117 . . . . 100.0 111.078 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -61.64 -41.79 91.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 124.982 1.313 . . . . 100.0 109.19 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.497 HG23 ' HB2' ' A' ' 18' ' ' ASP . 96.6 m -62.49 -41.72 99.0 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 122.959 0.504 . . . . 100.0 110.147 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -65.31 -40.29 93.59 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.238 0.615 . . . . 100.0 110.962 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -59.79 -35.87 75.54 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.259 1.024 . . . . 100.0 111.237 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -74.01 -11.67 60.4 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 115.415 1.635 . . . . 100.0 115.415 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.0 t -59.39 -43.73 96.84 Favored Pre-proline 0 C--N 1.362 1.12 0 CA-C-O 116.141 -1.885 . . . . 100.0 111.792 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 86.5 Cg_exo -57.37 -35.11 98.87 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.529 2.153 . . . . 100.0 111.939 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.32 -41.9 84.53 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 123.453 0.701 . . . . 100.0 111.291 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' O ' HD13 ' A' ' 108' ' ' LEU . 85.8 m95 -63.66 -45.73 88.81 Favored 'General case' 0 C--N 1.365 1.278 0 N-CA-C 109.197 -0.668 . . . . 100.0 109.197 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -90.79 69.81 6.55 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.838 -1.542 . . . . 100.0 106.838 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -167.75 -55.5 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 100.937 -3.727 . . . . 100.0 100.937 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.68 -43.27 99.24 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 106.674 -1.602 . . . . 100.0 106.674 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.415 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -63.31 -50.15 71.17 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.83 -23.59 29.54 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 113.287 0.847 . . . . 100.0 113.287 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -60.31 -41.24 93.04 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 123.674 0.79 . . . . 100.0 109.759 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.257 15.1 m -98.36 -34.43 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 115.958 1.836 . . . . 100.0 115.958 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . 0.292 68.9 m -107.05 -4.62 18.75 Favored 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 117.823 2.527 . . . . 100.0 117.823 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.339 66.3 mt-10 53.59 -119.31 1.47 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 114.636 1.347 . . . . 100.0 114.636 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -95.94 112.11 23.93 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 118.386 -1.326 . . . . 100.0 111.872 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 40.0 pt -145.12 153.83 53.53 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 104.155 -2.535 . . . . 100.0 104.155 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -61.21 126.18 18.78 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.622 2.214 . . . . 100.0 111.78 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.643 ' HB ' HD22 ' A' ' 144' ' ' LEU . 61.1 mt -133.35 134.88 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.685 -1.228 . . . . 100.0 107.685 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -116.0 131.59 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.928 -1.487 . . . . 100.0 108.687 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.5 mt -100.03 126.4 46.22 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 104.957 -2.238 . . . . 100.0 104.957 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 70.9 m -118.18 125.0 49.33 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 122.026 0.917 . . . . 100.0 111.871 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.92 101.21 2.57 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 104.492 -3.443 . . . . 100.0 104.492 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.58 HD21 ' HB3' ' A' ' 89' ' ' MET . 70.6 m-80 -81.31 163.17 23.11 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.611 1.164 . . . . 100.0 112.17 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 57.78 42.02 24.1 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.877 2.471 . . . . 100.0 115.442 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 148' ' ' ASP . 31.0 m -67.5 -13.84 17.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 112.051 0.389 . . . . 100.0 112.051 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.38 -38.86 92.8 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 126.641 1.976 . . . . 100.0 110.399 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.06 133.89 28.6 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 124.19 0.996 . . . . 100.0 110.583 -178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -62.59 -46.94 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 116.081 1.882 . . . . 100.0 116.081 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -85.26 77.11 10.06 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 118.587 0.63 . . . . 100.0 110.723 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -85.57 134.05 34.03 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -102.05 -40.87 6.65 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.681 -0.691 . . . . 100.0 112.355 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -98.07 106.7 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 106.028 -1.841 . . . . 100.0 106.028 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -76.69 146.86 37.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.951 -1.022 . . . . 100.0 109.375 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.0 88.57 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.412 1.085 . . . . 100.0 110.98 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.58 -40.09 95.8 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.71 1.204 . . . . 100.0 110.803 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.1 m -61.9 -38.24 87.6 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.358 1.463 . . . . 100.0 113.233 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.73 122.37 14.48 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 122.389 1.09 . . . . 100.0 110.07 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.61 -6.55 3.56 Favored 'Isoleucine or valine' 0 C--N 1.355 0.848 0 CA-C-N 113.785 -1.552 . . . . 100.0 112.21 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -58.89 -39.66 82.12 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.86 1.264 . . . . 100.0 111.323 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -61.07 -39.95 91.85 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 123.497 0.719 . . . . 100.0 111.616 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.08 -43.64 94.79 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 118.662 0.664 . . . . 100.0 112.101 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.27 -42.66 96.35 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.369 1.067 . . . . 100.0 111.337 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.22 6.94 47.57 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 118.325 2.713 . . . . 100.0 118.325 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 54.63 46.41 24.81 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.058 1.343 . . . . 100.0 113.943 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.643 HD22 ' HB ' ' A' ' 117' ' ' ILE . 38.0 mt -109.57 159.47 17.07 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-N 114.618 -1.173 . . . . 100.0 108.464 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -96.47 141.67 29.49 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 106.414 -1.699 . . . . 100.0 106.414 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -118.32 133.52 55.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.159 0.504 . . . . 100.0 111.268 -178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.74 134.85 43.48 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.663 -0.698 . . . . 100.0 111.991 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.436 ' HB3' HG11 ' A' ' 124' ' ' VAL . 43.3 m-20 -88.59 123.37 33.01 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 101.683 -3.451 . . . . 100.0 101.683 176.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.73 158.3 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 122.64 1.21 . . . . 100.0 112.302 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 28.7 t -143.12 111.32 6.13 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 105.751 -1.944 . . . . 100.0 105.751 176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.67 -38.89 92.14 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.549 -0.908 . . . . 100.0 108.549 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.17 -43.5 91.53 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 114.875 1.435 . . . . 100.0 114.875 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 87.5 p -100.89 -2.28 32.43 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 114.916 1.45 . . . . 100.0 114.916 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 70.79 9.53 6.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 125.774 1.629 . . . . 100.0 112.953 -178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -63.49 121.73 14.54 Favored 'General case' 0 C--N 1.358 0.961 0 CA-C-N 119.403 1.001 . . . . 100.0 108.945 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 53.34 34.58 18.23 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 127.271 2.228 . . . . 100.0 111.459 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 158' ' ' GLU . 10.8 p90 -59.67 -41.46 90.69 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 115.799 1.777 . . . . 100.0 115.799 -175.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.44 ' HG3' ' CE2' ' A' ' 157' ' ' PHE . 94.3 mt-10 -93.04 -3.48 54.25 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 115.503 1.668 . . . . 100.0 115.503 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.278 96.8 mttt -60.36 -44.31 95.56 Favored Pre-proline 0 N--CA 1.44 -0.974 0 N-CA-C 116.969 2.211 . . . . 100.0 116.969 -177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.4 -43.11 42.78 Favored 'Trans proline' 0 C--N 1.375 1.956 0 CA-C-N 122.5 1.929 . . . . 100.0 113.095 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -64.65 -43.68 92.89 Favored 'General case' 0 CA--C 1.493 -1.231 0 O-C-N 124.247 0.967 . . . . 100.0 111.863 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.438 HD21 ' HB2' ' A' ' 176' ' ' PHE . 96.1 mt -64.28 -43.25 95.39 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 118.827 -0.606 . . . . 100.0 112.565 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 58.4 t-105 -62.11 -46.62 88.24 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 123.487 0.492 . . . . 100.0 110.793 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 85' ' ' CYS . 83.5 mt -60.49 -42.77 97.0 Favored 'General case' 0 CA--C 1.493 -1.248 0 O-C-N 124.131 0.895 . . . . 100.0 110.686 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.81 -43.9 97.93 Favored 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 123.521 0.729 . . . . 100.0 111.154 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.434 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 72.2 mtt85 -63.48 -44.63 93.84 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-O 118.557 -0.735 . . . . 100.0 112.488 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -69.01 -43.14 75.42 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 123.406 0.441 . . . . 100.0 112.051 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 91.0 mt -66.2 -46.91 75.64 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 113.239 0.829 . . . . 100.0 113.239 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.16 -38.42 77.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 C-N-CA 125.29 1.436 . . . . 100.0 110.368 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.71 10.23 56.8 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 118.238 -1.312 . . . . 100.0 113.815 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -108.88 110.65 61.01 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.071 -1.455 . . . . 100.0 107.071 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.34 -22.22 66.36 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 123.912 3.074 . . . . 100.0 113.51 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -102.01 11.26 38.74 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 114.206 1.187 . . . . 100.0 114.206 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 25.4 tp -62.45 133.16 54.62 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -135.77 152.27 50.94 Favored 'General case' 0 CA--C 1.484 -1.564 0 CA-C-O 121.337 0.589 . . . . 100.0 111.687 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.438 ' HB2' HD21 ' A' ' 162' ' ' LEU . 80.1 t80 -74.21 132.74 42.45 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 105.813 -1.921 . . . . 100.0 105.813 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.22 138.42 54.4 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 CA-C-O 121.362 0.601 . . . . 100.0 110.207 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 23.08 -91.1 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 129.681 3.192 . . . . 100.0 117.487 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 58.2 ttm 97.24 124.97 0.02 OUTLIER Pre-proline 0 C--N 1.37 1.467 0 C-N-CA 127.725 2.41 . . . . 100.0 107.985 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.77 143.73 99.57 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.005 2.47 . . . . 100.0 109.467 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -60.94 135.13 57.7 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 124.074 0.859 . . . . 100.0 112.976 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.89 145.07 52.26 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.51 -1.223 . . . . 100.0 107.753 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -75.13 127.48 86.52 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-O 119.367 -0.349 . . . . 100.0 110.4 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -71.39 143.31 42.9 Favored 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 123.573 2.848 . . . . 100.0 110.023 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -69.95 125.82 12.48 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 122.016 1.811 . . . . 100.0 110.254 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.57 -42.04 71.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 123.712 0.633 . . . . 100.0 110.864 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.566 33.9 m 52.55 63.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.113 0 N-CA-C 119.469 3.137 . . . . 100.0 119.469 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.03 -41.71 10.18 Favored 'Isoleucine or valine' 0 C--N 1.363 1.177 0 C-N-CA 124.818 1.247 . . . . 100.0 112.138 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 86.3 mtp -70.73 167.43 18.76 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.078 1.351 . . . . 100.0 113.476 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.448 ' H ' ' HD2' ' A' ' 191' ' ' PRO . 37.9 t70 -123.84 -53.37 0.03 OUTLIER Pre-proline 0 C--N 1.363 1.191 0 N-CA-C 118.75 2.87 . . . . 100.0 118.75 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.448 ' HD2' ' H ' ' A' ' 190' ' ' ASP 0.289 52.6 Cg_endo -57.22 -68.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 N-CA-C 122.312 3.928 . . . . 100.0 122.312 -174.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.48 -41.19 96.64 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.908 1.231 . . . . 100.0 111.79 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.9 mt -62.78 -36.56 83.49 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 115.976 1.843 . . . . 100.0 115.976 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.65 164.28 7.91 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 118.49 2.774 . . . . 100.0 118.49 -176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 74.62 -60.83 0.51 Allowed 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 130.841 3.657 . . . . 100.0 116.721 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -61.55 -36.22 79.99 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 115.106 1.521 . . . . 100.0 115.106 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.438 ' CE2' HD11 ' A' ' 201' ' ' LEU . 52.5 t80 -61.56 -40.63 95.43 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 125.994 1.718 . . . . 100.0 112.813 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.99 -38.36 85.74 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 123.891 0.876 . . . . 100.0 112.309 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.453 ' CE1' ' HD2' ' A' ' 38' ' ' LYS . 39.3 t60 -59.02 -45.98 89.35 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 124.652 1.181 . . . . 100.0 110.724 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -66.75 -43.95 82.76 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.966 1.306 . . . . 100.0 112.073 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' A' ' 197' ' ' TYR . 94.4 mt -61.27 -44.63 96.92 Favored 'General case' 0 CA--C 1.484 -1.57 0 CA-C-O 118.567 -0.73 . . . . 100.0 112.81 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -61.79 -47.52 84.79 Favored 'General case' 0 CA--C 1.489 -1.368 0 O-C-N 123.829 0.706 . . . . 100.0 112.212 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 33.9 m -63.08 -41.0 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 O-C-N 123.828 0.705 . . . . 100.0 111.996 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -68.56 -45.37 72.28 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 114.68 1.363 . . . . 100.0 114.68 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -63.83 -40.44 96.6 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 124.861 1.265 . . . . 100.0 113.497 -177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.7 m -66.45 -40.97 89.75 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 124.626 1.17 . . . . 100.0 111.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 61.2 m -71.58 122.73 21.04 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 122.628 1.204 . . . . 100.0 111.865 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -80.92 159.71 24.89 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.961 -1.866 . . . . 100.0 105.961 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 78.1 mt -104.39 108.32 60.13 Favored Pre-proline 0 N--CA 1.442 -0.865 0 C-N-CA 119.809 -0.757 . . . . 100.0 112.411 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -80.24 110.95 2.57 Favored 'Trans proline' 0 C--N 1.367 1.531 0 N-CA-C 102.545 -3.675 . . . . 100.0 102.545 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -75.73 114.98 14.94 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.879 -1.156 . . . . 100.0 107.879 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -118.04 -64.16 1.33 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.884 -1.895 . . . . 100.0 105.884 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -133.9 33.92 3.41 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.616 0.722 . . . . 100.0 109.503 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.67 -20.77 65.17 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 125.446 1.498 . . . . 100.0 112.635 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.54 -38.96 86.16 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.039 1.336 . . . . 100.0 109.991 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 22.0 tp . . . . . 0 C--O 1.256 1.446 0 N-CA-C 106.233 -1.766 . . . . 100.0 106.233 179.15 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mtt . . . . . 0 CA--C 1.491 -1.292 0 N-CA-C 109.632 -0.507 . . . . 100.0 109.632 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.11 81.19 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 125.611 1.564 . . . . 100.0 111.009 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.78 -43.51 98.7 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 123.386 0.674 . . . . 100.0 110.156 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -73.4 -24.57 60.31 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 112.914 0.709 . . . . 100.0 112.914 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . 86.17 22.26 49.14 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 109.091 -1.604 . . . . 100.0 109.091 -178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 10' ' ' GLN 0.362 37.7 tt0 -92.75 99.2 2.72 Favored Pre-proline 0 N--CA 1.412 -2.355 0 C-N-CA 129.312 3.045 . . . . 100.0 103.79 -178.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 5' ' ' GLY . 76.0 Cg_endo -81.76 77.65 3.81 Favored 'Trans proline' 0 CA--C 1.479 -2.226 1 N-CA-C 96.28 -6.085 . . . . 100.0 96.28 177.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 6' ' ' GLU 0.256 89.8 mm-40 74.51 -60.75 0.51 Allowed 'General case' 0 N--CA 1.408 -2.553 0 CA-C-O 116.705 -1.617 . . . . 100.0 107.382 -169.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.1 130.46 63.27 Favored 'Isoleucine or valine' 0 C--N 1.365 1.279 0 N-CA-C 118.167 2.655 . . . . 100.0 118.167 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 6' ' ' GLU 0.288 45.9 tt0 -131.29 135.33 47.21 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 105.19 -2.152 . . . . 100.0 105.19 175.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . 0.278 80.9 m-85 -125.56 130.69 52.22 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 106.439 -1.689 . . . . 100.0 106.439 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -92.38 118.28 30.77 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 105.341 -2.096 . . . . 100.0 105.341 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.845 HD22 ' SG ' ' A' ' 85' ' ' CYS 0.362 4.3 mt -114.9 132.51 56.51 Favored 'General case' 0 CA--C 1.486 -1.503 0 N-CA-C 105.797 -1.927 . . . . 100.0 105.797 -178.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 64' ' ' TRP . 39.8 t -110.24 127.75 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 116.47 -2.092 . . . . 100.0 106.823 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 tp -103.17 118.01 35.83 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.344 -1.354 . . . . 100.0 107.344 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 108' ' ' LEU . 29.4 m -127.83 162.0 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.948 0 C-N-CA 125.479 1.512 . . . . 100.0 112.93 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 149.57 171.07 17.75 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.05 -1.62 . . . . 100.0 109.05 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HB2' HG23 ' A' ' 97' ' ' THR . 84.3 m-20 -70.42 159.27 34.5 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-O 121.97 0.89 . . . . 100.0 113.187 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.68 139.03 40.67 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.54 -1.024 . . . . 100.0 110.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 3.51 90.13 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-O 118.354 -1.248 . . . . 100.0 115.276 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.3 p -64.43 -38.75 92.13 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.095 1.448 . . . . 100.0 113.553 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.7 19.89 4.77 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 111.132 -0.787 . . . . 100.0 111.132 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -59.6 -48.72 80.55 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 124.334 1.054 . . . . 100.0 110.87 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.3 m -65.75 -43.42 88.96 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.228 1.411 . . . . 100.0 110.95 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.3 m -62.82 -41.66 99.4 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 124.393 1.077 . . . . 100.0 109.505 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -61.72 -47.51 84.92 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 124.103 0.961 . . . . 100.0 110.696 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.56 -41.31 91.89 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 O-C-N 122.893 0.121 . . . . 100.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -62.0 -39.92 93.88 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.56 0.744 . . . . 100.0 111.097 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -60.84 -44.09 97.43 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 123.069 0.548 . . . . 100.0 110.313 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -62.21 -43.92 97.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.812 0.671 . . . . 100.0 112.812 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 mt -70.69 -44.74 66.36 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 116.547 2.055 . . . . 100.0 116.547 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 75.5 p -117.4 -24.93 7.18 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 117.521 2.415 . . . . 100.0 117.521 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.01 -8.08 70.05 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.695 -0.962 . . . . 100.0 110.695 -177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -77.88 156.36 30.41 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 124.469 1.107 . . . . 100.0 109.671 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -115.8 116.56 28.24 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 101.087 -3.671 . . . . 100.0 101.087 178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -96.88 118.96 34.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.154 -1.424 . . . . 100.0 107.154 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.64 -11.18 34.84 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.828 -1.078 . . . . 100.0 113.235 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -101.22 126.18 47.92 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.174 -1.047 . . . . 100.0 108.174 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -95.04 116.42 28.68 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 121.927 0.87 . . . . 100.0 111.433 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.05 121.08 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 101.784 -3.413 . . . . 100.0 101.784 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.95 141.9 58.55 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 123.371 0.668 . . . . 100.0 112.591 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.7 m -94.51 129.06 41.45 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 105.281 -2.118 . . . . 100.0 105.281 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.37 129.15 48.75 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.053 -1.091 . . . . 100.0 108.053 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.74 -122.69 14.32 Favored Glycine 0 C--N 1.352 1.472 0 N-CA-C 109.614 -1.395 . . . . 100.0 109.614 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.48 143.25 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 109.157 -0.682 . . . . 100.0 109.157 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -127.32 125.55 41.01 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 103.608 -2.738 . . . . 100.0 103.608 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -99.04 125.46 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 108.509 -0.922 . . . . 100.0 108.509 -178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -121.45 123.71 27.51 Favored Pre-proline 0 N--CA 1.431 -1.381 0 CA-C-N 114.803 -1.09 . . . . 100.0 111.176 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.423 ' CB ' ' HE3' ' A' ' 60' ' ' LYS . 75.8 Cg_endo -80.08 126.64 6.46 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 124.702 3.602 . . . . 100.0 111.91 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.4 tp -133.45 130.12 38.19 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.927 -1.138 . . . . 100.0 107.927 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.8 t -118.25 134.61 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.775 -0.824 . . . . 100.0 108.775 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -124.98 142.61 51.37 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.374 -0.973 . . . . 100.0 108.374 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -98.43 124.0 42.89 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.851 -0.796 . . . . 100.0 108.851 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.1 p -121.36 -177.67 3.59 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.336 -0.847 . . . . 100.0 109.952 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -59.22 -35.61 73.95 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.388 2.275 . . . . 100.0 109.333 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -88.21 3.25 50.06 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.13 1.372 . . . . 100.0 113.266 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.59 -179.5 22.73 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.117 -1.193 . . . . 100.0 110.117 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 7' ' ' PRO . 72.4 Cg_endo -66.66 137.29 45.4 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 123.348 2.698 . . . . 100.0 113.919 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 pt -130.84 137.47 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.488 -1.301 . . . . 100.0 107.488 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HE3' ' CB ' ' A' ' 49' ' ' PRO . 85.4 tttt -105.1 133.51 49.76 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-O 121.967 0.889 . . . . 100.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.587 ' HD2' HD21 ' A' ' 13' ' ' LEU . 93.1 m-85 -110.94 116.85 31.92 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 103.098 -2.927 . . . . 100.0 103.098 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -93.06 99.25 11.89 Favored 'General case' 0 N--CA 1.434 -1.238 1 N-CA-C 99.979 -4.082 . . . . 100.0 99.979 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.53 125.69 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 108.768 -0.827 . . . . 100.0 108.768 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 14' ' ' VAL . 31.2 m95 -102.74 97.75 7.87 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 105.089 -2.189 . . . . 100.0 105.089 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -85.84 116.32 24.01 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 104.938 -2.245 . . . . 100.0 104.938 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -99.53 166.06 11.33 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 114.576 1.324 . . . . 100.0 114.576 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.21 131.75 34.16 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.625 0.77 . . . . 100.0 109.301 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.71 -8.47 82.77 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.45 0.54 . . . . 100.0 114.45 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -70.6 -39.67 73.65 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.462 1.505 . . . . 100.0 112.731 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.534 ' HB2' HH11 ' A' ' 76' ' ' ARG . 49.0 mt-10 -62.33 134.56 56.66 Favored 'General case' 0 CA--C 1.492 -1.276 0 C-N-CA 125.472 1.509 . . . . 100.0 113.689 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -73.24 154.51 40.18 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.04 -0.982 . . . . 100.0 109.984 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -67.21 132.73 48.36 Favored 'General case' 0 CA--C 1.503 -0.832 0 C-N-CA 125.95 1.7 . . . . 100.0 107.673 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 164.72 -175.51 40.68 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.001 -1.571 . . . . 100.0 114.14 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.78 -23.28 65.23 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 126.747 2.118 . . . . 100.0 113.6 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 pp -63.95 -28.34 69.75 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 124.416 1.087 . . . . 100.0 110.86 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.534 HH11 ' HB2' ' A' ' 70' ' ' GLU . 75.5 mtp85 -92.29 9.31 34.46 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.68 1.592 . . . . 100.0 114.562 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.59 -38.51 84.87 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 115.687 1.736 . . . . 100.0 115.687 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.95 89.89 Favored Glycine 0 C--N 1.352 1.433 0 C-N-CA 124.271 0.939 . . . . 100.0 113.433 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -61.54 -48.32 81.52 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.129 0.972 . . . . 100.0 109.086 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.549 ' HD1' ' HG ' ' A' ' 112' ' ' CYS 0.423 25.7 m-85 -70.64 -37.43 73.76 Favored 'General case' 0 CA--C 1.478 -1.808 0 N-CA-C 120.223 3.416 . . . . 100.0 120.223 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -54.03 131.97 16.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-O 121.78 0.8 . . . . 100.0 109.963 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 68.55 14.37 9.06 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 115.745 1.757 . . . . 100.0 115.745 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.19 145.73 54.05 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-N 118.882 0.764 . . . . 100.0 109.864 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -102.87 -30.72 10.66 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-N 115.369 -0.832 . . . . 100.0 110.51 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.845 ' SG ' HD22 ' A' ' 13' ' ' LEU . 31.9 p -160.81 170.08 21.42 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.315 0.646 . . . . 100.0 109.472 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.48 157.46 43.58 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 113.333 0.864 . . . . 100.0 113.333 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 82.5 mt -127.23 126.62 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 104.482 -2.414 . . . . 100.0 104.482 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.2 mt -109.59 123.97 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 103.286 -2.857 . . . . 100.0 103.286 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.455 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 40.4 mtt -114.09 135.28 54.2 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 115.322 1.601 . . . . 100.0 115.322 -179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -132.75 159.62 39.2 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.926 -1.943 . . . . 100.0 110.003 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -103.72 125.07 49.95 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.105 -1.813 . . . . 100.0 106.105 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.51 -19.79 24.85 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 N-CA-C 114.117 1.154 . . . . 100.0 114.117 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.4 p -88.45 -6.55 57.57 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 119.072 -0.49 . . . . 100.0 111.51 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.6 t -123.18 114.29 20.09 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 122.804 1.287 . . . . 100.0 112.238 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -65.43 -38.49 90.04 Favored 'General case' 0 CA--C 1.498 -1.047 0 CA-C-N 114.398 -1.274 . . . . 100.0 111.327 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.2 t -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 124.996 1.318 . . . . 100.0 109.154 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.54 HG23 ' HB2' ' A' ' 18' ' ' ASP . 99.8 m -62.76 -41.32 99.16 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.94 0.496 . . . . 100.0 110.16 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -65.23 -39.84 93.28 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 123.541 0.736 . . . . 100.0 110.973 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.501 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -59.33 -36.71 76.17 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 124.687 1.195 . . . . 100.0 111.101 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -74.28 -10.67 59.82 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 115.782 1.771 . . . . 100.0 115.782 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.43 -43.82 96.86 Favored Pre-proline 0 C--N 1.36 1.034 0 CA-C-O 116.128 -1.891 . . . . 100.0 111.621 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.8 Cg_exo -58.35 -33.6 97.91 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.576 2.184 . . . . 100.0 112.503 177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -67.23 -42.99 83.12 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.782 0.833 . . . . 100.0 109.862 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.567 ' O ' HD13 ' A' ' 108' ' ' LEU . 85.3 m95 -63.26 -46.98 84.32 Favored 'General case' 0 C--N 1.368 1.375 0 N-CA-C 108.649 -0.871 . . . . 100.0 108.649 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -89.53 70.75 7.96 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 122.892 1.33 . . . . 100.0 107.776 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -168.4 -55.54 0.02 OUTLIER 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 100.315 -3.957 . . . . 100.0 100.315 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.4 -42.04 99.13 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.267 -1.383 . . . . 100.0 107.267 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.567 HD13 ' O ' ' A' ' 104' ' ' TRP . 7.1 mp -61.88 -50.35 72.57 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 124.396 1.078 . . . . 100.0 112.806 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.259 32.8 m -70.15 -19.66 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 113.799 1.037 . . . . 100.0 113.799 -178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -60.55 -39.61 88.55 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 122.787 0.435 . . . . 100.0 110.511 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -99.89 -47.13 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-O 120.757 0.313 . . . . 100.0 110.792 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.549 ' HG ' ' HD1' ' A' ' 80' ' ' TYR . 95.9 m -70.87 -36.9 73.0 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 119.478 3.14 . . . . 100.0 119.478 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 61.72 -122.22 0.77 Allowed 'General case' 0 C--N 1.356 0.856 0 C-N-CA 126.053 1.741 . . . . 100.0 109.31 -175.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -93.41 113.02 25.08 Favored 'General case' 0 C--N 1.363 1.157 0 CA-C-N 121.294 1.861 . . . . 100.0 112.273 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 36.3 pt -144.4 149.16 43.4 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 105.133 -2.173 . . . . 100.0 105.133 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.505 ' HG2' ' HB3' ' A' ' 85' ' ' CYS . 41.5 Cg_endo -64.31 128.99 22.78 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.018 1.812 . . . . 100.0 110.437 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.733 ' HB ' HD22 ' A' ' 144' ' ' LEU . 76.6 mt -131.91 135.09 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.316 -1.364 . . . . 100.0 107.316 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.33 131.69 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 114.402 -1.272 . . . . 100.0 107.799 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 89.2 mt -97.9 126.55 43.34 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 105.388 -2.079 . . . . 100.0 105.388 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.455 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.5 m -118.95 125.93 50.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 122.055 0.931 . . . . 100.0 111.71 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.46 101.47 2.57 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 104.711 -3.356 . . . . 100.0 104.711 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.47 161.91 24.65 Favored 'General case' 0 CA--C 1.491 -1.292 0 C-N-CA 124.765 1.226 . . . . 100.0 112.489 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.4 mttt 57.81 43.28 22.03 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 127.858 2.463 . . . . 100.0 115.023 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 148' ' ' ASP . 28.7 m -68.9 -11.7 15.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 CA-C-N 115.983 -0.553 . . . . 100.0 111.603 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.51 -39.04 93.39 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.936 2.095 . . . . 100.0 109.74 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.1 mt -64.06 132.02 29.82 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 C-N-CA 124.095 0.958 . . . . 100.0 110.132 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -63.83 -45.0 91.56 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 116.435 2.013 . . . . 100.0 116.435 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -84.93 77.51 10.09 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.648 0.737 . . . . 100.0 109.731 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -82.8 137.66 34.26 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 108.503 -0.925 . . . . 100.0 108.503 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.07 -42.69 5.24 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 119.4 -0.333 . . . . 100.0 111.496 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.1 107.68 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 105.59 -2.004 . . . . 100.0 105.59 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -76.62 148.86 36.68 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.104 -0.953 . . . . 100.0 109.349 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.22 90.32 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.165 0.986 . . . . 100.0 110.91 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -62.4 -40.8 97.69 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.661 1.184 . . . . 100.0 110.907 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 65.4 m -61.49 -37.64 84.39 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 125.686 1.594 . . . . 100.0 113.556 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.42 123.52 15.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 CA-C-O 122.523 1.154 . . . . 100.0 110.035 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.64 HG12 HH21 ' A' ' 140' ' ' ARG . 27.4 m -127.52 -10.66 3.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 CA-C-N 113.531 -1.668 . . . . 100.0 112.592 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -58.49 -40.34 82.49 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.1 1.36 . . . . 100.0 111.864 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -61.17 -40.01 92.28 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 118.679 -0.677 . . . . 100.0 111.601 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.64 HH21 HG12 ' A' ' 137' ' ' VAL . 87.0 mtm-85 -64.04 -43.6 95.06 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 112.806 0.669 . . . . 100.0 112.806 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.65 -42.21 95.59 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 123.566 0.746 . . . . 100.0 111.853 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -97.28 6.81 47.74 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 117.902 2.556 . . . . 100.0 117.902 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.26 71.2 m-20 53.23 50.75 16.97 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-O 123.062 1.41 . . . . 100.0 114.279 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.733 HD22 ' HB ' ' A' ' 117' ' ' ILE . 35.3 mt -114.38 158.29 21.71 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.981 -1.463 . . . . 100.0 107.092 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.413 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 97.0 mm-40 -98.78 143.77 28.76 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.259 -1.015 . . . . 100.0 108.259 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -117.34 136.06 53.41 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.25 0.548 . . . . 100.0 112.344 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -134.05 137.74 44.87 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.356 -0.838 . . . . 100.0 112.838 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.423 ' HB3' HG11 ' A' ' 124' ' ' VAL . 48.8 m-20 -89.42 123.88 33.97 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 101.583 -3.488 . . . . 100.0 101.583 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 46.3 pt -133.85 157.44 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 CA-C-O 122.623 1.201 . . . . 100.0 112.084 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -143.91 111.36 5.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.35 90.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.066 0.946 . . . . 100.0 108.553 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.34 -46.79 84.95 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 126.637 1.975 . . . . 100.0 113.365 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.2 p -100.75 -2.84 31.34 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 115.44 1.645 . . . . 100.0 115.44 -177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 70.47 11.47 7.36 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 126.337 1.855 . . . . 100.0 113.353 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -67.2 118.33 10.45 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 107.686 -1.227 . . . . 100.0 107.686 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 54.31 29.31 10.58 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 128.756 2.822 . . . . 100.0 111.952 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . 0.413 3.7 p90 -62.53 -35.92 80.95 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 114.216 1.191 . . . . 100.0 114.216 -175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.272 40.6 mt-10 -85.93 -8.33 58.08 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 116.304 1.964 . . . . 100.0 116.304 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.303 95.3 mttt -60.6 -44.11 94.45 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 117.149 2.278 . . . . 100.0 117.149 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -59.45 -40.48 66.53 Favored 'Trans proline' 0 C--N 1.375 1.942 0 CA-C-N 122.333 1.869 . . . . 100.0 112.962 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.31 -44.36 95.18 Favored 'General case' 0 CA--C 1.496 -1.133 0 C-N-CA 124.608 1.163 . . . . 100.0 111.194 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.89 -43.71 92.0 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 112.661 0.615 . . . . 100.0 112.661 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.413 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 67.9 t-105 -61.92 -45.86 91.86 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 123.28 0.362 . . . . 100.0 110.577 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.545 HD22 ' HB2' ' A' ' 85' ' ' CYS . 89.6 mt -61.04 -42.8 99.17 Favored 'General case' 0 CA--C 1.495 -1.167 0 O-C-N 123.959 0.787 . . . . 100.0 110.442 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.3 99.12 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.554 0.741 . . . . 100.0 110.955 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.436 ' HG2' ' HB2' ' A' ' 174' ' ' LEU . 71.5 mtt85 -62.52 -45.33 93.49 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 123.147 0.579 . . . . 100.0 112.401 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.33 -43.55 77.29 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 112.119 0.415 . . . . 100.0 112.119 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 89.8 mt -65.69 -47.2 76.25 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.776 1.028 . . . . 100.0 113.776 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.26 -38.7 75.28 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 124.162 0.985 . . . . 100.0 109.852 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 97.22 9.63 55.38 Favored Glycine 0 C--N 1.353 1.472 0 CA-C-O 118.306 -1.274 . . . . 100.0 114.051 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.536 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 59.9 t0 -109.74 113.02 58.03 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 106.665 -1.606 . . . . 100.0 106.665 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.99 -16.91 50.81 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 123.87 3.047 . . . . 100.0 113.092 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -97.39 8.38 44.71 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 57.1 mt -60.89 134.13 56.78 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 119.233 0.924 . . . . 100.0 112.568 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.41 149.25 48.2 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.839 -1.073 . . . . 100.0 109.857 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.01 131.13 40.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 105.576 -2.009 . . . . 100.0 105.576 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.18 135.07 63.68 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 CA-C-O 121.426 0.631 . . . . 100.0 111.496 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 49.36 -127.94 2.1 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 125.952 1.701 . . . . 100.0 112.583 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 50.9 tpp 136.12 121.71 0.0 OUTLIER Pre-proline 0 CA--C 1.497 -1.082 0 N-CA-C 101.035 -3.691 . . . . 100.0 101.035 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -55.02 128.96 32.8 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.568 2.179 . . . . 100.0 110.921 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.27 131.85 35.23 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 106.918 -1.512 . . . . 100.0 106.918 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.1 mt -84.26 111.91 19.81 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 105.914 -1.884 . . . . 100.0 105.914 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -132.78 144.76 54.26 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -64.53 148.15 90.49 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.778 2.319 . . . . 100.0 110.626 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -63.33 154.4 68.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 123.701 2.934 . . . . 100.0 114.144 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -61.6 -49.13 77.83 Favored 'General case' 0 C--N 1.361 1.067 0 O-C-N 124.17 0.918 . . . . 100.0 111.19 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.301 5.9 m 52.35 -176.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 128.214 2.605 . . . . 100.0 117.848 177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.84 -67.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.387 0 N-CA-C 107.819 -1.178 . . . . 100.0 107.819 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 23.1 ptp -70.57 156.33 39.56 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 114.657 1.355 . . . . 100.0 114.657 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -128.18 -51.95 0.03 OUTLIER Pre-proline 0 C--N 1.36 1.034 0 N-CA-C 116.475 2.028 . . . . 100.0 116.475 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.91 -54.77 4.52 Favored 'Trans proline' 0 C--N 1.377 2.067 0 N-CA-C 121.33 3.55 . . . . 100.0 121.33 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.9 77.29 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 119.518 1.054 . . . . 100.0 111.153 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 31.5 tp -75.65 -8.56 57.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 126.259 1.824 . . . . 100.0 113.534 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.67 175.63 4.08 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.579 1.152 . . . . 100.0 110.334 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 79.45 -47.99 0.38 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.575 1.95 . . . . 100.0 111.591 -178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -60.38 -28.02 67.88 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.447 1.899 . . . . 100.0 111.155 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -61.28 -38.99 88.74 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 113.286 0.847 . . . . 100.0 113.286 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.93 -39.62 90.12 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 123.395 0.678 . . . . 100.0 110.304 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.09 -44.05 97.96 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 123.55 0.74 . . . . 100.0 111.156 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -64.73 -43.16 94.28 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 124.042 0.937 . . . . 100.0 111.529 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.49 -41.8 97.83 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 124.312 1.045 . . . . 100.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.37 -42.54 98.86 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.424 1.09 . . . . 100.0 110.963 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.12 -43.65 96.72 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 N-CA-C 108.325 -0.991 . . . . 100.0 108.325 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.0 90.1 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.269 1.027 . . . . 100.0 113.333 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -63.3 -40.39 97.22 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 125.11 1.364 . . . . 100.0 112.713 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 66.4 m -65.89 -41.79 91.08 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.879 1.672 . . . . 100.0 110.265 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.8 m -69.55 119.2 13.44 Favored 'General case' 0 C--N 1.361 1.102 0 CA-C-O 122.991 1.377 . . . . 100.0 107.87 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -103.49 138.15 40.6 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 105.208 -2.145 . . . . 100.0 105.208 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 97.4 mt -71.37 143.3 87.8 Favored Pre-proline 0 N--CA 1.435 -1.203 0 O-C-N 124.143 0.902 . . . . 100.0 109.021 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 209' ' ' LEU . 67.6 Cg_exo -53.93 122.11 10.8 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 N-CA-C 117.032 1.897 . . . . 100.0 117.032 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -109.52 121.26 44.79 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 102.343 -3.206 . . . . 100.0 102.343 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -91.86 -67.94 0.82 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 103.058 -2.942 . . . . 100.0 103.058 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -150.27 34.89 0.65 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 123.052 1.406 . . . . 100.0 107.547 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -61.67 -34.15 75.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 128.605 2.762 . . . . 100.0 110.812 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -59.6 -39.15 83.23 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 124.987 1.315 . . . . 100.0 111.943 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--O 1.255 1.357 0 CA-C-O 117.307 -1.33 . . . . 100.0 107.614 179.198 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mtt . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 110.607 -0.146 . . . . 100.0 110.607 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.94 -42.18 97.72 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 124.598 1.159 . . . . 100.0 112.439 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.39 -42.45 99.43 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.542 0.737 . . . . 100.0 110.66 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -65.32 -35.6 81.49 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 125.817 1.647 . . . . 100.0 111.633 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.43 15.9 42.12 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 107.801 -2.12 . . . . 100.0 107.801 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 10' ' ' GLN 0.257 36.4 tt0 -88.74 95.69 0.59 Allowed Pre-proline 0 N--CA 1.425 -1.689 0 C-N-CA 128.142 2.577 . . . . 100.0 104.153 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -61.13 -45.3 19.85 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 121.468 1.445 . . . . 100.0 108.354 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -131.91 -62.63 0.85 Allowed 'General case' 0 N--CA 1.419 -2.022 1 N-CA-C 99.345 -4.317 . . . . 100.0 99.345 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.413 HG23 HG23 ' A' ' 59' ' ' ILE . 23.4 m -123.57 145.06 31.18 Favored 'Isoleucine or valine' 0 C--N 1.37 1.468 0 N-CA-C 115.259 1.577 . . . . 100.0 115.259 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 6' ' ' GLU 0.262 23.5 tt0 -125.87 131.71 52.32 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.448 -2.427 . . . . 100.0 104.448 178.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.407 ' CD1' HD13 ' A' ' 168' ' ' LEU . 90.7 m-85 -125.71 134.12 51.9 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 109.268 -0.641 . . . . 100.0 109.268 177.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HE3' ' CE2' ' A' ' 64' ' ' TRP . 88.0 tttt -90.69 116.3 28.46 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.016 -1.105 . . . . 100.0 108.016 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 85' ' ' CYS . 41.5 mt -113.6 131.56 56.07 Favored 'General case' 0 CA--C 1.486 -1.505 0 N-CA-C 107.059 -1.459 . . . . 100.0 107.059 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.3 t -109.3 123.36 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 106.521 -1.659 . . . . 100.0 106.521 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.468 HD11 ' SD ' ' A' ' 89' ' ' MET . 64.6 tp -103.25 115.65 30.97 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 106.667 -1.605 . . . . 100.0 106.667 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.6 m -124.68 162.59 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 113.777 -1.556 . . . . 100.0 110.625 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.05 168.07 14.87 Favored Glycine 0 N--CA 1.434 -1.452 0 N-CA-C 108.098 -2.001 . . . . 100.0 108.098 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 97' ' ' THR . 71.1 m-20 -72.1 159.94 33.3 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 113.476 0.917 . . . . 100.0 113.476 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.4 140.24 40.89 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.756 -1.338 . . . . 100.0 109.756 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.84 1.77 89.81 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-O 118.913 -0.937 . . . . 100.0 114.344 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.2 m -64.09 -40.57 96.51 Favored 'General case' 0 C--N 1.358 0.971 0 CA-C-N 118.59 1.195 . . . . 100.0 112.303 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.08 15.49 7.79 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.956 -0.858 . . . . 100.0 110.956 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -60.94 -44.12 97.7 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.289 1.435 . . . . 100.0 111.436 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -65.17 -42.33 93.79 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 125.224 1.41 . . . . 100.0 109.738 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.16 -41.59 99.29 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.13 1.372 . . . . 100.0 109.369 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -60.15 -48.11 83.12 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.137 1.775 . . . . 100.0 109.769 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.87 -43.52 96.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 122.568 0.347 . . . . 100.0 111.491 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.27 -40.13 95.22 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 123.211 0.604 . . . . 100.0 112.099 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 35.1 ttp180 -62.15 -44.13 97.3 Favored 'General case' 0 N--CA 1.433 -1.313 0 C-N-CA 124.543 1.137 . . . . 100.0 109.482 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -63.84 -42.9 97.49 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 118.331 0.514 . . . . 100.0 112.081 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.8 mt -64.4 -48.41 75.53 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 115.508 1.67 . . . . 100.0 115.508 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 81.1 p -121.55 -21.62 6.16 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.06 -7.56 69.74 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 110.586 -1.006 . . . . 100.0 110.586 -177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 149.95 39.59 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 124.351 1.06 . . . . 100.0 109.666 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.527 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 98.3 m-85 -111.91 125.69 54.32 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 103.546 -2.761 . . . . 100.0 103.546 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -107.06 114.17 28.07 Favored 'General case' 0 N--CA 1.432 -1.344 0 C-N-CA 118.925 -1.11 . . . . 100.0 110.575 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.66 -43.29 63.36 Favored 'General case' 0 C--N 1.355 0.833 0 CA-C-N 114.659 -1.155 . . . . 100.0 113.047 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -73.02 135.45 44.91 Favored 'General case' 0 CA--C 1.49 -1.337 0 C-N-CA 125.514 1.525 . . . . 100.0 111.397 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -103.1 119.12 38.27 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.007 -1.479 . . . . 100.0 107.007 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -114.3 123.69 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 102.92 -2.993 . . . . 100.0 102.92 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.84 139.0 58.72 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.596 0.712 . . . . 100.0 112.198 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 89.0 m -97.07 125.06 41.26 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.326 -2.472 . . . . 100.0 104.326 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -106.09 130.11 54.05 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 106.464 -1.68 . . . . 100.0 106.464 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.8 -127.1 33.16 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 109.547 -1.421 . . . . 100.0 109.547 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.7 t -128.09 139.3 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 121.22 0.533 . . . . 100.0 109.89 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -115.53 123.16 47.81 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 103.58 -2.748 . . . . 100.0 103.58 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -102.65 120.4 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 106.894 -1.521 . . . . 100.0 106.894 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -124.6 121.72 25.79 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 115.273 -0.876 . . . . 100.0 111.007 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -78.71 130.43 9.7 Favored 'Trans proline' 0 N--CA 1.441 -1.612 0 C-N-CA 123.598 2.866 . . . . 100.0 111.03 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.58 128.52 48.05 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 106.873 -1.529 . . . . 100.0 106.873 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.5 t -110.04 128.56 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.583 -1.636 . . . . 100.0 106.583 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.14 131.45 56.41 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 177.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -99.33 122.54 42.61 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.228 -1.767 . . . . 100.0 106.228 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.8 p -122.42 -179.99 4.38 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.633 -0.712 . . . . 100.0 111.459 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -59.07 -37.36 76.88 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 125.913 1.685 . . . . 100.0 109.972 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -87.67 2.93 49.72 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.065 0.765 . . . . 100.0 113.065 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.27 -179.9 19.14 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 121.557 -0.715 . . . . 100.0 111.399 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.3 140.87 54.57 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 123.263 2.642 . . . . 100.0 113.794 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 9' ' ' VAL . 86.9 mt -130.35 138.58 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 103.565 -2.754 . . . . 100.0 103.565 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -116.27 128.66 55.77 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 118.972 -1.091 . . . . 100.0 108.692 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.64 118.06 35.81 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 105.077 -2.194 . . . . 100.0 105.077 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -91.94 106.46 18.48 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 101.889 -3.374 . . . . 100.0 101.889 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.84 124.95 47.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 107.966 -1.124 . . . . 100.0 107.966 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.429 ' CE2' ' HE3' ' A' ' 12' ' ' LYS . 19.2 m0 -103.56 106.8 17.41 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 106.304 -1.739 . . . . 100.0 106.304 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -86.04 116.29 24.17 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 104.136 -2.542 . . . . 100.0 104.136 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.3 p -98.44 163.11 12.82 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.46 0.911 . . . . 100.0 113.46 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.66 130.95 34.98 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.312 -0.995 . . . . 100.0 108.312 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.5 -11.0 80.94 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 116.624 -0.262 . . . . 100.0 112.56 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -67.6 -39.74 84.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 126.796 2.039 . . . . 100.0 111.809 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -61.32 141.73 57.38 Favored 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 125.275 1.43 . . . . 100.0 114.616 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.01 150.73 46.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.213 1.405 . . . . 100.0 110.982 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -72.95 132.22 43.17 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.236 -1.394 . . . . 100.0 107.236 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.3 -167.25 33.91 Favored Glycine 0 C--N 1.355 1.609 0 C-N-CA 119.077 -1.535 . . . . 100.0 115.007 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.69 -22.0 63.57 Favored Glycine 0 C--N 1.355 1.585 0 C-N-CA 127.541 2.496 . . . . 100.0 114.49 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.78 -38.41 87.96 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.236 1.814 . . . . 100.0 109.293 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -82.77 -2.21 53.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.301 2.64 . . . . 100.0 113.959 -176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -60.29 -42.93 96.51 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.88 -37.87 91.55 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 123.907 0.765 . . . . 100.0 113.489 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.0 m-30 -62.18 -43.52 98.65 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.236 1.814 . . . . 100.0 108.983 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.512 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 8.2 t80 -90.89 -13.94 32.68 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 114.296 1.221 . . . . 100.0 114.296 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.8 mt -60.69 134.15 26.12 Favored 'Isoleucine or valine' 0 C--N 1.364 1.199 0 CA-C-N 119.333 0.969 . . . . 100.0 109.876 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.29 24.55 14.32 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.498 1.919 . . . . 100.0 114.196 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.24 138.94 45.86 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 108.218 -1.03 . . . . 100.0 108.218 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -93.02 -34.61 13.64 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.138 -0.937 . . . . 100.0 108.676 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 13' ' ' LEU . 64.7 m -153.94 164.04 39.07 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 123.026 0.53 . . . . 100.0 110.978 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -139.98 153.32 46.84 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 113.838 1.051 . . . . 100.0 113.838 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -125.25 123.92 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 103.293 -2.854 . . . . 100.0 103.293 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.2 mt -110.21 122.38 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 102.579 -3.119 . . . . 100.0 102.579 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.492 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 58.5 mtp -112.23 132.99 54.62 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 113.574 0.953 . . . . 100.0 113.574 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -130.38 159.22 37.66 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 113.631 -1.622 . . . . 100.0 108.742 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -101.72 124.97 48.25 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 105.15 -2.167 . . . . 100.0 105.15 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.75 -21.87 29.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 113.683 0.994 . . . . 100.0 113.683 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.1 p -89.98 -4.58 57.37 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 118.888 -0.577 . . . . 100.0 111.591 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.16 115.78 24.33 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 122.464 1.126 . . . . 100.0 111.569 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -66.85 -38.44 86.38 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-N 114.362 -1.29 . . . . 100.0 110.554 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -61.76 -43.04 96.64 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 C-N-CA 125.394 1.478 . . . . 100.0 109.892 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 18' ' ' ASP . 92.2 m -63.16 -42.38 99.41 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.086 -0.709 . . . . 100.0 109.086 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -63.45 -40.23 96.58 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 123.29 0.636 . . . . 100.0 110.207 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -60.69 -37.41 81.55 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.314 1.046 . . . . 100.0 111.762 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.32 -12.03 60.7 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 114.502 1.297 . . . . 100.0 114.502 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.07 -43.4 94.01 Favored Pre-proline 0 C--N 1.364 1.203 0 CA-C-O 116.252 -1.832 . . . . 100.0 111.509 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 87.1 Cg_exo -58.65 -34.63 99.03 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.347 2.031 . . . . 100.0 112.645 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.38 -43.63 85.37 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.951 0.782 . . . . 100.0 110.106 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.426 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.8 m95 -62.98 -46.6 86.95 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 108.784 -0.821 . . . . 100.0 108.784 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -91.01 63.86 5.25 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 122.947 1.356 . . . . 100.0 109.524 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.0 ttm105 -157.93 -57.81 0.08 Allowed 'General case' 0 CA--C 1.485 -1.533 1 N-CA-C 100.155 -4.017 . . . . 100.0 100.155 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.66 -41.17 98.92 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 108.395 -0.965 . . . . 100.0 108.395 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.512 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 6.5 mp -62.04 -46.24 90.04 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.936 0.895 . . . . 100.0 111.492 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.55 -38.95 82.76 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 126.267 1.827 . . . . 100.0 109.543 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -59.7 -46.2 89.8 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.817 -0.438 . . . . 100.0 109.817 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.91 -49.25 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 115.494 1.665 . . . . 100.0 115.494 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.8 m -113.45 9.13 18.05 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 120.788 3.625 . . . . 100.0 120.788 -176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 55.45 -124.79 2.09 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 124.473 1.109 . . . . 100.0 112.561 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -102.74 115.74 31.19 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 120.276 1.398 . . . . 100.0 109.667 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 115' ' ' ILE . 41.7 pt -141.68 152.6 63.37 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 103.76 -2.681 . . . . 100.0 103.76 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.06 127.6 22.73 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.155 1.904 . . . . 100.0 112.412 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.705 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.2 mt -131.26 135.36 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 107.209 -1.404 . . . . 100.0 107.209 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.13 131.57 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 107.672 -1.233 . . . . 100.0 107.672 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 139' ' ' HIS . 86.5 mt -98.87 125.6 44.31 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.491 -2.411 . . . . 100.0 104.491 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.492 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.5 m -115.84 123.36 47.97 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.334 -0.848 . . . . 100.0 109.468 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.61 101.49 2.63 Favored Glycine 0 CA--C 1.485 -1.806 1 N-CA-C 102.8 -4.12 . . . . 100.0 102.8 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -86.73 165.72 15.84 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.985 0.898 . . . . 100.0 110.61 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 60.48 41.72 15.4 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 128.515 2.726 . . . . 100.0 113.521 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.5 m -67.52 -15.54 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.035 0 CA-C-N 115.866 -0.606 . . . . 100.0 111.937 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.74 -39.42 91.51 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 127.034 2.134 . . . . 100.0 110.355 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.01 130.7 30.48 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 C-N-CA 124.12 0.968 . . . . 100.0 108.498 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.46 -39.24 88.72 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 117.022 2.23 . . . . 100.0 117.022 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -83.04 76.78 9.82 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.892 0.853 . . . . 100.0 109.049 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -88.5 129.27 35.49 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.533 -1.284 . . . . 100.0 107.533 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.51 -41.25 7.06 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 115.407 -0.815 . . . . 100.0 111.216 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -96.69 108.26 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 103.803 -2.666 . . . . 100.0 103.803 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.47 151.31 23.62 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 114.777 -1.101 . . . . 100.0 110.665 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.45 96.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 124.165 0.986 . . . . 100.0 112.245 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.94 -41.16 99.41 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 124.331 1.053 . . . . 100.0 110.801 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 54.4 m -63.03 -38.13 89.96 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.999 1.72 . . . . 100.0 114.072 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.46 123.54 16.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 122.128 0.966 . . . . 100.0 109.204 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -123.25 -9.0 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.567 1.547 . . . . 100.0 111.464 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -59.17 -45.05 92.03 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.061 1.344 . . . . 100.0 111.935 -176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.479 ' HB3' HD12 ' A' ' 119' ' ' LEU . 52.5 p-80 -62.51 -41.02 98.56 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 112.799 0.666 . . . . 100.0 112.799 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -62.64 -45.86 90.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.168 1.387 . . . . 100.0 110.377 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.98 -42.62 89.6 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 123.498 0.719 . . . . 100.0 112.759 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -90.84 1.92 56.56 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 115.715 1.746 . . . . 100.0 115.715 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 55.92 47.17 20.6 Favored 'General case' 0 C--N 1.361 1.092 0 CA-C-O 122.922 1.344 . . . . 100.0 113.025 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.705 HD22 ' HB ' ' A' ' 117' ' ' ILE . 40.6 mt -112.59 160.07 18.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.323 -1.362 . . . . 100.0 107.323 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.0 tp60 -96.6 140.6 30.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 108.14 -1.059 . . . . 100.0 108.14 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -117.24 131.41 56.84 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-O 121.176 0.513 . . . . 100.0 111.469 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . 0.255 81.4 m-85 -128.75 138.3 52.03 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 114.979 -1.01 . . . . 100.0 111.616 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.39 121.34 31.54 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 101.973 -3.343 . . . . 100.0 101.973 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.17 152.97 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 CA-C-O 122.537 1.161 . . . . 100.0 111.535 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.1 t -134.8 117.09 15.57 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 104.116 -2.55 . . . . 100.0 104.116 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.94 88.63 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.703 0.627 . . . . 100.0 109.617 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.64 -41.16 79.8 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 115.426 1.639 . . . . 100.0 115.426 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.9 m -90.92 -4.63 56.37 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 115.275 1.584 . . . . 100.0 115.275 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.51 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 65.7 m-80 63.7 22.74 13.23 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.018 1.327 . . . . 100.0 112.484 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -76.0 123.6 26.01 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 106.239 -1.763 . . . . 100.0 106.239 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 53.27 40.54 31.44 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 127.141 2.176 . . . . 100.0 111.76 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -57.59 -49.31 76.81 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 126.227 1.811 . . . . 100.0 114.487 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -94.68 -6.82 42.42 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 115.424 1.639 . . . . 100.0 115.424 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.284 96.1 mttt -59.72 -45.3 98.48 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 118.857 2.91 . . . . 100.0 118.857 -176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -60.16 -41.67 49.54 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 122.782 2.029 . . . . 100.0 112.756 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -63.82 -45.04 91.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 O-C-N 124.235 0.959 . . . . 100.0 111.229 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 162' ' ' LEU . 96.9 mt -63.91 -42.9 97.3 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 118.699 -0.667 . . . . 100.0 112.793 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.19 -44.4 95.47 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 123.736 0.648 . . . . 100.0 109.955 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 85' ' ' CYS . 87.7 mt -61.4 -44.14 97.65 Favored 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 123.498 0.719 . . . . 100.0 110.693 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.36 99.01 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 124.061 0.944 . . . . 100.0 111.369 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -61.9 -45.3 94.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 C-N-CA 124.216 1.007 . . . . 100.0 110.998 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.1 -44.66 83.72 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 113.598 0.962 . . . . 100.0 113.598 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.407 HD13 ' CD1' ' A' ' 11' ' ' PHE . 74.0 mt -63.48 -47.31 82.28 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 123.412 0.685 . . . . 100.0 112.061 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 91.8 mt -70.09 -39.15 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 124.191 0.996 . . . . 100.0 111.217 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.97 10.96 58.21 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-O 118.562 -1.132 . . . . 100.0 111.874 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -108.47 109.46 61.52 Favored Pre-proline 0 C--N 1.362 1.111 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.14 -22.89 53.61 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 123.718 2.946 . . . . 100.0 113.933 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -92.03 3.91 54.23 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.118 1.367 . . . . 100.0 113.521 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.39 130.75 47.63 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-N 118.411 0.55 . . . . 100.0 110.175 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -136.4 153.16 51.18 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.323 0.582 . . . . 100.0 111.169 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -75.78 134.67 40.37 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 125.734 1.614 . . . . 100.0 109.114 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.44 156.66 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 N-CA-C 106.083 -1.821 . . . . 100.0 106.083 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.22 -85.51 0.01 OUTLIER 'General case' 0 C--N 1.356 0.891 0 N-CA-C 116.656 2.095 . . . . 100.0 116.656 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 54.5 tpp -157.71 100.59 1.83 Allowed Pre-proline 0 C--N 1.361 1.087 0 CA-C-N 119.471 1.032 . . . . 100.0 113.614 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -72.55 152.61 54.29 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 123.047 2.498 . . . . 100.0 107.382 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.23 115.24 22.34 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.344 -2.095 . . . . 100.0 105.344 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.0 mt -94.4 154.52 17.42 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 114.786 -1.097 . . . . 100.0 108.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -80.12 125.96 80.46 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.429 -1.322 . . . . 100.0 107.429 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.85 145.06 90.07 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 123.558 2.838 . . . . 100.0 113.261 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.96 166.27 30.08 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.532 2.821 . . . . 100.0 111.849 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -60.93 -43.86 98.05 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.446 1.098 . . . . 100.0 112.182 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.8 t 57.46 70.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.27 0 C-N-CA 126.484 1.913 . . . . 100.0 110.102 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 19.9 m -82.99 164.4 2.76 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 115.003 1.482 . . . . 100.0 115.003 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.305 61.5 mtm 51.42 -124.49 2.25 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 127.873 2.469 . . . . 100.0 116.816 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.417 ' N ' ' HD3' ' A' ' 191' ' ' PRO . 77.1 m-20 57.27 42.97 0.96 Allowed Pre-proline 0 C--N 1.369 1.421 0 N-CA-C 118.371 2.73 . . . . 100.0 118.371 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 190' ' ' ASP . 32.5 Cg_exo -61.51 -48.9 8.36 Favored 'Trans proline' 0 C--N 1.382 2.293 0 CA-C-N 122.5 1.928 . . . . 100.0 112.926 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.92 72.55 Favored 'General case' 0 CA--C 1.498 -1.022 0 C-N-CA 124.192 0.997 . . . . 100.0 110.671 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.79 -37.7 88.34 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 116.154 1.909 . . . . 100.0 116.154 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.24 165.21 24.12 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 113.075 0.769 . . . . 100.0 113.075 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 74.28 -44.38 0.56 Allowed 'General case' 0 C--N 1.368 1.41 0 C-N-CA 127.462 2.305 . . . . 100.0 115.024 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 71.8 tp60 -59.87 -36.13 76.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.386 1.874 . . . . 100.0 111.666 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -60.05 -39.98 87.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 124.183 0.993 . . . . 100.0 110.921 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -62.37 -43.13 99.55 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.038 0.935 . . . . 100.0 110.338 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -63.13 -41.24 99.28 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.54 1.136 . . . . 100.0 110.203 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -62.88 -40.93 99.03 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.97 1.308 . . . . 100.0 109.929 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 98.2 mt -62.9 -40.51 97.78 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.846 0.858 . . . . 100.0 110.316 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.37 -42.17 99.2 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.016 0.927 . . . . 100.0 110.871 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.71 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 C-N-CA 124.204 1.001 . . . . 100.0 108.418 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.13 98.82 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 124.419 1.088 . . . . 100.0 110.958 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.89 -42.7 99.39 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 124.943 1.297 . . . . 100.0 110.433 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.6 m -63.18 -42.2 99.34 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.682 1.193 . . . . 100.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 56.4 m -62.35 135.14 57.32 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.205 1.002 . . . . 100.0 112.551 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -71.78 144.38 49.21 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.107 0.963 . . . . 100.0 110.048 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 18.5 tp -99.88 125.64 39.58 Favored Pre-proline 0 N--CA 1.434 -1.27 0 N-CA-C 108.138 -1.06 . . . . 100.0 108.138 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -71.44 166.37 29.55 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.502 2.801 . . . . 100.0 110.113 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -77.11 109.78 11.24 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 106.807 -1.553 . . . . 100.0 106.807 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -126.09 -60.25 1.29 Allowed 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.042 -1.435 . . . . 100.0 107.282 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.527 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 53.9 p30 -111.53 13.13 21.37 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 114.711 1.374 . . . . 100.0 114.711 -178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -61.53 -37.59 84.3 Favored 'General case' 0 CA--C 1.499 -1.011 0 C-N-CA 124.024 0.93 . . . . 100.0 113.454 -178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.92 -41.75 96.76 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 113.31 0.855 . . . . 100.0 113.31 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 6.2 tp . . . . . 0 C--O 1.258 1.508 0 CA-C-O 117.192 -1.385 . . . . 100.0 108.853 -179.836 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 8.1 ttp . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 108.976 -0.75 . . . . 100.0 108.976 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.46 96.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.215 1.406 . . . . 100.0 112.062 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.516 ' HB2' HG23 ' A' ' 188' ' ' VAL . . . -61.74 -44.61 96.57 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 123.896 0.879 . . . . 100.0 110.651 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.48 -37.48 86.96 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 123.706 0.802 . . . . 100.0 111.738 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.41 21.75 23.73 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 106.698 -2.561 . . . . 100.0 106.698 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 1' ' ' MET 0.293 34.3 tt0 -87.59 100.24 1.63 Allowed Pre-proline 0 N--CA 1.422 -1.829 0 N-CA-C 102.049 -3.315 . . . . 100.0 102.049 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.27 -47.07 8.56 Favored 'Trans proline' 0 C--N 1.377 2.067 0 N-CA-C 106.072 -2.319 . . . . 100.0 106.072 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -128.92 -63.56 0.96 Allowed 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 100.478 -3.897 . . . . 100.0 100.478 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.419 ' HA ' ' HG3' ' A' ' 6' ' ' GLU . 60.3 t -130.45 145.03 36.22 Favored 'Isoleucine or valine' 0 C--N 1.373 1.599 0 CA-C-O 121.871 0.843 . . . . 100.0 110.504 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -124.46 132.42 53.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.968 -2.234 . . . . 100.0 104.968 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -118.05 135.27 54.29 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.995 -1.113 . . . . 100.0 107.995 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -91.31 112.59 24.56 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 106.302 -1.74 . . . . 100.0 106.302 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.438 HD23 HG22 ' A' ' 63' ' ' VAL . 41.4 tp -108.01 124.43 50.15 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 113.11 -1.859 . . . . 100.0 107.829 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 t -108.94 123.68 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 N-CA-C 106.225 -1.769 . . . . 100.0 106.225 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -105.98 117.97 35.41 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 106.696 -1.594 . . . . 100.0 106.696 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.8 m -127.21 162.97 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 C-N-CA 125.11 1.364 . . . . 100.0 110.896 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.46 171.77 19.71 Favored Glycine 0 CA--C 1.49 -1.53 0 N-CA-C 108.404 -1.878 . . . . 100.0 108.404 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.466 ' HB2' HG23 ' A' ' 97' ' ' THR . 65.4 m-20 -73.46 162.65 29.05 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 112.762 0.653 . . . . 100.0 112.762 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.06 140.52 36.18 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 110.079 -1.208 . . . . 100.0 110.079 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.12 1.63 90.54 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.667 0.651 . . . . 100.0 113.728 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.654 HG22 HD21 ' A' ' 122' ' ' ASN . 56.2 m -63.92 -41.57 97.63 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 117.817 0.809 . . . . 100.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.6 17.75 5.94 Favored Glycine 0 C--N 1.351 1.416 0 C-N-CA 120.211 -0.995 . . . . 100.0 112.06 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -61.29 -46.62 89.59 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.122 1.369 . . . . 100.0 110.125 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.0 m -63.92 -43.39 96.07 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 125.395 1.478 . . . . 100.0 109.5 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.6 m -63.61 -41.07 98.34 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.265 1.026 . . . . 100.0 110.044 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -60.13 -48.34 82.12 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.306 1.442 . . . . 100.0 109.727 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -64.74 -43.76 96.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 C-N-CA 123.08 0.552 . . . . 100.0 111.217 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.09 -39.25 94.14 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 112.477 0.547 . . . . 100.0 112.477 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 39.9 ttp180 -61.49 -44.61 96.77 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 124.321 1.048 . . . . 100.0 108.99 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -63.56 -44.34 94.41 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 112.405 0.52 . . . . 100.0 112.405 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.96 -48.6 73.48 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 116.371 1.989 . . . . 100.0 116.371 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.9 p -119.23 -24.0 6.57 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 117.07 2.248 . . . . 100.0 117.07 -175.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.93 -6.92 73.4 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 110.434 -1.066 . . . . 100.0 110.434 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.43 151.71 38.07 Favored 'General case' 0 C--N 1.359 1.0 0 CA-C-N 118.017 0.908 . . . . 100.0 109.766 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.575 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 99.0 m-85 -110.61 127.2 55.14 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.111 -2.552 . . . . 100.0 104.111 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -104.55 116.92 32.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.798 -0.816 . . . . 100.0 108.798 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -94.0 -34.33 13.08 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-N 116.181 -0.463 . . . . 100.0 110.785 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -86.04 126.29 34.05 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.105 -1.072 . . . . 100.0 108.105 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -98.38 124.25 42.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 118.312 -1.355 . . . . 100.0 109.377 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.42 130.0 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 101.829 -3.397 . . . . 100.0 101.829 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.35 139.66 58.14 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.692 0.758 . . . . 100.0 112.861 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.2 m -93.58 123.46 36.91 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.075 -2.935 . . . . 100.0 103.075 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.17 125.98 50.91 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 105.959 -1.867 . . . . 100.0 105.959 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.26 -125.45 34.09 Favored Glycine 0 C--N 1.355 1.605 0 N-CA-C 109.147 -1.581 . . . . 100.0 109.147 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.82 139.1 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 121.559 0.695 . . . . 100.0 110.601 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -110.5 123.93 50.84 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 103.215 -2.883 . . . . 100.0 103.215 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -99.86 116.66 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 106.217 -1.772 . . . . 100.0 106.217 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.47 118.91 21.59 Favored Pre-proline 0 N--CA 1.431 -1.423 0 C-N-CA 120.435 -0.506 . . . . 100.0 111.279 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -78.7 127.97 8.29 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.887 2.392 . . . . 100.0 109.658 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.24 126.84 45.81 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 106.248 -1.76 . . . . 100.0 106.248 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.85 128.04 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 105.875 -1.898 . . . . 100.0 105.875 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -118.66 131.74 56.17 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 105.649 -1.982 . . . . 100.0 105.649 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -97.28 123.98 41.25 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.0 p -124.19 179.71 4.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.815 -0.629 . . . . 100.0 110.85 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -58.79 -37.62 76.74 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.933 1.693 . . . . 100.0 110.208 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.45 -0.46 54.98 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 113.029 0.752 . . . . 100.0 113.029 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.53 -179.57 18.12 Favored Glycine 0 C--N 1.354 1.571 0 N-CA-C 110.842 -0.903 . . . . 100.0 110.842 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.01 138.23 43.39 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.415 2.744 . . . . 100.0 113.437 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -127.98 140.41 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 103.258 -2.868 . . . . 100.0 103.258 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -115.5 127.97 55.67 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 118.649 -1.22 . . . . 100.0 109.35 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -104.77 118.65 37.09 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 103.56 -2.755 . . . . 100.0 103.56 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -92.48 109.42 20.82 Favored 'General case' 0 N--CA 1.427 -1.58 1 N-CA-C 98.798 -4.519 . . . . 100.0 98.798 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.438 HG22 HD23 ' A' ' 13' ' ' LEU . 39.9 t -95.04 126.52 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 106.947 -1.501 . . . . 100.0 106.947 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -107.76 102.04 11.29 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.23 117.98 26.34 Favored 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 103.441 -2.8 . . . . 100.0 103.441 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.9 p -100.06 160.38 14.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 112.943 0.719 . . . . 100.0 112.943 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.58 132.0 36.97 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.085 -0.709 . . . . 100.0 109.085 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.36 -12.39 75.97 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 112.109 -0.396 . . . . 100.0 112.109 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -67.68 -39.46 84.47 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.625 1.57 . . . . 100.0 111.699 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.43 139.71 58.57 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 124.544 1.138 . . . . 100.0 113.385 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -67.15 147.91 52.5 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.48 1.912 . . . . 100.0 111.151 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -70.38 132.26 45.36 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.236 -1.764 . . . . 100.0 106.236 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.57 -166.87 33.96 Favored Glycine 0 C--N 1.357 1.716 0 C-N-CA 119.118 -1.515 . . . . 100.0 115.534 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.36 -22.7 63.66 Favored Glycine 0 C--N 1.356 1.646 0 C-N-CA 127.599 2.523 . . . . 100.0 114.337 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.6 tp -62.0 -38.43 88.61 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.704 2.002 . . . . 100.0 110.021 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -82.99 -1.0 51.42 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 127.509 2.323 . . . . 100.0 113.895 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -42.85 93.61 Favored 'General case' 0 CA--C 1.489 -1.366 0 N-CA-C 117.476 2.399 . . . . 100.0 117.476 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -38.53 93.01 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 118.672 0.669 . . . . 100.0 113.345 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -62.36 -43.43 98.84 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 125.9 1.68 . . . . 100.0 109.592 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.546 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 6.3 t80 -89.84 -14.26 34.76 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 114.173 1.175 . . . . 100.0 114.173 -175.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.3 mt -61.24 134.92 26.47 Favored 'Isoleucine or valine' 0 C--N 1.362 1.142 0 CA-C-N 119.369 0.986 . . . . 100.0 109.358 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 66.1 20.25 11.18 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 127.363 2.265 . . . . 100.0 113.296 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.09 139.1 52.5 Favored 'General case' 0 C--N 1.365 1.278 0 O-C-N 121.199 -0.938 . . . . 100.0 108.669 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -99.54 -31.7 11.48 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.514 -0.767 . . . . 100.0 109.008 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.501 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.2 p -148.75 160.35 43.28 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 120.733 0.301 . . . . 100.0 111.431 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -143.36 150.81 39.66 Favored 'General case' 0 CA--C 1.487 -1.479 0 C-N-CA 119.371 -0.931 . . . . 100.0 113.021 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.413 HG13 HD11 ' A' ' 13' ' ' LEU . 97.0 mt -125.74 126.41 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 103.592 -2.744 . . . . 100.0 103.592 176.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.81 122.28 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.423 -3.177 . . . . 100.0 102.423 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.482 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 38.5 mtt -111.89 134.29 53.54 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 114.459 1.281 . . . . 100.0 114.459 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -130.14 157.17 43.16 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 112.546 -2.115 . . . . 100.0 109.229 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -102.18 125.53 48.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.335 -2.098 . . . . 100.0 105.335 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 m -64.08 -21.66 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 113.762 1.023 . . . . 100.0 113.762 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.7 p -88.89 -5.84 57.73 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 118.996 -0.526 . . . . 100.0 111.62 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.1 t -119.79 116.79 26.61 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 122.859 1.314 . . . . 100.0 111.841 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.11 -39.71 86.73 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.887 -1.506 . . . . 100.0 110.804 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.79 -43.33 97.13 Favored 'Isoleucine or valine' 0 C--N 1.358 0.95 0 C-N-CA 125.24 1.416 . . . . 100.0 109.456 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.176 0.59 . . . . 100.0 109.914 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.44 -40.42 95.7 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 122.911 0.485 . . . . 100.0 110.723 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.512 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.2 mttt -60.77 -37.23 81.16 Favored 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 124.118 0.967 . . . . 100.0 111.445 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -73.43 -11.49 60.48 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 114.995 1.48 . . . . 100.0 114.995 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.35 -43.11 92.32 Favored Pre-proline 0 C--N 1.363 1.16 0 CA-C-O 116.165 -1.874 . . . . 100.0 111.48 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 90.9 Cg_exo -58.07 -35.28 98.87 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.726 2.284 . . . . 100.0 112.702 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -66.55 -43.03 86.21 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 124.488 1.115 . . . . 100.0 109.901 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.441 ' O ' HD13 ' A' ' 108' ' ' LEU . 81.0 m95 -63.16 -46.21 88.25 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 109.453 -0.573 . . . . 100.0 109.453 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -90.74 65.0 5.77 Favored 'General case' 0 C--N 1.36 1.063 0 CA-C-O 123.054 1.407 . . . . 100.0 107.883 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -159.69 -57.0 0.06 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 100.567 -3.864 . . . . 100.0 100.567 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.02 -43.72 98.24 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 125.107 1.363 . . . . 100.0 108.254 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.4 mp -62.5 -46.34 88.88 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.267 1.027 . . . . 100.0 112.145 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.53 -39.84 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 126.498 1.919 . . . . 100.0 109.309 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.2 ttp85 -59.68 -45.19 92.83 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 123.113 0.565 . . . . 100.0 110.75 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.99 -50.17 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 72.3 m -115.03 9.4 15.99 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.989 3.329 . . . . 100.0 119.989 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.257 80.9 mm-40 53.82 -123.16 2.1 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 125.45 1.5 . . . . 100.0 113.943 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -98.13 112.97 24.74 Favored 'General case' 0 CA--C 1.49 -1.338 0 CA-C-N 119.631 1.105 . . . . 100.0 112.416 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 43.3 pt -143.35 151.75 55.56 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 104.161 -2.533 . . . . 100.0 104.161 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.52 127.97 22.27 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 121.982 1.788 . . . . 100.0 112.503 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 144' ' ' LEU . 59.7 mt -130.56 136.0 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 107.271 -1.381 . . . . 100.0 107.271 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.84 131.39 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.175 -1.375 . . . . 100.0 107.922 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 139' ' ' HIS . 87.9 mt -99.43 125.12 45.09 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 104.329 -2.471 . . . . 100.0 104.329 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.8 m -116.49 122.19 44.01 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.986 0.898 . . . . 100.0 110.328 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.53 101.84 2.69 Favored Glycine 0 CA--C 1.476 -2.394 1 N-CA-C 102.862 -4.095 . . . . 100.0 102.862 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.654 HD21 HG22 ' A' ' 21' ' ' THR 0.412 56.7 p30 -92.69 170.31 9.82 Favored 'General case' 0 N--CA 1.423 -1.811 0 C-N-CA 118.899 -1.12 . . . . 100.0 113.943 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 93.1 mttt 60.81 40.39 15.99 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 128.105 2.562 . . . . 100.0 112.155 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 148' ' ' ASP . 33.5 m -65.77 -18.04 23.25 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 C-N-CA 123.474 0.71 . . . . 100.0 112.893 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -61.28 -39.14 89.33 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.054 1.742 . . . . 100.0 110.58 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.18 130.77 28.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 123.766 0.826 . . . . 100.0 109.109 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.35 -41.53 96.7 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.345 1.609 . . . . 100.0 115.345 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -84.26 81.39 8.84 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-O 121.482 0.658 . . . . 100.0 109.325 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -89.85 130.71 36.05 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 107.433 -1.321 . . . . 100.0 107.433 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.37 -44.36 7.26 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.598 -0.728 . . . . 100.0 109.821 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.95 112.16 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 N-CA-C 105.026 -2.213 . . . . 100.0 105.026 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -86.38 150.87 24.01 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 113.787 -1.551 . . . . 100.0 110.106 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.67 -40.25 94.29 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.171 0.989 . . . . 100.0 110.669 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.51 -41.02 98.55 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.096 1.358 . . . . 100.0 110.839 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 m -62.66 -38.51 90.62 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 125.757 1.623 . . . . 100.0 112.695 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 76.4 mt -65.67 121.7 15.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.646 1.213 . . . . 100.0 110.358 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 m -128.58 -4.61 3.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.69 0 CA-C-N 113.627 -1.624 . . . . 100.0 111.07 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 142' ' ' LYS . 66.3 t80 -59.77 -42.92 94.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.351 1.46 . . . . 100.0 111.339 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.469 ' HB3' HD12 ' A' ' 119' ' ' LEU . 48.1 p-80 -61.33 -42.19 98.28 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.534 0.733 . . . . 100.0 112.518 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -63.5 -45.07 92.37 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 123.937 0.895 . . . . 100.0 111.252 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.06 -41.19 95.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 123.512 0.725 . . . . 100.0 112.042 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 138' ' ' PHE . 74.6 mmtt -92.64 1.97 56.97 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 116.222 1.934 . . . . 100.0 116.222 -177.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 55.58 49.23 16.97 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 125.227 1.411 . . . . 100.0 113.572 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 117' ' ' ILE . 44.5 mt -118.7 159.11 24.24 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.676 -1.602 . . . . 100.0 106.676 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.308 78.9 mt-30 -101.63 140.23 36.2 Favored 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 118.609 -1.236 . . . . 100.0 110.578 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -109.38 131.15 55.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 112.987 0.736 . . . . 100.0 112.987 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -128.31 134.22 48.86 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.634 -1.166 . . . . 100.0 111.403 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.4 ' HB3' HG11 ' A' ' 124' ' ' VAL . 32.1 m-20 -87.53 120.86 29.27 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 102.802 -3.036 . . . . 100.0 102.802 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.1 pt -130.93 154.4 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 CA-C-O 122.355 1.074 . . . . 100.0 111.244 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.3 t -136.07 118.42 15.68 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 104.369 -2.456 . . . . 100.0 104.369 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.433 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.81 -44.99 88.08 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 123.273 0.629 . . . . 100.0 109.435 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -66.11 -43.56 86.84 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 114.276 1.213 . . . . 100.0 114.276 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.1 m -92.25 -5.22 52.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 115.276 1.584 . . . . 100.0 115.276 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.463 HD21 ' HZ ' ' A' ' 35' ' ' PHE . 63.9 m-80 64.26 21.78 12.62 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 124.861 1.264 . . . . 100.0 112.167 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -75.72 125.1 28.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.189 -1.782 . . . . 100.0 106.189 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 53.31 40.39 31.24 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.064 2.146 . . . . 100.0 111.979 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -57.71 -48.6 79.1 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 126.706 2.003 . . . . 100.0 111.297 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.501 ' HA ' ' CE2' ' A' ' 161' ' ' PHE . 92.7 mt-10 -80.59 -24.75 38.93 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 118.396 2.739 . . . . 100.0 118.396 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.302 95.0 mttt -59.16 -45.31 99.34 Favored Pre-proline 0 N--CA 1.435 -1.192 0 N-CA-C 121.456 3.872 . . . . 100.0 121.456 -173.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -60.04 -45.81 22.11 Favored 'Trans proline' 0 C--N 1.369 1.612 0 CA-C-N 123.098 2.142 . . . . 100.0 112.74 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 158' ' ' GLU 0.343 28.2 p90 -66.44 -40.72 89.63 Favored 'General case' 0 CA--C 1.489 -1.37 0 O-C-N 124.346 1.029 . . . . 100.0 113.113 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 176' ' ' PHE . 94.9 mt -63.71 -43.23 97.18 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-O 118.403 -0.808 . . . . 100.0 112.877 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -63.89 -43.2 96.72 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 118.807 -0.616 . . . . 100.0 110.415 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 85' ' ' CYS . 77.2 mt -60.78 -44.5 96.71 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.601 0.563 . . . . 100.0 110.806 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.63 -43.0 99.91 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.891 0.876 . . . . 100.0 111.417 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 97.8 mtt180 -62.96 -45.27 93.25 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.364 0.666 . . . . 100.0 111.473 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -64.32 -47.02 81.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 123.798 0.839 . . . . 100.0 112.347 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.93 -46.48 81.44 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 113.234 0.827 . . . . 100.0 113.234 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.08 -39.17 76.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 123.694 0.798 . . . . 100.0 110.527 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.62 8.53 59.5 Favored Glycine 0 N--CA 1.435 -1.388 0 CA-C-O 118.669 -1.073 . . . . 100.0 111.82 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -102.46 108.36 57.18 Favored Pre-proline 0 C--N 1.361 1.096 0 N-CA-C 106.655 -1.609 . . . . 100.0 106.655 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.12 -23.22 53.4 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 123.969 3.113 . . . . 100.0 113.569 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.6 6.72 47.33 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 125.161 1.384 . . . . 100.0 113.676 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 23.3 tp -63.05 128.75 37.31 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.648 0.658 . . . . 100.0 110.127 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -132.18 151.64 51.69 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.59 0.71 . . . . 100.0 110.509 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.439 ' HB2' HD21 ' A' ' 162' ' ' LEU . 67.6 t80 -81.15 135.02 35.73 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 125.273 1.429 . . . . 100.0 108.836 -179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -120.94 160.34 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.816 -1.179 . . . . 100.0 107.816 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.79 -91.4 0.0 OUTLIER 'General case' 0 C--N 1.357 0.898 0 N-CA-C 116.698 2.11 . . . . 100.0 116.698 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 56.8 tpp -155.8 97.58 2.3 Favored Pre-proline 0 C--N 1.36 1.057 0 CA-C-N 119.682 1.128 . . . . 100.0 113.611 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -75.02 156.43 42.89 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 123.356 2.704 . . . . 100.0 108.514 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -74.3 127.2 32.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.084 -1.821 . . . . 100.0 106.084 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.8 mt -112.17 134.96 53.41 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.798 -0.637 . . . . 100.0 110.4 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -83.58 127.55 67.55 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 103.429 -2.804 . . . . 100.0 103.429 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.66 141.18 90.08 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 123.175 2.583 . . . . 100.0 114.208 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.83 167.39 27.39 Favored 'Trans proline' 0 N--CA 1.442 -1.521 0 C-N-CA 123.839 3.026 . . . . 100.0 112.514 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.72 -42.21 96.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.68 1.592 . . . . 100.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 43.2 t 68.08 101.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.022 0 C-N-CA 127.374 2.27 . . . . 100.0 110.639 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 3' ' ' ALA . 19.1 m -129.25 166.99 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-N 113.956 -1.474 . . . . 100.0 108.809 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 82.7 mtp 53.21 -131.89 2.03 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 126.917 2.087 . . . . 100.0 115.4 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 51.11 46.8 3.98 Favored Pre-proline 0 C--N 1.373 1.607 0 C-N-CA 128.736 2.814 . . . . 100.0 118.521 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -63.65 -69.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 121.676 1.584 . . . . 100.0 113.219 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.03 -45.69 80.55 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 124.052 0.845 . . . . 100.0 113.009 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.356 89.3 mt -65.67 -41.27 92.68 Favored 'General case' 0 CA--C 1.482 -1.646 0 N-CA-C 120.921 3.674 . . . . 100.0 120.921 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -76.77 164.93 25.39 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 115.03 1.493 . . . . 100.0 115.03 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 71.92 -45.88 0.63 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 118.249 2.685 . . . . 100.0 118.249 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -58.21 -48.2 81.09 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 116.878 2.177 . . . . 100.0 116.878 -175.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -64.7 -45.15 87.81 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 114.647 1.351 . . . . 100.0 114.647 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -64.11 -40.08 95.44 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 123.636 0.774 . . . . 100.0 110.642 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -62.52 -42.3 99.42 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.595 1.158 . . . . 100.0 110.455 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -62.32 -43.87 97.82 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 123.911 0.884 . . . . 100.0 110.578 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.15 -43.83 97.97 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.384 0.674 . . . . 100.0 110.681 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.49 -44.58 96.02 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.552 1.141 . . . . 100.0 111.993 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.1 -42.55 97.0 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 C-N-CA 123.774 0.83 . . . . 100.0 109.295 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.89 97.88 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.642 0.777 . . . . 100.0 110.685 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -63.76 -40.76 97.49 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.357 1.063 . . . . 100.0 112.143 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -63.82 -42.96 97.55 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 124.732 1.213 . . . . 100.0 110.994 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 90.3 m -62.48 139.53 58.59 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 124.645 1.178 . . . . 100.0 111.688 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -67.06 131.01 44.96 Favored 'General case' 0 C--N 1.365 1.241 0 C-N-CA 123.958 0.903 . . . . 100.0 108.981 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.42 154.45 81.56 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 113.024 0.75 . . . . 100.0 113.024 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -73.26 -179.88 4.82 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 C-N-CA 123.176 2.584 . . . . 100.0 108.71 177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -62.63 120.9 12.08 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.154 0.978 . . . . 100.0 111.174 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -129.43 -57.16 1.14 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 106.593 -1.632 . . . . 100.0 106.593 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.575 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 54.7 p30 -110.88 5.2 20.35 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 114.5 1.296 . . . . 100.0 114.5 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.39 -35.58 79.63 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 124.459 1.104 . . . . 100.0 112.756 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -59.32 -41.88 90.11 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.619 1.567 . . . . 100.0 112.14 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.258 1.53 0 CA-C-O 117.136 -1.412 . . . . 100.0 108.605 -179.63 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.503 -0.848 0 CA-C-O 120.683 0.278 . . . . 100.0 110.546 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.36 -39.75 91.78 Favored 'General case' 0 CA--C 1.492 -1.274 0 C-N-CA 124.293 1.037 . . . . 100.0 112.272 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 190' ' ' ASP . . . -59.82 -46.01 90.59 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 123.861 0.725 . . . . 100.0 111.175 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -68.43 -37.55 80.36 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 113.443 0.905 . . . . 100.0 113.443 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.73 20.86 12.06 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 106.23 -2.748 . . . . 100.0 106.23 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.308 27.8 tt0 -86.31 100.2 1.32 Allowed Pre-proline 0 N--CA 1.417 -2.114 0 N-CA-C 103.168 -2.901 . . . . 100.0 103.168 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.404 ' HD3' ' HG3' ' A' ' 60' ' ' LYS . 61.5 Cg_endo -60.97 -46.09 17.38 Favored 'Trans proline' 0 C--N 1.38 2.219 0 N-CA-C 107.195 -1.886 . . . . 100.0 107.195 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.421 HE22 ' HA3' ' A' ' 57' ' ' GLY . 35.1 mt-30 -131.53 -60.3 0.94 Allowed 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 100.925 -3.732 . . . . 100.0 100.925 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.92 142.22 44.59 Favored 'Isoleucine or valine' 0 C--N 1.37 1.493 0 CA-C-O 121.458 0.647 . . . . 100.0 110.924 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -128.36 136.22 50.64 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 105.827 -1.916 . . . . 100.0 105.827 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -119.95 132.61 55.57 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.732 -1.581 . . . . 100.0 106.732 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -90.39 117.22 28.93 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -110.18 129.01 55.79 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 113.838 -1.528 . . . . 100.0 106.93 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -110.53 124.37 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 105.253 -2.129 . . . . 100.0 105.253 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.01 116.71 32.4 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.948 -1.871 . . . . 100.0 105.948 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.415 ' HA ' ' HZ1' ' A' ' 23' ' ' LYS . 32.9 m -125.31 162.16 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-N 113.696 -1.593 . . . . 100.0 110.496 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.91 168.2 15.39 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 107.476 -2.25 . . . . 100.0 107.476 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HB2' HG23 ' A' ' 97' ' ' THR . 76.6 m-20 -71.82 162.45 29.43 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 113.215 0.82 . . . . 100.0 113.215 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.78 141.43 38.28 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.293 -1.123 . . . . 100.0 110.293 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.18 1.44 90.36 Favored Glycine 0 C--N 1.349 1.28 0 C-N-CA 123.715 0.674 . . . . 100.0 113.982 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.8 m -65.02 -41.23 95.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.758 0.823 . . . . 100.0 111.648 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.43 15.77 6.86 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 120.57 -0.824 . . . . 100.0 112.087 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HZ1' ' HA ' ' A' ' 16' ' ' VAL . 20.1 ptmt -61.5 -44.32 97.29 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.77 1.228 . . . . 100.0 111.713 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.5 m -64.96 -42.31 94.7 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 124.906 1.282 . . . . 100.0 109.659 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 78.7 m -63.47 -41.01 98.61 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.272 1.029 . . . . 100.0 109.353 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -60.25 -47.5 85.73 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.072 1.349 . . . . 100.0 110.013 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.08 -43.6 97.53 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 C-N-CA 123.591 0.756 . . . . 100.0 111.831 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -61.6 -43.36 99.0 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.605 1.162 . . . . 100.0 109.734 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 36.8 ttp180 -61.72 -45.15 95.2 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 125.43 1.492 . . . . 100.0 110.462 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -63.9 -43.72 95.14 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.59 0.589 . . . . 100.0 112.59 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.9 mt -65.05 -47.58 76.83 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 115.23 1.567 . . . . 100.0 115.23 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.0 p -120.01 -23.57 6.32 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 119.104 3.002 . . . . 100.0 119.104 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.91 -4.33 71.57 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 110.733 -0.947 . . . . 100.0 110.733 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -76.94 147.15 37.11 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 126.422 1.889 . . . . 100.0 108.563 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HZ ' HD21 ' A' ' 154' ' ' ASN . 93.0 m-85 -114.29 126.32 54.9 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 105.391 -2.077 . . . . 100.0 105.391 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -105.49 113.93 27.79 Favored 'General case' 0 CA--C 1.496 -1.114 0 C-N-CA 120.071 -0.651 . . . . 100.0 111.907 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -72.96 -42.26 63.55 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 125.0 1.32 . . . . 100.0 112.511 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -84.75 130.91 34.62 Favored 'General case' 0 CA--C 1.488 -1.406 0 C-N-CA 125.904 1.682 . . . . 100.0 111.419 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -99.73 120.67 40.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 122.407 1.099 . . . . 100.0 110.77 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 1 N-CA-C 99.994 -4.076 . . . . 100.0 99.994 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 140.21 58.6 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 113.871 1.063 . . . . 100.0 113.871 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.8 m -91.45 126.18 36.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 103.708 -2.701 . . . . 100.0 103.708 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.0 mt -105.74 128.79 53.91 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.77 -125.38 30.56 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.378 -1.489 . . . . 100.0 109.378 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.8 t -126.79 139.51 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 123.56 0.744 . . . . 100.0 109.987 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -113.87 124.57 52.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.276 -2.861 . . . . 100.0 103.276 175.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 67.3 t -102.56 113.35 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 107.899 -1.148 . . . . 100.0 107.899 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -125.97 120.77 24.09 Favored Pre-proline 0 N--CA 1.433 -1.291 0 N-CA-C 113.018 0.747 . . . . 100.0 113.018 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.88 135.0 12.28 Favored 'Trans proline' 0 N--CA 1.437 -1.83 0 C-N-CA 122.475 2.117 . . . . 100.0 111.148 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.58 132.67 53.94 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 105.414 -2.069 . . . . 100.0 105.414 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.514 HG22 ' HE3' ' A' ' 60' ' ' LYS . 19.6 t -109.44 126.58 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 105.554 -2.017 . . . . 100.0 105.554 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -120.31 129.45 54.01 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.269 -1.752 . . . . 100.0 106.269 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -98.83 122.9 42.66 Favored 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 105.749 -1.945 . . . . 100.0 105.749 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.44 ' HB ' HD11 ' A' ' 174' ' ' LEU . 69.9 p -122.67 -178.3 3.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.426 -0.806 . . . . 100.0 110.787 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -59.41 -37.34 77.79 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.7 1.6 . . . . 100.0 108.6 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -81.33 -3.41 52.56 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.206 1.802 . . . . 100.0 112.458 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.421 ' HA3' HE22 ' A' ' 8' ' ' GLN . . . 109.81 -177.02 19.7 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 110.829 -0.908 . . . . 100.0 110.829 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.33 137.16 50.22 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.972 3.115 . . . . 100.0 113.418 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.8 mt -135.46 142.97 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 N-CA-C 105.317 -2.105 . . . . 100.0 105.317 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' HE3' HG22 ' A' ' 51' ' ' VAL 0.284 44.8 mttp -115.1 132.34 56.64 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 118.046 -1.462 . . . . 100.0 110.588 175.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -102.48 116.83 33.41 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.087 -2.931 . . . . 100.0 103.087 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -92.5 100.46 13.0 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 101.089 -3.671 . . . . 100.0 101.089 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.45 124.74 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.512 0 CA-C-N 115.704 -0.68 . . . . 100.0 109.276 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -106.72 106.36 16.85 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 104.954 -2.239 . . . . 100.0 104.954 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -85.51 117.11 24.22 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 102.934 -2.987 . . . . 100.0 102.934 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.6 p -100.14 162.64 12.84 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 113.14 0.792 . . . . 100.0 113.14 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.97 128.74 34.75 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.682 -0.859 . . . . 100.0 108.682 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.14 -12.19 82.7 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 116.02 -0.536 . . . . 100.0 113.133 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -67.77 -39.16 84.15 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.399 1.48 . . . . 100.0 112.069 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.34 137.66 58.3 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 124.778 1.231 . . . . 100.0 112.45 -177.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -71.76 153.9 41.68 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.869 -1.06 . . . . 100.0 112.427 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -68.08 131.99 46.43 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.818 1.647 . . . . 100.0 108.115 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.61 -171.4 34.78 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 119.237 -1.459 . . . . 100.0 115.446 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -21.04 62.85 Favored Glycine 0 C--N 1.356 1.692 0 C-N-CA 127.959 2.695 . . . . 100.0 113.601 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.9 tp -61.23 -37.93 84.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.362 2.265 . . . . 100.0 109.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -87.86 6.82 33.61 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 126.269 1.828 . . . . 100.0 115.19 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 -42.24 90.35 Favored 'General case' 0 CA--C 1.487 -1.465 0 N-CA-C 115.487 1.662 . . . . 100.0 115.487 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.44 -39.02 94.33 Favored Glycine 0 C--N 1.353 1.497 0 C-N-CA 123.804 0.716 . . . . 100.0 113.165 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -60.87 -45.56 94.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.448 1.499 . . . . 100.0 108.694 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.544 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 6.1 t80 -89.29 -11.05 44.57 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 115.076 1.51 . . . . 100.0 115.076 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.3 mt -60.5 131.66 25.44 Favored 'Isoleucine or valine' 0 C--N 1.366 1.326 0 CA-C-N 119.924 1.238 . . . . 100.0 110.838 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.309 63.9 mt-30 57.21 36.9 28.01 Favored 'General case' 0 N--CA 1.437 -1.106 0 C-N-CA 128.197 2.599 . . . . 100.0 113.863 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.88 142.87 42.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 105.611 -1.996 . . . . 100.0 105.611 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -100.15 -31.31 11.47 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.076 -1.083 . . . . 100.0 108.076 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.485 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -153.89 160.86 42.31 Favored 'General case' 0 N--CA 1.436 -1.126 0 C-N-CA 122.783 0.433 . . . . 100.0 110.377 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -141.82 153.46 44.52 Favored 'General case' 0 CA--C 1.484 -1.566 0 N-CA-C 113.578 0.955 . . . . 100.0 113.578 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.5 mt -126.26 125.81 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 103.935 -2.617 . . . . 100.0 103.935 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 69.7 mt -109.95 124.48 66.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 101.23 -3.618 . . . . 100.0 101.23 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -119.05 133.26 55.92 Favored 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 118.358 -1.337 . . . . 100.0 111.322 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -128.57 158.9 37.17 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 113.741 -1.572 . . . . 100.0 110.017 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.65 123.98 44.43 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 105.883 -1.895 . . . . 100.0 105.883 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -65.03 -21.08 28.79 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 113.348 0.87 . . . . 100.0 113.348 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.2 p -90.57 -5.8 55.48 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-O 118.712 -0.661 . . . . 100.0 111.765 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.7 t -119.65 116.7 26.53 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 122.83 1.3 . . . . 100.0 111.167 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -66.27 -39.6 89.55 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 113.566 -1.652 . . . . 100.0 111.336 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.62 -43.17 96.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 125.132 1.373 . . . . 100.0 109.326 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 18' ' ' ASP . 96.9 m -62.66 -43.17 99.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 122.89 0.476 . . . . 100.0 109.905 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -63.89 -39.54 94.41 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 122.811 0.445 . . . . 100.0 110.524 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 92.5 mttt -60.53 -38.33 84.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 125.271 1.429 . . . . 100.0 111.074 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -73.38 -12.07 60.7 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 114.569 1.322 . . . . 100.0 114.569 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -59.82 -43.09 94.17 Favored Pre-proline 0 C--N 1.364 1.236 0 CA-C-O 115.952 -1.975 . . . . 100.0 111.34 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 97.4 Cg_exo -57.41 -36.39 98.82 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.483 2.122 . . . . 100.0 112.517 177.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -66.35 -41.96 88.79 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.005 0.815 . . . . 100.0 111.164 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.417 ' O ' HD13 ' A' ' 108' ' ' LEU . 84.6 m95 -62.6 -46.35 88.72 Favored 'General case' 0 C--N 1.366 1.283 0 N-CA-C 108.928 -0.768 . . . . 100.0 108.928 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -91.62 65.9 5.21 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-O 123.0 1.381 . . . . 100.0 108.425 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 60.5 ttp85 -162.06 -56.6 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 101.103 -3.665 . . . . 100.0 101.103 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.23 -41.7 99.15 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.189 -1.041 . . . . 100.0 108.189 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.544 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.1 mp -62.66 -46.04 90.04 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 123.86 0.864 . . . . 100.0 111.534 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.87 -39.23 82.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 126.378 1.871 . . . . 100.0 109.438 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 65.1 ttp85 -58.8 -45.6 89.52 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.34 1.056 . . . . 100.0 109.971 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.66 -50.38 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 115.512 1.671 . . . . 100.0 115.512 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.9 m -111.81 8.83 20.67 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 120.981 3.697 . . . . 100.0 120.981 -176.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 53.98 -125.02 2.29 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 125.213 1.405 . . . . 100.0 113.241 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -97.88 113.98 25.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 120.289 1.404 . . . . 100.0 112.326 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.1 pt -142.73 152.74 60.18 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -62.03 127.15 20.47 Favored 'Trans proline' 0 C--N 1.367 1.548 0 C-N-CA 122.231 1.954 . . . . 100.0 113.066 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.667 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.4 mt -131.28 134.8 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.693 1.235 . . . . 100.0 107.756 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.66 133.04 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-N 113.598 -1.637 . . . . 100.0 108.332 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.408 HD12 ' HB3' ' A' ' 139' ' ' HIS 0.272 88.3 mt -100.6 126.74 47.1 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 104.614 -2.365 . . . . 100.0 104.614 176.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.5 m -116.58 123.02 46.34 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 121.839 0.828 . . . . 100.0 109.696 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.09 102.57 2.68 Favored Glycine 0 CA--C 1.478 -2.261 0 N-CA-C 103.33 -3.908 . . . . 100.0 103.33 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.412 54.0 p30 -94.45 173.36 7.66 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 114.584 1.328 . . . . 100.0 114.584 -179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 60.56 40.4 16.86 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 127.704 2.402 . . . . 100.0 111.323 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.45 -12.46 16.11 Favored 'Isoleucine or valine' 0 C--N 1.363 1.174 0 CA-C-N 115.717 -0.674 . . . . 100.0 112.417 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -61.82 -39.57 92.23 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.64 1.576 . . . . 100.0 109.588 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.2 mt -64.22 130.28 29.03 Favored 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 124.232 1.013 . . . . 100.0 109.822 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.42 -40.01 89.28 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 115.4 1.629 . . . . 100.0 115.4 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -82.96 81.18 8.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.344 -0.984 . . . . 100.0 108.344 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -90.86 134.1 34.71 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 106.243 -1.762 . . . . 100.0 106.243 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -101.35 -40.85 6.91 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 110.011 -0.366 . . . . 100.0 110.011 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -99.15 109.89 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.948 -2.241 . . . . 100.0 104.948 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -83.27 145.44 29.11 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.648 -1.16 . . . . 100.0 110.833 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.21 98.33 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.08 0.952 . . . . 100.0 112.257 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -63.15 -39.87 95.92 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.07 0.548 . . . . 100.0 111.599 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.7 m -62.18 -36.57 82.28 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.524 1.93 . . . . 100.0 113.471 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 93.8 mt -63.66 123.64 16.83 Favored 'Isoleucine or valine' 0 C--N 1.359 0.991 0 CA-C-O 122.336 1.065 . . . . 100.0 109.778 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.83 -4.3 5.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.772 0 C-N-CA 125.583 1.553 . . . . 100.0 112.001 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -59.41 -43.43 93.03 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 125.098 1.359 . . . . 100.0 111.456 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.408 ' HB3' HD12 ' A' ' 119' ' ' LEU . 51.7 p-80 -62.18 -40.53 96.34 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 112.766 0.654 . . . . 100.0 112.766 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -62.97 -45.72 91.1 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.295 1.038 . . . . 100.0 110.547 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.56 -41.41 96.32 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.793 0.837 . . . . 100.0 111.686 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.84 4.46 53.89 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 117.284 2.328 . . . . 100.0 117.284 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 57.05 46.08 19.86 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 122.176 0.989 . . . . 100.0 112.403 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.667 HD22 ' HB ' ' A' ' 117' ' ' ILE . 45.2 mt -115.24 162.28 17.29 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 108.251 -1.018 . . . . 100.0 108.251 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.408 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 97.3 mm-40 -101.34 139.18 37.36 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.783 -1.192 . . . . 100.0 107.783 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -114.29 130.34 56.65 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 121.384 0.611 . . . . 100.0 111.542 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -128.12 134.68 49.15 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.263 -0.881 . . . . 100.0 110.629 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -89.06 121.23 31.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 102.711 -3.07 . . . . 100.0 102.711 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 48.3 pt -132.63 157.19 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-O 122.194 0.997 . . . . 100.0 112.144 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.7 t -139.9 119.12 12.8 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 104.225 -2.509 . . . . 100.0 104.225 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.87 -44.17 93.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.359 -0.837 . . . . 100.0 109.614 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -63.18 -46.31 87.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.605 1.962 . . . . 100.0 114.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.4 p -97.16 -1.06 45.87 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 115.93 1.826 . . . . 100.0 115.93 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.49 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 63.1 m-80 64.65 21.77 12.48 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 125.075 1.35 . . . . 100.0 113.296 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -72.42 123.2 22.6 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 106.289 -1.745 . . . . 100.0 106.289 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.1 40.58 31.44 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.507 2.323 . . . . 100.0 112.389 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.418 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 18.4 t80 -55.83 -49.92 71.97 Favored 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 126.968 2.107 . . . . 100.0 115.589 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -96.34 -2.85 44.93 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.271 96.6 mttt -59.88 -44.86 97.91 Favored Pre-proline 0 CA--C 1.499 -0.992 0 N-CA-C 118.277 2.695 . . . . 100.0 118.277 -175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.14 -42.65 41.49 Favored 'Trans proline' 0 C--N 1.372 1.785 0 CA-C-N 122.523 1.937 . . . . 100.0 112.503 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -64.24 -43.95 93.31 Favored 'General case' 0 CA--C 1.488 -1.418 0 O-C-N 124.534 1.146 . . . . 100.0 112.297 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 176' ' ' PHE . 93.5 mt -63.64 -44.96 92.34 Favored 'General case' 0 CA--C 1.492 -1.288 0 O-C-N 123.923 0.764 . . . . 100.0 112.869 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.408 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 88.2 t90 -64.09 -42.58 96.88 Favored 'General case' 0 C--N 1.364 1.238 0 O-C-N 123.501 0.5 . . . . 100.0 110.296 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.485 HD22 ' HB2' ' A' ' 85' ' ' CYS . 85.7 mt -61.42 -43.66 98.48 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 118.892 -0.575 . . . . 100.0 111.106 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.4 -43.5 98.68 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 123.209 0.604 . . . . 100.0 111.478 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.49 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 89.5 mtt180 -62.44 -45.39 93.31 Favored 'General case' 0 CA--C 1.49 -1.357 0 C-N-CA 123.278 0.631 . . . . 100.0 111.546 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.8 tptp -65.02 -45.24 86.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.986 0.915 . . . . 100.0 111.714 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.89 -45.56 85.44 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 123.614 0.766 . . . . 100.0 112.947 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.47 -39.21 78.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 C-N-CA 123.545 0.738 . . . . 100.0 109.975 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.81 9.75 57.11 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-O 118.602 -1.11 . . . . 100.0 111.206 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -104.83 109.28 62.87 Favored Pre-proline 0 C--N 1.364 1.231 0 N-CA-C 107.705 -1.22 . . . . 100.0 107.705 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.51 -24.31 56.56 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 124.086 3.191 . . . . 100.0 113.994 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.36 3.62 51.59 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.609 1.964 . . . . 100.0 113.708 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 21.9 tp -62.85 130.75 46.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.451 0.537 . . . . 100.0 112.451 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -132.97 153.8 51.09 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.842 0.829 . . . . 100.0 110.595 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.407 ' HB2' HD21 ' A' ' 162' ' ' LEU . 87.7 t80 -80.08 132.79 36.03 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.943 -1.873 . . . . 100.0 105.943 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 25.4 m -118.08 158.59 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 107.969 -1.122 . . . . 100.0 107.969 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -42.47 -97.93 0.0 OUTLIER 'General case' 0 C--N 1.358 0.937 0 N-CA-C 118.929 2.937 . . . . 100.0 118.929 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 48.0 tpp -157.02 70.15 4.55 Favored Pre-proline 0 C--N 1.366 1.319 0 CA-C-N 120.321 1.418 . . . . 100.0 114.29 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.27 160.46 42.21 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 123.561 2.84 . . . . 100.0 109.82 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.63 144.98 56.57 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-O 121.394 0.616 . . . . 100.0 111.32 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.18 154.0 42.44 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 115.122 -0.944 . . . . 100.0 112.274 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.87 123.59 68.75 Favored Pre-proline 0 N--CA 1.434 -1.265 0 N-CA-C 104.158 -2.534 . . . . 100.0 104.158 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -62.87 135.03 49.64 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 123.47 2.78 . . . . 100.0 113.175 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.81 157.32 43.66 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 C-N-CA 123.28 2.654 . . . . 100.0 113.989 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.66 -38.73 92.21 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.868 1.667 . . . . 100.0 111.474 178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . 0.275 30.0 t 71.52 82.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 128.199 2.6 . . . . 100.0 109.836 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.24 163.57 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.945 2.098 . . . . 100.0 107.955 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 80.3 mtp 60.15 -114.02 0.63 Allowed 'General case' 0 C--N 1.355 0.847 0 N-CA-C 115.574 1.694 . . . . 100.0 115.574 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.461 ' H ' ' HB2' ' A' ' 3' ' ' ALA . 38.6 m-20 73.16 10.98 0.0 OUTLIER Pre-proline 0 C--N 1.371 1.512 1 N-CA-C 123.75 4.722 . . . . 100.0 123.75 -178.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.63 -85.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.042 0 CA-C-N 124.31 2.575 . . . . 100.0 112.855 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.25 -40.01 89.88 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 124.357 1.063 . . . . 100.0 112.214 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.8 mt -60.81 -39.83 90.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 117.687 2.477 . . . . 100.0 117.687 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.92 165.92 24.02 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 119.078 0.854 . . . . 100.0 112.979 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 73.23 -42.24 0.52 Allowed 'General case' 0 C--N 1.359 1.016 0 N-CA-C 117.483 2.401 . . . . 100.0 117.483 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.6 tp60 -60.05 -42.55 94.72 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 115.121 1.526 . . . . 100.0 115.121 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -61.06 -44.98 96.57 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.706 0.765 . . . . 100.0 111.343 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -61.55 -44.24 97.41 Favored 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 126.543 1.937 . . . . 100.0 110.067 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -61.05 -47.15 87.71 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.726 1.21 . . . . 100.0 111.874 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.01 -43.8 97.77 Favored 'General case' 0 CA--C 1.499 -0.993 0 O-C-N 123.595 0.56 . . . . 100.0 111.882 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.7 -45.4 94.15 Favored 'General case' 0 CA--C 1.498 -1.038 0 O-C-N 123.465 0.478 . . . . 100.0 111.58 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.4 -42.63 98.78 Favored 'General case' 0 CA--C 1.489 -1.401 0 CA-C-O 117.999 -1.0 . . . . 100.0 113.14 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.49 -45.0 99.54 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 CA-C-N 118.613 0.642 . . . . 100.0 109.311 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.98 -45.46 93.52 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 112.696 0.628 . . . . 100.0 112.696 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.28 -42.8 96.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 124.143 0.977 . . . . 100.0 112.877 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.7 m -63.95 -39.3 93.84 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.717 1.607 . . . . 100.0 111.913 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 85.7 m -53.93 127.5 26.49 Favored 'General case' 0 C--N 1.366 1.305 0 CA-C-O 122.295 1.045 . . . . 100.0 110.599 -177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.63 147.77 48.83 Favored 'General case' 0 CA--C 1.483 -1.604 0 CA-C-N 113.448 -1.705 . . . . 100.0 109.644 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 66.3 mt -108.1 125.32 32.28 Favored Pre-proline 0 N--CA 1.423 -1.809 0 CA-C-N 115.002 -0.999 . . . . 100.0 113.342 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -82.71 -152.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 124.104 3.203 . . . . 100.0 106.352 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -82.3 103.04 11.59 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 104.898 -2.26 . . . . 100.0 104.898 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -130.53 -57.69 1.06 Allowed 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.489 -0.778 . . . . 100.0 110.875 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -100.1 4.35 44.53 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 114.572 1.323 . . . . 100.0 114.572 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -61.29 -38.57 87.28 Favored 'General case' 0 CA--C 1.5 -0.976 0 C-N-CA 125.334 1.454 . . . . 100.0 112.417 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -60.6 -41.17 94.21 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.57 1.548 . . . . 100.0 112.323 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.257 1.458 0 CA-C-O 117.333 -1.318 . . . . 100.0 107.866 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.494 -1.174 0 CA-C-O 121.032 0.444 . . . . 100.0 110.222 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.766 ' HB1' ' H ' ' A' ' 187' ' ' VAL . . . -60.61 -42.44 96.8 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.459 1.504 . . . . 100.0 112.645 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.43 -45.52 93.95 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 124.507 1.123 . . . . 100.0 110.934 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -64.65 -36.56 84.65 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 125.547 1.539 . . . . 100.0 111.454 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . 95.35 19.43 30.27 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 107.3 -2.32 . . . . 100.0 107.3 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 10' ' ' GLN 0.283 35.0 tt0 -87.29 96.05 0.53 Allowed Pre-proline 0 N--CA 1.424 -1.771 0 C-N-CA 129.38 3.072 . . . . 100.0 103.822 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 5' ' ' GLY . 73.0 Cg_endo -61.7 -46.07 15.25 Favored 'Trans proline' 0 C--N 1.378 2.12 0 N-CA-C 107.663 -1.707 . . . . 100.0 107.663 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -130.1 -63.22 0.91 Allowed 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 100.327 -3.953 . . . . 100.0 100.327 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.97 144.01 36.52 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 N-CA-C 114.236 1.198 . . . . 100.0 114.236 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HB2' ' HB2' ' A' ' 6' ' ' GLU 0.272 30.9 tt0 -126.6 134.51 50.78 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 103.811 -2.663 . . . . 100.0 103.811 177.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.4 ' N ' ' HG2' ' A' ' 10' ' ' GLN . 80.0 m-85 -124.27 136.44 54.14 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 107.765 -1.198 . . . . 100.0 107.765 177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -90.74 116.31 28.49 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.543 -2.021 . . . . 100.0 105.543 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.78 128.57 55.8 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.436 -1.711 . . . . 100.0 107.574 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.6 t -110.27 122.1 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 106.098 -1.815 . . . . 100.0 106.098 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 tp -104.08 118.14 35.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.479 -1.674 . . . . 100.0 106.479 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.5 m -127.59 163.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-N 113.664 -1.607 . . . . 100.0 111.412 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.11 169.66 16.53 Favored Glycine 0 CA--C 1.493 -1.296 0 N-CA-C 108.053 -2.019 . . . . 100.0 108.053 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 97' ' ' THR . 82.0 m-20 -71.28 160.65 32.42 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-O 121.892 0.853 . . . . 100.0 113.022 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.32 140.25 41.06 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 110.428 -1.069 . . . . 100.0 110.428 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.4 2.01 90.54 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-O 119.381 -0.677 . . . . 100.0 114.643 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.409 HG21 ' C ' ' A' ' 89' ' ' MET . 68.5 m -64.28 -42.27 96.51 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 118.225 1.012 . . . . 100.0 112.279 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.04 17.73 4.46 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.689 -0.767 . . . . 100.0 111.846 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -60.71 -47.54 85.83 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 125.927 1.691 . . . . 100.0 110.354 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.6 m -64.5 -42.88 95.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 125.402 1.481 . . . . 100.0 109.509 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.1 m -62.72 -41.96 99.42 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 125.012 1.325 . . . . 100.0 109.473 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.435 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 88.4 t80 -60.55 -48.49 81.52 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.956 1.302 . . . . 100.0 110.49 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.3 -42.03 90.04 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 123.333 0.396 . . . . 100.0 111.289 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.93 -40.09 94.29 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.274 0.63 . . . . 100.0 112.139 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.435 ' NH1' ' HA ' ' A' ' 26' ' ' PHE . 32.3 ttp-105 -62.14 -44.31 96.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 123.78 0.832 . . . . 100.0 109.058 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -62.8 -45.61 91.85 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 112.332 0.493 . . . . 100.0 112.332 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.83 -48.75 73.21 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 116.459 2.022 . . . . 100.0 116.459 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 77.4 p -118.9 -21.45 7.75 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 116.689 2.107 . . . . 100.0 116.689 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.72 71.8 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.524 -0.598 . . . . 100.0 112.128 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -73.04 146.88 45.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.924 1.29 . . . . 100.0 109.022 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.479 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 97.0 m-85 -111.36 120.38 42.02 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 102.05 -3.315 . . . . 100.0 102.05 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -106.73 114.22 28.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 119.13 -1.028 . . . . 100.0 111.622 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.73 -43.72 62.59 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-N 114.595 -1.184 . . . . 100.0 113.512 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -76.44 145.58 39.17 Favored 'General case' 0 CA--C 1.494 -1.174 0 C-N-CA 123.161 0.584 . . . . 100.0 111.414 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -107.03 124.09 49.14 Favored 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 119.227 -0.989 . . . . 100.0 108.435 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -115.64 125.85 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 101.474 -3.528 . . . . 100.0 101.474 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.38 138.84 58.67 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 112.924 0.713 . . . . 100.0 112.924 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 80.6 m -96.23 125.36 40.69 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 103.665 -2.717 . . . . 100.0 103.665 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.6 mt -106.07 129.05 54.24 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.658 -1.608 . . . . 100.0 106.658 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.51 -126.33 32.69 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 109.742 -1.343 . . . . 100.0 109.742 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.1 t -127.75 137.58 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 C-N-CA 123.135 0.574 . . . . 100.0 109.907 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -114.36 126.11 54.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 103.827 -2.657 . . . . 100.0 103.827 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.02 121.36 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.854 -1.536 . . . . 100.0 106.854 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -127.37 122.78 22.99 Favored Pre-proline 0 N--CA 1.431 -1.405 0 CA-C-N 115.458 -0.792 . . . . 100.0 110.9 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.18 125.29 5.78 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.968 2.445 . . . . 100.0 110.225 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 95.6 mt -122.41 126.7 48.51 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 106.717 -1.586 . . . . 100.0 106.717 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.9 t -109.19 130.56 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 N-CA-C 106.821 -1.548 . . . . 100.0 106.821 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -118.36 132.42 56.27 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.513 -2.032 . . . . 100.0 105.513 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -102.8 123.49 46.55 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 106.541 -1.652 . . . . 100.0 106.541 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 p -123.64 -177.42 3.72 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.024 -0.535 . . . . 100.0 111.791 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -58.98 -38.26 78.74 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.263 1.825 . . . . 100.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -86.55 -0.23 55.7 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.861 0.864 . . . . 100.0 112.42 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.63 -178.8 19.51 Favored Glycine 0 N--CA 1.432 -1.63 0 O-C-N 122.034 -0.416 . . . . 100.0 112.194 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.99 139.46 61.62 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 124.092 3.195 . . . . 100.0 113.782 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 93.7 mt -129.66 138.43 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.472 -2.788 . . . . 100.0 103.472 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -118.68 128.94 54.99 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 118.4 -1.32 . . . . 100.0 108.889 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -108.63 117.58 34.56 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 106.258 -1.756 . . . . 100.0 106.258 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -92.25 106.53 18.52 Favored 'General case' 0 CA--C 1.48 -1.723 0 N-CA-C 102.519 -3.141 . . . . 100.0 102.519 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.37 124.4 43.88 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 CA-C-N 112.447 -2.16 . . . . 100.0 109.198 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -104.77 105.9 16.17 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 104.715 -2.328 . . . . 100.0 104.715 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -87.76 118.7 27.45 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 104.339 -2.467 . . . . 100.0 104.339 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.1 p -96.54 162.27 13.54 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 114.041 1.126 . . . . 100.0 114.041 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.71 128.73 34.75 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.139 -1.43 . . . . 100.0 107.139 178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.45 -13.39 80.44 Favored Glycine 0 C--N 1.355 1.63 0 CA-C-O 119.948 -0.362 . . . . 100.0 112.386 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -65.81 -41.04 92.37 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.359 1.864 . . . . 100.0 112.13 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.71 137.73 58.2 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 123.828 0.851 . . . . 100.0 111.991 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -71.8 156.24 39.53 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 122.3 1.048 . . . . 100.0 113.019 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -66.85 132.71 48.57 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.413 1.885 . . . . 100.0 108.267 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 156.92 -171.77 34.43 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 119.608 -1.282 . . . . 100.0 114.548 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.04 -21.53 63.82 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 127.915 2.674 . . . . 100.0 113.824 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.65 -36.88 84.25 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.595 1.558 . . . . 100.0 110.649 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.0 mmm-85 -87.45 1.21 54.08 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.742 1.617 . . . . 100.0 113.592 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.43 -39.78 92.06 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 116.044 1.868 . . . . 100.0 116.044 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.82 -38.11 91.67 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 118.836 0.744 . . . . 100.0 113.436 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -62.91 -42.2 99.71 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 126.24 1.816 . . . . 100.0 108.912 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.564 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 8.8 t80 -89.32 -14.31 36.01 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 114.271 1.211 . . . . 100.0 114.271 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.6 mt -61.83 135.86 25.92 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 CA-C-N 119.108 0.867 . . . . 100.0 108.862 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 64.56 21.71 12.5 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 126.558 1.943 . . . . 100.0 114.441 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.51 141.29 50.16 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 108.158 -1.053 . . . . 100.0 108.158 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -100.0 -32.38 10.98 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.006 -1.109 . . . . 100.0 108.006 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.534 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.7 p -150.3 160.96 43.33 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.964 0.411 . . . . 100.0 111.391 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.434 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -143.52 152.43 41.46 Favored 'General case' 0 CA--C 1.485 -1.554 0 C-N-CA 119.616 -0.834 . . . . 100.0 113.114 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 88.0 mt -126.16 126.7 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.258 -2.497 . . . . 100.0 104.258 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 105' ' ' HIS . 67.9 mt -109.27 124.26 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.079 0 N-CA-C 101.483 -3.525 . . . . 100.0 101.483 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.409 ' C ' HG21 ' A' ' 21' ' ' THR . 50.1 ttm -119.03 133.27 55.92 Favored 'General case' 0 N--CA 1.419 -2.004 0 C-N-CA 118.239 -1.384 . . . . 100.0 111.083 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -127.63 158.3 37.9 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.461 -1.7 . . . . 100.0 109.665 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -102.42 125.75 49.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 105.473 -2.047 . . . . 100.0 105.473 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.5 m -63.66 -22.96 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 114.167 1.173 . . . . 100.0 114.167 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -85.29 -10.83 55.97 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 118.736 -0.649 . . . . 100.0 111.072 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 t -116.17 116.71 28.31 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 123.272 1.511 . . . . 100.0 112.541 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -65.8 -41.45 91.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.938 -1.937 . . . . 100.0 109.223 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.08 -43.62 97.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 C-N-CA 125.431 1.492 . . . . 100.0 110.353 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 18' ' ' ASP . 97.7 m -63.17 -43.23 98.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 123.101 0.561 . . . . 100.0 109.74 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -64.11 -39.65 94.5 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 122.572 0.349 . . . . 100.0 110.289 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.505 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.4 mttt -60.25 -37.97 82.03 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 124.15 0.98 . . . . 100.0 111.335 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -73.27 -11.28 60.45 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.238 1.57 . . . . 100.0 115.238 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.1 t -59.97 -42.92 93.02 Favored Pre-proline 0 C--N 1.361 1.1 0 CA-C-O 116.58 -1.676 . . . . 100.0 110.806 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.505 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 92.9 Cg_exo -59.3 -34.27 97.87 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.488 2.125 . . . . 100.0 112.422 177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.98 -43.38 88.02 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 124.07 0.948 . . . . 100.0 110.116 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' O ' HD13 ' A' ' 108' ' ' LEU . 83.7 m95 -62.76 -47.11 84.95 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 109.111 -0.7 . . . . 100.0 109.111 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 88' ' ' ILE . 50.2 t-80 -91.46 64.52 5.06 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.78 1.276 . . . . 100.0 108.351 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -154.81 -60.59 0.12 Allowed 'General case' 0 CA--C 1.489 -1.387 1 N-CA-C 99.736 -4.172 . . . . 100.0 99.736 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -62.52 -39.99 95.32 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 123.192 0.597 . . . . 100.0 111.138 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -61.56 -45.85 92.39 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 122.998 0.519 . . . . 100.0 110.583 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 52.8 t -62.6 -39.08 83.27 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 126.395 1.878 . . . . 100.0 109.784 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . 0.27 45.7 mtm105 -59.01 -44.52 91.71 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 123.048 0.539 . . . . 100.0 109.753 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.4 t -78.43 -51.84 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 115.563 1.69 . . . . 100.0 115.563 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -108.26 4.02 24.21 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 119.911 3.3 . . . . 100.0 119.911 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 54.11 -121.05 1.76 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.326 1.45 . . . . 100.0 111.28 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -95.19 112.88 24.53 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 119.884 1.22 . . . . 100.0 111.134 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 115' ' ' ILE . 46.2 pt -144.79 153.09 53.81 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 102.942 -2.984 . . . . 100.0 102.942 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -62.31 126.0 17.57 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.311 2.007 . . . . 100.0 111.9 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.699 ' HB ' HD22 ' A' ' 144' ' ' LEU . 69.1 mt -130.69 133.81 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.461 -1.311 . . . . 100.0 107.461 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 160' ' ' PRO . 57.6 t -115.38 133.12 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 CA-C-N 114.044 -1.435 . . . . 100.0 108.077 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.89 124.8 47.11 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.69 -2.337 . . . . 100.0 104.69 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 74.8 m -116.94 122.34 44.0 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-O 121.75 0.786 . . . . 100.0 110.348 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.42 103.15 2.82 Favored Glycine 0 CA--C 1.478 -2.259 0 N-CA-C 103.626 -3.79 . . . . 100.0 103.626 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . 0.41 54.0 p30 -93.09 170.62 9.5 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 114.817 1.414 . . . . 100.0 114.817 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 89.7 mttt 61.11 41.67 13.4 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.586 2.754 . . . . 100.0 112.201 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 148' ' ' ASP . 33.8 m -64.76 -18.9 24.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 CA-C-N 115.275 -0.875 . . . . 100.0 112.781 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -61.11 -38.25 85.67 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 123.624 0.77 . . . . 100.0 112.4 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -62.61 130.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.036 0 CA-C-O 121.843 0.83 . . . . 100.0 108.981 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.61 -42.74 98.19 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.767 1.627 . . . . 100.0 114.84 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.32 77.03 10.06 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 122.51 1.147 . . . . 100.0 108.742 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -92.95 125.9 37.77 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.618 -1.623 . . . . 100.0 106.618 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -98.05 -39.17 9.06 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.32 -0.855 . . . . 100.0 112.302 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.96 107.65 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 103.908 -2.627 . . . . 100.0 103.908 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.9 144.34 31.04 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.422 -1.263 . . . . 100.0 109.962 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.84 -40.56 95.74 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 124.286 1.035 . . . . 100.0 111.348 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.95 -40.76 98.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.909 1.284 . . . . 100.0 110.722 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 67.6 m -63.28 -38.09 89.8 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.124 1.77 . . . . 100.0 113.057 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.01 123.76 15.34 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-O 122.553 1.168 . . . . 100.0 110.022 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.56 -5.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.434 -1.712 . . . . 100.0 110.701 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -59.61 -41.74 91.06 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.243 1.417 . . . . 100.0 111.4 -177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -61.27 -42.71 99.11 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.403 0.681 . . . . 100.0 112.364 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -63.8 -44.23 93.95 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 124.195 0.998 . . . . 100.0 110.859 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.8 -42.31 97.75 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 123.937 0.895 . . . . 100.0 111.928 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -95.69 4.46 52.98 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 116.655 2.095 . . . . 100.0 116.655 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 55.54 46.89 22.05 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-O 122.898 1.333 . . . . 100.0 113.257 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.699 HD22 ' HB ' ' A' ' 117' ' ' ILE . 40.7 mt -113.36 159.66 19.19 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.377 -1.342 . . . . 100.0 107.377 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.7 mm-40 -99.38 140.82 32.99 Favored 'General case' 0 CA--C 1.485 -1.557 0 N-CA-C 109.577 -0.527 . . . . 100.0 109.577 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -114.29 130.98 56.66 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.472 0.653 . . . . 100.0 112.067 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -129.06 135.1 48.47 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.027 -0.988 . . . . 100.0 111.401 177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB3' HG11 ' A' ' 124' ' ' VAL . 36.4 m-20 -90.04 120.83 31.57 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 101.872 -3.381 . . . . 100.0 101.872 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.8 pt -131.9 154.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-O 122.489 1.138 . . . . 100.0 112.07 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.1 t -138.95 118.2 12.71 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 104.497 -2.408 . . . . 100.0 104.497 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.239 -0.891 . . . . 100.0 109.142 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.49 -44.26 87.62 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 115.061 1.504 . . . . 100.0 115.061 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 88.7 p -93.73 -2.17 54.15 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.022 1.49 . . . . 100.0 115.022 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 66.46 21.0 10.89 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 125.012 1.325 . . . . 100.0 111.133 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -73.9 118.09 16.45 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 107.778 -1.193 . . . . 100.0 107.778 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 52.29 36.8 20.53 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 127.955 2.502 . . . . 100.0 111.145 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -63.06 -40.71 98.51 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 115.613 1.709 . . . . 100.0 115.613 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -88.57 -10.24 49.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 113.75 1.018 . . . . 100.0 113.75 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.311 94.8 mttt -60.14 -43.98 95.25 Favored Pre-proline 0 CA--C 1.496 -1.116 0 N-CA-C 118.605 2.817 . . . . 100.0 118.605 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.424 ' HB3' HG11 ' A' ' 118' ' ' VAL . 50.4 Cg_endo -59.65 -41.32 56.99 Favored 'Trans proline' 0 C--N 1.372 1.787 0 CA-C-N 123.187 2.174 . . . . 100.0 112.344 178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -63.38 -44.78 93.75 Favored 'General case' 0 CA--C 1.487 -1.448 0 O-C-N 124.051 0.844 . . . . 100.0 111.278 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.28 -42.61 96.33 Favored 'General case' 0 CA--C 1.483 -1.609 0 CA-C-O 118.394 -0.812 . . . . 100.0 112.73 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.44 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.2 t90 -64.25 -42.61 96.43 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 123.711 0.632 . . . . 100.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 85' ' ' CYS . 86.1 mt -60.72 -43.78 97.42 Favored 'General case' 0 CA--C 1.495 -1.14 0 O-C-N 123.406 0.441 . . . . 100.0 110.651 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.85 99.93 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.59 0.756 . . . . 100.0 111.548 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.456 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 87.5 mtt180 -61.77 -46.14 90.84 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 124.199 1.0 . . . . 100.0 111.11 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -65.8 -45.98 80.35 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 123.71 0.804 . . . . 100.0 112.685 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.96 -45.73 84.49 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.513 0.725 . . . . 100.0 112.397 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 98.3 mt -70.79 -38.16 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 124.207 1.003 . . . . 100.0 111.052 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.74 10.07 55.71 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 118.589 -1.117 . . . . 100.0 113.365 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -108.39 110.62 61.7 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 106.733 -1.58 . . . . 100.0 106.733 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -70.78 -18.08 32.48 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 123.272 2.648 . . . . 100.0 113.783 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -97.24 9.14 43.03 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.088 0.955 . . . . 100.0 112.595 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 26.9 tp -63.31 129.27 39.55 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 109.055 -0.72 . . . . 100.0 109.055 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -129.24 152.26 49.01 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.42 0.629 . . . . 100.0 111.017 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -80.87 135.51 35.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 124.515 1.126 . . . . 100.0 109.231 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.17 156.46 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 106.045 -1.835 . . . . 100.0 106.045 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.08 -88.83 0.0 OUTLIER 'General case' 0 C--N 1.356 0.888 0 N-CA-C 117.601 2.445 . . . . 100.0 117.601 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 53.9 tpp -156.57 100.07 2.05 Favored Pre-proline 0 C--N 1.359 1.004 0 CA-C-N 119.698 1.135 . . . . 100.0 110.31 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.88 157.03 52.14 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 123.437 2.758 . . . . 100.0 111.153 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -80.99 122.5 27.37 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 102.019 -3.326 . . . . 100.0 102.019 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.76 150.82 39.15 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 114.405 1.261 . . . . 100.0 114.405 -176.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -90.52 120.7 68.92 Favored Pre-proline 0 N--CA 1.432 -1.334 0 N-CA-C 101.094 -3.669 . . . . 100.0 101.094 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.52 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 66.9 Cg_endo -63.04 145.16 93.99 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.78 2.986 . . . . 100.0 116.224 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 24.7 Cg_exo -70.57 159.53 52.5 Favored 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.543 2.829 . . . . 100.0 111.57 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -61.14 -44.01 98.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.92 1.288 . . . . 100.0 112.581 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.766 ' H ' ' HB1' ' A' ' 2' ' ' ALA 0.27 24.9 t 62.97 84.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.08 0 C-N-CA 127.123 2.169 . . . . 100.0 110.515 -179.165 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 23.6 m -110.54 177.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 125.123 1.369 . . . . 100.0 109.548 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.277 85.9 mmm 54.44 -118.5 1.32 Allowed 'General case' 0 C--N 1.359 1.0 0 N-CA-C 117.862 2.542 . . . . 100.0 117.862 177.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . 0.28 86.7 m-20 54.34 51.22 7.63 Favored Pre-proline 0 C--N 1.367 1.337 0 N-CA-C 121.225 3.787 . . . . 100.0 121.225 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -65.5 -67.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.366 1.496 0 CA-C-N 120.965 1.38 . . . . 100.0 109.976 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.85 81.04 Favored 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 123.869 0.867 . . . . 100.0 112.418 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.317 93.2 mt -63.51 -37.6 87.92 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 117.202 2.297 . . . . 100.0 117.202 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -72.89 171.16 13.27 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-N 119.059 0.845 . . . . 100.0 112.3 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 76.78 -47.11 0.52 Allowed 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 127.126 2.17 . . . . 100.0 112.405 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.77 -44.35 93.91 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 114.656 1.354 . . . . 100.0 114.656 -177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . 0.265 21.0 m-30 -60.92 -50.45 73.37 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-O 122.114 0.959 . . . . 100.0 110.962 -177.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -64.7 -41.64 95.86 Favored 'General case' 0 CA--C 1.483 -1.602 0 C-N-CA 125.085 1.354 . . . . 100.0 111.878 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -61.47 -45.11 95.64 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.148 0.979 . . . . 100.0 111.03 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -63.2 -46.22 88.08 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 118.302 0.501 . . . . 100.0 111.908 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 94.2 mt -62.88 -45.13 93.97 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 123.451 0.469 . . . . 100.0 112.145 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -64.66 -42.97 95.03 Favored 'General case' 0 CA--C 1.49 -1.359 0 CA-C-O 118.1 -0.952 . . . . 100.0 112.516 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 62.8 t -63.18 -43.13 98.66 Favored 'Isoleucine or valine' 0 C--N 1.36 1.06 0 CA-C-O 118.626 -0.702 . . . . 100.0 109.581 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.19 95.18 Favored 'General case' 0 C--N 1.36 1.04 0 CA-C-N 118.034 0.379 . . . . 100.0 111.244 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -64.35 -42.37 96.27 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.898 0.879 . . . . 100.0 113.169 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 93.5 m -64.81 -39.45 93.6 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 125.935 1.694 . . . . 100.0 111.744 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 88.4 m -57.81 131.19 49.59 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 123.624 0.77 . . . . 100.0 110.091 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.69 140.83 55.43 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 114.461 -1.245 . . . . 100.0 108.487 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 10.8 mp -102.68 123.2 43.38 Favored Pre-proline 0 N--CA 1.428 -1.574 0 N-CA-C 113.888 1.07 . . . . 100.0 113.888 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 209' ' ' LEU . 20.5 Cg_exo -89.13 -141.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.485 0 N-CA-C 103.436 -3.332 . . . . 100.0 103.436 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -87.06 104.08 15.98 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 103.994 -2.595 . . . . 100.0 103.994 178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.14 -61.1 1.18 Allowed 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 109.17 -0.678 . . . . 100.0 109.17 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 43.4 p30 -111.57 11.92 21.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 113.26 0.837 . . . . 100.0 113.26 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -60.65 -38.27 84.3 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 125.905 1.682 . . . . 100.0 112.543 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.74 -40.67 93.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 124.8 1.24 . . . . 100.0 112.646 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--O 1.258 1.551 0 CA-C-O 117.136 -1.412 . . . . 100.0 108.878 -179.876 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 110.009 -0.367 . . . . 100.0 110.009 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.45 90.83 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 124.684 1.194 . . . . 100.0 112.031 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.19 97.52 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.911 0.884 . . . . 100.0 110.133 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -66.81 -37.01 83.69 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 124.697 1.199 . . . . 100.0 111.148 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.404 ' O ' ' HD3' ' A' ' 7' ' ' PRO . . . 96.1 18.51 31.34 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 107.197 -2.361 . . . . 100.0 107.197 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . 0.27 36.0 tt0 -87.26 96.08 0.53 Allowed Pre-proline 0 N--CA 1.422 -1.839 0 N-CA-C 103.099 -2.926 . . . . 100.0 103.099 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 5' ' ' GLY . 72.4 Cg_endo -61.68 -44.12 23.2 Favored 'Trans proline' 0 C--N 1.379 2.172 0 N-CA-C 107.602 -1.73 . . . . 100.0 107.602 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -132.16 -62.79 0.83 Allowed 'General case' 0 N--CA 1.417 -2.105 1 N-CA-C 99.961 -4.088 . . . . 100.0 99.961 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.21 144.76 36.24 Favored 'Isoleucine or valine' 0 C--N 1.371 1.509 0 CA-C-O 122.091 0.948 . . . . 100.0 111.091 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -125.26 131.77 53.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 104.387 -2.449 . . . . 100.0 104.387 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -119.49 135.43 54.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 108.102 -1.073 . . . . 100.0 108.102 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -92.85 120.58 33.34 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 123.176 1.465 . . . . 100.0 107.122 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 tt -110.47 128.72 55.74 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 112.638 -2.074 . . . . 100.0 106.526 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.8 t -109.82 123.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 105.926 -1.879 . . . . 100.0 105.926 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 23' ' ' LYS . 68.0 tp -106.19 118.04 35.58 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.148 -1.427 . . . . 100.0 107.148 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.49 164.28 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 113.6 -1.636 . . . . 100.0 110.657 -178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.05 172.16 21.09 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.203 -1.959 . . . . 100.0 108.203 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' HB2' HG23 ' A' ' 97' ' ' THR . 68.0 m-20 -74.43 164.07 27.03 Favored 'General case' 0 CA--C 1.5 -0.98 0 O-C-N 122.207 -0.584 . . . . 100.0 112.153 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.18 142.01 36.83 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 109.392 -1.483 . . . . 100.0 109.392 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.28 90.48 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 123.781 0.705 . . . . 100.0 114.012 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.437 HG22 HD21 ' A' ' 122' ' ' ASN . 60.1 m -63.58 -42.69 98.27 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 117.922 0.861 . . . . 100.0 112.268 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.88 12.58 7.71 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 120.145 -1.026 . . . . 100.0 111.863 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.425 ' HB2' HD21 ' A' ' 15' ' ' LEU . 59.0 pttt -61.97 -41.83 98.45 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.043 0.937 . . . . 100.0 112.601 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.4 m -64.18 -43.17 95.91 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.71 1.204 . . . . 100.0 109.122 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.1 m -63.03 -41.78 99.61 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.4 1.48 . . . . 100.0 109.46 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -59.69 -48.54 81.28 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 126.017 1.727 . . . . 100.0 109.929 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.74 -42.91 93.48 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 119.253 -0.403 . . . . 100.0 111.608 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.16 -39.77 93.76 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 123.027 0.531 . . . . 100.0 111.656 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.502 ' NH1' ' HA ' ' A' ' 154' ' ' ASN . 28.1 ttp180 -61.81 -44.59 96.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.797 1.239 . . . . 100.0 109.586 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -62.77 -44.79 95.28 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 118.175 0.443 . . . . 100.0 111.914 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.4 mt -65.06 -47.7 76.42 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 116.535 2.05 . . . . 100.0 116.535 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.5 p -118.47 -23.61 7.11 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 117.193 2.294 . . . . 100.0 117.193 -175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.43 -7.46 71.76 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 110.751 -0.94 . . . . 100.0 110.751 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.71 151.19 36.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 118.08 0.94 . . . . 100.0 109.531 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.536 ' H ' ' HB3' ' A' ' 213' ' ' ASP . 92.0 m-85 -112.07 124.69 52.95 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 102.084 -3.302 . . . . 100.0 102.084 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -104.8 113.56 27.22 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.66 -0.816 . . . . 100.0 110.311 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -72.76 -43.39 62.92 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 125.057 1.343 . . . . 100.0 112.826 177.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -74.6 134.93 42.04 Favored 'General case' 0 CA--C 1.487 -1.48 0 C-N-CA 123.519 0.727 . . . . 100.0 111.344 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -102.88 119.71 39.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.264 -1.384 . . . . 100.0 107.264 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.33 127.14 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 103.301 -2.852 . . . . 100.0 103.301 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.86 139.14 58.74 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.563 0.697 . . . . 100.0 112.73 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.0 m -93.09 124.58 37.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 104.085 -2.561 . . . . 100.0 104.085 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.42 HD23 HE22 ' A' ' 69' ' ' GLN . 83.7 mt -104.59 127.51 52.35 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.09 -1.819 . . . . 100.0 106.09 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 63.71 -125.72 33.58 Favored Glycine 0 C--N 1.354 1.558 0 N-CA-C 110.176 -1.17 . . . . 100.0 110.176 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.1 t -125.77 137.99 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 123.543 0.737 . . . . 100.0 110.038 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -114.43 124.87 53.02 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.084 -2.932 . . . . 100.0 103.084 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.18 117.4 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 C-N-CA 124.855 1.262 . . . . 100.0 107.731 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -129.29 119.9 19.77 Favored Pre-proline 0 N--CA 1.436 -1.14 0 N-CA-C 111.909 0.336 . . . . 100.0 111.909 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 60' ' ' LYS . 22.2 Cg_exo -79.94 128.98 7.77 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.811 2.341 . . . . 100.0 112.232 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.8 mt -124.67 130.97 53.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.544 -1.28 . . . . 100.0 107.544 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.46 130.9 61.69 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.706 -1.22 . . . . 100.0 107.706 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.37 130.47 54.41 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 105.646 -1.983 . . . . 100.0 105.646 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -99.85 122.59 43.03 Favored 'General case' 0 CA--C 1.486 -1.5 0 N-CA-C 105.584 -2.006 . . . . 100.0 105.584 -177.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 64.8 p -124.19 177.83 5.64 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.664 0.745 . . . . 100.0 110.891 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -59.54 -36.45 76.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.016 1.726 . . . . 100.0 109.7 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -85.4 0.9 50.78 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.329 1.051 . . . . 100.0 111.885 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.06 178.21 19.99 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 121.543 -0.723 . . . . 100.0 111.558 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -68.17 138.87 44.65 Favored 'Trans proline' 0 C--N 1.363 1.328 0 C-N-CA 123.297 2.665 . . . . 100.0 112.769 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.0 mm -130.51 140.53 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.668 -2.345 . . . . 100.0 104.668 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.431 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.8 ttmt -116.27 128.95 56.01 Favored 'General case' 0 CA--C 1.497 -1.081 0 C-N-CA 119.13 -1.028 . . . . 100.0 109.586 177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -104.11 118.51 36.83 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.64 -2.356 . . . . 100.0 104.64 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -93.37 107.8 19.57 Favored 'General case' 0 N--CA 1.429 -1.514 1 N-CA-C 100.028 -4.064 . . . . 100.0 100.028 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.9 t -95.13 123.01 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.025 -0.989 . . . . 100.0 109.092 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 35.5 m0 -103.15 106.51 17.04 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -87.3 117.79 26.3 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 103.595 -2.742 . . . . 100.0 103.595 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.3 p -100.19 163.0 12.6 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.755 -0.657 . . . . 100.0 112.401 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.88 131.0 35.33 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 109.58 -0.526 . . . . 100.0 109.58 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.9 -11.57 81.23 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 112.238 -0.345 . . . . 100.0 112.238 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.42 HE22 HD23 ' A' ' 43' ' ' LEU . 53.8 mt-30 -65.07 -41.88 94.69 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 127.832 2.453 . . . . 100.0 111.102 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -63.46 141.29 58.82 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.939 1.296 . . . . 100.0 113.632 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.36 149.22 50.71 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 126.784 2.034 . . . . 100.0 111.297 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -71.33 130.5 41.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.884 -1.525 . . . . 100.0 106.884 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 157.53 -169.24 34.41 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.184 -1.484 . . . . 100.0 115.501 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.55 -21.87 63.11 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 127.78 2.61 . . . . 100.0 114.325 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.99 -37.66 85.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.8 1.64 . . . . 100.0 109.886 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.5 mmm-85 -86.16 2.46 46.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.047 1.739 . . . . 100.0 113.955 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.22 -41.8 93.83 Favored 'General case' 0 CA--C 1.496 -1.118 0 N-CA-C 115.514 1.672 . . . . 100.0 115.514 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.95 -38.22 92.41 Favored Glycine 0 C--N 1.354 1.562 0 C-N-CA 123.858 0.742 . . . . 100.0 113.473 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -62.44 -43.51 98.64 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 125.745 1.618 . . . . 100.0 109.097 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.527 ' CE1' ' HG ' ' A' ' 108' ' ' LEU . 7.5 t80 -88.35 -14.25 38.65 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 114.266 1.21 . . . . 100.0 114.266 -176.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.5 mt -61.27 134.94 26.49 Favored 'Isoleucine or valine' 0 C--N 1.364 1.229 0 CA-C-N 119.56 1.073 . . . . 100.0 109.378 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 63.27 26.36 15.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.174 2.19 . . . . 100.0 113.396 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.25 139.68 42.71 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 107.456 -1.313 . . . . 100.0 107.456 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -97.97 -34.88 10.65 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.448 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.4 p -148.37 161.05 42.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-O 120.709 0.29 . . . . 100.0 111.476 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.44 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -142.06 152.6 43.48 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.07 -1.052 . . . . 100.0 113.737 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.5 mt -125.69 125.73 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 104.232 -2.507 . . . . 100.0 104.232 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.1 mt -108.98 123.65 65.02 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.123 0 N-CA-C 100.96 -3.719 . . . . 100.0 100.96 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.8 ttm -118.59 133.78 55.6 Favored 'General case' 0 N--CA 1.42 -1.97 0 C-N-CA 118.37 -1.332 . . . . 100.0 111.14 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -129.08 158.87 37.71 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.24 -1.8 . . . . 100.0 109.911 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -100.9 125.35 47.44 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 105.848 -1.908 . . . . 100.0 105.848 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.93 -22.26 30.62 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 113.71 1.004 . . . . 100.0 113.71 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -88.2 -7.48 56.79 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 118.953 -0.546 . . . . 100.0 111.568 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.1 t -117.86 116.55 27.19 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 122.891 1.329 . . . . 100.0 112.165 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -66.75 -40.18 88.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 113.553 -1.658 . . . . 100.0 110.141 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.92 -43.43 97.47 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 125.258 1.423 . . . . 100.0 109.754 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 18' ' ' ASP . 95.0 m -63.06 -42.96 99.8 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 122.851 0.46 . . . . 100.0 109.954 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -64.34 -39.74 94.49 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 122.818 0.447 . . . . 100.0 110.504 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 93.6 mttt -60.71 -37.56 82.08 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 124.814 1.245 . . . . 100.0 111.189 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -73.91 -11.14 60.27 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.072 1.508 . . . . 100.0 115.072 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -59.97 -43.08 93.62 Favored Pre-proline 0 C--N 1.364 1.226 0 CA-C-O 116.208 -1.853 . . . . 100.0 111.199 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 93.7 Cg_exo -58.03 -35.45 98.74 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.626 2.217 . . . . 100.0 112.516 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -65.56 -43.75 88.86 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 124.135 0.974 . . . . 100.0 109.979 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.433 ' O ' HD13 ' A' ' 108' ' ' LEU . 83.9 m95 -62.6 -47.31 84.33 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 109.507 -0.553 . . . . 100.0 109.507 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -91.11 64.62 5.35 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 123.055 1.407 . . . . 100.0 108.397 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -156.28 -62.12 0.1 Allowed 'General case' 0 CA--C 1.485 -1.527 1 N-CA-C 100.04 -4.059 . . . . 100.0 100.04 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -63.97 -39.75 94.83 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.376 -0.829 . . . . 100.0 110.428 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.527 ' HG ' ' CE1' ' A' ' 80' ' ' TYR . 7.0 mp -62.03 -46.05 90.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.123 0.569 . . . . 100.0 110.762 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.54 -39.57 85.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 126.19 1.796 . . . . 100.0 109.675 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -60.11 -44.51 94.82 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 119.082 -0.485 . . . . 100.0 110.507 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.4 t -72.51 -49.37 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 114.958 1.466 . . . . 100.0 114.958 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 67.9 m -113.47 11.03 18.32 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 120.16 3.393 . . . . 100.0 120.16 -176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 54.18 -126.52 2.33 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 125.166 1.386 . . . . 100.0 112.367 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -102.54 115.75 31.21 Favored 'General case' 0 C--N 1.364 1.23 0 C-N-CA 117.772 -1.571 . . . . 100.0 109.986 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.94 150.42 67.43 Favored Pre-proline 0 N--CA 1.438 -1.031 0 N-CA-C 102.453 -3.165 . . . . 100.0 102.453 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -60.82 128.5 25.8 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 121.917 1.745 . . . . 100.0 112.89 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.659 ' HB ' HD22 ' A' ' 144' ' ' LEU . 61.8 mt -131.16 135.17 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.479 -1.304 . . . . 100.0 107.479 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -114.77 131.63 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-N 113.579 -1.646 . . . . 100.0 108.169 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 139' ' ' HIS . 88.6 mt -98.55 124.6 43.39 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 104.328 -2.471 . . . . 100.0 104.328 176.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 92.6 m -114.81 121.76 44.27 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.201 -0.909 . . . . 100.0 109.438 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.49 102.33 2.69 Favored Glycine 0 CA--C 1.479 -2.165 0 N-CA-C 103.099 -4.0 . . . . 100.0 103.099 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.437 HD21 HG22 ' A' ' 21' ' ' THR 0.386 55.4 p30 -92.67 171.61 8.89 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 114.326 1.232 . . . . 100.0 114.326 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 87.0 mttt 61.05 40.9 14.55 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 128.339 2.656 . . . . 100.0 111.95 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.411 HG11 ' HB3' ' A' ' 148' ' ' ASP . 34.0 m -64.34 -19.89 25.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.075 0 CA-C-N 115.517 -0.765 . . . . 100.0 112.669 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -61.0 -38.09 84.82 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.143 0.977 . . . . 100.0 112.549 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 81.2 mt -62.66 129.82 26.44 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 N-CA-C 108.693 -0.855 . . . . 100.0 108.693 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -65.01 -41.25 95.49 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 116.357 1.984 . . . . 100.0 116.357 -178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.24 83.98 7.82 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.402 -1.333 . . . . 100.0 107.402 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -94.97 127.0 40.7 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 105.814 -1.921 . . . . 100.0 105.814 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.66 -38.66 9.03 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.994 -0.548 . . . . 100.0 112.304 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.33 105.93 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 103.804 -2.665 . . . . 100.0 103.804 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.37 151.32 25.58 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.265 -0.88 . . . . 100.0 111.187 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.4 -42.03 98.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.35 1.06 . . . . 100.0 111.555 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.11 -39.94 96.18 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.854 0.861 . . . . 100.0 111.102 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -62.54 -38.07 88.56 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 125.787 1.635 . . . . 100.0 112.982 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 90.4 mt -64.06 122.56 15.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 CA-C-O 122.421 1.105 . . . . 100.0 109.878 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.9 -7.25 4.71 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 C-N-CA 125.734 1.614 . . . . 100.0 111.598 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.77 -42.64 93.76 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 125.394 1.478 . . . . 100.0 111.261 -177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.409 ' HB3' HD12 ' A' ' 119' ' ' LEU . 44.2 p-80 -61.7 -42.23 98.66 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-O 118.82 -0.61 . . . . 100.0 112.077 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -63.18 -45.31 92.37 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 123.656 0.782 . . . . 100.0 111.491 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.29 -40.63 94.08 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 123.611 0.764 . . . . 100.0 112.343 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -92.84 3.28 55.96 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 116.283 1.957 . . . . 100.0 116.283 -178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 57.6 t30 55.51 50.36 14.76 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.501 1.52 . . . . 100.0 112.624 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.659 HD22 ' HB ' ' A' ' 117' ' ' ILE . 49.9 mt -118.11 159.33 23.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.726 1.21 . . . . 100.0 108.048 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 163' ' ' TRP . 92.2 mm-40 -98.29 140.19 32.94 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -114.58 130.62 56.79 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.554 0.692 . . . . 100.0 111.273 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -128.14 134.77 49.14 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.919 -1.037 . . . . 100.0 111.375 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.411 ' HB3' HG11 ' A' ' 124' ' ' VAL . 47.7 m-20 -88.42 120.95 30.28 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 102.348 -3.205 . . . . 100.0 102.348 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.4 pt -131.16 154.43 40.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 CA-C-O 122.652 1.215 . . . . 100.0 111.281 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.2 t -136.69 119.59 16.35 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 105.091 -2.188 . . . . 100.0 105.091 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.426 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -64.2 -45.1 89.8 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 124.211 0.944 . . . . 100.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.7 -44.68 89.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 115.145 1.535 . . . . 100.0 115.145 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 94.1 p -95.77 -0.26 51.54 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 115.537 1.68 . . . . 100.0 115.537 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.502 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 70.6 m-80 63.7 24.27 13.82 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.869 0.868 . . . . 100.0 112.638 -177.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -74.76 123.25 24.61 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 106.046 -1.835 . . . . 100.0 106.046 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.05 40.57 31.42 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 126.939 2.095 . . . . 100.0 112.011 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.44 ' HD1' ' CZ ' ' A' ' 29' ' ' ARG . 30.4 t80 -57.25 -49.04 77.3 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 126.369 1.867 . . . . 100.0 114.315 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.16 -9.02 40.85 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 115.463 1.653 . . . . 100.0 115.463 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.304 95.0 mttt -59.66 -44.44 97.44 Favored Pre-proline 0 CA--C 1.498 -1.045 0 N-CA-C 119.282 3.067 . . . . 100.0 119.282 -175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.1 -42.28 44.88 Favored 'Trans proline' 0 C--N 1.373 1.825 0 CA-C-N 122.391 1.89 . . . . 100.0 111.678 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -63.95 -44.13 93.75 Favored 'General case' 0 CA--C 1.492 -1.263 0 O-C-N 124.414 1.071 . . . . 100.0 111.794 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.62 -43.99 95.22 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 112.968 0.729 . . . . 100.0 112.968 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.424 ' CE2' ' HG3' ' A' ' 145' ' ' GLN . 86.5 t90 -64.61 -43.14 94.71 Favored 'General case' 0 N--CA 1.438 -1.075 0 O-C-N 123.834 0.709 . . . . 100.0 109.975 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 85' ' ' CYS . 88.9 mt -61.55 -43.06 99.55 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 123.448 0.468 . . . . 100.0 111.136 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.31 -43.27 99.22 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 123.78 0.832 . . . . 100.0 110.765 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.445 ' HG2' ' HB3' ' A' ' 174' ' ' LEU . 96.2 mtt180 -61.96 -45.39 93.87 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 123.514 0.726 . . . . 100.0 111.667 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -64.6 -46.84 80.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 123.289 0.636 . . . . 100.0 111.879 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.35 -46.13 81.44 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 113.675 0.991 . . . . 100.0 113.675 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.85 -38.86 79.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.67 0 C-N-CA 124.404 1.082 . . . . 100.0 109.388 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.67 8.9 59.17 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-O 118.635 -1.092 . . . . 100.0 112.414 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -107.62 110.15 62.64 Favored Pre-proline 0 C--N 1.361 1.074 0 N-CA-C 106.047 -1.834 . . . . 100.0 106.047 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.5 -18.85 43.33 Favored 'Trans proline' 0 C--N 1.366 1.488 0 C-N-CA 123.842 3.028 . . . . 100.0 113.834 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -97.78 11.02 38.61 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 124.39 1.076 . . . . 100.0 112.611 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.445 ' HB3' ' HG2' ' A' ' 166' ' ' ARG . 23.5 tp -63.19 130.47 44.71 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.742 0.817 . . . . 100.0 109.145 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -130.8 152.41 50.17 Favored 'General case' 0 CA--C 1.496 -1.118 0 CA-C-O 121.367 0.603 . . . . 100.0 110.413 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -80.1 133.53 36.1 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.576 -1.268 . . . . 100.0 107.576 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 26.5 m -119.03 155.65 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.834 -1.173 . . . . 100.0 107.834 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -42.28 -97.2 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 118.839 2.903 . . . . 100.0 118.839 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 54.7 tpp -157.27 86.27 2.75 Favored Pre-proline 0 C--N 1.364 1.236 0 N-CA-C 115.561 1.689 . . . . 100.0 115.561 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.32 160.19 42.47 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 123.338 2.692 . . . . 100.0 107.762 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.74 130.36 42.76 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.355 0.598 . . . . 100.0 109.805 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.5 mt -95.61 145.87 24.91 Favored 'General case' 0 CA--C 1.484 -1.583 0 CA-C-N 114.995 -1.002 . . . . 100.0 110.961 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -84.32 124.35 73.93 Favored Pre-proline 0 N--CA 1.431 -1.416 0 N-CA-C 102.697 -3.075 . . . . 100.0 102.697 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 60.8 Cg_endo -62.08 140.51 84.48 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 123.397 2.732 . . . . 100.0 113.905 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 184' ' ' PRO . 31.2 Cg_exo -67.18 155.18 71.76 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.244 2.629 . . . . 100.0 112.188 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.41 -45.3 94.91 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.32 1.048 . . . . 100.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.0 t 68.56 102.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.243 0 C-N-CA 126.651 1.98 . . . . 100.0 106.747 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 21.7 m -92.51 157.01 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 115.331 1.604 . . . . 100.0 115.331 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . 0.368 85.3 mmm 52.71 -118.44 1.33 Allowed 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.989 2.515 . . . . 100.0 117.548 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 57.13 47.62 2.67 Favored Pre-proline 0 C--N 1.365 1.269 0 N-CA-C 117.705 2.483 . . . . 100.0 117.705 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.38 -70.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.054 1.836 . . . . 100.0 110.005 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.04 90.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.658 1.583 . . . . 100.0 109.249 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 43.1 mt -63.14 -21.66 66.35 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 115.886 1.81 . . . . 100.0 115.886 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.76 157.7 36.82 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 119.532 1.06 . . . . 100.0 110.887 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . 75.42 -32.13 0.21 Allowed 'General case' 0 C--N 1.363 1.185 0 C-N-CA 127.739 2.416 . . . . 100.0 114.035 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -61.15 -37.93 84.63 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 127.031 2.132 . . . . 100.0 110.323 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -59.45 -43.73 93.11 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.101 0.96 . . . . 100.0 111.508 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -62.77 -43.04 99.84 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 123.634 0.774 . . . . 100.0 111.522 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -61.71 -44.5 96.81 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.756 1.222 . . . . 100.0 110.608 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -63.16 -41.94 99.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 C-N-CA 124.803 1.241 . . . . 100.0 111.234 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.63 -42.6 99.68 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 123.519 0.728 . . . . 100.0 111.084 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.77 -44.37 96.37 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.472 0.709 . . . . 100.0 111.239 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 76.8 t -62.76 -42.99 98.34 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 C-N-CA 123.844 0.857 . . . . 100.0 109.077 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.01 -42.83 99.59 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 124.274 1.029 . . . . 100.0 111.673 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -62.66 -42.7 99.75 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.921 0.888 . . . . 100.0 110.803 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.5 m -63.82 -42.69 97.61 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.734 1.214 . . . . 100.0 111.631 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.1 m -62.87 136.37 57.81 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 124.454 1.102 . . . . 100.0 113.454 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.24 143.88 52.02 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 124.805 1.242 . . . . 100.0 108.523 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 34.6 tp -97.68 124.49 48.13 Favored Pre-proline 0 N--CA 1.433 -1.323 0 CA-C-N 116.205 -0.452 . . . . 100.0 111.562 -177.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 209' ' ' LEU . 38.0 Cg_exo -71.54 166.26 29.94 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.856 3.038 . . . . 100.0 109.066 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -76.08 113.27 13.42 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.443 -1.317 . . . . 100.0 107.443 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -126.55 -56.48 1.39 Allowed 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.627 -1.624 . . . . 100.0 106.698 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.536 ' HB3' ' H ' ' A' ' 35' ' ' PHE . 25.7 p30 -111.64 5.66 19.44 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 115.442 1.645 . . . . 100.0 115.442 -178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -61.24 -38.8 87.98 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 114.133 1.16 . . . . 100.0 114.133 -177.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -61.16 -40.07 92.49 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 113.544 0.942 . . . . 100.0 113.544 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 C--O 1.259 1.556 0 CA-C-O 117.147 -1.406 . . . . 100.0 109.777 -179.002 . . . . . . . . 0 0 . 1 stop_ save_